Citrus Sinensis ID: 012610
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 460 | 2.2.26 [Sep-21-2011] | |||||||
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.997 | 0.746 | 0.867 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.997 | 0.734 | 0.811 | 0.0 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.993 | 0.737 | 0.805 | 0.0 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.997 | 0.730 | 0.806 | 0.0 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.963 | 0.737 | 0.733 | 0.0 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.989 | 0.749 | 0.586 | 1e-142 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.997 | 0.748 | 0.568 | 1e-140 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.976 | 0.703 | 0.545 | 1e-136 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.984 | 0.713 | 0.519 | 1e-136 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.986 | 0.718 | 0.529 | 1e-134 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/462 (86%), Positives = 426/462 (92%), Gaps = 3/462 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PT
Sbjct: 154 GEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPT 213
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP + N TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQ
Sbjct: 214 PPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQ 273
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQT
Sbjct: 274 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 333
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++I
Sbjct: 334 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 393
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 394 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 453
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 454 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 513
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 514 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 573
Query: 422 EWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQPDELSGPR 460
EWQKEEMFRQDFN+ T HP + WI+ DSTS I+ + SGPR
Sbjct: 574 EWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 715 bits (1845), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/471 (81%), Positives = 415/471 (88%), Gaps = 12/471 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN-QLNNPPPS------- 53
G IP SLTN+ +LQVLDLSNN+L+G +P NGSFSLFTPISFANN L P S
Sbjct: 155 GSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSP 214
Query: 54 ----PPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDV 109
PPP +QP P SG TGAIAGGVAAGAALLFAAPAIA A+WR+RKP D FFDV
Sbjct: 215 PFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDV 274
Query: 110 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE 169
PAEEDPEVHLGQLKRFSLRELQVA+D FSN+NILGRGGFGKVYKGRL DG+LVAVKRLKE
Sbjct: 275 PAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 334
Query: 170 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS 229
ERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER S
Sbjct: 335 ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS 394
Query: 230 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289
QPPL+W RK+IALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM
Sbjct: 395 QPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 454
Query: 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 349
DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARLANDD
Sbjct: 455 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 514
Query: 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
DVMLLDWVKGLLKEKKLE LVD D++ NY E E+EQ+IQVALLCTQGSPMERPKMSEVVR
Sbjct: 515 DVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVR 574
Query: 410 MLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 460
MLEGDGLAE+W+EWQK E+ R++ + +P+PN+ WI+DST ++ ELSGPR
Sbjct: 575 MLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/462 (80%), Positives = 404/462 (87%), Gaps = 5/462 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIP +LT+V LQVLD+SNN+L+GDIP NGSFSLFTPISFANN L + P PP PT
Sbjct: 161 GEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPT 219
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP SG T AIAGGVAAGAALLFA PAIA A+W +RKP+DHFFDVPAEEDPEVHLGQ
Sbjct: 220 PP-PPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQ 278
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRF+LREL VATDNFSN+N+LGRGGFGKVYKGRL DG+LVAVKRLKEERT+GGELQFQT
Sbjct: 279 LKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQT 338
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK I
Sbjct: 339 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHI 398
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCD KIIHRDVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVR
Sbjct: 399 ALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVR 458
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWVK +L
Sbjct: 459 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVL 518
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD+++EG Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWE
Sbjct: 519 KEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWE 578
Query: 422 EWQKEEMFRQDFNHT--PHPNNTWIVD-STSHIQPDELSGPR 460
EWQKEEM DFN+ PH W++ S S I+ D SGPR
Sbjct: 579 EWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/471 (80%), Positives = 412/471 (87%), Gaps = 12/471 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN-QLNNPPPS------- 53
G IP SLTN+ +LQVLDLSNN+L+G +P NGSFSLFTPISFANN L P S
Sbjct: 158 GPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSP 217
Query: 54 ----PPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDV 109
PPP + P G SATGAIAGGVAAGAALLFAAPA+A A+WR+RKP++ FFDV
Sbjct: 218 PFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDV 277
Query: 110 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE 169
PAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGRL DG+LVAVKRLKE
Sbjct: 278 PAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 337
Query: 170 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS 229
ERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER S
Sbjct: 338 ERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPS 397
Query: 230 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289
Q PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA+LM
Sbjct: 398 QLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLM 457
Query: 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 349
DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELITGQRAFDLARLANDD
Sbjct: 458 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDD 517
Query: 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
DVMLLDWVKGLLKEKKLE LVD D++ NY E EVEQLIQVALLCTQ SPMERPKMSEVVR
Sbjct: 518 DVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVR 577
Query: 410 MLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 460
MLEGDGLAE+W+EWQK E+ RQ+ + HP + WI+DST ++ ELSGPR
Sbjct: 578 MLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/462 (73%), Positives = 375/462 (81%), Gaps = 19/462 (4%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT + L VLD+SNN+L+GDIP NGSFS FT +SFANN+L
Sbjct: 156 GEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSFSQFTSMSFANNKLR----------PRP 204
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
+ S + + AI GVAAGAALLFA +RK + HF DVPAEEDPEV+LGQ
Sbjct: 205 ASPSPSPSGTSAAIVVGVAAGAALLFALAWWL-----RRKLQGHFLDVPAEEDPEVYLGQ 259
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
KRFSLREL VAT+ FS RN+LG+G FG +YKGRL D +LVAVKRL EERT+GGELQFQT
Sbjct: 260 FKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQT 319
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK I
Sbjct: 320 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHI 379
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCD KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVR
Sbjct: 380 ALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVR 439
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWVK +L
Sbjct: 440 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVL 499
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD+++EG Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWE
Sbjct: 500 KEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWE 559
Query: 422 EWQKEEMFRQDFNHT--PHPNNTWIVD-STSHIQPDELSGPR 460
EWQKEEM DFN+ PH W++ S S I+ D SGPR
Sbjct: 560 EWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 271/462 (58%), Positives = 326/462 (70%), Gaps = 7/462 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT--PISFANNQLNNPPPSPPPPLQ 59
G IP SLT ++ L + L +N L+G+IP SLF +F N L+ P P +
Sbjct: 150 GSIPDSLTGLSKLINILLDSNNLSGEIPQ----SLFKIPKYNFTANNLSCGGTFPQPCVT 205
Query: 60 PTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWR-KRKPEDHFFDVPAEEDPEVH 118
+ P S + TG IAG V+ A +L + K D F DV E D +
Sbjct: 206 ESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFFCKDKHKGYKRDVFVDVAGEVDRRIA 265
Query: 119 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ 178
GQL+RF+ RELQ+ATD FS +N+LG+GGFGKVYKG L+DG+ VAVKRL + GG+
Sbjct: 266 FGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYKGLLSDGTKVAVKRLTDFERPGGDEA 325
Query: 179 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR 238
FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N SVA CLRE P L+W R
Sbjct: 326 FQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSVAYCLREIKPGDPVLDWFRR 385
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
KQIALGAARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT
Sbjct: 386 KQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTT 445
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
VRGT+GHIAPE +STGKSSEKTDVFGYG+MLLEL+TGQRA D +RL +DDV+LLD VK
Sbjct: 446 QVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 505
Query: 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 418
L +EK+LE +VD ++ +YI+EEVE +IQVALLCTQ +P ERP MSEVVRMLEG+GLAE
Sbjct: 506 KLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALLCTQAAPEERPAMSEVVRMLEGEGLAE 565
Query: 419 RWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 460
RWEEWQ E+ RQ+ W DS ++ ELSG R
Sbjct: 566 RWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQDAIELSGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 274/482 (56%), Positives = 323/482 (67%), Gaps = 23/482 (4%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN------------------GSF--SLFT--P 39
G IP ++ N+ LQ L LS NKL G IP + G SLF
Sbjct: 132 GRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPK 191
Query: 40 ISFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWR- 98
+F +N LN P P + S TG IAG VA +LF R
Sbjct: 192 YNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCKDRH 251
Query: 99 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 158
K D F DV E D + GQLKRF+ RELQ+ATDNFS +N+LG+GGFGKVYKG L D
Sbjct: 252 KGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPD 311
Query: 159 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218
+ VAVKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N S
Sbjct: 312 NTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLS 371
Query: 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278
+A LRE P L+W RK+IALGAARG YLH+HC+PKIIHRDVKAAN+LLDE+FEA
Sbjct: 372 LAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEA 431
Query: 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 338
VVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQR
Sbjct: 432 VVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 491
Query: 339 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 398
A D +RL +DDV+LLD VK L +EK+L +VD +++G YI+EEVE +IQVALLCTQGSP
Sbjct: 492 AIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSP 551
Query: 399 MERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSG 458
+RP MSEVVRMLEG+GLAERWEEWQ E+ R+ W DS + ELSG
Sbjct: 552 EDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSG 611
Query: 459 PR 460
R
Sbjct: 612 GR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 263/482 (54%), Positives = 335/482 (69%), Gaps = 33/482 (6%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP----PP 57
G P SL+N+ L LDLS N L+G +P + S N L P + P
Sbjct: 167 GVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAA----KTFSIVGNPLICPTGTEPDCNGTT 222
Query: 58 LQP---------TPPGASSGNSATGAIAGGVAAG-AALLFAAPAIALAYWRKRKPEDHFF 107
L P P A + AIA G + G +L+F A + L +WR+R ++ FF
Sbjct: 223 LIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFL-WWRQRHNQNTFF 281
Query: 108 DVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR 166
DV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG L D ++VAVKR
Sbjct: 282 DVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKR 341
Query: 167 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 226
LK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M NGSVAS R
Sbjct: 342 LKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVAS----R 397
Query: 227 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286
+++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+ EAVVGDFGLA
Sbjct: 398 MKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLA 457
Query: 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 346
KL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+TGQRAF+ + A
Sbjct: 458 KLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAA 517
Query: 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDM--EGNYIEEEVEQLIQVALLCTQGSPMERPKM 404
N VM LDWVK + +EKKLE LVD ++ + +Y E E++++++VALLCTQ P RPKM
Sbjct: 518 NQKGVM-LDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKM 576
Query: 405 SEVVRMLEGDGLAERWEEWQKEEMFRQDFNH------TPHPNNTWIVDSTSHIQPDELSG 458
SEVVRMLEGDGLAE+WE Q+ + + N + + DS+ +Q ELSG
Sbjct: 577 SEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLVQAMELSG 636
Query: 459 PR 460
PR
Sbjct: 637 PR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 259/499 (51%), Positives = 338/499 (67%), Gaps = 46/499 (9%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP-------- 52
G+IP +L+ +LQ L ++NN LTG IP++ + + T + + N L+ P P
Sbjct: 143 GQIPFTLSYSKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFN 202
Query: 53 ------------------SPPPPLQPTPPGASSGNSATG------AIAGGVAAGAALLFA 88
+ P P+ T + + +S G A+ GV+ L
Sbjct: 203 VMGNSQICPTGTEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLI 262
Query: 89 APAIALAYWRKRKPED-HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGG 147
L +WR+R + FFD+ + E+ LG L+RF+ +ELQ AT NFS++N++G+GG
Sbjct: 263 IGFGFLLWWRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGG 322
Query: 148 FGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207
FG VYKG L DGS++AVKRLK+ GGE+QFQTE+EMIS+AVHRNLLRL GFC T +ER
Sbjct: 323 FGNVYKGCLHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSER 382
Query: 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 267
LLVYP+M NGSVAS R +++P L+W RK+IALGA RGL YLH+ CDPKIIHRDVKA
Sbjct: 383 LLVYPYMSNGSVAS----RLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKA 438
Query: 268 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 327
ANILLD+ FEAVVGDFGLAKL+D++++HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 439 ANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 498
Query: 328 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLI 387
++LLELITG RA + + AN +LDWVK L +EKKLEQ+VD D++ NY EVE+++
Sbjct: 499 ILLLELITGLRALEFGKAANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMV 557
Query: 388 QVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE-EWQKEEMFR-----QDFNHTPHPNN 441
QVALLCTQ P+ RPKMSEVVRMLEGDGL E+WE Q+ E R +F+ + ++
Sbjct: 558 QVALLCTQYLPIHRPKMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSD 617
Query: 442 TWIVDSTSHIQPDELSGPR 460
DS+ +Q ELSGPR
Sbjct: 618 L-TDDSSVLVQAMELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1229), Expect = e-134, Method: Compositional matrix adjust.
Identities = 254/480 (52%), Positives = 331/480 (68%), Gaps = 26/480 (5%)
Query: 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIP--TNGSFSLF-TPISFANNQLNNPPPSPPPP 57
+G P SL+ + L ++D+S N L+G +P + +F + + ++N P P
Sbjct: 159 IGTCPESLSKIEGLTLVDISYNNLSGSLPKVSARTFKVIGNALICGPKAVSNCSAVPEPL 218
Query: 58 LQPTPPGASSGNSATG---AIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEED 114
P SG G A+A + AA + +WR R+ + FFDV + D
Sbjct: 219 TLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYD 278
Query: 115 PEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG 174
PEV LG LKR++ +EL+ AT++F+++NILGRGG+G VYKG L DG+LVAVKRLK+ G
Sbjct: 279 PEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAG 338
Query: 175 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN 234
GE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYP+M NGSVAS L++ + +P L+
Sbjct: 339 GEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALD 398
Query: 235 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294
WS RK+IA+G ARGL YLH+ CDPKIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+
Sbjct: 399 WSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 458
Query: 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D R A+ VM L
Sbjct: 459 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVM-L 517
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414
DWVK L +E KL+QL+D D+ + E+E+++QVALLCTQ +P RPKMSEV++MLEGD
Sbjct: 518 DWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577
Query: 415 GLAERWEEWQKEEMFRQDFNHTPHP--------------NNTWIVDSTSHIQPDELSGPR 460
GLAERWE Q H P P + +I +S+ ++ ELSGPR
Sbjct: 578 GLAERWEATQNGTG-----EHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 460 | ||||||
| 333952414 | 620 | somatic embryogenesis receptor-like kina | 0.995 | 0.738 | 0.890 | 0.0 | |
| 312283129 | 594 | unnamed protein product [Thellungiella h | 0.997 | 0.772 | 0.870 | 0.0 | |
| 255558673 | 611 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.997 | 0.751 | 0.915 | 0.0 | |
| 397880702 | 632 | leucine-rich repeat receptor-like kinase | 0.997 | 0.726 | 0.865 | 0.0 | |
| 327422167 | 620 | somatic embryogenesis receptor-like kina | 0.997 | 0.740 | 0.877 | 0.0 | |
| 334187131 | 662 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.997 | 0.693 | 0.867 | 0.0 | |
| 18418211 | 615 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.997 | 0.746 | 0.867 | 0.0 | |
| 14573459 | 615 | somatic embryogenesis receptor-like kina | 0.997 | 0.746 | 0.867 | 0.0 | |
| 297798596 | 612 | bri1-associated receptor kinase [Arabido | 0.997 | 0.75 | 0.868 | 0.0 | |
| 356558614 | 616 | PREDICTED: BRASSINOSTEROID INSENSITIVE 1 | 0.997 | 0.745 | 0.878 | 0.0 |
| >gi|333952414|gb|AEG25668.1| somatic embryogenesis receptor-like kinase 3 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/465 (89%), Positives = 434/465 (93%), Gaps = 7/465 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
G IPRSLT +++LQVLDLSNN L GD+P NGSFSLFTPISFANN+LNNPPP+PPPP+ PT
Sbjct: 157 GTIPRSLTTIDTLQVLDLSNNGLVGDVPVNGSFSLFTPISFANNKLNNPPPAPPPPIPPT 216
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP A SG S+TGAIAGGVAAGAALLFAAPAI LA WRKRK DHFFDVPAEEDPEVHLGQ
Sbjct: 217 PP-AQSGISSTGAIAGGVAAGAALLFAAPAIVLALWRKRKAPDHFFDVPAEEDPEVHLGQ 275
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVATDNFSN+NILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQT
Sbjct: 276 LKRFSLRELQVATDNFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQT 335
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER +SQP L+W++RK+I
Sbjct: 336 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERSESQPALDWAIRKRI 395
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 396 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 455
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 456 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 515
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KE+KLE LVDSD+ GNYI+EEVEQLIQVALLCTQG+PMERPKMSEVVRMLEGDGLAERWE
Sbjct: 516 KERKLETLVDSDLNGNYIDEEVEQLIQVALLCTQGTPMERPKMSEVVRMLEGDGLAERWE 575
Query: 422 EWQKEEMFRQDFNHTPH-----PNNTWIV-DSTSHIQPDELSGPR 460
EWQKEEM RQ+FN H PN WI+ DSTSHI PDELSGPR
Sbjct: 576 EWQKEEMVRQEFNQAHHYSHHQPNANWIIADSTSHIPPDELSGPR 620
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312283129|dbj|BAJ34430.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/462 (87%), Positives = 428/462 (92%), Gaps = 3/462 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT V+SLQVLDLSNN LTGDIP NGSFSLFTPISFAN +L P +PPPP+ PT
Sbjct: 133 GEIPRSLTAVSSLQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPAAPPPPISPT 192
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP + N TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQ
Sbjct: 193 PPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQ 252
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVA+DNFSNRNILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQT
Sbjct: 253 LKRFSLRELQVASDNFSNRNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQT 312
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQ PL+W R++I
Sbjct: 313 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQQPLDWPKRQRI 372
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 373 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 432
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 433 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 492
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD D++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 493 KEKKLEALVDVDLQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 552
Query: 422 EWQKEEMFRQDFNHTPH--PNNTWIV-DSTSHIQPDELSGPR 460
EWQKEEMFRQDFN+ + PN +W++ DSTSHI+ + SGPR
Sbjct: 553 EWQKEEMFRQDFNYQNYNQPNTSWLIGDSTSHIENEYPSGPR 594
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558673|ref|XP_002520361.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540459|gb|EEF42027.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/459 (91%), Positives = 439/459 (95%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
G IP SLT + SLQVLDLSNNKLTGDIP NGSFSLFTPISF+NN LNNPPPSPPPPL P
Sbjct: 153 GTIPMSLTTIGSLQVLDLSNNKLTGDIPVNGSFSLFTPISFSNNSLNNPPPSPPPPLTPP 212
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PG S+GNSATGAIAGGVAAGAALLFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQ
Sbjct: 213 SPGPSNGNSATGAIAGGVAAGAALLFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQ 272
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVATD+FSN+NILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQT
Sbjct: 273 LKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQT 332
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER +SQ PLNW +RK+I
Sbjct: 333 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERPESQTPLNWPIRKRI 392
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 393 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 452
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 453 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 512
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
K+KKLE LVD+D++GNYI++EVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 513 KDKKLETLVDADLQGNYIDDEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 572
Query: 422 EWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDELSGPR 460
EWQKEEMFRQ+FNHT HP+ WIVDSTSHI PDELSGPR
Sbjct: 573 EWQKEEMFRQEFNHTYHPSTNWIVDSTSHIPPDELSGPR 611
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397880702|gb|AFO67895.1| leucine-rich repeat receptor-like kinase (mitochondrion) [Brassica rapa subsp. campestris] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/462 (86%), Positives = 425/462 (91%), Gaps = 3/462 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT V SLQVLDLSN +LTGDIP NGSFSLFTPISFAN L P SPPPP+ PT
Sbjct: 171 GEIPRSLTAVLSLQVLDLSNTRLTGDIPVNGSFSLFTPISFANTNLTPLPASPPPPISPT 230
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP + N TGAIAGGVAAGAALLFA PAIALA WR++KP+DHFFDVPAEEDPEVHLGQ
Sbjct: 231 PPSPAGSNRITGAIAGGVAAGAALLFAVPAIALALWRRKKPQDHFFDVPAEEDPEVHLGQ 290
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVA+DNFSNRNILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQT
Sbjct: 291 LKRFSLRELQVASDNFSNRNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 350
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLR+R +SQPPL+W R++I
Sbjct: 351 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRDRPESQPPLDWPKRQRI 410
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDE+FEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 411 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLMDYKDTHVTTAVR 470
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 471 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 530
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD D++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 531 KEKKLEALVDVDLQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 590
Query: 422 EWQKEEMFRQDFNHTPH--PNNTWIV-DSTSHIQPDELSGPR 460
EWQKEEMFRQDF++ + PN W++ DSTSHI+ D SGPR
Sbjct: 591 EWQKEEMFRQDFSYQNYNQPNTAWLIGDSTSHIENDYPSGPR 632
|
Source: Brassica rapa subsp. campestris Species: Brassica rapa Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|327422167|gb|AEA76434.1| somatic embryogenesis receptor-like kinase 2 protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 767 bits (1981), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/466 (87%), Positives = 429/466 (92%), Gaps = 7/466 (1%)
Query: 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQP 60
+G IP SLT +++LQVLDLSNN L GD+P NGSFSLFTPISFANN+LNNPPP+PPPP P
Sbjct: 156 VGTIPLSLTTIDTLQVLDLSNNGLIGDVPVNGSFSLFTPISFANNKLNNPPPAPPPP-IP 214
Query: 61 TPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLG 120
P A SG S+TGAIAGGVAAGAALLFAAPAI LA WRKRK DHFFDVPAEEDPEVHLG
Sbjct: 215 PTPPAQSGISSTGAIAGGVAAGAALLFAAPAIVLALWRKRKAPDHFFDVPAEEDPEVHLG 274
Query: 121 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQ 180
QLKRFSLRELQVATDNFSN+NILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQ
Sbjct: 275 QLKRFSLRELQVATDNFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQ 334
Query: 181 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 240
TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER + QP L+W++RK+
Sbjct: 335 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERSEFQPALDWAIRKR 394
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 300
IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV
Sbjct: 395 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 454
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360
RGTIGHIAPEYLSTGKSSEKTDV GYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL
Sbjct: 455 RGTIGHIAPEYLSTGKSSEKTDVSGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 514
Query: 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 420
LKE+KLE LVDSD+ GNYI+EEVEQLIQVALLCTQG+PMERPKMSEVVRMLEGDGLAERW
Sbjct: 515 LKERKLETLVDSDLNGNYIDEEVEQLIQVALLCTQGTPMERPKMSEVVRMLEGDGLAERW 574
Query: 421 EEWQKEEMFRQDFNHTPH-----PNNTWIV-DSTSHIQPDELSGPR 460
EEWQKEEM RQ+FN H PN WI+ DSTSHI PDELSGPR
Sbjct: 575 EEWQKEEMVRQEFNQAHHYNHHQPNANWIIADSTSHIPPDELSGPR 620
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334187131|ref|NP_001190904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] gi|332660824|gb|AEE86224.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/462 (86%), Positives = 426/462 (92%), Gaps = 3/462 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PT
Sbjct: 201 GEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPT 260
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP + N TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQ
Sbjct: 261 PPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQ 320
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQT
Sbjct: 321 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 380
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++I
Sbjct: 381 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 440
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 441 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 500
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 501 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 560
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 561 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 620
Query: 422 EWQKEEMFRQDFNH-TPHPNNT-WIV-DSTSHIQPDELSGPR 460
EWQKEEMFRQDFN+ T HP + WI+ DSTS I+ + SGPR
Sbjct: 621 EWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 662
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18418211|ref|NP_567920.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] gi|29427920|sp|Q94F62.2|BAK1_ARATH RecName: Full=BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1; Short=AtBAK1; Short=BRI1-associated receptor kinase 1; AltName: Full=Protein ELONGATED; AltName: Full=Somatic embryogenesis receptor kinase 3; Short=AtSERK3; AltName: Full=Somatic embryogenesis receptor-like kinase 3; Flags: Precursor gi|224589645|gb|ACN59355.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332660823|gb|AEE86223.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/462 (86%), Positives = 426/462 (92%), Gaps = 3/462 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PT
Sbjct: 154 GEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPT 213
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP + N TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQ
Sbjct: 214 PPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQ 273
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQT
Sbjct: 274 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 333
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++I
Sbjct: 334 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 393
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 394 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 453
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 454 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 513
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 514 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 573
Query: 422 EWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQPDELSGPR 460
EWQKEEMFRQDFN+ T HP + WI+ DSTS I+ + SGPR
Sbjct: 574 EWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14573459|gb|AAK68074.1|AF384970_1 somatic embryogenesis receptor-like kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/462 (86%), Positives = 426/462 (92%), Gaps = 3/462 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLFTPISFAN +L P SPPPP+ PT
Sbjct: 154 GEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPT 213
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP + N TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHLGQ
Sbjct: 214 PPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQ 273
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQFQT
Sbjct: 274 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 333
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R++I
Sbjct: 334 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 393
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 394 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 453
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 454 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 513
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
KEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAERWE
Sbjct: 514 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 573
Query: 422 EWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQPDELSGPR 460
EWQKEEMFRQDFN+ T HP + WI+ DSTS I+ + SGPR
Sbjct: 574 EWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 615
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798596|ref|XP_002867182.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] gi|297313018|gb|EFH43441.1| bri1-associated receptor kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/464 (86%), Positives = 427/464 (92%), Gaps = 5/464 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP--ISFANNQLNNPPPSPPPPLQ 59
GEIPRSLT V +LQVLDLSNN LTGDIP NGSFSLFTP ISFAN +L P SPPPP+
Sbjct: 149 GEIPRSLTAVLTLQVLDLSNNGLTGDIPVNGSFSLFTPGLISFANTKLTPLPASPPPPIS 208
Query: 60 PTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHL 119
PTPP + N TGAIAGGVAAGAALLFA PAIALA+WR++KP+DHFFDVPAEEDPEVHL
Sbjct: 209 PTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHL 268
Query: 120 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF 179
GQLKRFSLRELQVA+DNFSNRNILGRGGFGKVYKGRL DG+LVAVKRLKEERTQGGELQF
Sbjct: 269 GQLKRFSLRELQVASDNFSNRNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 328
Query: 180 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK 239
QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL+W R+
Sbjct: 329 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 388
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
+IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA
Sbjct: 389 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 448
Query: 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359
VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG
Sbjct: 449 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 508
Query: 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAER 419
LLKEKKLE LVD D++GNYI+EEVEQLIQVALLCTQ SPMERPKMSEVVRMLEGDGLAER
Sbjct: 509 LLKEKKLEALVDVDLQGNYIDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 568
Query: 420 WEEWQKEEMFRQDFNH-TPHPN-NTWIV-DSTSHIQPDELSGPR 460
WEEWQKEEMFRQDFN+ T HP + WI+ DSTS I+ + SGPR
Sbjct: 569 WEEWQKEEMFRQDFNYPTHHPAVSGWIIGDSTSQIENEYPSGPR 612
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558614|ref|XP_003547599.1| PREDICTED: BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/460 (87%), Positives = 427/460 (92%), Gaps = 1/460 (0%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQPT 61
G IP SLTNV+SLQVLDLSNN L G+IP NGSFSLFTPIS+ NN P P P+ PT
Sbjct: 157 GGIPISLTNVSSLQVLDLSNNHLKGEIPVNGSFSLFTPISYQNNLGLIQPKYTPSPVSPT 216
Query: 62 PPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
PP ASSGNS TGAIAGGVAAGAALLFAAPAIALAYWR+RKP+DHFFDVPAEEDPEVHLGQ
Sbjct: 217 PPPASSGNSNTGAIAGGVAAGAALLFAAPAIALAYWRRRKPQDHFFDVPAEEDPEVHLGQ 276
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRFSLRELQVATDNFSN++ILGRGGFGKVYKGRL DGSLVAVKRLKEERTQGGELQFQT
Sbjct: 277 LKRFSLRELQVATDNFSNKHILGRGGFGKVYKGRLADGSLVAVKRLKEERTQGGELQFQT 336
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER +SQPPL W RK+I
Sbjct: 337 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERQESQPPLGWPERKRI 396
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR
Sbjct: 397 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 456
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL
Sbjct: 457 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 516
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
K++KLE LVD+D++G+Y +EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE+WE
Sbjct: 517 KDRKLETLVDADLQGSYNDEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWE 576
Query: 422 EWQKEEMFRQDFNHT-PHPNNTWIVDSTSHIQPDELSGPR 460
+WQK+E FRQDFN+ HPN WIVDSTSHIQ DELSGPR
Sbjct: 577 QWQKDETFRQDFNNNIHHPNANWIVDSTSHIQADELSGPR 616
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 460 | ||||||
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.793 | 0.584 | 0.830 | 1.2e-179 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.793 | 0.581 | 0.830 | 3.1e-179 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.993 | 0.737 | 0.718 | 2.4e-177 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.963 | 0.737 | 0.686 | 4e-164 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.773 | 0.580 | 0.650 | 5.7e-124 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.791 | 0.575 | 0.596 | 1.1e-120 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.782 | 0.564 | 0.598 | 5.9e-118 | |
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.760 | 0.570 | 0.572 | 1.9e-110 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.967 | 0.701 | 0.477 | 2.4e-108 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.9 | 0.638 | 0.504 | 8.1e-108 |
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 1.2e-179, Sum P(2) = 1.2e-179
Identities = 303/365 (83%), Positives = 330/365 (90%)
Query: 96 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 155
+WR+RKP D FFDVPAEEDPEVHLGQLKRFSLRELQVA+D FSN+NILGRGGFGKVYKGR
Sbjct: 261 WWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGR 320
Query: 156 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 321 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 380
Query: 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275
NGSVASCLRER SQPPL+W RK+IALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 381 NGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 440
Query: 276 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 441 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 500
Query: 336 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 395
GQRAFDLARLANDDDVMLLDWV VD D++ NY E E+EQ+IQVALLCTQ
Sbjct: 501 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQ 560
Query: 396 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDE 455
GSPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ R++ + +P+PN+ WI+DST ++ E
Sbjct: 561 GSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVE 620
Query: 456 LSGPR 460
LSGPR
Sbjct: 621 LSGPR 625
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1595 (566.5 bits), Expect = 3.1e-179, Sum P(2) = 3.1e-179
Identities = 303/365 (83%), Positives = 328/365 (89%)
Query: 96 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 155
+WR+RKP++ FFDVPAEEDPEVHLGQLKRFSLRELQVATD+FSN+NILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 156 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215
L DG+LVAVKRLKEERT GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275
NGSVASCLRER SQ PL WS+R+QIALG+ARGL+YLHDHCDPKIIHRDVKAANILLDEE
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 276 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
FEAVVGDFGLA+LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG+MLLELIT
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 336 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 395
GQRAFDLARLANDDDVMLLDWV VD D++ NY E EVEQLIQVALLCTQ
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563
Query: 396 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQPDE 455
SPMERPKMSEVVRMLEGDGLAE+W+EWQK E+ RQ+ + HP + WI+DST ++ E
Sbjct: 564 SSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSHPTSDWILDSTDNLHAME 623
Query: 456 LSGPR 460
LSGPR
Sbjct: 624 LSGPR 628
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1675 (594.7 bits), Expect = 2.4e-177, Sum P(2) = 2.4e-177
Identities = 332/462 (71%), Positives = 362/462 (78%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAXXXXXXXXXXXXXXXXXX 61
GEIP +LT+V LQVLD+SNN+L+GDIP NGSFSLFTPISFA
Sbjct: 161 GEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPT 219
Query: 62 XXGASSGNSXXXXXXXXXXXXXXXXXXXXXXXXXYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
SG +W +RKP+DHFFDVPAEEDPEVHLGQ
Sbjct: 220 PP-PPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQ 278
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
LKRF+LREL VATDNFSN+N+LGRGGFGKVYKGRL DG+LVAVKRLKEERT+GGELQFQT
Sbjct: 279 LKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQT 338
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK I
Sbjct: 339 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHI 398
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCD KIIHRDVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVR
Sbjct: 399 ALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVR 458
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVXXXX 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWV
Sbjct: 459 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVL 518
Query: 362 XXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
VD+++EG Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWE
Sbjct: 519 KEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWE 578
Query: 422 EWQKEEMFRQDFNHT--PHPNNTWIVD-STSHIQPDELSGPR 460
EWQKEEM DFN+ PH W++ S S I+ D SGPR
Sbjct: 579 EWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 620
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1552 (551.4 bits), Expect = 4.0e-164, Sum P(2) = 4.0e-164
Identities = 317/462 (68%), Positives = 350/462 (75%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFAXXXXXXXXXXXXXXXXXX 61
GEIPRSLT + L VLD+SNN+L+GDIP NGSFS FT +SFA
Sbjct: 156 GEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSFSQFTSMSFANNKLRPRPASPSP----- 209
Query: 62 XXGASSGNSXXXXXXXXXXXXXXXXXXXXXXXXXYWRKRKPEDHFFDVPAEEDPEVHLGQ 121
+ SG S +W +RK + HF DVPAEEDPEV+LGQ
Sbjct: 210 ---SPSGTSAAIVVGVAAGAALLFALA-------WWLRRKLQGHFLDVPAEEDPEVYLGQ 259
Query: 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT 181
KRFSLREL VAT+ FS RN+LG+G FG +YKGRL D +LVAVKRL EERT+GGELQFQT
Sbjct: 260 FKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQT 319
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
EVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRER + P L+W RK I
Sbjct: 320 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHI 379
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
ALG+ARGLAYLHDHCD KIIH DVKAANILLDEEFEAVVGDFGLAKLM+Y D+HVTTAVR
Sbjct: 380 ALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVR 439
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVXXXX 361
GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ+AFDLARLANDDD+MLLDWV
Sbjct: 440 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVL 499
Query: 362 XXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
VD+++EG Y+E EVEQLIQ+ALLCTQ S MERPKMSEVVRMLEGDGLAERWE
Sbjct: 500 KEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWE 559
Query: 422 EWQKEEMFRQDFNHT--PHPNNTWIVD-STSHIQPDELSGPR 460
EWQKEEM DFN+ PH W++ S S I+ D SGPR
Sbjct: 560 EWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 5.7e-124, Sum P(2) = 5.7e-124
Identities = 233/358 (65%), Positives = 273/358 (76%)
Query: 104 DHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVA 163
D F DV E D + GQLKRF+ RELQ+ATDNFS +N+LG+GGFGKVYKG L D + VA
Sbjct: 257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316
Query: 164 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL 223
VKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC T TERLLVYPFM N S+A L
Sbjct: 317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376
Query: 224 RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283
RE P L+W RK+IALGAARG YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 436
Query: 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 343
GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +
Sbjct: 437 GLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 496
Query: 344 RLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403
RL +DDV+LLD V VD +++G YI+EEVE +IQVALLCTQGSP +RP
Sbjct: 497 RLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPV 556
Query: 404 MSEVVRMLEGDGLAERWEEWQKEEMFRQ-DFNHTPHPNNTWIVDSTSHIQPDELSGPR 460
MSEVVRMLEG+GLAERWEEWQ E+ R+ +F + W DS + ELSG R
Sbjct: 557 MSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFD-WGEDSMHNQDAIELSGGR 613
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
Identities = 223/374 (59%), Positives = 283/374 (75%)
Query: 96 YWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR 155
+WR R+ + FFDV + DPEV LG LKR++ +EL+ AT++F+++NILGRGG+G VYKG
Sbjct: 260 WWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGH 319
Query: 156 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215
L DG+LVAVKRLK+ GGE+QFQTEVE IS+A+HRNLLRLRGFC + ER+LVYP+M
Sbjct: 320 LNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMP 379
Query: 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275
NGSVAS L++ + +P L+WS RK+IA+G ARGL YLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 380 NGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDED 439
Query: 276 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELIT
Sbjct: 440 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499
Query: 336 GQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQ 395
GQ+A D R A+ VML DWV +D D+ + E+E+++QVALLCTQ
Sbjct: 500 GQKALDFGRSAHQKGVML-DWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQ 558
Query: 396 GSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQD-------FNHTPHPN--NTWIVD 446
+P RPKMSEV++MLEGDGLAERWE Q Q + +P + +I +
Sbjct: 559 FNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQE 618
Query: 447 STSHIQPDELSGPR 460
S+ ++ ELSGPR
Sbjct: 619 SSLVVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 5.9e-118, Sum P(2) = 5.9e-118
Identities = 224/374 (59%), Positives = 285/374 (76%)
Query: 96 YWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 154
+WR+R ++ FFDV EV LG L+RF RELQ+AT+NFS++N+LG+GG+G VYKG
Sbjct: 270 WWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKG 329
Query: 155 RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214
L D ++VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFC+T TE+LLVYP+M
Sbjct: 330 ILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYM 389
Query: 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 274
NGSVAS R +++P L+WS+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLD+
Sbjct: 390 SNGSVAS----RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445
Query: 275 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 334
EAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLEL+
Sbjct: 446 YCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELV 505
Query: 335 TGQRAFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDM--EGNYIEEEVEQLIQVALL 392
TGQRAF+ + AN VML DWV VD ++ + +Y E E++++++VALL
Sbjct: 506 TGQRAFEFGKAANQKGVML-DWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALL 564
Query: 393 CTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ---DFNHTPHPNNTW--IVDS 447
CTQ P RPKMSEVVRMLEGDGLAE+WE Q+ + + N ++ + + D
Sbjct: 565 CTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDD 624
Query: 448 TSH-IQPDELSGPR 460
+S +Q ELSGPR
Sbjct: 625 SSLLVQAMELSGPR 638
|
|
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 1.9e-110, Sum P(2) = 1.9e-110
Identities = 202/353 (57%), Positives = 262/353 (74%)
Query: 99 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 158
+R D FFDV E+D ++ GQLKRFSLRE+Q+ATD+F+ N++G+GGFGKVY+G L D
Sbjct: 251 RRTKYDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPD 310
Query: 159 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218
+ VAVKRL + + GGE FQ E+++IS+AVH+NLLRL GFC T +ER+LVYP+M N S
Sbjct: 311 KTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLS 370
Query: 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278
VA LR+ + L+W RK++A G+A GL YLH+HC+PKIIHRD+KAANILLD FE
Sbjct: 371 VAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEP 430
Query: 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 338
V+GDFGLAKL+D THVTT VRGT+GHIAPEYL TGKSSEKTDVFGYG+ LLEL+TGQR
Sbjct: 431 VLGDFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQR 490
Query: 339 AFDLARLANDDDVMLLDWVXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSP 398
A D +RL +++++LLD + VDS++ Y +EVE ++QVALLCTQGSP
Sbjct: 491 AIDFSRLEEEENILLLDHIKKLLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSP 549
Query: 399 MERPKMSEVVRMLEGDG-LAERWEEWQK-EEMFRQDFNHTPHPNNTWIVDSTS 449
+RP MSEVV+ML+G G LAE+W EW++ EE+ ++ P TW + T+
Sbjct: 550 EDRPAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWDEEETT 602
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 2.4e-108, Sum P(2) = 2.4e-108
Identities = 221/463 (47%), Positives = 287/463 (61%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLF-TPISFAXXXXXXXXXXXXXXX 58
G P SL+ + L LDLS N L G +P +F++ P+
Sbjct: 160 GPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGNPLICKNSLPEICSGSISASP 219
Query: 59 XXXXXGASSGNSXXXXXXXXXXXXXXXXXXXXXXXXXYWRKRKPEDHFFDVP-AEEDPEV 117
+SSG ++RK++ + +E+ +
Sbjct: 220 LSVSLRSSSGRRTNILAVALGVSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLL 279
Query: 118 HLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL 177
LG L+ F+ REL VATD FS+++ILG GGFG VY+G+ DG++VAVKRLK+ G
Sbjct: 280 GLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNS 339
Query: 178 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV 237
QF+TE+EMIS+AVHRNLLRL G+C + +ERLLVYP+M NGSVAS L+ ++P L+W+
Sbjct: 340 QFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWNT 395
Query: 238 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297
RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLDE FEAVVGDFGLAKL++++D+HVT
Sbjct: 396 RKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVT 455
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357
TAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA + + + ML +WV
Sbjct: 456 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAML-EWV 514
Query: 358 XXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 417
VD ++ Y EV +++QVALLCTQ P RPKMSEVV+MLEGDGLA
Sbjct: 515 RKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLA 574
Query: 418 ERWEEWQKEEMFRQDFNHTPHPNNTW--IVDSTSHIQPDELSG 458
ERW D +H H N ++ I + + Q L G
Sbjct: 575 ERWAA-------SHDHSHFYHANMSYRTITSTDGNNQTKHLFG 610
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1006 (359.2 bits), Expect = 8.1e-108, Sum P(2) = 8.1e-108
Identities = 214/424 (50%), Positives = 275/424 (64%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLF-TPISFAXXXXXXXXXXXXXXX 58
G P SL+ + L LDLS N L+G +P +F++ P+
Sbjct: 163 GPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGNPLICRSNPPEICSGSINASP 222
Query: 59 XXXXXGASSGNSXXXXXXXXXXXXXXXXXXXXXXXXXYW-RKRKPEDHFFDVPAEEDPEV 117
+SSG W RK++ ++ +++ +
Sbjct: 223 LSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGL 282
Query: 118 H-LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE 176
LG L+ F+ REL V TD FS++NILG GGFG VY+G+L DG++VAVKRLK+ G+
Sbjct: 283 QGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGD 342
Query: 177 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 236
QF+ E+EMIS+AVH+NLLRL G+C T ERLLVYP+M NGSVAS L+ S+P L+W+
Sbjct: 343 SQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLK----SKPALDWN 398
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
+RK+IA+GAARGL YLH+ CDPKIIHRDVKAANILLDE FEAVVGDFGLAKL+++ D+HV
Sbjct: 399 MRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHV 458
Query: 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 356
TTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA + + + ML +W
Sbjct: 459 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAML-EW 517
Query: 357 VXXXXXXXXXXXXVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 416
V +D ++ NY + EV +++QVALLCTQ P RPKMSEVV MLEGDGL
Sbjct: 518 VRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGL 577
Query: 417 AERW 420
AERW
Sbjct: 578 AERW 581
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| BAK1 | BAK1 (BRI1-ASSOCIATED RECEPTOR KINASE); kinase/ protein binding / protein heterodimerization/ protein serine/threonine kinase; Leu-rich receptor Serine/threonine protein kinase. Component of BR signaling that interacts with BRI1 in vitro and in vivo to form a heterodimer. Brassinolide-dependent association of BRI1 and BAK1 in vivo. Phosphorylation of both BRI1 and BAK1 on Thr residues was BR dependent. Although BAK1 and BRI1 alone localize in the plasma membrane, when BAK1 and BRI1 are coexpressed, the heterodimer BAK1/BRI1 they form is localized in the endosome. ; Dual specificity kin [...] (615 aa) | ||||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| AT5G46330.1-P | FLS2 (FLAGELLIN-SENSITIVE 2); ATP binding / kinase/ protein binding / protein serine/threonine [...] (1173 aa) | • | • | • | • | 0.999 | |||||
| BRI1 | BRI1 (BRASSINOSTEROID INSENSITIVE 1); kinase/ protein binding / protein heterodimerization/ pro [...] (1196 aa) | • | • | • | 0.999 | ||||||
| BRL1 | BRL1 (BRI 1 LIKE); kinase; mutant has Altered vascular cell differentiation; LRR Receptor Kinas [...] (1166 aa) | • | • | • | 0.997 | ||||||
| EFR | EFR (EF-TU RECEPTOR); ATP binding / kinase/ protein serine/threonine kinase; Encodes a predicte [...] (1031 aa) | • | • | • | • | 0.971 | |||||
| KAPP | KAPP (KINASE ASSOCIATED PROTEIN PHOSPHATASE); phosphoprotein phosphatase/ protein kinase bindin [...] (591 aa) | • | • | 0.933 | |||||||
| AT5G48380 | leucine-rich repeat family protein / protein kinase family protein; leucine-rich repeat family [...] (620 aa) | • | • | • | • | 0.918 | |||||
| BIK1 | BIK1 (BOTRYTIS-INDUCED KINASE1); kinase; Encodes a plasma membrane-localized ser/thr protein ki [...] (395 aa) | • | • | • | • | 0.911 | |||||
| PEPR1 | PEPR1 (PEP1 receptor 1); ATP binding / kinase/ protein binding / protein serine/threonine kinas [...] (1123 aa) | • | • | • | • | 0.887 | |||||
| BON1 | BON1 (BONZAI 1); calcium-dependent phospholipid binding; Encodes a plasma-membrane localized, c [...] (578 aa) | • | • | • | 0.883 | ||||||
| GSTF10 | GSTF10 (HALIANA GLUTATHIONE S-TRANSFERASE PHI 10); copper ion binding / glutathione binding / g [...] (215 aa) | • | 0.869 | ||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 460 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 142 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FG+VYKG+L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
L G C +V +M G + S LR+ +P L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 317 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375
+ K+DV+ +GV+L E+ T G++ + ++N++ +L+++K +L Q
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEE---VLEYLK---NGYRLPQ------- 224
Query: 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+L + L C P +RP SE+V +L
Sbjct: 225 ---PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 6e-50
Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 29/276 (10%)
Query: 142 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FG+VYKG L VAVK LKE+ ++ +F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
L G C ++V +M G + LR+ L+ S AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK- 122
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
IHRD+ A N L+ E + DFGL++ + D + + I +APE L GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 317 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375
+ K+DV+ +GV+L E+ T G+ + ++N + +L+++K K +L +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYP--GMSNAE---VLEYLK---KGYRLPK------- 225
Query: 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+L ++ L C P +RP SE+V +L
Sbjct: 226 ---PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 9e-49
Identities = 69/194 (35%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
LG GGFG VY R G VA+K +K+E + + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
LV + GS+ L+E + L+ +I L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 262 HRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 319
HRD+K NILLD + + DFGL+KL+ + + T + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 320 KTDVFGYGVMLLEL 333
K+D++ GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FG+VYKG+L VAVK LKE+ ++ F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-----PLNWSVRKQIALGAARGLAY 251
L G C LV +M G + LR+ P L+ A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---A 308
L K +HRD+ A N L+ E+ + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
PE L G + K+DV+ +GV+L E+ T G + L+N++ +L++++ K +L
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEE---VLEYLR---KGYRLP 227
Query: 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ Y +E+ +L+ C Q P +RP SE+V LE
Sbjct: 228 K-------PEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 85/284 (29%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 143 LGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
LG G FG+VYKG L VAVK LKE ++ +F E ++ H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
G C +V +M G + LR+ G+ L Q+AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI---APEYLST 314
+HRD+ A N L+ E + DFGL++ + D + G I APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKD 178
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
GK + K+DV+ +GV+L E+ T G++ + G+ E+ LE L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-----------------PGMSNEEVLELL---- 217
Query: 374 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+G + +E+ +L+ L C P +RP SE+V L
Sbjct: 218 EDGYRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 76/199 (38%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 199
LG G FG VYK + G +VAVK LK+ + + Q + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
LV + G + L G PL+ K+IAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS 318
IIHRD+K NILLDE + DFGLAK + + +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 319 EKTDVFGYGVMLLELITGQ 337
K DV+ GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 7e-47
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
+ LG G FGKVY R G LVA+K +K+++ + + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
RL + LV + G + L++RG+ +QI L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLHSK 116
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
I+HRD+K NILLDE+ + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 316 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375
+ D++ GV+L EL+TG+ F +D + L +K +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLELF--------KKIGKPKPPFPPP 219
Query: 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
I E + LI+ LL P +R E ++
Sbjct: 220 EWDISPEAKDLIR-KLLVKD--PEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 20/221 (9%)
Query: 141 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLR 198
+LGRG FG VY D G L+AVK ++ EL + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 199 GFCMTPTER-LLVY-PFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 253
G + L ++ ++ GS++S L++ G+ P+ +RK QI GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL----EGLAYLH 118
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYL 312
+ I+HRD+K ANIL+D + + DFG AK + D + T +VRGT +APE +
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353
+ D++ G ++E+ TG+ + + L N +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 200
+G+G FGKVY R +DG L +K + E + EV+++ H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPP------LNWSVRKQIALGAARGLAYLHD 254
+ +V + G ++ ++++ + P L+W V Q+ L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYLHS 121
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
KI+HRD+K NI L +GDFG++K++ T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 315 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K + K+D++ G +L EL T + F+ + L +L
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---------------------GENLLELALKI 215
Query: 374 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
++G Y E+ L+ +LL Q P ERP ++++++
Sbjct: 216 LKGQYPPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
F +G+GGFG+VYK R G VA+K +K E + E E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAYL 252
+ G + E +V F GS+ L+ Q L QIA +GL YL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ---TLT---ESQIAYVCKELLKGLEYL 114
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEY 311
H + IIHRD+KAANILL + E + DFGL+ L D K + GT +APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEV 168
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQ 337
++ K D++ G+ +EL G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 142 ILGRGGFGKVYKGRLT-DGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
+LG G FG VYKG +G VA+K L+EE + + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 253
L G C++ L+ M G + +R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYLE 126
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 312
+ +++HRD+ A N+L+ + DFGLAKL+D + + I +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 341
+ K+DV+ YGV + EL+T G + ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 136 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 193
N+ +++GRG FG VYKG L G VA+K++ E+ + L+ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+++ G T ++ + NGS+ +++ G L Q+ +GLAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+ +IHRD+KAANIL ++ + DFG+A ++ + +V GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRA-FDLA------RLANDDD 350
+S +D++ G ++EL+TG +DL R+ DD
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH 216
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 105/456 (23%), Positives = 197/456 (43%), Gaps = 88/456 (19%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSPPPPLQP 60
G+IP S + + L LDLS N+L+G+IP N G+ ++ ++N L+ PS L
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596
Query: 61 TPPGAS------SGNSATGA---------------IAGGVAAGAALLFAAPAIALAYWRK 99
+ G++ +G I + GA L+ A A + R
Sbjct: 597 NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTL--GAFLVLALVAFGFVFIRG 654
Query: 100 RKP-------------EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRG 146
R E FFD K ++ ++ + N++ RG
Sbjct: 655 RNNLELKRVENEDGTWELQFFDSKV----------SKSITINDILSSL---KEENVISRG 701
Query: 147 GFGKVYKGR-LTDGSLVAVKRLKE-------ERTQGGELQFQTEVEMISMAVHRNLLRLR 198
G YKG+ + +G VK + + E G+LQ H N+++L
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------------HPNIVKLI 749
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
G C + L++ ++ +++ LR L+W R++IA+G A+ L +LH C P
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
++ ++ I++D + E + L L+ ++ ++APE T +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDIT 856
Query: 319 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 378
EK+D++G+G++L+EL+TG+ D + +++W + + L+ +D + G+
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRGDV 913
Query: 379 I--EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ E+ +++ +AL CT P RP ++V++ LE
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 78/285 (27%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVE-MISMAVHR 192
++ LG G FG+VY R D LVA+K L ++ + +F E++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++L F LV ++ GS+ L ++ + PL+ S I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 253 HDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHV-----TTAVRGTIGH 306
H IIHRD+K NILLD + + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 307 IAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363
+APE L S +S +D++ G+ L EL+TG F+ + ++ L + L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTP 233
Query: 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408
L S I + L++ L P R S +
Sbjct: 234 SLASPLSPS--NPELISKAASDLLKKLL---AKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++G G FG+V +GRL VA+K LK + L F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
L G +++ +M NGS+ LRE G+ + G A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPE 310
+HRD+ A NIL++ V DFGL++ ++ + TT +R T APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 311 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEQ 368
++ K + +DV+ +G+++ E+++ G+R + D++ + DV+ K + +L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYRLPP 229
Query: 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+D L Q+ L C Q ERP S++V L+
Sbjct: 230 PMDCPS----------ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 30/293 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA 189
+ LG G FGKV R G VAVK L + F+ E+E++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 190 VHRNLLRLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
H N+++ +G C P R L+ ++ +GS+ L+ + +N + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICK 120
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IG 305
G+ YL + IHRD+ A NIL++ E + DFGLAK++ + G I
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD------LARLANDDDVMLLDWVKG 359
APE L T K S +DV+ +GV L EL T L + M++ +
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
LLKE E+L +EV L++ LC + P +RP ++++ +++
Sbjct: 238 LLKEG--ERLPRPP----SCPDEVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 91/284 (32%), Positives = 132/284 (46%), Gaps = 39/284 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++G+G FG VY G L D AVK L QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 197 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG--AARGLAYL 252
L G C+ P+E L+V P+M +G + + +R N +V+ I G A+G+ YL
Sbjct: 61 LLGICL-PSEGSPLVVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAP 309
K +HRD+ A N +LDE F V DFGLA+ + +Y H T + + +A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368
E L T K + K+DV+ +GV+L EL+T G + DV D LL+ ++L Q
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------PDVDSFDITVYLLQGRRLLQ 223
Query: 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E + L +V L C P RP SE+V +E
Sbjct: 224 ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
+G+G FG V G G VAVK LK++ F E +++ H NL++L G +
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 262
+V +M GS+ LR RG++ + + + AL G+ YL + +H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 263 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 322
RD+ A N+L+ E+ A V DFGLAK V+ T APE L K S K+D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSD 181
Query: 323 VFGYGVMLLELITGQRA 339
V+ +G++L E+ + R
Sbjct: 182 VWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 137 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
F+ LG G FG+V++G + VA+K LK + + FQ EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGA--ARGLAYLH 253
L C ++ M GS+ + LR GQ P V I + A G+AYL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP-----VASLIDMACQVAEGMAYLE 121
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+ IHRD+ A NIL+ E+ V DFGLA+L+ +D ++++ + APE S
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS 177
Query: 314 TGKSSEKTDVFGYGVMLLELIT 335
G S K+DV+ +G++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 142 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGG---ELQ------FQTEVEMISMAVH 191
++G+G +G+VY +T G ++AVK+++ T G Q ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N+++ GF T + ++ GS+ SCLR G+ + L +Q+ GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAY 123
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPE 310
LH I+HRD+KA N+L+D + + DFG++K D D +++G++ +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 311 YLSTGKS--SEKTDVFGYGVMLLELITGQR 338
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 143 LGRGGFGKVYKG---RLTDGSL---VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG+G FG VY+G + G VA+K + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARGLA 250
L G T L+V M G + S LR R P Q+A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTTAVRGTIG 305
YL K +HRD+ A N ++ E+ +GDFG+ + + DY K VR
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365
+APE L G + K+DV+ +GV+L E+ T LA +GL
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT------LAEQP----------YQGLSN--- 227
Query: 366 LEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E+++ ++G ++ E ++L+++ +C Q +P RP E+V L+
Sbjct: 228 -EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
+G+G FG VYKG L + VAVK + + +F E E++ H N+++L G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKI 260
+V + GS+ + LR++ V+K Q++L AA G+ YL
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLT-----VKKLLQMSLDAAAGMEYLESKN---C 114
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT----IGHIAPEYLSTGK 316
IHRD+ A N L+ E + DFG+++ ++ + T G I APE L+ G+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 317 SSEKTDVFGYGVMLLELITG 336
+ ++DV+ YG++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+ +LG+G G VYK R G + A+K++ + + Q E++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+++ G E +V +M GS+A L++ G + V IA +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLH 116
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
IIHRD+K +N+L++ + E + DFG++K+++ T V GT+ +++PE +
Sbjct: 117 T--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
S D++ G+ LLE G+ F L ++ + D
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFEL-----------MQAICDGP 219
Query: 374 ---MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 406
+ E I C Q P +RP +E
Sbjct: 220 PPSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 143 LGRGGFGKVYKG-RLTDGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLRL 197
LG G FG VY+G L DG AVK + + Q Q + E+ ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 198 RGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
G + L ++ +V GS+A L++ G P+ +QI LG L YLHD
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR- 121
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STG 315
+HRD+K ANIL+D + DFG+AK + + +G+ +APE + G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQG 177
Query: 316 KSSEKTDVFGYGVMLLELITGQ 337
D++ G +LE+ TG+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 23/270 (8%)
Query: 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+LG+G FG+V+KG L D + VAVK KE+ Q +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+V + G S LR++ + L + AL AA G+AYL I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD+ A N L+ E + DFG+++ D + + I APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 322 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEE 381
DV+ YG++L E F L G+ ++ EQ V+ + ++
Sbjct: 176 DVWSYGILLWE------TFSLGVCP----------YPGMTNQQAREQ-VEKGYRMSCPQK 218
Query: 382 EVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+ + +V C P RPK SE+ + L
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-23
Identities = 84/276 (30%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 140 RNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
G C ++ FM G++ LRE + + +N V +A + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK--- 123
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKS 317
IHRD+ A N L+ E V DFGL++LM DT+ A + I APE L+ K
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 318 SEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376
S K+DV+ +GV+L E+ T G + L+ V LL++ ME
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEK-------GYRMER 226
Query: 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E ++ ++ C Q +P +RP +E+ + E
Sbjct: 227 P--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 8e-23
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 143 LGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FGKV+ G D LVAVK LKE + F+ E E+++ H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERG----------QSQPPLNWSVRKQIALGAA 246
G C ++V+ +M +G + LR G L S QIA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGT- 303
G+ YL +HRD+ N L+ + +GDFG++ +D + T V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYRVGGHT 184
Query: 304 ---IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-23
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKR--LKEERTQGGELQF---QTEVEMISMAVHRNLL 195
+LG+G +G VY G G L+AVK+ L E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+ G C+ + F+ GS++S L G P+ KQI G+AYLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-----TAVRGTIGHIAPE 310
C ++HRD+K N++L + DFG A+ + + H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQ 337
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 136 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRN 193
+F N +G+G FG V+K R D + A+K++ + E + E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLN-WSVRKQIALGAARGLAY 251
++R + + +V + NG + L+ +RG+ P W QI LG LA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH KI+HRD+K+ N+ LD +GD G+AKL+ T V GT +++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL 172
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+EK+DV+ GV+L E TG+ FD AN+ ++L ++G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPP-------- 220
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ Y +QL Q+ C +RP +++R
Sbjct: 221 --VSQMY----SQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 143 LGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
LG G FG V +G + VAVK LK ++ F E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL----NWSVRKQIALGAARGLAYLHD 254
G +T ++V GS+ LR+ + +++V QIA G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIA----NGMRYLES 115
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT-IGHIAPEYL 312
+ IHRD+ A NILL + + +GDFGL + L +D +V APE L
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
T S +DV+ +GV L E+ T G+ + GL + L+++
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPW-----------------AGLSGSQILKKI-- 213
Query: 372 SDMEGNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVVRML 411
D EG +E + + V L C +P +RP + + L
Sbjct: 214 -DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-22
Identities = 74/292 (25%), Positives = 143/292 (48%), Gaps = 37/292 (12%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRL-TDG---SLVAVKRLKEERTQGGELQFQTEVEMI 186
++ + + + ++G G FG+V++G L G VA+K LK T+ F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 187 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL--G 244
H N++RL G +++ +M NG++ LR+ +S + + + G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRG 115
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRG 302
A G+ YL D +HRD+ A NIL++ E V DFGL++++ D + T+ T+ +
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 303 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGL 360
I APE ++ K + +DV+ +G+++ E+++ G+R + D++ + +VM K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVM-----KAI 223
Query: 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+L +D + Q+ L C Q RP+ ++V +L+
Sbjct: 224 NDGFRLPAPMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G +G VYK G +VA+K + + + E+ ++ +++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCD 257
T+ +V + GSV+ ++ ++ L ++IA +GL YLH +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKT---LT---EEEIAAILYQTLKGLEYLHSN-- 118
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IG---HIAPEYLS 313
K IHRD+KA NILL+EE +A + DFG++ + T A R T IG +APE +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172
Query: 314 TGKSSEKTDVFGYGVMLLELITG 336
+ K D++ G+ +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 86/291 (29%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 143 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 196
LG+G FG V R L D G +VAVK+L+ + L+ F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69
Query: 197 LRGFCMTPTER--LLVYPFMVNGSVASCL---RERGQSQPPLNWSVRKQIALGAARGLAY 251
+G C + R LV ++ GS+ L RER + L ++ QI +G+ Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA--SQIC----KGMEY 123
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP 309
L + +HRD+ NIL++ E +GDFGL K++ D + V I AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELIT------GQRAFDLARLAND-DDVMLLDWVKGLLK 362
E L+ K S +DV+ +GV+L EL T A + + ND M++ + LLK
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 363 EK-KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+L E I +E C P +RP SE+ +E
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKE----------CWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
I+G G FG V +G T G VAVK +K + T F E +++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ +V M G++ + LR RG++ + + Q +L A G+ YL K++
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL--QFSLDVAEGMEYLESK---KLV 122
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD+ A NIL+ E+ A V DFGLA++ + V+ T APE L K S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 322 DVFGYGVMLLELITGQRA 339
DV+ YGV+L E+ + RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 199
LG+G FGKV R D G L A+K LK+++ + TE ++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 200 FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHD 254
+ E+L LV + G + S L + G+ + + +I L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGR----FSEERARFYAAEIVLA----LEYLHS 111
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
II+RD+K NILLD + + DFGLAK + T GT ++APE L
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAFD 341
+ D + GV+L E++TG+ F
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 141 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 198
+G G +G+VYK R G LVA+K+++ E +G + E++++ H N++RL+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 199 GFCMTPTERL-----LVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAY 251
T + +V+ +M + + L ++ + KQ+ GL Y
Sbjct: 65 EIV---TSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK-CYMKQLL----EGLQY 115
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH + I+HRD+K +NIL++ + + DFGLA+ +++ T T+ + PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 312 L--STGKSSEKTDVFGYGVMLLELITGQRAF 340
L +T + + D++ G +L EL G+ F
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 59/302 (19%)
Query: 143 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
+G+G FG+V++ R ++VAVK LKEE + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRER------------------GQSQPPLNWSVR 238
L G C L++ +M G + LR R G + PL+ + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYKDTH 295
IA A G+AYL + K +HRD+ N L+ E + DFGL++ DY
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG--QRAFDLARLANDDDVML 353
A+ I + PE + + + ++DV+ YGV+L E+ + Q + +A
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--------- 238
Query: 354 LDWVKGLLKEKKLEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
E+++ +GN + + +L + LC P +RP + + R+
Sbjct: 239 -------------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285
Query: 411 LE 412
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 30/282 (10%)
Query: 142 ILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
LGRG FG+V+ + +LV VK L++ + + + +F+ E++M H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 196 RLRGFCMTPTERLLVYPFMVNGS-----VASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
RL G C ++ + G A+ ++ PPL+ + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
+L + + +HRD+ A N L+ + E V L+K + + + + +APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
+ S K+DV+ +GV++ E+ T Q L++++ V L+ KLE V
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE-------VLNRLQAGKLELPV 240
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+L ++ C +P +RP SE+V L
Sbjct: 241 PEGCP--------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 143 LGRGGFGKVYKG--RLTDGSL--VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
LG G FG V KG + G VAVK LK+E G+ +F E +++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
G C +LV G + L++R + S K++A A G+AYL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK--- 114
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK 316
+HRD+ A N+LL +A + DFG+++ + + TTA R + APE ++ GK
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 317 SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375
S K+DV+ YGV L E + G + + + + + +L+ ++L +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVIAMLE------SGERLPR------- 219
Query: 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414
EE +++ + L C + P +RP SE+ D
Sbjct: 220 ---PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 140 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRL 197
N +G G FGKVY L G L+AVK ++ + + + E++++ + H NL++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 198 RGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
G R VY FM G++ L L+ V + L GLAYLH
Sbjct: 65 YG---VEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHS 117
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEY 311
H I+HRD+K ANI LD +GDFG A + T + V+ G ++APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 312 LSTGKSSEK---TDVFGYGVMLLELITGQRAF 340
++ GK D++ G ++LE+ TG+R +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FG+V++G + + VAVK LK + F E +++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 262
+V M GS+ L+ L + +A A G+AYL IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 263 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 322
RD+ A N+L+ E V DFGLA+++ + I APE + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 323 VFGYGVMLLELIT 335
V+ +G++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 199
LG G FG+V+ G + VA+K LK+ G + F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 257
+T ++ +M NGS+ L+ + +N K I + A A G+A++
Sbjct: 69 -VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN----KLIDMAAQIAEGMAFIERK-- 121
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
IHRD++AANIL+ E + DFGLA+L++ + + I APE ++ G
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 318 SEKTDVFGYGVMLLELITGQR 338
+ K+DV+ +G++L E++T R
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 199
LG G FG+V+ G + VAVK LK G + F E +++ H L++L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-----GTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHCD 257
C +V +M GS+ L+ + L + + + A A G+AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP----QLVDMAAQIAEGMAYLESR-- 122
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPEYLST 314
IHRD+ A NIL+ E + DFGLA+L+ +D TA G I APE +
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEY-TAREGAKFPIKWTAPEAANY 178
Query: 315 GKSSEKTDVFGYGVMLLELIT 335
G+ + K+DV+ +G++L E++T
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 142 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR 198
+LG+G FG+ +Y+ R D SLV K + R E + E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
M L+ + G++ + + + + +A ++Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
I+HRD+K NI L + +GDFG++K++ + + T V GT +++PE K +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 319 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 378
K+D++ G +L EL+T +R FD N LV ++GNY
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVVKIVQGNY 218
Query: 379 IEEEVEQ----LIQVALLCTQGSPMERPKMSEVVRML 411
V LI + Q P +RP EV+
Sbjct: 219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 81/280 (28%), Positives = 133/280 (47%), Gaps = 40/280 (14%)
Query: 141 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
N LG G FG+VY+G TD VAVK L++ T + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLA 250
+++L G C+ + ++ M G + S LR+ R + P ++++ I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTIG 305
YL IHRD+ A N L+ E+ +GDFGLA+ + YK + G +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLP 176
Query: 306 --HIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362
+APE L GK + ++DV+ +GV++ E++T GQ+ + L N + +L V
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQE---VLQHVT---A 228
Query: 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 402
+L++ E +++ Q+ C P ERP
Sbjct: 229 GGRLQK----------PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FG V+ G+ VA+K ++E E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA----RGLAYLHDHCDP 258
+V +M NG + + LRER + + L + YL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-------LGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
IHRD+ A N L+ E+ V DFGLA+ + + + + PE + S
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 319 EKTDVFGYGVMLLELITG 336
K+DV+ +GV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 41/284 (14%)
Query: 142 ILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
++G G FG+V +GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 254
G +++ FM NG++ S LR+ GQ ++V + + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ------FTVIQLVGMLRGIAAGMKYLSE 124
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG--HIAPE 310
+HRD+ A NIL++ V DFGL++ + D D T+++ G I APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 311 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEQ 368
++ K + +DV+ YG+++ E+++ G+R + D++ + DV+ + ++ +L
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVI-----NAIEQDYRLPP 232
Query: 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+D L Q+ L C Q RPK ++V L+
Sbjct: 233 PMDCPT----------ALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-20
Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 43/284 (15%)
Query: 142 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
++G G FG+V GRL VA+K LK T+ F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIAL--GAARGLAYLHD 254
G ++V +M NGS+ + LR+ GQ ++V + + + G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------FTVIQLVGMLRGIASGMKYLSD 124
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYL 312
+HRD+ A NIL++ V DFGL++++ D + + T + I APE +
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+ K + +DV+ YG+++ E+++ G+R + ++N D + ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPY--WEMSNQDVIKAIE---------------- 223
Query: 372 SDMEGNYIEEEVE---QLIQVALLCTQGSPMERPKMSEVVRMLE 412
EG + ++ L Q+ L C Q ERPK ++V +L+
Sbjct: 224 ---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 4e-20
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
+G G FG V+ G + VA+K ++E E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 203 TPTERLLVYPFMVNGSVASCLR-ERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
+ LV+ FM +G ++ LR +RG+ SQ L + L G+AYL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---V 121
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 320
IHRD+ A N L+ E V DFG+ + + +T + + +PE S K S K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 321 TDVFGYGVMLLELIT 335
+DV+ +GV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKG----RLTDGS--LVAVKRLKEERTQGGELQFQTEVE 184
+V D+ + LG G FG+VY+G R D VAVK L E ++ E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 185 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER--GQSQP-PLNWSVRKQI 241
++S H+N++RL G R ++ M G + S LRE +P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTT 298
A A+G YL ++ IHRD+ A N LL + A + DFG+A+ + Y+ ++
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRK 177
Query: 299 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 333
R I + PE G + KTDV+ +GV+L E+
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-----FQTEVEMISMAVHRNLL 195
LG G F Y+ R + G+L+AVK++ R E + + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
R+ G + L +M GSV+ L + G +V RGL+YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 256 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEY 311
+IIHRDVK AN+L+D + + + DFG A + K T + GTI +APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQ 337
L + DV+ G +++E+ T +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 142 ILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNL 194
LG G FG+V K + S VAVK LK++ T+ +E+EM+ M H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP-------LNWSVRKQI------ 241
+ L G C +V + +G++ LR R +PP + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR---RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 242 --ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTT 298
A ARG+ +L K IHRD+ A N+L+ E+ + DFGLA+ + + D + TT
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 142 ILGRGGFGKVYKG-RLTDGSLVAVKRLK--------EERTQGGELQFQTEVEMISMAVHR 192
++G G FG VY G + G L+AVK+++ ++R + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++ G + + ++ GSVA+ L G + L + +QI +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-----AVRGTIGHI 307
H+ IIHRD+K ANIL+D + + DFG++K ++ T +++G++ +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
APE + + K D++ G +++E++TG+ F
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 199
LG+GGFG+V ++ G + A K+L ++R + GE E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 257
T + LV M G + + G+ P ++ QI G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR-- 114
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
+I++RD+K N+LLD+ + D GLA ++ K GT G++APE L
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 318 SEKTDVFGYGVMLLELITGQRAF 340
D F G L E+I G+ F
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 80/292 (27%), Positives = 134/292 (45%), Gaps = 47/292 (16%)
Query: 143 LGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG+G FG VY+G D + VAVK + E + ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLR------ERGQSQPPLNWSVRKQIALGAARGLA 250
L G L+V M +G + S LR E +PP Q+A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIA 308
YL+ K +HRD+ A N ++ +F +GDFG+ + + Y+ + +G + +A
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368
PE L G + +D++ +GV+L E+ + LA +GL E+ L+
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQP-------YQGLSNEQVLKF 233
Query: 369 LVDSDMEGNYI------EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414
+ M+G Y+ E V L++ +C Q +P RP E+V +L+ D
Sbjct: 234 V----MDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
+F ++G+G FGKV + D + A+K + +++ + RN+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-------------CVEKGSVRNV 47
Query: 195 LRLRGFCMTPTERLLV----YPFMVNGSVASC----------------LRERGQSQPPLN 234
L ER ++ +PF+VN + LR + +
Sbjct: 48 LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS 98
Query: 235 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294
K L YLH IIHRD+K NILLDE+ + DF +A
Sbjct: 99 EEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPD 153
Query: 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+TT+ GT G++APE L S D + GV E + G+R +
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 142 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLR 196
ILG G FG V +G+L+ DGS VAVK +K + E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 197 LRGFCMTPTER------LLVYPFMVNGSVAS-CLRERGQSQP---PLNWSVRKQIALGAA 246
L G C + +++ PFM +G + S L R P PL ++ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK--FMVDIA 123
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRG 302
G+ YL + IHRD+ A N +L E+ V DFGL+K + Y+ + +
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177
Query: 303 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 337
+ IA E L+ + K+DV+ +GV + E+ T GQ
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 143 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FGKVYKG LT + VA+K LKE + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 197 LRGFCMTPTERLLVYPFMVNG------------SVASCLRERGQSQPPLNWSVRKQIALG 244
L G C +++ ++ +G S + L+ S IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 303
A G+ YL H +HRD+ A N L+ E + DFGL++ + D + V +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 333
+ + PE + GK + ++D++ +GV+L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 141 NILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLR 198
+G+G FG V K R +DG ++ K + T+ + Q +EV ++ H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 199 GFCMTPTERLLVYPFM---VNGSVAS----CLRERGQSQPPLNWSVRKQIALGAARGLAY 251
+ + + L Y M G +A C +ER + W + Q+ L L
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----LYE 120
Query: 252 LH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
H ++HRD+K ANI LD +GDFGLAK++ + + T V GT +++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
E L+ EK+D++ G ++ EL F
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 143 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FGKV+ D LVAVK LKE ++ FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLR---------ERGQSQP--PLNWSVRKQIALGA 245
G C L+V+ +M +G + LR G+ L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTI 304
A G+ YL +HRD+ N L+ + +GDFG+++ + D + V I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ PE + K + ++D++ +GV+L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 7e-19
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 136 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 193
+ ++GRG FG V+ R D LV +K++ E+ T+ L Q E +++ + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARGL 249
++ + ++V + G++A +++R S L++ V+ +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------ 114
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
++H I+HRD+K NILLD+ V +GDFG++K++ K T V GT +I+
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYIS 169
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 345
PE ++K+D++ G +L EL + +RAF+ A L
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 142 ILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
+LG G FG VYKG + +G V A+K L E ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLH 253
L G C++PT + LV M +G + + E SQ LNW V+ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 312
+ +++HRD+ A N+L+ + DFGLA+L++ + + I +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 341
K + ++DV+ YGV + EL+T G + +D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 199
LG G FG+V+ G + + VAVK LK G + Q E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 200 FCMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
++ +M GS+ L+ E G+ P QIA G+AY+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIERK-- 122
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
IHRD++AAN+L+ E + DFGLA++++ + + I APE ++ G
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 318 SEKTDVFGYGVMLLELIT 335
+ K+DV+ +G++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 143 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+GRG FG+V+ GRL D + VAVK +E + +F E ++ H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+V + G + LR G P L Q+ AA G+ YL I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGK 316
HRD+ A N L+ E+ + DFG+++ ++ A G + I APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 317 SSEKTDVFGYGVMLLE 332
S ++DV+ +G++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER----TQGGELQFQTEVEMISMAV 190
N+ +LG+G FG+VY D G +AVK++ + T+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 191 HRNLLRLRGFCMTPTERLLVY-PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
H +++ G C+ E L ++ +M GSV L+ G L +V ++ G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHI 307
YLH + I+HRD+K ANIL D +GDFG +K + + T +V GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELIT 335
+PE +S K DV+ G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 78/299 (26%), Positives = 140/299 (46%), Gaps = 54/299 (18%)
Query: 140 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 195
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRKQIALGA 245
L G C L + +G++ LR+ ++ P S ++ + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 246 --ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 303
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + V+ T
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 181
Query: 304 IGHI-----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357
+G + A E L+ + +DV+ YGV+L E+++ G + A +
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 233
Query: 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLE 412
+ L + +LE+ ++ D +EV L++ C + P ERP ++++ RMLE
Sbjct: 234 EKLPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 33/279 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
D+ LG G G V K G ++AVK ++ E + + Q E++++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++ G + + +M GS+ L+E Q + + +IA+ +GL YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEY 311
+ KIIHRDVK +NIL++ + + DFG++ + T V GT ++APE
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+ S K+D++ G+ L+EL TG+ + ND + + L+ +V+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYP---PENDPPDGIFE---------LLQYIVN 218
Query: 372 SDM----EGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 406
G + + LC P ERP E
Sbjct: 219 EPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 142 ILGRGGFGKVYKG-RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
+LG G FG VYKG + DG VA+K L+E + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLH 253
L G C+T T +L V M G + +RE R SQ LNW V QIA +G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV--QIA----KGMSYLE 126
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL 312
+ +++HRD+ A N+L+ + DFGLA+L+D +T + I +A E +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFD 341
+ + ++DV+ YGV + EL+T G + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 191
F +LG G FG VYKG + +G VA+K L+E + + E +++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARG 248
++ RL G C+T T +L + M G + +RE SQ LNW V QIA +G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIA----KG 121
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 306
+ YL + +++HRD+ A N+L+ + DFGLAKL+ D K+ H + I
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKW 177
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 341
+A E + + ++DV+ YGV + EL+T G + +D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 20/221 (9%)
Query: 142 ILGRGGFGKVYKG-RLTDGSLVAVK-RLKEERTQGGELQFQTEVE-MISMAV--HRNLLR 196
+LG G FG V+KG + +G + + +K + + G FQ + M++M H ++R
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLH 253
L G C + +L V GS+ +R+ S P LNW V QIA +G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV--QIA----KGMYYLE 126
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYL 312
+H ++HR++ A NILL + + DFG+A L+ D + + + I +A E +
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 352
G+ + ++DV+ YGV + E+++ G + R D++
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-18
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 202 MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
+ L +V +M GS+ LR RG+S L + +L + YL +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 320
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 321 TDVFGYGVMLLELITGQR 338
+DV+ +G++L E+ + R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 140 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
++G G VY L + VA+KR+ E+ Q + + EV+ +S H N+++
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
+ E LV P++ GS+ ++ + L+ ++ + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST 314
IHRD+KA NILL E+ + DFG++ + T VR GT +APE +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 315 GKS-SEKTDVFGYGVMLLELITG 336
K D++ +G+ +EL TG
Sbjct: 181 VHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 72/230 (31%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 112 EEDPEVHLGQLKRFS-LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKE 169
++DPE K F+ LRE+ G G FG VY R +VA+K++
Sbjct: 10 KDDPE------KLFTDLREI-------------GHGSFGAVYFARDVRTNEVVAIKKMSY 50
Query: 170 ERTQGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 226
Q E ++Q EV + H N + +G + LV + + GS + L
Sbjct: 51 SGKQSNE-KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH 108
Query: 227 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286
+ PL I GA +GLAYLH H IHRD+KA NILL E + DFG A
Sbjct: 109 ---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162
Query: 287 KLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 333
L+ ++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 163 SLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 143 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
LG G FGKV Y + G +VAVK LK E Q ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 198 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLAYL 252
+G C + L+ ++ GS+ L P + Q+ L A + G+AYL
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIA 308
H IHRD+ A N+LLD + +GDFGLAK + + H VR + A
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPVFWYA 178
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELIT 335
E L K S +DV+ +GV L EL+T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
F+ +G+G FG+VYK +VA+K + E + Q E++ +S +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 196 RLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
+ G +L ++ + GS L+ L+ + I GL YLH+
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPE 310
IHRD+KAANILL EE + + DFG L M ++T V GT +APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPE 168
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITG 336
+ EK D++ G+ +EL G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 42/288 (14%)
Query: 143 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+G G FGKV G R + V VK L+ T +L F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 200 FCMTPTERLLVYPFMVNGSVASCLR-----ERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
C+ LLV F G + + LR +Q V +++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWLHQ 118
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEY- 311
IH D+ N L + +GD+GLA L Y + + T + +APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 312 ------LSTGKSSEKTDVFGYGVMLLELIT-GQRAF-DLARLANDDDVMLLDWVKGLLKE 363
L ++K++++ GV + EL T + + DL+ D+ V+ K +++E
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVL-----KQVVRE 225
Query: 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+ + +L ++ Y + E V C P RP EV +L
Sbjct: 226 QDI-KLPKPQLDLKYSDRWYE----VMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 142 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMIS-MAVHRNLLRL 197
I+G G F V + A+K L + + + + E E+++ + H +++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 198 RGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
+ E L V + NG + +R+ G L+ + A L YLH
Sbjct: 68 Y-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSK- 121
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------------YKDTHVT 297
IIHRD+K NILLD++ + DFG AK++D K+
Sbjct: 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+ GT +++PE L+ + + +D++ G ++ +++TG+ F
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 133 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMI-SM 188
T F ++G G +GKVYK R G LVA+K + E+ E + + E ++
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59
Query: 189 AVHRNLLRLRG--FCMTPT----ERLLVYPFMVNGSV---ASCLRERGQSQPPLNWSVRK 239
+ H N+ G P + LV GSV LR++G+ +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK------EE 113
Query: 240 QIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
IA RGLAYLH++ K+IHRD+K NILL + E + DFG++ +D
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 297 TTAVRGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQ 337
T + GT +APE ++ + + + DV+ G+ +EL G+
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 77/297 (25%), Positives = 137/297 (46%), Gaps = 45/297 (15%)
Query: 131 QVATDNFSNRNILGRGGFGKVY----KGRLTDG--SLVAVKRLKEERTQGGELQFQTEVE 184
+VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 185 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--------RGQSQPPLNWS 236
++ +++RL G L++ M G + S LR Q+ P L
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
+ Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + Y+ +
Sbjct: 122 I--QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 175
Query: 297 TTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
+G + ++PE L G + +DV+ +GV+L E+ T LA
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP----- 221
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEE---VEQLIQVALLCTQGSPMERPKMSEVV 408
+G+ E+ L + MEG +++ + L ++ +C Q +P RP E++
Sbjct: 222 --YQGMSNEQVLRFV----MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 142 ILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
LG G FGKV K + VAVK LKE + +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--------------------PLNW 235
+L G C LL+ + GS+ S LRE + P L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 236 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295
A +RG+ YL + K++HRD+ A N+L+ E + + DFGL++ + +D++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 296 VTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
V + R + +A E L + ++DV+ +GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G G +G VYK R G +VA+K++K ++G E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
+ LV+ FM + + +++R Q L S+ K +GLA+ H H I
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYLSTG 315
+HRD+K N+L++ E + DFGLA+ Y VT R APE L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR------APELLLGD 173
Query: 316 KS-SEKTDVFGYGVMLLELITGQRAF 340
K S D++ G + EL++ + F
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 143 LGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 198
LG G FG V +G+L D S+ VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 199 GFCMTPTER------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA--ARGLA 250
G C+ E +++ PFM +G + S L P + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAP 309
YL IHRD+ A N +L+E V DFGL+K + D + + + + IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368
E L+ + K+DV+ +GV + E+ T GQ + ++ + D+++ + +L+Q
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLR---QGNRLKQ 235
Query: 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
D ++ L + C +P +RP + LE
Sbjct: 236 PPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 262
+V +M NG + + LRE G+ P S ++ G+AYL + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 263 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV--RGTIGHIAPEYLSTGKSSEK 320
RD+ A N L+D++ V DFGL++ + D T++V + + PE L K S K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 321 TDVFGYGVMLLELIT-GQRAFDL 342
+DV+ +GV++ E+ + G+ ++
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 203 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
E + +V +M GS+ L+ G+ L +A A G+AY+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 322 DVFGYGVMLLELITGQR 338
DV+ +G++L EL T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHR 192
FS+ +G G FG VY R + + +VA+K++ Q E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N ++ RG + LV + + GS + L + PL + GA +GLAYL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY- 311
H H +IHRDVKA NILL E +GDFG A +M + V GT +APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 312 --LSTGKSSEKTDVFGYGVMLLEL 333
+ G+ K DV+ G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 136 NFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 193
+F LG+G +G VYK RL+D A+K + +Q E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++ + + + +V + G ++ + +R + + + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+ KI+HRD+K+ANILL +GD G++K++ K T + GT ++APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWK 174
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 348
S K+D++ G +L E+ T F+ AR D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 30/254 (11%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRL 197
++GRG +G VY+G+ + G +VA+K + + Q EV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
G + ++ + GSV + ++ ++ ++ +R+ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV-- 120
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
+IHRD+KAANIL+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 318 SE-KTDVFGYGVMLLELITGQ---------RAFDL------ARLANDDDVMLL-DWVKGL 360
+ K D++ G+ + E+ TG RA L RL ++ LL ++V
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238
Query: 361 LKEKKLEQLVDSDM 374
L E+ E+L ++
Sbjct: 239 LDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 142 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 198
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 199 GFCMT-----PTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 252
CMT P + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEHM 113
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 313 STGKSSEKT-DVFGYGVMLLELITGQRAF 340
G + + + D F G ML +L+ G F
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG+G FG+V+ G + VA+K LK T E F E +++ H L+ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPE-AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 203 TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
E + +V FM GS+ L+E L V +A A G+AY+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERM---NYI 124
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD++AANIL+ + + DFGLA+L++ + + I APE G+ + K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 322 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEE 381
DV+ +G++L EL+T R G++ + LEQ V+ +
Sbjct: 185 DVWSFGILLTELVTKGRVP----------------YPGMVNREVLEQ-VERGYRMPCPQG 227
Query: 382 EVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E L ++ LC + P ERP + LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G G +G VYK R + G LVA+K +K E E Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCDP 258
+ + +V + GS+ + ++ PL+ QIA +GLAYLH+
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLS---ELQIAYVCRETLKGLAYLHET--- 120
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH---IAPEYL-- 312
IHRD+K ANILL E+ + + DFG++ + T T A R + IG +APE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TA-TIAKRKSFIGTPYWMAPEVAAV 175
Query: 313 -STGKSSEKTDVFGYGVMLLELITGQ 337
G K D++ G+ +EL Q
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 199
LG G FG+V+ + VAVK +K G + F E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 200 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPPLNWSVRKQIALGA--ARGLAYLHDHC 256
+T ++ FM GS+ L+ + G QP + K I A A G+A++
Sbjct: 69 -VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKLIDFSAQIAEGMAFIEQR- 121
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 317 SSEKTDVFGYGVMLLELITGQR 338
+ K+DV+ +G++L+E++T R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 136 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRN 193
F N +G G +G VY+ R T G +VA+K+++ + + G + E+ ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 194 LLRLRGFCMTPTERLLVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
++ L+ + L F+V +AS L P + S K + L RGL
Sbjct: 68 IVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGL 121
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
YLH++ IIHRD+K +N+LL ++ + DFGLA+ +T V T+ + AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 310 EYL-STGKSSEKTDVFGYGVMLLELITGQ 337
E L + D++ G +L EL+ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 142 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 198
I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+ + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 199 GFCM-----TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYL 252
CM TP + + M G + L + G S+ + + + I GL ++
Sbjct: 60 -VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----GLEHM 113
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H+ +++RD+K ANILLDE + D GLA K H + GT G++APE L
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 313 STGKSSEKT-DVFGYGVMLLELITGQRAF 340
G + + + D F G ML +L+ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 143 LGRGGFGKVYKGRLTDG--SLVAVKRL----------KEERTQGGELQFQTEVEMISMAV 190
LG G FG VYK R + +L+A+K + K ER + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 191 -HRNLLRLRGFCMTPTERLLVYPFMVNGS----VASCLRERGQSQPPLN-WSVRKQIALG 244
H N++R +RL + ++ G+ + L+E+ Q W++ Q+ L
Sbjct: 67 RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
L YLH + +I+HRD+ NI+L E+ + + DFGLAK ++ +T+ V GTI
Sbjct: 126 ----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTI 177
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364
+ PE + EK DV+ +G +L ++ T Q F ML L K
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------ML------SLATK 224
Query: 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+E + + EG Y E+V +I C RP + +V M+
Sbjct: 225 IVEAVYEPLPEGMY-SEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 143 LGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FGKV+ D LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALG 244
G C ++V+ +M +G + LR G Q++ L S IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 303
A G+ YL +HRD+ N L+ +GDFG+++ + D + V
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
I + PE + K + ++DV+ +GV+L E+ T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 134 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+ + N +G G G+VYK G VA+K+++ + Q EL E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN-EILIMKDCKHP 75
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA---RGL 249
N++ + E +V +M GS+ + Q+ +N QIA +GL
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEP---QIAYVCREVLQGL 129
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
YLH +IHRD+K+ NILL ++ + DFG A + + + + V GT +AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQ 337
E + K D++ G+M +E+ G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 142 ILGRGGFGKV----YKGRLTDGSLVAVKRLKE----ERTQGGELQFQTEV-EMISMAVHR 192
+LGRG FGKV YK G L A+K LK+ R + L + + E + H
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-ALGAARGLAY 251
L+ L T V + G + + S+P R A GL Y
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLGLQY 116
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPE 310
LH++ KI++RD+K N+LLD E + DFGL K M + D T+ GT +APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
L+ + D +G GV++ E++ G+ F
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FG+V+ G + VAVK LK T E F E +++ H L++L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPE-SFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 203 TPTERL-LVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
E + +V +M GS+ L++ R P L +A A G+AY+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIERM--- 121
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
IHRD+++ANIL+ + + DFGLA+L++ + + I APE G+ +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 319 EKTDVFGYGVMLLELITGQR 338
K+DV+ +G++L EL+T R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 143 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FGKV+ D LVAVK LK+ + F E E+++ H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERG-------QSQPP--LNWSVRKQIALGAAR 247
G C+ ++V+ +M +G + LR G + P L S IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGH 306
G+ YL +HRD+ N L+ E +GDFG+++ + D + V I
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ PE + K + ++DV+ GV+L E+ T
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGF 200
LG G FGKVYK + G A K ++ E EL+ F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 201 CMTPTERLLVYPFMVNGSVASCLR--ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
+ ++ F G++ S + ERG ++P + + V +Q+ L +LH H
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML----EALNFLHSH--- 122
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
K+IHRD+KA NILL + + + DFG+ AK T GT +APE ++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETF 180
Query: 318 SE-----KTDVFGYGVMLLEL 333
+ K D++ G+ L+EL
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGF 200
+G G G V+K + G VA+K++ R +GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
+ +LV +M ++ LR+ + PL + K +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSE 319
+HRD+K AN+L+ + + DFGLA+L ++ + + T + APE L K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 320 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
D++ G + EL+ G F ++D+ L
Sbjct: 181 GVDLWAVGCIFAELLNGSPLF-----PGENDIEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 143 LGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+ +G +G+V+ K + T G + A+K +K+ Q E ++ ++ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 201 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
++ LV ++ G +AS L G L+ V + L YLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSN--- 112
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAK-------LMDYKDTHVTTAVRGTIGHIAPEY 311
IIHRD+K NIL+D + DFGL+K + D + GT +IAPE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 312 LSTGKSSEKTDVFGYGVMLLELITG 336
+ S+ D + G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 143 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 198 RGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+G C L+ F+ +GS+ L +++ +N + + A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLS 313
+ +HRD+ A N+L++ E + +GDFGL K ++ + T + + APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 314 TGKSSEKTDVFGYGVMLLELIT 335
K +DV+ +GV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 131 QVATDNFSNRNILGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTE 182
+V D LG G FG+V K + + VAVK LK + T+ +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 183 VEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----------GQSQP 231
+EM+ M H+N++ L G C ++ + G++ LR R P
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 232 PLNWSVRKQI--ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289
S + + A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 290 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ D + TT R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 4e-15
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT----EVEMISMAVH 191
+ LG G +G VYK R G +VA+K+++ + + G + E+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N+++L T + LV+ + + + L +R PL+ ++ K I RGLAY
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAY 113
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
H H +I+HRD+K NIL++ + + DFGLA+ T V T+ + APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169
Query: 312 L------STGKSSEKTDVFGYGVMLLELITGQ 337
L ST D++ G + E+ITG+
Sbjct: 170 LLGSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 143 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 193
LG G FG+V K + VAVK LK++ T +E+EM+ M H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---------------LNWSVR 238
++ L G C ++ + G++ LR R +PP L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRAR---RPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VT 297
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + D + T
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
T R + +APE L + ++DV+ +GV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 143 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 193
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQI 241
++ L G C ++ + G++ LR R + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 300
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
R + +APE L + ++DV+ +GV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 143 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRN 193
LG G FG+V K R VAVK LK+ T +E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 241
++ L G C ++ + G++ LR R P + + K
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 300
A ARG+ YL + IHRD+ A N+L+ E+ + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 30/188 (15%)
Query: 141 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHR 192
+G G +G VYK R L G VA+K+++ ++ G E+ ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 193 NLLRLRGFCMTP-TER----LLVYPFMVNGSVASCLR---ERGQSQPPLNWSVRKQIALG 244
N++RL C P T+R LV+ V+ +A+ L + G + + +Q+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKD-LMRQLL-- 117
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
RG+ +LH H I+HRD+K NIL+ + + + DFGLA++ Y T+V T+
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTL 170
Query: 305 GHIAPEYL 312
+ APE L
Sbjct: 171 WYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 143 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
LG FGK+YKG L LVA+K LK+ +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCL-------------RERGQSQPPLNWSVRKQIALG 244
G +++ ++ G + L E G + L+ IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 303
A G+ YL H +H+D+ A NIL+ E+ + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
I + PE + GK S +D++ +GV+L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 31/272 (11%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FG V+ G+ VA+K + E E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 203 TPTERLLVYPFMVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+V FM NG + + LR+R G+ + S+ + + G+ YL + I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC----EGMEYLERN---SFI 122
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 320
HRD+ A N L+ V DFG+ + + D + +++ + + PE + K S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 321 TDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379
+DV+ +GV++ E+ T G+ F + +N + V+ + + +L + + +
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPF--EKKSN------YEVVEMISRGFRLYR---PKLASMTV 230
Query: 380 EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
E V C P RP +E++R +
Sbjct: 231 YE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 142 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQF-QTEVEMISMAVHRNLLRLR 198
+LG+G FGKV L L AVK LK++ Q +++ TE ++++A L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
C +RL VNG L Q + + A GL +LH+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
II+RD+K N+LLD E + DFG+ K + T T+ GT +IAPE LS
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPY 173
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350
D + GV+L E++ GQ F+ +D+D
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFE----GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 129 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMI 186
E + D R +LG+G +G VY R L+ +A+K + E ++ +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALH 59
Query: 187 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER----GQSQPPLNWSVRKQIA 242
S HRN+++ G + + GS+++ LR + ++ + + KQI
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-KQI- 117
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAV 300
GL YLHD+ +I+HRD+K N+L++ + VV DFG +K + + T
Sbjct: 118 ---LEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETF 169
Query: 301 RGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 340
GT+ ++APE + G D++ G ++E+ TG+ F
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 120 GQLKRFSLRELQVATDN---FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG 175
G LK + EL D F++ +G G FG VY R + +VA+K++ Q
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 176 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP 232
E ++Q EV+ + H N + +G + LV + + GS + L + P
Sbjct: 67 E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKP 121
Query: 233 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292
L I GA +GLAYLH H +IHRD+KA NILL E + + DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 293 DTHVTTAVRGTIGHIAPEY---LSTGKSSEKTDVFGYGVMLLEL 333
++ V GT +APE + G+ K DV+ G+ +EL
Sbjct: 179 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 137 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
F+ +G+G FG+VYKG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
R G + T+ ++ ++ GS L+ PL + I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
+ IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 316 KSSEKTDVFGYGVMLLELITGQ 337
K D++ G+ +EL G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 143 LGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLR 198
+G G FG VY +VAVK++ Q E ++Q EV+ + H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
G + LV + + GS + L + PL I GA +GLAYLH H
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTG 315
+IHRD+KA NILL E + + DFG A ++ V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 316 KSSEKTDVFGYGVMLLEL 333
+ K DV+ G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 142 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRLR 198
+LG+G FGKV RL G L AVK LK++ Q +++ TE ++S+A + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG---------- 248
C +RL VNG L + ++K AR
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG-------------DLMFHIQKSRRFDEARARFYAAEITSA 108
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L +LHD II+RD+K N+LLD E + DFG+ K + T+ GT +IA
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351
PE L D + GV+L E++ G F+ N+DD+
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 27/204 (13%)
Query: 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANIL 271
FM GS+ ++ G P+ + +IA+ GL YL++ H +I+HRD+K +NIL
Sbjct: 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136
Query: 272 LDEEFEAVVGDFGLA-KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 329
++ + + DFG++ +L++ DT V GT +++PE + GK + K+DV+ G+
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 330 LLELITGQRAFDLARLAND--DDVM-LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQL 386
++EL G+ F + + +D DD M +LD ++ +++E +L SD E++
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-PRLPSSDF-----PEDLRDF 245
Query: 387 IQVALLCTQGSPMERPKMSEVVRM 410
+ LL P ERP ++ M
Sbjct: 246 VDACLLKD---PTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 190
+ + ++G G +G V K R G +VA+K+ KE E +T EV+++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
H N++ L+ LV+ + V ++ L PP +VR I + +A
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPD--AVRSYI-WQLLQAIA 114
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
Y H H IIHRD+K NIL+ E + DFG A+ + + T T + APE
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 311 YL----STGKSSEKTDVFGYGVMLLELITGQRAF 340
L + GK DV+ G ++ EL+ G+ F
Sbjct: 172 LLVGDTNYGKP---VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G + VYKGR LTD +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
T LV+ ++ + + L + G S +N K RGL Y H K+
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 319
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 320 KTDVFGYGVMLLELITGQRAF 340
+ D++G G + E+ TG+ F
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 59/221 (26%), Positives = 110/221 (49%), Gaps = 11/221 (4%)
Query: 136 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
NF LG G + VYKGR T G +VA+K + + +G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
+RL T + +LV+ +M + + + G + L+ + K +G+A+ H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
+ +++HRD+K N+L+++ E + DFGLA+ + V T+ + AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 315 GKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
++ S D++ G ++ E+ITG+ F N++D +L
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLF---PGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 21/282 (7%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+ + LG G G V K RL + ++ A+K + + + Q E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 194 LLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
+++ G + + + + GS+ S ++ + + V +IA +GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPE 310
LH KIIHRD+K +NILL + + + DFG++ +L++ T GT ++APE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPE 173
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
+ S +DV+ G+ LLE+ + F + ++ + ++ E L
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPE-LK 229
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
D G EE + I+ C + P RP MLE
Sbjct: 230 DEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPW---DMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 199
++G G +G+VYKGR + G L A+K + + T+ E + + E+ M+ + HRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 200 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+ + + LV F GSV ++ + +W I RGLA+LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLH 138
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 314 TGKSSEKT-----DVFGYGVMLLELITG 336
++ + T D++ G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 195
LG G FG VY R G LVA+K++K EE E++ + + H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-----LRKLNEHPNIV 61
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+L+ E V+ +M G++ +++R P + SV + I +GLA++H H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH 118
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--S 313
HRD+K N+L+ + DFGLA+ + + + T V T + APE L S
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRS 173
Query: 314 TGKSSEKTDVFGYGVMLLELITGQ 337
T SS D++ G ++ EL T +
Sbjct: 174 TSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FGKVYK + + +A ++ E +++ + E+E+++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 203 TPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
+ ++ F G+V + + E RG ++P + R+ + L YLH KI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM---KI 131
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYL--ST 314
IHRD+KA N+LL + + + DFG++ K + +D+ + GT +APE + T
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 315 GKSSE---KTDVFGYGVMLLEL 333
K + K D++ G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 137 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+ G + T+ ++ ++ GS L E G PL+ + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG----PLDETQIATILREILKGLDYLHSE 120
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLST 314
K IHRD+KAAN+LL E E + DFG+A + DT + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 315 GKSSEKTDVFGYGVMLLELITGQ 337
K D++ G+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 142 ILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 196
+LG+G FG V + +L DGS VAVK LK + ++ +F E + H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 197 LRGFCM--TPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 248
L G + RL ++ PFM +G + + L + P ++ + + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHI 307
+ YL IHRD+ A N +L+E V DFGL+K + D + A + + +
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 340
A E L+ + +DV+ +GV + E++T GQ +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 187
+N S LG G FGKV + +D + VAVK LK +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN--WSVRKQIALGA 245
+ H N++ L G C L++ + G + + LR + +S L S Q+A
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA--- 151
Query: 246 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGT 303
+G+A+L +C IHRD+ A N+LL + DFGLA+ +M+ + V R
Sbjct: 152 -KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ +APE + + ++DV+ YG++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 136 NFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISM-A 189
NF +LG G +GKV+ G G L A+K LK+ Q + T E + A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 190 VHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
V R L+ L T T+ L+ ++ G + + L +R VR IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIA-EIVL 116
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
L +LH II+RD+K NILLD E V+ DFGL+K ++ + GTI ++
Sbjct: 117 ALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 308 APEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 340
APE + G + D + GV+ EL+TG F
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL----KEERTQGGELQFQTEVEMISMAV 190
N+ +LGRG FG+VY D G +AVK++ + T + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 191 HRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
H +++ G P E+ L +M GS+ L+ G + +QI +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGH 306
++YLH + I+HRD+K ANIL D +GDFG +K + +V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
++PE +S K DV+ ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 137 FSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+ G + T+ ++ ++ GS LR G ++ K+I +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEIL----KGLDYLHSE 120
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
K IHRD+KAAN+LL E+ + + DFG+A + T V GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 316 KSSEKTDVFGYGVMLLELITGQ 337
K D++ G+ +EL G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-14
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRG 199
++G G +G+VYKGR + G L A+K + + T E + + E+ M+ + HRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 200 FCMTPT------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+ + LV F GSV ++ + W I RGL++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH 128
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
H K+IHRD+K N+LL E E + DFG++ +D T + GT +APE ++
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 184
Query: 314 TGKSSE-----KTDVFGYGVMLLELITG 336
++ + K+D++ G+ +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 142 ILGRGGFGKVYKGRLTD-GSLVAVKRLK---EERTQGGELQ-FQTEVEMISMAVHRNLLR 196
+LG+G FG+VY D G +AVK+++ E E+ + E++++ +H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 197 LRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
G P ER L M GS+ L+ G + +QI G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYL 312
+ I+HRD+K ANIL D +GDFG +K + T +V GT ++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 313 STGKSSEKTDVFGYGVMLLELIT 335
S K D++ G ++E++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVH 191
LG G + VYK R G +VA+K++K + E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGA 245
N++ L + LV+ FM + ++++ S+ K L
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMT 111
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 305
RGL YLH + I+HRD+K N+L+ + + DFGLA+ + +T V T
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 306 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351
+ APE L + D++ G + EL+ + F L D D+
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF----LPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 74/302 (24%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 130 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQ---FQT 181
+ ++ D + ++L G FG+++ G L D V VK +K+ E+Q
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQ 57
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLNWSVRKQ 240
E ++ H+N+L + C+ E V YP+M G++ L++ + ++ Q
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 241 ----IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMDYK- 292
+A+ A G++YLH +IH+D+ A N ++DEE + + D L++ MDY
Sbjct: 118 QLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 293 --DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 349
D + +A E L + S +DV+ +GV+L EL+T GQ +
Sbjct: 175 LGDNE-----NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY--------V 221
Query: 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
++ + L +L Q ++ ++L V C P ERP S++V+
Sbjct: 222 EIDPFEMAAYLKDGYRLAQPINCP----------DELFAVMACCWALDPEERPSFSQLVQ 271
Query: 410 ML 411
L
Sbjct: 272 CL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 LGRGGFGKVYKGRL-TDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 199
LG+GGFG+V ++ G + A K+L ++R + GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGAARGLAYLHDHCD 257
+ T LV M G + + G+ + + QI G LH H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI------LHLH-S 113
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
I++RD+K N+LLD++ + D GLA ++ KD T GT G++APE L
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 318 SEKTDVFGYGVMLLELITGQRAF 340
S D F G + E++ G+ F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 136 NFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 192
+ +G G FGK+Y K + +D +K + + E + + EV +++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARG 248
N++ +V + G + + R+RG L+W V QI+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG---- 113
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
L ++HD KI+HRD+K+ NI L + A +GDFG+A+ ++ T V GT ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+PE + KTD++ G +L EL T + F+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 65/206 (31%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 143 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVH-RNLLRLRG 199
LG+GGFG+V ++ G L A K+L ++R + + VE I VH R ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQP----PLNWSVRKQIALGAARGLAYLHDH 255
T T+ LV M G + + + P P QI G L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQR 116
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIAPEYLST 314
+II+RD+K N+LLD + + D GLA +L D + T GT G +APE L
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAF 340
+ D F GV L E+I + F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 127 LRELQVATDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 185
L L TD + +G+G +GKVYK DGSL AVK L E++ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 186 ISMAVHRNLLRLRGFC-----MTPTERLLVYPFMVNGSVASCLR---ERGQSQPPLNWSV 237
S+ H N+++ G + + LV GSV ++ GQ L+ ++
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR---LDEAM 129
Query: 238 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297
I GA GL +LH++ +IIHRDVK NILL E + DFG++ +
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 298 TAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITG 336
T+V GT +APE ++ + + + DV+ G+ +EL G
Sbjct: 187 TSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G + V+KGR LT +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
T LV+ ++ + + L G N K RGL+Y H KI
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHN---VKIFMFQLLRGLSYCHKR---KI 124
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 319
+HRD+K N+L++E+ E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 320 KTDVFGYGVMLLELITGQRAF 340
D++G G +L E+ TG+ F
Sbjct: 184 PIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
LG G FGKVYK + + ++A ++ + +++ + E+++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 262
++ F G+V + + E + PL + + L YLH++ KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 263 RDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
RD+KA NIL + + + DFG++ + + +D+ + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 319 E-----KTDVFGYGVMLLEL 333
+ K DV+ G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----MDY 291
+ KQI GL YLH +IIHRDVK NI +++ + +GD G A+
Sbjct: 162 IEKQIL----EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214
Query: 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 334
+ GT+ APE L+ K + K D++ G++L E++
Sbjct: 215 -------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 143 LGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+G G FGKV G + G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
C T LLV F G + LR R + + +++A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGK 316
IH D+ N LL + +GD+GL+ YK+ + T + + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 317 S-------SEKTDVFGYGVMLLEL 333
+++++V+ GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G + V+KGR LT+ +LVA+K ++ E +G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
T LV+ ++ + + + + G N K RGLAY H K+
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN---VKIFLYQILRGLAYCHRR---KV 125
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YLSTGKSSE 319
+HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 320 KTDVFGYGVMLLELITGQRAF 340
+ D++G G + E+ +G+ F
Sbjct: 185 QIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 61/278 (21%), Positives = 120/278 (43%), Gaps = 22/278 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 192
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++ + E +V G ++ ++ + + + + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372
+ K+D++ G +L E+ Q F D + L KK+EQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLC------KKIEQCDYP 226
Query: 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
+ ++ EE+ QL+ +C P +RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 134 TDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
NF +LG+G FGKV R L A+K LK++ + T VE +A+
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 193 N---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
L +L C +RL V ++ G + +++ G+ + P +I++G
Sbjct: 59 KPPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG---- 113
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L +LH II+RD+K N++LD E + DFG+ K D T GT +IA
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIA 169
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
PE ++ + D + YGV+L E++ GQ FD
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 43/279 (15%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLR- 198
++G+G +G+V R TDG +K+L E + + E +++S H N++ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 199 ----GFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPP---LNWSVRKQIALGAARGLA 250
+ +V F G + L+E +G+ P + W V QIA+ L
Sbjct: 67 SWEGEDGLL----YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV--QIAMA----LQ 116
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
YLH+ I+HRD+K N+ L VGD G+A++++ + +T + GT +++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
S + K+DV+ G + E+ T + AF+ A D + ++ ++G KL
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFN----AKDMNSLVYRIIEG-----KLPP-- 221
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
M +Y E E LI +L + P +RP + ++R
Sbjct: 222 ---MPKDYSPELGE-LIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK--RLKEERTQGGELQFQTEVEMISMAVH 191
D F +G G +G+VYK R D G LVA+K RL E+ +G + E++++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65
Query: 192 RNLLRLRGFCMTPTERL----------LVYPFM---VNGSVASCLRERGQSQPPLNWSVR 238
RN++ L+ + L LV+ +M + G + S L + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH---IKSFM 122
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
KQ+ GL Y H +HRD+K +NILL+ + + + DFGLA+L + +++ T
Sbjct: 123 KQL----LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 299 AVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T+ + PE L + DV+ G +L EL T + F
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 137 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 193
F +LG+GGFG+V ++ G + A K+L+++R + GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GLA 250
++ L T LV M G + + G++ + AA GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGLE 116
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
LH +I++RD+K NILLD+ + D GLA + + GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
+ + + D + G +L E+I GQ F K +K +++E+LV
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR--------------KKKIKREEVERLV 217
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMER 401
+++ Y E+ + + P ER
Sbjct: 218 -KEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK----EERTQGGELQFQTEVEMISMAV 190
N+ +LG+G FG+VY D G +A K+++ T + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 191 HRNLLRLRGFCMTPTERLLV--YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
H +++ G E+ L +M GSV L+ G L SV ++ G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEG 118
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGH 306
++YLH + I+HRD+K ANIL D +GDFG +K + T +V GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
++PE +S K DV+ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 78/294 (26%), Positives = 139/294 (47%), Gaps = 46/294 (15%)
Query: 141 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 196
+++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 244
L G C L + +G++ LR+ ++ P S ++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 303
ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362
+ +A E L+ + +DV+ YGV+L E+++ G + A + + L +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 226
Query: 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLE 412
+LE+ ++ D +EV L++ C + P ERP ++++ RMLE
Sbjct: 227 GYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 71/295 (24%), Positives = 136/295 (46%), Gaps = 46/295 (15%)
Query: 141 NILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLR 196
+++G G FG+V + + L A+K LKE ++ F E+E++ + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERG--QSQPPL--------NWSVRK--QIALG 244
L G C + + G++ LR+ ++ P + ++ Q A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGT 303
A G+ YL + + IHRD+ A N+L+ E + + DFGL++ ++ +V T R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362
+ +A E L+ + K+DV+ +GV+L E+++ G + A + + L +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 233
Query: 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV----RMLEG 413
++E+ + D +EV +L++ C + P ERP +++ RMLE
Sbjct: 234 GYRMEKPRNCD-------DEVYELMR---QCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 63/250 (25%), Positives = 119/250 (47%), Gaps = 41/250 (16%)
Query: 120 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 178
GQ L +L+ + +G G G+VYK R G ++AVK+++ RT E
Sbjct: 7 GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEEN 57
Query: 179 FQT--EVEMISMAVHR--NLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPL 233
+ +++++ + H +++ G+ +T ++ + M ++CL + + Q P+
Sbjct: 58 KRILMDLDVVLKS-HDCPYIVKCYGYFITDSDVFICMELM-----STCLDKLLKRIQGPI 111
Query: 234 NWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDY 291
+ ++ + + L YL + H +IHRDVK +NILLD + DFG++ +L+D
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAFD------ 341
K +A G ++APE + + K DV+ G+ L+EL TGQ +
Sbjct: 169 K-AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 342 --LARLANDD 349
L ++ ++
Sbjct: 226 EVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 143 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 185
LG G FG+V+ K + + LVAVK L+ + + F EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 186 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER-------GQSQPPLNWSVR 238
+S N+ RL G C ++ +M NG + L++ + L++S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTH 295
+A A G+ YL +HRD+ N L+ + + + DFG+++ + DY
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-- 187
Query: 296 VTTAVRGT----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
V+G I +A E + GK + K+DV+ +GV L E++T
Sbjct: 188 ----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 142 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRL 197
++G+G FGKV R +DGS AVK L+++ + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
T + V ++ G + L RER +P + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVASAIGYLHSL- 115
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTG 315
II+RD+K NILLD + V+ DFGL K ++ ++T T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 316 KSSEKTDVFGYGVMLLELITGQRAF 340
D + G +L E++ G F
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
D++ LG G + VYKG+ +G LVA+K ++ + +G E ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++ L T LV+ + V+ + + + P N K RGL+Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPEN---VKLFLFQLLRGLSYIH 120
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-YL 312
I+HRD+K N+L+ + E + DFGLA+ +H + T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL 176
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAF 340
+ + S D++G G + +E+I G AF
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRL-- 197
LG G FG+VYK R + G +VA+K++ E+ G + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74
Query: 198 ------RGFCMTPTERLLVYPFMV--------NGSVASCLRERGQSQPPLNWSVRKQIAL 243
+V P+M N SV L S K L
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------------LTESQIKCYML 122
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290
G+ YLH++ I+HRD+KAANIL+D + + DFGLA+ D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 192
D + N + G +G VY+ R G +VA+K+LK E+ +G + E+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 193 NLLRLRGFCM--TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
N++ ++ + + +V ++ + + S + + P S K + L G+A
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVA 120
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIG 305
+LHD+ I+HRD+K +N+LL+ + DFGLA+ L Y VT R
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR---- 173
Query: 306 HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
APE L + S D++ G + EL+T + F
Sbjct: 174 --APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 142 ILGRGGFGKVYKGRLTDGS-LVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNL 194
+LG+G FGKV L + A+K LK++ + E M+ V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFL 58
Query: 195 LRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA--RGLA 250
L FC T+ L V ++ G + ++ G+ + + A GL
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
+LH II+RD+K N+LLD++ + DFG+ K + +T GT +IAPE
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPE 166
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
L K +E D + +GV+L E++ GQ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVH 191
T+ + + +G G FG V R G VA+K++ K T + E++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N++ L ++P E + ++ + L R PL + RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKY 123
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
+H ++HRD+K +NIL++E + + DFGLA++ +D +T V T + APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRAPEI 176
Query: 312 LST-GKSSEKTDVFGYGVMLLELITGQRAF 340
+ T K + D++ G + E++ G+ F
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 140 RNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
+ ILG G G VYK L ++AVK + + T + Q +E+E++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK---------- 55
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ----IALGAARGLAYLHD 254
C +P F V ++ C + + + IA+ +GL YL
Sbjct: 56 --CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
KI+HRDVK +N+L++ + + DFG++ + ++ T V GT ++APE +S
Sbjct: 114 L---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISG 167
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ +DV+ G+ +EL G+ + N +M L + L+ +VD D
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPL---------QLLQCIVDEDP 217
Query: 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408
+ + E+ + C + P ERP ++
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 143 LGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 199
+G G FGK + K + DG +K + + E + + EV ++S H N+++ +
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 200 FCMTPTERLLVYPFMVNGSVASCL-RERG---QSQPPLNWSVRKQIALGAARGLAYLHDH 255
+V + G + + +RG L+W V QI L L ++HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICLA----LKHVHDR 120
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
KI+HRD+K+ NI L ++ +GDFG+A++++ T + GT +++PE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 316 KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347
+ K+D++ G +L E+ T + AF+ + N
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 191
D+F LG G FG+V R G A+K L + + E ++ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIALGAAR 247
L+ L G + LV ++ G + S LR+ G+ P + + Q+ L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVA--RFYAAQVVLA--- 113
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
L YLH D I++RD+K N+LLD + + DFG AK + + T + GT ++
Sbjct: 114 -LEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYL 165
Query: 308 APEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
APE + + GK+ D + G+++ E++ G F DD+ + +
Sbjct: 166 APEIILSKGYGKAV---DWWALGILIYEMLAGYPPFF------DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 136 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRN 193
NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAY 251
+++L T + LV+ F+ L++ + P + + K +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTHVTTAVRGTIGH 306
H H +++HRD+K N+L++ E + DFGLA+ + Y VT R
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR----- 167
Query: 307 IAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAF 340
APE L K S D++ G + E++T + F
Sbjct: 168 -APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 136 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
+F+ +LG+G FGKV R L A+K LK++ + Q + +M V + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VIIQDDDVECTM-VEKRV 53
Query: 195 LRLRG---------FCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 244
L L G C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
L +LH II+RD+K N++LD E + DFG+ K + T GT
Sbjct: 114 ----LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTP 165
Query: 305 GHIAPE---YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+IAPE Y GKS D + +GV+L E++ GQ FD
Sbjct: 166 DYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
N +G G G VYK G L A+K + Q E+E++ H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
E ++ FM GS L + V +QI G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQIL----SGIAYLHRR---H 188
Query: 260 IIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
I+HRD+K +N+L++ + DFG LA+ MD ++ V GTI +++PE ++T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTD 243
Query: 316 KSSEK-----TDVFGYGVMLLELITGQRAFDLAR 344
+ D++ GV +LE G+ F + R
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 142 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG 199
+LG+G FGKV L G AVK LK++ + T VE +A+ N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 200 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--GLAYLHDH 255
+C T+ L V F+ G + ++++G+ + + + A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHSK 115
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
II+RD+K N++LD + + DFG+ K + D +T GT +IAPE L
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGL 171
Query: 316 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD--------WVKGLLKEKK-- 365
K + D + +GV+L E++ GQ F DD+ L + + + + KE K
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH-----GDDEDELFESIRVDTPHYPRWITKESKDI 226
Query: 366 LEQLVDSD 373
LE+L + D
Sbjct: 227 LEKLFERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG----ELQFQTEVEMISMA 189
D + +G G +GKVYK R G LVA+K+ + E + G L+ + ++M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 190 VHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 242
++ ++RL + E LV+ ++ + PL K
Sbjct: 61 IY--IVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAK-----LMDYKDTHV 296
+G+A+ H H ++HRD+K N+L+D++ + + D GL + + Y V
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 297 TTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 340
T R APE L S D++ G + E+ Q F
Sbjct: 174 TLWYR------APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 30/281 (10%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV 190
NF +G+G F VYK L DG +VA+K+++ E E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 246
H N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
L ++H +I+HRD+K AN+ + +GD GL + K T + V GT +
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366
++PE + + K+D++ G +L E+ Q F D + L KK+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLC------KKI 220
Query: 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
E+ + ++ EE+ L+ C P +RP +S V
Sbjct: 221 EKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 136 NFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHR 192
+F+ +LG+G FGKV R L A+K LK++ Q +++ E +++++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 193 NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
L C +RL V ++ G + +++ G+ + P +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH II+RD+K N++LD E + DFG+ K + D T GT +IAPE
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEI 172
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
++ + D + +GV+L E++ GQ F+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 137 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 193
F +LG+GGFG+V ++ G + A KRL+++R + GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++ L T LV M G + + G P ++ AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
D ++RD+K NILLD+ + D GLA + + GT+G++APE L+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAF 340
+ + D +G G ++ E+I GQ F
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 142 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERT-QGGELQ-FQTEVEMISMAVHRNLLRL 197
+LG+G FGKV L TD + A+K LK++ Q ++ TE ++++A L
Sbjct: 2 VLGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
C +RL VNG L + Q + + A L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGD---LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
+I+RD+K NILLD E + DFG+ K TT GT +IAPE L +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEY 173
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351
D + GV++ E++ GQ F+ N+DD+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 161 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220
LVAVK L+ + T+ F E++++S + N++RL G C++ ++ +M NG +
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 221 SCLRER--------GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272
L +R + P ++ + +A+ A G+ YL +HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 273 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVML 330
+ + DFG+++ + Y + R I +A E + GK + +DV+ +GV L
Sbjct: 163 GNHYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 331 LELIT 335
E+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 142 ILGRGGFGKVYKGRL--TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 197
++GRG + KV RL T+ + A+K +K+E E QTE + A + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN---WSVRKQIALGAARGLAYLHD 254
C RL VNG +R + P + +S +AL YLH+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366
D + GV++ E++ G+ FD+ +++ D D++ ++ EK++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAV---HRNLLR 196
+G G +GKV+K R G VA+KR++ + +G L EV ++ H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 197 LRGFCM---TPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
L C T E L F V+ + + L + +P + K + RGL +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H H +++HRD+K NIL+ + + DFGLA++ ++ T+V T+ + APE L
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVL 181
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 356
+ D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 48/225 (21%)
Query: 137 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EVEMI 186
+ +G G +G V G VA+K++ F E++++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53
Query: 187 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 240
H N++ L + P +V M + L + +S PL +
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQY 107
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH----- 295
RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D +
Sbjct: 108 FLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 296 ---VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITG 336
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 165 EYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 142 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
+G G FG VY+G VAVK K + +F E ++ H ++++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 198 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
G ++ + P G + S L+ S L+ + + + LAYL
Sbjct: 73 IGVITENPVWIVMELAPL---GELRSYLQVNKYS---LDLASLILYSYQLSTALAYLESK 126
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
+ +HRD+ A N+L+ +GDFGL++ ++ + + + + I +APE ++
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 316 KSSEKTDVFGYGVMLLE-LITGQRAFDLARLANDDDVMLLD 355
+ + +DV+ +GV + E L+ G + F + N+D + ++
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF--QGVKNNDVIGRIE 222
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 137 FSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRN 193
F + +LG+GGFG+V ++ G + A K+L+++R + GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL-GAARGLAYL 252
++ L T LV M G + + G N +Q A+ AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG------NPGFDEQRAIFYAAELCCGL 115
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---TIGHIAP 309
D +I++RD+K NILLD+ + D GLA + +T VRG T+G++AP
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
E ++ K + D +G G ++ E+I GQ F
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 143 LGRGGFGKVYKGRL-TDGSLVAVKRLKE----ERTQGGELQFQTEVEMISMAVHRNLLRL 197
LG GGFG+V ++ + A+K +K+ E Q + +E E++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ--QEHIFSEKEILEECNHPFIVKL 58
Query: 198 -RGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
R F ++ +Y + + G + + LR+RG + + YLH
Sbjct: 59 YRTF----KDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLH 110
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYL 312
+ II+RD+K N+LLD + DFG AK L + T T GT ++APE +
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII 164
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
D + G++L EL+TG+ F +D+D M
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFG----EDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G + VYKGR LT LVA+K ++ E +G E ++ H N++ L
Sbjct: 13 LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCD 257
T LV+ ++ + + + G N VR Q+ RGLAY H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN--VRLFLFQLL----RGLAYCHQR-- 122
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDTHVTTAVRGTIGHIAPEYL 312
+++HRD+K N+L+ E E + DFGLA+ Y + VT R P+ L
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVL 175
Query: 313 --STGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 348
ST S+ D++G G + E+ TG+ F + D
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 39/93 (41%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHI 307
LAYLH IIHRDVK NI LDE AV+GDFG A KL + DT GT+
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+PE L+ KTD++ G++L E+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 137 FSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHR 192
F + +LG+GGFG+V + R T G + A K+L+++R + GE E +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR---GL 249
++ L T LV M G + + G ++ AA GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVFYAAEITCGL 115
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
LH +I++RD+K NILLD+ + D GLA ++ + GT+G++AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
E + + + D +G G ++ E+I G+ F
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 190
NF +LG G +GKV+ R G L A+K LK+ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 191 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGA 245
R L+ L T T+ L+ ++ G + + L RER + Q QI G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSGE 113
Query: 246 -ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
L +LH II+RD+K NILLD V+ DFGL+K + + GTI
Sbjct: 114 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 305 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF 340
++AP+ + G + D + GV++ EL+TG F
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 137 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRN 193
+ N ++G G +G V K + + G +VA+K+ E+ ++ + E+ M+ H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
L+ L LV+ F+ + + L + + L+ S ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTHVTTAVRGTIGHIA 308
H IIHRD+K NIL+ + + DFG A+ + Y D T R A
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYR------A 168
Query: 309 PEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 340
PE L K D++ G ++ E++TG+ F
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 59/165 (35%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIG 305
LA H H +IHRD+K+ANILL +GDFG +K+ Y T V GT
Sbjct: 154 LAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPY 210
Query: 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365
++APE S+K D+F GV+L EL+T +R FD N ++VM K L +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVMH----KTL--AGR 261
Query: 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
+ L S I E+ Q I ALL P RP S+++ M
Sbjct: 262 YDPLPPS------ISPEM-QEIVTALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 196
++G+G FGKV + DG AVK L+++ + + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQI-ALGAARGLAYLHD 254
L T + V ++ G + L RER +P R + A A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEIASALGYLHS 114
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 313
II+RD+K NILLD + V+ DFGL K +++ T T+ GT ++APE L
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLR 169
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAF 340
D + G +L E++ G F
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 159 GSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216
G VA+K L+ + + +F+ E + + H N++ L P L V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---D 273
G LRE + L ++ L LA H+ I+HRD+K NI++
Sbjct: 63 GRT---LREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 274 EEFEAVVGDFGLAKLM-DYKDTHVTTAVR-----GTIGHIAPEYLSTGKSSEKTDVFGYG 327
A V DFG+ L+ +D V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 328 VMLLELITGQRAFDLARLA-------NDDDVMLLDWVKGL 360
++ LE +TGQR A +A + DV L W+ G
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH 216
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 143 LGRGGFGKVYKG--RLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
LG G FG V KG ++ + VA+K LK E + + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCD 257
C E L++ M +G + + + ++ V Q+++G + YL
Sbjct: 63 VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGK-- 114
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTG 315
+HRD+ A N+LL + A + DFGL+K + D++ +A + + APE ++
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 316 KSSEKTDVFGYGVMLLELIT-GQRAF 340
K S ++DV+ YG+ + E + GQ+ +
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 200
+G G +G VYK R L G L AVK +K E G + Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
++ + + + GS+ G PL+ + +GLAYLH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLSTGK 316
+HRD+K ANILL + + + DFG+A + T A R GT +APE + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 317 S---SEKTDVFGYGVMLLELITGQRA-FDL 342
+ ++ D++ G+ +EL Q FDL
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV---HRNLLRL 197
+G G +G VYK R G VA+K ++ + + G L EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 255
C T +V V LR PP L K + RGL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
C I+HRD+K NIL+ + + DFGLA++ + T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQS 182
Query: 316 KSSEKTDVFGYGVMLLEL 333
+ D++ G + E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTDG----SLVAVKRLKEER-TQGGELQFQTEVEMISMAV 190
NF +LG G +GKV+ R G L A+K L++ Q + T E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 191 HRN---LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
R L+ L T + L+ ++ G + + L +R N+S +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEI 114
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
LA H H I++RD+K NILLD E V+ DFGL+K ++ T + GTI ++
Sbjct: 115 ILALEHLH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 308 APEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDL 342
APE + G + D + G+++ EL+TG F L
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 142 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE--MISMA-VHRNLLRL 197
+LG+G FGKV+ L A+K LK++ + T VE ++S+A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 198 RGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+C T+ L V ++ G + ++ + P +I G L +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK 115
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
I++RD+K NILLD + + DFG+ K D T GT +IAPE L
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 316 KSSEKTDVFGYGVMLLELITGQRAF 340
K + D + +GV+L E++ GQ F
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 53/223 (23%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEV------------------- 183
LG+G F K++KG ++ E GEL +TEV
Sbjct: 3 LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 184 -EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNW--SVRKQ 240
M+S H++L+ G C+ E ++V ++ GS+ + L++ + ++W V KQ
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQ 108
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 300
+A L +L D + H +V A N+LL E + G+ KL D ++ V
Sbjct: 109 LAW----ALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITV 158
Query: 301 RGT------IGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITG 336
I + PE + ++ S D + +G L E+ +G
Sbjct: 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 61/287 (21%)
Query: 142 ILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
ILG G FG++ +G L S VA+ L+ + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
G ++V +M NG++ S LR+ GQ L + G A G+ YL +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM- 126
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLST 314
+H+ + A +L++ + + F +L + K + T + G + APE +
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
S +DV+ +G+++ E+++ G+R + W D
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPY---------------W----------------D 211
Query: 374 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEV 407
M G + + VE L Q+ L C Q ERP+ S++
Sbjct: 212 MSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+G G +G V+K R + G +VA+K+ E+ ++ + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLIE 67
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ LV+ + + + L E ++ + + K+I + + + H H
Sbjct: 68 VFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---N 120
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSS 318
IHRDVK NIL+ ++ + + DFG A+++ T V T + APE L +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYG 179
Query: 319 EKTDVFGYGVMLLELITGQ 337
DV+ G + EL+TGQ
Sbjct: 180 PPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
DNF +G G G V + + G LVAVK++ + Q EL F EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++ + + E +V F+ G++ + + +N + L + L+ LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLH 133
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+IHRD+K+ +ILL + + DFG + K+ ++ GT +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELIS 189
Query: 314 TGKSSEKTDVFGYGVMLLELITGQ 337
+ D++ G+M++E++ G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 136 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
N +G G G V + G VAVK++ + Q EL F EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNI 78
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARGLAY 251
+ + + E +V F+ G++ + ++ QIA L + L++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSF 130
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH +IHRD+K+ +ILL + + DFG + K+ ++ GT +APE
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEV 186
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+S + D++ G+M++E++ G+ +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQFQTEVEMI----SMAVHRNLLR 196
+G+G FG+VY+ R D + A+K L K+E E+ I + ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
L+ T ++ LV +M G + L++ G+ ++ L L +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA----LEHLHKY- 115
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
I++RD+K NILLD + DFGL+K + D T GT ++APE L K
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 317 SSEK-TDVFGYGVMLLELITGQRAF 340
K D + GV++ E+ G F
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 143 LGRGGFGKVYKGRLTDGSLVA---VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+G G FGKV + + VA VK LK + + +F + + + H N+L+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRE----RGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
C+ LLV+ + G + S L + R SQ L +++A A G+ ++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMHKH 118
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT------AVRGTIGHIAP 309
+H D+ N L + VGD+G+ YK+ ++ T +R +
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 310 EY---LSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR--LANDDDVMLLDWVKGLLKEK 364
E+ L T + ++ ++V+ GV L EL F+ A ++ D +L+ V +K++
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDREVLNHV---IKDQ 225
Query: 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
++ +L +E Y E E L Q L SP +R EV R+L
Sbjct: 226 QV-KLFKPQLELPYSERWYEVL-QFCWL----SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 12/229 (5%)
Query: 142 ILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV-HRNLLRL 197
++GRG + KV L + A+K +K+E E QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
T + V F+ G L Q Q L + + + L +LH+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGD----LMFHMQRQRKLPEEHARFYSAEISLALNFLHER-- 115
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
II+RD+K N+LLD E + D+G+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366
D + GV++ E++ G+ FD+ ++++ D D++ ++ EK++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL-KEERTQGGELQFQTEV 183
+ +L++ ++F ++GRG FG+V R V A+K L K E + + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 184 EMISMAVHRN---LLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWS-- 236
I MA H N +++L ++ L V +M G + + + P W+
Sbjct: 94 RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARF 146
Query: 237 --VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 293
+AL A + + IHRDVK N+LLD+ + DFG MD +
Sbjct: 147 YTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANG 196
Query: 294 -THVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 340
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 44/215 (20%)
Query: 145 RGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
+G FG VY K R T G A+K LK+ +MI+ N+ R M
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKS-------------DMIAKNQVTNVKAERAIMM 51
Query: 203 TPTE-----RL-----------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
E +L LV ++ G AS ++ G P +W+ KQ
Sbjct: 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL--PEDWA--KQYIAEVV 107
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
G+ LH IIHRD+K N+L+D+ + DFGL++ V GT +
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDY 159
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+APE + + +D + G ++ E + G F
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNL 194
+G G +G VYK R G +VA+K+++ E G E+ E+ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP--PLNWSVRKQIALGAARGLAYL 252
+RL + + LV+ F + L++ S P L+ + K +G+AY
Sbjct: 61 VRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 305
H H +++HRD+K N+L+D E + DFGLA+ + Y TH VT R
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYR---- 166
Query: 306 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 340
APE L + S D++ G + E++ + F
Sbjct: 167 --APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 140 RNILGRGGFGKVY--------------------KGRLTDGSLVAVKRLKEERTQGGELQF 179
+ LG G FG+V+ KGR LVAVK L+ + + F
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66
Query: 180 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------- 226
EV+++S N++RL G C+ ++ +M NG + L
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 227 GQSQ--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284
+ P +++S +AL A G+ YL +HRD+ N L+ E + DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 285 LAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342
+++ + Y + R I +A E + GK + +DV+ +GV L E++ +
Sbjct: 184 MSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 343 ARLANDD 349
L ++
Sbjct: 243 GELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 10/179 (5%)
Query: 159 GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218
G VAVK++ + Q EL F EV ++ H N++ + + E +V F+ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278
+ + + +N + L R L+YLH+ +IHRD+K+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
+ DFG + K+ ++ GT +APE +S + D++ G+M++E+I G+
Sbjct: 158 KLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 133 ATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 191
A ++ N LG G + VYKG +G LVA+K + + +G E ++ H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N++ L T V+ +M ++ G P ++VR RGLAY
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP---YNVR-LFMFQLLRGLAY 118
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
+H I+HRD+K N+L+ E + DFGLA+ ++ V T+ + P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 312 L--STGKSSEKTDVFGYGVMLLELITGQRAF 340
L +T SS D++G G + +E++ GQ AF
Sbjct: 175 LLGATDYSSA-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 142 ILGRGGFGKVY-KGRLTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMAVHRNLLR 196
++G+G FGKV R DG AVK L+++ R + + + V ++ H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 197 LRGFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
L + TE+L VNG RER +P + + A L YLH
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-----IASALGYLHS 114
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLS 313
I++RD+K NILLD + V+ DFGL K + DT TT GT ++APE +
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAF 340
D + G +L E++ G F
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 12/228 (5%)
Query: 142 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR 198
++GRG + KV RL + + A+K +K+E E QTE + A L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
C T RL + VNG L Q Q L + A L +LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFLHER--- 115
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
II+RD+K N+LLD + + D+G+ K T+ GT +IAPE L +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 319 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366
D + GV++ E++ G+ FD+ + ++ D+ D++ ++ EK +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI--ITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRN 193
+F LG G FG+V + G A+K L K E + ++Q + + I M +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 194 LL--RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
+ + F + F+V G + + LR+ G+ + ++ L Y
Sbjct: 79 FIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEY 133
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH D II+RD+K N+LLD + V DFG AK K T + GT ++APE
Sbjct: 134 LHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEV 186
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ + + D + GV+L E I G F
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 142 ILGRGGFGKVY---KGRLTD-GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLR 196
+LG+G FGKV+ K D G L A+K LK+ + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
L T + L+ F+ G + + L +E ++ + + + ++AL L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELALA----LDHLHSL 117
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVRGTIGHIAPEYLS 313
II+RD+K NILLDEE + DFGL+K + K + + GT+ ++APE ++
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVN 171
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAF 340
++ D + +GV++ E++TG F
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 142 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLR 196
++G+GG G+VY D VA+K+++E+ ++ L+ F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 197 LRGFCMTPTERLLVY---PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA------- 246
+ C ++ VY P++ ++ S L+ Q + S+ K++A +
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKE-----SLSKELAEKTSVGAFLSI 118
Query: 247 -----RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----------- 290
+ Y+H ++HRD+K NILL E V+ D+G A
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 291 ------YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
Y + + GT ++APE L +SE TD++ GV+L +++T
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G G G V R G VAVK + + Q EL F EV ++ H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ E ++ F+ G++ + SQ LN + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD+K+ +ILL + + DFG + KD ++ GT +APE +S +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 322 DVFGYGVMLLELITGQ 337
D++ G+M++E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER-TQGGELQFQ-TEVEMISMAVHRNLLRLR 198
+LG+G FGKV R G A+K LK+E E+ TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 199 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
+ +RL NG RER S+ + + ++ L YLH C
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS-C 114
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
D +++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 D--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 317 SSEKTDVFGYGVMLLELITGQRAF 340
D +G GV++ E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLK---------EERTQGGE--LQFQT--EVEMI 186
LG G +GKV K T G +VA+K++K ++R G + F T E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 187 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
+ H N++ L + LV M AS L++ + L S K I L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LMDYKDTHVTTAV 300
GL LH +HRD+ ANI ++ + + DFGLA+ D T
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 301 RG-------TIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 340
R T+ + APE L K D++ G + EL+TG+ F
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 53/226 (23%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
LGRG +G V K R + G+++AVKR++ V S R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------------ATVN--SQEQKRLLMDL-DIS 53
Query: 202 MTPTERLLVYPFMVN--------GSVASCLR--------------ERGQSQPPLNWSVRK 239
M R + P+ V G V C+ ++G + P +
Sbjct: 54 M----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE---DILG 106
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
+IA+ + L YLH +IHRDVK +N+L++ + + DFG++ + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162
Query: 300 VRGTIGHIAPEYLSTGKSSE----KTDVFGYGVMLLELITGQRAFD 341
G ++APE ++ + + K+DV+ G+ ++EL TG+ +D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 143 LGRGGFGKVY------------KGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 185
LG G FG+V+ K D S LVAVK L+E+ + F E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 186 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPP------LNWSVR 238
+S N++RL C+T ++ +M NG + L R Q +++S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
+A A G+ YL +HRD+ N L+ + + + DFG+++ + Y +
Sbjct: 133 IFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGDYYRI 188
Query: 299 AVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
R I ++ E + GK + +DV+ +GV L E++T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 140 RNILGRGGFGKVYKGRLTDGS----LVAVKRLKEE---RTQGGELQFQTEVEMISMAVHR 192
+LG+GG+GKV++ R G+ + A+K LK+ R Q + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
++ L T + L+ ++ G + L G +I+L L +L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHL 116
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H II+RD+K NILLD + + DFGL K ++ T VT GTI ++APE L
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAF 340
+ D + G ++ +++TG F
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EVE 184
D + N + +G G +G+V T G VA+K+L FQ+ E+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELR 66
Query: 185 MISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSV 237
++ H N++ L TP L LV M + + ++ L+
Sbjct: 67 LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM-GADLNNIVK-----CQKLSDDH 119
Query: 238 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 296
+ + RGL Y+H IIHRD+K +NI ++E+ E + DFGLA+ D + T +V
Sbjct: 120 IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV 176
Query: 297 TTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T + APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 141 NILGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
+G+G FG+V+K R +VA+K+ L E +G + E++++ + H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 199 GFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
C T LV+ F + +A L S K++ GL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLY 133
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287
Y+H + KI+HRD+KAANIL+ ++ + DFGLA+
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 57/278 (20%), Positives = 118/278 (42%), Gaps = 22/278 (7%)
Query: 136 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAVHR 192
NF +GRG F +VY+ L D VA+K+++ E E++++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++ + E +V G ++ ++ + + + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H +++HRD+K AN+ + +GD GL + K T + V GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372
+ K+D++ G +L E+ Q F D + L +K+EQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLFSLC------QKIEQCDYP 226
Query: 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
+ + E++ +L+ +C P +RP + V ++
Sbjct: 227 PLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 64/288 (22%), Positives = 126/288 (43%), Gaps = 58/288 (20%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRG- 199
+GRG FG V K G+++AVKR++ + + + +++++ + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 200 --------FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
CM ++ Y + V + S + E + +IA+ +
Sbjct: 72 LFREGDCWICMELMDISLDKF--YKY-VYEVLKSVIPEE----------ILGKIAVATVK 118
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGH 306
L YL + + KIIHRDVK +NILLD + DFG++ +L+ D+ T G +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173
Query: 307 IAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAF----------------DLARLAN 347
+APE + ++DV+ G+ L E+ TG+ + D L+N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233
Query: 348 DDDVM----LLDWV-KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVA 390
++ ++++ L+K++ +E +I++ E+ + VA
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 143 LGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRG 199
+G+G FGKV + R D + A+K +++ T E +A ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+P + LV F+ G + L+ G+ + S + L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR----FDLSRARFYTAELLCALENLHKF---N 113
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
+I+RD+K NILLD + + DFGL KL + KD T GT ++APE L ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 320 KTDVFGYGVMLLELITG 336
D + GV+L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 27/227 (11%)
Query: 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 184
+R+LQ+ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 185 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 238
I MA + ++ FC ++ L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAE 150
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 297
+AL A + +IHRDVK N+LLD+ + DFG MD
Sbjct: 151 VVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 298 TAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 340
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 128 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL--VAVKRLKEERT--QGGELQFQTEV 183
R+ ++ ++F+ LG G FG+V + VA+KR ++ + Q +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 184 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 243
++++ H + L G + LV F++ G + LR + + QI L
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 303
YL I++RD+K N+LLD++ + DFG AK++D + T + GT
Sbjct: 143 I----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGT 191
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+IAPE L + D + G+ + E++ G F
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 144 GRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLR 198
GRG +G+VYK + DG A+K+ K ++ Q + E+ ++ H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 199 GFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
+ ++ L++ + + R + + S+ K + G+ YLH +
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128
Query: 257 DPKIIHRDVKAANILL--DEEFEAVV--GDFGLAKLMD------YKDTHVTTAVRGTIGH 306
++HRD+K ANIL+ + VV GD GLA+L + V TI +
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV----TIWY 181
Query: 307 IAPEYLSTGKSSEKT-DVFGYGVMLLELIT 335
APE L + K D++ G + EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 85/347 (24%), Positives = 132/347 (38%), Gaps = 91/347 (26%)
Query: 142 ILGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL 194
+LG G FGKV + + + + VAVK LKE T +E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 195 LRLRG--------------FCM---------------------TPTERLLVYPF------ 213
+ L G FC +P +R
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 214 --MVNGSVASCLRER------GQSQPPLN----WSVRKQI------ALGAARGLAYLHDH 255
+ AS L R G + PP W + + ARG+ +L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEYLS 313
K IHRD+ A NILL E + DFGLA+ + YKD + R + +APE +
Sbjct: 194 ---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARLPLKWMAPESIF 249
Query: 314 TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372
+ ++DV+ +GV+L E+ + G + G+ ++ Q +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQINEEFCQRLKD 292
Query: 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAER 419
E ++ ++ L C QG P ERP S +V +L GD L E
Sbjct: 293 GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDG---------SLVAVKRLKEERTQGGELQFQTEVEM 185
D+ +G G FG+V+ R ++ V RLK+E+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRV 54
Query: 186 ISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 243
+ H ++RL F +R L + ++ G + S LR G+ + S A
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYAS 108
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRG 302
L YLH +I++RD+K NILLD+E + DFG AK L D T + G
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCG 160
Query: 303 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T ++APE + + ++ D + G+++ E++ G F
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 15/150 (10%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G G +G V+K + + +VA+KR++ ++ +G E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 201 CMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
+ + LV+ + + SC G P + S Q+ +GLA+ H H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLL----KGLAFCHSH-- 118
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 287
++HRD+K N+L+++ E + DFGLA+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 145 RGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFC 201
RG FGKVY GR + L AVK +K+ + Q + E ++A+ ++ ++ L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ LV +++ G V S L G + K I+ A L YLH H II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLHRH---GII 126
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKL 288
HRD+K N+L+ E + DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G G +G VYK R +A+K+++ E+ +G E+ ++ H N++RL+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR--KQIALGAARGLAYLHDHCDP 258
+ LV+ ++ L++ S P + R K RG+AY H H
Sbjct: 70 VHSEKRLYLVFEYL-----DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--- 121
Query: 259 KIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L +
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRH 180
Query: 318 -SEKTDVFGYGVMLLELITGQRAF 340
S D++ G + E++ + F
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 189
++ D+F + LG G G V+K L+ ++L E Q E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 190 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
++ G + E + M GS+ L++ G+ + + ++++ +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGL 116
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 308
YL + KI+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
PE L S ++D++ G+ L+E+ G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 67/296 (22%), Positives = 100/296 (33%), Gaps = 44/296 (14%)
Query: 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHRNLLRLRGF 200
+ K + T +LVAVK++ + +L+ Q E+ H N+L
Sbjct: 9 CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 201 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDP 258
L +V P M GS L+ L I L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGF-- 122
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI------APEYL 312
IHR VKA++ILL + + V+ + M + +PE L
Sbjct: 123 --IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 313 STGKS--SEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGL---LKEKKL 366
+EK+D++ G+ EL G F D+ MLL+ V+G L +K
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDM-----PATQMLLEKVRGTVPCLLDKST 235
Query: 367 EQLVDSDMEGNYIEEEV----------------EQLIQVALLCTQGSPMERPKMSE 406
L + M + E E Q LC Q P RP S+
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 46/198 (23%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 143 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+G+G G V+ D G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLD 83
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ E +V ++ GS+ + E + + R+ + + L +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---Q 135
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
+IHRD+K+ N+LL + + DFG + + + +T V GT +APE ++
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 320 KTDVFGYGVMLLELITGQ 337
K D++ G+M +E++ G+
Sbjct: 195 KVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 36/232 (15%)
Query: 129 ELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTE 182
E+ ++T F LG FGKVYKG L VA+K LK++ +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 183 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS------------- 229
M S H N++ L G +++ + + + L R
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 230 ---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286
+P + QIA G+ +L H ++H+D+ N+L+ ++ + D GL
Sbjct: 119 STLEPADFVHIVTQIA----AGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 287 KLM---DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ + DY + + I ++PE + GK S +D++ YGV+L E+ +
Sbjct: 172 REVYAADYYKLMGNSLL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 142 ILGRGGFGK--VYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
++G G FG+ + + +D A+K ++ ++ + E +++ H N++ +
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 200 FCMTPTERLLVYPFMVNGSVASCLR-ERGQSQPP---LNWSVRKQIALGAARGLAYLHDH 255
+V + G + ++ +RG+ P L W V Q+ LG H H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQ------HIH 117
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
+ +++HRD+K+ NI L + + +GDFG A+L+ + T V GT ++ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 316 KSSEKTDVFGYGVMLLELITGQRAF 340
+ K+D++ G +L EL T + F
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLR 198
+LG+G FGKV R G A+K LK+E + TE ++ H L L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 199 GFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
T V ++ G + L RER S+ + + ++ L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG-- 114
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
KI++RD+K N++LD++ + DFGL K D GT ++APE L
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
D +G GV++ E++ G+ F N D L + + L+++ K + + +D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLFELI--LMEDIKFPRTLSAD 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 143 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G+G G VY + G VA+K++ ++ EL E+ ++ + N++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 322 DVFGYGVMLLELITGQRAF 340
D++ G+M +E++ G+ +
Sbjct: 197 DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 198
++G+G FGKV R + AVK L+++ + E +E ++ V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 199 GFCMTPTERLLVYPFMVNGS--VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
F ++L +NG RER +P + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----YAAEIASALGYLHSL- 115
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
I++RD+K NILLD + V+ DFGL K + + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 317 SSEKTDVFGYGVMLLELITGQRAF 340
D + G +L E++ G F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G G +G VYK R + G L A+K +K E + + Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ + + F GS+ G PL+ S ++ +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR----GTIGHIAPEYLST--- 314
HRD+K ANILL + + DFG++ + T A R GT +APE +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 315 GKSSEKTDVFGYGVMLLEL 333
G ++ D++ G+ +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G G +G VYKGR G +VA+K+++ E +G E+ ++ H N++ L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 201 CMTPTERLLVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
M + L++ F M L + L S QI G + + H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFCHSR--- 120
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKS 317
+++HRD+K N+L+D + + DFGLA+ V T T+ + APE L + +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 318 SEKTDVFGYGVMLLELITGQRAF 340
S D++ G + E+ T + F
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMA 189
++ D+F + LG G G V K + L+ ++L E Q E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 190 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
++ G + E + M GS+ L+E + + + ++++ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 116
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 308
AYL + +I+HRDVK +NIL++ E + DFG++ +L+D + + GT +++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 170
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
PE L S ++D++ G+ L+EL G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 143 LGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 198
+GRG VY R T G+LV V+ E L+ Q EV + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
T + ++ PFM GS S L+ G S+ ++ I GA RGL YLH +
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSE-----ALIGNILFGALRGLNYLHQN 120
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------YKDTHVTTAVRGTI 304
IHR++KA++IL+ + +V GL+ L Y +T+V +
Sbjct: 121 ---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---L 172
Query: 305 GHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGL 360
++PE L + K+D++ G+ EL TG+ F D+ R MLL +KG
Sbjct: 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGP 226
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRG 302
RGL Y+H +IHRD+K +N+L++E+ E +GDFG+A+ + T +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 303 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELI 334
T + APE LS + + D++ G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
R + YLH++ +IIHRD+KA NI ++ + +GDFG A + + GTI
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
APE L+ D++ G++L E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 7/98 (7%)
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTT 298
+I++ RGL YL + KI+HRDVK +NIL++ E + DFG++ +L+D +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 156
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
+ GT +++PE L + ++D++ G+ L+E+ G
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 143 LGRGGFGKVYKG---RLTDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLR 198
LG G FG V KG VAVK LK + + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIALGAARG 248
G C + L++ L E G PLN ++K ++ + G
Sbjct: 63 GICEAESWMLVME-----------LAELG----PLNKFLQKNKHVTEKNITELVHQVSMG 107
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGH 306
+ YL + +HRD+ A N+LL + A + DFGL+K + + + G +
Sbjct: 108 MKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 340
APE ++ K S K+DV+ +GV++ E + GQ+ +
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 143 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G+G G VY + G VA+K++ ++ EL E+ ++ H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 322 DVFGYGVMLLELITGQ 337
D++ G+M +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G+G G VY + G VA++++ ++ EL E+ ++ + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ E +V ++ GS+ + E + + R+ + + L +LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 321
HRD+K+ NILL + + DFG + + + +T V GT +APE ++ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 322 DVFGYGVMLLELITGQRAF 340
D++ G+M +E+I G+ +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 79/344 (22%), Positives = 127/344 (36%), Gaps = 90/344 (26%)
Query: 143 LGRGGFGKVYK------GRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNL- 194
LGRG FGKV + + VAVK LKE T TE++ +I + H N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 195 ----------------------------LRLRGFCMTPT------ERLLVYPFMVNGSVA 220
LR + C +P +R + +
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 221 SC-----------LRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCD 257
S + ++ S + PL + ARG+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYLSTG 315
K IHRD+ A NILL E + DFGLA+ + YKD R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 316 KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ ++DV+ +GV+L E+ + G + G+ +++ + +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQIDEEFCRRLKEGT 293
Query: 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 418
E ++ + L C +P +RP SE+V +L GD L E
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL-GDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 143 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERT------QGGE--LQFQTEVEMISMAVHRN 193
LG+G F +YKG L L V +E L F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
L++L G C+ E ++V ++ G + L + L+W + +A A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNN-VSLHWKL--DVAKQLASALHYLE 118
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVR-GTIGHIAPE 310
D K++H +V NIL+ G KL D T ++ R I IAPE
Sbjct: 119 DK---KLVHGNVCGKNILVARY-GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPE 174
Query: 311 YLSTGKSS--EKTDVFGYGVMLLEL 333
+ G++S D + +G LLE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 165 KRLKEERTQGGE---LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV--------YPF 213
+RL +R + G +Q + E+ + H N+L++ + ++ Y F
Sbjct: 193 ERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSF 252
Query: 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 273
M + + PL R I + Y+HD K+IHRD+K NI L+
Sbjct: 253 MYDEAFD-------WKDRPLLKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 274 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 333
+ + V+GDFG A + + GT+ +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 334 IT 335
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 135 DNFSNRNILGRGGFG--KVYKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 190
+F ++++GRG FG +V + + T G + A+K +K+ E F+ E +++S++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 191 HRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARG 248
+ +L+ + + L LV + G + S L R Q + ++ L
Sbjct: 60 SPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA---- 114
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
+H +HRD+K N+L+D + DFG A + + GT +IA
Sbjct: 115 ---IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 309 PEYLSTGKSSEKT------DVFGYGVMLLELITGQRAF 340
PE L+T K D + GV+ E+I G+ F
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 33/85 (38%), Positives = 50/85 (58%), Gaps = 5/85 (5%)
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG 315
K++HRD+K+ANI L +GDFG +K Y D+ V ++ GT ++APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 316 KSSEKTDVFGYGVMLLELITGQRAF 340
+ S+K D++ GV+L EL+T R F
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLK------EERTQGGELQFQTEVEMISMAVHRNLL 195
+G G F +V K + G A+K +K E+ E+Q + ++ H N+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-----ALRRLSPHPNIL 61
Query: 196 RLRGFCM-TPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLA 250
RL T RL LV+ M + ++ ++ R + P V+ Q+ + L
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK--RVKSYMYQLL----KSLD 114
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
++H + I HRD+K NIL+ ++ + DFG + + K + T T + APE
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPE 168
Query: 311 -YLSTGKSSEKTDVFGYGVMLLELIT 335
L+ G K D++ G + E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 146 GGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MIS--MAVHRNLLRLRGF 200
G FGKV K + T V K +K + F +E M+ M + N ++L
Sbjct: 27 GKFGKVSVLKHKPTQKLFV-QKIIKAK-------NF-NAIEPMVHQLMKDNPNFIKLYYS 77
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
T +L+ ++ +G L + + + L+ + K+I L LH H I
Sbjct: 78 VTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NI 130
Query: 261 IHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
IH D+K N+L D + + + D+GL K++ + GT+ + +PE +
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDV 185
Query: 320 KTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353
D + GV+ EL+TG+ F D+D L
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFK-----EDEDEEL 214
|
Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 45/257 (17%)
Query: 143 LGRGGFGKV-YKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRLR 198
+G G +G V G+ VA+K+L R EL + E+ ++ H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 199 GFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
TP L LV PFM + ++ S+ + + V + + +GL Y
Sbjct: 81 D-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKY 133
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAP 309
+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R AP
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR------AP 184
Query: 310 EY-LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-----E 363
E L+ ++ D++ G ++ E++TG+ F +D LD + ++K
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK----GHDH----LDQLMEIMKVTGTPS 236
Query: 364 KKLEQLVDSDMEGNYIE 380
K+ Q + S+ NY++
Sbjct: 237 KEFVQKLQSEDAKNYVK 253
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 203 TPTER----LLVYPFMVNGSVASCLRERGQSQPPLNW--SVRKQIALGAARGLAYLHDHC 256
+ ++R L Y + R ++ P+ S+ K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 257 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 310
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 311 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 340
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 134 TDNFSNRNILGRGGFGKVYK-GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+D + +G+G +GKV+K +GS AVK L E++ + + + +++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHP 75
Query: 193 NLLRLRGF-----CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
N+++ G + LV GSV ++ + + + I A
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
GL +LH + K IHRDVK NILL E + DFG++ + T+V GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191
Query: 308 APEYLSTGKS-----SEKTDVFGYGVMLLELITG 336
APE ++ + + DV+ G+ +EL G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGEL------QFQTEVEMISMAVHRNLL 195
LG+G FG VY + D VA +RLK + GEL Q E +++S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL------NWSVRKQIALGAARGL 249
+ + ++ + + L E + L W + Q+ L G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI--QLLL----GV 119
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
Y+H +I+HRD+KA NI L +GDFG+++L+ + T GT +++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
E L K+D++ G +L E+ AF
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 199
LG+G +G VYK + +KE R + E +F E++++ AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ +M GS+ L G + + V ++I +GL +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG---HIAPEYLSTGK 316
IIHRDVK N+L++ + + DFG++ + V + + IG ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 317 SSE------KTDVFGYGVMLLELITG 336
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 142 ILGRGGFGKV--YKGRLTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRL 197
+LG+G FGKV K + T G A+K LK+E + TE ++ + H L L
Sbjct: 2 LLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
+ T V + G + L RER S+ + + ++ L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALDYLH--S 113
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
+ +++RD+K N++LD++ + DFGL K KD GT ++APE L
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 317 SSEKTDVFGYGVMLLELITGQRAF 340
D +G GV++ E++ G+ F
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 143 LGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQT---------EVEMISMAV 190
+G G FG V+ +TD G VA+K++ FQ E++M+
Sbjct: 8 IGYGAFGVVWS--VTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFK 57
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
H N+L P ++V + S L + S PL+ K RGL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
YLH I+HRD+K N+L++ + DFGLA++ + ++ T T + APE
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 311 YLSTGKS-SEKTDVFGYGVMLLELITGQRAF 340
L + + D++ G + EL+ + F
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLDE 274
S + + S P L+ + + A+G+ +L +C IHRDV A N+LL +
Sbjct: 193 QSSDSKDEEDTEDSWP-LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 275 EFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 333
A + DFGLA+ +M+ + V R + +APE + + ++DV+ YG++L E+
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 334 IT 335
+
Sbjct: 308 FS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGT 303
A+G+ +L K IHRD+ A NILL E + DFGLA+ + YKD R
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARLP 244
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363
+ +APE + + ++DV+ +GV+L E+ F L A+ + +D
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLG--ASPYPGVKID-------- 288
Query: 364 KKLEQLVDSDMEGNYI---EEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
E+ EG + + ++ Q L C G P +RP SE+V L
Sbjct: 289 ---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ K +T V T +
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 307 IAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAF 340
APE L SE T DV+ G + EL+ + F
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ + D +T V T +
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 307 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 305
RGL Y+H ++HRD+K AN+ ++ E+ +GDFGLA+++D +H G +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 306 --HIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ +P LS ++ D++ G + E++TG+ F
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQFQTEVE 184
+R+L++ +++ ++GRG FG+V R V +L K E + + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 185 MISMAVHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNW----SVR 238
I MA + ++ F +R L V +M G + + + P W +
Sbjct: 95 DI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE 150
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-- 296
+AL A + + IHRDVK N+LLD+ + DFG M+ K+ V
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRC 200
Query: 297 TTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAF 340
TAV GT +I+PE L + G + D + GV L E++ G F
Sbjct: 201 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 59/259 (22%), Positives = 94/259 (36%), Gaps = 82/259 (31%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE----RTQGGELQFQTEVEMISMA 189
D+F ++GRG FG+V+ R G + A+K L++ R Q + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADA 58
Query: 190 VHRNLLRLRGFC-MTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI------ 241
+++L + E L LV +M G + +N +RK +
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETA 103
Query: 242 ---------ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292
AL + L + IHRD+K NIL+D + + DFGL K
Sbjct: 104 RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCK--KMN 152
Query: 293 DTHVTTAVR------------------------------GTIGHIAPEYLSTGKS-SEKT 321
GT +IAPE L G +
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLEC 211
Query: 322 DVFGYGVMLLELITGQRAF 340
D + GV+L E++ G F
Sbjct: 212 DWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK----LMDYKDTHVTTAVRG 302
+ L Y+H +IHRD+K +NILL+ + + DFGLA+ L + + V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 303 TIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAF 340
T + APE L ST + ++ D++ G +L E++ G+ F
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
+GRG +G VYK + DG LK+ G + E+ ++ H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 203 TPTER----LLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDHC 256
+ +R L Y + R ++ P L + K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 257 DPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTIGHIAPE 310
++HRD+K ANIL+ E + D G A+L + K V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 311 YLSTGKSSEKT-DVFGYGVMLLELITGQRAF 340
L + K D++ G + EL+T + F
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK--EERTQGGELQFQTEVEMISMAVH 191
+ F ++G G +G V K R + +VA+K+ K EE + E + E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N++ L+ + LV+ + V ++ L E PP VR I + + +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEK--VRSYI-YQLIKAIHW 115
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPE 310
H + I+HRD+K N+L+ + DFG A+ L + + + T V T + +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPE 171
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
L + D++ G +L EL GQ F
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGT 303
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D + H +T V T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 304 IGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAF 340
+ APE + K K D++ G +L E+++ + F
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ D + T T +
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 307 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
APE L+ ++ D++ G ++ EL+ G+ F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L YLH +++RD+K N++LD++ + DFGL K D GT ++A
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
PE L D +G GV++ E++ G+ F
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL--KEERTQGGELQ-FQTEVEMISMAVH 191
++F ++GRG FG+V +L + V ++ K E + E F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAARG 248
+ + L LV + V G + + L + P + IA+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGTIGHI 307
L Y +HRD+K NIL+D + DFG KLM+ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 308 APEYLST-----GKSSEKTDVFGYGVMLLELITGQRAF 340
+PE L GK + D + GV + E++ G+ F
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 51/271 (18%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 151 VYKGRLTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208
+YKG + V ++ K+ L + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268
++ LRE + L++ + +A+ +GL L+ + ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152
Query: 269 NILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAV---RGTIGHIAPEYLSTGKSSEKTD 322
+ L+ E ++ + GL K++ +K+ V V + I EY K D
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN--VNFMVYFSYKMLNDIFSEYT------IKDD 204
Query: 323 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEE 382
++ GV+L E+ TG+ F+ N L K++ L+ + + +
Sbjct: 205 IYSLGVVLWEIFTGKIPFE-----N-------------LTTKEIYDLIINKNNSLKLPLD 246
Query: 383 VEQLIQ-VALLCTQGSPMERPKMSEVVRMLE 412
I+ + CT ++RP + E++ L
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 26/54 (48%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNPPPS 53
GEIP++L N+L VLDLS N LTG+IP S +LF I F+N+ P S
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 246 ARGLAYL-HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 303
A+G+++L +C IHRD+ A NILL + DFGLA+ + +V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362
+ +APE + + ++DV+ YG++L E+ + G + G+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-----------------PGMPV 322
Query: 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ K +++ E ++ + C P++RP ++V+++E
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 43/217 (19%)
Query: 143 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV---------EMISMAVHR 192
+G G +G V G VA+K+L FQ+E+ ++ H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 193 NLLRLRG-FCMTPTER-----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
N++ L F + LV P+M + S+ + + V + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQML----- 127
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTI 304
GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T VT R
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 181
Query: 305 GHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
APE L+ ++ D++ G ++ E++TG+ F
Sbjct: 182 ---APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----G 315
+HRD+K N+LLD + DFG M+ T ++ GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 316 KSSEKTDVFGYGVMLLELITGQRAF 340
K + D + GV + E++ G+ F
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 177 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 236
L F ++S H +L + G C+ +E ++V F+ +G + CLR + + + P+ W
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWK 119
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
+ +A A L+YL D ++H +V A NILL + + G + + D V
Sbjct: 120 I--TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG---LAE-GTSPFIKLSDPGV 170
Query: 297 TTAVRG------TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 333
+ I IAPE + G S S D + +G LLE+
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 33/230 (14%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGE--LQFQTEVEMISMAVHRNLLRLRG 199
+G+GG+G+V+ + D G +VA+KR+K+ TE ++++ L++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI-----ALGAARGLAYLHD 254
L ++ G + L G R + A+ A L Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFEAVDALHELGY--- 122
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGHIAPEYL 312
IHRD+K N L+D + DFGL+K + VT A V G+ ++APE L
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGSPDYMAPEVL 170
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM--LLDWVKGL 360
D + G ML E + G F + ++ L W + L
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS---GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGT 303
R L Y+H + HRD+K NIL + + + + DFGLA++ + DT T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 304 IGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 340
+ APE + K + D++ G + E++TG+ F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 35/122 (28%), Positives = 46/122 (37%), Gaps = 28/122 (22%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQL------------- 47
G IP SL ++ SL+VLDLS N G IP + G + ++ N L
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
Query: 48 --------NNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRK 99
+N P L+ P S G A IA GV+ L I W K
Sbjct: 516 HRASFNFTDNAGLCGIPGLRACGPHLSVG--AKIGIAFGVSVAFLFL----VICAMCWWK 569
Query: 100 RK 101
R+
Sbjct: 570 RR 571
|
Length = 623 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-----STG 315
+HRD+K N+LLD+ + DFG + T + GT +I+PE L G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 316 KSSEKTDVFGYGVMLLELITGQRAF 340
+ + D + GV + E++ G+ F
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRG 302
GL Y+H ++HRD+K N+L++ + E + DFGLA+ +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 303 TIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T + APE LS ++ DV+ G +L EL+ + F
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 199
LG+G G+V+ RL G L A+K L K+E + ++ + TE E+++ H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLAY 251
T T LV + G + L Q QP K ++ AR L Y
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL----QRQP------GKCLSEEVARFYAAEVLLALEY 118
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR---------- 301
LH I++RD+K NILL E ++ DF L+K D + V+ A+R
Sbjct: 119 LHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 302 ------------------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
GT +IAPE +S D + G++L E++ G F
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEE----RTQGGELQFQTEVEMISMA 189
++F ++ G +G VY R + A+K++ ++ R Q Q E ++++ A
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ--IQQVFVERDILTFA 58
Query: 190 VHRNLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
N + FC T+R L V ++ G A+ L+ G L + +
Sbjct: 59 --ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVL 112
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDY----------KDTH 295
L YLH++ I+HRD+K N+L+ + DFGL+K LM KDT
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 296 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
+ V GT +IAPE + + D + G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 27/147 (18%), Positives = 53/147 (36%), Gaps = 17/147 (11%)
Query: 146 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL--RLRGFCMT 203
G +VY D V LK ++ + EV ++ + + L ++ +
Sbjct: 9 GLTNRVYLLGTKDEDYV----LKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 263
L+ ++ G++ ++ ++ IA A LA LH + H
Sbjct: 65 DGWSYLLMEWI-----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 264 DVKAANILLDEEFEAVVGDFGLAKLMD 290
D+ NIL+D+ + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 141 NILGRGGFGKVYKGRLTDGS-LVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
NI+G G FG VY+ D S VA+K+ L++ + + EL + H N++ L+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN------HINIIFLK 125
Query: 199 GFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
+ T + L V + +V ++ ++ L + K + R LAY
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHI--- 307
+H I HRD+K N+L+D + + DFG AK + A + ++ +I
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSR 234
Query: 308 ---APEYLSTGKSSEKT--DVFGYGVMLLELITGQRAF 340
APE L G ++ T D++ G ++ E+I G F
Sbjct: 235 FYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 30/82 (36%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS--FANNQLNNPPPSPPPPLQ 59
G IP SL N+ +LQ L L NKL+G IP FSL IS ++N L+ P LQ
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 60 PTPPGASSGNSATGAIAGGVAA 81
N+ TG I + +
Sbjct: 309 NLEILHLFSNNFTGKIPVALTS 330
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 16/29 (55%), Positives = 23/29 (79%)
Query: 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIP 29
+G+IP SLTN+ SL+ L L++N+L G IP
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 1/52 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52
G+IP +LT++ LQVL L +NK +G+IP N G + T + + N L P
Sbjct: 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 10/94 (10%)
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-- 303
ARG+ +L +HRD+ A N+LL + + DFGLA+ + + +V+ +G+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 304 --IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ +APE + + +DV+ YG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
G+ +LH IIHRD+K +NI++ + + DFGLA+ + T T +
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
APE + E D++ G ++ EL+ G F
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 2/79 (2%)
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLS 313
H + IIHRD+K N+L++ + +GDFG A T + GT+ APE L+
Sbjct: 277 HGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA 335
Query: 314 TGKSSEKTDVFGYGVMLLE 332
+ D++ G+++ E
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 45/236 (19%)
Query: 143 LGRGGFGKVY--KGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
+G G FG+V+ K + T ++ + LKE Q EV ++ H+N++R
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS----QLVIEVNVMRELKHKNIVR 76
Query: 197 -LRGFCMTPTERL-LVYPFMVNG----SVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
+ F ++L ++ F G ++ C + G+ + + +Q+ LA
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL----HALA 132
Query: 251 YLHDHCD----PKIIHRDVKAANILLDEEFE-----------------AVVGDFGLAKLM 289
Y H+ D +++HRD+K NI L A +GDFGL+K +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 290 DYKDTHVTTAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDLA 343
+ + + GT + +PE L T +K+D++ G ++ EL +G+ F A
Sbjct: 193 GIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK------LM-DYKDTHVTTAV 300
G+ +LH IIHRD+K +NI++ + + DFGLA+ +M Y VT
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 183
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
R APE + E D++ G ++ E+I G F
Sbjct: 184 R------APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 143 LGRGGFGKVYKGRLTDGS------------LVAVKRLKEERTQGGELQFQTEVEMISMAV 190
LGRG ++Y G L + + ++ + + L F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---PLNWSVRKQIALGAAR 247
H++++ L G C+ E ++V F+ G + L +S P + V KQ+ A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL----AS 116
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-LAKLMDYKDTHVTTAVRGT--- 303
L+YL D ++H +V NILL E + G+ G KL D +T R
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAR--EGIDGECGPFIKLSD-PGIPITVLSRQECVE 170
Query: 304 -IGHIAPEYLSTGKS-SEKTDVFGYGVMLLEL 333
I IAPE + K+ S D + +G L E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 460 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.54 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.01 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 96.95 | |
| PLN02236 | 344 | choline kinase | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.57 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.52 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.48 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.45 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 96.44 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 96.35 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.89 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.88 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.84 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.84 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.8 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.79 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-57 Score=432.12 Aligned_cols=289 Identities=53% Similarity=0.901 Sum_probs=254.5
Q ss_pred CccccCHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeee
Q 012610 121 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200 (460)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 200 (460)
..+.|+++++..+|++|...++||+|+||.||+|...++..||||++....... ..+|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999988999999887655443 4569999999999999999999999
Q ss_pred eecCC-cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 201 CMTPT-ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 201 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
|.+.+ +.++|||||++|+|.++|+..... +++|..|.+|+.++|+||+|||..+.+.|+|||||++|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 499999999999999999876543 689999999999999999999999988999999999999999999999
Q ss_pred EeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 280 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
|+|||+|+..............||.+|+|||++..+..+.|+|||||||+|+|++||+.+.+... ......+.+|+..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHHH
Confidence 99999997654312111111169999999999999999999999999999999999999887543 2334459999999
Q ss_pred HhhhccccccccccCC-CCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 360 LLKEKKLEQLVDSDME-GNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.+....+.+++|+.+. ..+.. .+...+..++.+|++.+|.+||+|.||++.|+.+
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999999987 55553 6888899999999999999999999999999653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=365.70 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=211.1
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC-cceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~e~ 213 (460)
+++..+.||+|..|+||+++++ ++..+|+|++.........+++.+|+++++..+||+||.++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3444578999999999999987 688999999977666666778999999999999999999999999988 49999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|++|+|..++...+ .+++...-.|+.+|++||.|||+ . +|+||||||+|||++..|+|||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999998764 38999999999999999999996 5 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
....++||..|||||.+.+..|+.++||||||+.++|+++|+.||-.. ........+.+.....+.. +
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~pp------P 300 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPP------P 300 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCC------C
Confidence 456678999999999999999999999999999999999999999543 1222233333333332211 1
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+... .+..++..++..|+++||.+|||++|+++
T Consensus 301 ~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 301 RLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 24567899999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=385.38 Aligned_cols=256 Identities=32% Similarity=0.511 Sum_probs=209.3
Q ss_pred CCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCC-cceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~e~ 213 (460)
.+...+.||+|+||+||+|.+.+...||||++....... ....|.+|+.++.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456699999999999999854559999998643222 2557999999999999999999999999887 78999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeeCCCCCCEEecCCC-cEEEeecccccccCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVKAANILLDEEF-EAVVGDFGLAKLMDY 291 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 291 (460)
+++|+|.++++.. ....+++..++.++.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999874 234599999999999999999999999 7 99999999999999998 999999999987654
Q ss_pred CCCceeecccccccccCccccc--CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... .+.+......
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~------ 261 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVG------ 261 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhc------
Confidence 32 2233367999999999999 66999999999999999999999999963211 1112222111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+......+...+..+|.+||+.||..||++.+++..|+.+
T Consensus 262 ---~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 262 ---GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ---CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 112222333567799999999999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=427.56 Aligned_cols=259 Identities=26% Similarity=0.528 Sum_probs=212.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
..+...++||+|+||.||+|+.. ++..||||++...... ...|++.+++++||||++++++|.+....++||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45777889999999999999974 7899999998643321 23468889999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++|+|.++++. ++|..+..++.|+++||+|||+.+.++|+||||||+||+++.++..++. |+.+......
T Consensus 765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999963 7899999999999999999997666699999999999999999888875 6655432211
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
....++..|+|||++.+..++.++|||||||++|||+||+.||+.. ........+|+...........+.|+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE---FGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc---cCCCCcHHHHHHHhcCccchhheeCcc
Confidence 1124788999999999999999999999999999999999999532 123445677777665555555566665
Q ss_pred CCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 374 MEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 374 ~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
+.. .....+...+.+++.+||+.+|++||||+||++.|+++
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 533 23445667889999999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=380.24 Aligned_cols=261 Identities=30% Similarity=0.457 Sum_probs=217.7
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+++..+.+...+.||+|.||.||.|.+.....||+|.++... -...+|.+|++++++++|+|||+++++|..+...+|
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 344445555667899999999999999977899999998653 234578999999999999999999999999889999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|||||..|+|.++|+.... ..+.....+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+++..
T Consensus 279 VtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999997332 3488999999999999999999999 9999999999999999999999999999965
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
............-+..|+|||.+..+.++.|||||||||+||||+| |+.|+. +....+.+..+-...++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--------~msn~ev~~~le~GyRl-- 423 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--------GMSNEEVLELLERGYRL-- 423 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--------CCCHHHHHHHHhccCcC--
Confidence 5444434443344678999999999999999999999999999999 888874 33344444444333333
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
..+..|+..+.++|..||+.+|++|||++.+...|++..
T Consensus 424 --------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 424 --------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred --------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 334556788999999999999999999999999988743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=357.48 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=207.1
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc------hhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG------GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++..... ......+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3466788899999999999999865 79999999998654332 2224679999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC---CcEEEee
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGD 282 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~D 282 (460)
..|+||||++||+|.+.+-..+. +.+...+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999977654 77778899999999999999999 99999999999999876 7899999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCCCC---CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
||+|+... ....+...+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||... .....+.+.+.
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~----~~~~sl~eQI~- 395 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE----YTDPSLKEQIL- 395 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc----cCCccHHHHHh-
Confidence 99999865 4455667889999999999977643 45889999999999999999999532 22222222211
Q ss_pred HhhhccccccccccC--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDM--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...+ .+..+....++..++|.++|..||++|||+.|+++
T Consensus 396 -----------~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 -----------KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----------cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 12234556678899999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=353.28 Aligned_cols=199 Identities=27% Similarity=0.472 Sum_probs=180.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc-ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.+|...+.||+|+||+||+|+++ ++..||||.+.+.. ..+..+.+..|+.+|+.++|||||.+++++..++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888888999999999999976 57899999998765 33445568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC------CcEEEeecccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLA 286 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfg~~ 286 (460)
||.||+|.++++..+. +++..++.++.|||.||++||++ +||||||||.|||++.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998763 89999999999999999999999 99999999999999875 45899999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+.+.. .......+|++.|||||++..++|+.|+|+||.|+|+|+|++|+.||+.
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98763 3445567899999999999999999999999999999999999999963
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=372.36 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=208.3
Q ss_pred cCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.+|..+++||+|+|+.||.++. ..|+.||+|++.+... ......+.+|+++.+.++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999998 6899999999986543 334556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
|+|..++|..+++.++ ++++.+++.++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998543 499999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.... ....+||+.|+|||++.....+..+||||+||+||.|+.|++||+... ++..+..-+..+.
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vkety~~Ik~~~Y-- 235 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKETYNKIKLNEY-- 235 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------HHHHHHHHHhcCc--
Confidence 5433 345789999999999999999999999999999999999999996321 1111111111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .+........+||.++|+.+|.+|||+++|+.
T Consensus 236 -~----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -S----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -c----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 11122345677888999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=342.71 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=209.3
Q ss_pred CCccCCeecccCCeEEEEEEE-CCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeee-eeecCCc-ceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRG-FCMTPTE-RLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~-~~~~~~~-~~lv~ 211 (460)
+|.+.++||+|.||+||++.. .+|..+|.|.++-.... ....++..|+.+|++++|||||++++ .+..+++ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 566668899999999999985 47999999999844333 33456889999999999999999998 4444455 88999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||.+|+|..+++.....+..+++..+|+++.|++.||..+|++... -|+||||||.||+++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999998877777899999999999999999999995432 39999999999999999999999999999987
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
..... ....+|||.||+||.+....|+.+|||||+||++|||+.-..||... ++.+.-. .+.......+.
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~-KI~qgd~~~~p 249 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCK-KIEQGDYPPLP 249 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHH-HHHcCCCCCCc
Confidence 55443 44577999999999999999999999999999999999999999632 2222221 22222211111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
......++..++..|+..||..||+.-.+++.+.
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1345677899999999999999999655554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=381.02 Aligned_cols=263 Identities=28% Similarity=0.466 Sum_probs=219.9
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
++...+....+.||+|+||+||+|+.. +...||||.++........++|++|++++..++|||||+++|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344556666788999999999999854 35689999999887777788999999999999999999999999999
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQS----------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 274 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~ 274 (460)
+..++|+|||..|+|.++|...... ..+++..+.+.|+.|||.||.||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999764321 34589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCceee-cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCcc
Q 012610 275 EFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVM 352 (460)
Q Consensus 275 ~~~~kl~Dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~ 352 (460)
+..|||+|||+++.+...+..... ...-.++|||||.+..+++|++||||||||+|||+++ |+.||....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------- 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------- 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------
Confidence 999999999999987655544332 2234679999999999999999999999999999999 999985321
Q ss_pred HHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.-+ |...+..+.+ -..++.++..+++||..||+.+|++||+++||-..|+.-
T Consensus 711 n~E-VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 711 NQE-VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred hHH-HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 111 1222222222 233556788999999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=343.14 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=204.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
..++|+..++||+|+||+|+.++.. +++.+|+|++++..... .......|..+|..++||+||+++..+++....|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3568999999999999999999865 58899999998765433 34568899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|+||+.||.|..+|++.+. +++..++.+++.|+.||.|||++ +|+||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999987654 89999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
- ........++||+.|||||++.+..|+..+|+||+||++|||++|.+||... +...+.......+.
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~---- 242 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKL---- 242 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcC----
Confidence 3 2333445578999999999999999999999999999999999999999532 23333333333320
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 403 (460)
...+.+ ......+++...++.||++|..
T Consensus 243 ---~~~p~~---ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 243 ---PLPPGY---LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ---CCCCcc---CCHHHHHHHHHHhccCHHHhcC
Confidence 011111 1245677888889999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=338.36 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=202.6
Q ss_pred cCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC--cceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv~ 211 (460)
.++...+.||+|+||+||++...+ |...|||.+....... ...+.+|+.+|.+++|||||+++|...... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 356677899999999999999764 8999999987653322 446889999999999999999999855544 588999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeecccccccC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 290 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 290 (460)
||+.+|+|.+++...+. .+++..++.++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999998764 399999999999999999999999 9999999999999999 7999999999998766
Q ss_pred C--CCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 291 Y--KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 291 ~--~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
. ..........||+.|||||++.++. ...++|||||||++.||+||+.||... ....+++.........
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~- 241 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL- 241 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC-
Confidence 3 2222234567999999999998643 345999999999999999999999631 1112222222111111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
+..+........+++.+|++.+|++|||+.++++.-
T Consensus 242 --------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 --------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 122333445688899999999999999999999743
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=348.36 Aligned_cols=269 Identities=27% Similarity=0.456 Sum_probs=215.1
Q ss_pred cccCHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeee
Q 012610 123 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFC 201 (460)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~ 201 (460)
.+.+..+|++..+.+.+...||+|.||+||+|++.+ .||||+++..... ...+.|+.|+.++++.+|.||+-+.|+|
T Consensus 380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred CCccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 345668888888999999999999999999999863 5999999876543 3455799999999999999999999999
Q ss_pred ecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 202 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
..+.. .+|+-+|+|.+|..+++.... .++....+.|+.|||+||.|||.+ +|+|||||..||++.+++.|||+
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence 98877 999999999999999997653 489999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-CceeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 282 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 282 Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
|||++.....-. ......-.|...|||||+++. .+|+..+|||||||++|||+||..||.. ...++.+...-
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi----~~~dqIifmVG 606 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI----QNRDQIIFMVG 606 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC----CChhheEEEec
Confidence 999997543221 111222337788999999864 4689999999999999999999999952 11111111000
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
++.+ ..+. ......+.+.+.+|+..||..++++||.+.+|+..|+..
T Consensus 607 rG~l----~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 607 RGYL----MPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cccc----Cccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 0000 0000 112345677899999999999999999999999988763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=331.02 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=211.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
..+.|+..++||.|..++||+|+.. .+..||||++.-+.+......+.+|+..++.++||||++++..|..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467899999999999999999864 679999999998888777778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
+||.+|++.+.++...... +++..+..|+.++++||.|||++ |.+|||||+.||||+.+|.|||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999998765443 99999999999999999999999 999999999999999999999999998766544
Q ss_pred CCCcee---ecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 292 KDTHVT---TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 292 ~~~~~~---~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
...... ...+|+++|||||++.. ..|+.|+|||||||+..||.+|..||...... ..+..- +... .
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm----kvLl~t----Lqn~-p 249 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM----KVLLLT----LQND-P 249 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH----HHHHHH----hcCC-C
Confidence 332211 44679999999999644 35899999999999999999999999532110 001111 1111 1
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....-..+..+........+.+++..|++.||++|||+.++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1001111122223334557889999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=320.88 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=204.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+.|+...++|+|+||+||+++.+ +|+.||||++....... ..+-.++|+++|+++.|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999987 59999999997654432 34457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||+. ++.+-|+.... .++....++++.|++.|+.|+|++ +++||||||+|||++.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9977 44444544332 388999999999999999999999 999999999999999999999999999998864
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH------------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG------------ 359 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------ 359 (460)
....++.++.|.+|.|||.+.+ .+|...+||||.||++.||++|.+.|-..+ +.+..-.+..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-----DiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-----DIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-----hHHHHHHHHHHHcccCHHHHHH
Confidence 4455666778999999999988 689999999999999999999998884321 1111111111
Q ss_pred HhhhccccccccccCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+........+.-+.... ........-+++++..|++.||.+|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111111110 111223346889999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=341.12 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=206.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 209 (460)
..+|..++.||+|+|++|++|+.. .++.||||++.+..... ..+.+..|-++|.++ .||.|++|+.-|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 468899999999999999999865 68999999998754332 233577888999998 79999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|+||+++|+|.++|++.+. +++...+.++.+|+.||+|||++ |||||||||+|||||++|++||+|||.|+.+
T Consensus 152 vLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999998764 99999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCc----------e--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 290 DYKDTH----------V--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 290 ~~~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
...... . ...++||..|.+||++..+..+..+|+|+||||||.|+.|++||.... +....+.+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliFqkI 299 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIFQKI 299 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHHHHH
Confidence 643211 1 245789999999999999999999999999999999999999996321 11111111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. . ++-..... ......+|+.+.|..||.+|+|.++|-+
T Consensus 300 ~---~-------l~y~fp~~----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 300 Q---A-------LDYEFPEG----FPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred H---H-------hcccCCCC----CCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1 0 11112222 2356778888899999999999977765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=350.20 Aligned_cols=263 Identities=28% Similarity=0.466 Sum_probs=205.0
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
++..++|++.++||+|+||.||+|... ++..||+|++...........+..|+.++..+ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 456678999999999999999999741 35689999997654444445688999999999 89999999998876
Q ss_pred CC-cceEEeeccCCCCHHHHhhhcCCC-----------------------------------------------------
Q 012610 204 PT-ERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 229 (460)
Q Consensus 204 ~~-~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 229 (460)
.+ ..+++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999998753211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc-eeeccccc
Q 012610 230 -----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 303 (460)
Q Consensus 230 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~ 303 (460)
..++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23478889999999999999999999 9999999999999999999999999999865322221 12223356
Q ss_pred ccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHH
Q 012610 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEE 382 (460)
Q Consensus 304 ~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (460)
..|+|||++.+..++.++|||||||++|||++ |..||..... .. ..... ....... ......
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~---~~~~~-~~~~~~~---------~~~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NE---EFCQR-LKDGTRM---------RAPENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cH---HHHHH-HhcCCCC---------CCCCCC
Confidence 78999999999999999999999999999997 9999953211 00 11111 1111100 011123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 383 VEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 383 ~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...+.+++.+||+.||++|||+.+|++.|++
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=372.94 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=216.8
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC--Cc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD--GS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
+..++.+..+.||+|.||.||.|.+.+ +. .||||.+++........+|.+|..+++.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 335667778899999999999998653 33 499999998887888889999999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQ---SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
..++++|||++|+|..+|++... ....++....+.++.|||+|+.||+++ ++|||||..+|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987522 134589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecc-cccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHH
Q 012610 283 FGLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
||+|+.+...+....... .-...|||||.+..+.++.|+|||||||++||++| |..||.. ....+.+..+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~--------~~n~~v~~~~ 917 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS--------RSNFEVLLDV 917 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC--------cchHHHHHHH
Confidence 999995544433322222 23468999999999999999999999999999999 8889842 1222222333
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..++++. .+..|++.++++|.+||+.+|++||++..|++.++.+
T Consensus 918 ~~ggRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 918 LEGGRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred HhCCccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 3333322 2345678899999999999999999999999987764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.48 Aligned_cols=244 Identities=27% Similarity=0.468 Sum_probs=204.6
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+.....+-||.|+.|.||+|++. ++.||||+++.-. ..+|+-|++++||||+.+.|+|....-++||||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 33344567999999999999997 6889999886422 35788899999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
..|.|.++|+... ++.......|..+||.||.|||.+ .|||||||.-||||+.+..|||+|||-++.....
T Consensus 195 a~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 195 AQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred ccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 9999999998754 478888999999999999999999 9999999999999999999999999999876544
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
.....+.||..|||||++.+.+.++|+||||||||||||+||..||..... ...+..+-...+
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----------------sAIIwGVGsNsL 328 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----------------SAIIWGVGSNSL 328 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----------------heeEEeccCCcc
Confidence 334457799999999999999999999999999999999999999953111 011111222222
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.-..+..+++.+.-|+++||+-.|..||++++++.-|+-
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 333455677888889999999999999999999998875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=337.03 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=206.5
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCC-cceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT-ERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~-~~~l 209 (460)
..++|...++||.|+||.||+|+.. .+..||||++++......+..-++|+..|++++ ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4567888899999999999999865 688999999986544433334578999999999 999999999998877 8999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|||||+ .+|.++++.+ ..++++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999995 5999999876 34699999999999999999999999 9999999999999998889999999999987
Q ss_pred CCCCCceeecccccccccCccccc-CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
..... .+.++.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|-+.+.. +..-.+-..+.......
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-----Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-----DQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-----HHHHHHHHHhCCCcccc
Confidence 65443 45567899999999875 567899999999999999999999888432211 11111111111111111
Q ss_pred ccc------------ccCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVD------------SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~------------~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... +.+.+ .....+..+..+++.+|+++||.+|||+.|.++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 000 01111 112235677899999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=334.42 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=208.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 209 (460)
.+.|+..++||+|+||.||+|+.. +|+.||+|++..+... ....-..+||.+|++++||||++|.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456788889999999999999864 7999999999876533 3344567999999999999999999998776 68999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|+|||+. +|..++...+. .+++.+++.++.||+.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999977 88888876543 389999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
........+..+-|.+|.|||++.|. .|+.+.|+||.||||.||++|++.|... .+....+.+..+........
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-----tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-----TEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-----cHHHHHHHHHHHhCCCChhc
Confidence 87776667777789999999999886 5999999999999999999999998532 22222222222221111111
Q ss_pred cccccCC--------CC-------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDME--------GN-------YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~--------~~-------~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..-..+. .. .........++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1000000 00 01122345678888899999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.84 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=208.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
..|....+||+|+.|.||.|... +++.||||++..... ....-+.+|+.+++..+|+|||.+++.+...++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 46777788999999999999854 688999999976543 3334578999999999999999999999888999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
|++|+|.+.+.... +++.++..|+..+++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999997654 89999999999999999999999 99999999999999999999999999998876554
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. .....+||++|||||++....|..+.||||||++++||+-|.+||-+. .....-|+-. ..+ ...+
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa--~ng-~P~l---- 489 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIA--TNG-TPKL---- 489 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHh--hcC-CCCc----
Confidence 4 344567999999999999999999999999999999999999999421 1111111100 000 0001
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhcCCCcc
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAE 418 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~~~~ 418 (460)
.........+.+++.+||..|+++|+++.|+|+ +|....-.+
T Consensus 490 ---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 490 ---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPES 533 (550)
T ss_pred ---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence 112333456888999999999999999999996 554443333
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.57 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=216.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
....+.++||.|.||.||+|+++ ....||||.++.....+.+.+|+.|..++.+++||||++|.|+........+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34456789999999999999876 24579999999988888888999999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
.|||++|+|..+|+.+.+. +.+.+...++.+||.||+||-+. ++|||||..+||||+.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999987754 88999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCceeecccc--cccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 291 YKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 291 ~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.......+...| +.+|.|||.+...+++.+||||||||+|||.++ |.+||... ..-+.+.....+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------SNQdVIkaIe~g---- 850 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------SNQDVIKAIEQG---- 850 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--------chHHHHHHHHhc----
Confidence 554333333333 468999999999999999999999999999877 99998531 112222222222
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.+-..+.+|+..|.+||+.||++|-.+||.+.+|+..|++
T Consensus 851 ------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 851 ------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 2222344577889999999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=310.03 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=197.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...- ...+...+|..+|+.+.||+++++.+.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57788899999999999999976 6889999999865432 33446788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||++||.|..++++.+. +++..++.++.+|+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999988654 89999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. ....+||+.|+|||.+....++.++|.|||||++|||+.|..||..... .. ..+.++.
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~---------iY~KI~~ 255 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQ---------IYEKILE 255 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HH---------HHHHHHh
Confidence 3 4557899999999999999999999999999999999999999953211 01 1111121
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMER 401 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 401 (460)
..+. ++......+.+|+...++.|-.+|
T Consensus 256 ~~v~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKVK--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Cccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 1111 122223456777777888888888
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=331.73 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=212.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
..|+..+.||+|.||.||+|.+. .++.||+|++..+........+.+|+.++..++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35677789999999999999865 68899999999887777777899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
|.||++.+.++... .+.+..+.-++.++..||.|||++ +.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999997644 247777888899999999999999 99999999999999999999999999998776544
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
... ..++||+.|||||++.+..|+.|+||||||++.+||++|.+|+... +..+..-++...
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~------------------hPmrvlflIpk~ 226 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL------------------HPMRVLFLIPKS 226 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc------------------CcceEEEeccCC
Confidence 433 5678999999999999889999999999999999999999999421 112222233222
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhhc
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEG 413 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~ 413 (460)
-.+.....+...+.+++..|++.||+.||++.++++ ++..
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 222223345566899999999999999999999985 4444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=334.03 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=204.1
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc----chhHHHHHHHHHHhccC-CCcceeeeeeeecCC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~ 205 (460)
....+|...+.||+|+||+|++|... ++..||+|++...... .....+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568899999999999999999865 6899999977654211 23445778999999999 999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 284 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg 284 (460)
..++||||+.+|+|.+++...+ ++.+..+..++.|++.|++|+|++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998743 388899999999999999999999 99999999999999999 999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCC-CC-cccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ....... ..
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~k-i~ 236 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRK-IR 236 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHH-Hh
Confidence 999874 2333455677999999999999877 74 78999999999999999999996311 1111111 01
Q ss_pred hccccccccccCCCCCcHHH-HHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 363 EKKLEQLVDSDMEGNYIEEE-VEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
. ..+ .++... ...+..++.+|+..||.+|+|+.+|+
T Consensus 237 ~--------~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 237 K--------GEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c--------CCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 000 001111 46688999999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=302.08 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=209.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|...++||+|.||.||+|+.. +|+.||||+++.....+ ......+|++.|+.++|+||+.+++++.......+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999865 69999999998654433 34467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||+. +|...++... ..++...++.++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9965 8999998654 3588999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
....... +-|..|.|||.+.|. .|+...|+||.|||+.||+.|.+-|.. ..+.+....+.+.+.....+++.+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-----~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-----DSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-----CchHHHHHHHHHHcCCCCcccCcc
Confidence 5443333 578999999998875 589999999999999999998876632 223333344444443333333222
Q ss_pred ccCC--------------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDME--------------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~--------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
-... ......+....++++..++..||.+|+|+.|+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 1110 1123344566799999999999999999999885
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=334.52 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=210.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|...+.||+|.||+||+|+-+ +.+.||+|.+.+.... +..+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788889999999999999865 5789999999765443 344568999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.| +|..++...+. ++++.+..++.+++.||.|||+. +|.|||+||.|||++..|++|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9977 99999987654 99999999999999999999999 999999999999999999999999999998864
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
...+.+.+.||+.|||||...++.|+..+|.||+|||+||+++|++||... .+.+.++...++...
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v~------ 218 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPVK------ 218 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCCC------
Confidence 455666778999999999999999999999999999999999999999532 233444444333211
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+......+..++...+.+||..|.|..+++.
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11234456778888899999999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=342.81 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=205.1
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
.+..++|+..+.||+|+||.||+|+. .++..||||+++..........+.+|+.++..+ +||||++++++|..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456788899999999999999963 235689999997554444455688999999999 89999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCC------------------------------------------------------
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQS------------------------------------------------------ 229 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 229 (460)
....++||||+++|+|.++++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999998753210
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 230 -----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 230 -----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 293 DTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 293 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .......++ ......
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~----~~~~~~~~~----~~~~~~--- 336 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP----VDSKFYKMI----KEGYRM--- 336 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC----chHHHHHHH----HhCccC---
Confidence 2211 112234567999999999999999999999999999998 888885321 111111111 111000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.||++|||+.+|++.|++
T Consensus 337 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 ------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0011123568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=325.97 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=204.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|.+.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888899999999999999753 3568999999865444445578899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||.... ..+.+... .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--------~~~~~~~~-~~~~~-- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--------GQDVIKAV-EDGFR-- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHH-HCCCC--
Confidence 3222111112234678999999999999999999999999999775 999995321 11111111 11100
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+...+.+++.+||+.+|.+||++++|++.|++
T Consensus 227 -------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01122244668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=342.12 Aligned_cols=265 Identities=29% Similarity=0.423 Sum_probs=213.5
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEECC--C--cE-EEEEEecc--ccccchhHHHHHHHHHHhccCCCcceeee
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD--G--SL-VAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLRLR 198 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 198 (460)
.-..|+...++....++||+|+||.||+|++.. + .. ||||..+. ........+|..|.++++.++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344567777888888999999999999998652 2 23 89999985 23445566899999999999999999999
Q ss_pred eeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 199 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
|++......++|||+|.||+|.++|+.... .++..++..++.+.|.||+|||++ +++||||-.+|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence 999999999999999999999999998664 389999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceee-cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 356 (460)
||+|||+++.... ..... ...-+..|+|||.+..+.++.++|||||||++||+++ |..||... ...+.
T Consensus 302 KISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~~~v 371 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KNYEV 371 (474)
T ss_pred EeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CHHHH
Confidence 9999999986531 11111 1124679999999999999999999999999999999 88898532 12222
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
........ .........+..+..++.+||..+|+.||||.++.+.|+...
T Consensus 372 ~~kI~~~~---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 372 KAKIVKNG---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHHHhcC---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 22221111 111122234567888899999999999999999999998743
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.46 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=204.1
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-----------------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCccee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 196 (460)
.++|...+.||+|+||.||++.+.+ +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 33699999976544444557899999999999999999
Q ss_pred eeeeeecCCcceEEeeccCCCCHHHHhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012610 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ---------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261 (460)
Q Consensus 197 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 261 (460)
+++++.+.+..+++|||+.+|+|.+++..... ....+++..++.++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999998999999999999999999865321 113478889999999999999999999 999
Q ss_pred eeCCCCCCEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh--CCC
Q 012610 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQR 338 (460)
Q Consensus 262 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~ 338 (460)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 1222335778999999988899999999999999999987 556
Q ss_pred ccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 339 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 339 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
||.... .......+......... ... ......+...+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~-----~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT-----DEQVIENAGEFFRDQGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC-----HHHHHHHHHHHhhhccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 664211 11122222222111110 000 00111234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.31 Aligned_cols=260 Identities=15% Similarity=0.257 Sum_probs=202.5
Q ss_pred CccccCHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccch--hHHHHHHHHHHhccCCCcceeee
Q 012610 121 QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLR 198 (460)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~ 198 (460)
+++.+..++++ ......||+|++|.||+|++ +|+.||||.++....... ...+.+|++++.+++||||++++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34455555552 22236799999999999998 478999999976533221 34678999999999999999999
Q ss_pred eeeec----CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC
Q 012610 199 GFCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 274 (460)
Q Consensus 199 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~ 274 (460)
+++.+ ....++||||+.+|+|.+++.... .+++.....++.+++.||.|||+.. +++||||||+||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence 99876 346789999999999999997643 3889999999999999999999732 7889999999999999
Q ss_pred CCcEEEeecccccccCCCCCceeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCcc
Q 012610 275 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352 (460)
Q Consensus 275 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 352 (460)
++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------- 226 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------- 226 (283)
T ss_pred CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------
Confidence 9999999999998654321 12347889999999976 678999999999999999999999996321
Q ss_pred HHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+.......... .......+...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 227 ~~~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 227 TKEIYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1122121111110 001111234568899999999999999999999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.88 Aligned_cols=244 Identities=27% Similarity=0.373 Sum_probs=201.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccC-CCcceeeeeeeecCCc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 206 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 206 (460)
...-++|...++||+|.||+|+++..+ +++.+|||.+++... .+..+..+.|..++...+ ||.+++++.++++.+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999987 578999999998653 233456778888877765 9999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+.||++..+.+.. .+++..+..+++.|+.||.|||++ +|+|||||.+|||||.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999954444322 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+..-.. ....+.++||+.|||||++.+..|+.++|+|||||+||||+.|..||...+ +
T Consensus 516 Ke~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----E----------------- 573 (694)
T KOG0694|consen 516 KEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD----E----------------- 573 (694)
T ss_pred cccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC----H-----------------
Confidence 865422 335667899999999999999999999999999999999999999995321 1
Q ss_pred cccccccCC--CCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 367 EQLVDSDME--GNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 367 ~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
+++.|..+. ..++.....+...++.+.+..+|++|..+
T Consensus 574 ee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 EEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111111111 11233345678889999999999999887
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=340.15 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=204.9
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
....++|...+.||+|+||.||+|... ++..||+|+++..........+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345568889999999999999998742 23579999997654444455688999999999 89999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCC-------------------------------------------------------
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 228 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 228 (460)
....++||||+.+|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864321
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc-e
Q 012610 229 -----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-V 296 (460)
Q Consensus 229 -----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 296 (460)
...++++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478889999999999999999999 9999999999999999999999999999765432221 1
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... ...... .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~----~~~~~~---------~ 333 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYK----MVKRGY---------Q 333 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHH----HHHccc---------C
Confidence 112234567999999998899999999999999999997 9999953211 111111 111110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||+.||++|||+.+|++.|++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00001123568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=330.46 Aligned_cols=268 Identities=23% Similarity=0.376 Sum_probs=219.3
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+...+...+.++||+|.||.|.++....+.+||||.++.......+.+|..|+++|.+++||||+.++|+|..++.++++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34556777889999999999999999888999999999888877778999999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+|||++|+|.+++....... +.......|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++.+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999998764322 45556678999999999999999 99999999999999999999999999999765
Q ss_pred CCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh--CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 291 YKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 291 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
..+.. .....+-+.+|||+|.+..+++++++|||+||+++||+++ ...||.... +....+-...++......
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCcc
Confidence 44433 3333445789999999999999999999999999999765 778885321 112233333333332222
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.++ ..+.-++..++++|.+||..+..+||+++++...|++.
T Consensus 764 ~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 221 12334567899999999999999999999999988764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.60 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=199.3
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
....++|+..++||+|+||.||+|+-+ +|..+|+|++++.... .....++.|-++|...++|+||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345689999999999999999999865 6999999999876432 3345688999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
||||||++||++..+|...+ .|++..++.++.+.+.|+.-||+. |++||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999998765 499999999999999999999999 99999999999999999999999999985
Q ss_pred ccCCC-----------------------CC-----------------------ceeecccccccccCcccccCCCCCccc
Q 012610 288 LMDYK-----------------------DT-----------------------HVTTAVRGTIGHIAPEYLSTGKSSEKT 321 (460)
Q Consensus 288 ~~~~~-----------------------~~-----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~ 321 (460)
.+... .. ......+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43110 00 001124599999999999999999999
Q ss_pred CchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 012610 322 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER 401 (460)
Q Consensus 322 Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 401 (460)
|+||||||+|||+.|.+||...... ..-..+..|...+.. .. ......+..++|.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~f------P~--------~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKF------PE--------EVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccC------CC--------cCcccHHHHHHHHHHhc-CHHHh
Confidence 9999999999999999999532110 001112222221111 00 11112557788889888 99999
Q ss_pred CC
Q 012610 402 PK 403 (460)
Q Consensus 402 Pt 403 (460)
..
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 77
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=335.04 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=203.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc--ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
-|..++.||.|+.|.|.+|++. +|+.+|||++.+.. .......+.+|+.+|+.+.|||++++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4667789999999999999864 79999999997653 22234458899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++|.|.+++...+ ++++.++..++.||+.|+.|+|.. +|+||||||+|+|+|..+.+||+|||+|.+-.
T Consensus 93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 999999999998765 489999999999999999999999 99999999999999999999999999997643
Q ss_pred CCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
........+|++-|.|||++.|.+| ..++||||+|||||.|+||+.||+.. .-..+...|+. +.++
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~~----G~f~---- 230 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQR----GVFE---- 230 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHHc----Cccc----
Confidence 2334455679999999999999988 67999999999999999999999621 11112222221 1111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.....+..+|+.+|+..||++|.|++||++
T Consensus 231 ------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 231 ------MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ------CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 11223355778899999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=297.23 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=211.0
Q ss_pred HHhcCCccCCeecccCCeEEEEEE-ECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC-----C
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----T 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~ 205 (460)
+..++|.+.+.||+|+|+-||+++ ..++..+|+|++.... .......++|++..++++|||++++++++..+ .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 456789999999999999999998 4468899999998765 34455688999999999999999999887544 3
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
+.|++++|...|+|.+.++.....+.-+++.+.+.|+.+|++||++||+. .+.+.||||||.|||+++.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999998877777799999999999999999999998 33599999999999999999999999999
Q ss_pred ccccCCCCCc--------eeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHH
Q 012610 286 AKLMDYKDTH--------VTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 286 ~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 354 (460)
+....-.... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 8765422111 112234688999999885 34568999999999999999999999974221
Q ss_pred HHHHHHhhhccc-cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 355 DWVKGLLKEKKL-EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 355 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+.+ -.+....+.........+.+.+++.+|++.||.+||++.+++..+++
T Consensus 247 -------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 -------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 11111 11122222222222256789999999999999999999999998875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=320.22 Aligned_cols=257 Identities=24% Similarity=0.428 Sum_probs=206.0
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+..++|+..++||+|++|.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34567888999999999999999988888899999865322 2457889999999999999999999999889999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.++++.... ..+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999976432 2478899999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
..........++..|+|||.+.+..++.++|||||||++|+|++ |+.||.... .......+. .....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~---~~~~~---- 223 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMSALQ---RGYRM---- 223 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHHHHH---cCCCC----
Confidence 32222222335678999999988889999999999999999998 999985211 111111111 11000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.+|++||+++++.+.|++
T Consensus 224 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=317.77 Aligned_cols=250 Identities=29% Similarity=0.516 Sum_probs=194.8
Q ss_pred cCCeecccCCeEEEEEEEC-----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 139 NRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
..+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+.+++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999876 25789999997654444566899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++|+|.+++.... ...+++..+..|+.||+.||+|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998862 23489999999999999999999999 99999999999999999999999999998763222
Q ss_pred C-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 294 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 294 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. ...........|+|||.+.+..++.++||||||+++|||++ |+.||... ...++...........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~~~---- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQRLP---- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEETT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccccce----
Confidence 2 12222346678999999999999999999999999999999 77887421 2223333332221111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
....+...+.+++.+||+.+|++|||+++|++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112345688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.24 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=202.1
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
++|+..+.||+|+||.||++...++..+|+|.+.... .....+..|++++++++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4577888999999999999998888889999886432 22346888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++|+|.+++..... .+++..++.++.+++.||+|||++ +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999875432 388999999999999999999999 999999999999999999999999999876533222
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+........ ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~---~~~~~ 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFR---LYRPK 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCC---CCCCC
Confidence 22222235568999999998889999999999999999999 899985321 1122222211111 11111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.....+.+++.+||+.+|++||++.++++.|.
T Consensus 225 -------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=297.10 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=206.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
-++|++++.||+|.||.||.|+.+ ++-.||+|++.+.... ....++.+|+++-+.++||||+++++++.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 457889999999999999999875 6788999999765432 2345789999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+||..+|++...|...... .+++.....++.|+|.||.|+|.. +|+||||||+|+|++.++.+||+|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999864433 388888999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.......+||..|++||+..+..++..+|+|++|++.||++.|.+||+.... .+ .++.-..-++.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~e----tYkrI~k~~~~ 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SE----TYKRIRKVDLK 240 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HH----HHHHHHHcccc
Confidence 3334557799999999999999999999999999999999999999964221 11 11111111111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
++ ........++|.+|+..+|.+|.+..||+.
T Consensus 241 ~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 FP-------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11 223355788999999999999999999986
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=321.64 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=205.7
Q ss_pred cCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++|...+.||+|+||.||+|.... ...||+|.+...........+.+|+..+..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998642 25799999876544444556889999999999999999999999888899
Q ss_pred EEeeccCCCCHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 209 LVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
++|||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999764211 13588999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHH
Q 012610 277 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 354 (460)
.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999976533221 12222346788999999988899999999999999999998 9999853211 1
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
+.... +..... ......+...+.+++.+||+.+|.+||++.+|++.|++
T Consensus 234 ~~~~~-i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEM-IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 111111 11122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.81 Aligned_cols=268 Identities=24% Similarity=0.397 Sum_probs=223.6
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEECC---C--cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeee
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLTD---G--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~ 201 (460)
..++++..+.....++||.|.||.||+|.+.+ | -.||||.-+.+...+..+.|+.|..+++.++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 33455555666677899999999999998653 2 368999998877777778899999999999999999999999
Q ss_pred ecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 202 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
.+ ...|+|||.++-|.|..+|+....+ ++......++.||+.||+|||+. ++|||||..+||||.....+||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 76 4579999999999999999987654 88899999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHH
Q 012610 282 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 282 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
|||+++.+........+...-++.|||||.+.-.+++.+||||.|||.+||+++ |..||...
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----------------- 596 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----------------- 596 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc-----------------
Confidence 999999988776665554445678999999999999999999999999999987 99999632
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCcch
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAER 419 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 419 (460)
+..+.--.+...-+...++.|+..|+.+|.+||..+|.+||++.|+...|+++.+.++
T Consensus 597 -kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 597 -KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred -cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 1122222222333334456677889999999999999999999999999988655443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.91 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=175.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||.||+++.. ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999976 5788999998765444444578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 3889999999999999999999862 6999999999999999999999999998765322
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12234589999999999999999999999999999999999999953
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=334.32 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=206.0
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 203 (460)
.+..++|.+.++||+|+||.||+|+.. .+..||||++...........+.+|++++..+. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445678889999999999999999853 134799999976544444557899999999996 9999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCC-------------------------------------------------------
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------- 228 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 228 (460)
....++||||+++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999865321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEE
Q 012610 229 -------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 229 -------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 271 (460)
....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012478888999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCC
Q 012610 272 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 349 (460)
Q Consensus 272 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 349 (460)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence 999999999999999865432221 1122336678999999999899999999999999999997 9999853110
Q ss_pred CccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
. ........... ...........+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 346 ~----~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 346 D----STFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred h----HHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 0 00111111110 001112234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=316.78 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=198.0
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
|...+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++..++|+|++++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 6899999998754322 2233577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+|+|..++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988865332 2489999999999999999999999 99999999999999999999999999998653221
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~-------- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKEDQ-------- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhccc--------
Confidence 223345899999999999999999999999999999999999999632211 01111111111100
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
..........+.+++.+||+.||.+||+ +.++++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122356888999999999999997 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=316.32 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=205.7
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+..++|+..+.||+|++|.||+|...++..||+|.++.... ....+.+|++++++++|+|++++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34567888999999999999999987778899999875432 2446889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997643 23489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
...........+..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .............
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~---~~~~~~~~~~~~~---- 223 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----N---AEVLQQVDQGYRM---- 223 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HHHHHHHHcCCCC----
Confidence 22111111223457999999999899999999999999999999 999985311 1 1111111111000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111234668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.69 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=206.0
Q ss_pred hcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|+..+.||+|+||.||+|.+.. ...||+|.+...........+..|+..++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998752 457999998765554455678899999999999999999999999889999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+|||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 290 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 290 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVEDGYRL- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHHHcCCCC-
Confidence 522222 1112234578999999998899999999999999999998 999984211 11111111111000
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.96 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=211.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccch-hHHHHHHHHHHhccCCCcceeeeeeeecCCc-ceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~-~~lv~ 211 (460)
++|+..+++|+|+||.+++++.+ ++..+++|.+........ +....+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999876 578999999986654333 3357899999999999999999999998887 89999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
+|++||++.+.+....+ .-++++.+..|+.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999987653 3489999999999999999999998 999999999999999999999999999999876
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.... ...+.||+.||.||.+.+.+|+.|+|||||||++|||++-+++|+..+. ...+-.... ....
T Consensus 159 ~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~-----~~~~ 224 (426)
T KOG0589|consen 159 EDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINR-----GLYS 224 (426)
T ss_pred chhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhh-----ccCC
Confidence 5533 3446699999999999999999999999999999999999999964321 122221111 1111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
.........+..++..|++.+|..||++.+++..
T Consensus 225 -----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1233345668899999999999999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=320.35 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=197.8
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||+|+||.||+++.. +++.||+|++..... ......+..|++++..++||||+++++++...+..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 578999999875422 22334678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99997643 388999999999999999999999 99999999999999999999999999997543222 22233
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... . ...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~-~----------~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP-L----------RFP 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC-C----------CCC
Confidence 568999999999999999999999999999999999999995311 122222221110 0 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCc
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 417 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 417 (460)
......+.+++.+||+.||.+||++..+.+.|.-..+.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 12235678899999999999999876666666655543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.58 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=201.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||.||+|+.. +++.||+|++...... .....+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 5889999999754322 23346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 388999999999999999999999 999999999999999999999999999976433
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~---~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWK---ETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcc---cccc
Confidence 22334589999999999999999999999999999999999999953211 11111111100 0010
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
..............+.+++.+||..+|.+||+++++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000001234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.21 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=206.1
Q ss_pred hcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|...+.||+|+||.||+|...+ +..||+|.++..........+.+|++++..++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567788999999999999998642 4789999997665544456799999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc
Q 012610 208 LLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 277 (460)
+++|||+++++|.+++...+. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976432 223578999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHH
Q 012610 278 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 355 (460)
+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... . .+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~---~~ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----N---EE 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----H---HH
Confidence 99999999975432221 11122235678999999999999999999999999999998 999985321 1 11
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.+.... ...... ........+.+++.+||+.+|++|||+.||++.|++
T Consensus 233 ~~~~~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECIT-QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHH-cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111 111110 111234568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=302.62 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=200.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccch-hHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 210 (460)
++|+..+.|++|+||.||+|+++ +++.||+|+++.+..... ...-.+|+.+|.+++|||||.+.++.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35666788999999999999976 688999999986653322 33467999999999999999999987643 578999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
||||+. +|..++.... .++...+++.+..|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999976 8999998765 3589999999999999999999999 89999999999999999999999999999886
Q ss_pred CCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc---c
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---L 366 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 366 (460)
... ...+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||+++++.|... .+....+.+...+.... .
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~-----sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK-----SEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC-----chHHHHHHHHHHhCCCccccC
Confidence 543 334556689999999999876 5899999999999999999999988532 22222222222221110 0
Q ss_pred cccccc--------------cCCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDS--------------DMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~--------------~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+... .+...+... ..+.-++++...+..||.+|.|+.+.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000000 000011000 2245677888899999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=317.74 Aligned_cols=268 Identities=18% Similarity=0.240 Sum_probs=200.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|+||.||+++.. +++.||+|++...... .....+.+|++++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999986 5788999998754322 234467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.++.+..+.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554322 2488999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCC-------CCccHHHHHHHHhhhcc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 365 (460)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+....++.........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 33223334588999999999988899999999999999999999999953211000 00000000111111100
Q ss_pred ccccccccCCC------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEG------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......+.... .........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 10000000000 001112356899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=319.48 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=204.3
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
+..++|+..+.||+|++|.||+|... .+..||+|.+...........+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 46778999999999999999999753 246799999865433334456889999999999999999999999888
Q ss_pred cceEEeeccCCCCHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
..++||||+.+++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999999764321 22467888999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHH
Q 012610 280 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 357 (460)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVL 231 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999987554322211 111234678999999998899999999999999999999 788885311 11111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...... .... ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 ~~~~~~-~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEG-GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcC-CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 1110 011223568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=328.00 Aligned_cols=263 Identities=29% Similarity=0.440 Sum_probs=204.0
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
++..++|++.+.||+|+||.||+|... +++.||+|++...........+..|++++.++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 455678999999999999999999642 24789999997654444445678899999999 89999999998865
Q ss_pred C-CcceEEeeccCCCCHHHHhhhcCCC-----------------------------------------------------
Q 012610 204 P-TERLLVYPFMVNGSVASCLRERGQS----------------------------------------------------- 229 (460)
Q Consensus 204 ~-~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 229 (460)
. ...+++|||+.+++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 5678999999999999998643211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce-eecccccc
Q 012610 230 ----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTI 304 (460)
Q Consensus 230 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~ 304 (460)
..++++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||++..+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12589999999999999999999999 99999999999999999999999999998764322211 12233567
Q ss_pred cccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHH
Q 012610 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEV 383 (460)
Q Consensus 305 ~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (460)
.|+|||++.+..++.++|||||||++|||++ |..||..... ...+. ......... .......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~~----~~~~~~~~~---------~~~~~~~ 302 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEFC----RRLKEGTRM---------RAPEYAT 302 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHHH----HHHhccCCC---------CCCccCC
Confidence 8999999999999999999999999999998 9999853111 10111 111111100 0011223
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 384 EQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 384 ~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+.+++.+||+.+|++||++.||++.|++
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=323.26 Aligned_cols=242 Identities=23% Similarity=0.283 Sum_probs=194.2
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
++||+|+||.||+++.. +++.||+|+++.... ......+..|++++..++||||+++++++...+..++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 688999999975432 222345778999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 297 (460)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 9999987643 489999999999999999999999 99999999999999999999999999987532221 222
Q ss_pred ecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCC
Q 012610 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377 (460)
Q Consensus 298 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (460)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......... .. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~-~~------~~---- 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILM-EE------IR---- 213 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHc-CC------CC----
Confidence 33568999999999999999999999999999999999999995311 1111111111 00 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 378 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 378 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
........+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1112235688899999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.12 Aligned_cols=239 Identities=24% Similarity=0.309 Sum_probs=194.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888899999999999999976 588999999975422 122346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997643 378899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.. ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+....... ....
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~-~~~~---- 233 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEKILA-GRLK---- 233 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHHHhc-CCcC----
Confidence 22 22458999999999999999999999999999999999999995311 1111111111 1100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 403 (460)
. .......+.+++.+||+.||.+||+
T Consensus 234 --~----p~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 234 --F----PNWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred --C----CCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 0 1112245789999999999999997
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.30 Aligned_cols=265 Identities=28% Similarity=0.379 Sum_probs=197.0
Q ss_pred CCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHh--ccCCCcceeeeeeeecCC----cceE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTPT----ERLL 209 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~~~h~niv~l~~~~~~~~----~~~l 209 (460)
.....++||+|.||.||+|.+. ++.||||++.... ...|..|-++++ .++|+||+++++.-.... ++++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445578999999999999997 5999999997543 346777777765 568999999998765444 7899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH------CDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
|++|.+.|+|.++|..+. ++|....+|+..+++||+|||+. .+|.|+|||||++||||.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999998764 89999999999999999999975 4678999999999999999999999999
Q ss_pred ccccccCCCCCc-eeecccccccccCcccccCCCC------CcccCchhhHHHHHHHHhCCCcccc--------ccccCC
Q 012610 284 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITGQRAFDL--------ARLAND 348 (460)
Q Consensus 284 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~------~~~~Dvws~G~il~el~tg~~p~~~--------~~~~~~ 348 (460)
|+|..+...... .....+||.+|||||++.+... -.+.||||+|.|||||+++..-++. +...+-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999887643322 2233679999999999976532 2468999999999999997655431 111010
Q ss_pred C-CccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 349 D-DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 349 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. ...+.+.....+..+.-..+.+.=. ....+..+.+.+..||+.||+-|.|+.=|.+.+...
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 0 1111122122222221111111110 113456788999999999999999999988877653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.62 Aligned_cols=245 Identities=23% Similarity=0.277 Sum_probs=198.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 688999999864322 123346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~-~~----- 215 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAG-KL----- 215 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-Cc-----
Confidence 2 122458999999999999889999999999999999999999995321 11111111111 10
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
.........+.+++.+||+.||.+||+ ++++++
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 001112345789999999999999995 666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=317.77 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=198.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|...+.||+|+||.||+|... ++..||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999876 68899999997654444444678899999999999999999999988889999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+ +|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 89998875432 378899999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh---------
Q 012610 294 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--------- 363 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 363 (460)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcc
Confidence 21 223347889999998865 56899999999999999999999999532111 001111110000
Q ss_pred ---ccccccccccCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 ---KKLEQLVDSDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ---~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+...... .........+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000 0012345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.81 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=201.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.+|+..+.||+|+||.||+|++. ++. .||+|.++..........+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888999999999999999864 333 48999987654444455788999999999999999999998764 5789
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+++|+.+|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999976432 378999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcee-ecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 290 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 290 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
........ ....++..|+|||.+.+..++.++|||||||++|||++ |+.||+... ..++.. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~~-~~~~~~-- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISS-ILEKGE-- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH-HHhCCC--
Confidence 53332211 11224568999999999999999999999999999998 999985311 111111 111110
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
... ....+...+.+++.+||+.+|++||++.+++..|...
T Consensus 229 ~~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 229 RLP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCC-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 0111235688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=319.13 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=197.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999976 6889999999765443334467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 68888876543 2378899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc-----
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL----- 366 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 366 (460)
.. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......+.........
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD----IQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhCCCChhhccc
Confidence 21 1223457899999998865 4578899999999999999999999963211 00111111111000000
Q ss_pred ----cccccccC---CCCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 ----EQLVDSDM---EGNYIEE------EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ----~~~~~~~~---~~~~~~~------~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........ ....... ....+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 0000000 1245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=313.51 Aligned_cols=262 Identities=19% Similarity=0.308 Sum_probs=208.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||.||+|+.. +++.||||.+..... ......+..|+++++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999875 689999998864322 223446888999999999999999999999889999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++.........+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999875443344588999999999999999999999 999999999999999999999999999887543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.... .....+........ .
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~------~ 225 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQCD------Y 225 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhcCC------C
Confidence 3221 122347889999999988889999999999999999999999984211 11122222111100 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
+ ..........+.+++.+||+.+|++||++.+|++.|++..
T Consensus 226 ~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 P---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 1112233466899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=317.10 Aligned_cols=266 Identities=27% Similarity=0.371 Sum_probs=200.2
Q ss_pred ccCCeecccCCeEEEEEEE-----CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEE
Q 012610 138 SNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 210 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 210 (460)
...+.||+|+||+||++.. .++..||+|.+...........+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988753 257789999997654434455788999999999999999999988654 357899
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++... .+++..++.++.|++.||.|||++ +++||||||+||++++++.++|+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999753 289999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 291 YKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 291 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccccccchhhhhh
Confidence 32211 1112235667999999988889999999999999999999999985321100 000000000000001111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+..............+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111111222346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.37 Aligned_cols=255 Identities=29% Similarity=0.413 Sum_probs=203.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..+|...+.||+|++|.||+|... .++.||+|.+.... .....+.+|++++..++|+|++++++++......+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345777889999999999999875 47889999987532 223468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999976432 3489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+.........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~------- 222 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKGY------- 222 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCC-------
Confidence 2221112224567999999998999999999999999999998 999985211 111111111110
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 223 ---RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 011111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=316.01 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=199.1
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-------------chhHHHHHHHHHHhccCCCcceee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------------GGELQFQTEVEMISMAVHRNLLRL 197 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~niv~l 197 (460)
..-+.|++.+.||+|.||.|-+|+.. +++.||||++.+.... ...+...+|+.+++++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44568999999999999999999875 6899999999753211 112368899999999999999999
Q ss_pred eeeeecC--CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC
Q 012610 198 RGFCMTP--TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275 (460)
Q Consensus 198 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 275 (460)
+++..+. +..|+|+|||..|.+...=- ....+++.++++++.++..||+|||.+ +|+||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998775 57899999999887643321 112289999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCC----CceeecccccccccCcccccCCC----CCcccCchhhHHHHHHHHhCCCccccccccC
Q 012610 276 FEAVVGDFGLAKLMDYKD----THVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLAN 347 (460)
Q Consensus 276 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 347 (460)
|++||+|||.+....... ........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 999999999998663221 11122256999999999987743 3678899999999999999999994211
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
.. + -...++...+......+..+.+.+|+.++|.+||+.|.+..+|....
T Consensus 324 --~~---~---------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 --EL---E---------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --HH---H---------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 1 11223333333222334556788999999999999999999998654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=309.35 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=208.4
Q ss_pred cCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccch--hHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.+|++.+.||+|.||.|-+|.. ..|+.||||.++++...+. ...+.+|+++++.++||||+.++++|.+.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4688889999999999999985 5799999999987765443 336889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||..+|.|.+++...+. +++.+++.++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999988764 99999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
......++|++-|.+||++.+.+| .+.+|.|||||+||.|+.|.-||+.. +....++... .+...+
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs-~GaYrE-- 272 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQIS-RGAYRE-- 272 (668)
T ss_pred --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhh-cccccC--
Confidence 334566889999999999999988 68899999999999999999999642 2222222221 111111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
+ +.+....-||++|+..+|++|.|+.+|+.--
T Consensus 273 -P--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -P--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -C--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1123466789999999999999999998754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=312.31 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=201.3
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
++|...+.||+|++|.||+|+..++..+|+|.+..... ....+.+|+.++.+++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46777889999999999999987777799999875432 2346889999999999999999999998888899999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+|+|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999976432 489999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~------- 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVSQGLRL------- 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHhcCCCC-------
Confidence 11122235568999999988889999999999999999998 999985311 11111111111110
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.........+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112367899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.64 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=203.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..++|++.+.||+|++|.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 4467888899999999999999988888899999876433 2346889999999999999999999875 456899999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|.+++.... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999997643 23488999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+..........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------ 221 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVERGYR------ 221 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC------
Confidence 2222222235568999999988889999999999999999999 889985311 1111111111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||..+|++|||+.++.+.|++
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.26 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=196.1
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
+.||+|+||.||+|... +++.+|+|.+...........+.+|+++++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 68899999887554444455788999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee-e
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 298 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 298 (460)
.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997543 2488999999999999999999999 999999999999999999999999999875432111110 1
Q ss_pred cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCC
Q 012610 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377 (460)
Q Consensus 299 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (460)
....+..|+|||.+.++.++.++||||||+++|||++ |..||..... .. ........ ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~---------~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQG---------VRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcC---------CCCC
Confidence 1123456999999999899999999999999999998 8888853110 01 11111110 0011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 378 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 378 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
........+.+++.+||+.+|++|||+.+|++.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11223456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=324.54 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=192.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+|+..+.||+|+||.||+|+.. +++.||||++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556688999999999999875 689999999976544444557889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+|+|.... ...+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986432 256777889999999999999999 999999999999999999999999999986543221
Q ss_pred ceeecccccccccCcccccC-----CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
......|+..|+|||.+.. ...+.++|||||||++|||++|+.||..... ..............
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~----- 292 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQ----- 292 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccC-----
Confidence 1233458999999998743 2345689999999999999999999962211 11111111110000
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...........+.+++.+||+.||++|||+.||++
T Consensus 293 -----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 -----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111123456889999999999999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=326.92 Aligned_cols=263 Identities=28% Similarity=0.424 Sum_probs=220.0
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
.++|+....+.....+||.|.||.||.|.++. ...||||.++.+... ..+|+.|..+++.+.|||+|+++|+|....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 46677777777888999999999999999875 467999999876543 457999999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..|||+|||..|+|.+||+...... ++-...+.++.||+.||+||..+ ++|||||..+|+||.++..+|++|||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999998865433 77788899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++++............-.+.|.|||.+....++.|+|||+|||+|||+.| |..||- +.++.+..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------GidlSqVY------- 476 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------GIDLSQVY------- 476 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------CccHHHHH-------
Confidence 99986544333332334678999999999999999999999999999998 888873 22222222
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.++....+.+.+..|+..+++||++||+++|.+||++.|+-+.++..
T Consensus 477 ---~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 477 ---GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ---HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 22333334444566788999999999999999999999999988764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.91 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=175.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
..++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999976 578899998876544444456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.... .+++..+..++.+++.||.|||+.. +++|+||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 3789999999999999999999742 799999999999999999999999999875432
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 12234588999999999988899999999999999999999999963
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.21 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=206.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
...+|+..++||.|+||.||+|...++..+|+|.+..... .....+..|+.+++.++|+||+++++++......+++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4457888899999999999999988889999999875433 223468889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++..... ..+++..++.++.+++.||+|||++ +++|+||+|+||+++.++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999976432 3489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+..........
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------ 222 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGYR------ 222 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhCCc------
Confidence 211 122335678999999988889999999999999999998 899995321 1111111111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=318.95 Aligned_cols=264 Identities=29% Similarity=0.434 Sum_probs=207.5
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+.+..++|+..+.||+|+||.||++...+ ...+|+|.+...........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34556778889999999999999998642 3679999987654444445688999999999 7999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCE
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 270 (460)
.....+++|||+.+|+|..+++... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9889999999999999999997532 2234589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 348 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~ 348 (460)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----
Confidence 99999999999999998654322111 111224567999999988899999999999999999998 988884211
Q ss_pred CCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+.... ..... ...........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 240 ----~~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 ----VEELFKL-LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHH-HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111 11111 0011112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=312.38 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=202.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..++|++.++||+|+||.||+|+..++..||+|.+..... ....+.+|+++++.++|+||+++++.+. ....+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 3467889999999999999999987777899999975332 2346889999999999999999999874 456799999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+|+|.+++..... ..+++..++.++.+++.||+|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999975422 2478999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.........++..|+|||...+..++.++|||||||++|||++ |..||.... . .+.........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~---~~~~~~~~~~~------- 220 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N---REVLDQVERGY------- 220 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----h---HHHHHHHhcCC-------
Confidence 3222222335678999999988899999999999999999999 888885311 0 01111110000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...........+.+++.+|++.+|++||++.++++.|++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 221 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 001122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.13 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=208.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCC-cEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeee-eec-----
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGF-CMT----- 203 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~-~~~----- 203 (460)
+...++++.++|.+|||+.||+|....+ ..||+|++-.. .......+.+|+++++.|. |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 4455677889999999999999998765 99999998765 4445557899999999997 9999999993 221
Q ss_pred -CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 204 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 204 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
.-+.+|+||||.||.|-+++..+.... |++.++++|+.++++|+++||.. .+.|+|||||.+||||+.+++.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 135689999999999999998776554 99999999999999999999997 66799999999999999999999999
Q ss_pred cccccccCCCCCce--------eecccccccccCcccc---cCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCc
Q 012610 283 FGLAKLMDYKDTHV--------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351 (460)
Q Consensus 283 fg~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 351 (460)
||.+.-.-...... .....-|+.|+|||++ .+...++|+|||+|||+||-|+....||+..
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-------- 261 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-------- 261 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--------
Confidence 99986433222110 0012258899999987 5778899999999999999999999999631
Q ss_pred cHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 352 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
-.-.|++....-.........+.+||..||+.||.+||++-+|+..+-.+
T Consensus 262 -------------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 262 -------------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -------------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 12233333333333456778899999999999999999999999888653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=311.47 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=199.8
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.+|+..+.||+|++|.||++...++..+|+|.+..... ....+.+|+++++.++|+||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 35778889999999999999987777899999864322 2346788999999999999999999999888999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999976432 489999999999999999999999 999999999999999999999999999876542221
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||+.... .+..........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~-------- 219 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVSAGYR-------- 219 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHHcCCc--------
Confidence 11111123457999999999999999999999999999999 8999853211 111111111100
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
..........+.+++.+||+.+|++|||+.+|++.|
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 001112345699999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.28 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=192.2
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|+||.||+++.. +++.||+|+++..... .....+..|+.++..+ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 5789999999764322 2233567788887766 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99998886543 389999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...............++.......... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------C--
Confidence 23356899999999999999999999999999999999999999643222222222223332222211110 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
+......+.+++.+||+.||++||+.
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11223457889999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=306.81 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=197.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC-----cceE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLL 209 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~l 209 (460)
.|...+++|+|+||.||+|... +++.||||+.-.+.... .+|+++|+++.|||||++..++.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4666789999999999999975 46899999987655432 36899999999999999998876432 2358
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 288 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~ 288 (460)
|||||+. +|.++++........++...++-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 99999986544445588889999999999999999998 99999999999999987 8999999999998
Q ss_pred cCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
+.......+ +..|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|... .+.+....+...+.....+
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-----s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-----SSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-----CHHHHHHHHHHHhCCCCHH
Confidence 876555433 3367899999998875 5899999999999999999999998531 2222222222222222112
Q ss_pred ccc----------cccCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLV----------DSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~----------~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
++. .+.+... .......+..+++.++++.+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111 1111111 12234467889999999999999999999985
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=307.72 Aligned_cols=248 Identities=30% Similarity=0.453 Sum_probs=198.3
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHH
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 220 (460)
++||+|+||.||+|...++..+|+|.+...........+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876554444456889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecc
Q 012610 221 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 300 (460)
Q Consensus 221 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 300 (460)
+++..... .+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99865432 378999999999999999999999 999999999999999999999999999875432221111122
Q ss_pred cccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 301 ~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
.++..|+|||++.+..++.++||||||+++|++++ |..||.... .............. ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--------~~~~~~~~~~~~~~----------~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--------NQQAREQVEKGYRM----------SCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHHcCCCC----------CCC
Confidence 34567999999998899999999999999999998 999985211 11111111111000 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=326.12 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=198.9
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
++....++|+..+.||+|+||.||+++.. +++.+|+|++.+... ......+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455678999999999999999999976 578999999865322 222345778999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999653 278899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCC----CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
+...............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~ 260 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIM 260 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 9876433322233456999999999987543 7889999999999999999999995321 111111111
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 410 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 410 (460)
..... +...........+.+++..|+..++.+ |+|+.|+++.
T Consensus 261 ~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11100 000001112345677888888755543 8899888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=310.41 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=204.7
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+..++|...++||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+|++++++++. .+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 45578889999999999999999988889999999875433 2346889999999999999999999864 45789999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999876432 3488999999999999999999999 999999999999999999999999999976553
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+.........
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~---- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--------NPEVIQNLERGYRM---- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--------hHHHHHHHHcCCCC----
Confidence 22222222335678999999998889999999999999999999 999995321 11111111111000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.+|++|||++++++.|+.
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111123569999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.45 Aligned_cols=261 Identities=21% Similarity=0.331 Sum_probs=209.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|++|.||+|... +++.||+|.++.... ......+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999986 789999998864322 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|..++.........+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999976544445689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....+....... .....
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~~--- 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEK-CDYPP--- 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhc-CCCCC---
Confidence 3222 222347889999999998889999999999999999999999985321 112222111111 11000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||..+|++|||+.+|++.|++.
T Consensus 228 -----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01113345788999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.15 Aligned_cols=246 Identities=25% Similarity=0.334 Sum_probs=193.5
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+++.. +++.||+|+++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 5889999999764322 2233577889988888 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99998886543 389999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+.............++........... +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p- 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IP- 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CC-
Confidence 23356899999999999999999999999999999999999999743332222222233332222221111 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
......+.+++.+||+.||.+|||+
T Consensus 226 ---~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 226 ---RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1123458889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=314.58 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=207.9
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC-----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec-CC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~ 205 (460)
+..++|...++||+|+||.||+|...+ +..|++|++...........+.+|+.+++.++|+|++++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456788899999999999999999765 688999998765444445568899999999999999999998776 46
Q ss_pred cceEEeeccCCCCHHHHhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQS----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
..+++++|+.+++|.+++...... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999764322 14589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHH
Q 012610 282 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 282 Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
|||+++.+....... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||.... ...+..++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLK- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHH-
Confidence 999998654332221 122335678999999988889999999999999999999 999995311 111111111
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...... ....+...+.+++.+||..+|++|||+.+|++.|+..
T Consensus 234 --~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 --DGYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred --cCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111100 1112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.98 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=200.3
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
...++|+..+.||+|+||.||+++.. ++..||+|++..... ......+..|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568899999999999999999876 588999999965322 122335778999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998653 278888999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeecccccccccCcccccCC----CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~ 263 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHK 263 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC
Confidence 543322223345689999999998653 47889999999999999999999995321 111111111111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 410 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 410 (460)
...... ........+.+++.+|++.+|.+ |||+.++++.
T Consensus 264 ~~~~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NSLTFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCCCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000000 00112356788999999999987 9999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.97 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=196.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..+|...+.||+|+||.||++... +++.||+|.... ..+.+|+++++.++||||+++++++......++++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 467999999999999999999875 688999996532 246789999999999999999999998889999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
++. ++|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 68888886543 388999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCC---CccHHHHHHHHhhh-c----
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD---DVMLLDWVKGLLKE-K---- 364 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~-~---- 364 (460)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||-........ ...+...+...... .
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 222233456999999999999999999999999999999999999886321110000 00011111000000 0
Q ss_pred ----cccc---------cccccCCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ----KLEQ---------LVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ----~~~~---------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ...+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000000 001123457889999999999999999999984
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=314.08 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=202.3
Q ss_pred cCCccCCeecccCCeEEEEEEE-----CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++|+..+.||+|+||.||+|.. ..+..+++|.+...........+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677788999999999999974 24578999999765444444578899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 210 VYPFMVNGSVASCLRERGQ-------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
+|||+.+++|.+++..... ....+++...+.++.+++.||+|||++ +++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 123478899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHH
Q 012610 277 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 354 (460)
.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------NQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999986543221 11222335678999999988889999999999999999998 998984211 01
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..... ....... .........+.+++.+||+.+|++||++.+|++.|.+
T Consensus 234 ~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEM-VRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 1111110 0111223568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.77 Aligned_cols=252 Identities=25% Similarity=0.312 Sum_probs=195.8
Q ss_pred CCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccc---cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
+|++.+.||+|+||.||+++.. ++..||+|++.+... ......+..|++++..+ .|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999753 578999999875322 12234577899999999 499999999999988999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987643 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..............||..|+|||.+.+.. ++.++|||||||++|||++|+.||..... ..............
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~--- 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE----RNTQSEVSRRILKC--- 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC----CCCHHHHHHHHhcC---
Confidence 65433333333456899999999998754 78899999999999999999999953211 11111111111110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
+..+. ......+.+++.+||+.||++|| +++++++
T Consensus 227 ----~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ----DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 11234578899999999999999 5556553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.60 Aligned_cols=242 Identities=23% Similarity=0.290 Sum_probs=193.1
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
+.||+|+||.||+++.. +|..||+|++..... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 689999999975432 222335678999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 297 (460)
+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998886543 389999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred ecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCC
Q 012610 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377 (460)
Q Consensus 298 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (460)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~-~~------~~--- 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-EI------RF--- 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-CC------CC---
Confidence 334589999999999999999999999999999999999999953211 1111111110 00 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 378 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 378 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.......+.+++.+||+.||.+|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112235678999999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=327.68 Aligned_cols=264 Identities=21% Similarity=0.340 Sum_probs=205.7
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM 202 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~ 202 (460)
+++..++|.+.++||+|+||.||+|++. .+..||+|+++..........+..|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455567888899999999999999853 246899999986544444456889999999997 999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC------------------------------------------------------
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ------------------------------------------------------ 228 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 228 (460)
.....++||||+.+|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 98899999999999999999975421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 012610 229 ----------------------------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 229 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 268 (460)
....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113467888899999999999999998 9999999999
Q ss_pred CEEecCCCcEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccccccc
Q 012610 269 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 346 (460)
Q Consensus 269 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~ 346 (460)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986432221 11122346788999999998889999999999999999998 8889853210
Q ss_pred CCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.+.......... ...........+.+++.+||..+|.+||++++|++.|++
T Consensus 348 -------~~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 -------NEQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -------hHHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111110 000111123568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=314.10 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=206.0
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
+..++|...+.||+|+||.||+|.... +..||+|.+...........+.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345678888999999999999998642 36899999875544444556889999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQS------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
..+++|||+.+|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999999764321 22478899999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHH
Q 012610 280 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 357 (460)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||.... ..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEVL 231 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--------HHHHH
Confidence 9999998765433221 1222335778999999988889999999999999999998 999985211 11111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.... ..... .........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 232 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVI-DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHh-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 11100 0111124678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.43 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=196.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++|+..+.||+|+||.||+|.+. ++. .+++|.+..........++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777899999999999999874 343 4788887543333333467778888999999999999998754 45788
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
++||+.+|+|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 290 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 290 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||.... .....+++ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~----~~~~-- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLL----EKGE-- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH----HCCC--
Confidence 432221 1223346778999999998899999999999999999998 999985311 11111111 1111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
....+ ..+...+.+++.+||..+|++|||+.|+++.|..
T Consensus 229 ~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 RLAQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred cCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 00111 1123457889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.73 Aligned_cols=242 Identities=25% Similarity=0.294 Sum_probs=194.1
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
++||+|+||.||++... +++.||+|++..... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 689999999975432 222346788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 297 (460)
+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998886543 389999999999999999999999 99999999999999999999999999987533221 122
Q ss_pred ecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCC
Q 012610 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377 (460)
Q Consensus 298 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (460)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~~~-------~~~~--- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-------DIKF--- 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhccC-------CccC---
Confidence 33568999999999999999999999999999999999999995321 11111111110 0011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 378 YIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 378 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.......+.+++.+||+.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 111235688899999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.01 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=200.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|...+.||+|+||.||+++.. +++.||+|+++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 688999999976432 223445788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999976522 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCccccc------CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..........||+.|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 3333333346899999999986 4567899999999999999999999995321 1111122211111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.....+ .......+.+++..|++ +|.+|||+.++++
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111000 01123557888899997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=315.11 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=205.7
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
++..++|++.+.||+|+||.||+|... .+..||+|.+...........+.+|+..++.++|+||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456788999999999999999999753 24579999987554333444678899999999999999999999988
Q ss_pred CcceEEeeccCCCCHHHHhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
+..+++|||+.+|+|.+++..... ......+..+..++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999976432 123457788899999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 356 (460)
+|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||.... ..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 999999987653322111 112234678999999998899999999999999999998 788885311 1111
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
........... ........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 231 ~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111111100 0112235799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.98 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=197.5
Q ss_pred hcCCccCCeecccCCeEEEEEEECC--CcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|...+.||+|+||.||+|...+ +..||+|.+..... ......+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578888999999999999998643 36899999865422 2233467889999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......... ...
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--------~~~~~~~i~~-~~~--- 245 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--------PLLIYQKILE-GII--- 245 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--------HHHHHHHHhc-CCC---
Confidence 432 123458999999999999889999999999999999999999995311 1111111111 100
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
... ......+.+++.+|++.+|++|+ +++++++
T Consensus 246 ---~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 ---YFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---CCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 001 11224577899999999999995 7777764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=312.49 Aligned_cols=259 Identities=27% Similarity=0.386 Sum_probs=203.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
.+++|.+.+.||+|++|.||+|.+.+ +..||+|.+...........+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999998753 567899988755444445568899999999999999999999998888
Q ss_pred ceEEeeccCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEE
Q 012610 207 RLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 280 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl 280 (460)
.+++|||+.+++|.+++...... ...+++..++.++.||+.||+|||+. +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999765321 22489999999999999999999999 999999999999998765 5999
Q ss_pred eecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHH
Q 012610 281 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999998663222111 111123467999999999999999999999999999997 9999853211 11111
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
........ .........+.+++.+||+.+|++|||+.+|++.|+
T Consensus 233 ~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111110 111122356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=305.05 Aligned_cols=254 Identities=23% Similarity=0.266 Sum_probs=203.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
..+.|+..+.||+|.-|+||++++.+ +..+|+|++.+..... ...+...|-++|+.++||.+..|+..++.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34566777889999999999999874 5899999998765432 23367789999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+||||+||+|..+.+.+... .+++..++.++..|+-||+|||.. |||+|||||+||||.++|++.|+||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999876544 499999999999999999999999 9999999999999999999999999987433
Q ss_pred CC---------------------------------C-C---------------------CceeecccccccccCcccccC
Q 012610 290 DY---------------------------------K-D---------------------THVTTAVRGTIGHIAPEYLST 314 (460)
Q Consensus 290 ~~---------------------------------~-~---------------------~~~~~~~~g~~~y~aPE~~~~ 314 (460)
.. . . ......++||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 11 0 0 011223568999999999999
Q ss_pred CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHcc
Q 012610 315 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCT 394 (460)
Q Consensus 315 ~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 394 (460)
...+.++|+|+|||++|||+.|..||.... ....+.. ++-..+.-.........+.+||++.|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~----~~~Tl~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN----NKETLRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCC----chhhHHH-------------HhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999996422 1111222 22222211112234567889999999
Q ss_pred CCCCCCCCC----HHHHH
Q 012610 395 QGSPMERPK----MSEVV 408 (460)
Q Consensus 395 ~~~P~~RPt----~~evl 408 (460)
.+||++|.. +.||-
T Consensus 373 vKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred ccChhhhhccccchHHhh
Confidence 999999999 55554
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.97 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=204.0
Q ss_pred hcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++|||++++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 457888899999999999999752 24568999886543 23344688999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 208 LLVYPFMVNGSVASCLRERGQ---------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999975431 223489999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHH
Q 012610 279 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 356 (460)
||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999999765432211 1122235678999999998899999999999999999998 8999853211 111
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
..... ...... . .......+.+++.+||+.+|.+|||+.+|++.|+++.
T Consensus 232 ~~~i~-~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 232 IECIT-QGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHH-cCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111 111100 0 1112346899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=316.11 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
....++|...+.||+|+||.||++... .+..+|+|.++..........+.+|+++++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567999999999999999999742 24579999987654444445688999999999 79999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
.+..+++|||+.+|+|.++++.... ..+++..++.++.+++.||+|||++ +++|+||||+||+++.++.++|+||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999975432 2389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHh
Q 012610 284 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 284 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...... ..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~----~~ 257 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYK----LI 257 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHH----HH
Confidence 999865433221 1122235678999999999999999999999999999998 9999853211 101111 11
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.... ...........+.+++.+||+.+|++|||+.+|++.|++
T Consensus 258 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 258 KEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1110 000011123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.22 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=204.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CC---cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+...........+..|++++..++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999875 23 37999998765444445578899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+|||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999997543 2489999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCCceeec--ccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 290 DYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 290 ~~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
.......... ...+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..++..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~~~i~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVMKAINDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHHHHHhcCCCC
Confidence 4332221111 123457999999988889999999999999999997 999995321 11222221111000
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ----------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.81 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=202.5
Q ss_pred CCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+|...+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 2357899988765444444578899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 210 VYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
++||+.+++|.+++..... ...++++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999865321 123588999999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccC
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 347 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 347 (460)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999997653322211 122235678999999988889999999999999999998 999985211
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..++. ....... ...........+.+++.+||+.+|++||++.++++.|++.
T Consensus 235 -----~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 -----PERLF-NLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -----HHHHH-HHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11111 1111110 0111112335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=326.72 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=201.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|...+.||+|+||.||+|+.. +++.||||++..... ......+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999976 689999999975432 123446888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999997652 489999999999999999999998 999999999999999999999999999986543
Q ss_pred CC----------------------------CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccc
Q 012610 292 KD----------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 343 (460)
Q Consensus 292 ~~----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~ 343 (460)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11122345899999999999999999999999999999999999999532
Q ss_pred cccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 012610 344 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRM 410 (460)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~~ 410 (460)
. ............ ....-+. .......+.+++.+|+. +|.+||+ ++++++.
T Consensus 234 ~--------~~~~~~~i~~~~--~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 T--------LQETYNKIINWK--ESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred C--------HHHHHHHHhccC--CcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 111111111100 0000000 00124568889999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.25 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=206.1
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+..++|++.+.||+|++|.||+|...++..+|||.+..... ....+.+|+++++.++|+|++++++++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999988788899999875432 2356889999999999999999999998888999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++..... ..+++..+..++.+++.||+|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999976432 2489999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||.... . ............
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~---~~~~~~~~~~~~----- 222 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----N---REVLEQVERGYR----- 222 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHcCCC-----
Confidence 22111112224568999999998889999999999999999999 999984211 1 111111111100
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011124568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.36 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=202.1
Q ss_pred cCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.+|...+.||+|+||.||+|...+ +..||+|++...........+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346667889999999999998642 47899999976544333456889999999999999999999999988999
Q ss_pred EEeeccCCCCHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 209 LVYPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
+++||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123478899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHH
Q 012610 277 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 354 (460)
.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||... ...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQ 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------CHH
Confidence 9999999998865432211 1222335678999999988889999999999999999998 88888521 111
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
++...... .... .....+...+.+++.+||+.+|.+||++++|++.|+.
T Consensus 234 ~~~~~i~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRN-RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222111 1111 1112234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.66 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=201.2
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.++|...+.||+|++|.||++...++..+|+|.+..... ....+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 356888899999999999999987777899998865332 2346888999999999999999998875 4568899999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.++++.... ..+++..+..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999976432 3478999999999999999999999 99999999999999999999999999997654332
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
........++..|+|||...+..++.++||||||+++|||++ |+.||.... ......+ ......
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~---~~~~~~------- 221 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NREVLEQ---VERGYR------- 221 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH---HHcCCC-------
Confidence 222222335678999999988899999999999999999999 899985311 1111111 111100
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||+.+|++||++++|++.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112234668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=311.10 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=192.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC--CCcEEEEEEeccccccc-hhHHHHHHHHHHhcc---CCCcceeeeeeeec-----
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT----- 203 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~----- 203 (460)
++|+..+.||+|+||.||+|+.. ++..||+|.+....... ....+.+|++++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46789999987543322 233456677766655 69999999998852
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
....++||||+. ++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999996 689999876432 2488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-----~~~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGL 227 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCC
Confidence 999865433 222334589999999999888999999999999999999999999963211 1111111111000
Q ss_pred ---ccc-------cccccccCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 ---KKL-------EQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ---~~~-------~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .......... .........+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000 000112345778999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=307.83 Aligned_cols=260 Identities=21% Similarity=0.341 Sum_probs=206.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|++|.||++... ++..+|||.+..... ......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778889999999999999864 789999998865322 223346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.........+++..++.++.+|+.||+|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999876444444689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... .....+..... ....
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~------~~~~ 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE------QCDY 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhh------cCCC
Confidence 3221 223457889999999988889999999999999999999999985211 11111111111 1111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
+... .......+.+++.+||+.+|++|||+.+|++.+.+
T Consensus 226 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111 12234568899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=309.21 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=191.5
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||+|+||+||++... +++.+|+|.+....... ....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 68899999987543222 224567899999999999999999999988899999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
..++.........+++..++.++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988865444445689999999999999999999999 9999999999999999999999999999765433222 223
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ............ .... ...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~---------~~~~--~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRIL---------NDSV--TYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc----chhHHHHHHhhc---------ccCC--CCc
Confidence 4588999999999999999999999999999999999999953211 001111111111 0000 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
......+.+++.+||+.||++||+++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 22345688999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=335.40 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=204.4
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC----
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~---- 205 (460)
...++|.+.+.||+|+||+||+|+.. +++.||||++..... ......+.+|+..+..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999864 689999999875433 233446788999999999999999887765332
Q ss_pred ----cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 206 ----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 206 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
..++||||+.+|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 25799999999999999987655555699999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 282 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 282 Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence 999998654322 12223456899999999999999999999999999999999999999532 122222222
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .... + .......+.+++.+||+.+|.+||++.++++
T Consensus 258 ~~~-~~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAG-RYDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcC-CCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 211 1100 1 1123356889999999999999999999976
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.94 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=203.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|.+.+.||+|+||.||+|... .+..+|+|.++..........+..|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357788899999999999999864 2347999998765444445578899999999999999999999999899999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+|||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999976432 478999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeec--ccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 290 DYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 290 ~~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
.......... ..++..|+|||.+.+..++.++||||||+++||+++ |..||..... .+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEEGYRL 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhCCCcC
Confidence 5433222221 123467999999998899999999999999999886 9999853211 1111111111000
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0111234568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=312.75 Aligned_cols=266 Identities=22% Similarity=0.378 Sum_probs=202.2
Q ss_pred hcCCccCCeecccCCeEEEEEEECC---------------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD---------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 198 (460)
.++|++.+.||+|+||.||++...+ ...||+|.++..........+.+|++++.+++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987542 2358999997654444455788999999999999999999
Q ss_pred eeeecCCcceEEeeccCCCCHHHHhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCE
Q 012610 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQ--------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270 (460)
Q Consensus 199 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 270 (460)
+++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112478899999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh--CCCccccccccC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLAN 347 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~~ 347 (460)
+++.++.+||+|||++......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 9999999999999999765332211 1122234678999999998899999999999999999998 5667742111
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+........ .... ..........+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 239 ---~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 ---EQVIENTGEFFRNQG-RQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHHhhhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111100 0000 00011123579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=313.12 Aligned_cols=239 Identities=28% Similarity=0.395 Sum_probs=189.8
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|+.. +++.||+|++..... ......+..|.+++..+ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 578999999975432 22334566788888766 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999887643 388999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~----~~------ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE----VV------ 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCC----CC------
Confidence 233468999999999999899999999999999999999999995321 112222211110 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSE 406 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 406 (460)
........+.+++.+||+.||++||++.+
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 01112356788999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=305.52 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=194.6
Q ss_pred eecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCC
Q 012610 142 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
.||+|+||.||+|.+. .+..||+|.+...........+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 345799999976544444456889999999999999999999875 456799999999999
Q ss_pred HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceee
Q 012610 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298 (460)
Q Consensus 219 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 298 (460)
|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987533 2489999999999999999999999 9999999999999999999999999999765433222111
Q ss_pred --cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 299 --AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 299 --~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
...++..|+|||.+.+..++.++|||||||++||+++ |..||.... ..++.........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~---------- 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPEVMSFIEQGKR---------- 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHHCCCC----------
Confidence 1123568999999988889999999999999999996 999995321 1111111111110
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
......+...+.+++.+||..+|++||++.+|++.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011122346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.02 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=200.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCc--EEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 209 (460)
.++|+..+.||+|+||.||+|... ++. .+|+|.++..........+.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999875 343 46888776544444455788899999999 89999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc
Q 012610 210 VYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 277 (460)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999976432 123588999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHH
Q 012610 278 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 356 (460)
+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||.... ..+.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~ 232 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 232 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--------hHHH
Confidence 9999999986432111 1111123567999999988889999999999999999998 999985211 1111
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.... ... ............+.+++.+||+.+|++||++.++++.|+.+
T Consensus 233 ~~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 233 YEKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 110 00001111234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=321.96 Aligned_cols=252 Identities=19% Similarity=0.279 Sum_probs=196.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999976 588999999975422 122345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHH
Q 012610 292 KDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 334 (460)
Q Consensus 292 ~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~ 334 (460)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011235899999999999999999999999999999999
Q ss_pred hCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 012610 335 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK---MSEVVR 409 (460)
Q Consensus 335 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl~ 409 (460)
+|..||.... ..+............... .. ......+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~-----~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDN--------PQETYRKIINWKETLQFP-----DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCC--------HHHHHHHHHcCCCccCCC-----CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999995321 111111111110000000 00 0122456778888886 9999998 766654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=314.70 Aligned_cols=242 Identities=26% Similarity=0.345 Sum_probs=192.8
Q ss_pred CeecccCCeEEEEEEEC----CCcEEEEEEeccccc---cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 141 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.||+|+||.||+++.. +++.||+|+++.... ......+..|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 578999999975422 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++...+ .+.+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999997643 378888999999999999999999 99999999999999999999999999987533222
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .. .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~-~~------~ 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKG-KL------N 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-CC------C
Confidence 12233468999999999998889999999999999999999999995321 11112221111 00 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
+ .......+.+++.+||+.+|++|| ++.++++
T Consensus 219 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 L----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 111234588999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.35 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=201.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-C-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.|...+.||+|++|.||+|... + +..||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888899999999999999764 3 5788888765432 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++|+|.+++........++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999876544445689999999999999999999999 99999999999999999999999999998764322
Q ss_pred C-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 294 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 294 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+...... ....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~-~~~~---- 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYG-KYDP---- 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCCC----
Confidence 2 12334568999999999999999999999999999999999999995321 12222222111 1100
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+.+++.+||+.+|++||++.+++.
T Consensus 291 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112356889999999999999999999874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=320.15 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=193.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.|+..+.||+|+||+||+|+.. +++.||+|++..... ......+..|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 578999999975432 2233468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997643 388999999999999999999999 9999999999999999999999999997643210
Q ss_pred CC----------------------------------------------ceeecccccccccCcccccCCCCCcccCchhh
Q 012610 293 DT----------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 326 (460)
Q Consensus 293 ~~----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~ 326 (460)
.. .......||..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123468999999999998899999999999
Q ss_pred HHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHH--ccCCCCCCCCCH
Q 012610 327 GVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL--CTQGSPMERPKM 404 (460)
Q Consensus 327 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPt~ 404 (460)
||++|||++|+.||..... .+........... . .... .......+.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~---~--~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP--------TETQLKVINWENT---L--HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH--------HHHHHHHHccccc---c--CCCC--CCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999953211 0000111100000 0 0000 00112345566655 667777789999
Q ss_pred HHHHH
Q 012610 405 SEVVR 409 (460)
Q Consensus 405 ~evl~ 409 (460)
.++++
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.67 Aligned_cols=262 Identities=29% Similarity=0.411 Sum_probs=204.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+..++|.+.+.||+|+||.||+++.. ....+|+|.+...........+..|++++..+ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33467899999999999999999753 13469999998654334445688899999999 7999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCE
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 270 (460)
..+..++||||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999976432 123488999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 348 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~ 348 (460)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~----- 246 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----- 246 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----
Confidence 99999999999999987654222111 111123468999999998889999999999999999998 88888421
Q ss_pred CCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...+..... ..... ..........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 247 ---~~~~~~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 247 ---PVEELFKLL-KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ---CHHHHHHHH-HcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111211111 11110 011112345688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.07 Aligned_cols=261 Identities=20% Similarity=0.360 Sum_probs=193.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC-----Ccce
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERL 208 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~~ 208 (460)
+|+..++||+|+||.||+|+.. ++..||||++..... ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999875 689999999875322 22334688999999999999999999987543 2478
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998886543 389999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--ceeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh--
Q 012610 289 MDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-- 362 (460)
Q Consensus 289 ~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 362 (460)
...... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCC
Confidence 432211 12233458999999999866 5789999999999999999999999953211 001111100000
Q ss_pred ---------hcccccccc---ccCCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 ---------EKKLEQLVD---SDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ---------~~~~~~~~~---~~~~~~~---~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......... ....... .......+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 0000000 0112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.20 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=200.4
Q ss_pred cCCccCCeecccCCeEEEEEEECC-C--cEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD-G--SLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 210 (460)
++|+..++||+|+||.||+|...+ + ..+++|.++..........+.+|++++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478888999999999999998753 3 347888887544334445688999999998 799999999999988899999
Q ss_pred eeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 211 YPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975431 113488999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 357 (460)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAELY 228 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 999999986432111 1111123457999999998889999999999999999998 999995321 11111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
....... ...........+.+++.+||+.+|.+|||+.++++.|+...
T Consensus 229 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 EKLPQGY----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111110 00111123356889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.60 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=206.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeee
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 201 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 201 (460)
.+..++|.+.+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.++..+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345678888999999999999999742 24579999987654444445788999999999 899999999999
Q ss_pred ecCCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 202 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 202 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
......+++|||+.+|+|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999976432 123478899999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccC
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 347 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 347 (460)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---- 243 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---- 243 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----
Confidence 999999999999999998664332221 122235678999999998889999999999999999998 78887421
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...++.......... .....+...+.+++.+||+.+|++|||+.+|++.|++
T Consensus 244 ----~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 244 ----PVEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ----CHHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 122222222111110 0111234568889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=309.80 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=201.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|+..++||+|+||+||+|++. ++. .||+|.+...........+.+|+.++..+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888899999999999999854 343 4899998765544445578899999999999999999999875 4578
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++++|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997543 2389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||+... ......++. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLE----KGER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----CCCc
Confidence 65332221 111224678999999998899999999999999999998 899985311 111111111 1100
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
. .........+.+++.+||+.||++||++.++++.|+...
T Consensus 230 ~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 L---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred C---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 011123456889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.03 Aligned_cols=257 Identities=23% Similarity=0.414 Sum_probs=204.0
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
++..++|...+.||+|+||.||++...++..+|+|.+.... .....+.+|+++++.++|+|++++.+++.. ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 34557888999999999999999998777889999887532 223468889999999999999999999877 778999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++++|.+++..... ..+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999976432 3478899999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
...........++..|+|||.+.+..++.++|+|||||++|++++ |+.||.... ......++ ......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~----~~~~~~-- 222 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRAL----ERGYRM-- 222 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHH----hCCCCC--
Confidence 332222222335677999999998889999999999999999999 899985311 11111111 111000
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.31 Aligned_cols=200 Identities=22% Similarity=0.342 Sum_probs=173.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||+||++... +++.||+|++..... ......+..|++++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 588999999975432 122345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCC
Q 012610 292 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337 (460)
Q Consensus 292 ~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~ 337 (460)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346899999999999999999999999999999999999
Q ss_pred Cccc
Q 012610 338 RAFD 341 (460)
Q Consensus 338 ~p~~ 341 (460)
.||.
T Consensus 234 ~Pf~ 237 (363)
T cd05628 234 PPFC 237 (363)
T ss_pred CCCC
Confidence 9995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=320.03 Aligned_cols=261 Identities=21% Similarity=0.292 Sum_probs=200.9
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeec
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 203 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 203 (460)
+.++....++|+..+.||+|+||.||+++.. +++.+|+|++..... ......+.+|+.++..++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4456667789999999999999999999976 578999999864321 1223357789999999999999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
....++||||+++|+|.+++.... ++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999987532 78888999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCC----CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 99987654333233345699999999998654 37889999999999999999999996321 1111111
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVRM 410 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 410 (460)
...........+ .......+.+++.+|+..++.+ |+++.++++.
T Consensus 259 i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111000110 1122345778888999844433 6788887764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=309.01 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=205.6
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-----------------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCccee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-----------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 196 (460)
.++|++.+.||+|+||.||++...+ +..||+|.+...........+.+|++++.+++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987642 24589999886655445567889999999999999999
Q ss_pred eeeeeecCCcceEEeeccCCCCHHHHhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 197 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
+++++......+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999998999999999999999999976542 122589999999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh--CCCcccccccc
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLA 346 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~ 346 (460)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999876543221 12223345678999999988889999999999999999998 667774211
Q ss_pred CCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.......+............. .........+.+++.+||+.+|++|||+.+|++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111111111101 011122357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=309.65 Aligned_cols=266 Identities=23% Similarity=0.367 Sum_probs=202.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-----------------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCccee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-----------------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 196 (460)
.++|++.+.||+|+||.||++... +...+|+|.+...........+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357888999999999999998532 234689999976544444557899999999999999999
Q ss_pred eeeeeecCCcceEEeeccCCCCHHHHhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 197 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
+++++...+..+++|||+.+++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999764321 12477889999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh--CCCcccccccc
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT--GQRAFDLARLA 346 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t--g~~p~~~~~~~ 346 (460)
|+++.++.++|+|||+++.+...... ......++..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 99999999999999999765332211 1112234578999999888889999999999999999998 6778753211
Q ss_pred CCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
................ .... .....+...+.+++.+||+.||++||++.+|++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ----EQVIENTGEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111111111111100 0000 0011233678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=304.63 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=193.8
Q ss_pred eecccCCeEEEEEEEC---CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 142 ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
.||+|+||.||+|.+. ++..+|+|+++..... .....+..|+.+++.+.|+||+++++++. .+..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5788999998754332 23456889999999999999999999875 45678999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 297 (460)
+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996543 388999999999999999999999 999999999999999999999999999987654332211
Q ss_pred e--cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 298 T--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 298 ~--~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
. ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..++.... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~i-~~~~~-------- 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--------GNEVTQMI-ESGER-------- 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HCCCC--------
Confidence 1 1223578999999988889999999999999999998 999995321 11111111 11110
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||+.||++||++.+|.+.|++
T Consensus 217 -~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 -MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=312.28 Aligned_cols=239 Identities=24% Similarity=0.349 Sum_probs=187.6
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhc-cCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|+.. +++.||+|+++.... ......+..|.+++.. .+||||+++++++......++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 578899999975432 1223345556666654 4899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999987643 388999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-------~---- 213 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSILNDR-------P---- 213 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-------C----
Confidence 334568999999999999999999999999999999999999995321 111111111100 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSE 406 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 406 (460)
.........+.+++.+||+.+|++||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 011112345788999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.52 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=203.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.+|...+.||+|+||.||+++.. ++..+++|.+.... ......+.+|++.+++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999743 34568899886433 223346889999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 209 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999976431 123488999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHH
Q 012610 277 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 354 (460)
.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 9999999999765432211 1222345778999999999999999999999999999999 9999853211 1
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
+.+... ....... ........+.+++.+||+.+|++|||+++|++.|+++
T Consensus 233 ~~~~~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECI-TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHH-hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 1111111 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.22 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=188.4
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHH---HhccCCCcceeeeeeeecCCcceEE
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEM---ISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~---l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
|++.+.||+|+||.||+|... +++.||||+++.... ......+..|.++ +..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999875 588999999975431 1222345566554 4567899999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|...+... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888642 389999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~-~---- 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDE-V---- 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C----
Confidence 222 22234568999999999999999999999999999999999999995321 111111111110 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
.. .......+.+++.+||+.||.+||++
T Consensus 219 --~~----p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 --RY----PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --CC----CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 01 11123557889999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=304.41 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=197.1
Q ss_pred CeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|++.. +..+|+|.+...........+..|+.+++.+.|+|++++++++. .+..+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997642 26899999986655444557889999999999999999999875 4567999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997654 489999999999999999999999 99999999999999999999999999998664433222
Q ss_pred eec--ccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 297 TTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 297 ~~~--~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
... ..++..|+|||.+.+..++.++|||||||++|||++ |..||.... ......++. .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~---~~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLE---SGERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHH---cCCcC-------
Confidence 111 113467999999998899999999999999999998 999995321 111222211 11110
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01112235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=314.71 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=204.4
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeee
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 201 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~ 201 (460)
....++|.+.+.||+|+||.||+++.. ....+|+|.++..........+..|++++..+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999742 24578999987654444445688899999998 699999999999
Q ss_pred ecCCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 202 MTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 202 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
......+++|||+.+|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 988889999999999999999976421 123588999999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccC
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 347 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 347 (460)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--- 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---
Confidence 999999999999999998654322111 111224467999999998899999999999999999999 888884311
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+.... ....... .........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 242 -----~~~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 242 -----VEELFKL-LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -----HHHHHHH-HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111 1111100 11112235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.75 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=204.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
..++|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|+.++++++|||++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999863 4678999998765444445568899999999999999999999999889
Q ss_pred ceEEeeccCCCCHHHHhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 012610 207 RLLVYPFMVNGSVASCLRERGQ------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 268 (460)
.+++|||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999975321 123478899999999999999999999 9999999999
Q ss_pred CEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccccccc
Q 012610 269 NILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 346 (460)
Q Consensus 269 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~ 346 (460)
||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--- 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--- 236 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999998755322211 1111224567999999988899999999999999999998 88888421
Q ss_pred CCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...+..... ....... ........+.+++.+||+.+|++|||+.||++.|++
T Consensus 237 -----~~~~~~~~~-~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -----AHEEVIYYV-RDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----CHHHHHHHH-hcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111222211 1111110 011223568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=307.69 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=198.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+|+..++||+|+||.||++... +++.||+|.+...... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999875 6889999999754322 223356789999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886543 23489999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+........
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~------- 221 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQ------- 221 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhhcc-------
Confidence 21 223458899999999998889999999999999999999999996321 1111111111111100
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
..........+.+++.+||+.||++|| +++++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111122345688999999999999999 6777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=304.23 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=200.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc----hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++|...+.||+|++|.||++... ++..+|+|.+....... ....+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999865 58899999986543211 22357889999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
++||+++++|.+++.... .+++..++.++.+++.||+|||+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987643 378899999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCcee--ecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 290 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 290 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~-~~~~~~~~~~--- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------M-AAIFKIATQP--- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------H-HHHHHHhccC---
Confidence 43221111 234477899999999998899999999999999999999999953110 0 1111111100
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
............+.+++.+||..+|++|||+.++++.
T Consensus 224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111112234568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=304.57 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=203.5
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.++|+..+.||+|++|.||+|... ++.||+|.+..... ...++..|+.+++.++|+|++++++++......++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 467888899999999999999876 78899999976543 345788999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999976542 2489999999999999999999999 99999999999999999999999999998653221
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
. ....+..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+..........
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------- 217 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPHVEKGYR------- 217 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHhcCCC-------
Confidence 1 2234567999999988889999999999999999997 999985321 1111111111100
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||..+|++|||+++++++|+.
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01111224668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=306.74 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=195.7
Q ss_pred ccCCeecccCCeEEEEEEECC-Cc--EEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC------Ccc
Q 012610 138 SNRNILGRGGFGKVYKGRLTD-GS--LVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 207 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~ 207 (460)
.+.++||+|+||.||+|...+ +. .+|+|.++.... ......+..|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998764 32 689998875432 22344688899999999999999999987532 246
Q ss_pred eEEeeccCCCCHHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 208 LLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
+++|||+.+|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999875432 2223489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhh
Q 012610 286 AKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 286 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYDYLRQG 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHcC
Confidence 98764332211 112235678999999999899999999999999999999 788885311 11111111111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.... ........+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1100 011233568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.13 Aligned_cols=245 Identities=25% Similarity=0.314 Sum_probs=191.5
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+++.. +++.||+|+++..... .....+..|..++.++ .||||+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999764322 2233577888888877 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99999886543 389999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......+++.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~------~-- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN--PDMNTEDYLFQVILEKPIR------I-- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC--cccccHHHHHHHHHhCCCC------C--
Confidence 23456899999999999999999999999999999999999999632211 1111222222222211110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
.......+.+++.+||+.||.+|+++.
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 111234578899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=313.51 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=195.9
Q ss_pred CeecccCCeEEEEEEE----CCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRL----TDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
+.||+|+||.||+++. .+++.+|+|++...... .....+..|++++.+++||||+++++++......++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 25789999999754322 223356789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999986543 389999999999999999999999 999999999999999999999999999976543222
Q ss_pred eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~-~~--------- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKA-KL--------- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcC-CC---------
Confidence 2234568999999999998889999999999999999999999995321 11111111111 00
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHH--HHHHhhcCC
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSE--VVRMLEGDG 415 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e--vl~~L~~~~ 415 (460)
.........+.+++.+||+.||++||++.+ +.+.+....
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 011112355788999999999999999766 444444433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=317.23 Aligned_cols=265 Identities=27% Similarity=0.396 Sum_probs=206.3
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF 200 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~ 200 (460)
+++...+|.+.+.||+|+||.||++... .+..||+|.++..........+.+|++++.++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445567889999999999999999742 12368999887654444455788999999999 79999999999
Q ss_pred eecCCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 012610 201 CMTPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 201 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 268 (460)
+......++++||+.+|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9988899999999999999999976421 123478899999999999999999999 9999999999
Q ss_pred CEEecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccccccc
Q 012610 269 NILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 346 (460)
Q Consensus 269 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~ 346 (460)
||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--- 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence 9999999999999999997654322111 111223567999999999999999999999999999998 88888421
Q ss_pred CCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
...++....... ... .........+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 241 -----~~~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 241 -----PVEELFKLLKEG-HRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -----CHHHHHHHHHcC-CCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 112222221111 110 111122356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=314.86 Aligned_cols=242 Identities=22% Similarity=0.283 Sum_probs=192.5
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
+.||+|+||.||++... ++..||+|++...... .....+..|++++..++||||+++.+++...+..++||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 6889999999754322 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
+|..++.... .+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9999886543 38999999999999999999997 6 999999999999999999999999999875332221 2
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......... ... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~-~~~------~~p- 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILM-EEI------RFP- 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhc-CCC------CCC-
Confidence 223458999999999999999999999999999999999999995321 1111111110 000 011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
......+.+++.+||+.||++|+ ++.++++
T Consensus 217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 ---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 11234588899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=312.50 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=191.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCC-cceeeeeeeecCCcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~ 211 (460)
+|+..+.||+|+||.||+|+.. +++.||+|++..... ......+..|.+++..+.|+ +|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 478899999975432 22334577888999988765 5788888988889999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987643 378999999999999999999999 999999999999999999999999999875322
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~-~------ 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIMEH-N------ 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-C------
Confidence 222 2233458999999999999999999999999999999999999995321 11111111110 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
. .........+.+++.+||..||.+|++.
T Consensus 218 ~----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 V----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 0111123467889999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=305.14 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=199.2
Q ss_pred CccCCeecccCCeEEEEEEECC----CcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCc-----
Q 012610 137 FSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 206 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 206 (460)
|.+.+.||+|+||.||+|.... +..||+|.++..... .....+..|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999999764332 233468899999999999999999998866543
Q ss_pred -ceEEeeccCCCCHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 207 -RLLVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 207 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
.++++||+++|+|..++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999999865421 223589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHh
Q 012610 284 GLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 284 g~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... . .+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----N---HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHH
Confidence 9998664332211 111224668999999988889999999999999999999 888884311 1 11111111
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..... .........+.+++.+||+.||++|||+.||++.|++
T Consensus 230 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 230 HGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred cCCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11110 1112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.32 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=191.3
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|+.. +++.||+|++..... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 578999999976432 22233566788888765 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 99999887543 388999999999999999999999 999999999999999999999999999875432222 2
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~----~~~----- 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDD----VLY----- 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC----CCC-----
Confidence 233458999999999999899999999999999999999999996321 111122211111 000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERP-------KMSEVVR 409 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RP-------t~~evl~ 409 (460)
.......+.+++.+||+.||++|| ++.++++
T Consensus 216 --p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 --PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111235688899999999999999 6666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=305.35 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=195.2
Q ss_pred CeecccCCeEEEEEEECC-Cc--EEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLTD-GS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|...+ +. .+++|.++..........+..|++++.++ .||||+++++++......+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998753 33 46888887544444455788999999999 799999999999998899999999999
Q ss_pred CCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 217 GSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 217 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999976431 123478999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.... ..+........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHHhCC
Confidence 986322111 1111223567999999988889999999999999999997 999995311 11111111111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
... .........+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000 01112235688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.46 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=203.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCc-ceeeeeeeecCC------
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPT------ 205 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~------ 205 (460)
..|...++||+|+||+||+|+.. +|+.||+|++..... +.......+|+.+++.++|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666678999999999999865 689999999986654 333445679999999999999 999999998877
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++|+||++. +|..++.........++...++.++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 77899999954 99999987654323477789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
|+....... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|..... ......+...+...
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCCC
Confidence 997653332 24455689999999999887 689999999999999999999988853221 12222222222211
Q ss_pred cccc---cc---cccC--C----C-CCcHHH---HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 365 KLEQ---LV---DSDM--E----G-NYIEEE---VEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 365 ~~~~---~~---~~~~--~----~-~~~~~~---~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
..+. +. +... . . ...... .....+++.+|++.+|.+|.|++..++.
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 00 1000 0 0 001111 1357889999999999999999999874
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.22 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=195.3
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||+|+||.||+++.. +|+.||+|.+...... .....+..|++++.+++||||+++.+++......++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 5899999999653322 2233456799999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
..++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865432 2488999999999999999999999 99999999999999999999999999987654322 2233
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.... ......+........ . ... . .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~-~----~~~--~---~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTLED-E----VKF--E---H 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhhcc-c----ccc--c---c
Confidence 458899999999998889999999999999999999999995321 111111111111110 0 000 0 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+.+++.+||+.||++||+++|+++.+..
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 1123568899999999999999999888765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.11 Aligned_cols=277 Identities=22% Similarity=0.302 Sum_probs=212.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-------hhHHHHHHHHHHhcc-CCCcceeeeeeeecCC
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------GELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 205 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~ 205 (460)
+.|...+.||+|..++|.++..+ +|..+|+|++....... ..++-.+|+.+|+++ -||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56777889999999999988765 67889999986433221 122356789999987 4999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++|+|.|+.|.|.++|...- .+++...+.|+.|+.+|++|||.+ +||||||||+|||+|++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999997543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccC------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
++.+... ......+||++|+|||.+.- ..|+..+|+|++|||||.++.|.+||..-... -.+ .
T Consensus 170 a~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--------lML-R 238 (411)
T KOG0599|consen 170 ACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--------LML-R 238 (411)
T ss_pred eeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--------HHH-H
Confidence 9877543 34456789999999998843 35788999999999999999999999531110 000 1
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCcchhhHHHHhhhhhccCCCCCCC
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNHTPHP 439 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (460)
++.+++. ......+.+......+++.+|++.||++|.|++|+++ +.|......+++-..++.+
T Consensus 239 ~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La-----------Hpff~q~~~~~~r~msP~~ 301 (411)
T KOG0599|consen 239 MIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA-----------HPFFIQIAQQQARQMSPVV 301 (411)
T ss_pred HHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc-----------ChHHHHHHHhcccccCCCc
Confidence 1111111 1223335556677889999999999999999999985 3444444334444445544
Q ss_pred CCccccc
Q 012610 440 NNTWIVD 446 (460)
Q Consensus 440 ~~~~~~~ 446 (460)
......|
T Consensus 302 ~~~~~k~ 308 (411)
T KOG0599|consen 302 EVELVKD 308 (411)
T ss_pred chhhhhh
Confidence 4444444
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=306.11 Aligned_cols=254 Identities=27% Similarity=0.465 Sum_probs=200.7
Q ss_pred CCccCCeecccCCeEEEEEEECC-C---cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTD-G---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+|...+.||+|+||.||+|.... + ..||||.+...........+..|+..++.++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 2 3699999976544444567999999999999999999999999989999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999876432 388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCce--eeccc--ccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 292 KDTHV--TTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 292 ~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||.... ......++. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~---~~~~~ 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIE---QDYRL 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH---cCCcC
Confidence 22111 11111 2357999999998899999999999999999886 999985311 111111111 11000
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
....+.+..+.+++.+||+.+|++||++++|+..|++
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=302.13 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=202.4
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc-ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||++... ++..|++|.+.... .......+..|+++++.++|||++++++++...+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 58899999986532 223445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++.... ...+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998642 23488999999999999999999999 99999999999999999999999999988665332
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||.... .......... ....
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~------ 219 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIR-GVFP------ 219 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-CCCC------
Confidence 22 223457889999999999999999999999999999999999995321 1111111111 1111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.+|++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111123466899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=317.62 Aligned_cols=263 Identities=28% Similarity=0.426 Sum_probs=201.0
Q ss_pred HHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 204 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~ 204 (460)
...++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|++++..+ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4457899999999999999999973 246789999997654433445688899999999 689999999988654
Q ss_pred -CcceEEeeccCCCCHHHHhhhcCCC------------------------------------------------------
Q 012610 205 -TERLLVYPFMVNGSVASCLRERGQS------------------------------------------------------ 229 (460)
Q Consensus 205 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 229 (460)
...+++|||+.+|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999998653210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc-eeec
Q 012610 230 ---------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTA 299 (460)
Q Consensus 230 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 299 (460)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999 9999999999999999999999999999765322211 1112
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCC
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 378 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (460)
..++..|+|||.+.+..++.++||||||+++|||++ |..||..... . ..... ..........
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~~-~~~~~~~~~~--------- 303 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----D---EEFCR-RLKEGTRMRA--------- 303 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----c---HHHHH-HHhccCCCCC---------
Confidence 235667999999998899999999999999999997 9999853211 0 01111 1111110000
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 379 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 379 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001124588999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=308.72 Aligned_cols=264 Identities=26% Similarity=0.387 Sum_probs=202.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--Ccc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 207 (460)
..|...+.||+|+||.||++++. ++..||+|.++..........+.+|+++++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677889999999999999742 47889999987654444455789999999999999999999998775 567
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
+++|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999986543 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc-------CCCCccHHHHHH
Q 012610 288 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-------NDDDVMLLDWVK 358 (460)
Q Consensus 288 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~ 358 (460)
........ ......++..|+|||.+.+..++.++|||||||++|||++++.|....... .........++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 112344667899999998888999999999999999999987765321000 001111111111
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. ....... .........+.+++.+||+.+|++|||++++++.|+.+
T Consensus 238 ~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 V-LEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-HHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1 1111100 01112345799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.48 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=198.2
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHH
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 220 (460)
++||.|++|.||++...+++.||+|.+...........+.+|+++++.++|+||+++++++......+++|||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987789999999876544434557889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee-ec
Q 012610 221 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 299 (460)
Q Consensus 221 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 299 (460)
+++..... .+++..+..++.+++.||+|||++ +++||||+|+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99976432 378999999999999999999999 999999999999999999999999999976542211111 11
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCC
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 378 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (460)
...+..|+|||.+.++.++.++||||||+++|||+| |..||..... ...... .... .....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~-~~~~---------~~~~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRER-IESG---------YRMPA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHH-HhcC---------CCCCC
Confidence 223567999999988899999999999999999999 8888843110 111111 1100 00011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 379 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 379 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.......+.+++.+||..+|++|||+.||++.|++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 12234568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.02 Aligned_cols=252 Identities=18% Similarity=0.244 Sum_probs=193.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|...+.||+|+||.||++... +++.||||++..... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999865 688999999865322 222346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997543 388999999999999999999999 999999999999999999999999999863311
Q ss_pred CCCc----------------------------------------------eeecccccccccCcccccCCCCCcccCchh
Q 012610 292 KDTH----------------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 325 (460)
Q Consensus 292 ~~~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 325 (460)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999999999999999
Q ss_pred hHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCC---C
Q 012610 326 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER---P 402 (460)
Q Consensus 326 ~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---P 402 (460)
|||++|||++|+.||..... .+.............+.+ .......+.+++.+|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS--------HETYRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999953111 111111111000000000 00122457788888987 66665 5
Q ss_pred CHHHHHH
Q 012610 403 KMSEVVR 409 (460)
Q Consensus 403 t~~evl~ 409 (460)
|+.++++
T Consensus 298 ~~~~~l~ 304 (377)
T cd05629 298 GAHEIKS 304 (377)
T ss_pred CHHHHhc
Confidence 8888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.33 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=197.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..++||+|+||.||+|... ++..||+|.+...........+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999864 68899999987554334445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 267888999999999999999999 99999999999999999999999999997653221
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ......+....... . ...
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~-----~~~ 219 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-SLMPLQLLQCIVDE-D-----PPV 219 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-ccchHHHHHHHhcc-C-----CCC
Confidence 2234588999999999998999999999999999999999999964221110 11111111111110 0 011
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
+. .......+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 10 01123458899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=325.91 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=191.2
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC-------
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------- 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------- 204 (460)
...+|...++||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999875 57899999885432 1345799999999999999998876432
Q ss_pred -CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEee
Q 012610 205 -TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGD 282 (460)
Q Consensus 205 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~D 282 (460)
...++||||+.+ +|.+++.........+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999975 78777765433444689999999999999999999999 999999999999999665 799999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
||+++....... .....|++.|+|||++.+. .++.++|||||||++|||++|..||..... ...+...+.. .
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~-~ 287 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS----VDQLVRIIQV-L 287 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHH-h
Confidence 999986543222 2234578999999998764 689999999999999999999999953211 0011111110 0
Q ss_pred hhcc----------ccccccccCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 KEKK----------LEQLVDSDMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 ~~~~----------~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ...+.-+.+.. .+.......+.+++.+||+.||.+|||+.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 00000000000 011112356889999999999999999999884
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=302.72 Aligned_cols=251 Identities=17% Similarity=0.283 Sum_probs=202.1
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+|+..+.||+|+||.||++... ++..+|+|.++..........+..|+.+++.++|+|++++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999876 688999999865444444556888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886533 23478999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.... ......... ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~------ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVC-QGSYKP------ 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHh-cCCCCC------
Confidence 2223458889999999998889999999999999999999999995311 111111111 111111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
........+.+++.+||+.||++|||+.+|+..
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223458889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.17 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=189.3
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhc-cCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|+.. ++..||+|.++.... ......+..|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 588999999975432 2223345667777765 4899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence 99999987643 388999999999999999999999 999999999999999999999999999874322221 2
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ . +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~~~~~~~~-~------~~~-- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDELFESIRVD-T------PHY-- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-C------CCC--
Confidence 234568999999999999999999999999999999999999995321 11111111110 0 001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 408 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 408 (460)
.......+.+++.+||+.||++||++. +++
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234578899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.70 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=189.4
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhc-cCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|+||.||+|... +++.||+|+++.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 578999999976432 2223345667777765 5899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 99999997542 388999999999999999999999 999999999999999999999999999875322221 2
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ . +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~-~------~~~-- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRMD-N------PCY-- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-C------CCC--
Confidence 233458999999999999999999999999999999999999995321 11111111100 0 001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 408 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 408 (460)
.......+.+++.+||+.+|++||++. ++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111234578899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.83 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=211.5
Q ss_pred HhcCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccch--hHHHHHHHHHHhccC-CCcceeeeeeeecCCcce
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGG--ELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~ 208 (460)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+...... ...+.+|+.+|+++. ||||+.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578888999999999999999874 99999999987655432 357899999999998 999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC----CcEEEeecc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFG 284 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg 284 (460)
+|||++.||.|.+.+... .+++..+..++.|++.+++|||+. +|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999876 189999999999999999999999 99999999999999644 479999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.... ....... +...
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~----~~~~~~~-----i~~~ 253 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET----EFEIFLA-----ILRG 253 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC----hhHHHHH-----HHcC
Confidence 9998765 445566789999999999999999999999999999999999999996322 1111111 1111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ......+........+++..|+..||.+|+|+.++++
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 2233445555677889999999999999999999998
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=306.49 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=200.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++...++||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46677889999999999999642 35678999886432 333457889999999999999999999999988999
Q ss_pred EEeeccCCCCHHHHhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc
Q 012610 209 LVYPFMVNGSVASCLRERGQS-----------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 277 (460)
++|||+.+++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999999764321 12488999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHH
Q 012610 278 AVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 355 (460)
+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TE 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HH
Confidence 999999999765332211 1112234678999999999999999999999999999998 8999842111 11
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
........... .........+.+++.+||+.||++||++++|++.|++
T Consensus 233 ~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111100 0011223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=305.24 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=201.8
Q ss_pred hcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|...+.||+|+||.||+|...+ ...||||.............+.+|+.+++.++|||++++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4567888999999999999998643 246899988765444445578899999999999999999998865 55789
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+|||+++++|.+++.... ..+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997643 2389999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
............++..|+|||.+.+..++.++||||||+++||+++ |..||..... ...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~---~~~~~~~-- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----NDVIGR---IENGERL-- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH---HHcCCcC--
Confidence 4432222222234567999999988889999999999999999986 9999953211 111111 1111111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.........+.+++.+|+..+|.+|||+.+++..|++..
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122356889999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.51 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=191.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+|...+.||+|+||.||+|+.. ++..||+|.+.+.... .....+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 5789999999764321 2223456677777766 5889999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987643 388999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... ...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~i~~-~~~----- 218 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIME-HNV----- 218 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCC-----
Confidence 22 12234568999999999999999999999999999999999999995321 1111111111 110
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
.........+.+++.+|++.+|++|++.
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.72 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=192.1
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|+||+||++... ++..||+|+++.... ......+..|.+++..+ +||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578999999975432 22233567788888777 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 99999887643 389999999999999999999999 999999999999999999999999999875322221 1
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~~~-~~---------- 213 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSILED-EV---------- 213 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcC-CC----------
Confidence 223458999999999999999999999999999999999999995321 11111111111 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKM-----SEVVR 409 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~ 409 (460)
.........+.+++.+||+.||.+|||+ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011123568899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=300.35 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=191.7
Q ss_pred CeecccCCeEEEEEEECC---CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 141 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998653 45789998876544444457888999999999999999999999888999999999999
Q ss_pred CHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 218 SVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 218 ~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
+|.+++...... ....++..++.++.|++.||+|||+. +++|+||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999764321 22467788889999999999999999 99999999999999999999999999997543322211
Q ss_pred -eecccccccccCcccccCC-------CCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 297 -TTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 297 -~~~~~g~~~y~aPE~~~~~-------~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||...... +........ ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~-~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--------QVLTYTVRE-QQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHhhc-ccC
Confidence 1223467789999988643 35789999999999999996 99999532110 100111111 111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
...++.+. ......+.+++.+|| .+|++|||+++|+..|+
T Consensus 229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 112345778899999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.34 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=195.7
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC-----cce
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 208 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 208 (460)
+|+..+.||+|+||.||++... +++.||+|++..... ......+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999875 689999999865322 223346889999999999999999999988766 689
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+|+||+. ++|.+.+.... .+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57887775432 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.............++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSLE 227 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCHH
Confidence 543333333334578899999998774 4789999999999999999999999632210 0111111100000000
Q ss_pred -----------ccccccCCC-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 -----------QLVDSDMEG-------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 -----------~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+....... .........+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000 001112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.12 Aligned_cols=251 Identities=32% Similarity=0.486 Sum_probs=202.8
Q ss_pred CeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|+||.||+|.... +..+++|.+...........+.+|++.+..++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998763 7889999998765444456788999999999999999999999998899999999999
Q ss_pred CCHHHHhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 217 GSVASCLRERGQS-----QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 217 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
++|.+++...... ...+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875321 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 292 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 292 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~---- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYR---- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCC----
Confidence 321 11223346789999999988889999999999999999999 699995321 1111121111100
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
..........+.+++.+||+.+|++|||+.++++.|+
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.28 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=203.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++|...+.||+|+||.||+|+.. +...+++|.+...........+.+|++++++++|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 246799998865443323456889999999999999999999999888999
Q ss_pred EEeeccCCCCHHHHhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 209 LVYPFMVNGSVASCLRERGQSQ-----PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
+||||+++|+|.+++....... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654221 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.... . ...+.. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~---~~~~~~-~~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----D---EEVLNR-LQ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----h---HHHHHH-HH
Confidence 9987543322222223345678999999988888999999999999999999 788884211 0 111111 11
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
...... .........+.+++.+||+.+|++|||+.+++..|.+
T Consensus 233 ~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111110 0111233568899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.99 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=170.7
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+|+..++||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 578999999975422 2223468889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997643 378899999999999999999999 9999999999999999999999999997532110
Q ss_pred C----------------------------------------------CceeecccccccccCcccccCCCCCcccCchhh
Q 012610 293 D----------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 326 (460)
Q Consensus 293 ~----------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~ 326 (460)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112458999999999999999999999999
Q ss_pred HHHHHHHHhCCCccc
Q 012610 327 GVMLLELITGQRAFD 341 (460)
Q Consensus 327 G~il~el~tg~~p~~ 341 (460)
||++|||++|+.||.
T Consensus 235 Gvil~elltG~~Pf~ 249 (382)
T cd05625 235 GVILYEMLVGQPPFL 249 (382)
T ss_pred hHHHHHHHhCCCCCC
Confidence 999999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=309.29 Aligned_cols=201 Identities=24% Similarity=0.361 Sum_probs=171.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||.||+++.. +++.||+|++.+... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999976 588999999974321 222345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975332 388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCcccccC-----CCCCcccCchhhHHHHHHHHhCCCccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 33222233458999999999863 457889999999999999999999995
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.67 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=198.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 357888999999999999999974 678999999865432 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|.+++.... ++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999987542 488999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.. ......++..|+|||.+. ...++.++|||||||++|||++|+.||....... .... ......
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----------~~~~-~~~~~~ 226 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------ALFL-MSKSNF 226 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----------hhee-eecCCC
Confidence 21 112345788999999874 3457889999999999999999999985321100 0000 000000
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
..+... ........+.+++.+||+.+|++|||+++|++.|
T Consensus 227 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 0112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.17 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=199.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--Ccc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 207 (460)
++|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|++++..++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46778899999999999999742 47899999986543 23344688999999999999999999987543 467
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++|+||+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 899999999999999975432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcee--ecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc-----C--CCCccHHHHHH
Q 012610 288 LMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-----N--DDDVMLLDWVK 358 (460)
Q Consensus 288 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~-----~--~~~~~~~~~~~ 358 (460)
.......... ....++..|+|||.+.+..++.++|||||||++|||++|..++...... . ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 7643322111 1122345699999999888999999999999999999988775321100 0 00000000011
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..... .............+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 237 ~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111 000011112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.45 Aligned_cols=241 Identities=25% Similarity=0.309 Sum_probs=188.7
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHH-HHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||+||+|+.. +++.||+|++...... .....+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 6899999999754321 12234445544 46789999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999987543 488999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... . .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~------~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-L------RLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-C------CCCC
Confidence 233458999999999999999999999999999999999999995321 112222211110 0 0111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
. ....+.+++.+|++.||.+||++++.+
T Consensus 218 ~----~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 218 N----ISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred C----CCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 1 235688899999999999999996433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.75 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=192.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+|++.+.||+|+||.||+++.. +++.||||++..... ......+.+|++++..++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 588999999865322 1223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 378899999999999999999999 9999999999999999999999999997533110
Q ss_pred C------------------------------------------CceeecccccccccCcccccCCCCCcccCchhhHHHH
Q 012610 293 D------------------------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330 (460)
Q Consensus 293 ~------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il 330 (460)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001124689999999999999999999999999999
Q ss_pred HHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 012610 331 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP---KMSEV 407 (460)
Q Consensus 331 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---t~~ev 407 (460)
|||++|+.||..... .+.............+.. .......+.+++.+|+ .+|.+|+ |+.++
T Consensus 235 yell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTP--------AETQLKVINWETTLHIPS-------QAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCH--------HHHHHHHhccCccccCCC-------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999953211 111111111000000000 0111234566666665 4999999 77777
Q ss_pred HH
Q 012610 408 VR 409 (460)
Q Consensus 408 l~ 409 (460)
++
T Consensus 299 l~ 300 (376)
T cd05598 299 KA 300 (376)
T ss_pred hC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.36 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=199.0
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeee-cCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~-~~~~~~lv~e 212 (460)
.++|...+.||+|+||.||++... +..+|+|.+.... ....+..|+.++++++|+|++++++++. ..+..++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357888899999999999999876 7789999986432 2346889999999999999999999764 4567899999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++..... ..+++..++.++.+++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999976433 2478999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+........ ..
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~-~~----- 217 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVEKG-YK----- 217 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcC-CC-----
Confidence 1 12234568999999988889999999999999999998 99998521 112222211111 00
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=307.67 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=197.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|...+.||+|+||.||+|+.. ++..||+|.+...........+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 57889999997654444444677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+ +|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888765432 378899999999999999999999 99999999999999999999999999997643322
Q ss_pred CceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc--------
Q 012610 294 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-------- 364 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 364 (460)
.. .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+.......
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 21 222347889999998865 45789999999999999999999999532111 0001010000000
Q ss_pred ----cccccccccCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ----KLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ----~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000 00112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.30 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=200.7
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.+|+..+.||+|+||.||++...++..+|+|.+..... ....+..|+++++.++|||++++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46777889999999999999887778999998865332 2346889999999999999999999999888999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++..... .+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999875432 378999999999999999999999 999999999999999999999999999876533222
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||.... ....+....... ....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~---~~~~~~ 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAGF---RLYKPR 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCCC---CCCCCC
Confidence 11112224568999999998889999999999999999998 999985311 111222111110 111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
. ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 ~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 2356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=309.51 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=190.4
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHH-HHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEV-EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~-~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|+||.||+|+.. +++.||+|++...... .....+..|. .+++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 5788999999754321 1222344444 456788999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|.+++.... .+.+..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 99999997643 377888899999999999999999 999999999999999999999999999875432221 2
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~------~~~- 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PL------QLK- 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhC-Cc------CCC-
Confidence 234568999999999999999999999999999999999999995311 11111111111 00 011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+.+++.+|++.+|.+||++.+.+..+.+
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 217 ---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred ---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 1123457889999999999999999865544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=300.28 Aligned_cols=249 Identities=31% Similarity=0.446 Sum_probs=198.5
Q ss_pred CeecccCCeEEEEEEECC--C--cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLTD--G--SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|++|.||+|.+.+ + ..||+|.+...........+..|+..+++++||||+++++++.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 36899999876554445578899999999999999999999888 888999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc-
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 295 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 295 (460)
++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987542 3589999999999999999999999 9999999999999999999999999999876442221
Q ss_pred -eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 296 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 296 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+......... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~--~~~---- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEG--ERL---- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcC--CcC----
Confidence 1112346778999999998899999999999999999999 999985321 111111111110 000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
......+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.02 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=201.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..++||+|+||.||+|... +++.||+|++...... ....++.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999876 5889999999754322 22446889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 212 PFMVNGSVASCLRERGQ-------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
||+++|+|.+++..... .....++..++.++.||++||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999875321 122356778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccC
Q 012610 285 LAKLMDYKDT-----------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347 (460)
Q Consensus 285 ~~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 347 (460)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521110 0111245899999999999999999999999999999999999999531110
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEG 413 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~ 413 (460)
... ..... .++. ........+..+.+++.+|++.||++|| +++++++.|+.
T Consensus 238 ----ki~-------~~~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 ----KIS-------YRDVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ----hhh-------hhhhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 00000 0000 0000112335688899999999999995 56777777765
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.18 Aligned_cols=249 Identities=19% Similarity=0.322 Sum_probs=199.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.+|+..+.||+|++|.||+|... ++..+|+|.+...... ....+.+|+.+++.+.|+|++++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 47888899999999999999864 6889999998754433 234688899999999999999999999998999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998643 378899999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+.. ...... ..
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~-~~~~~~-~~----- 235 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL-IATNGT-PE----- 235 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHH-HhcCCC-CC-----
Confidence 21 1223578899999999988899999999999999999999999953211 011110 000000 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .........+.+++.+||..+|++|||+.+|++
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 011223356888999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=306.46 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=200.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|+||.||++... ++..+|+|.+..........++.+|++++..++||||+++++++..++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999875 57889999887543333345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.++++... .+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997642 3889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc--------
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-------- 365 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 365 (460)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....+.........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccc
Confidence 122345788999999998888999999999999999999999998532110 00000000000000
Q ss_pred ----------------ccccccccCCCCC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 366 ----------------LEQLVDSDMEGNY-IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 366 ----------------~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
...+.... .... .......+.+++.+||+.+|++|||+.+|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000 00123458899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=305.51 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=190.7
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHH-HHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|+.. +++.||+|++...... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5889999998754321 12234455554 57889999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
++|...+.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998886533 378889999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~------~~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHK-PL------QL-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcC-CC------CC--
Confidence 233458999999999998899999999999999999999999995321 11111111111 00 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHhhcCC
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVRMLEGDG 415 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~~L~~~~ 415 (460)
.......+.+++.+|++.+|.+||+.. ++.+.++...
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 111234688999999999999999874 3444444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=289.23 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=203.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++.|++.++||+|.|+.||+.... +|+.+|+|++..... ...-+.+.+|+.+.+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 466777889999999999998754 688999998864432 224457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC---CcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~ 288 (460)
|+|.|++|..-+-.+. -.++..+-..+.||++||.|+|.+ +|||||+||+|+++... --+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999987665542 267788888999999999999999 99999999999999543 3589999999998
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
+. .........||+.|||||++...+|+..+|||+.|||||-|+.|+.||.... ...+.+.+. . .
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~rlye~I~---~-----g 227 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYEQIK---A-----G 227 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHHHHHHHh---c-----c
Confidence 77 5556666789999999999999999999999999999999999999995311 111111111 0 0
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+..+.+..++...+...+++++|+..||.+|.|+.|.+.
T Consensus 228 --~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 --AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111223334445566888999999999999999998775
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.62 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=196.8
Q ss_pred CeecccCCeEEEEEEECC-------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 141 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.||+|+||.||+|+..+ +..+|+|.+...........+.+|+++++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886554334455788999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-----cEEEeeccc
Q 012610 214 MVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-----EAVVGDFGL 285 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg~ 285 (460)
+++++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999764321 23478999999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhh
Q 012610 286 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 286 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||.... . .+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~---~~~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----N---QEVLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----H---HHHHHHHhcC
Confidence 8765322211 1112235678999999999999999999999999999998 999985211 1 1111111000
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
. ...........+.+++.+||..+|++||++.+|++.|+.
T Consensus 230 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 001112234668899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.77 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=198.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccc-cccchhHHHHHHHHHHhccCCCcceeeeeeeec-----CC
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PT 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-----~~ 205 (460)
....|...+.||+|++|.|+.+..+ +|..||||++... ......++..+|+++|+.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666788999999999999876 6899999999743 233345567899999999999999999998765 35
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..|+|+|+| +.+|...++... .++...+..++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 689999999 668888887643 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCceeecccccccccCccccc-CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 286 AKLMDYK-DTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 286 ~~~~~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+..... .....+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|+.-|.+.+ .......+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-----~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-----YVHQLQLILELLGT 246 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-----hHHHHHHHHHhcCC
Confidence 9987532 122335566899999999875 4579999999999999999999999985322 11111111111111
Q ss_pred c---cccccc--------cc--cCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 K---KLEQLV--------DS--DMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~---~~~~~~--------~~--~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .+..+. .. ..... .........++++.+||..||.+|+|++|.++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000 00 00000 01122345778999999999999999999985
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=300.20 Aligned_cols=250 Identities=32% Similarity=0.453 Sum_probs=191.4
Q ss_pred CeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~e~~~ 215 (460)
+.||+|+||.||+|... .+..+|+|.+...........+.+|+.+++.++|||++++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998654333344578889999999999999999998764 456789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+++|.+++..... ...+..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999975432 267788889999999999999999 9999999999999999999999999999755322111
Q ss_pred ---eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhC-CCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 296 ---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 296 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
......++..|+|||.+.+..++.++|||||||++|||++| ..||... ...+...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------DSFDITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhcCCCC-----
Confidence 11122356789999999888999999999999999999995 4555321 111222221111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.21 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=202.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 211 (460)
++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778889999999999999985 57899999987654444455788999999999999999999988654 4678999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865443444588999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||+..............++.. .....+.+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence 221 12346788999999998899999999999999999999999997432211111112222111 01111111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .. ........+.+++.+||+.+|++|||+.||++
T Consensus 231 ~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1 00 00123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.07 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=195.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecC------
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP------ 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~------ 204 (460)
+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999875 57889999986532 2334678899999988 699999999998653
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
...+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||++ +|+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 357899999999999999976432 3488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||..... .....
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~-- 226 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-- 226 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH--
Confidence 9976543222 123345888999999986 33578899999999999999999999953211 01110
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... .... .......+.+++.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 LIPRNPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhcCCC-----CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000 1111 1112356889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=300.78 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=201.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.|+..+.||.|+||.||+|... ++..||+|.+...........+.+|+++++.++|+|++++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999875 578999999875544444557889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++... ++++.....++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998642 378899999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~----------~~~~~ 217 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFL----------IPKNN 217 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhh----------hhcCC
Confidence 122234788899999998888999999999999999999999998532110 00000 00011
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112233455678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.72 Aligned_cols=246 Identities=24% Similarity=0.297 Sum_probs=191.1
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHH-HHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||.||+|+.. +|+.+|+|++...... .....+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 6889999999754221 22234555554 46779999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998886543 489999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~-~~------~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHK-PL------VLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcC-Cc------cCCC
Confidence 233458999999999999999999999999999999999999995321 11111211111 00 0111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
. ....+.+++.+|++.+|.+||++++.++.+..
T Consensus 218 ~----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 218 G----ASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred C----CCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 1 23457789999999999999999765544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=317.39 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=204.2
Q ss_pred CccCCeecccCCeEEEEEEEC--CCc--EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 137 FSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
....++||+|.||+|++|.++ +|+ .||||++..+........|.+|+..+.+++|+|+++|+|+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344578999999999999986 343 6899999887665556689999999999999999999999876 66789999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
.++.|+|.+.|++ .....+.......++.|||.||.||.++ ++|||||..+|+||-....|||+|||+.+.+...
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999988 3344588899999999999999999999 9999999999999999999999999999988654
Q ss_pred CCcee--ecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
+.... ....-...|.|||.+....++.++|||+|||++|||+| |..||-... -.+.++ .
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~----------~ 327 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILK----------N 327 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHH----------h
Confidence 43321 12224568999999999999999999999999999999 888884321 112111 1
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
+|..-.-.....|.++++++|..||..+|++|||+..|.+.
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 22222223345577899999999999999999999999743
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=301.91 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=202.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||.|++|.||+|+.. +++.+|+|.+...........+.+|+++++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999876 58899999987654444445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++... ++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998754 489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .......+
T Consensus 153 ~~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~-~~~~~~~~---- 218 (274)
T cd06609 153 SK-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLI-PKNNPPSL---- 218 (274)
T ss_pred cc-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHh-hhcCCCCC----
Confidence 21 2233578889999999998899999999999999999999999953210 1111111 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .....+.+++.+||..+|++|||++++++
T Consensus 219 -~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 -EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 100 03356888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.20 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=198.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555678999999999999865 578899999875544444456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++... .+++..+..++.++++||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988642 388999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..... . ..... ..... .+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~---~~~~~-~~~~~-----~~-- 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-----M---RVLFL-IPKNS-----PP-- 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-----h---hHHhh-hhcCC-----CC--
Confidence 11223478899999999988899999999999999999999999852110 0 00000 00000 01
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.+|++||++.+|++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111123456889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.09 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=204.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec--CCcc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~ 207 (460)
+.|...+.||+|+||.||++... ++..+|||.+...........+.+|++.++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999854 3678999999765443345578999999999999999999999877 5578
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
+++|||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCC------C-ccHHHHHH
Q 012610 288 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD------D-VMLLDWVK 358 (460)
Q Consensus 288 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~------~-~~~~~~~~ 358 (460)
......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... . .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11123456799999998889999999999999999999999998532111000 0 00111111
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..... ........+...+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 238 -~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 -LLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -HHHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11110 00111122336689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=306.33 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=197.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|...+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 57899999987554444444677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. ++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 589888875432 378999999999999999999999 99999999999999999999999999997643322
Q ss_pred CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh----------
Q 012610 294 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 362 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 362 (460)
.. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhh
Confidence 21 1223468899999988654 478899999999999999999999953211 011111111100
Q ss_pred --hccccccccccCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 --EKKLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 --~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000000 00112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.28 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=202.4
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-C----cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-G----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
..+|...+.||+|+||.||+|.... + ..+|+|.+...........+.+|+..+..++|+|++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3567888999999999999998642 3 26899988766544445578899999999999999999999987 7889
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++|||+.+|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999976433 389999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceee-cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
.......... ...++..|+|||.+....++.++||||||+++||+++ |+.||+... ..++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGER- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCCC-
Confidence 6533222111 1123567999999988889999999999999999998 999995321 1122211111110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
... ...+...+.+++.+||..+|++||++.++++.|++.
T Consensus 230 --~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 --LPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --CCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 111224588899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=296.50 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=201.5
Q ss_pred cCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|++|.||+|...+ +..+++|.+..... ...+.+|+++++.++|+|++++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578888999999999999999864 78999999865432 45789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999987543 3489999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . +... ..... .
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~-~~~~-~~~~~-----~- 217 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------A-IFMI-PNKPP-----P- 217 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------h-hhhh-ccCCC-----C-
Confidence 2 2223347889999999998899999999999999999999999996321110 0 0000 00000 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...........+.+++.+||+.+|++|||+.+|++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 -TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00111223356889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=307.79 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=194.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|...+.||+|+||.||+++.. +++.||+|.+.+... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 578899999875321 222335778899999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976432 388999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccC-----CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..........|++.|+|||++.+ +.++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCCc
Confidence 33333333568999999999875 467889999999999999999999995321 11111111111000
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~ 409 (460)
.. + ..........+.+++.+|+..++++ |++++++++
T Consensus 227 ~~-----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 FQ-----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cc-----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00 0 0111122356778888888765543 456766654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=294.46 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=189.6
Q ss_pred eecccCCeEEEEEEECCC---cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCC
Q 012610 142 ILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
.||+|+||.||++...++ ..+++|.+...........+.+|+..++.++||||+++++.+......++||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 34667776654433445578899999999999999999999999899999999999999
Q ss_pred HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC-cee
Q 012610 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVT 297 (460)
Q Consensus 219 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 297 (460)
|.+++..........++..++.++.||+.||+|||+. +++||||||+|||++.++.++|+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999987543334467788889999999999999999 999999999999999999999999999864321111 111
Q ss_pred ecccccccccCcccccC-------CCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 298 TAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 298 ~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
....++..|+|||++.. ..++.++|||||||++|||++ |..||.... ..+......... ...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~-~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKDQ-QVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhhc-cccc
Confidence 23447789999998753 235789999999999999997 566774211 112222222221 1222
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222222 2345777888999 57999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.23 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=194.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++......+++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346888999999999999999976 478899996432 235689999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
++. ++|..++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 994 688888865332 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCc---cHHHHHHHHhh-hcccc
Q 012610 293 DTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV---MLLDWVKGLLK-EKKLE 367 (460)
Q Consensus 293 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~ 367 (460)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+-.......... .+...+..... .....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 211 12234589999999999999999999999999999999998876532111111111 11111111000 00000
Q ss_pred cc----------------ccccCCCCCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QL----------------VDSDMEGNYIE---EEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~----------------~~~~~~~~~~~---~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ..+........ .....+.+++.+||+.||.+|||+.|+++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 00000000000 11235788999999999999999999986
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=307.03 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=194.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..++||+|+||.||+++.. +++.+|+|++.+... ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999976 477899999864321 122334778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976432 388999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCcc
Confidence 3333333356899999999986 3457889999999999999999999995321 12222222111100
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP--MERPKMSEVVRM 410 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P--~~RPt~~evl~~ 410 (460)
.. . ..........+.+++.+|+..++ ..|+++.++++.
T Consensus 227 ~~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQ-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0 01111223456777777775443 346888888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=310.67 Aligned_cols=198 Identities=24% Similarity=0.296 Sum_probs=166.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC-----
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----- 205 (460)
..++|+..+.||+|+||.||++... ++..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999875 588999999975432 233446788999999999999999999886443
Q ss_pred -cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 206 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 206 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
..++||||+.+ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999965 56666542 278888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99754322 122334588999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=299.32 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=198.8
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhH-HHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
|+..+.||+|+||+||+++.. +++.+|+|.+.......... ...+|+.++..++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999987 46689999998764433322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++.... .+++..++.++.|+++||++||+. +++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998332 389999999999999999999999 99999999999999999999999999997642 222
Q ss_pred ceeecccccccccCccccc-CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......++..|+|||.+. +..++.++||||+|+++|+|++|..||... ......................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~--- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRPLPSSSQ--- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTHHHHHTT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhccccccccccc---
Confidence 3344456889999999998 888999999999999999999999999632 0011111111111100000000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+.+++.+||+.||++|||+.++++
T Consensus 225 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011267999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.45 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=197.2
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.|+..++||+|+||.||++... +++.||+|.+....... ....+..|+.+++.++|+|++.+++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999876 68899999987543222 22356789999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998865432 2488999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ...+.......... .
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~~~------~ 222 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEVQ------E 222 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhhhh------h
Confidence 21 12335899999999999999999999999999999999999999632110 00111111111000 0
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
. ........+.+++.+||+.||++||| ++|+++
T Consensus 223 ~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 E----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 11112345789999999999999999 667764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.26 Aligned_cols=263 Identities=23% Similarity=0.297 Sum_probs=201.5
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee-
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM- 202 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~- 202 (460)
.++.+..+.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++..+ +|||++++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34555667789999999999999999999875 57899999886432 2234577899999998 6999999999874
Q ss_pred ----cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 203 ----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 203 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
..+..+++|||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 33567999999999999998875433344588999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccC-----CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~ 353 (460)
||+|||+++....... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||..... .
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~ 235 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------M 235 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------h
Confidence 9999999876543221 1223358899999998753 4578899999999999999999999853211 0
Q ss_pred HHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
... ...... ......++ ......+.+++.+||+.+|++|||+.||++.
T Consensus 236 ~~~-~~~~~~-~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 RAL-FKIPRN-PPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHH-hhcccc-CCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000000 00001111 1123468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=305.64 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=191.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~ 211 (460)
+|+..+.||+|+||.||+|... +++.||+|++..... ......+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677789999999999999875 688999999975432 222345677888888776 567888999998888999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987543 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~-~~----- 218 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIMEH-NV----- 218 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CC-----
Confidence 221 2233458999999999999899999999999999999999999995321 11111111111 10
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
.........+.+++.+||+.+|.+|++..
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 01111234678899999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=298.61 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=200.1
Q ss_pred CCccCCeecccCCeEEEEEEECC--CcEEEEEEecccc---------ccchhHHHHHHHHHHhc-cCCCcceeeeeeeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER---------TQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT 203 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~ 203 (460)
+|+..+.||+|+||.||+|.... +..+|+|.+.... .......+..|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999764 6789999886322 11122346678887764 799999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986543334458999999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVE 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhh
Confidence 99998754432 2233458889999999998889999999999999999999999985321 1111111111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
....... .......+.+++.+||+.||++||++.||.++++
T Consensus 228 -~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -AVYEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -ccCCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111000 0112356889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=297.63 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=198.4
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++.+++++.....||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456667777789999999999999865 577899998865432 23446889999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeeccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAK 287 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~ 287 (460)
+++||+.+++|.+++...... ...++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999764221 1127888899999999999999999 9999999999999986 6799999999987
Q ss_pred ccCCCCCceeecccccccccCcccccCCC--CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ....+......
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--- 228 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMFK--- 228 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhhc---
Confidence 6532222 122234788999999986644 788999999999999999999998531110 00001000000
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............+.+++.+||+.+|++|||+.+|++
T Consensus 229 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001112223456889999999999999999999885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=300.80 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=204.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|++|+||++... ++..||+|++...........+.+|++++..++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356777889999999999999875 5889999988765444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++...+ ++++..+..++.+++.||.|||+.. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999987643 4899999999999999999999732 8999999999999999999999999998654222
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCC---CCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND---DDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 369 (460)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ ......+++........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---- 230 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence 1 1234588999999999888899999999999999999999999964322111 11111222222221110
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
+.+. .......+.+++.+||+.||++|||+.||++..
T Consensus 231 --~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 --PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 112345688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=311.00 Aligned_cols=200 Identities=23% Similarity=0.359 Sum_probs=172.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||.||++... +++.||+|++..... ......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999876 588999999975321 223346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999875421
Q ss_pred CCC----------------------------------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCC
Q 012610 292 KDT----------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337 (460)
Q Consensus 292 ~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~ 337 (460)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346899999999999999999999999999999999999
Q ss_pred Cccc
Q 012610 338 RAFD 341 (460)
Q Consensus 338 ~p~~ 341 (460)
.||.
T Consensus 234 ~Pf~ 237 (360)
T cd05627 234 PPFC 237 (360)
T ss_pred CCCC
Confidence 9995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.85 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=199.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|+..+.||+|+||.||+|... ++. .+|+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356777889999999999999864 343 57899887654444444688899999999999999999998754 467
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+++||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999876432 378999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .....+++. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~----~~~- 228 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLE----KGE- 228 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH----CCC-
Confidence 54332211 112234678999999998899999999999999999997 889985311 111112211 110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.... ...+...+.+++.+||..+|++||++.++++.|+.+
T Consensus 229 -~~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 -RLPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000 111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=296.69 Aligned_cols=240 Identities=23% Similarity=0.364 Sum_probs=186.3
Q ss_pred CeecccCCeEEEEEEECC-------------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 141 NILGRGGFGKVYKGRLTD-------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
+.||+|+||.||+|+... ...+++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 2358889876543 22334678889999999999999999999998899
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc-------EEE
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------AVV 280 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------~kl 280 (460)
+++|||+.+|+|..++.... .++++..++.++.||++||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999999886533 2489999999999999999999999 9999999999999987664 899
Q ss_pred eecccccccCCCCCceeecccccccccCccccc-CCCCCcccCchhhHHHHHHHH-hCCCccccccccCCCCccHHHHHH
Q 012610 281 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||..... .+. .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-H
Confidence 999998654322 1234778899999886 466899999999999999997 58888743111 110 0
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
..... .. . . .......+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ~~~~~-~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEG-QC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhc-Cc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11110 00 0 0 0112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=297.22 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=198.4
Q ss_pred CCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-----chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+|...+.||+|+||.||+|...+++.+|+|.+...... .....+.+|++.++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36778899999999999999888899999998643221 1223588899999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997543 378999999999999999999999 99999999999999999999999999987643
Q ss_pred CCC-----CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 291 YKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 291 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGL 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHHhhhccCC
Confidence 211 1112234578899999999988899999999999999999999999953211 0010000000000
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 227 -----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=331.23 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=199.0
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC--Cc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE 206 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~ 206 (460)
+...++|.+.+.||+|+||+||+++.. .+..+|+|.+...... .....+..|+.++..++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344568999999999999999999976 5778999998754322 2344688999999999999999999987543 46
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeeCCCCCCEEecCC-------
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD----PKIIHRDVKAANILLDEE------- 275 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlkp~Nill~~~------- 275 (460)
.++||||+.+|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999997654434459999999999999999999998521 259999999999999642
Q ss_pred ----------CcEEEeecccccccCCCCCceeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCccccc
Q 012610 276 ----------FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 343 (460)
Q Consensus 276 ----------~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~ 343 (460)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998654322 1233458999999999854 45789999999999999999999999531
Q ss_pred cccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 344 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ....++....... .+. .......+.+++.+||+.+|.+||++.|++.
T Consensus 247 ~-------~~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 N-------NFSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred C-------cHHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 1222222111110 000 0112356889999999999999999999983
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.63 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=188.9
Q ss_pred eecccCCeEEEEEEECC---CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCC
Q 012610 142 ILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
.||+|+||.||+|...+ ...+++|.+...........+.+|++.++.++|+||+++++.+......++||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 357888887654443444568889999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce-
Q 012610 219 VASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 296 (460)
Q Consensus 219 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 296 (460)
|.+++...... ....++...+.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765432 22356788899999999999999999 99999999999999999999999999986543222111
Q ss_pred eecccccccccCcccccC-------CCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 297 TTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... . .+.......... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~---~~~~~~~~~~~~-~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----D---EQVLKQVVREQD-IK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----H---HHHHHHHhhccC-cc
Confidence 122235677999998743 356889999999999999999 778884211 0 111111111111 11
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
+..+.. .......+.+++..|| .||++|||+++|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 1123345677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.26 Aligned_cols=252 Identities=32% Similarity=0.491 Sum_probs=201.2
Q ss_pred CccCCeecccCCeEEEEEEECC-----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 137 FSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+++.+.||.|+||.||+++..+ +..||+|.+...........+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999998763 37899999976654445567899999999999999999999999989999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++...... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999764321 189999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
..........++..|+|||.+.+..++.++||||||+++++|++ |..||... ...............
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~---- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLKKGYRL---- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhcCCCC----
Confidence 32222212236789999999988889999999999999999998 78888531 111111111111110
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
.........+.+++.+|++.+|++|||+.++++.|
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111345688999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.34 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=191.1
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhcc---CCCcceeeeeeeecC-----C
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTP-----T 205 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~-----~ 205 (460)
+|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 58899999987543222 223455677766554 799999999987642 3
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 4689999997 489888875432 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..... ......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~-~~~~~~ 227 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFD-LIGLPP 227 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHH-HhCCCC
Confidence 98654322 12234578899999999988999999999999999999999999853211 001111111 000000
Q ss_pred ccc----------cccccCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQ----------LVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~----------~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ....... ..........+.+++.+|++.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000 0001123456789999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.54 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=195.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHH-HhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|+||.||++... +|..||+|+++..........+..|+.. ++...|||++++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 6899999999765433334455566665 566789999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|++ |+|.+++.........+++..++.++.||+.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888888764444456899999999999999999999853 7999999999999999999999999998765322
Q ss_pred CCceeecccccccccCcccccC----CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... . .+.+....... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~-~~~~~~~~~~~-~-- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------P-FQQLKQVVEEP-S-- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------C-HHHHHHHHhcC-C--
Confidence 1 1122347889999998865 4468899999999999999999999952110 0 11111111110 0
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+. .......+.+++.+||..+|++||++.+|++
T Consensus 226 ---~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ---PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0010 0112356889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=295.67 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=194.1
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
|+..+.||+|+||+||++... +++.+|+|.+...... .....+.+|++++..++|+|++.+.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 6889999998654322 2233567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|..++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 3489999999999999999999999 99999999999999999999999999987653222
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... . ...+.+....... ..
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~-~~~~~~~~~~~~~--~~----- 222 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----K-VKREEVDRRVLET--EE----- 222 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----H-HHHHHHHHhhhcc--cc-----
Confidence 1 2234589999999999988999999999999999999999999953211 0 0001111111110 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 406 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 406 (460)
.........+.+++.+||+.+|++||++.+
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 223 ---VYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 011122345788999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.33 Aligned_cols=193 Identities=25% Similarity=0.390 Sum_probs=164.6
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
....+|+..+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++|+||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999976 4678999975432 234689999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+|++. ++|.+++.... .++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99994 68888886533 3489999999999999999999999 99999999999999999999999999997533
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~ 340 (460)
... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 122345899999999999999999999999999999999865554
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.09 Aligned_cols=249 Identities=19% Similarity=0.312 Sum_probs=199.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.+|...+.||+|++|.||++... +++.||+|.+...... ....+.+|+.+++.++|+|++++++++......++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 57888899999999999999864 6899999998654332 334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++... .+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998653 378899999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+. ...... .+
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~----~~~----~~~~~~------~~- 233 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALY----LIATNG------TP- 233 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch----hee----eeccCC------CC-
Confidence 21 222347889999999998889999999999999999999999995321100 000 000000 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...........+.+++.+||+.+|++||++++|++
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 -ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011223355788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.72 Aligned_cols=249 Identities=23% Similarity=0.412 Sum_probs=197.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--------hhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
+|...+.||+|++|.||+|... ++..+|+|.+....... ....+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999865 57899999886543221 12357889999999999999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997643 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc-----eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 287 KLMDYKDTH-----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 287 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
+........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHh
Confidence 866422111 11123478899999999988899999999999999999999999963210 01111100
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...+ .........+.+++.+||+.+|++||++.+|++
T Consensus 226 ~------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E------NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c------cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0111 111223466889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.90 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=203.6
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+|+..+.||+|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777789999999999999986 588999999976654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
.+++|.+++.... .++++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999997653 348899999999999999999999 7 99999999999999999999999999987653222
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.+........ +.
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~------~~ 223 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEPP------PR 223 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCCC------CC
Confidence 11 14578899999999999999999999999999999999999953211 11112222222221110 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+. .......+.+++.+||..+|++|||+.+++.
T Consensus 224 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 10 1113456889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=293.99 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc----chhHHHHHHHHHHhccCCCcceeeeeeeecC--Ccc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 207 (460)
.+|+..+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999875 5889999988643221 2234578899999999999999999988653 567
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997643 378899999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC--CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 288 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 288 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~~~- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQP- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhcCC-
Confidence 653211 111122347889999999998889999999999999999999999995311 111111111000
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............+.+++ +||..+|++||+++||++
T Consensus 226 --------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111222234455555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.55 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=203.4
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc-ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..++||.|+||.||.++.. ++..+++|.+.... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999865 58899999986543 233345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 23488999999999999999999999 99999999999999999999999999998664433
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. ......++..|+|||.+.+..++.++||||||+++|||++|..||.... ..+........ ....
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~-~~~~----- 220 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQG-NYTP----- 220 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC-CCCC-----
Confidence 2 2233458899999999988889999999999999999999999995311 11222222111 1111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
........+.+++.+||+.+|.+||+++++++.+
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0122345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.18 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=196.2
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
...+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|+++++.++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999999999999754 35789999886432 35689999999999999999999998889999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+||++. ++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 6888888432 2489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+...+.. +.......
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~-~~~~~~~~ 313 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRC-MQVHPLEF 313 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHH-hccCcccc
Confidence 433221 2223568999999999999999999999999999999999999995322111 00111111110 00000000
Q ss_pred c-------------ccccCCCCCc-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 369 L-------------VDSDMEGNYI-------EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 369 ~-------------~~~~~~~~~~-------~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
. .......... ......+.+++.+||..||++|||+.|++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 0112457788999999999999999999863
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=292.35 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=201.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|++|.||+|... ++..+++|.+...... ....+.+|+++++.++|||++++++++......+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57888899999999999999875 5788999999755333 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999987642 2488999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccCC---CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .-.... ... ...
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~~~~-~~~---~~~ 222 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RALFLI-SKS---NFP 222 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-Hhc---cCC
Confidence 1 12234578899999999776 7889999999999999999999999532110 000000 000 000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ..........+.+++.+||..+|.+|||+.+|+.
T Consensus 223 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0112234567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=298.76 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=199.4
Q ss_pred cCHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
.++.++....+.|+..+.||.|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 345555566788999999999999999999975 57899999886432 2234577888888888 6999999999885
Q ss_pred c------CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 203 T------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 203 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
. .+..+++|||+.+|+|.+++..... ..+++..++.++.||+.||+|||+. +++|+||+|+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 3567899999999999999976432 2478888999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCc
Q 012610 277 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 351 (460)
.++|+|||++........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----- 232 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----- 232 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----
Confidence 999999999876532221 122345788999999875 345788999999999999999999999532110
Q ss_pred cHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 352 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ...... . ..... ........+.+++.+||+.||.+|||+.||++
T Consensus 233 --~~-~~~~~~-~-----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 --RA-LFLIPR-N-----PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hh-hhhHhh-C-----CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 0 00000 01123456899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=307.55 Aligned_cols=265 Identities=19% Similarity=0.223 Sum_probs=194.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC------
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 204 (460)
..++|...+.||+|+||.||++... .++.||||.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 5889999999754322 2334677899999999999999999987643
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
...+++|||+.+ +|.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999965 67666643 278899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCC-------ccHHH--
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-------VMLLD-- 355 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~-------~~~~~-- 355 (460)
+++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ....+
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865332 12233458999999999999899999999999999999999999995321100000 00000
Q ss_pred -----HHHHHhhh-cccccccccc------C--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 356 -----WVKGLLKE-KKLEQLVDSD------M--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 356 -----~~~~~~~~-~~~~~~~~~~------~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+...... .....+..+. . ...........+.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00001000 0000000000 0 00011112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=302.73 Aligned_cols=199 Identities=22% Similarity=0.300 Sum_probs=164.1
Q ss_pred cCCeeccc--CCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 139 NRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 139 ~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+.++||+| +|++||++... +|+.||+|++....... ....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 68899999875 68999999997654322 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999965432 2388999999999999999999999 999999999999999999999999986543321111
Q ss_pred c------eeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 295 H------VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 295 ~------~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0111235678999999876 4588999999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.17 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=201.1
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeec--CCcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~ 211 (460)
+|+..+.||.|+||.||++... ++..+|+|.+..... ......+..|+++++.++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999865 678999999875432 2334468889999999999999999998764 34578999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
||+.+++|.+++........++++..++.++.+++.||+||| +. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999875444456899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....... ......
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~ 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASK-IKEGKF 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHH-HhcCCC
Confidence 876543321 223457889999999998889999999999999999999999996321 1111111 111111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+|++.+|++|||+++|++
T Consensus 228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1112233467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=292.91 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=204.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||.|++|+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 57899999997655444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12489999999999999999999999 99999999999999999999999999987665433
Q ss_pred Cc---eeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 294 TH---VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 294 ~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.. ......|+..|+|||.+... .++.++|+|||||++|||++|+.||...... ..... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~----~~~~~----- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLML----TLQND----- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHH----HhcCC-----
Confidence 22 12234578899999998777 7899999999999999999999999532110 01111 11110
Q ss_pred ccccCCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ........+.+++.+||+.||++|||+.+|++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011100 01233466889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=296.75 Aligned_cols=249 Identities=18% Similarity=0.320 Sum_probs=199.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.+|+..+.||.|++|.||+|... +++.|++|.+..... .....+.+|++.++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 46888899999999999999864 688999999865432 2344678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|..++... .+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988643 388999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .......... .....
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~-~~~~~---- 235 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATN-GTPEL---- 235 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc-CCccc----
Confidence 21 2234578899999999988899999999999999999999999953211 1111111110 00000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||..+|++|||+.+|++
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 ---QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122345888999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=294.77 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=196.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.|++.+.||.|+||.||+|+.. ++..+++|.+.... ......+.+|+++++.++|+|++++++.+..+...++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 57888899999999999999976 47899999986542 22344688899999999999999999999988999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|..++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999888765332 389999999999999999999999 99999999999999999999999999987543221
Q ss_pred CceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
. ......++..|+|||.+. ...++.++|||||||++|||++|..||.... .............
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~--- 232 (292)
T cd06644 165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEP--- 232 (292)
T ss_pred c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHhcCCC---
Confidence 1 122334788999999885 3446789999999999999999999985311 0111111111100
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.. .........+.+++.+||+.+|++||++.++++
T Consensus 233 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 ---PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 001122346888999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=294.17 Aligned_cols=247 Identities=30% Similarity=0.458 Sum_probs=196.7
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
++|...+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.++..++|||++++++++.. +..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence 4678889999999999999975 47789999986532 23468899999999999999999998865 4579999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999976432 2478999999999999999999998 99999999999999999999999999987543211
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~-------- 215 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECVEKGYR-------- 215 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHHHhCCCC--------
Confidence 11224567999999988899999999999999999998 999985321 1111111111100
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..........+.+++.+||+.+|++||++.+|++.|++
T Consensus 216 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 --MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=300.18 Aligned_cols=196 Identities=23% Similarity=0.373 Sum_probs=159.5
Q ss_pred CCeecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec--CCcceEEeecc
Q 012610 140 RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFM 214 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~ 214 (460)
.++||+|+||.||+|+.. ++..+|+|.+..... ...+.+|+++++.++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999864 467899999865322 2356789999999999999999998854 34578999998
Q ss_pred CCCCHHHHhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe----cCCCcEEEeeccc
Q 012610 215 VNGSVASCLRERGQ-----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGL 285 (460)
Q Consensus 215 ~~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~ 285 (460)
. ++|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 588888754321 123488999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCC--ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 286 AKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 286 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 987643221 122334588999999998774 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.86 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=199.3
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHh--ccCCCcceeeeeeeecCC----
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS--MAVHRNLLRLRGFCMTPT---- 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~~~h~niv~l~~~~~~~~---- 205 (460)
.......+.+.||+|.||.||+|++. |+.||||++... .+..+.+|.++++ .++|+||+.+++.-..++
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 33456777899999999999999997 789999999643 2345777777765 579999999998765443
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeeCCCCCCEEecCCCcEEE
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-----HCDPKIIHRDVKAANILLDEEFEAVV 280 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dlkp~Nill~~~~~~kl 280 (460)
+.|+|++|.+.|||.++|.... ++....++++..+|.||++||. +.+|.|.|||||+.||||.+++.+.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 5789999999999999998743 8899999999999999999995 36789999999999999999999999
Q ss_pred eecccccccCCCCCc---eeecccccccccCcccccCCCC------CcccCchhhHHHHHHHHhCC----------Cccc
Q 012610 281 GDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKS------SEKTDVFGYGVMLLELITGQ----------RAFD 341 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~------~~~~Dvws~G~il~el~tg~----------~p~~ 341 (460)
+|+|+|......... .....+||.+|||||++...-. -..+||||||.|+||++-.. .||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999765543221 2344579999999999865421 24689999999999998632 3443
Q ss_pred cccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 342 LARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
..-.. +. ..+-+...+...++...++.+ -...+.+..+.++|..||..+|.-|-|+-.|-+.|.++.
T Consensus 438 d~Vp~---DP-s~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPS---DP-SFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCC---CC-CHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 11111 11 111111111111111111111 124567888999999999999999999999988887643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.51 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=195.7
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||+|+.. ++..||+|.+...... .....+.+|+.++..++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 6889999998754322 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. ++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888865432 23589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh----------
Q 012610 294 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 362 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 362 (460)
. ......++..|+|||.+.+. .++.++|||||||++|||+||+.||...... ............
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcch
Confidence 1 12223467899999988654 4688999999999999999999999532110 000000000000
Q ss_pred -hccccccccccCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 -EKKLEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 -~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.............. .........+.+++.+||+.||++|||+++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 001112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.98 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=196.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346777788999999999999865 588999999865432 223357789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|.+++...+ .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999987543 389999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.. ......|+..|+|||.+. ...++.++|||||||++|+|++|+.||..... ... +...... . .
T Consensus 160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~----~~~----~~~~~~~-~---~ 226 (267)
T cd06645 160 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP----MRA----LFLMTKS-N---F 226 (267)
T ss_pred cc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc----hhh----HHhhhcc-C---C
Confidence 21 122345889999999874 45688999999999999999999999842110 000 0000000 0 0
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+.... .......+.+++.+||+.+|++|||+++|++
T Consensus 227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000 0012345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=291.53 Aligned_cols=238 Identities=24% Similarity=0.391 Sum_probs=188.3
Q ss_pred CeecccCCeEEEEEEECCCc-----------EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 141 NILGRGGFGKVYKGRLTDGS-----------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999976432 5788877644322 4578899999999999999999999988 77899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-------cEEEee
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-------EAVVGD 282 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~kl~D 282 (460)
||||+.+|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999986542 488999999999999999999999 999999999999999888 799999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCC--CCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHH
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
||++..... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||..... ..+...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHH
Confidence 999986543 1223366789999999876 78999999999999999999 5777743211 011111
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
. .... . .... ....+.+++.+||..+|.+|||+.+|++.|+
T Consensus 219 ~-~~~~--~-----~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 Y-QDQH--R-----LPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred H-hcCC--C-----CCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 0000 0 0000 0156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.16 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=198.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~e 212 (460)
.|+..+.||+|++|.||+++.. +++.+|+|.+..... ......+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 578899999865432 2234467889999999999999999988764 345789999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++.... ..++++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997632 23489999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. ......+++.|+|||.+.+..++.++||||||+++++|++|+.||.... .......... ....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~~----- 220 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIE-GKLP----- 220 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh-cCCC-----
Confidence 22 2233457889999999999999999999999999999999999985311 1122222111 1111
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.+|++|||+.++++
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=307.07 Aligned_cols=198 Identities=23% Similarity=0.279 Sum_probs=167.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC------
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 204 (460)
..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999865 578999999975432 22344677899999999999999999987543
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
...++||||+.+ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999965 77777643 278889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 998653321 22334588999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=294.44 Aligned_cols=239 Identities=25% Similarity=0.370 Sum_probs=184.1
Q ss_pred eecccCCeEEEEEEECC-------------------------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCccee
Q 012610 142 ILGRGGFGKVYKGRLTD-------------------------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~ 196 (460)
.||+|+||.||+|.... ...|++|.+..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997421 23588998865432 22346788899999999999999
Q ss_pred eeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 197 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
+++++......++||||+++|+|..++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999999865332 378999999999999999999999 999999999999998654
Q ss_pred -------cEEEeecccccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHH-hCCCccccccccC
Q 012610 277 -------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELI-TGQRAFDLARLAN 347 (460)
Q Consensus 277 -------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~-tg~~p~~~~~~~~ 347 (460)
.+|++|||++....... ...++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 37999999886432211 1236788999998865 56799999999999999984 69999853211
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.....+ .... ...... ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 228 ---~~~~~~----~~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERF----YEKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHH----HHhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 001111 1100 000011 1235889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.88 Aligned_cols=254 Identities=20% Similarity=0.343 Sum_probs=199.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|+||.||++... ++..||+|.+...........+.+|++++.+++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36778899999999999999976 68999999987543333345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|..++.... ....+++..+..++.+++.||.|||+.. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999887632 1234899999999999999999999632 89999999999999999999999999987653221
Q ss_pred CceeecccccccccCcccccCCC------CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ......+..... ...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-~~~- 227 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVD-GDP- 227 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhh-cCC-
Confidence 12234778999999986543 47899999999999999999999953210 111111111111 000
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.+|++||++.+++.
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 --------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1112224566889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=312.53 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=206.8
Q ss_pred ccCCeecccCCeEEEEEEEC-C----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 138 SNRNILGRGGFGKVYKGRLT-D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
...++||+|+||+||+|.+- + +.+||||++......+...+++.|.-.+..++|||+++++++|.... ..+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34588999999999999863 3 35799999988777777778999999999999999999999998765 789999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||+.|+|.++++..+. ++.....+.|..|||+||.|||.+ +++||||-.+||||.+-.++||.|||+++.+...
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999988654 488899999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeecc-cccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 293 DTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 293 ~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
........ .-.+.|||-|.+....++.++|||||||++||++| |..|++.... +-+..+++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dlle~------- 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDLLEK------- 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHHHhc-------
Confidence 54433222 23568999999999999999999999999999998 9999864221 111222221
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+-..+..+..++..+|.+||..|+..||+++++...+.+
T Consensus 916 --geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 916 --GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred --cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11112233456779999999999999999999999987754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=295.85 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=201.1
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
.+.++..+.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++.++ +|||++++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34445556789999999999999999999875 68899999986532 2234577889888888 79999999999875
Q ss_pred C-----CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 204 P-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 204 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
. ...++||||+.+++|.++++........+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 357899999999999999875433344589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCC-----CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~ 353 (460)
||+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------- 238 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------- 238 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--------
Confidence 99999998765432211 1223578899999987543 368899999999999999999999853110
Q ss_pred HHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..-+..... .....+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 VKTLFKIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011111111 11111111 1123356889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=309.65 Aligned_cols=244 Identities=26% Similarity=0.432 Sum_probs=196.1
Q ss_pred CCeecccCCeEEEEEEEC-CCcEEEEEEeccc---cccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc--ceEEeec
Q 012610 140 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE---RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLVYPF 213 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~--~~lv~e~ 213 (460)
..+||+|+|-+||+|.+. +|..||--.++.. +......+|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999875 4666664444322 223334679999999999999999999999887655 6789999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 292 (460)
+..|+|..|+++.+. ++...++.|+.||++||.|||++ .|+|+|||||.+||+|+.+ |.|||+|+|+|..+...
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988764 78889999999999999999998 6789999999999999764 89999999999987544
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. ..+.|||.|||||++. ..|++.+||||||+.++||+|+..||.. ......++..|.+..+...+..+.|+
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 32 2366999999999987 7899999999999999999999999952 12222333333333343344444433
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.++|.+|+.. ..+|||+.|+|.
T Consensus 272 ------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 478899999998 999999999985
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.03 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=201.1
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|+||.+|++... +++.||+|.+..... ......+.+|+++++.++||||+++.+++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 688999999875432 22334688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999876432 2378999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....|+..|+|||.+.+...+.++|||||||++++|++|+.||.... ..+.+....... .
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~-~------- 218 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGS-Y------- 218 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCC-C-------
Confidence 11 122347888999999998889999999999999999999999985321 112222221111 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.+|++||++.+|++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111223456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=303.89 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=192.7
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC-----
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP----- 204 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~----- 204 (460)
...++|...+.||+|+||.||+|... ++..||||.+...... .....+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999865 6789999998754322 2234577899999999999999999887533
Q ss_pred -CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 205 -TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 205 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
...+++++++ +++|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 78998887542 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
|+++..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+.. ...
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~-~~~ 233 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIME-VVG 233 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH-HhC
Confidence 999865432 223458899999999877 56899999999999999999999999532110 00000000 000
Q ss_pred hcc-----------cccccc--ccCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 EKK-----------LEQLVD--SDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ~~~-----------~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ...... +..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000 000000 00011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=296.69 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=197.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|++|.||+|+.. +++.||+|++...... .....+.+|+++++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 5889999998654322 223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|..++.... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887765432 389999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh--------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-------- 363 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 363 (460)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChHHhhh
Confidence 22 1222347788999999876 4578999999999999999999999953211 0001111100000
Q ss_pred ---cc-ccccccccCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 ---KK-LEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ---~~-~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ......+..... ........+.+++.+||+.+|++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000000000000 01112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.23 Aligned_cols=257 Identities=24% Similarity=0.283 Sum_probs=200.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|...+.||+|++|.||++... ++..+|+|.+....... ....+..|++++..++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 48999999997654332 3446888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987542 23489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc----------------------------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccc
Q 012610 292 KDTH----------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 343 (460)
Q Consensus 292 ~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~ 343 (460)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 011234788899999999888999999999999999999999999532
Q ss_pred cccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 344 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.. . ...... .+..............+.+++.+||..+|++|||....++.+..
T Consensus 236 ~~----~----~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NR----D----ETFSNI---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ch----H----HHHHHH---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 0 000111 11111111111134679999999999999999995444444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=295.07 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=199.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCC-----
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT----- 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~----- 205 (460)
.+++|+..+.||+|++|.||+|... +++.+++|.+..... ....+.+|+++++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 578899999875432 234688999999998 6999999999987644
Q ss_pred -cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 206 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 206 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
..+++|||+.+++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876543344589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccC-----CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... . .....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~----~~~~~ 229 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----M----RALFK 229 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----H----HHHHH
Confidence 9876543222 1223447889999998754 3467899999999999999999999952110 0 00111
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... .... + .........+.+++.+||..||++|||+.+|++
T Consensus 230 ~~~~-~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN-PPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc-CCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 0000 0 111223457889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=293.69 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=198.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|++.+.||.|++|.||++... ++..+|+|.+.... ......+..|+++++.++|+|++++++++..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356888899999999999999875 58899999986432 2233468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|.+++..... ++++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999876432 489999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
... .....++..|+|||.+. ...++.++||||||+++|||++|+.||.... ....+....... .
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~- 225 (280)
T cd06611 157 LQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKILKSE-P- 225 (280)
T ss_pred ccc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHHhcCC-C-
Confidence 221 22334788999999875 3446789999999999999999999995321 111111111110 0
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.+ .........+.+++.+||+.+|.+||++.+|++
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 000 001122346888999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=294.83 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=198.9
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
-|...+.||+|+||.||+|... ++..+|+|.+...........+.+|++.+..++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999865 678999999865444444456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998642 388999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
......++..|+|||.+.+...+.++|||||||++|+|++|..||.... ........ .....
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~-------- 218 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLI-PKNNP-------- 218 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHH-hcCCC--------
Confidence 1222357889999999988888999999999999999999999985211 01111111 11100
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.+|.+||++.++++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111123356888999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=297.52 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=208.6
Q ss_pred cCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccch-hHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.-|...+.||+|.|++|-+|++ -.|..||||++.+...... ..++.+|+..++.++|||||+++++.......|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3567778999999999999974 3799999999987655443 3468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec-CCCcEEEeecccccccCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 291 (460)
.-++|+|.+++-+... .+.+..+++++.||+.|+.|+|+. .+|||||||+||.+- +-|-|||+|||++..+..
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999977643 389999999999999999999999 899999999999775 568899999999976543
Q ss_pred CCCceeecccccccccCcccccCCCCC-cccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.......+|+..|-|||++.+..|+ +++||||||||||-|++|+.||+.+... +.+.-+.
T Consensus 172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmIm 232 (864)
T KOG4717|consen 172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIM 232 (864)
T ss_pred --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhh
Confidence 3344556799999999999999885 6889999999999999999999743322 2333444
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
|... ..+.....+..+||..|+..||++|.+.+||+.
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 5433 335556677889999999999999999999985
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.70 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=194.2
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
|+..+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++|||++++++++...+..++|+||+.
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566688999999999999976 47788999886432 2334468889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+++|..++.... .++++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 999999876532 2489999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred eeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 296 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
......++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+......... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~ 229 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPP-TLA 229 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcCCC-CCC
Confidence 122345788999999884 3457789999999999999999999985311 11111111111100 000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+.+++.+||+.+|.+||++.++++
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 -------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112356889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=295.63 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=195.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 67899999987654333334567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+ +|.+++..... .+++..++.++.|+++||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 89998875432 488999999999999999999999 99999999999999999999999999987543221
Q ss_pred CceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh---cccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLEQL 369 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 369 (460)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...........+.. .....+
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcCCCChhhhhhh
Confidence 11 122236788999998876 4578999999999999999999999953210 00000000000000 000000
Q ss_pred ------cccc---CCCCC----cHH--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 ------VDSD---MEGNY----IEE--EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ------~~~~---~~~~~----~~~--~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ..... ... ....+.+++.+|++.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 000 1156778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.38 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=197.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|++|.||+|... +++.||+|++....... ....+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999986 58899999986543322 34467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|..+..... .+++..++.++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999998888765432 389999999999999999999999 9999999999999999999999999998865433
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh----------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---------- 361 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 361 (460)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .....-+....
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----IDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHHHhCCCchhhHHH
Confidence 22 2223447889999999875 3468899999999999999999999853210 00000000000
Q ss_pred -hhcc-ccccccccCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 -KEKK-LEQLVDSDMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 -~~~~-~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ......+.... .........+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 00000000000 001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=291.43 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=198.6
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc----cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+|+..+.||+|++|.||+|... ++..|++|.+..... ......+.+|+++++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999976 789999999865332 12334688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+||+++++|.+++.... ++++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997643 378999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..+.............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~- 222 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELPP- 222 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCCC-
Confidence 332 223345788999999987766 8999999999999999999999995321 1111111111011111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+.+++.+||+.+|++||++.+++.
T Consensus 223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122356788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=305.42 Aligned_cols=245 Identities=30% Similarity=0.433 Sum_probs=198.2
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccch--hHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.|...+.||.|+||.||.|++. +.+.||||++.-.-.+.. ..++..|+..|.+++|||.+.+.|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4566678999999999999865 678999999975443333 3368899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||- |+-.+++.... .++.+.++..|..+.+.||+|||+. +.||||||..|||+++.|.|||+|||.+......
T Consensus 107 YCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 994 57788877653 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
..++||++|||||++. .+.|+-++|||||||+..||.-.++|.-+..- +..++. +.+.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----------MSALYH---IAQN 240 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYH---IAQN 240 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----------HHHHHH---HHhc
Confidence 3467999999999885 46899999999999999999999999732211 011111 1111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
-.+.+. ..+....+.+++..|+++-|++|||..+++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 112222 2344566888899999999999999998875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=290.81 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=194.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc----chhHHHHHHHHHHhccCCCcceeeeeeeecC--Ccc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 207 (460)
.+|+..++||+|+||.||++... ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888899999999999999875 5889999988643211 1234678899999999999999999988664 457
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
+++|||+++++|.+++.... .+++...+.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 79999999999999987543 378888999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 288 LMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 288 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.... .... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~-~~~~~~~-- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAA-IFKIATQ-- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHH-HHHHhcC--
Confidence 6532111 11223457889999999988889999999999999999999999995211 0111 1111100
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.............+.+++.+|+. +|++||++++|++
T Consensus 225 -------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 -------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00111223334567788888985 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=308.83 Aligned_cols=244 Identities=26% Similarity=0.424 Sum_probs=197.4
Q ss_pred eecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHH
Q 012610 142 ILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 220 (460)
+||+|.||+||.|++.+ ...+|||-+...... ...-+.+|+.+.+.++|.|||+++|.+.++...-++||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 69999999999999764 557899988654322 2335889999999999999999999999888888999999999999
Q ss_pred HHhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec-CCCcEEEeecccccccCCCCCcee
Q 012610 221 SCLRERGQSQPPL--NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVT 297 (460)
Q Consensus 221 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 297 (460)
++|+...+ |+ .+.+.-.+..||++||.|||.+ .|||||||-+||||+ -.|.+||+|||-++.+..- ....
T Consensus 661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 99986543 34 6788889999999999999999 999999999999996 5789999999999876533 3334
Q ss_pred ecccccccccCcccccCCC--CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 298 TAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 298 ~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
..+.||..|||||++..++ |..++|||||||.+.||.||++||-..... ...-+..+++ ...
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----qAAMFkVGmy-----------KvH 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----QAAMFKVGMY-----------KVH 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----hHhhhhhcce-----------ecC
Confidence 5567999999999998764 789999999999999999999999532111 0111111111 123
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+..+.+.......++++|+.+||..||+++++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3445666778889999999999999999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=293.52 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=200.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||+|... ++..||+|++..... ......+.+|+.+++.++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 688999999876543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+ +++|.+++.... .++++..++.++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987643 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc-------
Q 012610 294 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------- 365 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 365 (460)
........++..|+|||.+.+. .++.++||||||+++|||++|..||.... .......+...+....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhc
Confidence 2223334588899999998654 46899999999999999999987774211 1111111111110000
Q ss_pred -----ccccccccCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 -----LEQLVDSDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 -----~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...+....... ....+....+.+++.+|++.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 001122467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.97 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=196.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc---------chhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ---------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
+|...+.||.|++|.||+|... +++.+|+|.++..... ...+.+..|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 6889999988642211 11235778999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-eeecccccccccCcccccCCC--CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 286 AKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 286 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
++........ ......++..|+|||.+.... ++.++||||||+++||+++|..||.... .. ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~-~~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-------AI-AAMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-------hH-HHHHHhhc
Confidence 9764322111 122344788999999987654 7899999999999999999999985211 01 11111111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ....+. ..........+.+++.+||+.+|++|||+.+|++
T Consensus 227 ~~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 KR-SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cc-cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 10 011111 1111223467889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=293.26 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=197.7
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC---CCcceeeeeeeecCCcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~ 211 (460)
.|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|+++++.+. |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999964 688999999876544444456888999988886 999999999999888999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++... ++++...+.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998653 488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..... ...... .... .
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~-~~~~-----~ 218 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMML-IPKS-----K 218 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhc-cccC-----C
Confidence 3322 2234588899999988654 468999999999999999999999953211 111100 0000 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.+... .....+.+++.+||+.||++||++.+++.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111111 13456889999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=296.53 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=194.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||+|+.. +|..+|+|.+...... .....+.+|+++++.++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 6889999998754322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. ++|.+++.... ..+++..++.++.||++||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 57888776532 2389999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc------c
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------L 366 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 366 (460)
.. .....++..|+|||.+.+.. ++.++|||||||++|||++|..|+.... ........+........ .
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC----CHHHHHHHHHHHhCCCChHHhHHh
Confidence 11 22234688999999987654 6899999999999999999999863211 10011111111000000 0
Q ss_pred cccccc----cCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDS----DMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~----~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+..+. .... .........+.+++.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.16 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=202.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||.||++... .++.|++|.+..... ......+.+|++++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999876 578999999875432 222346778999999999999999999999888999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++.... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997643 388999999999999999999999 999999999999999999999999999864211
Q ss_pred CCC--------------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 292 KDT--------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 292 ~~~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
... .......++..|+|||.+.+..++.++|||||||++|||++|+.||... ...++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--------~~~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHH
Confidence 100 0011234678899999998888999999999999999999999999521 111222
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 416 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 416 (460)
....... ...+... ......+.+++.+||+.+|++||++.++.+.|+....
T Consensus 226 ~~~~~~~----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 226 GQVISDD----IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHHhcc----cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 2211110 0011100 1123568899999999999999998888888877544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=289.93 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=198.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||++... ++..+|+|.+..... ......+..|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 678999999875432 22345688999999999999999999999888899999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 292 (460)
+++++|.+++..... ..+++..++.++.+++.||+|||++ +++|+||+|+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999976432 3488999999999999999999999 99999999999999865 46899999999866433
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+... ....+...... ....+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~--- 221 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMSG-TFAPI--- 221 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHHhc-CCCCC---
Confidence 21 122347889999999998889999999999999999999999995321 11111111111 11111
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1113456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=307.26 Aligned_cols=238 Identities=23% Similarity=0.272 Sum_probs=182.3
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhcc---CCCcceeeeeeeecCCcceEEeeccCC
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMA---VHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
||+|+||+||+|+.. +++.||+|++...... .....+..|..++... .||||+++++++...+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 5889999998653221 1122344566666554 699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 99999887543 388999999999999999999999 999999999999999999999999999875432221 2
Q ss_pred eecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 297 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
.....||..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....... ... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~-~~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAF-GKV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHc-CCC------CCC
Confidence 2345689999999998765 47899999999999999999999995321 1111111111 110 011
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSE 406 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 406 (460)
.. .....+.+++.+||+.||++||++.+
T Consensus 218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 218 KN---VLSDEGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred Cc---cCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence 11 12345778999999999999996543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.28 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=186.0
Q ss_pred CeecccCCeEEEEEEECC--------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 141 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+.||+|+||.||+|.... ...+++|.+.... ......+.+|..+++.+.|||++++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999997642 2348888875432 2233467889999999999999999999999889999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc--------EEEeecc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--------AVVGDFG 284 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg 284 (460)
|+.+|+|.++++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999976543 488999999999999999999999 9999999999999988765 5899999
Q ss_pred cccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCC-CccccccccCCCCccHHHHHHHHhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQ-RAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
++...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+..... .... ....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~-~~~~ 219 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKL-QFYE 219 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHH-HHHH
Confidence 88654321 223477899999999764 5789999999999999999985 55532110 0110 0111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
. . . .+. ......+.+++.+||+.+|++|||++++++.|+
T Consensus 220 ~-~-~-----~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D-R-H-----QLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-c-c-----cCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0 011 112246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.45 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=195.0
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+++|...+.||+|+||.||+|... ++..||+|.+...........+.+|+++++.++|+||+++++++......++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467889999999999999999865 6889999999765444444467789999999999999999999999889999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+. ++|.+++.... ..+.+..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 67777765432 2377888899999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh---------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 362 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 362 (460)
... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||+..... ...+.+ +.....
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~-~~~~~~~~~~~~~~~ 231 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEK-IWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHH-HHHHcCCCChhhhhh
Confidence 211 1223468899999998764 4788999999999999999999999632110 000000 000000
Q ss_pred ---hccccccccccCCCCCc------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 ---EKKLEQLVDSDMEGNYI------EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ---~~~~~~~~~~~~~~~~~------~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
................. ......+.+++.+|+..||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 011346778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=293.11 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=196.4
Q ss_pred CccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 137 FSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
|.+.++||+|+||.||+|... .+..||||++..... .....++.+|+++++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999854 367899999975432 223446888999999999999999999876532
Q ss_pred cceEEeeccCCCCHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
..+++++|+.+|+|..++..... ....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23688999999999988754321 122478899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHh
Q 012610 284 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 284 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
|+++........ ......++..|++||.+.+..++.++|||||||++|||++ |+.||.... ......++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~--- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYLI--- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHHH---
Confidence 999865432211 1112234578999999988889999999999999999999 888885211 111111111
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...... . .......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110 0 112335799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=300.27 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=201.7
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccc-ccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcce
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~ 208 (460)
.+....|++.++||+||.+.||++...+.+.+|+|++.... ......-|..|++.|.+++ |.+|+++++|-..+...|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34566788999999999999999998888888888876433 3334456999999999995 999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||= .-+|..+|+...... ..| .++.+..|++.|+.++|.+ ||||.||||.|+|+-.+ .+||+|||+|..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~--~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSID--PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANA 508 (677)
T ss_pred EEeecc-cccHHHHHHhccCCC--chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcc
Confidence 999976 559999998765432 234 7889999999999999999 99999999999998764 899999999998
Q ss_pred cCCCCCc-eeecccccccccCcccccCC-----------CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHH
Q 012610 289 MDYKDTH-VTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 289 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 356 (460)
+...... .....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||... .
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~-- 576 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------I-- 576 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------H--
Confidence 8755443 34456799999999988532 2467899999999999999999999521 0
Q ss_pred HHHHhhhccccccccccCCCCCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. -.++..+.++...-++.. .....++++|..||+.||.+|||+.|+++
T Consensus 577 --n~--~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 --NQ--IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HH--HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 00 123445555543222211 01123999999999999999999999996
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=289.93 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=199.2
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|...+.||+|++|.||++... ++..|++|.++..... .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 6889999998765433 2445788999999999999999999999989999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++.... .+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997642 378899999999999999999999 99999999999999999999999999998765433
Q ss_pred Cceee---cccccccccCcccccCCC---CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 294 THVTT---AVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 294 ~~~~~---~~~g~~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
..... ...++..|+|||.+.+.. ++.++||||||+++||+++|+.||.... .. ....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~---~~~~~~~-~~~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NE---FQIMFHV-GAGH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----ch---HHHHHHH-hcCC--
Confidence 22111 245788999999998766 8899999999999999999999995321 00 0110000 0000
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.+.. .......+.+++.+||+.+|.+|||+.+++.
T Consensus 224 ---~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000100 1112456788999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=287.01 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=205.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|++|.||+|... +++.|++|++...........+..|++.+..++|+|++++++++...+..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999977 48999999987654434455788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
+++++|.+++... .++++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 348999999999999999999999 8 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+........ .. .
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~-~~-----~ 221 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDG-PP-----P 221 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcC-CC-----C
Confidence 3221 233478899999999998899999999999999999999999953221 1112222221111 00 0
Q ss_pred cCCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... ....+.+++.+||+.+|++|||+.++++
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 222 ----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11111 3467999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.51 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=199.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-----chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+|+..+.||+|++|.||++... +++.+|+|.+...... .....+..|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4677889999999999999864 6889999998754321 123468899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeecccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKL 288 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~ 288 (460)
|+||+.+++|.+++.... ++++..++.++.|++.||+|||++ +++|+||+|+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997543 488999999999999999999999 999999999999998776 599999999876
Q ss_pred cCCCCCc---eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 289 MDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 289 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
....... ......++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIAS--- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhc---
Confidence 6432111 11234578899999999888899999999999999999999999953211 111111111100
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..............+.+++.+|+..+|.+|||+.++++
T Consensus 226 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111222334467889999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.98 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=194.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+.|...+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+++++.++|||++++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778889999999999999875 688999999864322 222346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+. |++.+++.... .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 57777775432 2489999999999999999999999 999999999999999999999999999876542
Q ss_pred CCCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.. ...++..|+|||.+. ...++.++||||||+++|||++|+.||..... ......... ...
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~-~~~-- 231 (307)
T cd06607 168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-NDS-- 231 (307)
T ss_pred CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhc-CCC--
Confidence 21 234778999999874 35678899999999999999999999853211 011111100 000
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
+.. ........+.+++.+||+.+|++||++.+|+..
T Consensus 232 ---~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 012234568999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.56 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=194.4
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
|.....||+|+||.||++... ++..||||.+.... ......+.+|+..+..++|+|++++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333466999999999999875 58899999986432 2334468899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+++|.+++... .+++..++.++.||+.||+|||++ +++||||||+||++++++.++|+|||++.........
T Consensus 103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999988542 378999999999999999999999 9999999999999999999999999998765432221
Q ss_pred eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+... .. .....+.
T Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~-~~-----~~~~~~~ 239 (292)
T cd06658 175 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--------PLQAMRRI-RD-----NLPPRVK 239 (292)
T ss_pred -CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-Hh-----cCCCccc
Confidence 122447889999999988889999999999999999999999985311 01111111 00 0111111
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .......+.+++.+||..+|++|||++++++
T Consensus 240 ~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 240 D--SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred c--ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 1112345778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=292.63 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=199.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|++|.||+|... +++.||+|.++.... ......+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999876 578999999875432 2234568899999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.++.+..+.... ..+++..++.++.+|+.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987766655432 2388999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh----------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---------- 361 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 361 (460)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhh
Confidence 33223334578899999999888 789999999999999999999999853211 00000000000
Q ss_pred --hhccccc--cccccCC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 --KEKKLEQ--LVDSDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 --~~~~~~~--~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ..+.... ..........+.+++.+||..+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 0000000 0011112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=295.39 Aligned_cols=195 Identities=24% Similarity=0.386 Sum_probs=158.3
Q ss_pred CeecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec--CCcceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~~ 215 (460)
.+||+|+||.||+|+.. ++..||+|.+..... ...+.+|+++++.++||||+++++++.. ....++++||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999865 357899998865322 2357789999999999999999998854 456789999986
Q ss_pred CCCHHHHhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe----cCCCcEEEeecccc
Q 012610 216 NGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 286 (460)
Q Consensus 216 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 286 (460)
+ +|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 7877775321 1123488999999999999999999999 99999999999999 56679999999999
Q ss_pred cccCCCCCc--eeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 287 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 287 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+........ ......+|..|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876433221 12234578999999998764 578999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.67 Aligned_cols=249 Identities=19% Similarity=0.308 Sum_probs=198.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|...+.||+|+||.||++... ++..||+|.+..... .....+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 67888899999999999999864 578899999864332 2334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++... .+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998753 278899999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....++..|+|||.+.+..++.++||||||+++|++++|+.||....... .+....... .
T Consensus 170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~~~--------~ 232 (293)
T cd06647 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG--------T 232 (293)
T ss_pred cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhcCC--------C
Confidence 22 222357889999999988889999999999999999999999995321100 000000000 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111223356888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.57 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=194.4
Q ss_pred cCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 139 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
....||+|+||.||++... +++.||+|.+..... .....+.+|+..+..++|||++++++++...+..++++||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3457999999999999875 688999999865332 23446788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCcee
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 297 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 297 (460)
+|..++... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 104 ~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 104 ALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 999987542 388999999999999999999999 999999999999999999999999999875543221 12
Q ss_pred ecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCC
Q 012610 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377 (460)
Q Consensus 298 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (460)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.+... ........ .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~-~~~~~~~~-------~ 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRL-RDSPPPKL-------K 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hccCCCCc-------c
Confidence 234588899999999988899999999999999999999999953110 1111111 11000000 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 378 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 378 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+.+++.+||+.+|++||++.+|++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 01112345788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.26 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=162.8
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC------CCcceeeeee
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLRGF 200 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~------h~niv~l~~~ 200 (460)
+++...+++|++.++||+|+||+||+|... .++.||||+++.... .......|++++..++ |.+++.++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344556789999999999999999999875 578899999964321 1223455666666554 4558888888
Q ss_pred eecC-CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCC--
Q 012610 201 CMTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-- 276 (460)
Q Consensus 201 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~-- 276 (460)
+... ...++||+++ +++|.+++...+ .+++..++.++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 8764 4678899988 778998887543 48999999999999999999997 5 899999999999998765
Q ss_pred --------------cEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 277 --------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 277 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998764321 22345689999999999999999999999999999999999999963
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.09 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=193.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|...+.||+|+||.||++... +++.+|+|.+...........+..|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999875 588999999876544444556888999999986 99999999999988899999999
Q ss_pred cCCCCHHHHhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
+.. ++.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 555543221 111235899999999999999999999742 8999999999999999999999999999765332
Q ss_pred CCceeecccccccccCcccccCC---CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... ....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+.+.......
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~----- 227 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD----- 227 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC-----
Confidence 211 223478899999998776 68899999999999999999999995321 1111111111100
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.+...........+.+++.+||+.+|++|||+++|++
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111111224456899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=290.06 Aligned_cols=244 Identities=24% Similarity=0.318 Sum_probs=197.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|++|.||++... +++.+|+|.+..... ......+.+|++++++++||||+++++++...+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999876 588999999875432 223446888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 488999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... .......... ...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~----- 215 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILE-GKV----- 215 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCc-----
Confidence 3 223458889999999988888999999999999999999999995321 1111111111 100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVV 408 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl 408 (460)
.+ .......+.+++.+||..+|.+|+ ++++++
T Consensus 216 -~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 -RF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -cC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01 111235688999999999999998 556665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=294.44 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=200.6
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
+..+.|+.-++||+|+||.||-+... +|+.+|.|++.+.+.. ..+...+.|-.+|.+++.+.||.+-..+++.+..+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44567888999999999999999865 6899999999765432 23334678999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+|+..|.||+|.-+|.+.+. +.+++..+..++.+|+.||++||+. +||+|||||+|||+|+.|+++|+|+|+|..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999988765 4599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
+..... ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||..... +.-.+
T Consensus 337 i~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke------------------Kvk~e 396 (591)
T KOG0986|consen 337 IPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE------------------KVKRE 396 (591)
T ss_pred cCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh------------------hhhHH
Confidence 654333 3334699999999999999999999999999999999999999963211 11111
Q ss_pred cccccC---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 369 LVDSDM---EGNYIEEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 369 ~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
-+|.++ ...+.+...++..++....|+.||.+|..-+
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 111111 1122333344555666667799999997665
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=290.87 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=202.1
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++.|+..+.||+|++|.||++... ++..+++|.+..... ....+..|++++..++|+|++++++++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456778889999999999999986 688999999975433 3456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998754 2489999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... .......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~- 237 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLITT-KGIPPLK- 237 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-cCCCCCc-
Confidence 221 11223477899999999888899999999999999999999999852110 011111100 0111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........+.+++.+||+.+|.+|||+.+|++
T Consensus 238 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01113456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.71 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=195.0
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||.|++|.||+|+.. ++..||||.+...... .....+..|++++++++||||+++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 6889999998754322 2234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. ++|..++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689888865432 3489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh---------
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--------- 363 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 363 (460)
.. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||.... ...............
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCChhhhhhhh
Confidence 11 12233678899999887654 5889999999999999999999995321 100111111100000
Q ss_pred ------ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 ------KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............ .........+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000112245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=270.86 Aligned_cols=268 Identities=23% Similarity=0.390 Sum_probs=203.4
Q ss_pred cCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeeccCC
Q 012610 139 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
....||.|+.|.||++... .|...|||.+.........++++..++++.+.. .|.||+.+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3455999999999999976 588999999987655555567777787766654 8999999999999999999999984
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
..+..+++... .++++..+-.+...+..||.||..++ +|+|||+||+|||+|+.|.+|++|||++..+-... .
T Consensus 175 ~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A 247 (391)
T KOG0983|consen 175 TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A 247 (391)
T ss_pred HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence 35666666543 35899999999999999999999987 99999999999999999999999999997654332 2
Q ss_pred eecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 297 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.+...|-+.|||||.+.- ..|+.++|||||||.++||.||+.||..... + .+.+...+.+.. +.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----d---Fe~ltkvln~eP------P~ 314 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----D---FEVLTKVLNEEP------PL 314 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----c---HHHHHHHHhcCC------CC
Confidence 233458899999999864 4688999999999999999999999964221 1 122222222111 22
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--h-hcCCCcchhhHHHHhhhh
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM--L-EGDGLAERWEEWQKEEMF 429 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L-~~~~~~~~~~~~~~~~~~ 429 (460)
+.+.. .....+.+++..||++|+.+||...++++. + .=..+..+...|+.+-|.
T Consensus 315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~ 371 (391)
T KOG0983|consen 315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMA 371 (391)
T ss_pred CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHh
Confidence 22211 133558889999999999999999999862 1 112344566677777663
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.46 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=203.0
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||+++.. ++..+++|.+..... ......+..|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999865 678999999875432 22344677899999999999999999999988999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++.........+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877544445689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ....... ......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYK-VQRGKY------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HhcCCC-------
Confidence 1222347889999999999889999999999999999999999995321 1111111 111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+|++.+|++|||+.++++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 --PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=290.24 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=196.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 210 (460)
++|+..+.||+|++|.||+|... +++.+|+|.++..... .....+.+|++++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999986 5789999999754332 2233567899999999999999999998877 789999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+. ++|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 499998876432 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh-------
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK------- 362 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 362 (460)
..... .....++..|+|||.+.+.. ++.++||||||+++|||++|..||...... .....+.....
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-----DQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchHHH
Confidence 43221 22234678899999987654 688999999999999999999999532110 00000000000
Q ss_pred ----h------ccccccccccCCCCCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 ----E------KKLEQLVDSDMEGNYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ----~------~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ..........+...+... ....+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000111111111 2456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=290.99 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=196.6
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc----chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+|...+.||+|++|.||+|... +++.||+|.+...... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999975 6889999999755432 1233567899999999999999999999998899999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+ +++|.+++.... ..+++..++.++.||++||+|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997543 2489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc-----
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK----- 364 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 364 (460)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.... ...............
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-----DIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-----cHHHHHHHHHHcCCCchhhh
Confidence 33221 122336778999998865 457899999999999999999987774311 111111111000000
Q ss_pred ----cccccccccCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ----KLEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ----~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............. ........+.+++.+||+.+|++|||+.||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000 11223467889999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=319.61 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=215.0
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEEC----C----CcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeee
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLT----D----GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRG 199 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~ 199 (460)
.+++..++..+.+.||+|.||.|++|... . ...||||.++..........+..|++++..+ .|+|++.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56677777778889999999999999743 1 4579999999877776677899999999888 5999999999
Q ss_pred eeecCCcceEEeeccCCCCHHHHhhhcC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 012610 200 FCMTPTERLLVYPFMVNGSVASCLRERG---QS-------Q--PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 267 (460)
Q Consensus 200 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 267 (460)
+|......++|+||+..|+|..+++... .. . ..++....+.++.|||.|++||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999889999999999999999998866 10 0 2388999999999999999999999 999999999
Q ss_pred CCEEecCCCcEEEeecccccccCCCCCceeecccc--cccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccccc
Q 012610 268 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLAR 344 (460)
Q Consensus 268 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~ 344 (460)
+|||++++..+||+|||+++..............+ ...|||||.+....++.++|||||||+||||+| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999999665544443222222 456999999999999999999999999999999 8888842
Q ss_pred ccCCCCcc-HHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 345 LANDDDVM-LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 345 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.. ..+... .++.+ .+...+..+..+++++|+.||+.+|++||++.++.+.|+..
T Consensus 525 ------~~~~~~l~~-~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 ------IPPTEELLE-FLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ------CCcHHHHHH-HHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 112211 22221 11122334557799999999999999999999999999873
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.95 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=197.0
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.|...+.||+|++|.||++... ++..+++|.+.... ......+.+|+.+++.+.|+|++++++++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3455678999999999999864 68899999886432 223445788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999998762 388999999999999999999999 999999999999999999999999998875543222
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ........... ... ..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~-~~~-----~~ 235 (285)
T cd06648 171 R-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDN-LPP-----KL 235 (285)
T ss_pred c-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhc-CCC-----CC
Confidence 1 223447889999999988889999999999999999999999985311 11222211111 000 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ........+.+++.+||+.+|++|||+.++++
T Consensus 236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 01112356899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.28 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=204.4
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
-|.+.++||+|+||.||+|.++ .|+.+|||.+..+ ....++..|+.++++...|++|+++|.+......|+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3556788999999999999875 6999999998754 33456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
..|++.+.++.+. .++.+.++..++..-++||+|||.. .-+|||||..|||++.+|++||+|||.+..+....
T Consensus 111 GAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 111 GAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred CCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 9999999998754 3599999999999999999999998 88999999999999999999999999997654322
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc--c--
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL--V-- 370 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-- 370 (460)
.....+.||+.|||||++..-.|+.++||||||+...||.-|++||... ..+..+ +
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--------------------HPMRAIFMIPT 243 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--------------------HPMRAIFMIPT 243 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc--------------------cccceeEeccC
Confidence 2234456999999999999999999999999999999999999999521 111111 1
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.-.-..+......+-+++++|+-+.|++|-|+-++++
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111111234556778999999999999999999998886
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.88 Aligned_cols=195 Identities=25% Similarity=0.366 Sum_probs=167.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-C-----CcceeeeeeeecCCcc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-H-----RNLLRLRGFCMTPTER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h-----~niv~l~~~~~~~~~~ 207 (460)
-+|++.++||+|+||.|-+|.+. +++.||||+++..... ..+-..|+.+|..++ | -|+|++++++.-.++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 38899999999999999999865 6899999999865432 224567888888887 3 4799999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC--cEEEeeccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGL 285 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~ 285 (460)
|+|+|.+ ..+|.++++...- .+++...++.++.||+.||.+||+. +|||+||||+||||.+-+ .+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999 5599999988654 3499999999999999999999999 999999999999997543 699999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
+....... . ...-+..|.|||++.|.+|+.+.|+||||||+.||++|.+.|.
T Consensus 338 Sc~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 338 SCFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 98754322 2 3446789999999999999999999999999999999987774
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.06 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=199.9
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
+|+..+.||.|+||.||++... ++..||+|.+...... .....+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 5889999999754322 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|.+++... .++++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999764 2488999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..++....... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~----- 218 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--AD----- 218 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--cc-----
Confidence 2 223345788999999998888999999999999999999999999642211 11111111111 00
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKM--SEVV 408 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~--~evl 408 (460)
..........+.+++.+||+.+|.+||++ +|++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 ---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 01111233678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=289.16 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=197.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+|+..+.||.|++|.||+|+.. ++..||||.+...........+.+|+++++.++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999986 588999999976544444456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+ +|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 88888876442 23589999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh---hc------
Q 012610 295 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---EK------ 364 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------ 364 (460)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....+..... ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-----DQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhHHHHh
Confidence 11223467889999988664 4688999999999999999999999632210 00000000000 00
Q ss_pred cccccccccCC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... .... ..........+.+++.+|++.+|.+||++.++++
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000 0001122456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=283.32 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=199.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|+||.||++... ++..+|+|.+...... .....+.+|+++++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999976 5788999998654322 2344678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 292 (460)
+.+++|.+++..... ..+++..++.++.+++.||+|||+. +++|+||+|+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999976432 2478999999999999999999999 999999999999999886 4699999999766432
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|..||.... ..+++...... ....+
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~--- 222 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQG-YFAPI--- 222 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcc-cCCCC---
Confidence 22 2222347889999999988889999999999999999999999985321 22222222111 11100
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+.+++.+||..+|++|||+.+|++
T Consensus 223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=285.53 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=194.2
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||.|++|.||+++.. ++..+|+|.+...... .....+.+|+++++.++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 4889999999754332 3345688999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
.+++.... .+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 388999999999999999999998 99999999999999999999999999998765332 1222
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...+......... ......
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---------~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGN---------GKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccC---------CCCCCC
Confidence 3578899999999888899999999999999999999999963211 1122222211100 011111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122467999999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=284.25 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=204.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|...+.||.|++|.||++... ++..+++|++...... .....+..|+++++.++|+|++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999976 5889999999765432 3345688999999999999999999999888999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543335699999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.||.... ..+....... .....+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~---- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILK-GQYPPI---- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhc-CCCCCC----
Confidence 22233457889999999988889999999999999999999999995321 1122222111 111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+.+++.+||..+|++|||+.++++
T Consensus 224 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 -----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=287.98 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=193.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccC-CCcceeeeeeeecCCc-----
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE----- 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~----- 206 (460)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+++++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999975 6889999998654322 22346788999999995 6999999998876655
Q ss_pred ceEEeeccCCCCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeecc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 284 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg 284 (460)
.+++|||+.+ +|.+++...... ...+++..++.++.||+.||.|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888654332 34589999999999999999999999 9999999999999999 8899999999
Q ss_pred cccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...+..... ....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~-~~~~ 230 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFK-LLGT 230 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHH-HhCC
Confidence 98765332211 112236788999998865 4578999999999999999999999953110 000000000 0000
Q ss_pred ccc---ccccc-------ccCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKL---EQLVD-------SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~---~~~~~-------~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ..... +.... .........+.+++.+||+.+|.+||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000 00000 001123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=281.85 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=201.2
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|+++++.++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3677789999999999999986 688999999976543 33457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987643 3489999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... .........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~~~~~-- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIAT-NGPPGLRNP-- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHHh-cCCCCcCcc--
Confidence 233457889999999988889999999999999999999999995321 0111111110 111111110
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......+.+++.+||+.||++|||+.++++
T Consensus 221 -----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111356889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=297.17 Aligned_cols=263 Identities=20% Similarity=0.331 Sum_probs=194.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC-----Ccc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 207 (460)
+++|.+.+.||+|++|.||+|... +++.||+|.+...........+..|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 68899999987543333445678899999999999999999887644 347
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++++||+. ++|..++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 89999996 4888777542 389999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc--eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 288 LMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 288 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence 65432211 1122457889999998755 4688999999999999999999999953211 00011111101000
Q ss_pred ---ccccccccc-------C--CCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 365 ---KLEQLVDSD-------M--EGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 365 ---~~~~~~~~~-------~--~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
....+.+.. . ... ........+.+++.+||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0 000 001123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=290.90 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=193.6
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
|...+.||+|+||.||+++.. ++..+|+|.+...... .....+..|+++++.++|+|++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999875 6889999998654222 2234688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. |+|.+.+.... .++++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 57877775432 2489999999999999999999999 9999999999999999999999999998754322
Q ss_pred CceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
....++..|+|||.+. .+.++.++|||||||++|||++|+.||.... .............
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~----- 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES----- 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccC-----
Confidence 2234788999999874 4568899999999999999999999984211 1111111111110
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
...........+.+++.+||+.+|.+||++.+|++.+.
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00011123356889999999999999999999998554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.77 Aligned_cols=273 Identities=19% Similarity=0.256 Sum_probs=187.3
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC--CcEEEEEEe--------------ccc--cccchhHHHHHHHHHHhccCCCc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRL--------------KEE--RTQGGELQFQTEVEMISMAVHRN 193 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~--------------~~~--~~~~~~~~~~~e~~~l~~~~h~n 193 (460)
...++|++.+.||+|+||+||++.... +...++|.+ .+. ........+.+|++++..++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987542 222222211 110 01112335789999999999999
Q ss_pred ceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS-QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 194 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
|+++++++...+..+++++++. ++|.+++...... ........++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 5777776543211 12234566778999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCcc
Q 012610 273 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352 (460)
Q Consensus 273 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 352 (460)
+.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|..++...... .....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHH
Confidence 99999999999999876543333333456899999999999999999999999999999999987543211100 00111
Q ss_pred HHHHHHHHhh-hccc-------ccccccc-C--CCCCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 353 LLDWVKGLLK-EKKL-------EQLVDSD-M--EGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 353 ~~~~~~~~~~-~~~~-------~~~~~~~-~--~~~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.+.+..... .... .+.++.. + ...... .....+.+++.+|++.||++|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111110000 0000 0000000 0 000000 01234677889999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.04 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=191.8
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecC--CcceEEee
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLVYP 212 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~lv~e 212 (460)
|+..+.||+|+||.||+|... ++..+|+|.++.............|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999865 688999999876543333334557888888885 99999999999887 78899999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+. ++|.+.+.... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 58888876533 2489999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh----------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---------- 361 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 361 (460)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+.....
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHh
Confidence 221 22347889999997654 5578899999999999999999999953211 11111111111
Q ss_pred -hhccccccccccCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 -KEKKLEQLVDSDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 -~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+..... ........+.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000000 01123577999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=289.00 Aligned_cols=261 Identities=18% Similarity=0.228 Sum_probs=183.6
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccch-h---------HHHHHHHHHHhccCCCcceee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGG-E---------LQFQTEVEMISMAVHRNLLRL 197 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~-~---------~~~~~e~~~l~~~~h~niv~l 197 (460)
+..++|.+.++||+|+||.||+|...+ +..+|+|.......... + .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 344689999999999999999998764 34566665432221110 0 011223344566789999999
Q ss_pred eeeeecCC----cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec
Q 012610 198 RGFCMTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 273 (460)
Q Consensus 198 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~ 273 (460)
++++.... ..+++++++. .++.+.+.... ..++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 98765543 3367777763 36666665432 256788899999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccC
Q 012610 274 EEFEAVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347 (460)
Q Consensus 274 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 347 (460)
.++.++|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999986542221 11122458999999999999999999999999999999999999996421110
Q ss_pred CC-CccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 348 DD-DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 348 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.. .....+++... ...... .......+.+++..|++.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKRL---------HEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHHh---------hhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00 00001111111 111110 1122466889999999999999999999998763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=285.85 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=193.8
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|+..+.||+|++|.||+|+..+ ++.||||.++..........+..|++++.+.. |+||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4577888999999999999999874 88999999976543334445666777666664 999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+. +++.+++..... ++++..+..++.+++.||+|||+.. +++||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 577777655332 5899999999999999999999732 899999999999999999999999999876543
Q ss_pred CCCceeecccccccccCcccccCCC----CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..+......... ..
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~ 237 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEE-PP 237 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCC-CC
Confidence 2221 2234678899999987654 78899999999999999999999953110 011111111111 00
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
.... .......+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00123568999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=287.21 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=195.8
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc-ccchhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEEee
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYP 212 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~e 212 (460)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... .......+.+|+++++.++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999976 47899999998654 222334678899999999999999999999887 78999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 8888886542 2489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc---c
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---Q 368 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 368 (460)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.... ......+.......... .
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchhhccc
Confidence 3222233346788999998765 4578999999999999999999999953211 11111111110000000 0
Q ss_pred ccc--------c--cCCC---CCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVD--------S--DMEG---NYIEE-EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~--------~--~~~~---~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+ . .... ..... +...+.+++.+||+.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0 0000 00001 2467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=286.04 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=198.4
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||.|+||.||+++.. +++.+++|.+...... .....+.+|++++.+++|+|++++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 4899999998754332 2344688899999999999999999999988999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC-----
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----- 294 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 294 (460)
.+++.... .+++..+..++.||++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997644 489999999999999999999999 999999999999999999999999999876543211
Q ss_pred --ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 295 --HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 295 --~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.......++..|+|||...+...+.++||||||+++|++++|+.||.... ..+....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~----- 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-GKIE----- 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCcC-----
Confidence 12223447789999999988889999999999999999999999995321 1111111111 0000
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 416 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 416 (460)
..........+.+++.+||+.+|.+|||+.++.+.|+...+
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 220 ---WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred ---CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 00000124668899999999999999999888888776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=288.12 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=197.3
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC----
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT---- 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~---- 205 (460)
...++|++.+.||+|+||.||+|... +++.||+|.++.... ......+.+|+++++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 588999999975432 223346778999999999999999999887654
Q ss_pred ------cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 206 ------ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 206 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
..++++||+.+ ++...+... ...+++..++.++.|++.||+|||+. +|+|+||+|+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 68899999976 777776543 22489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 280 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
|+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~~~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLELIS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHH
Confidence 999999987654332222223357789999988654 56889999999999999999999996321 111111111
Q ss_pred HHhhhccc---ccccccc----------CCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 359 GLLKEKKL---EQLVDSD----------MEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 359 ~~~~~~~~---~~~~~~~----------~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........ ..+.... ... .........+.+++.+||+.+|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111000 0000000 000 000112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=285.92 Aligned_cols=243 Identities=28% Similarity=0.338 Sum_probs=184.9
Q ss_pred eecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHH---hccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 142 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMI---SMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l---~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
+||+|+||.||++... +++.+|+|.+....... ....+.+|..++ ....|||++.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999987543221 122334444433 34479999999999998889999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999987543 389999999999999999999999 99999999999999999999999999987543222
Q ss_pred eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 296 VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|..||...... ... .+...... ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~-~~~~~~~~------~~~-- 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKH-EIDRMTLT------VNV-- 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHH-HHHHHhhc------CCc--
Confidence 122358899999998864 55789999999999999999999999632111 111 11111000 011
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRM 410 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 410 (460)
.........+.+++.+||+.||++|| |++++++.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 --ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11222345688999999999999999 58877663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=277.14 Aligned_cols=203 Identities=29% Similarity=0.366 Sum_probs=180.4
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccch--hHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
+..++|...++||+|.||.|-+++.+ .++.+|+|+++++..... ...-..|-.+|...+||.+..+...++..+..|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 44578889999999999999999876 689999999998754332 334567899999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||..||.|.-+|.... .+++...+.+-..|+.||.|||++ +||+||||.+|.|+|++|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999998887643 388899999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
-- ........++||+.|+|||++....|..++|.|.+||++|||++|+.||.+
T Consensus 318 ~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 318 EI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred cc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 32 334556678999999999999999999999999999999999999999964
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.39 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=194.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc----ccchhHHHHHHHHHHhccCCCcceeeeeeeecC--Ccc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~ 207 (460)
.+|+..+.||+|++|.||+|... ++..||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999875 58899999875321 122334688899999999999999999998764 457
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++++||+++++|.+++.... .+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987543 378899999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC--CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 288 LMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 288 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
...... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .. ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~-~~~~~~~~~~- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AM-AAIFKIATQP- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HH-HHHHHHHcCC-
Confidence 653211 111123457889999999998889999999999999999999999995311 01 1111111100
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............+.+++.+||+ +|..||++.+++.
T Consensus 226 --------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111222334668889999998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.60 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=195.0
Q ss_pred CccCCeecccCCeEEEEEEECCC-cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 137 FSNRNILGRGGFGKVYKGRLTDG-SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
|+++..||.|+||.||+|..++. -..|.|++... .......+..|+++|+...||+||++++.|.-.+.++++.|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 44456699999999999998753 34466666432 33334578899999999999999999999888999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
||.+...+-..+. ++.+.++..++.+++.||.|||++ +|+|||||..|||++-+|.++|+|||.+-... ....
T Consensus 113 GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQ 185 (1187)
T ss_pred CchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHh
Confidence 9999988876543 499999999999999999999999 99999999999999999999999999985432 1223
Q ss_pred eeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 296 VTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
....+.||++|||||+.. ..+|+.++|||||||.|.||..+.+|...... ...+-...+.. ...+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKSe-PPTL- 255 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE-PPTL- 255 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhcC-CCcc-
Confidence 344567999999999763 56899999999999999999999999742111 11111111110 0011
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
-.+......+.+++.+||.+||..||++.++++
T Consensus 256 ------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 ------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 113345567889999999999999999999886
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=286.44 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=194.5
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
|+..+.||.|++|.||+|... +|..||+|++...... .....+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999875 6899999998754322 22345788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
. ++|.+++..... ..+++..++.++.|+++||+|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689999876442 2489999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc---------
Q 012610 295 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK--------- 364 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 364 (460)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ...+...........
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhhhhh
Confidence 1 1222367889999988664 568899999999999999999999953211 000111111000000
Q ss_pred --c----ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 --K----LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 --~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ......... ..........+.+++.+||+.+|++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 0001112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.38 Aligned_cols=203 Identities=26% Similarity=0.395 Sum_probs=167.1
Q ss_pred CCccCCeecccCCeEEEEEEEC---CCcEEEEEEecccc--ccchhHHHHHHHHHHhccCCCcceeeeeeeecC--Ccce
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT---DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERL 208 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~ 208 (460)
+|...+.||+|++|.||+|... ++..||+|.+.... .......+.+|++++..++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999975 37899999997643 122234577899999999999999999999887 7789
Q ss_pred EEeeccCCCCHHHHhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC----CCcEEEeec
Q 012610 209 LVYPFMVNGSVASCLRERGQSQ-PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----EFEAVVGDF 283 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Df 283 (460)
+||||+.+ +|.+.+....... ..+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 6777765433322 3689999999999999999999999 9999999999999999 999999999
Q ss_pred ccccccCCCCCc--eeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 284 GLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 284 g~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
|++......... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 999865433221 12223468889999988764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.55 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=195.6
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC------
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------ 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------ 204 (460)
..++|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 688999999865322 22334577899999999999999999987643
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
...++||||+. ++|.+.+... ++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34689999995 5888877532 78889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccC----------CCCccHH
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN----------DDDVMLL 354 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~----------~~~~~~~ 354 (460)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .....+.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 223347889999999999999999999999999999999999995321100 0000000
Q ss_pred HH----HHHHhhhcc------ccccccccCC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 355 DW----VKGLLKEKK------LEQLVDSDME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 355 ~~----~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. +........ ..+....... ..........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000000 0000000000 0001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=288.96 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=190.7
Q ss_pred Ceeccc--CCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
..||+| +||+||+++.. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999875 6899999998754332 2335688899999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999887532 2488999999999999999999999 99999999999999999999999998654322111100
Q ss_pred ------eecccccccccCcccccCC--CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH---------
Q 012610 297 ------TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG--------- 359 (460)
Q Consensus 297 ------~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 359 (460)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCcccc
Confidence 0011245679999998764 4789999999999999999999999532110 000000000
Q ss_pred -------H-------hhhcccc---------ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 -------L-------LKEKKLE---------QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 -------~-------~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ....... .+.+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0000000 001111111122345567899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.23 Aligned_cols=260 Identities=25% Similarity=0.313 Sum_probs=202.3
Q ss_pred CCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccc---cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
+|+..+.||+|++|.||+++.. ++..||||.++.... ......+..|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677789999999999999743 467899999875322 22234578899999999 599999999999888889
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+++|.+++.... .+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986532 388999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCceeecccccccccCcccccCCC--CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||.... ......+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~- 228 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----EQNSQSEISRRILKSK- 228 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc----ccchHHHHHHHHHccC-
Confidence 65443332223345788999999987665 7889999999999999999999995311 1111122222211110
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCc
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLA 417 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 417 (460)
... .......+.+++.+||+.+|++|||+.++.+.|+...+.
T Consensus 229 ------~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~ 270 (288)
T cd05583 229 ------PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270 (288)
T ss_pred ------CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence 011 111234578899999999999999999999998876653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=278.51 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=202.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEEe
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVY 211 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 211 (460)
+|...+.||+|++|.||+|... ++..+++|.+..... ......+.+|++.+++++|+|++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667789999999999999976 688999999875442 22345688999999999999999999999888 7899999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.... .+++..++.++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997654 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......++..|+|||.+.+...+.++||||||+++++|++|..||.... .....+.........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~---- 222 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEP---- 222 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCC----
Confidence 4321 1223457889999999988889999999999999999999999996322 111111111110011
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+|++.+|++||++.++++
T Consensus 223 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 -----PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112222467899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=281.66 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=196.1
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeecc
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
|.+.+.||+|++|.||+|+.. +++.|+||++.............+|+..+.+++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999986 478899999876543333334567899999999 999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887654 23489999999999999999999999 999999999999999999999999999986543222
Q ss_pred ceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCC--------CCccHHHHHHHHhhhcc
Q 012610 295 HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--------DDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 365 (460)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ .......|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122347889999998754 4578999999999999999999999853211000 00000011111111111
Q ss_pred ccccccccCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........... .........+.+++.+||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 11111110000 000111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=297.88 Aligned_cols=200 Identities=30% Similarity=0.427 Sum_probs=173.8
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC------CcceE
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERLL 209 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~l 209 (460)
+...+.||+|+||.||+++.+ .|+.||||.++........+...+|++++++++|+|||+++++=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445578999999999999965 79999999998876666677889999999999999999999875543 35689
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec--CCC--cEEEeeccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEF--EAVVGDFGL 285 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~--~~kl~Dfg~ 285 (460)
+||||.+|+|...+....+. ..+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999876543 3599999999999999999999999 999999999999984 333 369999999
Q ss_pred ccccCCCCCceeecccccccccCccccc-CCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
|+.++... ....++||..|++||.+. .+.|+..+|.|||||++|+.+||..||..
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99876443 566778999999999998 58899999999999999999999999964
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=286.59 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=194.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 209 (460)
.++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999975 5899999998754322 2233466899999999999999999998754 45799
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 8888887543 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc--
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL-- 366 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 366 (460)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-----EIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCChhh
Confidence 533211 122235778999999866 457899999999999999999999995321 11111111111000000
Q ss_pred ----------cccccccCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 ----------EQLVDSDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ----------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............ .......+.+++.+|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000 0112455788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=285.64 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=186.7
Q ss_pred eecccCCeEEEEEEECCCcEEEEEEeccc-cccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHH
Q 012610 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 220 (460)
.+|.|+++.|++++. +++.||+|++... ........+..|+++++.++|+||+++++++...+..+++|||+.+|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444444444444 5899999999765 23334457889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC------
Q 012610 221 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------ 294 (460)
Q Consensus 221 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 294 (460)
+++...... .+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 88 ~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHFPE--GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999865322 388999999999999999999999 999999999999999999999999998865432211
Q ss_pred ceeecccccccccCcccccCC--CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh----------
Q 012610 295 HVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---------- 362 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 362 (460)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ....+...+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCchhh
Confidence 111223467789999998763 5788999999999999999999999632110 011111110000
Q ss_pred -hccccc----ccccc----CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 -EKKLEQ----LVDSD----MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 -~~~~~~----~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... ..+.. ............+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 00000 001112233456889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=282.80 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=191.0
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||+|+||+||++... +++.+|+|.+..... ......+..|+++++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 688999999865322 22233567899999999999999999999998999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 999976543 3489999999999999999999999 9999999999999999999999999998765431 11223
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... ... . ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-----~~~--~----~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRRT-----LEM--A----VEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhcc-----ccc--c----ccCC
Confidence 34778999999998888999999999999999999999999532210 0111110100 000 0 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH-HHHHh
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSE-VVRML 411 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~e-vl~~L 411 (460)
......+.+++.+||+.+|.+||++++ .+..|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 122456889999999999999995555 34333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=281.48 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=197.3
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
|+..+.||.|++|.||++... +++.+++|.+...... .....+..|+++++.++|+|++++++++...+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456688999999999999875 6889999998754332 23446788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.+ +|.+++.... ..+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888887643 2489999999999999999999999 99999999999999999999999999997765433
Q ss_pred ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh---ccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---KKLEQLV 370 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 370 (460)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+...+.. .......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCchHhcccch
Confidence 112223477889999998876 7899999999999999999999998532110 000000000000 0000000
Q ss_pred c---------cc----CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 D---------SD----MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~---------~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+ +. ............+.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00 000112234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.84 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=192.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|++|.||+|... +++.||+|.+...... .....+.+|+++++.++|+|++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999876 6889999998654322 223467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeecccccccCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 291 (460)
|+. ++|.+++..... ..+++..++.++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 578887755332 2367888899999999999999999 9999999999999985 55799999999976543
Q ss_pred CCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... ......++..|+|||.+.+. .++.++|||||||++|+|+||+.||...... ....... ...... .....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~-~~~~~~-~~~~~ 228 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIF-RILGTP-NEETW 228 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-HHhCCC-Chhhc
Confidence 211 11223467899999988664 5788999999999999999999999532110 0000000 000000 00000
Q ss_pred -------c-----ccCCCC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 -------D-----SDMEGN----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 -------~-----~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+ +..... ........+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 00112345788999999999999999999986
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=292.49 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=203.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccch-hHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
...|.+.+.||+|.|+.|.+|+.. ++..||||.+.+...... ...+.+|++++..++|||||+++++.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 357888899999999999999865 689999999987654433 345889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|.+.+++.+.+. ..+..+..++.|+..|++|||++ .|+|||||++||||+.+..+||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998765 45588889999999999999999 999999999999999999999999999998763
Q ss_pred CCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||+.... ..+-
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---------------------k~Lr 264 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---------------------KELR 264 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---------------------cccc
Confidence 334455779999999999999876 6899999999999999999999974221 1111
Q ss_pred cccCCCCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNY--IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+..+.+.+ ......+.-+++++++-.+|.+|++++++..
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11111111 1111234567788888999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.45 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=192.9
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhcc---CCCcceeeeeeeecCCc-----
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMTPTE----- 206 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~~~~----- 206 (460)
|+..+.||+|+||.||+|+.. +++.+|+|.+....... ....+.+|++++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999986 48999999997543322 233456677766555 69999999999987766
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 89988876432 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
........ .....++..|+|||.+.+..++.++|||||||++|||++|..||..... ...+..+..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCChH
Confidence 77643322 1223467889999999999999999999999999999999999853211 11111111110000000
Q ss_pred c---------ccccccCC---CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 E---------QLVDSDME---GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~---------~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ........ ..........+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000 0111233466789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=286.83 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=192.8
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.|...+.||+|++|.||+|+.. ++..+|+|.+..... .....++.+|+++++.++|+|++++.+++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566678999999999999975 578899999864322 2223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+. |++.+.+.... .++++..+..++.+++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68888775433 2488999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||.... ..+......... ..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~-~~-- 232 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE-SP-- 232 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcC-CC--
Confidence 2234788999999874 3567889999999999999999999985311 011111111110 00
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.. ........+.+++.+||+.+|++||++.+|++...
T Consensus 233 ---~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ---AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---Cc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 01123456889999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=277.13 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=189.5
Q ss_pred HHHhcCCccCCee--cccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhc-cCCCcceeeeeeeecCCc
Q 012610 131 QVATDNFSNRNIL--GRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 131 ~~~~~~~~~~~~l--g~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~ 206 (460)
....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+..... .+|+|++++++++...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3344667776766 99999999999865 57889999986542221 12222222 269999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeeccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGL 285 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~ 285 (460)
.++||||+++++|.+++.... ++++..++.++.|+++||.|||+. +++||||+|+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997643 489999999999999999999999 999999999999999998 999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.||.... ........+.... ...
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--~~~ 226 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQ--QKK 226 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhh--ccc
Confidence 87654322 2347889999999999899999999999999999999999996321 1111122222211 000
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~ 409 (460)
. .........+.+++.+||+.+|.+||+ ++++++
T Consensus 227 ~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 011123456889999999999999996 588873
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=286.01 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=191.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCc------
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------ 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------ 206 (460)
++|+..+.||+|+||.||+|... +++.||||.+...... .....+.+|++++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47888999999999999999875 6889999998654322 223346689999999999999999999876543
Q ss_pred --ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 207 --RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 207 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
.++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 489999996 48888876543 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---eeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 285 LAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 285 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
++......... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~~ 239 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQL 239 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHH
Confidence 99765432221 112234678899999886654 68899999999999999999999853211 1111111111
Q ss_pred hh---hcccccc-----ccc-cCCCCC---cH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 361 LK---EKKLEQL-----VDS-DMEGNY---IE------EEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 361 ~~---~~~~~~~-----~~~-~~~~~~---~~------~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ....... .+. ...... .. .....+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 10 0000000 000 000000 00 01245678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=277.11 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=189.7
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHH-HhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|++|.||+|... +++.||+|.+....... ....+..|..+ .....|+|++++++++...+..++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999875 58899999986543211 12233444444 4456899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
++|.+++.... ++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997643 388999999999999999999999 999999999999999999999999999875432
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
.....++..|+|||.+.+..++.++||||||+++|||++|..||.... .......... .... ...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~------~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDAVFDNILS-RRIN------WPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh-cccC------CCC
Confidence 122347889999999988888999999999999999999999995311 1111111111 1100 000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 377 NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 377 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.+|++||++.++.+.|..
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1111234668999999999999999998877776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=278.17 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=200.4
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|+..+.||+|++|.||++... +++.|++|.+...... .....+.+|++++.+++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999875 5789999999765432 2344688999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987652 489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.. .....++..|+|||...+..++.++||||||+++|+|++|+.||.... ..... ..... ...
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~-~~~~~-~~~------- 216 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAAL-FRIVQ-DDH------- 216 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHH-HHHhc-cCC-------
Confidence 22 223457889999999988888999999999999999999999985321 01111 11110 000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||..+|++|||+.+++.
T Consensus 217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111122456889999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.69 Aligned_cols=263 Identities=20% Similarity=0.321 Sum_probs=195.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec----CCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~ 207 (460)
.++|+..+.||+|++|.||+|... ++..||+|++...... .....+..|+.++..++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368899999999999999999865 5899999998754322 234457789999999999999999988753 3467
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+. ++|.+++.... .+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 89999995 68888886432 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCc---eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 288 LMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 288 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCC
Confidence 65432211 1123457889999998865 45889999999999999999999999532110 000100000000
Q ss_pred -----------ccccccccc-cCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 -----------KKLEQLVDS-DMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 -----------~~~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+. ..... ........+.+++.+||+.+|++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 00000 01123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=281.76 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=194.5
Q ss_pred CCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccc---cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
+|+..+.||.|+||.||+++.. +|..||+|++..... ......+..|++++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 688999999875322 22234678899999999 599999999999888889
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+++++|.+++.... ++++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997643 478899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCC--CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||.... .......+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~ 229 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEP 229 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccCC
Confidence 6543332222334578899999998753 46789999999999999999999995321 11112222222211110
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.........+.+++.+||+.+|++|| ++++++.
T Consensus 230 -----------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -----------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01111235678899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=281.00 Aligned_cols=243 Identities=21% Similarity=0.342 Sum_probs=192.7
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
.+||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999875 68899999885432 23344688899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
.+++... .+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9987542 378999999999999999999999 999999999999999999999999999876543222 1233
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..++..|+|||.+.+..++.++||||||+++|+|++|..||.... ....+... .... ..... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--------~~~~~~~~-~~~~-----~~~~~--~~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMI-RDNL-----PPKLK--NL 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-HhhC-----CcccC--Cc
Confidence 457889999999988888999999999999999999999985311 01111111 1000 00000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112345788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=320.15 Aligned_cols=251 Identities=28% Similarity=0.377 Sum_probs=197.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+-++..+.+||.|.||.||.|... +|...|+|-++-... ........+|..++..++|||+|+++|+=...+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345666788999999999999854 688999998764322 233346789999999999999999999988889999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
|||.+|+|.+.++..+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986543 66777778889999999999999 999999999999999999999999999987754
Q ss_pred CCCc---eeecccccccccCcccccCCC---CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH-hhhc
Q 012610 292 KDTH---VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-LKEK 364 (460)
Q Consensus 292 ~~~~---~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 364 (460)
.... ......||+.|||||++.+.. ...+.||||+|||++||+||++||...+ .+|...+ +..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---------ne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---------NEWAIMYHVAAG 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---------chhHHHhHHhcc
Confidence 4211 122346999999999997654 4668999999999999999999995321 1222111 1112
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...+ .+......-.+++.+|+..||++|.++.|+++
T Consensus 1458 h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2222 22223445667889999999999988887765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=284.22 Aligned_cols=244 Identities=29% Similarity=0.418 Sum_probs=190.7
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
|...+.||+|+||.||+|+.. ++..|++|.+...... .....+..|+++++.++|||++++++++.+.+..+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999875 5889999998654322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. |++.+++.... .++++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 95 57877776533 2489999999999999999999999 9999999999999999999999999998643221
Q ss_pred CceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
....|+..|+|||.+. ...++.++|||||||++|||++|..||.... ....+....... .....
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~-~~~~~ 241 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQND-SPTLQ 241 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC-CCCCC
Confidence 2345788999999984 4567889999999999999999999985311 111111111110 00000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+.+++.+||+.+|.+||++.+++.
T Consensus 242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112345888999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=280.30 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=195.6
Q ss_pred CCccCCeecccCCeEEEEEEECC-CcEEEEEEecccc----ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+|.+.+.||+|+||.||+++... +..+++|.++... ......++..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998753 4456666665322 122334567789999999999999999999988899999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+||+.+++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876544445699999999999999999999999 9999999999999986 569999999987654
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||... ............ .
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~-~----- 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIVEG-P----- 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcC-C-----
Confidence 3222 222345788999999998888899999999999999999999998521 111111111111 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ..........+.+++.+||+.+|++||++.++++
T Consensus 222 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 T----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 1112234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.51 Aligned_cols=210 Identities=25% Similarity=0.365 Sum_probs=187.5
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeee
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 202 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 202 (460)
.+.+++...++|++.++||+|+||.|.+++.+ +++.||.|++.+... ......|..|-+++...+.+-|+.++..|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35667778899999999999999999999986 578899999987422 223446889999999999999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
+.++.|+|||||+||+|..++.+.. ++++..++.++..|.-||.-||+. |+|||||||+|||+|..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999998765 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCccccc----C-CCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS----T-GKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
||.+-.+.....-.....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999888766666666778999999999984 2 5789999999999999999999999964
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.60 Aligned_cols=266 Identities=26% Similarity=0.336 Sum_probs=215.2
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeee
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 200 (460)
+.++.+..++++...++.+|.||.||+|.+. +.+.|.+|.++....+-....+..|--++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 5667778888999999999999999999654 3456788888876666556678889889999999999999998
Q ss_pred eecC-CcceEEeeccCCCCHHHHhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC
Q 012610 201 CMTP-TERLLVYPFMVNGSVASCLRERGQ----SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275 (460)
Q Consensus 201 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 275 (460)
+... ...++++.++.-|+|..++...+. ....++..+...++.|++.|++|||++ +|+|.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8654 678999999999999999984322 223577888889999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCceee-cccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccH
Q 012610 276 FEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVML 353 (460)
Q Consensus 276 ~~~kl~Dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 353 (460)
.++||+|=.+++.+-..+....+ ....+..||+||.+.+..|+.++|||||||+||||+| |+.|+.. .+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae--------IDP 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE--------IDP 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc--------cCH
Confidence 99999999999877655544322 2335678999999999999999999999999999998 8899842 112
Q ss_pred HHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.+......++.++.+ +.+|+++++.+|.-||...|++||+++|++..|.+
T Consensus 505 fEm~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 505 FEMEHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 222222222333333 33467889999999999999999999999999865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=287.11 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=196.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTER 207 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~ 207 (460)
...+++|+..+.||.|+||.||++... ++..||+|++..... ......+..|++++..++|||++++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 688999998865332 2234567889999999999999999998865 4578
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++++||+ +++|..++... ++++.....++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 56898887642 378888899999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCC-------CCccHHHHHHH
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDWVKG 359 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~ 359 (460)
...... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .+....++...
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 543221 22346788999998766 5689999999999999999999999953211000 00000111111
Q ss_pred HhhhccccccccccCCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
........-+..-...... .......+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111000000000000000 01123678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=287.34 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=194.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc-ccchhHHHHHHHHHHhcc-CCCcceeeeeeeecC--Ccc
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER-TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP--TER 207 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~--~~~ 207 (460)
..++|+..+.||+|+||.||+|... ++..+|+|++.... .......+..|+.++..+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999876 57899999886432 122233567899999999 999999999988653 357
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+. ++|..++... .+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5998888653 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----ceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCC-----------CCc
Q 012610 288 LMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-----------DDV 351 (460)
Q Consensus 288 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-----------~~~ 351 (460)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543321 12223457889999998765 4578899999999999999999999953211000 000
Q ss_pred cHHHHHHHHhhhccccccccccC--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 352 MLLDWVKGLLKEKKLEQLVDSDM--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+..+ ........+..+..... ...........+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESI-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHH-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00000 00000000000000000 00001113456889999999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=310.17 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=187.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec---------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 203 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------- 203 (460)
..+|+..++||+|+||.||+++.+ ||+.||||++...........+.+|+..+++++|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 357888899999999999999987 8999999999765444444568899999999999999998642100
Q ss_pred ----------------------------------------------C---------------------------------
Q 012610 204 ----------------------------------------------P--------------------------------- 204 (460)
Q Consensus 204 ----------------------------------------------~--------------------------------- 204 (460)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 012610 205 -------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253 (460)
Q Consensus 205 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 253 (460)
...|+-||||+..++.++++...-. -.....++++.+|++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHH
Confidence 0126778999888888777664321 146788999999999999999
Q ss_pred hCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC-----------------CCCCceeecccccccccCcccccCC-
Q 012610 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----------------YKDTHVTTAVRGTIGHIAPEYLSTG- 315 (460)
Q Consensus 254 ~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~- 315 (460)
++ +||||||||.||++|++..|||+|||+++... .......+...||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998721 0111133455699999999999765
Q ss_pred --CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHc
Q 012610 316 --KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLC 393 (460)
Q Consensus 316 --~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 393 (460)
.|+.|+|+||+|||++||+. ||... ..-...+.. ++.+.+..- ..+..+....=.+++.++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-------MERa~iL~~-LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS-------MERASILTN-LRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch-------HHHHHHHHh-cccCCCCCC------cccccccchHHHHHHHHH
Confidence 49999999999999999986 46321 011111111 111111111 122333344456789999
Q ss_pred cCCCCCCCCCHHHHHH
Q 012610 394 TQGSPMERPKMSEVVR 409 (460)
Q Consensus 394 l~~~P~~RPt~~evl~ 409 (460)
++.||++|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999985
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=288.25 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=194.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC-----Cc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 206 (460)
.++|...+.||+|+||+||+++.. ++..||||.+..... ......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888899999999999999865 689999999875322 22234577899999999999999999987644 34
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++++||+. ++|.+++.... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68888886532 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh---
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 362 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 362 (460)
+...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ............
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 8654332 12223457889999998865 4688999999999999999999999953211 000000000000
Q ss_pred --------hccccccccc---cCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 363 --------EKKLEQLVDS---DMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 363 --------~~~~~~~~~~---~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
.......... .... .........+.+++.+||+.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0000 0011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=284.14 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=191.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
.++|+..+.||+|++|.||+|... +++.+|+|++....... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999975 58899999986543222 2335678999999999999999998875433
Q ss_pred --cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 206 --ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 206 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
..++++||+.+ ++...+.... ..+++..++.++.|+++||+|||++ +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999965 6777665432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc----------eeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCcc
Q 012610 284 GLAKLMDYKDTH----------VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352 (460)
Q Consensus 284 g~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 352 (460)
|++......... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-----~~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-----ID 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 999765432211 11223467889999987654 578999999999999999999999853211 11
Q ss_pred HHHHHHHHhhhc---------cccccc----cccCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 353 LLDWVKGLLKEK---------KLEQLV----DSDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 353 ~~~~~~~~~~~~---------~~~~~~----~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....+....... ...... ....... ........+.+++.+|++.+|.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111110000 000000 0000000 00112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=278.52 Aligned_cols=242 Identities=27% Similarity=0.358 Sum_probs=184.5
Q ss_pred eecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHH---HHhccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 142 ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~---~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
+||+|+||.||++... +++.||+|.+....... ....+..|.. .+....|||++.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 57899999987543221 1122333433 3445679999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+++|..++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999886532 489999999999999999999999 999999999999999999999999999875532221
Q ss_pred eeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 296 VTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
....|+..|+|||.+.++ .++.++|||||||++|||++|+.||....... .... ...... ....+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~------~~~~~ 218 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEI-DRMTLT------MAVEL 218 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHH-HHHhhc------cCCCC
Confidence 223588999999998754 68899999999999999999999996421110 0010 000000 01111
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.......+.+++.+|+..+|.+|| ++.++++
T Consensus 219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111235688999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=279.85 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=199.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 210 (460)
++|...+.||+|++|.||++... ++..||+|++..... ......+..|.+++.+++ |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999876 689999999875332 222346788999999998 99999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC-------------------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCc
Q 012610 291 YKDT-------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351 (460)
Q Consensus 291 ~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 351 (460)
.... .......++..|+|||...+..++.++||||||++++++++|+.||.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~- 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E- 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H-
Confidence 3321 12223447889999999988889999999999999999999999996322 0
Q ss_pred cHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 012610 352 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM----SEVVR 409 (460)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~----~evl~ 409 (460)
......... . ...........+.+++.+||+.+|++|||+ +++++
T Consensus 228 --~~~~~~~~~---~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 --YLTFQKILK---L--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHHh---c--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111110 0 001111224568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=271.10 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=194.7
Q ss_pred ccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhc-cCCCcceeeeeeeecCCcceEEeeccC
Q 012610 138 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
+....||.|+||+|++..++ .|+..|||++.........++++.|.+...+ -+.||||+++|.+......|+.||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 33456999999999999876 6899999999877766666688889887554 479999999999999999999999994
Q ss_pred CCCHHHHhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 216 NGSVASCLRER-GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 216 ~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
-+|..+.+.- ......+++...-.|......||.||.... .|+|||+||+|||++..|.+||+|||++..+..+
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 4666554331 112234888888888888999999999875 8999999999999999999999999999765322
Q ss_pred ceeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
...+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.|++... +..+.+...+.... ..+..
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdp-p~l~~- 292 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDP-PILLF- 292 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCC-CeecC-
Confidence 22233447889999999854 358999999999999999999999995311 13333333333221 11111
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.....+....+.+++..|+.+|-..||...++.+
T Consensus 293 ---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 ---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1112234567889999999999999999999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.53 Aligned_cols=261 Identities=22% Similarity=0.308 Sum_probs=197.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC-----cce
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 208 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-----~~~ 208 (460)
+|...+.||.|++|.||+|+.. ++..+|+|++..... ......+..|+++++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999976 488999999876432 233456889999999999999999999987765 789
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++|||+. ++|.+++.... ++++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58888886543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc-
Q 012610 289 MDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 364 (460)
Q Consensus 289 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 364 (460)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCC
Confidence 654321 112233478899999999887 7899999999999999999999999532210 0001000000000
Q ss_pred ----------cccccccc-cCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ----------KLEQLVDS-DMEG-----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ----------~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.....+.. .... .........+.+++.+||+.+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 0000 001113456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=284.28 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=196.0
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeec
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 203 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 203 (460)
...++...+++|...+.||+|+||.||++... ++..||+|++..... ......+.+|++++..++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 44566778899999999999999999999864 688999999975432 2223457789999999999999999998754
Q ss_pred C------CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc
Q 012610 204 P------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277 (460)
Q Consensus 204 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 277 (460)
. ...+++++++ +++|.+++... .+++..++.++.|+++||+|||+. +++||||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3357788876 78998887642 388999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHH
Q 012610 278 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 356 (460)
+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~ 230 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLI 230 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999998754321 223357889999998866 4678899999999999999999999953211 0001100
Q ss_pred HHHH----------hhhcc-------ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 357 VKGL----------LKEKK-------LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 357 ~~~~----------~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+... +.... .......... .........+.+++.+|++.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000 00000 0000000000 000012345789999999999999999998885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=276.65 Aligned_cols=260 Identities=26% Similarity=0.356 Sum_probs=196.4
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
|+..+.||+|++|.||+|+.. +++.+|+|.+..... ......+..|+++++.++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999976 489999999986542 222346778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
. ++|.+++.... ..+++..++.++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999998653 2489999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc------c
Q 012610 295 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL------E 367 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 367 (460)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+......... .
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHhhc
Confidence 1 2223356789999998776 789999999999999999999999853211 0111111111000000 0
Q ss_pred cc--ccccC---CC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QL--VDSDM---EG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~--~~~~~---~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+ .+... .. .........+.+++.+||..+|++||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 00000 00 001112456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=282.15 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=189.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
.++|...+.||+|++|.||+|... +++.||+|++..... ......+.+|+++++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999865 689999999875432 222345788999999999999999999886542
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++++||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 6766542 1388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH-----
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG----- 359 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 359 (460)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+......
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----DQLTQILKVTGVPG 235 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCC
Confidence 87643221 22346788999999876 46889999999999999999999999632110 000000000
Q ss_pred -----Hhhhcccccccc--ccCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 -----LLKEKKLEQLVD--SDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 -----~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............ +...... .......+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000000 0000000 0112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=283.42 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=192.8
Q ss_pred cCCcc-CCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-------------hhHHHHHHHHHHhccCCCcceeeee
Q 012610 135 DNFSN-RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------------GELQFQTEVEMISMAVHRNLLRLRG 199 (460)
Q Consensus 135 ~~~~~-~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~~~h~niv~l~~ 199 (460)
++|.. .+.||.|+||.||+|... +++.||||.+....... ....+.+|++++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999875 68899999986543221 0124678999999999999999999
Q ss_pred eeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 200 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
++...+..+++|||+. |+|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 68999886532 388999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCC-------------CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccc
Q 012610 280 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL 345 (460)
Q Consensus 280 l~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~ 345 (460)
|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~- 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN- 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999997654111 1111222367789999998765 46889999999999999999999995321
Q ss_pred cCCCCccHHHHHHHHhhhcccc---cc--------ccccCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 346 ANDDDVMLLDWVKGLLKEKKLE---QL--------VDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......+.......... +. ....... .........+.+++.+||+.+|++|||+.+++.
T Consensus 239 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 ----EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ----HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111111111100000 00 0000000 001122456889999999999999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=262.81 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=195.2
Q ss_pred hcCCccC-CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecC----Cc
Q 012610 134 TDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----TE 206 (460)
Q Consensus 134 ~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~----~~ 206 (460)
+++|.+. ++||-|-.|.|-.+..+ +++.+|+|++.... ...+|+++..+. .|||||.+++++.+. .-
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4455543 57999999999998865 68899999986432 345788887666 599999999988653 34
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeec
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 283 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df 283 (460)
+.+|||.|+||.|...++.++.. .+++.++-+|+.||+.|+.|||+. +|.||||||+|+|.+. +-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 57899999999999999887643 599999999999999999999999 9999999999999965 446899999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+|+.-.... ....-+-|++|.|||++...+|+...|+||+||++|-|++|.+||.... . ..+..-++..+..
T Consensus 209 GFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h----g-~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH----G-LAISPGMKRRIRT 281 (400)
T ss_pred ccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC----C-ccCChhHHhHhhc
Confidence 9998754322 2233457999999999999999999999999999999999999995311 1 1111111111111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+. ..+....+....+...++|+..|..+|.+|.|+.+++.
T Consensus 282 gq------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cC------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11 11222345566777888999999999999999999986
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=280.91 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=193.2
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCC-----
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----- 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----- 205 (460)
..++|...+.||+|++|.||++... ++..||||++...... .....+.+|+++++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999865 6889999998653322 22345788999999999999999999887543
Q ss_pred -cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 206 -ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 206 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
..++||||+ +++|..++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999998 77998887642 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCC-------CCccHHHH
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLDW 356 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-------~~~~~~~~ 356 (460)
++....... ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||........ ......++
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997653221 22346889999998876 4578999999999999999999999953211000 00000011
Q ss_pred HHHHhhhcccccccc--ccCCC----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 357 VKGLLKEKKLEQLVD--SDMEG----NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ....... +.... .........+.+++.+|++.||++|||+.+++.
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1110000 0000000 00000 001122345789999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=285.42 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=188.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC---------
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------- 204 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--------- 204 (460)
.+|...+.||.|+||.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999875 588999999865433 3344688899999999999999998766543
Q ss_pred -----CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcE
Q 012610 205 -----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEA 278 (460)
Q Consensus 205 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~ 278 (460)
...+++|||+. ++|.+++... .+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999996 5888887542 388999999999999999999999 9999999999999974 5678
Q ss_pred EEeecccccccCCCCCc--eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHH
Q 012610 279 VVGDFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 355 (460)
||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~~~~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL----EQMQL 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 99999999765422111 1122346788999998754 56788999999999999999999999532110 00000
Q ss_pred HHHHHh----------hhccccccccccCCCC-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 356 WVKGLL----------KEKKLEQLVDSDMEGN-----YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 356 ~~~~~~----------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... ................ ........+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000000000000000 00112356789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=262.29 Aligned_cols=205 Identities=25% Similarity=0.363 Sum_probs=170.2
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-----CcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeec-CCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT-PTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~ 206 (460)
...|+....||+|.||.||+|.-.+ ...+|||.++...... ......+|+.+++.++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999996432 2378999998664432 23456789999999999999999998877 677
Q ss_pred ceEEeeccCCCCHHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC----CcEEEe
Q 012610 207 RLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVG 281 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~ 281 (460)
.++++||.+. +|...++-... ....++...++.|+.||+.|+.|||++ =|+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999977 78888865432 224689999999999999999999999 69999999999999888 999999
Q ss_pred ecccccccCCCCCc--eeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCcccc
Q 012610 282 DFGLAKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 282 Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
|||+++.+...-.. ....++-|..|.|||.+.|.+ |+.+.|||+.|||+.||+|-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999987643322 233456799999999998864 89999999999999999999988854
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=283.53 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=193.2
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCc----
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 206 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~---- 206 (460)
..++|+..+.||+|++|.||+|+.. ++..||+|++..... ......+.+|+.+++.++|+|++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999976 578999999865322 2223457789999999999999999987765544
Q ss_pred --ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 207 --RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 207 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
.++|+||+ +++|.+++... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 67999988642 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-----~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-----IDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCC
Confidence 99765432 222347888999998865 3678999999999999999999999953211 0000000000000
Q ss_pred -----------ccccccccc---cCCCCC---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 -----------KKLEQLVDS---DMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 -----------~~~~~~~~~---~~~~~~---~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......... ...... .......+.+++.+||+.+|++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000000 0112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=269.43 Aligned_cols=237 Identities=29% Similarity=0.331 Sum_probs=191.4
Q ss_pred ecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
||.|++|.||++... +++.+|+|.+....... ....+..|+++++.++|+|++++++.+......+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 58899999987654322 344688899999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeec
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 299 (460)
.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997653 389999999999999999999998 99999999999999999999999999997654332 12233
Q ss_pred ccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 300 ~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
..++..|+|||...+...+.++|+||||+++|++++|+.||..... ......... .. ....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~----------~~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DP----------LRFP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CC----------CCCC
Confidence 4578899999999888889999999999999999999999953211 111111111 00 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSE 406 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~e 406 (460)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112456889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=256.94 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=196.7
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEE-ECCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeec
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 203 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 203 (460)
.+.++-..++ +.||+|+++.|..++ ..+|..+|||++.+. ....+.++.+|++++...+ |+||+.++++|++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3555555554 689999999999887 457999999999876 3344567889999998885 9999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc---EEE
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVV 280 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl 280 (460)
+...|+|||-|.||.|..+++++.. +++.++.++..+|+.||.|||.+ ||.||||||+|||-..-.. +||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999987653 89999999999999999999999 9999999999999976544 799
Q ss_pred eecccccccCCCC------CceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCC
Q 012610 281 GDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 349 (460)
Q Consensus 281 ~Dfg~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~ 349 (460)
+||.+..-..... ......-+|+..|||||+.. ...|+.+.|.||||||+|-|++|..||...-.. +-
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~-dC 299 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA-DC 299 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC-cC
Confidence 9999875432211 11122345888999999763 346899999999999999999999999653221 11
Q ss_pred Ccc---HHHHHHHHhhhccccccccccC--CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 350 DVM---LLDWVKGLLKEKKLEQLVDSDM--EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 350 ~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+++ ....-+..+ .+.+-+... ....+........+++...+..++..|.++.++++
T Consensus 300 GWdrGe~Cr~CQ~~L----FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKL----FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHH----HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 111111111 111111111 11112223344556667777899999999998887
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=276.76 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=187.5
Q ss_pred CCccCCeecccCCeEEEEEEEC-C--CcEEEEEEecccccc-chhHHHHHHHHHHhcc-CCCcceeeeeeeecC----Cc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-D--GSLVAVKRLKEERTQ-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTP----TE 206 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~----~~ 206 (460)
+|+..+.||+|+||.||+++.. . +..||+|++...... .....+.+|++++.++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999975 3 678999998753222 2234677899999998 599999999875432 44
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.+++++|+. ++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888885 6898888643 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCC-------CCccHHH
Q 012610 287 KLMDYKDTH---VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-------DDVMLLD 355 (460)
Q Consensus 287 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~-------~~~~~~~ 355 (460)
+........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .+....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 765432211 1122457889999998765 4688999999999999999999999853211000 0000000
Q ss_pred HHHHHhhhcc------ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 356 WVKGLLKEKK------LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 356 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
+......... ........+. .........+.+++.+|++.+|++|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0000000000 00011235688999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.54 Aligned_cols=204 Identities=28% Similarity=0.406 Sum_probs=175.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccch--hHHHHHHHHHHhcc-CCCcceeeeeeeecCCc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 206 (460)
.+...+|....+||+|+||.|.+|.-+ +.+.+|||+++++...+. .+--+.|-++|+.. +-|.+++++.+++..+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 444567889999999999999999865 467899999998754332 22234567777766 46789999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
+|+||||+.||+|--.+++.+. +.+..+..++..||-||-+||++ +|++||||.+||++|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999999988765 67778889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+.--. .......++||+.|+|||++..++|+.++|+|||||+||||+.|+.||+.
T Consensus 498 KEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 498 KENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred ccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 85332 23345568899999999999999999999999999999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.14 Aligned_cols=146 Identities=32% Similarity=0.448 Sum_probs=130.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|.+.+.||+|+||.||+|... +++.||||+++..... .....+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999976 6889999999754322 22346888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
||+.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 378899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=263.42 Aligned_cols=221 Identities=20% Similarity=0.176 Sum_probs=175.2
Q ss_pred cCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhh
Q 012610 146 GGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 224 (460)
Q Consensus 146 G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 224 (460)
|.+|.||++... +++.+|+|.+.... .+..|...+....|||++++++++...+..+++|||+.+|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999875 68899999987542 22344455555679999999999999999999999999999999987
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccc
Q 012610 225 ERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304 (460)
Q Consensus 225 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~ 304 (460)
... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 643 389999999999999999999999 9999999999999999999999999987654322 11233567
Q ss_pred cccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHH
Q 012610 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 384 (460)
Q Consensus 305 ~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (460)
.|+|||.+.+..++.++||||+|+++|||++|+.|++..... ........+ ......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------------~~~~~~~~~----~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------------INTHTTLNI----PEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------------cccccccCC----cccCCH
Confidence 899999998888899999999999999999999887521100 000000001 111235
Q ss_pred HHHHHHHHccCCCCCCCCCHHH
Q 012610 385 QLIQVALLCTQGSPMERPKMSE 406 (460)
Q Consensus 385 ~l~~l~~~cl~~~P~~RPt~~e 406 (460)
.+.+++.+|++.||++||++.+
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCCc
Confidence 6888999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=241.73 Aligned_cols=212 Identities=24% Similarity=0.360 Sum_probs=176.1
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
....+++..++......||+|++|.|-+.++. +|...|+|.+......+..+++..|+++..+. .+|.+|.++|....
T Consensus 37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 33446677777777888999999999988864 79999999998766655566788888876554 69999999999988
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
....++.||.|+ .+|..+...--.....+++..+-+|+..|..||.|||++. .++|||+||+|||++.+|++|++||
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 899999999994 4888776654444556899999999999999999999986 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccC----CCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
|++..+..+.. .+.-.|-..|||||.+.. ..|+.++||||||+.+.||.+++.||+.
T Consensus 194 GIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99976643322 222347788999998853 3689999999999999999999999963
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=280.08 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=189.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++.|+....+|.|+|+.|..+... +++..++|++.+... +..+|+.++.+. +|||++++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567888888999999999998865 578899999976522 233566555544 6999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe-cCCCcEEEeecccccccC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~ 290 (460)
|.+.++-+.+.+.... .....+..|+.+|+.|+.|||++ ||+||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998888876543 22367778999999999999999 99999999999999 699999999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. ...-+-|..|.|||++....|++++|+||||++||+|++|+.||.... .+ .+... .+
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P----~~---~ei~~-~i--------- 526 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP----AG---IEIHT-RI--------- 526 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC----ch---HHHHH-hh---------
Confidence 43 122235778999999999999999999999999999999999996321 11 11111 11
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+.+.........+|+.+||+.||.+||+|.++..
T Consensus 527 ---~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 ---QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112222333456778999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=271.81 Aligned_cols=243 Identities=25% Similarity=0.339 Sum_probs=193.8
Q ss_pred CeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCC
Q 012610 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
++||+|.||+||-|+.. +|+.||||++.+.+.. +.+.++.+|+.+|..+.||.||.+.-.|+..+..++|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 78999999999999865 7999999999876654 3455789999999999999999999999999999999999955 5
Q ss_pred HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC---CcEEEeecccccccCCCCCc
Q 012610 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 219 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+.+++-... ...+++...+.++.||+.||.|||.+ +|+|+||||+|||+... -++||+|||+|+++..+ .
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 555543322 22389999999999999999999999 99999999999999654 36999999999997643 3
Q ss_pred eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
....++||+.|+|||++.++.|+..-|+||.|||+|--++|..||.. +.++.+.++... +. ..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE-------dEdIndQIQNAa-------FM---yP 784 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE-------DEDINDQIQNAA-------FM---YP 784 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC-------ccchhHHhhccc-------cc---cC
Confidence 34557799999999999999999999999999999999999999952 222222222210 00 11
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
...+.+.....+++|...++..-.+|-|...-+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 223444455677788888888888888876554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=281.46 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=206.2
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec----
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT---- 203 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~---- 203 (460)
+...++.|++.++||.|.+|.||+++.. +++.+|+|++......+ .+.+.|.++++.. .|||++.++|++..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3345678899999999999999999854 68999999987655433 3567788888876 59999999998863
Q ss_pred -CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 204 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 204 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
++++|||||||.+|+..+++++.. ...+.|..+..|+..++.|+.+||.+ .++|||+|-.|||++.++.|||+|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 578999999999999999998866 44599999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCC-----CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
||.+..+...... .....||+.|||||++.-. .|+.++|+||||++..||.-|.+|+-..-..
T Consensus 167 FGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------- 234 (953)
T KOG0587|consen 167 FGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------- 234 (953)
T ss_pred eeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----------
Confidence 9999877644333 3345699999999998533 4678999999999999999999998321100
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+ +.-..++...-..+....+++.++|..|+.+|-..||++.++++
T Consensus 235 raL-----F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 RAL-----FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhh-----ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000 11111222222345677888999999999999999999999886
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=276.93 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=197.2
Q ss_pred cCCccCCeecccCCeEEEEEEECCCc-EEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~-~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++.....||-|+||.|-++...... .+|+|++++... ......+..|-.++...+.|.||+++.-|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45556678999999999999876433 489999986543 333446778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
|-|-||.|+..++.++. ++....+.++..+.+|++|||++ +|++|||||+|.+++.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999998765 88889999999999999999999 999999999999999999999999999998764
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.. ..-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||...+.... +. ..++.-.
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-----Yn---~ILkGid------ 636 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-----YN---LILKGID------ 636 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-----HH---HHHhhhh------
Confidence 43 34457899999999999999999999999999999999999999975332211 01 1111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 403 (460)
...++....+...+++++.+..+|.+|..
T Consensus 637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 ---KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11122333455677888888899999976
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.73 Aligned_cols=260 Identities=23% Similarity=0.278 Sum_probs=198.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCC--Cc----ceeeeeeeecCC
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RN----LLRLRGFCMTPT 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~n----iv~l~~~~~~~~ 205 (460)
.+.+|.+...+|+|.||.|-.+.+. .+..||||+++.-. .-..+.+-|++++.++.+ |+ ++.+.+|+.-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3688999999999999999999765 47899999997533 223356678999998842 23 777888898889
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec------------
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD------------ 273 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~------------ 273 (460)
..++|+|.+ |-++.+++..+. ..+++...++.|+.|++++++|||+. +++|-||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999998 779999998744 44699999999999999999999999 999999999999983
Q ss_pred --------CCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccc
Q 012610 274 --------EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 345 (460)
Q Consensus 274 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~ 345 (460)
++..++++|||.|+...... ...+.|.-|.|||++.+..++..+||||+||||.|+.||...|+...
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe- 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE- 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-
Confidence 13458999999998654332 44567899999999999999999999999999999999999996422
Q ss_pred cCCCCccHHHHHHHHhh-----------------hcccc-----------ccccccC----CCCCcHHHHHHHHHHHHHc
Q 012610 346 ANDDDVMLLDWVKGLLK-----------------EKKLE-----------QLVDSDM----EGNYIEEEVEQLIQVALLC 393 (460)
Q Consensus 346 ~~~~~~~~~~~~~~~~~-----------------~~~~~-----------~~~~~~~----~~~~~~~~~~~l~~l~~~c 393 (460)
+......++..+. .+.+. .+.+... .....+.+...|++|+.++
T Consensus 314 ----n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 314 ----NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ----cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 1121122222111 11000 0000000 0011234566799999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 012610 394 TQGSPMERPKMSEVVR 409 (460)
Q Consensus 394 l~~~P~~RPt~~evl~ 409 (460)
+..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=254.05 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=200.6
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchh--HHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGE--LQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
+..++|...++||+|+|+.|-++++. +.+.+|+|+++++-....+ .=.+.|-.+.... +||.+|-++.+++.....
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34578999999999999999999875 5788999999876433322 1245566666554 799999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++|.||++||+|--++++.. .++++.++.+...|+-||.|||+. ||++||||.+|||+|..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999999987776543 399999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.-- ........++||+.|+|||++.+..|...+|+|++||+++||+.|+.||+... .++.+.+-.+++...+-++.+.
T Consensus 400 e~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg-m~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 400 EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG-MDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred cCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec-CCCcccchhHHHHHHHhhhccc
Confidence 542 34455677889999999999999999999999999999999999999998655 3344444455555444433222
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 403 (460)
- +.....+...++..-+++||.+|..
T Consensus 478 i----------prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 I----------PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c----------cceeehhhHHHHHHhhcCCcHHhcC
Confidence 1 1111223445666778999999853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=281.32 Aligned_cols=263 Identities=18% Similarity=0.188 Sum_probs=170.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-C----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeee------e
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-D----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF------C 201 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~------~ 201 (460)
..++|+..+.||+|+||.||+|++. + +..||+|++...... .....+ .+....+.++..+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999976 4 689999987643211 111111 1122222222222111 2
Q ss_pred ecCCcceEEeeccCCCCHHHHhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC
Q 012610 202 MTPTERLLVYPFMVNGSVASCLRERGQS----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 265 (460)
Q Consensus 202 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 265 (460)
......++|+||+.+++|.+++...... ........+..++.||+.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 3456789999999999999998753210 00112344567999999999999999 9999999
Q ss_pred CCCCEEecC-CCcEEEeecccccccCCCCCceeecccccccccCcccccCC----------------------CCCcccC
Q 012610 266 KAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG----------------------KSSEKTD 322 (460)
Q Consensus 266 kp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D 322 (460)
||+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986544333333445689999999965322 2345679
Q ss_pred chhhHHHHHHHHhCCCcccccc-----ccCCCCccHHHHHHHHhhhccccccccccCCC--CCcHHHHHHHHHHHHHccC
Q 012610 323 VFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQ 395 (460)
Q Consensus 323 vws~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~ 395 (460)
||||||++|||+++..+++... .....+.....|....... ....+.. ...........+++.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999999877653210 0000111122221111000 0000000 0001112235589999999
Q ss_pred CCCCCCCCHHHHHH
Q 012610 396 GSPMERPKMSEVVR 409 (460)
Q Consensus 396 ~~P~~RPt~~evl~ 409 (460)
.||++|||++++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999987
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=226.78 Aligned_cols=197 Identities=25% Similarity=0.429 Sum_probs=167.2
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+|...++||+|.+|+|++|+.. +++.||+|+++.+... .......+|+-+++.+.|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555678999999999999965 5889999999865433 3344678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
|.. +|..+.....+ .++.+..+.++.|+++||.|+|++ ++.||||||.|.|++.+|++|++|||+++.+....
T Consensus 83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 954 78888765443 388999999999999999999999 99999999999999999999999999999876543
Q ss_pred CceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHh-CCCcc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELIT-GQRAF 340 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~t-g~~p~ 340 (460)
. .....+-|..|.+|.++.+.+ |++..|+||-|||+.|+.. |++.|
T Consensus 156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 3 233445789999999998865 8999999999999999987 55445
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=254.58 Aligned_cols=239 Identities=29% Similarity=0.385 Sum_probs=191.5
Q ss_pred CCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhh
Q 012610 147 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 225 (460)
Q Consensus 147 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 225 (460)
+||.||+|+.. +++.+++|++...........+.+|++.+++++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997654433256789999999999999999999999998999999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeeccccccc
Q 012610 226 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 305 (460)
Q Consensus 226 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~ 305 (460)
... +++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 432 78999999999999999999999 99999999999999999999999999998765432 2233457889
Q ss_pred ccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHH
Q 012610 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 385 (460)
Q Consensus 306 y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (460)
|++||.+.+..++.++||||||+++++|++|..||.... ......++ ......... .........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~----~~~~~~~~~-------~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKK----IGKPKPPFP-------PPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHH----HhccCCCCc-------cccccCCHH
Confidence 999999988888999999999999999999999995311 11111111 111111000 000003356
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 012610 386 LIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 386 l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=261.49 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=194.2
Q ss_pred hcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccch------hHHHHHHHHHHhccCCCcceeeeeeeec-CC
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGG------ELQFQTEVEMISMAVHRNLLRLRGFCMT-PT 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~ 205 (460)
.++|-...+||+|+|+.||+|.+ ...+.||||+-........ .+...+|..+.+.+.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45677778999999999999975 4578899998754433222 2246689999999999999999999865 46
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEee
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGD 282 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~D 282 (460)
..|-|+|||+|.+|.-+|+.... +++.+++.|+.||+.||.||... .++|+|-||||.|||+.+ -|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 67899999999999999987653 89999999999999999999986 678999999999999954 47899999
Q ss_pred cccccccCCCCCc------eeecccccccccCcccccCC----CCCcccCchhhHHHHHHHHhCCCccccccccCCCCcc
Q 012610 283 FGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352 (460)
Q Consensus 283 fg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 352 (460)
||++++++..... ......||.+|++||++.-+ +.+.++||||.|||+|..+.|+.||...- ...
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq----sQQ- 691 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ----SQQ- 691 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch----hHH-
Confidence 9999998754322 34456699999999988543 46889999999999999999999995311 111
Q ss_pred HHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
+ .+....+-....-.+. .-.........+|++||+..-++|....+++
T Consensus 692 --d----ILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 --D----ILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --H----HHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 1111111111110010 0111224466789999999999998877776
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=268.24 Aligned_cols=200 Identities=25% Similarity=0.361 Sum_probs=171.4
Q ss_pred cCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.-|..++.||-|+||.|.++.- .+...||.|.+.+... ......++.|-++|.....+-||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3466678899999999999974 3467899999976432 223446788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
+|++||++-.+|.+.+. +.+..++.++..+..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+..
T Consensus 709 dYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999987764 88999999999999999999999 999999999999999999999999999864321
Q ss_pred CCC-----------------------------------------ceeecccccccccCcccccCCCCCcccCchhhHHHH
Q 012610 292 KDT-----------------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330 (460)
Q Consensus 292 ~~~-----------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il 330 (460)
... ......+||+.|+|||++....++..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 000 001124599999999999999999999999999999
Q ss_pred HHHHhCCCccc
Q 012610 331 LELITGQRAFD 341 (460)
Q Consensus 331 ~el~tg~~p~~ 341 (460)
|||+.|+.||-
T Consensus 862 ~em~~g~~pf~ 872 (1034)
T KOG0608|consen 862 YEMLVGQPPFL 872 (1034)
T ss_pred HHHhhCCCCcc
Confidence 99999999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=270.45 Aligned_cols=264 Identities=22% Similarity=0.250 Sum_probs=179.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEE-----------------CCCcEEEEEEeccccccc-------------hhHHHHHH
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRL-----------------TDGSLVAVKRLKEERTQG-------------GELQFQTE 182 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e 182 (460)
..++|++.++||+|+||+||+|.. ..++.||||++....... .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235679999986532211 11123446
Q ss_pred HHHHhccCCCcc-----eeeeeeeec--------CCcceEEeeccCCCCHHHHhhhcCCC--------------------
Q 012610 183 VEMISMAVHRNL-----LRLRGFCMT--------PTERLLVYPFMVNGSVASCLRERGQS-------------------- 229 (460)
Q Consensus 183 ~~~l~~~~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------- 229 (460)
+.++.+++|.++ ++++++|.. ....++||||+.+++|.++++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 667777653 34679999999999999998753210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCc
Q 012610 230 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309 (460)
Q Consensus 230 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aP 309 (460)
...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788999999999999999999 999999999999999999999999999976543222111222347899999
Q ss_pred ccccCCCC----------------------CcccCchhhHHHHHHHHhCCC-ccccccccCC----CCccHHHHHHHHhh
Q 012610 310 EYLSTGKS----------------------SEKTDVFGYGVMLLELITGQR-AFDLARLAND----DDVMLLDWVKGLLK 362 (460)
Q Consensus 310 E~~~~~~~----------------------~~~~Dvws~G~il~el~tg~~-p~~~~~~~~~----~~~~~~~~~~~~~~ 362 (460)
|.+..... ..+.||||+||++++|++|.. ||........ ....+..|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 98754321 234799999999999999875 6642111100 0111111111 01
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP---MERPKMSEVVR 409 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPt~~evl~ 409 (460)
... ..............+++.+++..+| .+|+|+.|+++
T Consensus 458 ~~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 100 0011112233557778888888765 68999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.60 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=191.3
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC--------C
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--------T 205 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--------~ 205 (460)
.|+...+||+|.||.||+|+.+ +|+.||+|++..+.. ..-.....+|+++|..+.|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4556678999999999999876 477889887654322 22233567899999999999999999988642 2
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||.+|+. +|..+|.+... .++..++..++.++..||.|+|.. .|+|||+|+.|+|++.+|.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 36899999976 78888876543 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce---eecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 286 AKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 286 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
++.+....... .+..+.|..|++||.+.+. .|+++.|||.-|||+.||.||.+-++. +.++.....+..+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg-----nteqqql~~Is~Lc 245 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG-----NTEQQQLHLISQLC 245 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC-----ChHHHHHHHHHHHh
Confidence 98765443221 2333468999999998875 589999999999999999999988753 12222222222221
Q ss_pred hhcccccccc-------------ccCCCCC---cHHHH------HHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 KEKKLEQLVD-------------SDMEGNY---IEEEV------EQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 ~~~~~~~~~~-------------~~~~~~~---~~~~~------~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ...++.. +.+.... ..+.. ....+++..++..||.+|+++.+++.
T Consensus 246 Gs-~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 246 GS-ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cc-CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11 1111000 0011000 01111 24667888889999999999999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=271.52 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=184.1
Q ss_pred CccCCeecccCCe-EEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeecc
Q 012610 137 FSNRNILGRGGFG-KVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 137 ~~~~~~lg~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
|...+++|.|+.| .||+|.+. |+.||||++-... ..-..+|+..|+.- .|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4455678999876 57999986 7899999985433 22456899998877 5999999998888888999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---C--CcEEEeeccccccc
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---E--FEAVVGDFGLAKLM 289 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~--~~~kl~Dfg~~~~~ 289 (460)
..+|.++++..............+.++.|++.||++||+. +||||||||.||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5599999987411111122245678889999999999998 9999999999999976 3 46899999999988
Q ss_pred CCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhC-CCccccccccCCCCccHHHHHHHHhhh-cc
Q 012610 290 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKE-KK 365 (460)
Q Consensus 290 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 365 (460)
....... .....||-+|+|||++....-+.++||||+||++|+.++| .+||...... -.+.+.. ..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R----------~~NIl~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER----------QANILTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh----------hhhhhcCccc
Confidence 7554332 2345589999999999999989999999999999999985 9999521110 0001110 00
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+..+ . ...++ ...+||.+|++++|..||++.+|+.
T Consensus 732 L~~L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVHL-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeee-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0000 0 01111 5678999999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=236.28 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=192.9
Q ss_pred ccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC-----CcceEE
Q 012610 138 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLV 210 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~~lv 210 (460)
+..+-||-|+||.||.+.+. +|+.||+|++..-.. -...+.+.+|+++|..++|.|++..+++..-. .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34477999999999999875 799999999864321 12344688999999999999999998876544 356778
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+|.|. .+|...+ .+..+++-..++-++.||++||+|||+. +|.||||||.|.|++.+..+||+|||+++...
T Consensus 136 TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 88873 3555544 3444588888999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc-
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ- 368 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 368 (460)
......++..+-|.+|.|||++++. .|+.+.||||.|||+.|++..+..|+..... ...+.+..++....++.
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-----qQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-----EQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-----HHHHHHHHHhCCCcHHHH
Confidence 7666666667789999999999886 5899999999999999999999888642211 11222222222211111
Q ss_pred ----------cccccCCC-------CC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 369 ----------LVDSDMEG-------NY--IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 369 ----------~~~~~~~~-------~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
++...... .. .......-..+...++..||.+|.+..+.+.-+..
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11110000 00 01122234556667889999999999988876544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=226.56 Aligned_cols=211 Identities=35% Similarity=0.517 Sum_probs=182.6
Q ss_pred ecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHHH
Q 012610 143 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 221 (460)
Q Consensus 143 lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 221 (460)
||+|.+|.||++...+ ++.+++|++...........+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999999765443234578899999999999999999999998889999999999999999
Q ss_pred HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeecccccccCCCCCceeecc
Q 012610 222 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTTAV 300 (460)
Q Consensus 222 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 300 (460)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 997653 2488999999999999999999999 9999999999999999 89999999999986654321 12223
Q ss_pred cccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCc
Q 012610 301 RGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379 (460)
Q Consensus 301 ~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (460)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 467889999999887 788999999999999999
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 380 EEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 380 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=239.06 Aligned_cols=133 Identities=23% Similarity=0.361 Sum_probs=111.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-----C---Ccceeeeeeeec
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----H---RNLLRLRGFCMT 203 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h---~niv~l~~~~~~ 203 (460)
...+|...++||-|.|++||++.+. +.+.||+|+.+..... .+....||++|+.++ | ..||+|++.|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY--tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY--TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH--HHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3478999999999999999999875 5788999999764332 334678999998874 3 349999998863
Q ss_pred ----CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 204 ----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 204 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
+.+.++|+|++ |.+|..+|...... .++...+++|+.||+.||.|||.+| +|+|-||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 46789999999 77999999875543 4899999999999999999999998 99999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=221.01 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=190.0
Q ss_pred hcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecC--CcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~l 209 (460)
.++|++.+++|+|.++.|+.|.. .++++++||+++.-. .+.+.+|+.+|..+. ||||+.++++..++ ....+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 46788899999999999999984 468899999997643 336889999999998 99999999998776 45679
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 288 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~ 288 (460)
++||+.+.+...+... ++...+..++.+++.||.|+|+. ||+|||+||.|+++|.. ..++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999999888776643 77788899999999999999999 99999999999999875 4689999999998
Q ss_pred cCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ....+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||-. ..++.+..-.+...+....+.
T Consensus 183 YHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh----G~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 183 YHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH----GHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred cCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC----CCCCHHHHHHHHHHhChHHHH
Confidence 654332 333446778999998855 4578899999999999999999999832 111111111111111111111
Q ss_pred c-------cccccCCC----------------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 Q-------LVDSDMEG----------------NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~-------~~~~~~~~----------------~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .+|+.... +...-...+.++++...+..|.++|+|++|.+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 11221110 000001245677888888999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=246.18 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=168.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----h--hHHHHHHHHHHhccC---CCcceeeeeeeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----G--ELQFQTEVEMISMAV---HRNLLRLRGFCMT 203 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~--~~~~~~e~~~l~~~~---h~niv~l~~~~~~ 203 (460)
.+|...+.+|.|+||.|++|.++ +...|+||.+.+++.-. . .-..-.|+.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788899999999999999987 46678999987754211 1 112556999999997 9999999999999
Q ss_pred CCcceEEeecc-CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 204 PTERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 204 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
++.+|++||-. ++-+|.+++.... .+++.+++.|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 4568899987543 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccc
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
||.+....... ...++||..|.|||++.|.+| ...-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987654332 344679999999999999887 677899999999999999998884
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=224.09 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=190.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeee-eecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF-CMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~-~~~~~~~~lv~ 211 (460)
+.|.+.+.||+|.||.+-+++++ +.+.+++|.++..... ..+|.+|...--.+ .|.||+.-++. ++..+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 56888899999999999999976 5788999999865433 45688888764444 58999988765 45667788999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec--CCCcEEEeeccccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLM 289 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~ 289 (460)
||++.|+|..-+...+ +.+...+.++.|++.|+.|+|++ ++||||||.+||||- +..++||+|||..+..
T Consensus 102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999887654 78889999999999999999999 999999999999993 3347999999998764
Q ss_pred CCCCCceeecccccccccCcccccCC-----CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
+..- ....-+..|.+||..... ...+.+|||.|||+++.++||+.||+.....+...+....|.++...
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 4221 112235579999977433 24678999999999999999999998666665555556666544322
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.+.. ........+.++..+-+..+|++|=-..++...-.
T Consensus 248 ~~P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ALPK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCch---------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1111 11223345677777888999999955555554433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=224.54 Aligned_cols=262 Identities=22% Similarity=0.246 Sum_probs=191.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC------Cc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TE 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~ 206 (460)
.+|...+.+|.|.- .|..+.+. .++.||+|++..... ....++..+|...+..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888888 66666543 588999998865422 23344677899999999999999999988533 45
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.|+|||+| ..+|...+... ++-.....++.|++.|++|||+. +|+||||||+||++..++.+||.|||++
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 78999999 55888888732 67788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc----------CCCCccH---
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA----------NDDDVML--- 353 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~----------~~~~~~~--- 353 (460)
+.-... ...+.++.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.... +..+...
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 864432 3556677899999999999988999999999999999999999888432110 0011111
Q ss_pred -HHHHHHHhhhcccc------c-cccccCCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 354 -LDWVKGLLKEKKLE------Q-LVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 354 -~~~~~~~~~~~~~~------~-~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...+..++...... + +.|..... +...-......+++.+||-.+|++|.+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11111111110000 0 01111110 111123345778899999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=222.62 Aligned_cols=199 Identities=34% Similarity=0.515 Sum_probs=170.3
Q ss_pred CccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccC
Q 012610 137 FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
|...+.||.|++|.||++...+ ++.+++|.+...........+..|++.+..++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999874 889999999765433234578899999999999999999999998889999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+++|.+++...... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999764321 78899999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeecccccccccCcccc-cCCCCCcccCchhhHHHHHHHHhCCCccc
Q 012610 296 VTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22233467889999998 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=247.66 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=196.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+....+|.|.+|.||++++. .++..|+|.++.+.... ..-..+|+-+++..+||||+.++|.+...+..+++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 367888899999999999999976 68999999998654332 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||.+|+|.+..+..+ ++++.++..+.....+||+|||++ +-+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus 93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999876543 588999999999999999999999 8899999999999999999999999998765432
Q ss_pred CCceeecccccccccCcccc---cCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
. .....+.||++|||||+. ..+.|...+|||+.|+...|+---+.|.-. +...-..++.. +..
T Consensus 166 i-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd----------lhpmr~l~LmT---kS~ 231 (829)
T KOG0576|consen 166 I-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD----------LHPMRALFLMT---KSG 231 (829)
T ss_pred h-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc----------cchHHHHHHhh---ccC
Confidence 2 223446699999999976 456789999999999999999877766411 00000011111 111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.++....+ .......+.++++.|+.++|++|||++.+++
T Consensus 232 ~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111 1123355788999999999999999987765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=230.83 Aligned_cols=205 Identities=22% Similarity=0.258 Sum_probs=170.2
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC------CCcceeeee
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV------HRNLLRLRG 199 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~------h~niv~l~~ 199 (460)
+.-.++...+|.+....|+|-|++|.+|... .|..||||++...... .+.=+.|+++|.+|+ --+.++++.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3334567789999999999999999999875 4789999999764322 223457899999885 346888888
Q ss_pred eeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cE
Q 012610 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EA 278 (460)
Q Consensus 200 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~ 278 (460)
.|...+++|+|+|-+ ..+|.++|+..+.. ..|....+..++.|+.-||..|-.. +|+|.||||+||||++.. .+
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 888899999999988 56999999987653 3488899999999999999999998 999999999999998764 57
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccc
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
||||||.|....... .+.+..+..|.|||++.|.+|+...|+||.||.||||.||+..|.
T Consensus 577 KLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 577 KLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred eeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 999999997654332 222334567999999999999999999999999999999999884
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=260.46 Aligned_cols=195 Identities=14% Similarity=0.100 Sum_probs=136.2
Q ss_pred ccCC-Ccceeeeeeee-------cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012610 188 MAVH-RNLLRLRGFCM-------TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259 (460)
Q Consensus 188 ~~~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 259 (460)
.++| +||+++++++. .....++++||+ +++|.+++.... .++++..++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 57777777762 223456778887 669999997532 3489999999999999999999999 9
Q ss_pred eEeeCCCCCCEEecCCC-------------------cEEEeecccccccCCCCC---------------ceeeccccccc
Q 012610 260 IIHRDVKAANILLDEEF-------------------EAVVGDFGLAKLMDYKDT---------------HVTTAVRGTIG 305 (460)
Q Consensus 260 i~H~dlkp~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~---------------~~~~~~~g~~~ 305 (460)
|+||||||+||||+..+ .+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455666666543211000 00111347888
Q ss_pred ccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHH
Q 012610 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ 385 (460)
Q Consensus 306 y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (460)
|||||++.+..++.++|||||||+||||++|..|+.... ......... ...+. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~---------~~~~~-----~~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR---------VLPPQ-----ILLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh---------hcChh-----hhhcCHH
Confidence 999999999999999999999999999999988874210 001111000 01110 0111233
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 012610 386 LIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 386 l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...++.+||+.+|.+||++.||++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 567888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=204.62 Aligned_cols=166 Identities=23% Similarity=0.263 Sum_probs=124.6
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|.++++..+ .++++..++.++.||+.||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997643 2499999999999999999999998 5 999999999999999 99998654322
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCC
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG 376 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (460)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..................+ .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~----~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMPADDPRD----R 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhccCCccc----c
Confidence 2488999999999999999999999999999999999999953211 1111111111110000000 0
Q ss_pred CCcHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 377 NYIEEEVE--QLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 377 ~~~~~~~~--~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
........ .+.+++.+||+.+|.+||++.|+++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01112222 58999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=217.35 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=163.6
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE 206 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~ 206 (460)
...+.|...++||.|.|++||++.+. ..+.||+|.+..... ...+..|+++|..+. +.||+++.+++...+.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 44567888999999999999999754 367899999875433 346889999999885 9999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeeccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL 285 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~ 285 (460)
..+|+||++..+..+++.. ++...+..++..+..||+++|.+ |||||||||+|+|.+.. +.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 9999999999999988865 67888999999999999999999 99999999999999764 5678999999
Q ss_pred ccccCCC---------------------------------C----------CceeecccccccccCcccccCC-CCCccc
Q 012610 286 AKLMDYK---------------------------------D----------THVTTAVRGTIGHIAPEYLSTG-KSSEKT 321 (460)
Q Consensus 286 ~~~~~~~---------------------------------~----------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~ 321 (460)
+...... . ........||++|.|||++... .-+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 8621000 0 0011123499999999998765 458899
Q ss_pred CchhhHHHHHHHHhCCCccc
Q 012610 322 DVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 322 Dvws~G~il~el~tg~~p~~ 341 (460)
||||.|||++-+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999984
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=203.55 Aligned_cols=246 Identities=21% Similarity=0.343 Sum_probs=186.2
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCC
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
..+|.+...|..|+|+++ |..+++|++..... ......|..|.-.|+.+.||||+.++|.|..+.+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345888999999999998 45567788865433 2334479999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe--ecccccccCCCCCce
Q 012610 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG--DFGLAKLMDYKDTHV 296 (460)
Q Consensus 219 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~ 296 (460)
|...++.... ..++..++.+++.++|+|++|||+. .+-|.---|.+..+++|++.+++|. |--++.. .
T Consensus 274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---e---- 343 (448)
T KOG0195|consen 274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---E---- 343 (448)
T ss_pred HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---c----
Confidence 9999987543 3467788999999999999999997 3345555789999999999988763 3222211 0
Q ss_pred eecccccccccCcccccCCCC---CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 297 TTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~---~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
....-.+.||+||.++..+- -.++|+|||++++||+.|...||......+.. -.+.-..
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----------------mkialeg 405 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----------------MKIALEG 405 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----------------hhhhhcc
Confidence 11113578999999987654 35789999999999999999999533222110 0111122
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
++...+......+.++|.-|++.||.+||.+..|+-.|++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 23333344456688999999999999999999999999863
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=208.50 Aligned_cols=177 Identities=21% Similarity=0.202 Sum_probs=133.9
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC--CCcEEEEEEecccc----ccchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
....++|...+.||+|+||+||+|... +++.+|||++.... .......+.+|++++..++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 445678999999999999999999865 57778999875331 12234468999999999999999853322 2
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC-CCCCEEecCCCcEEEeec
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDF 283 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Df 283 (460)
...++||||++|++|... .. .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 11 11 146788999999999999 9999999 999999999999999999
Q ss_pred ccccccCCCCCce-------eecccccccccCcccccCCC------CCcccCch
Q 012610 284 GLAKLMDYKDTHV-------TTAVRGTIGHIAPEYLSTGK------SSEKTDVF 324 (460)
Q Consensus 284 g~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~------~~~~~Dvw 324 (460)
|+++.+....... .....++..|+|||.+...+ .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9998765432111 12345788899999986432 23456766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=200.28 Aligned_cols=259 Identities=19% Similarity=0.225 Sum_probs=191.0
Q ss_pred CCccCCeecccCCeEEEEEEECCC--cEEEEEEeccccccchhHHHHHHHHHHhccCC----Ccceeeeeee-ecCCcce
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDG--SLVAVKRLKEERTQGGELQFQTEVEMISMAVH----RNLLRLRGFC-MTPTERL 208 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h----~niv~l~~~~-~~~~~~~ 208 (460)
+|.+.+.||+|+||.||++..... ..+|+|........... .+..|..++..+.. .++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999997653 47888887665433333 57778888887763 5788888888 4677889
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-----CcEEEeec
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDF 283 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Df 283 (460)
+||+.+ |.+|.++..... ...++..+...|+.|++.+|++||+. |++||||||.|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 889999886655 33599999999999999999999999 99999999999999865 36899999
Q ss_pred ccccccC--CCCCc------e-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHH
Q 012610 284 GLAKLMD--YKDTH------V-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 284 g~~~~~~--~~~~~------~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 354 (460)
|+++... ..... . .....||..|.++....+...+.+.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998322 11111 1 2335599999999999999999999999999999999999999964322111 1
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.-+...... ..... ..... ...+.++...+-..+..++|....+...|.+..
T Consensus 247 ~~~~~~~~~----~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 247 SKFEKDPRK----LLTDR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHHHhhh----hcccc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111111111 11110 11112 233445555555689999999999999876643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=218.99 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=182.7
Q ss_pred cCCeecccCCeEEEEEEEC-CCcEEEEEEeccc--cccch---hHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 139 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE--RTQGG---ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~---~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..+++|.|++|.|+..... ....++.|..... ..... ...+..|+-+-..+.|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999977777643 3333444433211 11111 1124556666678899999888877776666666699
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||++ +|..++...+ .+....+..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999987652 277888899999999999999999 9999999999999999999999999999876544
Q ss_pred CC---ceeecccccccccCcccccCCCCCc-ccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 293 DT---HVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 293 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.. ......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||..+...+... .......+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~~~~~~~ 543 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KTNNYSDQ 543 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hhhccccc
Confidence 33 3445567899999999999998865 6799999999999999999997544322110 00000000
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.-...-........+.....++.++++.+|.+|.|+++|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000011123344566778999999999999999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=184.01 Aligned_cols=200 Identities=19% Similarity=0.274 Sum_probs=169.2
Q ss_pred cCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e 212 (460)
-+|.++++||+|.||.++.|+. -+++.||||.-... ...-++..|....+.+. .+.|..++.+...+-...+|+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4788999999999999999984 47899999965432 22336788888888875 6889999888888888899999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-----CcEEEeeccccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-----FEAVVGDFGLAK 287 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg~~~ 287 (460)
.+ |-+|.++..-.+.. ++..++..++.|++.-++|+|++ .+|+|||||+|+||..- ..+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 98 88999998766543 89999999999999999999999 99999999999999643 358899999999
Q ss_pred ccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccc
Q 012610 288 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 344 (460)
Q Consensus 288 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~ 344 (460)
.+...... ......||.+||+-....+..-+.+.|.=|+|-++++++-|..||+...
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 87544332 2344569999999999999999999999999999999999999997543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-22 Score=189.56 Aligned_cols=262 Identities=28% Similarity=0.366 Sum_probs=196.5
Q ss_pred CccCCeecccCCeEEEEEEECCCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCC-cceeeeeeeecCCcceEEeec
Q 012610 137 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHR-NLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~-niv~l~~~~~~~~~~~lv~e~ 213 (460)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|...+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999987 788999998765544 356789999999999988 799999999766667999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 292 (460)
+.++++.+++...... ..+.......++.+++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654321 2488899999999999999999999 999999999999999998 7999999999865443
Q ss_pred CCc-----eeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 293 DTH-----VTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 293 ~~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... .......... ...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~-~~~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKII-LEL 230 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHH-Hhc
Confidence 322 2345668999999999987 57889999999999999999999997532210 0011111111 111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
... .................+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100 000000000001223467788889999999999999887753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=175.52 Aligned_cols=260 Identities=18% Similarity=0.225 Sum_probs=192.2
Q ss_pred HHhcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhccCC-CcceeeeeeeecCCcceE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~l 209 (460)
+...+|..++.||+|+||.+|.|.. .+|..||||.-...... -++..|..+...+++ ..|..+..+..+.....+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3456799999999999999999985 57999999986543322 257788899888875 557777778888888999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEEeecccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLA 286 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~ 286 (460)
||+.+ |-+|.+++.-.... ++..+.+-++-|++.-++|+|.+ +++||||||+|+|..-+. .+.++|||++
T Consensus 89 VMdLL-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeecc-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 99998 88999988755432 88999999999999999999999 999999999999997543 5789999999
Q ss_pred cccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 287 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 287 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
+.+...... ......||.+|.+-....+..-+.+.|+=|+|.+|.++.-|..||+....... .+.. ..
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKy-Ek 235 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKY-EK 235 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHH-HH
Confidence 876433222 12234589999999888888889999999999999999999999975322110 0000 00
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
+.+.++.-.+.. .+...+.++.-.+..|-..--++-|...-+-+.+.
T Consensus 236 I~EkK~s~~ie~-----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 236 ISEKKMSTPIEV-----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHhhcCCCHHH-----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 111111111110 12223455666777888888888999877766554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=208.38 Aligned_cols=266 Identities=23% Similarity=0.274 Sum_probs=194.4
Q ss_pred CCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHH--HhccCCCcceeeeeeeecCCcceEEeec
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++...+.||++.|=+|.+|++.+|. |+||++-+....-....+.++++- ...++|||.+++.-+.......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999998776 889998665433333334433332 5667899999998877777778888888
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC--
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-- 291 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-- 291 (460)
... +|.+.+..+ +-+...+.+-|+.|++.||.-+|.. +|+|||||.+||||+.=.-+.|+||...+...-
T Consensus 103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 854 787777543 3367778888999999999999999 999999999999999988999999987764321
Q ss_pred CCCcee----ecccccccccCcccccCC----------C-CCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHH
Q 012610 292 KDTHVT----TAVRGTIGHIAPEYLSTG----------K-SSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 292 ~~~~~~----~~~~g~~~y~aPE~~~~~----------~-~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 355 (460)
.+.... .......+|+|||.+... . .+++-||||+||++.||++ |++||..... ..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------~a 246 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------LA 246 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH--------Hh
Confidence 111111 112234579999987541 1 4678899999999999988 7888853211 01
Q ss_pred HHHH--HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCcchhhHHHHhhhhh
Q 012610 356 WVKG--LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 430 (460)
Q Consensus 356 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 430 (460)
+-.+ ...+..++.+-| ..+.+++..|++.||.+|.++++.++.-.+..+++-+--+..+++.+
T Consensus 247 Yr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~ 311 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDR 311 (1431)
T ss_pred HhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHh
Confidence 0000 000011111111 24888999999999999999999999999999999999998888643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=193.78 Aligned_cols=216 Identities=23% Similarity=0.386 Sum_probs=162.0
Q ss_pred HhccCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeeC
Q 012610 186 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI-IHRD 264 (460)
Q Consensus 186 l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~d 264 (460)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..... .+++.....++.+|+.||+|||+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---KLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---CccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3568899999999999999999999999999999999987433 389999999999999999999997 44 9999
Q ss_pred CCCCCEEecCCCcEEEeecccccccCCC-CCceeecccccccccCcccccCCC-------CCcccCchhhHHHHHHHHhC
Q 012610 265 VKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGK-------SSEKTDVFGYGVMLLELITG 336 (460)
Q Consensus 265 lkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dvws~G~il~el~tg 336 (460)
++++|+++|....+||+|||+....... .........-..-|.|||.+.+.. .+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998776421 111111112344699999987641 46789999999999999999
Q ss_pred CCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 337 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 337 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
+.||+........ .+.+....+ ......-+.+... .+....+..++.+||..+|.+||++++|-..++...
T Consensus 155 ~~~~~~~~~~~~~----~eii~~~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP----DEIILRVKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCCh----HHHHHHHHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999754333222 122222111 1111111111111 133346899999999999999999999999888754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=172.40 Aligned_cols=141 Identities=18% Similarity=0.201 Sum_probs=107.9
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchh-------------------------HHHHHHHHHHhccCCCcc
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE-------------------------LQFQTEVEMISMAVHRNL 194 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~-------------------------~~~~~e~~~l~~~~h~ni 194 (460)
...||+|++|.||+|...+|+.||||+++........ .....|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999754321100 112348889999887776
Q ss_pred eeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeeCCCCCCEEec
Q 012610 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRDVKAANILLD 273 (460)
Q Consensus 195 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nill~ 273 (460)
.....+.. ...++||||+.++++....... .+++...+..++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43332221 2348999999988776543222 2488899999999999999999 687 999999999999998
Q ss_pred CCCcEEEeecccccccC
Q 012610 274 EEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 274 ~~~~~kl~Dfg~~~~~~ 290 (460)
+ +.++|+|||++....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=175.81 Aligned_cols=175 Identities=10% Similarity=0.096 Sum_probs=134.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchh--HH------HHHHHHHHhccCCCcceeeeeeee
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE--LQ------FQTEVEMISMAVHRNLLRLRGFCM 202 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~~~h~niv~l~~~~~ 202 (460)
.+...+|...+++|.|+||.||++.. ++..+|||.+......... .. +.+|+..+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 35578999999999999999999766 5678999999765433221 11 578899999999999999988765
Q ss_pred cC--------CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC
Q 012610 203 TP--------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 274 (460)
Q Consensus 203 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~ 274 (460)
.. ...+++|||++|.+|.++.. ++. ....+++.+|..+|+. +++|||++|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 33 35789999999999988732 222 2456889999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh
Q 012610 275 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335 (460)
Q Consensus 275 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t 335 (460)
++ ++|+|||........... ..+.....+..++|+||||+.+.-+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 98 999999988654211110 013334456679999999998776543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-21 Score=166.24 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=110.5
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccch-------------------------hHHHHHHHHHHhccCCCcc
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG-------------------------ELQFQTEVEMISMAVHRNL 194 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~-------------------------~~~~~~e~~~l~~~~h~ni 194 (460)
.+.||+|++|.||+|...+|+.||||+++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999987899999999976422100 1123578889999999987
Q ss_pred eeeeeeeecCCcceEEeeccCCCCHHHH-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEe
Q 012610 195 LRLRGFCMTPTERLLVYPFMVNGSVASC-LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 272 (460)
Q Consensus 195 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill 272 (460)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544443322 35899999998865443 332 136788899999999999999999 8 99999999999999
Q ss_pred cCCCcEEEeecccccccCC
Q 012610 273 DEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 273 ~~~~~~kl~Dfg~~~~~~~ 291 (460)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=160.47 Aligned_cols=184 Identities=17% Similarity=0.080 Sum_probs=137.0
Q ss_pred cCCeecccCCeEEEEEEECCCcEEEEEEeccccccch---hHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeecc
Q 012610 139 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---ELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
....|++|+||+||.+.. .+.+++.+.+........ ...+.+|++++.++. |+++.+++++ +..+++|+|+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999997766 578888887765433211 224789999999995 5778888886 4569999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC-CCCCEEecCCCcEEEeecccccccCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV-KAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
.|.+|...+.. . ...++.+++.+|.++|++ ||+|||| ||.|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998654321 1 135678899999999999 9999999 7999999999999999999998654332
Q ss_pred Cc----e--------eecccccccccCcccccCC-CCC-cccCchhhHHHHHHHHhCCCccc
Q 012610 294 TH----V--------TTAVRGTIGHIAPEYLSTG-KSS-EKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 294 ~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~Dvws~G~il~el~tg~~p~~ 341 (460)
.. . ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..++.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 11 0 0111246677777754322 223 56788999999999999998874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=170.88 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=146.3
Q ss_pred CccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCC----------Ccceeeeeee--
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVH----------RNLLRLRGFC-- 201 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h----------~niv~l~~~~-- 201 (460)
+...+.||.|+++.||.+++. +++.+|+|++...... ...+++++|.-....+.+ -.++.-++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999986 5899999998654322 223355555544444322 1121111211
Q ss_pred -------ecCC--------cceEEeeccCCCCHHHHhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 012610 202 -------MTPT--------ERLLVYPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 263 (460)
Q Consensus 202 -------~~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 263 (460)
.... +.+++|+-+ .++|.+++.. .......+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1111 236778877 6688887543 222222345566677789999999999999 99999
Q ss_pred CCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccC--------CCCCcccCchhhHHHHHHHHh
Q 012610 264 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELIT 335 (460)
Q Consensus 264 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~G~il~el~t 335 (460)
||+|+|++++.+|.++|+||+.....+. .......+..|.+||.... -.++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987764332 1221234578999997643 246889999999999999999
Q ss_pred CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 012610 336 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER 401 (460)
Q Consensus 336 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 401 (460)
|..||+.......... .. ..+.+.++.+..++..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------~f----------~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------DF----------SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------GG----------TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------cc----------hhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999974332211111 01 1122566789999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=186.59 Aligned_cols=234 Identities=25% Similarity=0.270 Sum_probs=178.2
Q ss_pred eecccCCeEEEEEEE----CCCcEEEEEEeccccccch-hHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeeccC
Q 012610 142 ILGRGGFGKVYKGRL----TDGSLVAVKRLKEERTQGG-ELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~ 215 (460)
++|+|.||.|+++.- ..+..+|.|.+++...... ......|..++...+ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998742 2477889998876543222 114456777888887 9999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+|.|...+..... +.+.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988866543 67777788888999999999999 9999999999999999999999999999865322211
Q ss_pred eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
+||..|||||++. ....++|.||||++++||+||..||.. +.+...++..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~----------- 203 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE----------- 203 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc-----------
Confidence 6999999999997 577889999999999999999999952 1222222210
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHhh
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKM--SEVVRMLE 412 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~--~evl~~L~ 412 (460)
...+........+++.++...+|..|--. ..+.+.++
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 11123333445566667778889988766 34444443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=167.88 Aligned_cols=198 Identities=23% Similarity=0.293 Sum_probs=136.3
Q ss_pred cCCCcceeeeeeeec---------------------------CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHH
Q 012610 189 AVHRNLLRLRGFCMT---------------------------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241 (460)
Q Consensus 189 ~~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i 241 (460)
.+|||||++.++|.+ +...|+||.-.. .+|.+++-... .+.....-+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~ 346 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVI 346 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHH
Confidence 369999999886642 123478887764 48888886544 556677788
Q ss_pred HHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe--cCCC--cEEEeecccccccCCCC-----CceeecccccccccCcccc
Q 012610 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILL--DEEF--EAVVGDFGLAKLMDYKD-----THVTTAVRGTIGHIAPEYL 312 (460)
Q Consensus 242 ~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~ 312 (460)
+.|+++|+.|||.+ +|.|||+|++|||+ |+|+ .+.|+|||++-..+... ....-...|...-||||+.
T Consensus 347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999999 99999999999998 3443 46799999885433211 1111123367789999988
Q ss_pred cCCCC------CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHH
Q 012610 313 STGKS------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQL 386 (460)
Q Consensus 313 ~~~~~------~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (460)
...+- -.++|.|+.|.+.||+++...||..-. ..+ +......+---+. .++.++..+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG------em~-------L~~r~Yqe~qLPa----lp~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG------EML-------LDTRTYQESQLPA----LPSRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc------hhe-------echhhhhhhhCCC----CcccCChHH
Confidence 65432 358999999999999999999995311 001 1111111111111 122334457
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 387 IQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 387 ~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.+++...++.||++|++..-....|+
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 78888899999999999887777664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=187.84 Aligned_cols=201 Identities=20% Similarity=0.236 Sum_probs=160.9
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC---CCcceeeeeeeecC
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTP 204 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~ 204 (460)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+......- .--.+++.+|+ -+-|+.+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHHHHHHccC
Confidence 345667788999999999999999999988899999999876654432 11122333333 23455555555667
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-------CCc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------EFE 277 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~~~ 277 (460)
+..++|++|.+.|+|.+++... +.++|.....++.|++..++.||.. +|||+||||+|+||.. ..-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 7889999999999999999833 3489999999999999999999999 9999999999999942 345
Q ss_pred EEEeecccccccC-CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCc
Q 012610 278 AVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 339 (460)
Q Consensus 278 ~kl~Dfg~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 339 (460)
++|+|||.+-.+. ..+.......++|-.+-.+|+..|..++...|.|.|+.+++-|+.|+..
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 8999999986553 2333455667788999999999999999999999999999999999743
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-19 Score=155.76 Aligned_cols=137 Identities=20% Similarity=0.219 Sum_probs=103.9
Q ss_pred CccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-----CCCcceeeeeeeecCC---c-c
Q 012610 137 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPT---E-R 207 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-----~h~niv~l~~~~~~~~---~-~ 207 (460)
+...+.||+|++|.||. .-.++.. +||++..... .....+.+|+.++..+ .||||++++|++.++. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34457899999999996 2223444 6898865422 2345689999999999 5799999999998864 3 2
Q ss_pred eEEeec--cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeeCCCCCCEEecC----CCcEEE
Q 012610 208 LLVYPF--MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL-AYLHDHCDPKIIHRDVKAANILLDE----EFEAVV 280 (460)
Q Consensus 208 ~lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl 280 (460)
.+|+|| +.+++|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 378999 55799999996532 4444 35577777777 999999 9999999999999974 347999
Q ss_pred eecccc
Q 012610 281 GDFGLA 286 (460)
Q Consensus 281 ~Dfg~~ 286 (460)
+||+-+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=155.04 Aligned_cols=144 Identities=15% Similarity=0.095 Sum_probs=110.3
Q ss_pred cCCccCCeecccCCeEEEEEE--ECCCcEEEEEEeccccccc-----------------------hhHHHHHHHHHHhcc
Q 012610 135 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQG-----------------------GELQFQTEVEMISMA 189 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~ 189 (460)
.-|.+.+.||+|++|.||+|. ..+|+.||+|+++...... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347778899999999999998 4579999999987542110 012356799999888
Q ss_pred CCCc--ceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeeCCC
Q 012610 190 VHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-IIHRDVK 266 (460)
Q Consensus 190 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlk 266 (460)
.+.. +.+++++ ...++||||+.+++|....... ..+.......++.|++.++++||+. + ++|||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 7533 3334432 2458999999998887654222 1255666788999999999999999 8 9999999
Q ss_pred CCCEEecCCCcEEEeecccccccC
Q 012610 267 AANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 267 p~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 7899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-18 Score=150.87 Aligned_cols=135 Identities=20% Similarity=0.320 Sum_probs=113.0
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccc-------hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.||+|++|.||+|.. .+..+++|......... ....+.+|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 56789999876432211 123477899999999999988777777777888999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++|++|.+++.... . .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 2 7789999999999999999 999999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.6e-18 Score=148.67 Aligned_cols=143 Identities=20% Similarity=0.130 Sum_probs=109.9
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc---------------------chhHHHHHHHHHHhcc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---------------------GGELQFQTEVEMISMA 189 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~~ 189 (460)
......|...+.||+|+||.||++...+|+.||||++...... ........|+..+..+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 3333447778999999999999999888999999987643210 0111356788888888
Q ss_pred CCCc--ceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 012610 190 VHRN--LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 267 (460)
Q Consensus 190 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 267 (460)
.|++ +...++ ....+++|||+++++|...... .....++.+++.++.++|+. +++|+||+|
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 7774 343433 2455899999999998765421 23457888999999999998 999999999
Q ss_pred CCEEecCCCcEEEeecccccccC
Q 012610 268 ANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 268 ~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
.||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-19 Score=178.09 Aligned_cols=211 Identities=22% Similarity=0.318 Sum_probs=139.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..+|+.+++|..|++|.||.++++ ..+.+|+| +++... +.+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee-----------------
Confidence 357888999999999999999876 36778884 333211 1111 22222333322
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+-...++..+. ++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~~g~----lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP----LPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccCCC----Ccchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 444455554332 22222 6789999999 9999999999999999999999999998754221
Q ss_pred C--------------CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 293 D--------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 293 ~--------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
. ...-..++||+.|.|||++..+.|...+|+|++|+|+||++-|+.||.. +..+..+..++.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG----dtpeelfg~vis 272 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG----DTPEELFGQVIS 272 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC----CCHHHHHhhhhh
Confidence 1 0112335799999999999999999999999999999999999999953 111111222211
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
..+. ..+. |. ....+..+++.+.++.+|.+|--..
T Consensus 273 d~i~--wpE~--de--------a~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 273 DDIE--WPEE--DE--------ALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhcc--cccc--Cc--------CCCHHHHHHHHHHHHhChHhhcccc
Confidence 1110 0000 11 1224466677778889999995443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=148.04 Aligned_cols=131 Identities=18% Similarity=0.302 Sum_probs=106.3
Q ss_pred eecccCCeEEEEEEECCCcEEEEEEeccccccc-------hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.||+|++|.||+|.. ++..+++|......... ...++.+|++++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 46789999865432111 1235678999999999887665555556667789999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 7889999999999999 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-19 Score=167.81 Aligned_cols=175 Identities=25% Similarity=0.369 Sum_probs=130.0
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++.|++|...+|.++|..... ....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46899999999999999975433 2347888999999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCC-----CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHH
Q 012610 286 AKLMDYKD-----THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 286 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
........ ....+...||..||+||.+.+..|+.++||||||+||+|++. =..+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------ 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------ 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence 87665433 223344569999999999999999999999999999999988 222221
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
....+.++.|..+.+.+..+.+ .=..++.+++.+.|.+||++.++.
T Consensus 465 --r~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 465 --RIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred --HHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHh
Confidence 1112222222222211111111 134577889999999999555443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=169.63 Aligned_cols=138 Identities=17% Similarity=0.263 Sum_probs=111.5
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEe-cccccc------chhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQ------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~-~~~~~~------~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
...|...+.||+|+||+||++.+.+.. +++|+. .+.... .....+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445566789999999999999876443 444432 221111 112357889999999999999888877777778
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999885 2467899999999999999 99999999999999 5779999999999
Q ss_pred cc
Q 012610 287 KL 288 (460)
Q Consensus 287 ~~ 288 (460)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-17 Score=167.76 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=185.7
Q ss_pred cCCccCCeecccCCeEEEEEEECC--CcEEEEEEecccc-ccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD--GSLVAVKRLKEER-TQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv 210 (460)
..|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-..+. |.|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346666779999999998887543 3456666665432 1122223445666666676 99999999999999999999
Q ss_pred eeccCCCCHHHHh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeeCCCCCCEEecCCC-cEEEeeccccc
Q 012610 211 YPFMVNGSVASCL-RERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~ 287 (460)
.+|..++++.+-+ +.... ..+......++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999888 33221 2555667788999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC--CCCceeecccc-cccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 288 LMDY--KDTHVTTAVRG-TIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 288 ~~~~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
.+.. .........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++....... ....|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~--- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK--- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc---
Confidence 7766 22334444567 9999999999885 557789999999999999999999976543321 111111110
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ..............++..+++..+|..|.+.+++..
T Consensus 248 ~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cc--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 001112222344667777888899999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.7e-16 Score=137.04 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=96.3
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchh-HH----------------------HHHHHHHHhccCCCc--c
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGE-LQ----------------------FQTEVEMISMAVHRN--L 194 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~-~~----------------------~~~e~~~l~~~~h~n--i 194 (460)
.+.||+|+||.||+|...+++.||||++......... .. ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753221110 00 124445555544332 3
Q ss_pred eeeeeeeecCCcceEEeeccCCCCHHH-HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEe
Q 012610 195 LRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILL 272 (460)
Q Consensus 195 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill 272 (460)
.+.+++ ...+++|||++++.+.. .+.... .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 34689999999854332 111111 11 5577899999999999999 7 99999999999999
Q ss_pred cCCCcEEEeecccccccC
Q 012610 273 DEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 273 ~~~~~~kl~Dfg~~~~~~ 290 (460)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-15 Score=128.53 Aligned_cols=134 Identities=18% Similarity=0.136 Sum_probs=112.2
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCC--CcceeeeeeeecCCcceEEeeccCCC
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++.+....+..+++|||+.++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999999864 7899999865433 3468889999999976 58888888887778899999999887
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
.+..+ +......++.+++++|++||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4456678899999999999996444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.3e-15 Score=134.53 Aligned_cols=136 Identities=18% Similarity=0.200 Sum_probs=104.1
Q ss_pred CCeec-ccCCeEEEEEEECCCcEEEEEEeccccc------------cchhHHHHHHHHHHhccCCCcc--eeeeeeeecC
Q 012610 140 RNILG-RGGFGKVYKGRLTDGSLVAVKRLKEERT------------QGGELQFQTEVEMISMAVHRNL--LRLRGFCMTP 204 (460)
Q Consensus 140 ~~~lg-~G~~g~v~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~~~h~ni--v~l~~~~~~~ 204 (460)
...|| .|+.|+||.+... +..++||.+..... ......+.+|++++..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999876 67889998853210 1122357889999999998875 5666654332
Q ss_pred C----cceEEeeccCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 205 T----ERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 205 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
. ..++|||++++ .+|.+++... +++.. .+.+|+.+|.+||+. ||+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6898887642 24443 356789999999999 999999999999999999999
Q ss_pred Eeecccccc
Q 012610 280 VGDFGLAKL 288 (460)
Q Consensus 280 l~Dfg~~~~ 288 (460)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=135.51 Aligned_cols=206 Identities=19% Similarity=0.292 Sum_probs=143.7
Q ss_pred HHHHHHhccCCCcceeeeeeeecC-----CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 012610 181 TEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255 (460)
Q Consensus 181 ~e~~~l~~~~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 255 (460)
.-+..+-.+.|-||++++.|..+. ....++.|||..|++..+|++.......+......+|+.||..||.|||+
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 344556677899999999887643 34679999999999999999877666678888999999999999999999
Q ss_pred CCCCeEeeCCCCCCEEecCCCcEEEeecccccccC---CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHH
Q 012610 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD---YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 332 (460)
Q Consensus 256 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~e 332 (460)
|.|.|+|+++..+.|++..+|-+|+.----...-. ...........+-++|.|||.-.....+.++|||+||+..+|
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 47899999999999999999988874322111100 001111222346789999998877788889999999999999
Q ss_pred HHhCCCc-cccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 333 LITGQRA-FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 333 l~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
|..+..- ....+.. ..+.....++-.. . ...=...+..|++..|+.||+|++++.
T Consensus 275 mailEiq~tnseS~~--------------~~ee~ia~~i~~l-e-------n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 275 MAILEIQSTNSESKV--------------EVEENIANVIIGL-E-------NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHheeccCCCccee--------------ehhhhhhhheeec-c-------CccccCcCcccccCCCCCCcchhhhhc
Confidence 9887532 1110000 0000000000000 0 000123567899999999999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=135.37 Aligned_cols=141 Identities=23% Similarity=0.255 Sum_probs=98.6
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccch---------------------------------------hHHHHH
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 181 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 181 (460)
+.||.|++|.||+|++.+|+.||||+.+....... +.+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865321100 012344
Q ss_pred HHHHHhcc----CCCcceeeeeeee-cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 012610 182 EVEMISMA----VHRNLLRLRGFCM-TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR-GLAYLHDH 255 (460)
Q Consensus 182 e~~~l~~~----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~ 255 (460)
|...+.++ +|.+-+.+-.++. .....++||||++|++|.++....... . .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHhC
Confidence 44444443 2333333333332 234579999999999998876542111 2 23456666655 46788988
Q ss_pred CCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 256 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|++|+|++|.||+++.++.++++|||++..++
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-13 Score=132.61 Aligned_cols=248 Identities=21% Similarity=0.207 Sum_probs=175.9
Q ss_pred CCccCCeecc--cCCeEEEEEEE--C-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcce
Q 012610 136 NFSNRNILGR--GGFGKVYKGRL--T-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 136 ~~~~~~~lg~--G~~g~v~~~~~--~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~ 208 (460)
.|....-+|. |.+|.||.+.. . ++..+|+|.-+.... ......=.+|+....+++ |+|.++...........+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555677899 99999999987 3 577889987543222 122223346677777764 999999888888888889
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeec
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----GLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDF 283 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Df 283 (460)
+-+|++. .+|..+.+..... ++....+.+..+..+ ||.++|+. +++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~---~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNF---LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccccc---CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999884 7888888765442 566667777777777 99999999 99999999999999999 88999999
Q ss_pred ccccccCCCCCc----eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 284 GLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 284 g~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
|+...+....-. ......|...|++||.. .+.++..+|+|++|.++.+..++......... . .|.+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~-----~W~~- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN---S-----SWSQ- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC---C-----Cccc-
Confidence 998877544311 11222477789999987 45678899999999999999998776632100 0 0000
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ..+..++.......+...+.++++.+|-.|++.+.+..
T Consensus 338 ------~r~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ------LRQ---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------ccc---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 00111222222344556888899999999999887764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.8e-12 Score=123.14 Aligned_cols=233 Identities=17% Similarity=0.172 Sum_probs=152.1
Q ss_pred CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHH
Q 012610 157 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWS 236 (460)
Q Consensus 157 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~ 236 (460)
.++.+|.|...+.... .......+-++.++.++||||++++.........|+|+|-+. -|..++++. ...
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3577888887765443 223346677889999999999999999999999999999874 466677653 355
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCC
Q 012610 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316 (460)
Q Consensus 237 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 316 (460)
...-.+.||+.||.|||+.+ +++|++|.-+.|+|+..|+.||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 66677899999999999876 999999999999999999999999998764332221 001111122466666543222
Q ss_pred CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCC
Q 012610 317 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQG 396 (460)
Q Consensus 317 ~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 396 (460)
...|.|-|||+++|++.|..+-.. .....+..- .-..... .+.+..... . ... .++++..|...
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~~~--~~~~~~~ip-k~~~~~~----~k~~~~~~~----~--r~n-~~~~~~~~~~~ 245 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLTKT--DLSNTGKIP-KALIELY----CKKLGATEL----K--RPN-KLRFILECRLL 245 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCcch--hhhccCccc-hhHHHHH----HHHhccccc----c--ccc-hhhHHHHHHhc
Confidence 346999999999999999332210 000000000 0000000 000000000 0 011 55667777777
Q ss_pred CCCCCCCHHHHHHHhhcCCCcc
Q 012610 397 SPMERPKMSEVVRMLEGDGLAE 418 (460)
Q Consensus 397 ~P~~RPt~~evl~~L~~~~~~~ 418 (460)
..-.|=.+-+++.+|++..+.+
T Consensus 246 ~gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 246 GGFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred cccccchHHHHHHHHHhcccCc
Confidence 7788888888888888876654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.1e-13 Score=133.61 Aligned_cols=146 Identities=22% Similarity=0.243 Sum_probs=92.8
Q ss_pred cCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccc---------------------------------hh----
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQG---------------------------------GE---- 176 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~---- 176 (460)
..|+. +.||.|++|.||+|++.+ |+.||||++++..... -.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 689999999999999987 9999999997542110 01
Q ss_pred --HHHHHHHHHHhccC----CCcceeeeeeeec-CCcceEEeeccCCCCHHHH--hhhcCCCCCCCCHHHHHHHHHHHHH
Q 012610 177 --LQFQTEVEMISMAV----HRNLLRLRGFCMT-PTERLLVYPFMVNGSVASC--LRERGQSQPPLNWSVRKQIALGAAR 247 (460)
Q Consensus 177 --~~~~~e~~~l~~~~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~i~~ 247 (460)
.++.+|...+.+++ +.+.+.+-.++.+ ....++||||+.|+.+.+. +...+.....+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 12333443333332 3333333333322 3456899999999999874 2222211111222222223333
Q ss_pred HHHHHHhCCCCCeEeeCCCCCCEEecCCC----cEEEeecccccccCC
Q 012610 248 GLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDFGLAKLMDY 291 (460)
Q Consensus 248 ~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 291 (460)
++.. |++|+|+||.||+++.++ .+++.|||+...++.
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3345 999999999999999988 999999999877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-12 Score=110.95 Aligned_cols=130 Identities=20% Similarity=0.180 Sum_probs=95.1
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcce-eeeeeeecCCcceEEeeccCCCCH
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
+.|+.|.++.||+++.. +..+++|....... ....+..|.+.+..+.+.+++ +++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56889999999999876 67899998765432 122467888888888655544 344432 3346899999999877
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
... . . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 1 11245678999999999982 12369999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.1e-11 Score=103.15 Aligned_cols=137 Identities=15% Similarity=0.112 Sum_probs=97.2
Q ss_pred CeecccCCeEEEEEEECC-------CcEEEEEEecccc---------------c------cchhHHH----HHHHHHHhc
Q 012610 141 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEER---------------T------QGGELQF----QTEVEMISM 188 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~---------------~------~~~~~~~----~~e~~~l~~ 188 (460)
..||.|.-+.||.|...+ +..+|||+.+... . ......+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 569999999999997553 4789999885211 0 0111222 378888888
Q ss_pred cCC--CcceeeeeeeecCCcceEEeeccCCCCHHH-HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeeC
Q 012610 189 AVH--RNLLRLRGFCMTPTERLLVYPFMVNGSVAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYL-HDHCDPKIIHRD 264 (460)
Q Consensus 189 ~~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~d 264 (460)
+.. -++..++.+ ...++||||+.++.+.. .++.. .++......+..+++.+|..| |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 753 345555543 56789999997654422 22221 144556677889999999999 777 999999
Q ss_pred CCCCCEEecCCCcEEEeecccccccC
Q 012610 265 VKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 265 lkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.5e-11 Score=105.93 Aligned_cols=143 Identities=20% Similarity=0.235 Sum_probs=107.1
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCC--CcceeeeeeeecC---CcceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTP---TERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~---~~~~lv~e~~~ 215 (460)
+.|+.|..+.||++...+|..+++|.............+..|.+++..+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998876688999998654332233467889999988875 3456677766553 25689999999
Q ss_pred CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 012610 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--------------------------------------- 256 (460)
Q Consensus 216 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 256 (460)
|.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765531 12566667777778888888877421
Q ss_pred --------------CCCeEeeCCCCCCEEecC--CCcEEEeecccccc
Q 012610 257 --------------DPKIIHRDVKAANILLDE--EFEAVVGDFGLAKL 288 (460)
Q Consensus 257 --------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~ 288 (460)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-11 Score=119.70 Aligned_cols=245 Identities=19% Similarity=0.175 Sum_probs=167.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC--CCcEEEEEEeccccccchhH-HHHHHHHHHhcc-CCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGEL-QFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 209 (460)
..+|..+..||.|.|+.|+..... ++..|++|.+.+.......+ .-..|+.+...+ .|.+++.+...+...+..++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888889999999999987643 57889999887654333222 223455555555 48888887776666677789
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKL 288 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~ 288 (460)
--||++++++...+... ..++...++.+..+++.++.++|+. .++|+|++|+||++..+ +..++.|||++..
T Consensus 344 p~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 99999999988776322 2377888899999999999999999 99999999999999986 7789999999874
Q ss_pred cCCCCCceeeccccccccc--CcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTHVTTAVRGTIGHI--APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+...... ....-+++ +++......+..+.|++|||.-+.|.+++..--... .+|
T Consensus 417 ~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----------~~~---------- 472 (524)
T KOG0601|consen 417 LAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----------VQS---------- 472 (524)
T ss_pred cceeccc----ccccccccccchhhccccccccccccccccccccccccCcccCccc----------ccc----------
Confidence 3222111 11223344 555556667888999999999999999986432210 000
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
..+....+ .... .....+..+...+...++..||.+.++....
T Consensus 473 ~~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 473 LTIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred eeeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 00000000 0000 1113344555566789999999998876544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.9e-10 Score=94.19 Aligned_cols=132 Identities=20% Similarity=0.294 Sum_probs=97.6
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEec-cccccch------hHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGG------ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~-~~~~~~~------~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
..+++|+-+.+|.+.+. |..+++|.=. +...... ..+..+|..++.++.--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 3446666432 2211111 12356788888887655554444455677888999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++|..|.+++... ...++..|-.-+.-||.. +|+|+||.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 245666677778889999 999999999999998875 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.3e-10 Score=92.93 Aligned_cols=144 Identities=18% Similarity=0.252 Sum_probs=104.0
Q ss_pred cCCeecccCCeEEEEEEECCCcEEEEEEeccccc--c-----chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 139 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT--Q-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
....|-+|+-+.|+++.+. |+.+.||.-..... + -...+..+|...+.++.--.|.-..-++.+.+...++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3467889999999999986 67777775322211 1 11335678899888876555544445566777788999
Q ss_pred eccCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEEeeccccc
Q 012610 212 PFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 287 (460)
Q Consensus 212 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~ 287 (460)
||++| -++.+++....... .........+..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 47788876644321 22233367788888999999999 999999999999997655 35899999986
Q ss_pred c
Q 012610 288 L 288 (460)
Q Consensus 288 ~ 288 (460)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-09 Score=104.20 Aligned_cols=171 Identities=20% Similarity=0.247 Sum_probs=129.8
Q ss_pred CCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec----CCcceEEeeccCC-CCHH
Q 012610 147 GFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPFMVN-GSVA 220 (460)
Q Consensus 147 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~ 220 (460)
.-.+.|++... +|..|++|+++..+.....+ ...-+++++++.|.|+|++.+++.. +...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK-DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCccc-chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34678888754 89999999996554433221 2345788999999999999998763 4567899999875 5777
Q ss_pred HHhhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 221 SCLRERG-----------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 221 ~~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
++..... ......++..+|.++.|+..||.++|+. |+..+-|.+.+|+++.+.+++|..+|...++
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 6553321 1223578899999999999999999999 9999999999999999999999999988766
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 339 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p 339 (460)
...... .+ .--.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 543311 11 112467889999999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.4e-11 Score=123.38 Aligned_cols=252 Identities=19% Similarity=0.202 Sum_probs=163.1
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
.....+.+.+.+-+.+|.++.++.++-. .|...++|........ ........+-.++-...+|-++...--+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3455667777778888999999887643 3444444444321110 001112222222223345655554444444567
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.+++++|..+++|...++..+ +.+..-....+..+.++++|||+. .+.|+|++|.|.+...+++.+++|||..
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence 789999999999999998765 244455566667788899999998 7999999999999999999999999843
Q ss_pred cccCCC------------------------------CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhC
Q 012610 287 KLMDYK------------------------------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336 (460)
Q Consensus 287 ~~~~~~------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg 336 (460)
...... .........+|+.|.+||...+......+|+|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 221100 00112334589999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccHHHHHHHHhhhccccccccccCCC-CCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 337 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 337 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
..||...... ...+.+......+ ...........+++...+..+|.+|-.+.
T Consensus 1032 ~pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999632211 0111111111111 11112223355566667788999998776
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-08 Score=95.62 Aligned_cols=264 Identities=16% Similarity=0.152 Sum_probs=158.6
Q ss_pred cCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeee------eecCC-cceEE
Q 012610 139 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGF------CMTPT-ERLLV 210 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~------~~~~~-~~~lv 210 (460)
.++-||+|+.+.+|-.-.- ...+.|+.+...... -.+.++.|... .||-+-.=+.| .-+.. ...++
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567999999999965322 123567666433221 11233344433 35543221111 11112 25678
Q ss_pred eeccCCCCHHHHhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 211 YPFMVNGSVASCLRE---RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
|+.+.+..--..+.+ +..+.+...|...++.+..++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 888776532222221 233456689999999999999999999999 99999999999999999999999866554
Q ss_pred ccCCCCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhC-CCccccccccCCCCccHH-HHHHHH
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLL-DWVKGL 360 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~~~~~~~~-~~~~~~ 360 (460)
+. .+......-+|...|++||.-. +...+...|.|-||+++++++.| ++||............+. +.....
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 43 2333444556889999999764 33457789999999999999886 999965433322222111 111111
Q ss_pred hhhccccccccccCCCC-CcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHhhc
Q 012610 361 LKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQG--SPMERPKMSEVVRMLEG 413 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~--~P~~RPt~~evl~~L~~ 413 (460)
+....-...--..-... ...-....+..+..+|+.. .+.-|||++-++..|..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 11000000000000000 0112233455666677754 46789999999998865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.4e-09 Score=94.55 Aligned_cols=142 Identities=14% Similarity=0.099 Sum_probs=98.9
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEecccccc----------chhHHHHHHHHHHhccCCCcc--eeeeeeeec-----
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ----------GGELQFQTEVEMISMAVHRNL--LRLRGFCMT----- 203 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~~~h~ni--v~l~~~~~~----- 203 (460)
+.+-......|.+... +|+.+.||........ .....+.+|...+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455667666 4778999977433211 111136788888877753332 334444432
Q ss_pred CCcceEEeeccCCC-CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-------C
Q 012610 204 PTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-------E 275 (460)
Q Consensus 204 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~ 275 (460)
....++|+|++++. +|.+++..... .+.+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 89988864321 2345667788999999999999999 9999999999999985 4
Q ss_pred CcEEEeecccccc
Q 012610 276 FEAVVGDFGLAKL 288 (460)
Q Consensus 276 ~~~kl~Dfg~~~~ 288 (460)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.5e-09 Score=90.76 Aligned_cols=127 Identities=20% Similarity=0.229 Sum_probs=82.1
Q ss_pred EEEEEEECCCcEEEEEEecccc--------------c------cc-----hhHHHHHHHHHHhccCCC--cceeeeeeee
Q 012610 150 KVYKGRLTDGSLVAVKRLKEER--------------T------QG-----GELQFQTEVEMISMAVHR--NLLRLRGFCM 202 (460)
Q Consensus 150 ~v~~~~~~~~~~vavK~~~~~~--------------~------~~-----~~~~~~~e~~~l~~~~h~--niv~l~~~~~ 202 (460)
.||.|...+|..+|+|..+... . .. ......+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999889999999885321 0 00 012367799999998765 45555544
Q ss_pred cCCcceEEeeccC--CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 203 TPTERLLVYPFMV--NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY-LHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 203 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
....+||||++ |..+..+.... ++......++.+++..+.. +|.. +++|+||.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24589999998 54554433221 1133455677777776655 4677 99999999999999988 999
Q ss_pred EeecccccccC
Q 012610 280 VGDFGLAKLMD 290 (460)
Q Consensus 280 l~Dfg~~~~~~ 290 (460)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-09 Score=93.41 Aligned_cols=137 Identities=20% Similarity=0.167 Sum_probs=97.2
Q ss_pred CccCCeecccCCeEEEEEEECCCcEEEEEEeccccc---------------------cchhHHHHHHHHHHhccCCC--c
Q 012610 137 FSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------------------QGGELQFQTEVEMISMAVHR--N 193 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~~~h~--n 193 (460)
..++..||-|.-+.||.|...+|.++|||.-+..++ .-.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445678999999999999999999999996532110 11123467889999888644 5
Q ss_pred ceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec
Q 012610 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 273 (460)
Q Consensus 194 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~ 273 (460)
+.+.+++ +...+||||++|-.|...- ++......++..|++-+.-+-.. |+||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 5555543 5668999999886554332 12233344555555555544455 999999999999999
Q ss_pred CCCcEEEeeccccccc
Q 012610 274 EEFEAVVGDFGLAKLM 289 (460)
Q Consensus 274 ~~~~~kl~Dfg~~~~~ 289 (460)
++|.+.++||--+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999877543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.9e-10 Score=111.46 Aligned_cols=150 Identities=17% Similarity=0.310 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc--------eeecccccccccCcccccC
Q 012610 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEYLST 314 (460)
Q Consensus 243 ~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~ 314 (460)
.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+......... ..........|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999985 9999999999999999999999999987654331111 0111123457999999999
Q ss_pred CCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHc
Q 012610 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLC 393 (460)
Q Consensus 315 ~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 393 (460)
...+.++|+||+|+++|.+.. |+.-+.... ....... ....+..-...+....+.++.+=+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-----~~~~~~~----------~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG-----GLLSYSF----------SRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC-----Ccchhhh----------hhcccccccccccccCcHHHHHHHHHH
Confidence 888999999999999999984 554443211 0111111 111111111122234456677778888
Q ss_pred cCCCCCCCCCHHHHHH
Q 012610 394 TQGSPMERPKMSEVVR 409 (460)
Q Consensus 394 l~~~P~~RPt~~evl~ 409 (460)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8999999998887765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.9e-07 Score=82.78 Aligned_cols=105 Identities=20% Similarity=0.206 Sum_probs=80.7
Q ss_pred HHHHHHHHHhccCCCc--ceeeeeeeecC----CcceEEeeccCCC-CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 012610 178 QFQTEVEMISMAVHRN--LLRLRGFCMTP----TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250 (460)
Q Consensus 178 ~~~~e~~~l~~~~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 250 (460)
...+|...+..+.... +...+++.... ...++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence 4677888776664322 34455555442 2347999999884 79998876332 455667889999999999
Q ss_pred HHHhCCCCCeEeeCCCCCCEEecCCC---cEEEeeccccccc
Q 012610 251 YLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLM 289 (460)
Q Consensus 251 ~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~ 289 (460)
-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999987 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.6e-07 Score=78.76 Aligned_cols=139 Identities=21% Similarity=0.163 Sum_probs=101.2
Q ss_pred ecccCCeEEEEEEECCCcEEEEEEeccccc-----cchhHHHHHHHHHHhccCCCc--ceeeeeeee-c--C--CcceEE
Q 012610 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERT-----QGGELQFQTEVEMISMAVHRN--LLRLRGFCM-T--P--TERLLV 210 (460)
Q Consensus 143 lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~-~--~--~~~~lv 210 (460)
-|+||-+.|++..+. |..+-+|+-..... .-....|.+|+..+..+..-+ +.++. ++. . + ...+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 456888999998776 45788998752211 234557999999998885332 44444 222 1 1 235789
Q ss_pred eeccCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc--EEEeeccccc
Q 012610 211 YPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~ 287 (460)
+|-+.+ -+|.+++...... +.+...+..++.+|+..++-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 5888887654322 356777889999999999999999 9999999999999986666 9999998765
Q ss_pred c
Q 012610 288 L 288 (460)
Q Consensus 288 ~ 288 (460)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2e-07 Score=92.61 Aligned_cols=142 Identities=19% Similarity=0.221 Sum_probs=90.0
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccch---------------------------------------hHHHHH
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG---------------------------------------ELQFQT 181 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 181 (460)
+-|+.++-|.||+|++.+|+.||||+.+....... +.++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999999999999999865321100 111333
Q ss_pred HHHHHhccC----CCcceeeeeeeec-CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 012610 182 EVEMISMAV----HRNLLRLRGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG-LAYLHDH 255 (460)
Q Consensus 182 e~~~l~~~~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~ 255 (460)
|...+.+++ ...-+.+=.++.+ .....++|||++|-.+.+........ ++.. .++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k---~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRK---ELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHH---HHHHHHHHHHHHHHHhc
Confidence 333333321 1112222223322 35678999999998888874322211 4422 333333332 2223334
Q ss_pred CCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 256 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
|+.|.|.+|.||+++.+|++.+.|||+...++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.6e-06 Score=76.50 Aligned_cols=139 Identities=13% Similarity=0.133 Sum_probs=83.8
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc--ceeeeeeeecCCcceEEeeccCCCC
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
..||+|..+.||+.. +..+++|...... ......+|.+++..+..-. +.+.+++....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 468999999999842 4467788876432 2234678999888875433 4556777766667789999998863
Q ss_pred -HHHHh---------------------hhcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEee
Q 012610 219 -VASCL---------------------RERGQSQPPLNWSVRKQ-IAL----------GAAR-GLAYLHDH-CDPKIIHR 263 (460)
Q Consensus 219 -L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~i~H~ 263 (460)
+...+ +...... ........ +.. .+.. ...+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 21111 1110011 11111100 000 0111 12233221 12367999
Q ss_pred CCCCCCEEecCCCcEEEeecccccc
Q 012610 264 DVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 264 dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
|+.|.||++++++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.1e-06 Score=73.16 Aligned_cols=138 Identities=12% Similarity=0.113 Sum_probs=89.7
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHH---------HHHHHHHHhccCCC---cceeeee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---------FQTEVEMISMAVHR---NLLRLRG 199 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~e~~~l~~~~h~---niv~l~~ 199 (460)
+...+|...+++-......|.+-... |..+++|......... ... ..+.+..+..++.. ....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45667888788887777777776654 6889999887543221 111 22333333333222 2222222
Q ss_pred eee-----cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC
Q 012610 200 FCM-----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE 274 (460)
Q Consensus 200 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~ 274 (460)
+.. -....+++|||++|..|.++.. ++. .++..+.+++.-||.. |+.|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 221 1234568999999987766542 222 2445677889999999 9999999999999997
Q ss_pred CCcEEEeeccccc
Q 012610 275 EFEAVVGDFGLAK 287 (460)
Q Consensus 275 ~~~~kl~Dfg~~~ 287 (460)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 65 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.6e-06 Score=76.48 Aligned_cols=154 Identities=20% Similarity=0.225 Sum_probs=95.9
Q ss_pred cCHHHHHHHhcCCccCC---eecccCCeEEEEEEECCCcEEEEEEeccccccc------------------hhHH-----
Q 012610 125 FSLRELQVATDNFSNRN---ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG------------------GELQ----- 178 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~---~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~------------------~~~~----- 178 (460)
.++..+.....+..+.. .|+.|.-+.||+|...++..+|||+++...... ...+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34444444445544444 455677889999998889999999986432110 0000
Q ss_pred HHHHHHHHhccC--CCcceeeeeeeecCCcceEEeeccCCCC-HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 012610 179 FQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255 (460)
Q Consensus 179 ~~~e~~~l~~~~--h~niv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 255 (460)
...|+..|.++. +-.+.+-+.+ ....+||||+.... -.-.|... ++.......+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh
Confidence 233555555542 2222223332 24579999995531 11112211 123335667778888888887773
Q ss_pred CCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 256 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
+ ++||+||+.-|||+. ++.+.|+|+|-+....
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 3 999999999999999 7799999999987554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2e-07 Score=91.64 Aligned_cols=181 Identities=21% Similarity=0.159 Sum_probs=127.5
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc-ceeeeeeeecCCcceEEeeccCCC-C
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVYPFMVNG-S 218 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~ 218 (460)
.-+++|+++.+++.+....+....+.+... ....-++++|.+++||| .+..++-+......++.++++.++ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 347889999999887554444445554332 34556899999999999 666677666677788999999877 2
Q ss_pred HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceee
Q 012610 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298 (460)
Q Consensus 219 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 298 (460)
...-... ....+.......+...-.++++|||+. .=+|+| ||+..+ +..+..||+....+.... ...
T Consensus 322 ~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 322 SALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 1111110 011123333344455556789999987 558888 777766 578999999987665443 233
Q ss_pred cccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcc
Q 012610 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340 (460)
Q Consensus 299 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~ 340 (460)
...+++.|+|||......+..+.|+|++|+--.++.-|-.|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 445899999999999999999999999998777777777664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=72.10 Aligned_cols=141 Identities=16% Similarity=0.089 Sum_probs=83.7
Q ss_pred ecccCC-eEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeeccCCCCHH
Q 012610 143 LGRGGF-GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220 (460)
Q Consensus 143 lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 220 (460)
|..|.. +.||+.... +..+.+|+..... ...+.+|++++..+. +--+.+++++....+..++||++++|.++.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444554 889998765 4678888876432 224567888877763 333556677766666689999999998776
Q ss_pred HHh-------------------hhcCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 012610 221 SCL-------------------RERGQSQPPLNWS--VRKQIAL--------------------GAARGLAYLHD----H 255 (460)
Q Consensus 221 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~ 255 (460)
... +.......++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1110001011100 0000000 01111222211 1
Q ss_pred CCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 256 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
..+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234699999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-05 Score=66.13 Aligned_cols=127 Identities=15% Similarity=0.192 Sum_probs=88.4
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCccee-eeeeeecCCcceEEeeccCCCC
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-LRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~-l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
.+.|++|.+|.||++.+. |..+|+|+-..+ .....+..|.++|..+.-.++.+ ++.|. ..++.|||+.|-.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 467999999999999987 457888876543 33446889999999888766654 33332 2345599999988
Q ss_pred HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCC-CCCEEecCCCcEEEeecccccc
Q 012610 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVK-AANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 219 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-p~Nill~~~~~~kl~Dfg~~~~ 288 (460)
|.++.... +. +-+..+++.---|... ||-|+.|. |...++..++.+.|+||..|+.
T Consensus 99 L~~~~~~~-------~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-------DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-------cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87765421 11 2233445554445555 99999997 5555555566999999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.5e-06 Score=80.61 Aligned_cols=142 Identities=22% Similarity=0.253 Sum_probs=88.6
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccch------------------------------------hHHHHHHHH
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG------------------------------------ELQFQTEVE 184 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~------------------------------------~~~~~~e~~ 184 (460)
+-||.-+.|.||+|++++|+.||||+-+..-.... +.+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999999999999998875321110 112333333
Q ss_pred HHh----ccCCCcc---eeeeeeeec-CCcceEEeeccCCCCHHHH--hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012610 185 MIS----MAVHRNL---LRLRGFCMT-PTERLLVYPFMVNGSVASC--LRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254 (460)
Q Consensus 185 ~l~----~~~h~ni---v~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 254 (460)
-.. .+.|-+. |.+=.++.+ .....++||||+|..+.+. +.+.+ ++...+ +..+.++ |++.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~i---~~~l~~~--~~~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-----ISPHDI---LNKLVEA--YLEQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-----CCHHHH---HHHHHHH--HHHH
Confidence 222 2234441 112222222 2467899999999877665 33333 444433 3333332 2232
Q ss_pred CCCCCeEeeCCCCCCEEecC----CCcEEEeecccccccCCC
Q 012610 255 HCDPKIIHRDVKAANILLDE----EFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 255 ~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~~ 292 (460)
....|++|+|-+|.||++.. ++.+.+.|||+.......
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22238999999999999984 678999999998766543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=72.40 Aligned_cols=143 Identities=17% Similarity=0.183 Sum_probs=82.1
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCC--cceeeeeeeec---CCcceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR--NLLRLRGFCMT---PTERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~~~~~~---~~~~~lv~e~~~ 215 (460)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.++.. ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999999886 68999987654 2334567788887776533 24455554432 234689999999
Q ss_pred CCCHHH----------------Hh---hhcCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 012610 216 NGSVAS----------------CL---RERGQSQPPLNWSVR---------KQI------------ALGAAR-GLAYLHD 254 (460)
Q Consensus 216 ~g~L~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~l~~LH~ 254 (460)
+..+.. .+ +.......+...... ... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 11 111111111111110 000 011222 2333332
Q ss_pred ----CCCCCeEeeCCCCCCEEec-CCCcEEEeeccccc
Q 012610 255 ----HCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAK 287 (460)
Q Consensus 255 ----~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~ 287 (460)
.....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.4e-05 Score=84.07 Aligned_cols=151 Identities=11% Similarity=0.199 Sum_probs=92.7
Q ss_pred CCeecccCCeEEEEEEECCC---cEEEEEEeccccccchhHHHHHHHHHHhccC-CCcc--eeeeeeeecC---CcceEE
Q 012610 140 RNILGRGGFGKVYKGRLTDG---SLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNL--LRLRGFCMTP---TERLLV 210 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~ni--v~l~~~~~~~---~~~~lv 210 (460)
.+.++.|.++.+|+....++ ..+++|+............+.+|.++++.+. |.++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35688999999999887653 4677887654332223346889999999885 6654 7777877654 457899
Q ss_pred eeccCCCCHHH--------------------H---hhhcCCC-------CCCCCH--HHHHHHH---------------H
Q 012610 211 YPFMVNGSVAS--------------------C---LRERGQS-------QPPLNW--SVRKQIA---------------L 243 (460)
Q Consensus 211 ~e~~~~g~L~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~ 243 (460)
|||++|..+.+ . |+..... ..+..+ ..+..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 1111100 011111 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEeeCCCCCCEEecCC-Cc-EEEeecccccccC
Q 012610 244 GAARGLAYLHDHCD--------PKIIHRDVKAANILLDEE-FE-AVVGDFGLAKLMD 290 (460)
Q Consensus 244 ~i~~~l~~LH~~~~--------~~i~H~dlkp~Nill~~~-~~-~kl~Dfg~~~~~~ 290 (460)
.+...+.+|..+.. +.++|+|+++.||+++.+ +. +-|.||+++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 23344667754322 359999999999999853 34 5699999886543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.8e-06 Score=70.35 Aligned_cols=106 Identities=20% Similarity=0.187 Sum_probs=82.2
Q ss_pred HHHHHHHhccCC-CcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012610 180 QTEVEMISMAVH-RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258 (460)
Q Consensus 180 ~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 258 (460)
..|.-++..+++ +++.+++|+| ..+++.||...+++...-... ......+|..+.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357788888876 6899999999 347899999877664321000 0011268999999999999999999986544
Q ss_pred CeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 259 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
.+.-.|++++|+.+++++++|++|........
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 68889999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.3e-06 Score=87.47 Aligned_cols=53 Identities=38% Similarity=0.663 Sum_probs=37.3
Q ss_pred CCCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 1 ~G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
+|.||.++++|++|+.|||++|+|+|.+|.. +.+.++..+++++|.+.|..|.
T Consensus 455 ~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 508 (623)
T PLN03150 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508 (623)
T ss_pred cCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCCh
Confidence 3667777777777777777777777777764 5666777777777777765553
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.09 E-value=9.9e-05 Score=64.40 Aligned_cols=134 Identities=23% Similarity=0.332 Sum_probs=92.1
Q ss_pred cCCeecccCCeEEEEEEECCCcEEEEEEecccc---------------ccchhHHHHHHHHHHhccC------CCcceee
Q 012610 139 NRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER---------------TQGGELQFQTEVEMISMAV------HRNLLRL 197 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~~~------h~niv~l 197 (460)
....||+|+.-.||. +++.....||+..... ......+..+|+.....+. +..|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999986 4455667899887655 1112345666666555544 7889999
Q ss_pred eeeeecCCcceEEeeccCC------CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEE
Q 012610 198 RGFCMTPTERLLVYPFMVN------GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 198 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 271 (460)
+|+..++....+|+|.+.+ -+|.+++.... ++. ...+.+ -+-..||-.. .|+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L---~~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQAL---DEFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHH---HHHHHHHHHc---CCeecCCCcccEE
Confidence 9999999888999988743 36777775432 444 333333 3445677777 8999999999999
Q ss_pred ecCCC----cEEEee-cccc
Q 012610 272 LDEEF----EAVVGD-FGLA 286 (460)
Q Consensus 272 l~~~~----~~kl~D-fg~~ 286 (460)
+.... .+.|+| ||..
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 96432 466776 4544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0003 Score=60.88 Aligned_cols=135 Identities=25% Similarity=0.349 Sum_probs=91.6
Q ss_pred CccccCHHHHHHHhcCCccCCeecccCC-eEEEEEEECCCcEEEEEEeccc----------ccc----------chhHHH
Q 012610 121 QLKRFSLRELQVATDNFSNRNILGRGGF-GKVYKGRLTDGSLVAVKRLKEE----------RTQ----------GGELQF 179 (460)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~-g~v~~~~~~~~~~vavK~~~~~----------~~~----------~~~~~~ 179 (460)
.+..|+. .+.+++..+.||.|.. |.||+++.. |..+|+|.+..- ... ....-|
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 3455554 2378899999999999 999999986 679999994320 000 001237
Q ss_pred HHHHHHHhccC---CCcc--eeeeeeeecC------------------CcceEEeeccCCCCHHHHhhhcCCCCCCCCHH
Q 012610 180 QTEVEMISMAV---HRNL--LRLRGFCMTP------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWS 236 (460)
Q Consensus 180 ~~e~~~l~~~~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~ 236 (460)
..|.....+++ +.++ ++.+||..-. ....||.||..... .+...
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~ 168 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR 168 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh
Confidence 78888877775 4455 8888886322 11246677665432 12333
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 237 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
. +.++.+-|..+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 169 ~----~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 D----IPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H----HHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 3 34555667889998 9999999999986 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00019 Score=65.16 Aligned_cols=141 Identities=16% Similarity=0.196 Sum_probs=80.3
Q ss_pred CeecccCCeEEEEEEECC--CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEeeccCCC
Q 012610 141 NILGRGGFGKVYKGRLTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 217 (460)
+.|..|-...+|+....+ +..+++|+....... .....+|+.++..+....+ .++++.+. ..++|||++|.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 457788899999998764 678889977543211 1133468888777753333 34443322 24899999887
Q ss_pred CHHHH--------------h---hhcCCCC-------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 012610 218 SVASC--------------L---RERGQSQ-------PPL-NWSVRKQIAL----------------------GAARGLA 250 (460)
Q Consensus 218 ~L~~~--------------l---~~~~~~~-------~~l-~~~~~~~i~~----------------------~i~~~l~ 250 (460)
++... + +...... ... .+..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 1 1111110 011 1222212211 1111112
Q ss_pred HH----HhC-CCCCeEeeCCCCCCEEecC-CCcEEEeeccccc
Q 012610 251 YL----HDH-CDPKIIHRDVKAANILLDE-EFEAVVGDFGLAK 287 (460)
Q Consensus 251 ~L----H~~-~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~ 287 (460)
.| ... ....++|+|+.+.|||++. ++.+.++||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 111 2337999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00034 Score=65.70 Aligned_cols=78 Identities=14% Similarity=0.060 Sum_probs=55.1
Q ss_pred ccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCC---Ccceeeeeeeec---CCcceEEe
Q 012610 138 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH---RNLLRLRGFCMT---PTERLLVY 211 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h---~niv~l~~~~~~---~~~~~lv~ 211 (460)
...+.||.|..+.||+....++ .+.+|..+... ....+..|.+.++.+.- -.+.+++++|.. .+..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3446799999999999976655 46677743311 12367889998887753 357777877754 35689999
Q ss_pred eccCCCCH
Q 012610 212 PFMVNGSV 219 (460)
Q Consensus 212 e~~~~g~L 219 (460)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00011 Score=77.68 Aligned_cols=196 Identities=20% Similarity=0.217 Sum_probs=135.0
Q ss_pred HHHHHHHHhccCCCcceeeeeeeecCCcc----eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012610 179 FQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254 (460)
Q Consensus 179 ~~~e~~~l~~~~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 254 (460)
...|++.+..+.|+|++.++.|....... .+..+++..-++...+...+ .++....+.+..++.+||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence 44567778899999999999887654322 34557788888888776544 37888888999999999999999
Q ss_pred CCCCCeEeeCCCCC---CEEecCCCcEEEe--ecccccccCCCCCceeecccccccccCcccccCCCCCc--ccCchhhH
Q 012610 255 HCDPKIIHRDVKAA---NILLDEEFEAVVG--DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE--KTDVFGYG 327 (460)
Q Consensus 255 ~~~~~i~H~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dvws~G 327 (460)
. ...|.-+..+ +...+.++.+.++ ||+.++......... ...-+..|.|+|......+.. ..|+|++|
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence 8 6666666555 5556777777777 998887655433221 122345677888776655543 47999999
Q ss_pred HHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 012610 328 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407 (460)
Q Consensus 328 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 407 (460)
..+..+..|..+-..... ...+.+.. ....+.+...+|+..++++|++..++
T Consensus 380 ll~~~~~~~~~i~~~~~~--------------------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV--------------------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHhhhhhcCcccccccc--------------------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhh
Confidence 999999988755421110 00111100 00136667788999999999999999
Q ss_pred HHHh
Q 012610 408 VRML 411 (460)
Q Consensus 408 l~~L 411 (460)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00023 Score=64.57 Aligned_cols=31 Identities=29% Similarity=0.459 Sum_probs=26.4
Q ss_pred CCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 258 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+.++|+|+.+.||+++++...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4699999999999999776567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00029 Score=64.81 Aligned_cols=139 Identities=15% Similarity=0.089 Sum_probs=77.7
Q ss_pred ecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEeeccCCCCHHH
Q 012610 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNGSVAS 221 (460)
Q Consensus 143 lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~ 221 (460)
+..|-.+.+|+... ++..+++|........- .....+|.++++.+....+ .+++... ..++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 55688889999874 46678888765432111 0135678888887754333 2333332 2478999998866532
Q ss_pred --------------H---hhhcCCCCCCCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCCeEeeCCCCCC
Q 012610 222 --------------C---LRERGQSQPPLNWSVR-KQIALGA---------ARGLAYLHDH-----CDPKIIHRDVKAAN 269 (460)
Q Consensus 222 --------------~---l~~~~~~~~~l~~~~~-~~i~~~i---------~~~l~~LH~~-----~~~~i~H~dlkp~N 269 (460)
. ++.......+++.... ..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1111111112222211 1111111 1112222111 12368999999999
Q ss_pred EEecCCCcEEEeecccccc
Q 012610 270 ILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~ 288 (460)
|++++++ +.++||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999887 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0013 Score=63.91 Aligned_cols=76 Identities=14% Similarity=0.124 Sum_probs=52.0
Q ss_pred CeecccCCeEEEEEEECCC-cEEEEEEeccccc------cchhHHHHHHHHHHhccC---CCcceeeeeeeecCCcceEE
Q 012610 141 NILGRGGFGKVYKGRLTDG-SLVAVKRLKEERT------QGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~------~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv 210 (460)
+.||.|.++.||++...+| +.++||.-..... .-...+...|.+.|..+. -..+.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998876 4899998542211 112335667777777653 2446666665 44567899
Q ss_pred eeccCCCC
Q 012610 211 YPFMVNGS 218 (460)
Q Consensus 211 ~e~~~~g~ 218 (460)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=1.6e-05 Score=85.76 Aligned_cols=160 Identities=13% Similarity=0.023 Sum_probs=116.1
Q ss_pred HHHHHHHhccCCCcceeeeeeee--cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012610 180 QTEVEMISMAVHRNLLRLRGFCM--TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257 (460)
Q Consensus 180 ~~e~~~l~~~~h~niv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 257 (460)
..|.+-++...|+++.....=.. +..+.+..++|+.+|.+.+.+-+.....+++...-+...-.+...+..-.|+...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34444556677888766543222 2345688999999999999998766555555555444444443444555554421
Q ss_pred --CCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh
Q 012610 258 --PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335 (460)
Q Consensus 258 --~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t 335 (460)
.-.+|+++|+-|.++..+..+|++++|+.++... .....+...+++.|++|+....-.++.++|+|..|+-+|+..-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 2368999999999999999999999999984432 2233344557889999999988889999999999999999999
Q ss_pred CCCcc
Q 012610 336 GQRAF 340 (460)
Q Consensus 336 g~~p~ 340 (460)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 98887
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=6.2e-05 Score=78.14 Aligned_cols=52 Identities=33% Similarity=0.548 Sum_probs=42.5
Q ss_pred CCCCCCCCCCCCCCCEEECcCCcceecCCCC-C-CCCCCccccccCCCCCCCCC
Q 012610 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-G-SFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 1 ~G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~-~~~~l~~~~~~~N~l~~~~p 52 (460)
+|.||.++++|++|+.|||++|+|+|.+|.. + .+..+..+++.+|...|..|
T Consensus 479 sg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 5899999999999999999999999999975 2 22345667889998776544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00067 Score=64.10 Aligned_cols=141 Identities=23% Similarity=0.244 Sum_probs=81.5
Q ss_pred CeecccCCeEEEEEEECC-------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEee
Q 012610 141 NILGRGGFGKVYKGRLTD-------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e 212 (460)
+.+..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .++++++. ...|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence 356678888999998654 47889998765321 11245677777777653333 33444442 246899
Q ss_pred ccCCCCHHHH-----------------hhhcCCCC-------CCCCHHHHHHH--------------------------H
Q 012610 213 FMVNGSVASC-----------------LRERGQSQ-------PPLNWSVRKQI--------------------------A 242 (460)
Q Consensus 213 ~~~~g~L~~~-----------------l~~~~~~~-------~~l~~~~~~~i--------------------------~ 242 (460)
|++|..+... ++...... .+.-+.....+ .
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9888765431 11111110 00111111111 1
Q ss_pred HHHHHHHHHHHh------CCCCCeEeeCCCCCCEEecCC----CcEEEeeccccc
Q 012610 243 LGAARGLAYLHD------HCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAK 287 (460)
Q Consensus 243 ~~i~~~l~~LH~------~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~ 287 (460)
..+...+.+|.. .....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 122222334432 134579999999999999985 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0031 Score=60.07 Aligned_cols=31 Identities=26% Similarity=0.284 Sum_probs=26.7
Q ss_pred CCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 257 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
..+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4489999999999999977556899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00093 Score=62.94 Aligned_cols=143 Identities=16% Similarity=0.089 Sum_probs=83.1
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc--ceeeeee------eecCCcceEEe
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGF------CMTPTERLLVY 211 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~------~~~~~~~~lv~ 211 (460)
.+.|..|....+|+....+ ..+++|+... . ....+..|++++..+.+.. +.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 4557778889999987654 4688898764 1 1234566777776664322 3333321 12234568999
Q ss_pred eccCCCCHHH----H----------hhhcCCC-------CCCCCHHHHH----------HHHHHHHHHHHHHHh----CC
Q 012610 212 PFMVNGSVAS----C----------LRERGQS-------QPPLNWSVRK----------QIALGAARGLAYLHD----HC 256 (460)
Q Consensus 212 e~~~~g~L~~----~----------l~~~~~~-------~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~ 256 (460)
+|++|..+.. . ++..... .....|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998866432 1 1111100 0011222111 011123344555553 12
Q ss_pred CCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 257 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
..+++|+|+.|.||++++++.+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3479999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0021 Score=60.94 Aligned_cols=144 Identities=15% Similarity=0.138 Sum_probs=80.0
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc--ceeeeeee------ecCCcceEEe
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFC------MTPTERLLVY 211 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~------~~~~~~~lv~ 211 (460)
.+.++.|....+|+....++ .+++|+...... ...+..|.+++..+.... +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 35577787889999876544 577887754321 223445666665553211 33333211 1234568999
Q ss_pred eccCCCCHH-----------HH---hhhcCCCC-CC-------CCHHHHH------------HHHHHHHHHHHHHHh---
Q 012610 212 PFMVNGSVA-----------SC---LRERGQSQ-PP-------LNWSVRK------------QIALGAARGLAYLHD--- 254 (460)
Q Consensus 212 e~~~~g~L~-----------~~---l~~~~~~~-~~-------l~~~~~~------------~i~~~i~~~l~~LH~--- 254 (460)
+|++|..+. .. ++...... .+ -.|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885432 11 11111100 00 0111100 011123344555543
Q ss_pred -CCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 255 -HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 255 -~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234589999999999999998777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00037 Score=64.06 Aligned_cols=137 Identities=17% Similarity=0.147 Sum_probs=92.0
Q ss_pred CCccCCeecccCCeEEEEEEECCCcEEEEEEecccc----------------ccc-----hhHHHHHHHHHHhccC-CCc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER----------------TQG-----GELQFQTEVEMISMAV-HRN 193 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----------------~~~-----~~~~~~~e~~~l~~~~-h~n 193 (460)
-+..++.||-|.-+.||.+-..+|++.++|.-...+ ... .+....+|+..++.+. |..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999999999989999888543111 000 1223456777777764 222
Q ss_pred -ceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 194 -LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 194 -iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
+.+.++ .+..++|||++.+-.|...-+-. +. ..+...+..-+.-|-.+ |+||+|..-=||++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-------d~---~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE-------DP---PTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC-------Ch---HHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 223333 34568999999887766543221 11 22333344445556677 99999999999999
Q ss_pred cCCCcEEEeeccccccc
Q 012610 273 DEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 273 ~~~~~~kl~Dfg~~~~~ 289 (460)
++++.++++||--....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999765443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0032 Score=58.99 Aligned_cols=148 Identities=20% Similarity=0.224 Sum_probs=82.6
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEecc-ccccchhHHHHHHHHHHhccCC--CcceeeeeeeecCC--cceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKE-ERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPT--ERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~--~~~lv~e~~~ 215 (460)
+.+..|....+|..... ++.++++ ... ...........+|+.+++.+.- --+...+++|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 34444555555655554 6778888 332 2223333456677777776632 22344566776655 6799999998
Q ss_pred CCCHHHHh------------------hh---cCCCC------------CC-CCHHHHHHHH--------HHHHHHHHHHH
Q 012610 216 NGSVASCL------------------RE---RGQSQ------------PP-LNWSVRKQIA--------LGAARGLAYLH 253 (460)
Q Consensus 216 ~g~L~~~l------------------~~---~~~~~------------~~-l~~~~~~~i~--------~~i~~~l~~LH 253 (460)
|..+.+.+ .. ..... .+ -.|......+ -....-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84322211 11 00000 00 0111111000 01122344555
Q ss_pred hCC-----CCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 254 DHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 254 ~~~-----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
.+. .+.++|+|+.+.|++++.++-+=+.||+++..-+
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 432 3469999999999999999889999999997654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0022 Score=60.18 Aligned_cols=143 Identities=18% Similarity=0.246 Sum_probs=93.0
Q ss_pred ccCCeecccCCeEEEEEEECCCcEEEEEEecccc--------------------ccchhHH-----HHHHHHHHhccCCC
Q 012610 138 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER--------------------TQGGELQ-----FQTEVEMISMAVHR 192 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------------------~~~~~~~-----~~~e~~~l~~~~h~ 192 (460)
++...|..|.-+.||.|...+|..+|||+.+... +...... ...|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3446788999999999999999999999886310 1111111 23455556665433
Q ss_pred cceeeeeeeecCCcceEEeeccCCCCHH-HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEE
Q 012610 193 NLLRLRGFCMTPTERLLVYPFMVNGSVA-SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 193 niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 271 (460)
.|.-.--+.. ....|||+|+...... -.|+. -.++...+..+-.+++.-|.-|-+.| ++||.||+--|+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence 2211100000 2347899999543221 11222 23666777788888888898898887 9999999999999
Q ss_pred ecCCCcEEEeecccccccC
Q 012610 272 LDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 272 l~~~~~~kl~Dfg~~~~~~ 290 (460)
+.++ .+.|+|.+-+...+
T Consensus 298 yhdG-~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 298 YHDG-KLYIIDVSQSVEHD 315 (520)
T ss_pred EECC-EEEEEEccccccCC
Confidence 8765 88999998775443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0059 Score=56.68 Aligned_cols=31 Identities=29% Similarity=0.482 Sum_probs=26.2
Q ss_pred CCeEeeCCCCCCEEecCCCc-EEEeecccccc
Q 012610 258 PKIIHRDVKAANILLDEEFE-AVVGDFGLAKL 288 (460)
Q Consensus 258 ~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~ 288 (460)
+.++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999998555 45999999865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0062 Score=56.64 Aligned_cols=73 Identities=21% Similarity=0.269 Sum_probs=46.2
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC---CCcceeeeeeeecCCcceEEeeccCC
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
.+.++.|....+|+.. .+++.+.||+-... ....|..|.+-|+.+. --.+.+++++....+..++++||++.
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4568889999999988 56788999987522 2235778888777773 44567788887777778999999987
Q ss_pred C
Q 012610 217 G 217 (460)
Q Consensus 217 g 217 (460)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.001 Score=73.56 Aligned_cols=52 Identities=37% Similarity=0.700 Sum_probs=31.0
Q ss_pred CCCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 1 ~G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
+|.+|..++++++|+.|||++|+++|.+|.. ..+..+..+++++|.+.|..|
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 3556666666666666666666666666653 344555666666666665444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.01 Score=57.11 Aligned_cols=141 Identities=16% Similarity=0.158 Sum_probs=79.4
Q ss_pred CeecccCCeEEEEEEECC-----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcce-eeeeeeecCCcceEEeecc
Q 012610 141 NILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~~~~~~~~~~~lv~e~~ 214 (460)
..+..|-...+|++...+ ++.|++|+...... ......+|..++..+..-++. ++++.+.. ..|++|+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi 115 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFI 115 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEee
Confidence 345568889999987542 36788998765421 111235688887777544433 34554422 2578888
Q ss_pred CCCCHHHH-----------------hhhcCCC--CCCCCHHHHHHHHHH-----------------HHHHHHHHH----h
Q 012610 215 VNGSVASC-----------------LRERGQS--QPPLNWSVRKQIALG-----------------AARGLAYLH----D 254 (460)
Q Consensus 215 ~~g~L~~~-----------------l~~~~~~--~~~l~~~~~~~i~~~-----------------i~~~l~~LH----~ 254 (460)
++.++... +|..... ..+..+.....+..+ +...+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665321 1111100 111223333333211 111222222 1
Q ss_pred -CCCCCeEeeCCCCCCEEecC-CCcEEEeeccccc
Q 012610 255 -HCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAK 287 (460)
Q Consensus 255 -~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~ 287 (460)
.....++|+|+++.||++++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22336899999999999986 4689999998875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.044 Score=51.94 Aligned_cols=29 Identities=34% Similarity=0.408 Sum_probs=25.5
Q ss_pred CCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 258 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999998 578999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.05 Score=51.90 Aligned_cols=73 Identities=12% Similarity=0.016 Sum_probs=45.8
Q ss_pred eecccCCeEEEEEEECCC-cEEEEEEecccc------ccchhHHHHHHHHHHhccC--CCc-ceeeeeeeecCCcceEEe
Q 012610 142 ILGRGGFGKVYKGRLTDG-SLVAVKRLKEER------TQGGELQFQTEVEMISMAV--HRN-LLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~------~~~~~~~~~~e~~~l~~~~--h~n-iv~l~~~~~~~~~~~lv~ 211 (460)
.||.|....||++...+| +.|+||.-.... ..-...+...|.+.|.... -|. +.+++. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999997654 579999764221 1222234455666665543 343 444444 3455667999
Q ss_pred eccCC
Q 012610 212 PFMVN 216 (460)
Q Consensus 212 e~~~~ 216 (460)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.025 Score=54.06 Aligned_cols=142 Identities=15% Similarity=0.180 Sum_probs=78.2
Q ss_pred CeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcce-eeeeeeecCCcceEEeeccC
Q 012610 141 NILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL-RLRGFCMTPTERLLVYPFMV 215 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~~~~~~~~~~~lv~e~~~ 215 (460)
+.|..|-...+|+....+ +..|++|+...... ....-.+|..++..+..-++. ++++++.. .+|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~----G~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN----GMIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC----cEeehhhc
Confidence 346568888999987543 23788998765322 112345778887777654443 44554422 25888887
Q ss_pred CCCHHH--------------Hh---hhcCCC--CCCCCHHHHHHHHHHH----------------------HHHHHHHHh
Q 012610 216 NGSVAS--------------CL---RERGQS--QPPLNWSVRKQIALGA----------------------ARGLAYLHD 254 (460)
Q Consensus 216 ~g~L~~--------------~l---~~~~~~--~~~l~~~~~~~i~~~i----------------------~~~l~~LH~ 254 (460)
+.++.. .+ |..... ..+-.|..+..+..++ ..-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765421 11 111101 1111233332222221 111222211
Q ss_pred -----CCCCCeEeeCCCCCCEEecC-CCcEEEeecccccc
Q 012610 255 -----HCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKL 288 (460)
Q Consensus 255 -----~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~ 288 (460)
.....++|+|+.+.||++++ ++.++++||..|..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11224899999999999975 57899999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.076 Score=51.63 Aligned_cols=74 Identities=12% Similarity=0.033 Sum_probs=48.7
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccc------cchhHHHHHHHHHHhccC---CCcceeeeeeeecCCcceEE
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT------QGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv 210 (460)
.+.||.|....||+.... +..++||.-..... .-...+-..|.+.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998875 45688998752211 012223344566665543 346777888776 456889
Q ss_pred eeccCC
Q 012610 211 YPFMVN 216 (460)
Q Consensus 211 ~e~~~~ 216 (460)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0018 Score=41.26 Aligned_cols=37 Identities=30% Similarity=0.588 Sum_probs=28.6
Q ss_pred CCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCC
Q 012610 12 NSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 12 ~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~ 49 (460)
++|++|+|++|+++. +|. ...+..+..+++++|.++.
T Consensus 1 ~~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCCC
Confidence 478999999999995 565 6788888999999998764
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0027 Score=43.82 Aligned_cols=44 Identities=39% Similarity=0.588 Sum_probs=32.1
Q ss_pred CC-CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCC
Q 012610 4 IP-RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQL 47 (460)
Q Consensus 4 iP-~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l 47 (460)
|| ..+.++++|++|+|++|+++.-.|.. ..+..+..+.+++|.+
T Consensus 16 i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 16 IPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp ECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 45 46677888888888888888765543 5667777788888764
|
... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.038 Score=48.41 Aligned_cols=151 Identities=14% Similarity=0.132 Sum_probs=84.5
Q ss_pred CCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhc
Q 012610 147 GFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 226 (460)
Q Consensus 147 ~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 226 (460)
+-++.-.++.+=| +..+|++......-...-|..+..+++++. .|+++.. .+.....++.|.|-.-
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~--------- 139 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI--------- 139 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc---------
Confidence 3344444443323 345666654333322334677788877762 3555552 1233456888887331
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccc
Q 012610 227 GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306 (460)
Q Consensus 227 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y 306 (460)
.....-.|..+ +.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+.-.. .+..|
T Consensus 140 -------~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~ 197 (308)
T PF07387_consen 140 -------KINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNM 197 (308)
T ss_pred -------ccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeE
Confidence 11111122222 3667888865 34899999999999999999999999775421 01111
Q ss_pred cCcccccCCCCCcccCchhhHHHHHHHHhC
Q 012610 307 IAPEYLSTGKSSEKTDVFGYGVMLLELITG 336 (460)
Q Consensus 307 ~aPE~~~~~~~~~~~Dvws~G~il~el~tg 336 (460)
.--| ....+.++.+-+|=.-+++++..
T Consensus 198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 198 VNIE---YESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred Eeee---ccccChHHHHHHHHHHHHHHHHH
Confidence 1111 11235666776666666666653
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.15 Score=56.30 Aligned_cols=142 Identities=15% Similarity=0.170 Sum_probs=76.5
Q ss_pred eecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-------CCCcceeee-e----eeec-CC--c
Q 012610 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-------VHRNLLRLR-G----FCMT-PT--E 206 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-------~h~niv~l~-~----~~~~-~~--~ 206 (460)
.|+ |..-.+|+....+|..+++|+.+..... .....|.+.+..+ .-|.+++-. | .... .. .
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 353 4567889988877888999999764321 2233344444332 234444322 1 1111 12 3
Q ss_pred ceEEeeccCCCCHHHHh-----------------hh----cC--CCCCCCCHHH-----------------HHHHHHHHH
Q 012610 207 RLLVYPFMVNGSVASCL-----------------RE----RG--QSQPPLNWSV-----------------RKQIALGAA 246 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l-----------------~~----~~--~~~~~l~~~~-----------------~~~i~~~i~ 246 (460)
.+.+++|++|..+.+.. +. .. .....+.|.. .+.++..+.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999997776511 10 00 0011122321 112222232
Q ss_pred HHHH----HHHhCCCCCeEeeCCCCCCEEecCCC--cEE-Eeeccccc
Q 012610 247 RGLA----YLHDHCDPKIIHRDVKAANILLDEEF--EAV-VGDFGLAK 287 (460)
Q Consensus 247 ~~l~----~LH~~~~~~i~H~dlkp~Nill~~~~--~~k-l~Dfg~~~ 287 (460)
+... ..-.....++||+|+.+.|||++.++ ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 11122344799999999999999875 555 99999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.11 Score=49.30 Aligned_cols=32 Identities=19% Similarity=0.288 Sum_probs=28.5
Q ss_pred CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 257 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
..+++|+|+.++||+++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.23 Score=47.14 Aligned_cols=140 Identities=16% Similarity=0.205 Sum_probs=79.1
Q ss_pred ecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC---CCccee---eeee----eecCCcceEEee
Q 012610 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLR---LRGF----CMTPTERLLVYP 212 (460)
Q Consensus 143 lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~---l~~~----~~~~~~~~lv~e 212 (460)
|.+ .-..+|+....+|+. ++|+.... .. ..++..|++.+..+. .+-.++ +-|- ...+...+.+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WT--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CC--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 567889988877666 88888765 22 234556666666553 222222 2221 111125678999
Q ss_pred ccCCCCHHH-H--------------hhhcCCC--------CCCCCHHH----H---------HHHHHHHHHHHHHHHhC-
Q 012610 213 FMVNGSVAS-C--------------LRERGQS--------QPPLNWSV----R---------KQIALGAARGLAYLHDH- 255 (460)
Q Consensus 213 ~~~~g~L~~-~--------------l~~~~~~--------~~~l~~~~----~---------~~i~~~i~~~l~~LH~~- 255 (460)
|++|..+.. . ++..... .....|.. . .....++...+..+...
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887772 1 1111100 01123321 0 01223344444444443
Q ss_pred ---CCCC---eEeeCCCCCCEEecCCCc-EEEeeccccc
Q 012610 256 ---CDPK---IIHRDVKAANILLDEEFE-AVVGDFGLAK 287 (460)
Q Consensus 256 ---~~~~---i~H~dlkp~Nill~~~~~-~kl~Dfg~~~ 287 (460)
.... +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2223 999999999999999875 8899999875
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.0029 Score=33.55 Aligned_cols=18 Identities=56% Similarity=0.859 Sum_probs=15.9
Q ss_pred CCCEEECcCCcceecCCCC
Q 012610 13 SLQVLDLSNNKLTGDIPTN 31 (460)
Q Consensus 13 ~L~~l~ls~N~l~G~iP~~ 31 (460)
+|++||||+|+|+ .||..
T Consensus 1 ~L~~Ldls~n~l~-~ip~~ 18 (22)
T PF00560_consen 1 NLEYLDLSGNNLT-SIPSS 18 (22)
T ss_dssp TESEEEETSSEES-EEGTT
T ss_pred CccEEECCCCcCE-eCChh
Confidence 5899999999999 88864
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.026 Score=55.44 Aligned_cols=51 Identities=16% Similarity=0.207 Sum_probs=39.4
Q ss_pred hHHHHHHHHHHhccCCCcceeeeeeeecCC-cceEEeeccCCCCHHHHhhhcC
Q 012610 176 ELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPFMVNGSVASCLRERG 227 (460)
Q Consensus 176 ~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~ 227 (460)
..++.....+++.+.|+|+..++.+..... ...+|+|++ +.+|.+.+..+.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 345677788999999999999998876543 356888988 668888886543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.21 Score=47.63 Aligned_cols=71 Identities=18% Similarity=0.166 Sum_probs=42.0
Q ss_pred cCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCC--ccee---eee--eeecCCcceEEeeccCCCC
Q 012610 146 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR--NLLR---LRG--FCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 146 G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~---l~~--~~~~~~~~~lv~e~~~~g~ 218 (460)
+.-..||+....++..+++|+.+.... ...++..|++.+..+... .++. .-| +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 456789999887788899998764332 233456677766554311 1222 112 1122345678899987754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 460 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-179 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-171 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 460 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-156 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-142 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-80 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-62 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-62 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-60 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-59 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-59 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-55 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-55 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-55 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-54 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-54 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-51 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-50 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-50 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-48 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-41 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-39 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-39 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-39 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-39 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-39 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-38 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-38 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-38 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-38 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 8e-38 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-37 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-36 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-36 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-36 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-36 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-36 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-36 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-35 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-35 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-35 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-35 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-35 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-35 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 8e-35 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-34 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-34 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-34 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-34 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-34 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-34 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-34 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-34 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-34 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-34 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 7e-34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-34 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-33 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-33 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-33 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-33 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-33 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-33 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-32 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-32 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-32 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-31 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-31 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-30 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-29 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-29 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-29 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-28 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-28 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-28 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-28 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-27 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-26 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-26 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-26 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-26 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-25 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-25 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-25 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-25 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-24 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-24 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-23 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-21 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-21 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-21 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-21 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-21 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-21 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-21 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 9e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-20 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-20 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-20 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 6e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-19 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-19 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-19 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-19 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-19 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 6e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-19 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-19 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-19 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-19 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-18 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-18 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-18 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-18 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-18 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-18 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-18 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-18 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-18 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 6e-18 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-18 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-18 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-18 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 8e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 8e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-17 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-17 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-17 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-17 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-16 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-16 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-16 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-15 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-15 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-15 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-10 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-14 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-13 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-08 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-08 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-08 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-08 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-08 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-07 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-07 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-07 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-07 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-07 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-07 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-05 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-05 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-13 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-09 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-08 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-08 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-08 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 8e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 8e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 9e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-07 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-07 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-06 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-05 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-05 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-05 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-05 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-04 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-04 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-07 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-06 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-04 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-04 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-04 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-04 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-04 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-06 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-05 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-05 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-05 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-05 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-04 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-04 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-04 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-05 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-05 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-04 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-04 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-05 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-04 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-04 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-04 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 632 bits (1632), Expect = 0.0
Identities = 305/326 (93%), Positives = 317/326 (97%)
Query: 106 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVK 165
FFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL DG+LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 166 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE 225
RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 226 RGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285
R +SQPPL+W R++IALG+ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 345
AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 346 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 405
ANDDDVMLLDWVKGLLKEKKLE LVD D++GNY +EEVEQLIQVALLCTQ SPMERPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 406 EVVRMLEGDGLAERWEEWQKEEMFRQ 431
EVVRMLEGDGLAERWEEWQKEEMFRQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 443 bits (1143), Expect = e-156
Identities = 113/314 (35%), Positives = 173/314 (55%), Gaps = 22/314 (7%)
Query: 112 EEDPEVHLGQLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVK 165
+ EV + FS EL+ T+NF R N +G GGFG VYKG + + + VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 166 RLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASC 222
+L + QF E+++++ H NL+ L GF + LVY +M NGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 223 LRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282
L PPL+W +R +IA GAA G+ +LH++ IHRD+K+ANILLDE F A + D
Sbjct: 121 LSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 283 FGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
FGLA+ + + T +T+ + GT ++APE L G+ + K+D++ +GV+LLE+ITG A D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 342 LARLANDDDVMLLDWVKGLLKEKK-LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME 400
R + +LLD + + E+K +E +D M + VE + VA C +
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 401 RPKMSEVVRMLEGD 414
RP + +V ++L+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 409 bits (1054), Expect = e-142
Identities = 114/306 (37%), Positives = 173/306 (56%), Gaps = 7/306 (2%)
Query: 110 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKE 169
A + + R L +L+ AT+NF ++ ++G G FGKVYKG L DG+ VA+KR
Sbjct: 14 DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73
Query: 170 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS 229
E +QG +F+TE+E +S H +L+ L GFC E +L+Y +M NG++ L
Sbjct: 74 ESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 230 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289
++W R +I +GAARGL YLH IIHRDVK+ NILLDE F + DFG++K
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 290 -DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 348
+ TH++T V+GT+G+I PEY G+ +EK+DV+ +GV+L E++ + A +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PR 247
Query: 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408
+ V L +W +LEQ+VD ++ E + + A+ C S +RP M +V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 409 RMLEGD 414
LE
Sbjct: 308 WKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-80
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 33/311 (10%)
Query: 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 184
L + + RG FG V+K +L VAVK + Q Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYEVY 70
Query: 185 MISMAVHRNLLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 240
+ H N+L+ G + L+ F GS++ L+ ++W+
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 241 IALGAARGLAYLHDH-------CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YK 292
IA ARGLAYLH+ P I HRD+K+ N+LL A + DFGLA + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 293 DTHVTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347
T GT ++APE L + + D++ G++L EL + A D +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPVD 243
Query: 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE------QLIQVALLCTQGSPMER 401
+ + + + + ++++V + + + + L + C R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 402 PKMSEVVRMLE 412
V +
Sbjct: 304 LSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-62
Identities = 71/322 (22%), Positives = 115/322 (35%), Gaps = 44/322 (13%)
Query: 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE 184
+ E + DN ++GRG +G VYKG L D VAVK Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKN 57
Query: 185 MISMAV--HRNLLRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSV 237
+ + + H N+ R E LLV + NGS+ L +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 238 RKQIALGAARGLAYLH------DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291
++A RGLAYLH DH P I HRD+ + N+L+ + V+ DFGL+ +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 292 -------KDTHVTTAVRGTIGHIAPEYL-------STGKSSEKTDVFGYGVMLLELITGQ 337
++ + + GTI ++APE L + ++ D++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 338 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD-------MEGNYIEEEVEQLIQVA 390
+ + V + ++ LV + V L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 391 LLCTQGSPMERPKMSEVVRMLE 412
C R +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-62
Identities = 77/314 (24%), Positives = 145/314 (46%), Gaps = 23/314 (7%)
Query: 101 KPEDHFFDVPAEEDPEVHLGQLK-RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDG 159
K H + + P + ++ + + + + +G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 160 SLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218
S VAVK L E+ + F EV ++ H N++ G P +V ++ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 219 VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278
+ L + G ++ L+ R +A A+G+ YLH + +P I+HR++K+ N+L+D+++
Sbjct: 121 LYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 338
V DFGL++L + + GT +APE L S+EK+DV+ +GV+L EL T Q+
Sbjct: 179 KVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 339 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 398
+ ++ V + + K ++ + + +V +I+ C P
Sbjct: 238 PW--------GNLNPAQVVAAVGFKCKRLEIPRN------LNPQVAAIIE---GCWTNEP 280
Query: 399 MERPKMSEVVRMLE 412
+RP + ++ +L
Sbjct: 281 WKRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-60
Identities = 74/308 (24%), Positives = 129/308 (41%), Gaps = 40/308 (12%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
++GRG FG V K + VA+K+++ E + F E+ +S H N+++L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGA 69
Query: 201 CMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
C+ P E + GS+ + L P + L ++G+AYLH
Sbjct: 70 CLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 257 DPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
+IHRD+K N+LL + + DFG A + T +G+ +APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 316 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375
SEK DVF +G++L E+IT ++ FD + + + + + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPP--LIKN-- 228
Query: 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNH 435
+ + +E L+ C P +RP M E+V+++ L + +E + H
Sbjct: 229 ---LPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT--HLMRYFP--GADEPLQYPCQH 278
Query: 436 TPHPNNTW 443
+ P
Sbjct: 279 SLPPGEDG 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-59
Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 47/290 (16%)
Query: 141 NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL------QFQTEVEMISMAVHRN 193
+G+GGFG V+KGR + D S+VA+K L ++G +FQ EV ++S H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 194 LLRLRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
+++L G P E F+ G + L ++ P+ WSV+ ++ L A G+
Sbjct: 85 IVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGI 135
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAV-----VGDFGLAKLMDYKDTHVTTAVRGTI 304
Y+ + +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNF 190
Query: 305 GHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362
+APE + +EK D + + ++L ++TG+ FD + + ++ + +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGKIKFINMIRE 244
Query: 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E + + + +I+ LC G P +RP S +V+ L
Sbjct: 245 EGLRPTIPED------CPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-59
Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL---QFQTEVEMISMAVHRNLLRL 197
I+G GGFGKVY+ G VAVK + + + + E ++ +M H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
RG C+ LV F G + L + + + A+ ARG+ YLHD
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 258 PKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
IIHRD+K++NIL+ ++ E + DFGLA+ T +A G +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMAP 183
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369
E + S+ +DV+ YGV+L EL+TG+ F + L G+ K +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------RGIDGLAVAYGVAMNKLALPI 235
Query: 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ E +L++ C P RP + ++ L
Sbjct: 236 PST------CPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 72/325 (22%), Positives = 129/325 (39%), Gaps = 42/325 (12%)
Query: 102 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL 161
PE + + A P L+E + + ++G+G FG+VY GR G
Sbjct: 2 PEMNLSLLSARSFPRKA--SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE- 57
Query: 162 VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220
VA++ + ER +L+ F+ EV H N++ G CM+P ++ ++
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 221 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 280
S +R+ L+ + +QIA +G+ YLH I+H+D+K+ N+ D + V+
Sbjct: 118 SVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVI 170
Query: 281 GDFGLAKLMD----YKDTHVTTAVRGTIGHIAPEYLSTGKS---------SEKTDVFGYG 327
DFGL + + G + H+APE + S+ +DVF G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 328 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLI 387
+ EL + F + + + L + +E+ ++
Sbjct: 231 TIWYELHAREWPFKT---------QPAEAIIWQMGTGMKPNLSQIG-----MGKEISDIL 276
Query: 388 QVALLCTQGSPMERPKMSEVVRMLE 412
C ERP ++++ MLE
Sbjct: 277 L---FCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 45/290 (15%)
Query: 141 NILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+LG+G FG+ K G ++ +K L + + F EV+++ H N+L+ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ ++ G++ ++ WS R A A G+AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------------YKDTHVTTAVRGTIGH 306
IIHRD+ + N L+ E VV DFGLA+LM D V G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366
+APE ++ EK DVF +G++L E+I A D++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-------------DYL-------PR 228
Query: 367 EQLVDSDMEGNY---IEEEV-EQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++ G + + C P +RP ++ LE
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-55
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 199
L G+++KGR G+ + VK LK + + F E + + H N+L + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 200 FCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCD 257
C +P + +M GS+ + L E + ++ S + AL ARG+A+LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 317
P I + + ++++DE+ A + + + +APE L
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPE 185
Query: 318 ---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
D++ + V+L EL+T + F D+ ++ + E +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPF--------ADLSNMEIGMKVALEGLRPTIPPG-- 235
Query: 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
I V +L++ +C P +RPK +V +LE
Sbjct: 236 ----ISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 41/282 (14%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 201
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 202 MTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
P T+ + S+ L IA ARG+ YLH
Sbjct: 90 TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPE---YL 312
IIHRD+K+ NI L E+ +GDFGLA +H + G+I +APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEQLV 370
+ S ++DV+ +G++L EL+TGQ + + + N D ++ + +G L +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQII---EMVGRGSLSPDLSKVRS 252
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ + +++L+ C + ERP ++ +E
Sbjct: 253 NCP-------KRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-50
Identities = 62/298 (20%), Positives = 119/298 (39%), Gaps = 39/298 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 198
+G+G +G+V++G G VAVK E + E E+ + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 199 GFCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 253
MT T+ L+ + GS+ L+ L+ +I L A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 254 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 306
P I HRD+K+ NIL+ + + + D GLA + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 307 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDVML---L 354
+APE + S ++ D++ +G++L E+ + + + D V
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ ++ ++ + + + + + +L++ C +P R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 63/298 (21%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 198
+G+G +G+V+ G+ G VAVK E + E E+ + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 199 GFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 253
+ T+ L+ + NGS+ L+ L+ ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 254 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGH 306
P I HRD+K+ NIL+ + + D GLA V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 307 IAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDV---MLL 354
+ PE + +S D++ +G++L E+ + + +L D V
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ ++ ++ KKL + + ++ +L+ C +P R V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLLRLR 198
+G+G FG+V++G+ G VAVK E + E E+ + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 199 GFCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH- 253
T T+ LV + +GS+ L + + ++AL A GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 254 ----DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRGTIGH 306
P I HRD+K+ NIL+ + + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 307 IAPEYL------STGKSSEKTDVFGYGVMLLELITGQRAFDLA---RLANDDDV---MLL 354
+APE L +S ++ D++ G++ E+ + +L D V +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ ++ ++ E+KL + + + + ++++ C + R + + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 143 LGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+GRG FG+V+ GRL + VAVK +E + +F E ++ H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+V + G + LR G L Q+ AA G+ YL I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA------VRGTIGHIAPEYLSTG 315
HRD+ A N L+ E+ + DFG+++ + + V+ T APE L+ G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWT----APEALNYG 290
Query: 316 KSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ S ++DV+ +G++L E + G + +Q +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY---------------------PNLSNQQTREFVE 329
Query: 375 EGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+G + + V +L+ C P +RP S + + L+
Sbjct: 330 KGGRLPCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQ 370
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 195
ILG G FG V +G L VAVK +K + + E++ F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 196 RLRGFC-----MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAARG 248
RL G C + +++ PFM G + + L P + ++ + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 307
+ YL + +HRD+ A N +L ++ V DFGL+K + D + +G I +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 308 ----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362
A E L+ + K+DV+ +GV + E+ T G + + N
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY--PGVQN--------------- 255
Query: 363 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++ D + G+ ++ +E+ +++ C + P++RP S + LE
Sbjct: 256 ----HEMYDYLLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLE 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 197 LRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
L G C+ L+V P+M +G + + +R L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYL 312
K +HRD+ A N +LDE+F V DFGLA+ M +Y H T + + +A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 313 STGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
T K + K+DV+ +GV+L EL+T G + + +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYP---------------------DVNTFDITV 243
Query: 372 SDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++G + + + L +V L C RP SE+V +
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 69/288 (23%), Positives = 111/288 (38%), Gaps = 34/288 (11%)
Query: 141 NILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
LG G FGKV G +VAVK LK + ++ E++++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 196 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+ +G C LV ++ GS+ L L A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 310
IHRD+ A N+LLD + +GDFGLAK + + + APE
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPE 207
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
L K +DV+ +GV L EL+T + L+ + + + +L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 371 DSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ G + EV L+ C + RP ++ +L+
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILK 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 56/297 (18%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 195
+LG+G FG V + +L VAVK LK + +++ F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 196 RLRGFC------MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--QIALGAAR 247
+L G +++ PFM +G + + L + P N ++ + + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRG 302
G+ YL IHRD+ A N +L E+ V DFGL++ + D + V+
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 303 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLL 361
A E L+ + +DV+ +GV + E++T GQ + A + N
Sbjct: 206 L----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AGIEN-------------- 245
Query: 362 KEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++ + + GN ++ EEV L+ C P +RP + + LE
Sbjct: 246 -----AEIYNYLIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELE 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 113 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-----VAVKR 166
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 167 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 226
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 227 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 284 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 337
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 338 R 338
+
Sbjct: 218 K 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 34/289 (11%)
Query: 141 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
LG G FGKV R G VAVK LK E + E+E++ H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 196 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+ +G C L+ F+ +GS+ L + +N + + A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLG 143
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 310
+ +HRD+ A N+L++ E + +GDFGL K + D T + APE
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPE 199
Query: 311 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369
L K +DV+ +GV L EL+T L M+ + + +L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQM----TVTRL 252
Query: 370 VDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
V++ EG + +EV QL+ C + P R ++ E
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++GRG FG VY G L D AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 197 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
L G C +E L+V P+M +G + + +R L A+G+ +L
Sbjct: 155 LLGIC-LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 311
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +A E
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 312 LSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
L T K + K+DV+ +GV+L EL+T G + + +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP---------------------DVNTFDIT 306
Query: 371 DSDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++G + + + L +V L C RP SE+V +
Sbjct: 307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 82/321 (25%), Positives = 131/321 (40%), Gaps = 42/321 (13%)
Query: 141 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
+ LG+G FG V R G+LVAVK+L+ + FQ E++++ ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIV 87
Query: 196 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 250
+ RG P + LV ++ +G + L+ L +S QI +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS--QIC----KGME 141
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGHIA 308
YL + +HRD+ A NIL++ E + DFGLAKL+ + V + I A
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
PE LS S ++DV+ +GV+L EL T ++ + D L
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-------ALS 251
Query: 368 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWE 421
+L++ EG + EV +L+ LC SP +RP S + L D L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQL--DMLWSG-S 305
Query: 422 EWQKEEMFRQDFNHTPHPNNT 442
+ F H +
Sbjct: 306 RGCETHAFTAHPEGKHHSLSF 326
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-38
Identities = 61/312 (19%), Positives = 124/312 (39%), Gaps = 44/312 (14%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQF-QTEVEMISMAVH 191
NF +GRG F +VY+ L DG VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 247
N+++ + E +V G ++ ++ + + + W Q+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
L ++H +++HRD+K AN+ + +GD GL + K T + V GT ++
Sbjct: 149 -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
+PE + + K+D++ G +L E+ Q F + ++
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLY--------------- 244
Query: 368 QLVDSDMEGNY--IEEEV--EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEW 423
L + +Y + + E+L Q+ +C P +RP ++ V + A+R
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV------AKRMHAC 298
Query: 424 QKEEMFRQDFNH 435
+ +H
Sbjct: 299 TASSLEHHHHHH 310
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-38
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++G+G FG VY G D + A+K L F E ++ H N+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 197 LRGFCMTPTE--RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
L G P E ++ P+M +G + +R L ARG+ YL +
Sbjct: 87 LIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE 142
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEY 311
K +HRD+ A N +LDE F V DFGLA+ + +Y R + A E
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 312 LSTGKSSEKTDVFGYGVMLLELIT 335
L T + + K+DV+ +GV+L EL+T
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 76/326 (23%), Positives = 131/326 (40%), Gaps = 55/326 (16%)
Query: 111 AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS------LVAV 164
+P +V N + LG G FG+VY+G+++ VAV
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 165 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 224
K L E ++ EL F E +IS H+N++R G + R ++ M G + S LR
Sbjct: 66 KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 225 E-RGQSQPPLNWSVRK--QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV- 280
E R + P + ++ +A A G YL ++ IHRD+ A N LL V
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182
Query: 281 --GDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLEL 333
GDFG+A+ + + +G + PE G + KTD + +GV+L E+
Sbjct: 183 KIGDFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 334 IT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQL 386
+ G + +N +++++ G ++ V ++
Sbjct: 239 FSLGYMPY--PSKSN-------------------QEVLEFVTSGGRMDPPKNCPGPVYRI 277
Query: 387 IQVALLCTQGSPMERPKMSEVVRMLE 412
+ C Q P +RP + ++ +E
Sbjct: 278 M---TQCWQHQPEDRPNFAIILERIE 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 141 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74
Query: 196 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLA 250
+ +G C + R L+ ++ GS+ L++ + L ++ QI +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 128
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHI 307
YL + IHRD+ NIL++ E +GDFGL K++ D I
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWY 184
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
APE L+ K S +DV+ +GV+L EL T + + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVF 239
Query: 368 QLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
L++ + +E+ ++ C + +RP ++ ++
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 74/300 (24%), Positives = 128/300 (42%), Gaps = 63/300 (21%)
Query: 141 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
LG+G FG VY+G VA+K + E + ++F E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER------GQSQPPLNWSVRKQIALGAARG 248
+RL G L++ M G + S LR P + S Q+A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI- 307
+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D + +G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 308 ----APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVK 358
+PE L G + +DV+ +GV+L E+ T LA L+N
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSN----------- 246
Query: 359 GLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
EQ++ MEG ++ + + +L+ +C Q +P RP E++ ++
Sbjct: 247 --------EQVLRFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIK 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 32/288 (11%)
Query: 141 NILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
LG+G FG V R G +VAVK+L+ T+ F+ E+E++ H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105
Query: 196 RLRGFCMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+ +G C + R L+ ++ GS+ L++ + ++ Q +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT---IGHIAPE 310
+ IHRD+ NIL++ E +GDFGL K++ D I APE
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPE 218
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
L+ K S +DV+ +GV+L EL T + ++ +E L
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHLIELL- 276
Query: 371 DSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ +E+ ++ C + +RP ++ ++
Sbjct: 277 ---KNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 199
+GRG F VYKG VA L++ + E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 200 FCMTPTE---RLLVYP-FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
+ + +++ M +G++ + L+ + V + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR 148
Query: 256 CDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
P IIHRD+K NI + +V +GD GLA L AV GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 315 GKSSEKTDVFGYGVMLLELITGQ 337
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 43/311 (13%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 192
+ + +G G FGK + DG +K + R E + + EV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP----LNWSVRKQIALGAARG 248
N+++ R +V + G + + + L+W V QI L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L ++HD KI+HRD+K+ NI L ++ +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368
PE + K+D++ G +L EL T + AF+ A ++
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE----AGS-----------------MKN 232
Query: 369 LVDSDMEGNY--IEEEV-EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQK 425
LV + G++ + L + + +P +RP ++ + LE +A+R E++
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLS 289
Query: 426 EEMFRQDFNHT 436
++ ++F
Sbjct: 290 PQLIAEEFCLK 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 113 EDP-EVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKR 166
E P + L LK ++++V LG G FG VYKG VA+K
Sbjct: 2 EAPNQALLRILKETEFKKIKV----------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51
Query: 167 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 226
L+E + + E +++ + ++ RL G C+T T L+ M G + +RE
Sbjct: 52 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH 110
Query: 227 GQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283
+ LNW V QIA +G+ YL D +++HRD+ A N+L+ + DF
Sbjct: 111 KDNIGSQYLLNWCV--QIA----KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161
Query: 284 GLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQ 337
GLAKL+ ++ ++ A E + + ++DV+ YGV + EL+T G
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 338 R 338
+
Sbjct: 218 K 218
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 57/292 (19%)
Query: 140 RNILGRGGFGKVYKGRLTDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FG V +G VA+K LK+ + + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
L G C +LV G + L + + + S ++ + G+ YL +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLST 314
+HRD+ A N+LL A + DFGL+K + D++ T G + APE ++
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K S ++DV+ YGV + E ++ GQ+ +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYK-------------------------------K 216
Query: 374 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLE 412
M+G + +EQ L + C +RP V + +
Sbjct: 217 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGSL-----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 195
+LG G FG V+KG V +K ++++ + + I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 252
RL G C + LV ++ GS+ +R+ + P LNW V QIA +G+ YL
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIA----KGMYYL 131
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHI 307
+H ++HR++ A N+LL + V DFG+A L+ D + + ++
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---- 184
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELIT-GQR 338
A E + GK + ++DV+ YGV + EL+T G
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 55/296 (18%)
Query: 141 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
LG G FG+VY+G+++ VAVK L E ++ EL F E +IS H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRE-RGQSQPPLNWSVRK--QIALGAARGLAY 251
+R G + R ++ M G + S LRE R + P + ++ +A A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVV---GDFGLAKLMDYKDTHVTTAVRGTIGHI- 307
L ++ IHRD+ A N LL V GDFG+A+ + + +G +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249
Query: 308 ----APEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362
PE G + KTD + +GV+L E+ + G + +N
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSN--------------- 292
Query: 363 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+++++ G ++ V +++ C Q P +RP + ++ +E
Sbjct: 293 ----QEVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 64/297 (21%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVN 65
Query: 194 LLRLRGF-------------CMTPTERLLVYPFM---VNGSVASCLRERGQSQPP--LNW 235
++ G + ++ ++ M G++ + +R + L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 236 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295
+ +QI G + Y+H K+I+RD+K +NI L + + +GDFGL +
Sbjct: 126 ELFEQITKG----VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLANDDDVMLL 354
+ GT+ +++PE +S+ ++ D++ G++L EL+ AF+ ++ D
Sbjct: 179 TRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD------ 230
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
L++ + + D + L+Q P +RP SE++R L
Sbjct: 231 ------LRDGIISDIFDKKE---------KTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QTEVEMISMAVHR 192
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 193 NLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQIAL 243
N++R + T L ++V G +AS + + + + L+ V Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 244 GAARGLAYLHDHCDP--KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
L H D ++HRD+K AN+ LD + +GDFGLA+++++ + T V
Sbjct: 123 A----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
GT +++PE ++ +EK+D++ G +L EL F A
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFS------------- 220
Query: 362 KEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
++L EG + +E+ ++I RP + E++
Sbjct: 221 ----QKELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
+ +V +M GS+ L+ L V +A A G+AY+
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM---NY 301
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 320
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 321 TDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYI 379
+DV+ +G++L EL T G+ + + N + + ++ G +
Sbjct: 362 SDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE-------------------RGYRM 400
Query: 380 E------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E + L+ C + P ERP + LE
Sbjct: 401 PCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE 436
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 109 VPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK 168
+ ++ P ++ + + LG G FG V G+ VA+K +K
Sbjct: 3 LGSKNAP-----STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK 57
Query: 169 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQ 228
E E +F E +++ H L++L G C ++ +M NG + + LRE
Sbjct: 58 EGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR- 114
Query: 229 SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288
++ + YL + +HRD+ A N L++++ V DFGL++
Sbjct: 115 --HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 289 MDYKDTHVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
+ D + ++ VR + PE L K S K+D++ +GV++ E+ +
Sbjct: 170 V-LDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 71/319 (22%), Positives = 120/319 (37%), Gaps = 72/319 (22%)
Query: 141 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 191
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 239
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 300 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 349
V+ APE L + ++DV+ +GV++ E+ T L +
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPV-- 311
Query: 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 403
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 312 -----------------EELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 351
Query: 404 MSEVVRMLEGDGLAERWEE 422
++V L+ EE
Sbjct: 352 FKQLVEDLDRILTLTTNEE 370
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-35
Identities = 70/335 (20%), Positives = 122/335 (36%), Gaps = 63/335 (18%)
Query: 97 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL 156
+ P D DPE +LK L + + LG G FG V +G
Sbjct: 304 KPRPMPMDTSVFESPFSDPE----ELKDKKLFLKR--DNLLIADIELGCGNFGSVRQGVY 357
Query: 157 TDGS---LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213
VA+K LK+ + + E +++ + ++RL G C +LV
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEM 416
Query: 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD 273
G + L + + + S ++ + G+ YL + +HR++ A N+LL
Sbjct: 417 AGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLV 470
Query: 274 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLSTGKSSEKTDVFGYGVMLL 331
A + DFGL+K + D++ T G + APE ++ K S ++DV+ YGV +
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 332 ELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQ----- 385
E ++ GQ+ + M+G + +EQ
Sbjct: 531 EALSYGQKPYK-------------------------------KMKGPEVMAFIEQGKRME 559
Query: 386 --------LIQVALLCTQGSPMERPKMSEVVRMLE 412
L + C +RP V + +
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 103 EDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL- 161
+ H + +P+ + +++ ++++G G FG+V K R+ L
Sbjct: 2 KKHHHHHHGKNNPDPTI--YPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR 52
Query: 162 --VAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS 218
A+KR+KE ++ F E+E + + H N++ L G C L + +G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 219 VASCLRERGQSQPPLNWSVRK------------QIALGAARGLAYLHDHCDPKIIHRDVK 266
+ LR+ + +++ A ARG+ YL + IHRD+
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLA 169
Query: 267 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKT 321
A NIL+ E + A + DFGL++ + V+ T+G + A E L+ + +
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 322 DVFGYGVMLLELIT 335
DV+ YGV+L E+++
Sbjct: 223 DVWSYGVLLWEIVS 236
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G G FG V+ G + VA+K ++E E F E E++ H L++L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
C+ LV FM +G ++ LR + + L G+AYL + +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTG 315
IHRD+ A N L+ E V DFG+ + + D + ++ V+ +PE S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 316 KSSEKTDVFGYGVMLLELIT 335
+ S K+DV+ +GV++ E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 44/297 (14%)
Query: 128 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEV 183
R+ ++ + +G G FG V++G VA+K K + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 184 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 243
+ H ++++L G ++ G + S L+ R L+ + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAY 498
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTA 299
+ LAYL + +HRD+ A N+L+ +GDFGL++ M+ YK +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVK 358
++ APE ++ + + +DV+ +GV + E++ G + F + N
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKN----------- 598
Query: 359 GLLKEKKLEQLVDSDMEGNYIEEEV---EQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++ G + L + C P RP+ +E+ L
Sbjct: 599 --------NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-35
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 142 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
ILG G FG+VY+G T+ VAVK K++ T + +F +E ++ H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 198 RGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
G PT ++ G + L S L +L + +AYL
Sbjct: 79 IGIIEEEPT--WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESI- 132
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYL 312
+HRD+ NIL+ +GDFGL++ ++ +D + + ++ +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 313 STGKSSEKTDVFGYGVMLLELIT 335
+ + + +DV+ + V + E+++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 69/309 (22%), Positives = 118/309 (38%), Gaps = 72/309 (23%)
Query: 141 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 191
LG G FG+V VAVK LK++ T+ +E+E M + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------ 239
+N++ L G C ++ + G++ LR R ++ + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
ARG+ YL K IHRD+ A N+L+ E + DFGLA+ ++ D + T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 300 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 349
V+ APE L + ++DV+ +GV++ E+ T L +
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPV-- 265
Query: 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 403
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 266 -----------------EELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 305
Query: 404 MSEVVRMLE 412
++V L+
Sbjct: 306 FKQLVEDLD 314
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
LG G FG V G+ VAVK +KE E +F E + + H L++ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+V ++ NG + + LR G+ L S ++ G+A+L H + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLSTGK 316
HRD+ A N L+D + V DFG+ + + D +V++ V+ + APE K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 317 SSEKTDVFGYGVMLLELIT 335
S K+DV+ +G+++ E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 70/304 (23%)
Query: 143 LGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG G FGKV+ + S LVAVK LK+ T FQ E E+++ H ++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIALG 244
G C ++V+ +M +G + LR G L + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA----- 299
A G+ YL +HRD+ N L+ +GDFG+++ + D +
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLL 354
+R PE + K + ++DV+ +GV+L E+ T + L+N
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSN------- 241
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVV 408
++++ +G +E +EV ++ L C Q P +R + E+
Sbjct: 242 ------------TEVIECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIY 286
Query: 409 RMLE 412
++L
Sbjct: 287 KILH 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 60/302 (19%), Positives = 112/302 (37%), Gaps = 61/302 (20%)
Query: 141 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
LG FGKVYKG L + VA+K LK++ +F+ E + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QIA 242
+ L G +++ + +G + L R + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--- 299
A G+ YL H ++H+D+ N+L+ ++ + D GL + + D +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 300 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 356
+R APE + GK S +D++ YGV+L E+ + G + + +N
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSN--------- 236
Query: 357 VKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
+ +V+ + V L+ + C P RP+ ++
Sbjct: 237 ----------QDVVEMIRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFKDIHSR 283
Query: 411 LE 412
L
Sbjct: 284 LR 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 72/307 (23%)
Query: 143 LGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 193
LG G FG+V + VAVK LK + T+ +E+E M + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------QI 241
++ L G C ++ + G++ L+ R +++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 299
A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D + T
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 300 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDV 351
V+ APE L + ++DV+ +GV+L E+ T L +
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPV---- 299
Query: 352 MLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMS 405
E+L EG+ ++ E+ ++ C P +RP
Sbjct: 300 ---------------EELFKLLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFK 341
Query: 406 EVVRMLE 412
++V L+
Sbjct: 342 QLVEDLD 348
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 62/299 (20%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQ 180
S R+ ++ + +G G FG V++G VA+K K + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 181 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQ 240
E + H ++++L G ++ G + S L+ R L+ +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---YSLDLASLIL 120
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 300
A + LAYL + +HRD+ A N+L+ +GDFGL++ M+ + +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 359
+ I +APE ++ + + +DV+ +GV + E++ G + F + N +DV+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKN-NDVI------- 227
Query: 360 LLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++E G + + L+ C P RP+ +E+ L
Sbjct: 228 ----GRIEN-------GERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 31/275 (11%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG+G FG+V+ G + VA+K LK F E +++ H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 201 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
+E +V +M GS+ L+ L V +A A G+AY+
Sbjct: 331 V---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAYVERM--- 382
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
+HRD++AANIL+ E V DFGLA+L++ + + I APE G+ +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 319 EKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377
K+DV+ +G++L EL T G+ + + N + + ++ +G ++ +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVE--RGY----RMPCPPECP---- 490
Query: 378 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E L + C + P ERP + LE
Sbjct: 491 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 142 ILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRL 197
LG G FG V KG + VAVK LK E E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP--LNWSVRKQIALGAARGLAYLHDH 255
G C + +LV G + L++ + + Q++ G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--QVS----MGMKYLEES 136
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPEYLS 313
+HRD+ A N+LL + A + DFGL+K + + + G + APE ++
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 314 TGKSSEKTDVFGYGVMLLELIT-GQR 338
K S K+DV+ +GV++ E + GQ+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 61/301 (20%)
Query: 141 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
LG G FGKV+ + LVAVK LKE ++ FQ E E+++M H+++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRER-----------GQSQPPLNWSVRKQIAL 243
+R G C L+V+ +M +G + LR + PL +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DY--KDTHVTT 298
A G+ YL +HRD+ N L+ + +GDFG+++ + DY
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357
+R PE + K + ++DV+ +GV+L E+ T G++ + +L+N
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--YQLSN---------- 266
Query: 358 KGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRML 411
+ +D +G +E EV ++ C Q P +R + +V L
Sbjct: 267 ---------TEAIDCITQGRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARL 314
Query: 412 E 412
+
Sbjct: 315 Q 315
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 70/308 (22%)
Query: 141 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 193
LGRG FG+V + VAVK LKE T +E++ +I + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 194 LLRLRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK------------Q 240
++ L G C P +++ F G++++ LR + P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 299
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 300 ----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDD 350
++ APE + + ++DV+ +GV+L E+ + L + D++
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEE 259
Query: 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKM 404
++L++ G + E+ Q + L C G P +RP
Sbjct: 260 FC-----------RRLKE-------GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTF 298
Query: 405 SEVVRMLE 412
SE+V L
Sbjct: 299 SELVEHLG 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 201 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 137
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 193
Query: 320 KTDVFGYGVMLLELIT 335
K+DV+ +G++L E+ +
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 141 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+ LG G +G+VY+G SL VAVK LKE+ + +F E ++ H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 338
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
IHR++ A N L+ E V DFGL++LM + I APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 320 KTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY 378
K+DV+ +GV+L E+ T G + + LL+ K ++E+
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLE--KDY----RMERPEGC------ 444
Query: 379 IEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E++ ++ C Q +P +RP +E+ + E
Sbjct: 445 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 38/302 (12%)
Query: 128 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 186
+ + ++ LG GGF V L DG A+KR+ Q E + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 187 SMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 242
+ H N+LRL +C+ L+ PF G++ + + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 301
LG RGL +H HRD+K NILL +E + V+ D G A+
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 302 -------GTIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350
TI + APE L + +S E+TDV+ G +L ++ G+ +D+
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ----- 251
Query: 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
KG ++ + + + QL+ + P +RP + ++
Sbjct: 252 -------KGDSVALAVQNQLSIPQSPRH-SSALWQLLNSMM---TVDPHQRPHIPLLLSQ 300
Query: 411 LE 412
LE
Sbjct: 301 LE 302
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 67/209 (32%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 142 ILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLL 195
LG G FG V +G S VAVK LK + E F EV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYL 252
RL G +TP +V GS+ LR+ ++V Q+A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA----EGMGYL 137
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT--IGHIAPE 310
+ IHRD+ A N+LL +GDFGL + + D H APE
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 311 YLSTGKSSEKTDVFGYGVMLLELIT-GQR 338
L T S +D + +GV L E+ T GQ
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G FG+V+ G + VAVK LK+ F E ++ H+ L+RL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAV 76
Query: 201 CMTPTER--LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDP 258
T+ ++ +M NGS+ L+ + +N + +A A G+A++ +
Sbjct: 77 V---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL--DMAAQIAEGMAFIEER--- 128
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLS 313
IHRD++AANIL+ + + DFGLA+L+ + + ++ T APE ++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT----APEAIN 183
Query: 314 TGKSSEKTDVFGYGVMLLELIT 335
G + K+DV+ +G++L E++T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 82/341 (24%), Positives = 135/341 (39%), Gaps = 70/341 (20%)
Query: 96 YWRKRKPEDHFFDVPAE-EDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 154
Y++ + PE F+ P E+P + R RE++ I+G G G+V G
Sbjct: 15 YFQGKLPEPQFYAEPHTYEEPG----RAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYG 68
Query: 155 RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210
RL VA+K LK T+ F +E ++ H N++RL G ++V
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270
+M NGS+ + LR + G G+ YL D +HRD+ A N+
Sbjct: 129 TEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNV 182
Query: 271 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFG 325
L+D V DFGL++++ D G G I APE ++ S +DV+
Sbjct: 183 LVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTG--GKIPIRWTAPEAIAFRTFSSASDVWS 239
Query: 326 YGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 384
+GV++ E++ G+R + +M + VE
Sbjct: 240 FGVVMWEVLAYGERPYW-------------------------------NMTNRDVISSVE 268
Query: 385 Q-------------LIQVALLCTQGSPMERPKMSEVVRMLE 412
+ L Q+ L C +RP+ S++V +L+
Sbjct: 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+G+G FG V G G+ VAVK +K + T F E +++ H NL++L G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 201 CMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ L +V +M GS+ LR RG+S + + + +L + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL--KFSLDVCEAMEYLEGN---N 309
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
+HRD+ A N+L+ E+ A V DFGL K V+ T APE L K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 365
Query: 320 KTDVFGYGVMLLELIT 335
K+DV+ +G++L E+ +
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 62/261 (23%), Positives = 88/261 (33%), Gaps = 25/261 (9%)
Query: 87 FAAPAIALAYWRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRG 146
+ + +P F A E + R Q +F + LG G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----SFQRLSRLGHG 68
Query: 147 GFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 202
+G+V+K R DG L AVKR + + E+ S H +RL
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 203 TPTERLLVYPFM--VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLHDHCDPK 259
+Y S+ G S P W + L LA+LH
Sbjct: 128 EGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHSQ---G 177
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
++H DVK ANI L +GDFGL + G ++APE L G
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAPELLQ-GSYGT 234
Query: 320 KTDVFGYGVMLLELITGQRAF 340
DVF G+ +LE+
Sbjct: 235 AADVFSLGLTILEVACNMELP 255
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 74/356 (20%), Positives = 132/356 (37%), Gaps = 87/356 (24%)
Query: 99 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 158
+ P + +P +P+ L L+ +N +G G FG+V++ R
Sbjct: 21 RLHPNPMYQRMPLLLNPK----------LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 159 G------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212
++VAVK LKEE + + FQ E +++ + N+++L G C L++
Sbjct: 71 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130
Query: 213 FMVNGSVASCLRERGQSQPPLNWSVRK--------------------QIALGAARGLAYL 252
+M G + LR IA A G+AYL
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI----- 307
+ K +HRD+ N L+ E + DFGL++ + D + I
Sbjct: 191 SER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWM 243
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVMLLDWVKGLLK 362
PE + + + ++DV+ YGV+L E+ + +A+
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQPYYGMAH--------------- 282
Query: 363 EKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E+++ +GN + E+ L+ LC P +RP + R+L+
Sbjct: 283 ----EEVIYYVRDGNILACPENCPLELYNLM---RLCWSKLPADRPSFCSIHRILQ 331
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 75/314 (23%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 141 NILGRGGFGKVYKGRLTDG------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
LG G FGKV K + VAVK LKE + +E ++ H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK--------------- 239
++L G C LL+ + GS+ LRE + P S
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 240 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294
A ++G+ YL + K++HRD+ A NIL+ E + + DFGL++ + +D+
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 295 HVTTAVRGTIGHI-----APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR----- 344
+ V+ + G I A E L + ++DV+ +GV+L E++T L
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPG 255
Query: 345 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSP 398
+ E+L + G+ +E EE+ +L+ L C + P
Sbjct: 256 IPP-------------------ERLFNLLKTGHRMERPDNCSEEMYRLM---LQCWKQEP 293
Query: 399 MERPKMSEVVRMLE 412
+RP +++ + LE
Sbjct: 294 DKRPVFADISKDLE 307
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G FG+V+ + VAVK +K F E ++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260
T ++ FM GS+ L+ S+ PL + + A G+A++
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQR---NY 305
Query: 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 320
IHRD++AANIL+ + DFGLA++++ + + I APE ++ G + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 321 TDVFGYGVMLLELIT 335
+DV+ +G++L+E++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 78/333 (23%), Positives = 133/333 (39%), Gaps = 65/333 (19%)
Query: 141 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++G G FG+V GRL S VA+K LK T+ F E ++ H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
L G ++V +M NGS+ S LR+ + G A G+ YL D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 314
+HRD+ A NIL++ V DFGL +++ D + + T + I +PE ++
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K + +DV+ YG++L E+++ G+R + +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYW-------------------------------E 253
Query: 374 MEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 420
M + + V++ L Q+ L C Q RPK ++V +L+
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD-------- 305
Query: 421 EEWQKEEMFRQDFNHTPHPNNTWIVDSTSHIQP 453
+ + + + P+N + S I
Sbjct: 306 KLIRNPGSLKIITSAAARPSNLLLDQSNVDITT 338
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 49/285 (17%)
Query: 141 NILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL++L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 76
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
C ++ FM G++ LRE + + + +A + + YL
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL--YMATQISSAMEYLEKK---N 131
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-----VRGTIGHIAPEYLST 314
IHRD+ A N L+ E V DFGL++LM DT+ A ++ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----APESLAY 186
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K S K+DV+ +GV+L E+ T G + + Q+ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDL-------------------SQVYELL 225
Query: 374 MEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ +E E+V +L+ C Q +P +RP +E+ + E
Sbjct: 226 EKDYRMERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 62/305 (20%), Positives = 110/305 (36%), Gaps = 67/305 (21%)
Query: 141 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 193
LG G FGKV + VAVK LK + +E++ M + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----------QIAL 243
++ L G C L++ + G + + LR + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---- 299
A+G+A+L IHRDV A N+LL A +GDFGLA+ + ++
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 300 -VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDDDVML 353
V+ APE + + ++DV+ YG++L E+ + L + +
Sbjct: 229 PVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFY- 277
Query: 354 LDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPKMSEV 407
K ++ +G + + + ++ C P RP ++
Sbjct: 278 ----------KLVK-------DGYQMAQPAFAPKNIYSIM---QACWALEPTHRPTFQQI 317
Query: 408 VRMLE 412
L+
Sbjct: 318 CSFLQ 322
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 53/248 (21%), Positives = 96/248 (38%), Gaps = 19/248 (7%)
Query: 97 WRKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR- 155
W + E++ V L + + E + +++ +GRG FG+V++ +
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79
Query: 156 LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215
G AVK+++ E + E+ + ++ L G + +
Sbjct: 80 KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 216 NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275
GS+ +++ G Q L GL YLH +I+H DVKA N+LL +
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQA-L---EGLEYLHTR---RILHGDVKADNVLLSSD 186
Query: 276 FEAV-VGDFGLAKLMDYKDTHVTTA----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330
+ DFG A + + + GT H+APE + K D++ M+
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 331 LELITGQR 338
L ++ G
Sbjct: 247 LHMLNGCH 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 70/304 (23%), Positives = 126/304 (41%), Gaps = 57/304 (18%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+F +LG+G FG+V K R D A+K+++ T+ +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 193 NLLRLRGF--------CMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP-LNWSVR 238
++R + F+ NG++ + +Q W +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY------- 291
+QI L+Y+H IIHRD+K NI +DE +GDFGLAK +
Sbjct: 123 RQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 292 -------KDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLA 343
++T+A+ GT ++A E L TG +EK D++ G++ E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST-- 230
Query: 344 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403
+ +L L+ +E D + N ++ E +++I+ L+ P +RP
Sbjct: 231 --GMERVNILKK-----LRSVSIE--FPPDFDDNKMKVE-KKIIR-LLIDH--DPNKRPG 277
Query: 404 MSEV 407
+
Sbjct: 278 ARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 54/302 (17%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+F LGRGGFG V++ + D A+KR++ + + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 194 LLRLRG-------FCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPP---LNWSVR 238
++R VY ++ ++ + R + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
QIA + +LH ++HRD+K +NI + VGDFGL MD + T
Sbjct: 125 LQIAEA----VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 299 AVR-----------GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347
GT +++PE + S K D+F G++L EL+ F
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS----TQ 230
Query: 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+ V L + L + E ++Q SPMERP+ +
Sbjct: 231 MERVRTL---------TDVRNLKFPPLFTQKYPCEY-VMVQ---DMLSPSPMERPEAINI 277
Query: 408 VR 409
+
Sbjct: 278 IE 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 71/309 (22%)
Query: 141 NILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 193
LG G FGKV + VAVK LK +E++ + + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 239
++ L G C L++ + G + + LR + S S
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
+ A+G+A+L IHRD+ A NILL + DFGLA+ + +V
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 300 -----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR-----LANDD 349
V+ APE + + ++DV+ YG+ L EL + L + D
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS------LGSSPYPGMPVDS 255
Query: 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSPMERPK 403
K ++ EG + E+ ++ C P++RP
Sbjct: 256 KFY-----------KMIK-------EGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPT 294
Query: 404 MSEVVRMLE 412
++V+++E
Sbjct: 295 FKQIVQLIE 303
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 129 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 187
E D +R +LG+G +G VY GR L++ +A+K + E ++ + E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHK 74
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 244
H+N+++ G + + GS+++ LR + ++ KQI L
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-L- 132
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGT 303
GL YLHD+ +I+HRD+K N+L++ + + DFG +K + + T GT
Sbjct: 133 --EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
Query: 304 IGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQR 338
+ ++APE + G + D++ G ++E+ TG+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 66/296 (22%)
Query: 142 ILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++G G FG+VYKG L S VA+K LK T+ + F E ++ H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
L G +++ +M NG++ LRE+ + + G A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTA-----VRGTIGHIAPE 310
+HRD+ A NIL++ V DFGL++++ D + TT+ +R T APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 311 YLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369
+S K + +DV+ +G+++ E++T G+R +
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------------------- 252
Query: 370 VDSDMEGNYIEEEVEQ-------------LIQVALLCTQGSPMERPKMSEVVRMLE 412
++ + + + + + Q+ + C Q RPK +++V +L+
Sbjct: 253 ---ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 58/293 (19%)
Query: 142 ILGRGGFGKVYKGRLTDGSL--------VAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
LG+G F K++KG + V +K L + + F M+S H++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
L+ G C+ E +LV F+ GS+ + L++ + + W + ++A A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKL--EVAKQLAAAMHFLE 130
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAV--------VGDFGLAKLMDYKDTHVTTAVRGTIG 305
++ +IH +V A NILL E + + D G++ + + +
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV-- 184
Query: 306 HIAPEYLSTGKS-SEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 363
PE + K+ + TD + +G L E+ + G + L +
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-----------------ALDSQ 225
Query: 364 KKLEQLVDSDMEGNYIEE----EVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+KL+ + + + E+ LI C P RP ++R L
Sbjct: 226 RKLQFY----EDRHQLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLN 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 65/314 (20%), Positives = 110/314 (35%), Gaps = 76/314 (24%)
Query: 141 NILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 193
+LG G FGKV S VAVK LKE+ +E++ M + H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------------- 239
++ L G C L++ + G + + LR + +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 240 -----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294
A A+G+ +L +HRD+ A N+L+ + DFGLA+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 295 HVTTA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR----- 344
+V V+ APE L G + K+DV+ YG++L E+ + L
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPYPG 277
Query: 345 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE------EEVEQLIQVALLCTQGSP 398
+ D + K ++ G ++ EE+ ++ C
Sbjct: 278 IPVDANFY-----------KLIQ-------NGFKMDQPFYATEEIYIIM---QSCWAFDS 316
Query: 399 MERPKMSEVVRMLE 412
+RP + L
Sbjct: 317 RKRPSFPNLTSFLG 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 61/310 (19%), Positives = 123/310 (39%), Gaps = 60/310 (19%)
Query: 123 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRL-KEERTQGGELQFQT 181
+ + + V +S +G GG KV++ + A+K + EE ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 182 EVEMISMAVHRNL--LRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSV 237
E+ ++ + +RL + +T +Y M N + S L+++ P
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---R 129
Query: 238 R---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYK 292
+ K + + +H H I+H D+K AN L+ + ++ DFG+A M
Sbjct: 130 KSYWKNM----LEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPD 179
Query: 293 DTHVT-TAVRGTIGHIAPEYL-----------STGKSSEKTDVFGYGVMLLELITGQRAF 340
T V + GT+ ++ PE + S K S K+DV+ G +L + G+ F
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 341 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGS 397
+ + KL ++D + E + E++++ +++ C +
Sbjct: 240 Q-----QIINQI-----------SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRD 280
Query: 398 PMERPKMSEV 407
P +R + E+
Sbjct: 281 PKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 60/292 (20%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 197
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 198 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 252
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 124
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 309
H H I+H D+K AN L+ + ++ DFG+A M T V + GT+ ++ P
Sbjct: 125 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 310 EYL-----------STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
E + S K S K+DV+ G +L + G+ F + +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI------ 227
Query: 359 GLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEV 407
KL ++D + E + E++++ +++ C + P +R + E+
Sbjct: 228 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 52/281 (18%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 253
GF +V S+ + R P R QI G YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 132
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
S + DV+ G ++ L+ G+ F+ + ++++
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET--------YLRIKK----- 229
Query: 374 MEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
Y I LIQ +L Q P RP ++E++
Sbjct: 230 --NEYSIPKHINPVAASLIQ-KML--QTDPTARPTINELLN 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMISMAVHRNLLRLRG 199
LG+G F VY+ + G VA+K + K+ + G + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN-WSVRK---QIALGAARGLAYLHDH 255
+ LV NG + L+ R + P + R QI G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQII----TGMLYLHSH 131
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
I+HRD+ +N+LL + DFGLA + T GT +I+PE +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 316 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375
++DV+ G M L+ G+ FD D V L ++V +D E
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNT-----------LNKVVLADYE 230
Query: 376 G-NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+++ E + LI LL + +P +R +S V+
Sbjct: 231 MPSFLSIEAKDLIH-QLL--RRNPADRLSLSSVLD 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 5e-31
Identities = 36/301 (11%), Positives = 75/301 (24%), Gaps = 50/301 (16%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
L G V+ R + A+K + E ++ + + + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 199 GFC--------------------------MTPTERLLVYPFMV--NGSVASCLRERGQSQ 230
LL+ P + S L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 231 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290
+ R A L ++H N+ + + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 291 YKDTHVTTAVRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFDLARLAND 348
K A + + E+L+ + + + + G+ + + F L
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408
W + L+ + L + + V+ LI L R E +
Sbjct: 302 G-----SWKRPSLRVPGTDSLAFGSCTP--LPDFVKTLIG-RFLNFD--RRRRLLPLEAM 351
Query: 409 R 409
Sbjct: 352 E 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 57/292 (19%), Positives = 115/292 (39%), Gaps = 60/292 (20%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNL--LRL 197
+G GG KV++ + A+K + E L ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 198 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYL 252
+ +T +Y M N + S L+++ P + K + + +
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWE---RKSYWKNMLE----AVHTI 171
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVT-TAVRGTIGHIAP 309
H H I+H D+K AN L+ + ++ DFG+A M T V + G + ++ P
Sbjct: 172 HQH---GIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 310 EYLS-----------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
E + K S K+DV+ G +L + G+ F + +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI------ 274
Query: 359 GLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEV 407
KL ++D + E + E++++ +++ C + P +R + E+
Sbjct: 275 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 143 LGRGGFGKVYKGRLTD-GSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
LG+GGF K ++ D + A K L + + + E+ + H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLH 253
GF +V S+ + R P R QI G YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIV----LGCQYLH 158
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+ ++IHRD+K N+ L+E+ E +GDFGLA ++Y GT +IAPE LS
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 214
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
S + DV+ G ++ L+ G+ F+ + L+ KK E +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKET-----YLRIKKNEYSIPK- 262
Query: 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+I LIQ +L Q P RP ++E++
Sbjct: 263 ----HINPVAASLIQ-KML--QTDPTARPTINELLN 291
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 13/213 (6%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
D++ + ++G G V VA+KR+ E+ Q + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR-KQIAL---GAARGL 249
++ + E LV + GSV ++ + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT-IGH-- 306
YLH + IHRDVKA NILL E+ + DFG++ + VR T +G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 307 -IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
+APE + + K D++ +G+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 45/243 (18%), Positives = 76/243 (31%), Gaps = 47/243 (19%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-- 190
T F +G G FG V+K DG + A+KR K+ + Q E+ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68
Query: 191 -HRNLLRLRGFCMTPTERLLVYPFM---VNGSVASCLRERGQSQPPLN----WSVRKQIA 242
H +++R E + GS+A + E + + Q+
Sbjct: 69 QHSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV-------------------GDF 283
G L Y+H ++H D+K +NI + GD
Sbjct: 126 RG----LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDL 342
G + G +A E L + K D+F + ++ +
Sbjct: 179 GHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 343 ARL 345
Sbjct: 234 GDQ 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+ F+ +G+G FG+V+KG +VA+K + E + Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 249
+ + G + T+ ++ ++ GS L + QIA +GL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--------QIATILREILKGL 132
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
YLH K IHRD+KAAN+LL E E + DFG+A + T V GT +AP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQ 337
E + K D++ G+ +EL G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGG-ELQFQTEVEMIS 187
Q A ++F LG+G FG VY R ++A+K L K + + G E Q + EVE+ S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
H N+LRL G+ T L+ + G+V L++ + + ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--- 121
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
L+Y H ++IHRD+K N+LL E + DFG + GT+ ++
Sbjct: 122 -LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYL 174
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
PE + EK D++ GV+ E + G+ F+
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 47/293 (16%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMA 189
V +F +++LG G G + + D VAVKR+ E EV+ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 190 VHRNLLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLN-WSVRKQIALGAA 246
H N++R Y + ++ + ++ + L ++ +Q
Sbjct: 76 EHPNVIRYFCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQT----T 128
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLAKLMD---YKDTHVTT 298
GLA+LH I+HRD+K NIL+ A++ DFGL K + + + +
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 299 AVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354
GT G IAPE LS + D+F G + +I+ G F
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG------KSLQRQA 238
Query: 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+ + G L+ L + + +LI+ ++ P +RP V
Sbjct: 239 NILLG---ACSLDCLHPEK----HEDVIARELIE-KMIAMD--PQKRPSAKHV 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 43/311 (13%), Positives = 88/311 (28%), Gaps = 74/311 (23%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 178
+LG+ + G V ++KEE + L+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 179 -----FQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPFMV--NGSVASCLRERGQS 229
F +++ + ++R+R R +YP M + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 230 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 290 DYKDTHVTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQR 338
+ + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 339 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 398
D + +W+ K I + V L++ L
Sbjct: 312 PIT-----KDAALGGSEWIFRSCKN---------------IPQPVRALLE-GFLRYP--K 348
Query: 399 MERPKMSEVVR 409
+R + +
Sbjct: 349 EDRLLPLQAME 359
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 43/254 (16%), Positives = 84/254 (33%), Gaps = 24/254 (9%)
Query: 107 FDVPAEEDPEVHLGQLKRFSL-RELQVATDNFSNRNILGRGGFGKVYKGRLTD------G 159
V + + +L E Q+ + ++LG G F +VY+ D
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 160 SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 219
+K K + Q +E + ++ ++ + +LV G++
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 220 ASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------ 272
+ + + + + A+ + +HD +IIH D+K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 273 -----DEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 326
D + D G + M + + TA T G E LS + + D FG
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 327 GVMLLELITGQRAF 340
+ ++ G
Sbjct: 272 AATVYCMLFGTYMK 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 59/329 (17%), Positives = 112/329 (34%), Gaps = 52/329 (15%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 189
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 190 VHRNLLRLRGFCMTPTERLLVYPFMV-----NGSVASCLRERGQSQPPLN----WSVRKQ 240
H+N+++L T R + ++ GS+ + L E + L V +
Sbjct: 65 NHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRD 120
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMDYKDTHV 296
+ G+ +L ++ I+HR++K NI+ D + + DFG A+ ++ D
Sbjct: 121 V----VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQF 172
Query: 297 TTAVRGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLAND 348
+ GT ++ P+ D++ GV TG F
Sbjct: 173 VSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408
+ K ++ + + + E + S + ++ V+
Sbjct: 232 N--------KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 409 R-MLEGDGLAERWEEWQKEEMFRQDFNHT 436
+LE D + W F Q F T
Sbjct: 284 ANILEADQ-EKCW-------GFDQFFAET 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 51/300 (17%), Positives = 100/300 (33%), Gaps = 53/300 (17%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKRLK----------------EERTQGGELQFQTEVEMI 186
L +G F K+ A+K+ + + + F+ E+++I
Sbjct: 39 LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 187 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG-----QSQPPLNWSVRK-- 239
+ + L G E ++Y +M N S+ + ++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 240 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
+ +Y+H+ + I HRDVK +NIL+D+ + DFG ++ M D +
Sbjct: 158 KSVLNS----FSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 299 AVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL-- 354
+ GT + PE+ S + K D++ G+ L + F ++ L
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFN 263
Query: 355 -------DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
++ S N++ E ++ L P ER +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK-LFLRKN--PAERITSEDA 320
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 23/235 (9%)
Query: 118 HLGQLKRFSLRELQVATDNFSNRNILGRG--GFGKVYKGR-LTDGSLVAVKRLKEERTQG 174
H+ L + + ++G+G V R G V V+R+ E
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 175 GELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL 233
+ F Q E+ + + H N++ R + E +V FM GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GM 125
Query: 234 NWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290
N IA G + L Y+H +HR VKA++IL+ + + + M
Sbjct: 126 N---ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 291 ---YKDTHVTTAVRGTIGHI---APEYLSTGKS--SEKTDVFGYGVMLLELITGQ 337
+ V + ++ + +PE L K+D++ G+ EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 42/305 (13%), Positives = 84/305 (27%), Gaps = 63/305 (20%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVK--------------RLKEERTQGGELQ-------- 178
+LG+ + G V ++KEE + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 179 -----FQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPFMV--NGSVASCLRERGQS 229
F +++ + ++R+R R +YP M + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 230 QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289
L R Q+ L R LA LH + ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 290 DYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLAR 344
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-- 319
Query: 345 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404
D + +W+ K I + V L++ L + +R
Sbjct: 320 ---DAALGGSEWIFRSCKN---------------IPQPVRALLEGFL---RYPKEDRLLP 358
Query: 405 SEVVR 409
+ +
Sbjct: 359 LQAME 363
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 199
LG+G FG VY R + ++A+K L + + + + Q + E+E+ S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ L+ F G + L++ G+ + + +++A L Y H+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA----LHYCHER---K 134
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
+IHRD+K N+L+ + E + DFG + T GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMC--GTLDYLPPEMIEGKTHDE 191
Query: 320 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
K D++ GV+ E + G FD
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTET 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 58/335 (17%), Positives = 112/335 (33%), Gaps = 44/335 (13%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 189
+ + +ILG+G V++GR G L A+K E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 190 VHRNLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQIALG 244
H+N+++L T R L+ F GS+ + L E + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG- 123
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDYKDTHVTTAV 300
G+ +L ++ I+HR++K NI+ + + DFG A+ ++ D +
Sbjct: 124 ---GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY 176
Query: 301 RGTIGHIAPEYLSTGKS--------SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
GT ++ P+ D++ GV TG F +
Sbjct: 177 -GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--- 232
Query: 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR-ML 411
K ++ + + + E + S + ++ V+ +L
Sbjct: 233 -----KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 412 EGDGLAERWEEWQKEEMFRQDFNHTPHPNNTWIVD 446
E D + W F Q F T + ++
Sbjct: 288 EAD-QEKCW-------GFDQFFAETSDILHRMVIH 314
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 56/304 (18%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRN 193
+ + ILG G G V G VAVKR+ + E++ + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPN 70
Query: 194 LLRLRGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIA---LGAARG 248
++R T + + N ++ + + S L A G
Sbjct: 71 VIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 249 LAYLHDHCDPKIIHRDVKAANILLD-------------EEFEAVVGDFGLAKLMD----Y 291
+A+LH KIIHRD+K NIL+ E ++ DFGL K +D
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 292 KDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELIT-GQRAFDLA 343
T++ GT G APE L + + D+F G + +++ G+ F
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-D 242
Query: 344 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK 403
+ + + +++ +G+ +++ L D + E LI ++ P++RP
Sbjct: 243 KYSRESNII-----RGIFSLDEMKCLHDRS-----LIAEATDLIS-QMIDHD--PLKRPT 289
Query: 404 MSEV 407
+V
Sbjct: 290 AMKV 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+ + LG GGFG V + G VA+K+ ++E + ++ E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 193 NLLRLRGFCMTPTE-RLLVYPFMV-----NGSVASCLRERGQSQPPLNWSVR---KQIAL 243
N++ R + P + G + L + +R I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAV 300
L YLH++ +IIHRD+K NI+L + + + D G AK +D + T V
Sbjct: 133 A----LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV 184
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDD 350
GT+ ++APE L K + D + +G + E ITG R F R +++
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+++ D + G +K + L + + ++E+ +Q L +R +
Sbjct: 244 IVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 32/240 (13%)
Query: 128 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL---KEERTQGGELQFQTEV 183
+ +++ R +L GGF VY+ + + G A+KRL +EE+ + EV
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR----AIIQEV 76
Query: 184 E-MISMAVHRNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNW 235
M ++ H N+++ E L+ + G + L++ +S+ PL+
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSC 135
Query: 236 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 295
+I R + ++H P IIHRD+K N+LL + + DFG A + + +
Sbjct: 136 DTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 296 VTTA-----------VRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFD 341
+A T + PE + + EK D++ G +L L Q F+
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 76/261 (29%), Positives = 111/261 (42%), Gaps = 38/261 (14%)
Query: 100 RKPEDHFFDVPAEEDP-----------EVHLGQLKRFSLRELQVATD---NFSNRNILGR 145
H +D+P E+ G LK + EL D FS+ +G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 146 GGFGKVYKGR-LTDGSLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202
G FG VY R + + +VA+K+ +++ EV + H N ++ RG +
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGLAYLHDHCDPK 259
LV + GS + L + PL +IA GA +GLAYLH H
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKK---PLQ---EVEIAAVTHGALQGLAYLHSH---N 174
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
+IHRDVKA NILL E +GDFG A +M ++ V GT +APE + +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 229
Query: 320 ---KTDVFGYGVMLLELITGQ 337
K DV+ G+ +EL +
Sbjct: 230 YDGKVDVWSLGITCIELAERK 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 41/205 (20%), Positives = 77/205 (37%), Gaps = 21/205 (10%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
+ GG G +Y +G V +K L + E + ++ VH +++++ F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 201 CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
++V G L+ + P+ ++ L L+YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAIA--YLLEILPALSYLHSI- 201
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
+++ D+K NI+L EE + + D G ++ + GT G APE +
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTG 252
Query: 317 SSEKTDVFGYGVMLLELITGQRAFD 341
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 143 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 197
LG GG VY D L VA+K + + E F+ EV S H+N++ +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 198 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
E Y M + G L E +S PL+ G+ + H
Sbjct: 77 IDVD-----EEDDCYYLVMEYIEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
D +I+HRD+K NIL+D + DFG+AK + T V GT+ + +PE
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFD 341
+ E TD++ G++L E++ G+ F+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 120 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 178
L L L+ F ++G G +G+VYKGR + G L A+K + G E +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEE 65
Query: 179 -FQTEVEMIS-MAVHRNLLR-----LRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQ 230
+ E+ M+ + HRN+ ++ ++L LV F GSV ++
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKG 123
Query: 231 PPLNWSVRKQIAL---GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287
L + IA RGL++LH H K+IHRD+K N+LL E E + DFG++
Sbjct: 124 NTLK---EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 337
+D T + GT +APE ++ ++ + K+D++ G+ +E+ G
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+ + LG G FGKVYK + G+L A K ++ + + E + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 249
+++L G + ++ F G+V + + E + L QI + L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLT---EPQIQVVCRQMLEAL 130
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIG 305
+LH +IIHRD+KA N+L+ E + + DFG K + +D+ + GT
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182
Query: 306 HIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 337
+APE + + K D++ G+ L+E+ +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 143 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 197
+GRGG G VY+ D VA+K + E + + Q E +++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 198 --RGFCMTPTERLLVYPFM--VNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
G +Y M +NG +A+ LR +G PL I L
Sbjct: 100 HDFG-----EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAA 150
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPE 310
H HRDVK NIL+ + A + DFG+A D +T GT+ ++APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPE 205
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
S ++ + D++ +L E +TG +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 143 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 197
LG GG +V+ R D VAVK L+ + + F+ E + + H ++ +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 198 --RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
G TP L Y M V+G LR+ ++ P+ ++ A + L + H
Sbjct: 78 YDTGEAETPAGP-LPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIGHIAPEY 311
+ IIHRDVK ANI++ V DFG+A+ + VT AV GT +++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
++DV+ G +L E++TG+ F
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 14/229 (6%)
Query: 112 EEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEE 170
+E L + ++ D+F + LG G G V+K G ++A K + E
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 171 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ 230
Q E++++ ++ G + E + M GS+ L++ G
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 126
Query: 231 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLM 289
+ + ++++ +GL YL + KI+HRDVK +NIL++ E + DFG++ +L+
Sbjct: 127 -RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183
Query: 290 DYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
D ++ V GT +++PE L S ++D++ G+ L+E+ G+
Sbjct: 184 DSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 191
+ F LG G +G VYK G +VA+K++ E Q + E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDS 83
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARG 248
++++ G T+ +V + GSV+ +R R + L +IA +G
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLT---EDEIATILQSTLKG 137
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L YLH + IHRD+KA NILL+ E A + DFG+A + T + GT +A
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMA 193
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
PE + + D++ G+ +E+ G+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
++ +G+G G VY + G VA++++ ++ EL E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 249
N++ + E +V ++ GS+ + E + QIA + L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQAL 129
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
+LH + ++IHRD+K+ NILL + + DFG + + + +T V GT +AP
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQ 337
E ++ K D++ G+M +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 120 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ 178
G+LK + ++ + +GRG +G V K G ++AVKR++ + + Q
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 179 FQTEVEMI-SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP-PLNWS 236
+++++ + +++ G + + M + S + +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE 125
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTH 295
+ +I L + L +L + + KIIHRD+K +NILLD + DFG+ +L+D
Sbjct: 126 ILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----- 178
Query: 296 VTTAVRGTIG---HIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQ 337
+ A G ++APE + S ++DV+ G+ L EL TG+
Sbjct: 179 -SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+ +G G G V R G VAVK + + Q EL EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL---GAARGL 249
N++ + + E ++ F+ G++ + + LN +QIA + L
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLN---EEQIATVCEAVLQAL 154
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
AYLH +IHRD+K+ +ILL + + DFG + + V GT +AP
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQ 337
E +S + + D++ G+M++E++ G+
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 15/232 (6%)
Query: 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM 188
++V D+ LGRG +G V K R G ++AVKR++ + + +++ ISM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD-ISM 60
Query: 189 AV--HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
+ G + + M + S+ ++ + + +IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
+ L +LH +IHRDVK +N+L++ + + DFG++ + D G +
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPY 175
Query: 307 IAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
+APE ++ + S K+D++ G+ ++EL + F +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQ 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 48/280 (17%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISM----AVHR 192
LG+GGFG V+ G LTD VA+K R+ + EV ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
++RL + T +LV + + + E+G + Q+ + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQH 154
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
H ++HRD+K NIL+D + DFG L+ D T GT + PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYSPPE 208
Query: 311 YLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369
++S + + V+ G++L +++ G F+ D +++ + L
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEIL-----EAELHFPA---- 254
Query: 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
++ + LI+ L P RP + E++
Sbjct: 255 --------HVSPDCCALIR-RCLAP--KPSSRPSLEEILL 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 72/253 (28%), Positives = 113/253 (44%), Gaps = 18/253 (7%)
Query: 107 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVK 165
F E D Q K L + ++FS I+GRGGFG+VY R D G + A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 166 RLKEER--TQGGELQFQTE---VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVA 220
L ++R + GE E + ++S ++ + TP + + M G +
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 221 SCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 280
L + G +I LG L ++H+ +++RD+K ANILLDE +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILLDEHGHVRI 333
Query: 281 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRA 339
D GLA K H +V GT G++APE L G + + + D F G ML +L+ G
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
Query: 340 FDLARLANDDDVM 352
F + + ++
Sbjct: 391 FRQHKTKDKHEID 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 14/216 (6%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 187
V + F +LG+GGFG+V ++ G + A K+L+++R + GE E +++
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQIALGA 245
R ++ L T LV M G + + GQ+ P +V +I G
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 305
L LH +I++RD+K NILLD+ + D GLA + T GT+G
Sbjct: 299 ---LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350
Query: 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
++APE + + + D + G +L E+I GQ F
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMIS 187
+ D F + +LGRGGFG+V+ ++ G L A K+L ++R + G E ++++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 188 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QIA 242
R ++ L + L LV M G + + + P QI
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 301
G L +LH II+RD+K N+LLD++ + D GLA L + T
Sbjct: 300 SG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
GT G +APE L + D F GV L E+I + F
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 63/278 (22%), Positives = 114/278 (41%), Gaps = 46/278 (16%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMISMAVHR--NL 194
LG GGFG VY G ++D VA+K R+ + + EV ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 195 LRLRGFCMTPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+RL + P +L+ + + ERG Q L S Q+ + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRHCH 166
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
+ ++HRD+K NIL+D + + DFG L+ KDT T GT + PE++
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPEWI 220
Query: 313 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+ V+ G++L +++ G F+ +D++++ +G + ++
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFFRQ------ 264
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ E + LI+ L P +RP E+
Sbjct: 265 ------RVSSECQHLIR-WCLAL--RPSDRPTFEEIQN 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 191
++ + LG G +G+V R A+K +++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 247
N+++L F LV G L + + N + KQ+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQV----LS 147
Query: 248 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
G+ YLH H I+HRD+K N+LL +++ + DFGL+ + +++ GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTA 202
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+IAPE L K EK DV+ GV+L L+ G F
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 44/303 (14%)
Query: 41 SFANNQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKR 100
S +N+ N ++ P + + + A A L + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLP-NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 101 KPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG--RLTD 158
E+ +F ED K F + ++++GRG V + R T
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRAT- 118
Query: 159 GSLVAVK-------RLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLV 210
G AVK RL E+ + + E + +A H +++ L + + LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 211 YPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 264
+ M G L E+ S+ + + +++LH + I+HRD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETR------SIMRSLL----EAVSFLHAN---NIVHRD 225
Query: 265 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVF 324
+K NILLD+ + + DFG + + + + GT G++APE L K S
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEIL---KCSMDETHP 280
Query: 325 GYG 327
GYG
Sbjct: 281 GYG 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE--LQFQTEVEMISMAV 190
+D + + +LG+G FG+V + G AVK + + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAA 246
H N+++L F LV G L + S+ + + +Q+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQV----L 136
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 303
G+ Y+H + KI+HRD+K N+LL ++ + DFGL+ ++ + GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGT 191
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363
+IAPE L G EK DV+ GV+L L++G F+ ++ +L +
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN----GANEYDIL---------K 237
Query: 364 KKLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
K + ++ + E + LI+ +L P R +
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIR-KMLTY--VPSMRISARDA 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE 184
+ Q ++ N +G G G+V+K R G ++AVK+++ + + +++
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 185 -MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 243
++ +++ G +T T+ + M + R +G P+ + ++ +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 303
+ L YL + +IHRDVK +NILLDE + + DFG++ + D G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGC 187
Query: 304 IGHIAPEYLSTGKSSE-----KTDVFGYGVMLLELITGQ 337
++APE + ++ + DV+ G+ L+EL TGQ
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 33/227 (14%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVK---RLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198
LG G +GKV + AVK + K R GE + E++++ H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 199 GFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR--------GLA 250
++ + +MV ++E L+ K+ + A GL
Sbjct: 73 DVLYNEEKQKM---YMVMEYCVCGMQEM------LDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAP 309
YLH I+H+D+K N+LL + G+A+ + + +G+ P
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 310 EYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
E + S K D++ GV L + TG F+ D++ L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKL 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 191
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAAR 247
N+++L + +V G L + + + + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVF----S 132
Query: 248 GLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++ GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA 187
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364
+IAPE L G EK DV+ GV+L L++G F ++ +L ++
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY----GKNEYDIL---------KR 233
Query: 365 KLEQLVDSDMEG-NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
D+ I ++ + LI+ +L P R ++
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIR-KMLTFH--PSLRITATQC 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEER-------TQGGELQFQTEVEMISMAVHRNL 194
LG G FG V+ V VK +K+E+ + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 195 LRLRGFCMTPTERLLVYPFMVNGS-VASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+++ LV +G + + + + PL + +Q+ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
IIHRD+K NI++ E+F + DFG A ++ + T GTI + APE L
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTFC-GTIEYCAPEVLM 202
Query: 314 TGKSSE--KTDVFGYGVMLLELITGQRAFD 341
G + +++ GV L L+ + F
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 44/248 (17%)
Query: 134 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK--------RLKEERTQGGELQFQTEV 183
+N+ + ILGRG V + + T AVK E Q EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 184 E-MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWS 236
+ + ++ H N+++L+ T T LV+ M G L E+
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------K 128
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
+ + + + LH I+HRD+K NILLD++ + DFG + +
Sbjct: 129 IMRALL----EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEK 179
Query: 297 TTAVRGTIGHIAPEYLSTGKSSEKT------DVFGYGVMLLELITGQRAFDLARLANDDD 350
V GT ++APE + + D++ GV++ L+ G F +
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQ 234
Query: 351 VMLLDWVK 358
+++L +
Sbjct: 235 MLMLRMIM 242
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 44/210 (20%), Positives = 78/210 (37%), Gaps = 43/210 (20%)
Query: 216 NGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272
++ + R + + + QIA + +LH ++HRD+K +NI
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLHSK---GLMHRDLKPSNIFF 197
Query: 273 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR-----------GTIGHIAPEYLSTGKSSEKT 321
+ VGDFGL MD + T GT +++PE + S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 322 DVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIE 380
D+F G++L EL+ + R+ D ++ K L
Sbjct: 258 DIFSLGLILFELLYSFSTQMERVRIITD------------VRNLKFPLLFT-----QKYP 300
Query: 381 EEVEQLIQVALLCTQGSPMERPKMSEVVRM 410
+E ++Q SP ERP+ ++++
Sbjct: 301 QEH-MMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 51/280 (18%)
Query: 143 LGRGGFGKVYKGR--LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+G+G F KV R LT G VA+K + K + + EV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHC 256
T L+ + G V L G+ + R QI + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE---ARSKFRQIV----SAVQYCHQKR 134
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
I+HRD+KA N+LLD + + DFG + + G + APE GK
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFC-GAPPYAAPELFQ-GK 188
Query: 317 SSE--KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ + DV+ GV+L L++G FD ++ L +++ +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKEL--------RERV-------L 227
Query: 375 EGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
G Y + + E L++ L +P++R + ++++
Sbjct: 228 RGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMK 264
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 134 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 184
D + LG G G+V R T VA++ + R L +TE+E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 185 MISMAVHRNLLRLRGFCMTPTERLLVYPFM--VNGS------VAS-CLRERGQSQPPLNW 235
++ H +++++ F Y + + G V + L+E
Sbjct: 193 ILKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELFDKVVGNKRLKEATCK------ 242
Query: 236 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYK 292
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++
Sbjct: 243 LYFYQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293
Query: 293 DTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITG 336
+T + + GT ++APE L + + + D + GV+L ++G
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 49/294 (16%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK------------EERTQGGELQFQ 180
+++ LG G +G+V + S A+K +K + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 181 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WS 236
E+ ++ H N+++L LV F G L E+ ++ + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 293
+ KQI G+ YLH H I+HRD+K NILL + + DFGL+ +
Sbjct: 151 IMKQI----LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSK 201
Query: 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353
+ GT +IAPE L K +EK DV+ GV++ L+ G F +D
Sbjct: 202 DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFG----GQND---- 252
Query: 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+ ++K+ + + + I +E ++LI+ +L +R E
Sbjct: 253 ----QDIIKKVEKGKYYFDFNDWKNISDEAKELIK-LMLTY--DYNKRCTAEEA 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 126 SLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ 180
S RE + LG G FG V+ + G +K + ++R+Q Q +
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 181 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG----------SVASCLRERGQSQ 230
E+E++ H N++++ +V G + L E ++
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 231 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 287
+ KQ+ LAY H ++H+D+K NIL + DFGLA+
Sbjct: 129 ------LMKQMM----NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
L D H T A GT ++APE + K D++ GV++ L+TG F
Sbjct: 176 LFK-SDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 317
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377
+E DV+ G++L ++ G+ +D +D DW +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYL----------NPWK 232
Query: 378 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
I+ L+ L +P R + ++ +
Sbjct: 233 KIDSAPLALLHKIL---VENPSARITIPDIKK 261
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 133 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EV---E 184
AT + +G G +G VYK R G VA+K ++ GG + EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 185 MISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVRK 239
+ H N++RL C T LV+ + + + + L + P L K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKA--PPPGLPAETIK 123
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTH 295
+ RGL +LH + I+HRD+K NIL+ + DFGLA++ M T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 296 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 57/233 (24%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQF-QTEVEMIS 187
V D+F +G+G FGKV + D + A+K + K++ + E++ E++++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 188 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQ-SQPPLNWSVR---KQIA 242
H L+ L + E + +V ++ G + L++ + +V+ ++
Sbjct: 71 GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFICELV 125
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 302
+ L YL + +IIHRD+K NILLDE + DF +A ++ + T A G
Sbjct: 126 MA----LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--G 176
Query: 303 TIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQRAFDLARLANDDDVM 352
T ++APE S+ K + + D + GV EL+ G+R + + + +++
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 52/248 (20%), Positives = 81/248 (32%), Gaps = 53/248 (21%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLRL 197
+G+G +G V ++ A+K + + +TEV ++ H N+ RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG------------- 244
LV G + L + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 245 ----------------AAR-------GLAYLHDHCDPKIIHRDVKAANILL--DEEFEAV 279
+ L YLH+ I HRD+K N L ++ FE
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 280 VGDFGLAKLMDYKDTH----VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLEL 333
+ DFGL+K + +TT GT +APE L+T K D + GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 334 ITGQRAFD 341
+ G F
Sbjct: 270 LMGAVPFP 277
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
LG G +G+V VAVK + +R + E+ + M H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
+ L + G + + P Q+ G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----GVVYLHGI---GIT 127
Query: 262 HRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVRGTIGHIAPEYLSTGK--S 317
HRD+K N+LLDE + DFGLA + Y ++ + GT+ ++APE L +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK-RREFH 185
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN 377
+E DV+ G++L ++ G+ +D +D DW +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYL----------NPWK 232
Query: 378 YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
I+ L+ L +P R + ++ +
Sbjct: 233 KIDSAPLALLHKIL---VENPSARITIPDIKK 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 48/225 (21%), Positives = 98/225 (43%), Gaps = 18/225 (8%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 182
++++++ ++F ++GRG FG+V +L + + A+K L K E + E F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 183 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSV--RKQ 240
+++ + + L LV + V G + + L + + + P + +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLAE 183
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 300
+ + + +H +HRD+K NIL+D + DFG + T ++
Sbjct: 184 MVIA----IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 301 RGTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAF 340
GT +I+PE L + + D + GV + E++ G+ F
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 191
+ ++ +LG+G FG+V K + AVK + + + + EVE++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 245
N+++L + +V G E ++ + KQ+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVF--- 131
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 302
G+ Y+H H I+HRD+K NILL +++ + + DFGL+ ++T + + G
Sbjct: 132 -SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-G 185
Query: 303 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
T +IAPE L G EK DV+ GV+L L++G F
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFY 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 32/246 (13%)
Query: 110 PAEEDPEVHLGQLKRFSLRELQVATDNFSNR----NILGRGGFGKVYKG--RLTDGSLVA 163
+ K++ + +++ D+ + LG G FG V++ R T G+ A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT-GNNFA 186
Query: 164 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------ 217
K + E + E++ +S+ H L+ L E +++Y FM G
Sbjct: 187 AKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
Query: 218 -SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276
+ + E + +Q+ +GL ++H++ +H D+K NI+ +
Sbjct: 246 ADEHNKMSEDEAVE------YMRQV----CKGLCHMHEN---NYVHLDLKPENIMFTTKR 292
Query: 277 EAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 334
+ DFGL +D V GT APE TD++ GV+ L+
Sbjct: 293 SNELKLIDFGLTAHLD-PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350
Query: 335 TGQRAF 340
+G F
Sbjct: 351 SGLSPF 356
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 25/239 (10%)
Query: 110 PAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL- 167
AE P Q + + + ++F ILG G F V R A+K L
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 168 KEERTQGGELQF-QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER 226
K + ++ + E +++S H ++L + + NG + +R+
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 124
Query: 227 GQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282
G + + + +I L YLH IIHRD+K NILL+E+ + D
Sbjct: 125 GS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNEDMHIQITD 173
Query: 283 FGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQ 337
FG AK L + GT +++PE L+ KSS D++ G ++ +L+ G
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 19/216 (8%)
Query: 134 TDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 188
+ + N +GRG +G+V A K++ + + + +F+ E+E++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKS 62
Query: 189 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
H N++RL T+ LV G + + + + + K +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----SA 118
Query: 249 LAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 305
+AY H + HRD+K N L + + DFGLA + GT
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPY 173
Query: 306 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+++P+ L G + D + GVM+ L+ G F
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 53/229 (23%), Positives = 86/229 (37%), Gaps = 26/229 (11%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVK----RLKEERTQGGELQFQTEVEMISMAVHRNLLR 196
++G+G F V + G AVK + E + M H +++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLN----WSVRKQIALGAARGLAYL 252
L + +V+ FM + + +R + + +QI L A L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI-LEA---LRYC 146
Query: 253 HDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
HD+ IIHRDVK +LL + +G FG+A + V GT +AP
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 310 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
E + + DV+G GV+L L++G F L + +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFY------GTKERLFEGII 245
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 128 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKR-LKEERTQGGELQFQTEVEMI 186
+ + ++N ++G G FG V++ +L + VA+K+ L+++R + ELQ V+
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-- 90
Query: 187 SMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 239
H N++ L+ F + ++ LV ++ +V R + + + + K
Sbjct: 91 ----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 240 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTH 295
Q+ R LAY+H I HRD+K N+LLD + + DFG AK
Sbjct: 146 YMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK-------- 190
Query: 296 VTTAVRGTIGHI------APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
+ A + +I APE + + + D++ G ++ EL+ GQ
Sbjct: 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 34/234 (14%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGEL-QFQTE 182
L+E+++ D+F ++GRG F +V ++ G + A+K + K + + GE+ F+ E
Sbjct: 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 183 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
+++ R + +L F L LV + V G + + L + G ++I
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-----------ERI 159
Query: 242 ALGAAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
AR + +H +HRD+K NILLD + DFG +
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG-------YGVMLLELITGQRAF 340
T + GT +++PE L T +G GV E+ GQ F
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 66/282 (23%), Positives = 102/282 (36%), Gaps = 50/282 (17%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G G FG R LVAVK + ER + Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDP 258
+TPT ++ + G + + G+ R Q+ G++Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS----GVSYCHSM--- 135
Query: 259 KIIHRDVKAANILLDEEFEAV--VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 316
+I HRD+K N LLD + DFG +K + + V GT +IAPE L +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV-GTPAYIAPEVLL-RQ 192
Query: 317 --SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ DV+ GV L ++ G F+ D + +K Q + +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRD--------YRKTIQRI---L 235
Query: 375 EGNY-------IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
Y I E LI P R + E+
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIF---VADPATRISIPEIKT 274
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 191
+ + N ++G G +G V K R G +VA+K+ E ++ E++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
NL+ L C LV+ F+ + ++ L L++ V ++ G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGF 139
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGH 306
H H IIHRD+K NIL+ + + DFG A+ + T R
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191
Query: 307 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
APE L + DV+ G ++ E+ G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 67/300 (22%), Positives = 105/300 (35%), Gaps = 56/300 (18%)
Query: 140 RNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRL 197
++LG G +V L AVK ++++ + EVE + HRN+L L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76
Query: 198 RGFCMTPTERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAY 251
F LV+ M GS+ S + +R S V + +A L +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------VVQDVA----SALDF 126
Query: 252 LHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHV-------TTAVR 301
LH+ I HRD+K NIL ++ + DF L + T
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC- 182
Query: 302 GTIGHIAPEYLSTGKSSEKT-----DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 356
G+ ++APE + D++ GV+L L++G F W
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV------GRCGSDCGW 236
Query: 357 VKGLLKEKKLEQLVDSDMEGNY---------IEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+G L +S EG Y I + LI LL +R ++V
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS-KLLVR--DAKQRLSAAQV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 134 TDNFSNRNILGRGGFGKVYKG--RLTDGSLVAVK-------RLKEERTQGGELQFQTEVE 184
D + LG G G+V R T VA+K + R L +TE+E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 185 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVR 238
++ H +++++ F + +V M G L+E
Sbjct: 68 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKL------YF 120
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 295
Q+ L + YLH++ IIHRD+K N+LL +E+ + DFG +K++ +T
Sbjct: 121 YQMLLA----VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETS 171
Query: 296 VTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVML 330
+ + GT ++APE L + + + D + GV+L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRL-KEERTQGGELQ-FQTE 182
+R+L++ +++ ++GRG FG+V R + A+K L K E + + F E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 183 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 239
++++ A +++L +V +M G + + + + R
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTA 175
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
++ L L +H IHRDVK N+LLD+ + DFG M+ +
Sbjct: 176 EVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 300 VRGTIGHIAPEYLSTGKSSEK----TDVFGYGVMLLELITGQRAF 340
GT +I+PE L + D + GV L E++ G F
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 192
+ + +G G +G VYK + + G +VA+KR++ + G + E+ ++ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N++ L + LV+ FM + L E L S K RG+A+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHC 135
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---TH--VTTAVRGTIGHI 307
H H +I+HRD+K N+L++ + + DFGLA+ TH VT R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 308 APEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
AP+ L K S D++ G + E+ITG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 50/245 (20%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVK-------------------------RLKEERTQGGE 176
+G+G +G V D + A+K + +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 177 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV----NGSVASCLRERGQSQPP 232
Q E+ ++ H N+++L P E L +MV N +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSED 137
Query: 233 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292
+ + G + YLH KIIHRD+K +N+L+ E+ + DFG++
Sbjct: 138 QARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 293 DTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDD 349
D ++ V GT +APE LS + S + DV+ GV L + GQ F D+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DE 243
Query: 350 DVMLL 354
+M L
Sbjct: 244 RIMCL 248
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 30/212 (14%)
Query: 134 TDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMIS 187
+ FS+ LG+G F V + T G A K + ++ + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQI 241
H N++RL + LV+ + G E S +QI
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQI 114
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTT 298
+AY H + I+HR++K N+LL + + DFGLA + D+
Sbjct: 115 L----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWH 165
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330
GT G+++PE L S+ D++ GV+L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
F +LG G F +V+ + G L A+K +K+ + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGAA 246
N++ L + T LV + G E+ S V +Q+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVL---- 116
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 303
+ YLH++ I+HRD+K N+L +E + ++ DFGL+K+ ++ ++TA GT
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GT 170
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVML 330
G++APE L+ S+ D + GV+
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 187
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 241
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 297
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 187
D + LG G F V K R + G A K + + R + + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VAS-CLRERGQSQPPLNWSVRKQI 241
+H N++ L T+ +L+ + G L E + KQI
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 297
G+ YLH KI H D+K NI+L + + + DFGLA +D
Sbjct: 125 L----DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 42/208 (20%), Positives = 79/208 (37%), Gaps = 25/208 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 191
T+ + LG+G F V + + G A + ++ + Q + E + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQPPLNWSVRKQIALGA 245
N++RL L++ + G E S +QI
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------CIQQIL--- 120
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 302
+ + H ++HR++K N+LL + + DFGLA ++ + G
Sbjct: 121 -EAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 303 TIGHIAPEYLSTGKSSEKTDVFGYGVML 330
T G+++PE L + D++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 50/241 (20%), Positives = 92/241 (38%), Gaps = 35/241 (14%)
Query: 128 RELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTE 182
++L + F++ +G G + + AVK + + + E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----E 65
Query: 183 VEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNW 235
+E++ H N++ L+ +V M G + ER S
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----- 120
Query: 236 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDY 291
V I + + YLH ++HRD+K +NIL E++ + DFG AK +
Sbjct: 121 -VLFTIT----KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351
++ + T T +APE L D++ GV+L ++TG F +++
Sbjct: 173 ENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
Query: 352 M 352
+
Sbjct: 232 L 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 199
LG G FGKV G G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
TPT+ +V ++ G + + + G+ + + +QI + Y H H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA----VDYCHRH---M 131
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--S 317
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 188
Query: 318 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
+ D++ GV+L L+ G FD D+ V L
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD------DEHVPTL 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 87.6 bits (216), Expect = 2e-18
Identities = 58/359 (16%), Positives = 109/359 (30%), Gaps = 95/359 (26%)
Query: 107 FDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNIL--GRGGFGKVYKGRLTDGSLVAV 164
++V + +L++ +L EL+ +N+L G G GK + VA+
Sbjct: 129 YNVSRLQ----PYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---------TWVAL 168
Query: 165 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSV 219
+ Q + ++ +++ C +P L L+Y N
Sbjct: 169 DVCLSYKVQ---CKMDFKIFWLNL----------KNCNSPETVLEMLQKLLYQIDPNW-- 213
Query: 220 ASCLRERGQSQPPLNW-SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278
R S L S++ ++ R L + + ++ +V+ A F
Sbjct: 214 --TSRSDHSSNIKLRIHSIQAEL-----RRLLKSKPYENCLLVLLNVQNAKAW--NAF-- 262
Query: 279 VVGDFGLAKLMDYKDTHVTTAVRG-TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
+ L+ + VT + T HI+ ++ S + ++ LL
Sbjct: 263 ---NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV------KSLLLKYLDC 313
Query: 338 RAFDLARLAND--------------DDVMLLDWVKGLLKEKK-------LEQLVDSDMEG 376
R DL R D + D K + +K L L ++
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 377 NYIE-----EEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFR 430
+ I LL + + + VV L L E+ KE
Sbjct: 374 MFDRLSVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK---QPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 48/348 (13%), Positives = 109/348 (31%), Gaps = 89/348 (25%)
Query: 108 DVPAEEDPEVHLGQLKRFSL--RELQVATDNFSNRNILGRGGFGKVYKGRLTDG------ 159
+V ++ + F+L + L + T + L + +
Sbjct: 252 NV---QNAKA----WNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 160 -SLVA------VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF------------ 200
SL+ + L E + + +I+ ++ L +
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRR----LSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 201 -----CMTPTE------RLLVYPFMVN--GSVASCLRERGQSQPP---LNWSVRKQ-IAL 243
+ P E RL V+P + + S + +N + +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 244 GAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVG----DFGLAKLMDYKDTHVTT 298
+ + + K+ + A + + + + D L Y +H
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH--- 476
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL--ITGQ-RAFDLARLAND---DDVM 352
IGH +L + E+ +F ++ L+ + + R A A+ + +
Sbjct: 477 -----IGH----HLKNIEHPERMTLFR--MVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
Query: 353 LLDWVKGLL--KEKKLEQLVDS------DMEGNYIEEEVEQLIQVALL 392
L + K + + K E+LV++ +E N I + L+++AL+
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 26/223 (11%)
Query: 119 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL 177
+G+ F + +DN+ + LG+G F V + T G A K + ++ +
Sbjct: 13 MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 72
Query: 178 Q-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG------SVASCLRERGQSQ 230
Q + E + H N++RL + LV+ + G E S
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS- 131
Query: 231 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 287
+QI +AY H + I+HR++K N+LL + + DFGLA
Sbjct: 132 -----HCIQQIL----ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330
+ D+ GT G+++PE L S+ D++ GV+L
Sbjct: 180 EV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 31/219 (14%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 187
D++ LG G F V K R G A K RL R + + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 241
H N++ L T+ +L+ + G L E +Q KQI
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQI 117
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 297
G+ YLH +I H D+K NI+L + + + DFG+A ++
Sbjct: 118 L----DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFK 169
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
GT +APE ++ + D++ GV+ L++G
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+ + + LG G + VYKG+ +LVA+K ++ E +G EV ++ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++ L T LV+ ++ + + L + G +N K RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCH 117
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIGH 306
K++HRD+K N+L++E E + DFGLA+ Y + VT R
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYR----- 167
Query: 307 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
P+ L S + D++G G + E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 199
LG G F K AVK + + E Q E+ + H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQ------SQPPLNWSVRKQIALGAARGLAYLH 253
LV + G + ++++ S + +++ ++++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLV----SAVSHMH 123
Query: 254 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
D ++HRD+K N+L ++ E + DFG A+L + + T T+ + APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
L+ E D++ GV+L +++GQ F + D + ++K+ K
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQ-----SHDRSLTCTSAVEIMKKIKKGDF- 233
Query: 371 DSDMEGNY---IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
EG + +E + LIQ LL P +R KMS +
Sbjct: 234 --SFEGEAWKNVSQEAKDLIQ-GLLTV--DPNKRLKMSGLRY 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 45/308 (14%)
Query: 45 NQLNNPPPSPPPPLQPTPPGASSGNSATGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 104
+ ++ L S + + + ++
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPV----KSKRTSA 61
Query: 105 HFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSN------RNILGRGGFGKVYKGR-LT 157
D+PA P F R + ++ ILG G FG+V+K
Sbjct: 62 LAVDIPAPPAP---------FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 158 DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217
G +A K +K + E + + E+ +++ H NL++L + + +LV ++ G
Sbjct: 113 TGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 218 -------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270
+ L E KQI G+ ++H I+H D+K NI
Sbjct: 172 ELFDRIIDESYNLTELDTI------LFMKQIC----EGIRHMHQM---YILHLDLKPENI 218
Query: 271 LLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 328
L + DFGLA+ + GT +APE ++ S TD++ GV
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 329 MLLELITG 336
+ L++G
Sbjct: 277 IAYMLLSG 284
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 191
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 192 RNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSVRK----QI 241
N++RLR F + E+ LV ++ +V R +++ L K Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV 300
R LAY+H I HRD+K N+LLD + + + DFG AK + + + +
Sbjct: 166 F----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYI 217
Query: 301 -----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
R APE + + DV+ G +L EL+ GQ
Sbjct: 218 CSRYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 29/249 (11%)
Query: 98 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-L 156
+ P+ + +D E+ + ++ Q + D + LG G FG V++
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELGSGAFGVVHRCVEK 73
Query: 157 TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216
G + K + + E+ +++ H L+ L E +L+ F+
Sbjct: 74 ATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 217 G-------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269
G + + E +Q GL ++H+H I+H D+K N
Sbjct: 133 GELFDRIAAEDYKMSEAEVIN------YMRQAC----EGLKHMHEH---SIVHLDIKPEN 179
Query: 270 ILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 327
I+ + + + V DFGLA ++ D V T APE + TD++ G
Sbjct: 180 IMCETKKASSVKIIDFGLATKLN-PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 328 VMLLELITG 336
V+ L++G
Sbjct: 238 VLGYVLLSG 246
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 135 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGG-------E---LQFQTE 182
+ +G G +GKV+K R G VA+KR++ + + G E L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR---- 66
Query: 183 VEMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSV 237
+ H N++RL C LV+ + + + + L + + P +
Sbjct: 67 --HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE--PGVPTET 121
Query: 238 RKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKD 293
K + RGL +LH H +++HRD+K NIL+ + + DFGLA++ M
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 294 TH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
T VT R APE L + D++ G + E+ +
Sbjct: 177 TSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 5e-18
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 27/217 (12%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVH 191
+ +G G +G V+K + +VA+KR++ + G + E+ ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
+N++RL + + LV+ F + + L+ + K +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGF 116
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTI 304
H ++HRD+K N+L++ E + +FGLA+ + Y + VT R
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYR--- 168
Query: 305 GHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 340
P+ L K S D++ G + EL R
Sbjct: 169 ---PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 5e-18
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHR 192
+ + +G G +G VYK + G A+K+++ E+ G + T E+ ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++L T +LV+ + + + L L K L G+AY
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYC 116
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-----LMDYKDTH--VTTAVRGTIG 305
HD +++HRD+K N+L++ E E + DFGLA+ + Y TH VT R
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR---- 167
Query: 306 HIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
AP+ L K S D++ G + E++ G
Sbjct: 168 --APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLRG 199
LG G FGKV VA+K + + + ++ + E+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
TPT+ ++V + G + + E+ + +QI + Y H H K
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH---K 128
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
I+HRD+K N+LLD+ + DFGL+ +M + T+ G+ + APE ++ GK
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPEVIN-GKLYA 185
Query: 320 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
+ DV+ G++L ++ G+ FD D+ + L
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNL 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 35/218 (16%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAV 190
+ + +G G +G V+K R G +VA+K+ E + E+ M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
H NL+ L LV+ + + +V L + + + K I + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVN 116
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-----RGTIG 305
+ H H IHRDVK NIL+ + + DFG A+L+ + V R
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR---- 169
Query: 306 HIAPEYL------STGKSSEKTDVFGYGVMLLELITGQ 337
+PE L DV+ G + EL++G
Sbjct: 170 --SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 39/246 (15%)
Query: 115 PEVHLGQLKRFSLRELQVAT--DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEER 171
E S+ AT D + LG G +G+VYK VA+KR++ E
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 172 TQGGELQF-QT---EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG 227
+ G T EV ++ HRN++ L+ L++ + + L++
Sbjct: 72 EEEG---VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYM 123
Query: 228 QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----D 282
P ++ V K G+ + H + +HRD+K N+LL + D
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 283 FGLAKLM-----DYKDTH--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELI 334
FGLA+ + TH +T R PE L + S D++ + E++
Sbjct: 181 FGLARAFGIPIRQF--THEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 335 TGQRAF 340
F
Sbjct: 233 MKTPLF 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVH 191
D F + G+G FG V G+ G VA+K+ +++ R + ELQ ++ +++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78
Query: 192 RNLLRLRGFCMTPTER-------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRK----Q 240
N+++L+ + T ER +V ++ ++ C R + Q + K Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 241 IALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA 299
+ R + LH + HRD+K N+L++E + DFG AK + + +V
Sbjct: 138 LI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 300 V----RGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
R APE + + + D++ G + E++ G+
Sbjct: 193 CSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 133 ATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 191
++ F LG G + VYKG T G VA+K +K + +G E+ ++ H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCL--RERGQSQPPLNWSVRKQIALGAARGL 249
N++RL T + LV+ FM + + + R G + L ++ K +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-----DYKDTH--VTTAVRG 302
A+ H++ KI+HRD+K N+L+++ + +GDFGLA+ + + VT R
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYR- 175
Query: 303 TIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
AP+ L ++ S D++ G +L E+ITG+
Sbjct: 176 -----APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 189
+ + LG G F VYK R +VA+K++K + +T E++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 190 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
H N++ L + LV+ FM + +++ L S K L +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGL 125
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287
YLH H I+HRD+K N+LLDE + DFGLAK
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 31/219 (14%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVK-----RLKEERTQGGELQFQTEVEMIS 187
D + LG G F V K R + G A K R K R + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQI 241
H N++ L T+ +L+ + G L E ++ KQI
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQI 123
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV-VGDFGLAKLMDYKDTHVT 297
G+ YLH +I H D+K NI+L + + + DFGLA +D
Sbjct: 124 L----NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFK 175
Query: 298 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
GT +APE ++ + D++ GV+ L++G
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 39/226 (17%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQF-QT---EVEMISMA 189
+ +G+G FG+V+K R G VA+K++ E + G F T E++++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 190 VHRNLLRLRGFCMTPTERL--------LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
H N++ L C T LV+ F + +A L S K++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRV 129
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-------T 294
GL Y+H + KI+HRD+KAAN+L+ + + DFGLA+ T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 295 H--VTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
+ VT R PE L + D++G G ++ E+ T
Sbjct: 187 NRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 199
LG G FGKV G+ G VAVK L ++ + ++ + + E++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
TP++ +V ++ G + + + G+ + + +QI G + Y H H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG----VDYCHRH---M 136
Query: 260 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 319
++HRD+K N+LLD A + DFGL+ +M + T+ G+ + APE +S G+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPNYAAPEVIS-GRLYA 193
Query: 320 --KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354
+ D++ GV+L L+ G FD DD V L
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFD------DDHVPTL 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 199
LGRG F V + + G A K L K R Q + E+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 200 FCMTPTERLLVYPFMVNG--------SVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
+E +L+ + G +A + E + + KQI G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQIL----EGVYY 146
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAV---VGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
LH + I+H D+K NILL + + DFG+++ + + + GT ++A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM-GTPEYLA 201
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITG 336
PE L+ + TD++ G++ L+T
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 64/314 (20%), Positives = 113/314 (35%), Gaps = 59/314 (18%)
Query: 118 HLGQLKRFSLRELQVATDNFSN-----RNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEE 170
H + + ++ + +LG G GKV + G A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP 66
Query: 171 RTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER----LLVYPFMVNGSVASCLRE 225
+ + EV+ + +++ + L++ M G L
Sbjct: 67 K-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFS 115
Query: 226 RGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEF 276
R Q + ++ R + I + +LH H I HRDVK N+L +++
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIG----TAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168
Query: 277 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 336
+ DFG AK + T T ++APE L K + D++ GV++ L+ G
Sbjct: 169 VLKLTDFGFAKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
Query: 337 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNY---IEEEVEQLIQVALLC 393
F +N G+ + +L Q + E+ +QLI+ LL
Sbjct: 226 FPPFY----SNTGQ----AISPGMKRRIRLGQY---GFPNPEWSEVSEDAKQLIR-LLLK 273
Query: 394 TQGSPMERPKMSEV 407
T P ER +++
Sbjct: 274 TD--PTERLTITQF 285
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 36/266 (13%)
Query: 99 KRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD 158
K+ E + E L + + S Q+ D F LG G FG+V + +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 159 -GSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMV 215
G+ A+K L K++ + +++ E ++ L++L + +V ++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 216 NGSVASCLRERGQSQPPLNWSVRK----QIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271
G + S LR G+ + + QI L YLH +I+RD+K N+L
Sbjct: 125 GGEMFSHLRRIGR----FSEPHARFYAAQIVLT----FEYLHSL---DLIYRDLKPENLL 173
Query: 272 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGV 328
+D++ V DFG AK + T + GT +APE + + K+ D + GV
Sbjct: 174 IDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA---VDWWALGV 226
Query: 329 MLLELITGQRAFDLARLANDDDVMLL 354
++ E+ G F D + +
Sbjct: 227 LIYEMAAGYPPFF------ADQPIQI 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 186
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396
Query: 187 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 245
L +L C +RL V ++ G + +++ G+ + P +IA+G
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG- 454
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTI 304
L +L II+RD+K N++LD E + DFG+ K + T T GT
Sbjct: 455 ---LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTP 506
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
+IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 550
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+D F + LGRG VY+ + A+K LK + +TE+ ++ H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHP 108
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGS-----VA-SCLRERGQSQPPLNWSVRKQIALGAA 246
N+++L+ TPTE LV + G V ER + KQI
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVKQIL---- 158
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 303
+AYLH++ I+HRD+K N+L + + DFGL+K+++++ T GT
Sbjct: 159 EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GT 213
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVML 330
G+ APE L + D++ G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
+ + LGRG FG V++ + K +K ++ + E+ ++++A HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNG-------SVASCLRERGQSQPPLNWSVRKQIALGA 245
N+L L + E ++++ F+ + A L ER S Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV------SYVHQVC--- 112
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGT 303
L +LH H I H D++ NI+ + + +FG A+ + +
Sbjct: 113 -EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLF-TA 166
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ APE S TD++ G ++ L++G F
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 48/279 (17%)
Query: 100 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRN------------ILGRGG 147
H +D+P E+ + + T + ++GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 148 FGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMT 203
+ KV RL + A++ +K+E E + E + H L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQ 123
Query: 204 PTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR----------GLAYL 252
RL V + VNG G L + +++Q L L YL
Sbjct: 124 TESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEY 311
H+ II+RD+K N+LLD E + D+G+ K + DT T+ GT +IAPE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350
L D + GV++ E++ G+ FD+ +++ D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 26/262 (9%)
Query: 100 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD- 158
+P++ P Q+ +F ++G+G FGKV R
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 159 GSLVAVKRLKEERTQGGELQFQTEVE---MISMAVHRNLLRLRGFCMTPTERL-LVYPFM 214
AVK L+++ + + E ++ H L+ L F ++L V ++
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI 121
Query: 215 VNGSVASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271
G + L+ P R +IA L YLH I++RD+K NIL
Sbjct: 122 NGGELFYHLQRERCFLEPR---ARFYAAEIASA----LGYLHSL---NIVYRDLKPENIL 171
Query: 272 LDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330
LD + V+ DFGL K +++ T T+ GT ++APE L D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 229
Query: 331 LELITGQRAFDLARLANDDDVM 352
E++ G F + + M
Sbjct: 230 YEMLYGLPPFY----SRNTAEM 247
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 143 LGRGGFGKVYKGR---LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+GRG +G VYK + D A+K+++ G + E+ ++ H N++ L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85
Query: 200 FCMTPTERL--LVYPFM---VNGSVASCLRERGQSQP-PLNWSVRKQIALGAARGLAYLH 253
++ +R L++ + + + + +P L + K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAV----VGDFGLAKLMDY---KDTHVTTAVRGTIGH 306
+ ++HRD+K ANIL+ E + D G A+L + + V T +
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 307 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ 337
APE L + ++ D++ G + EL+T +
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 48/241 (19%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK---------EERTQGGELQFQ 180
+ + +F LG G FG+V+ R G A+K LK E T
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 181 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK- 239
E M+S+ H ++R+ G + ++ ++ G + S LR+ + P V K
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKF 110
Query: 240 ---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
++ L L YLH II+RD+K NILLD+ + DFG AK V
Sbjct: 111 YAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDV 159
Query: 297 TTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353
T + GT +IAPE +ST KS D + +G+++ E++ G F D + M
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFY------DSNTMK 210
Query: 354 L 354
Sbjct: 211 T 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 186
++ +F+ +LG+G FGKV L AVK LK++ + T VE +
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 187 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 245
L +L C +RL V + VNG G L + +++
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEY-VNG---------GD----LMYHIQQVGRFKE 120
Query: 246 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 294
GL +L II+RD+K N++LD E + DFG+ K + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
T GT +IAPE ++ + D + +GV+L E++ GQ F+ D+D +
Sbjct: 178 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDEL 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 25/259 (9%)
Query: 108 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVA 163
D + H + + +V +NF +LG G +GKV+ R G L A
Sbjct: 27 DGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 164 VKRLKEER-TQGGELQFQTEVE-MISMAVHRN--LLRLRGFCMTPTERL-LVYPFMVNGS 218
+K LK+ Q + T E + + ++ L+ L + +L L+ ++ G
Sbjct: 87 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGE 145
Query: 219 VASCLRERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275
+ + L +R + V+ +I L L +LH II+RD+K NILLD
Sbjct: 146 LFTHLSQRERFTEHE---VQIYVGEIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195
Query: 276 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV--FGYGVMLLEL 333
V+ DFGL+K +T GTI ++AP+ + G S V + GV++ EL
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 334 ITGQRAFDLARLANDDDVM 352
+TG F + N +
Sbjct: 256 LTGASPFTVDGEKNSQAEI 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 26/264 (9%)
Query: 98 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT 157
+K+ + F + D + + +V + F +LG+G FGKV +
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 158 D-GSLVAVKRLKEERTQGGELQFQTEVE--MISMAVHRNLLRLRGFCMTPTERL-LVYPF 213
G A+K LK+E + T E ++ + H L L+ + +RL V +
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 214 MVNGSVASCL-RERGQSQPPLNWSVR---KQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269
G + L RER S+ R +I L YLH + +++RD+K N
Sbjct: 230 ANGGELFFHLSRERVFSED----RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLEN 279
Query: 270 ILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 328
++LD++ + DFGL K + T GT ++APE L D +G GV
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 329 MLLELITGQRAFDLARLANDDDVM 352
++ E++ G+ F D + +
Sbjct: 338 VMYEMMCGRLPFY----NQDHEKL 357
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 27/232 (11%)
Query: 131 QVATDNFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 185
+ F +LG+G FGKV+ L A+K LK+ ++ + E ++
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 186 ISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---KQI 241
+ H +++L + +L L+ F+ G + + L + V+ ++
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---VKFYLAEL 135
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTTAV 300
AL L +LH II+RD+K NILLDEE + DFGL+K +D++ +
Sbjct: 136 ALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSF 186
Query: 301 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
GT+ ++APE ++ ++ D + +GV++ E++TG F D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ----GKDRKET 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMA 189
++ DNF +LG+G FGKV R+ + G L AVK LK++ + T E ++
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 190 VHRN---LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 245
+ RN L +L C +RL V F VNG G L + ++K
Sbjct: 79 LARNHPFLTQLF-CCFQTPDRLFFVMEF-VNG---------GD----LMFHIQKSRRFDE 123
Query: 246 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 294
AR L +LHD II+RD+K N+LLD E + DFG+ K + T
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 295 HVTTAVRGTIGHIAPEYLSTGKSSEKT-DVFGYGVMLLELITGQRAFDLARLANDDDVM 352
T GT +IAPE L D + GV+L E++ G F+ A ++D +
Sbjct: 181 --TATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFE----AENEDDL 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 41/252 (16%)
Query: 100 RKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNR-----NILGRGGFGKVYKG 154
+ P PA+ P + LQ+ + + +LG G GKV +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 155 R-LTDGSLVAVKRL-KEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTER---- 207
A+K L + + EVE + +++R+
Sbjct: 82 FNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 208 LLVYPFMVNGSVASCLRERGQSQPPLNWS------VRKQIALGAARGLAYLHDHCDPKII 261
L+V + G L R Q + ++ + K I + YLH I
Sbjct: 135 LIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAIQYLHSI---NIA 183
Query: 262 HRDVKAANILL-DEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 318
HRDVK N+L + A++ DFG AK +TT T ++APE L K
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLGPEKYD 241
Query: 319 EKTDVFGYGVML 330
+ D++ GV++
Sbjct: 242 KSCDMWSLGVIM 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE---MI 186
+ +F ++GRG + KV RL + A+K +K+E E + E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 187 SMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 245
+ H L+ L C RL V + VNG G L + +++Q L
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEY-VNG---------GD----LMFHMQRQRKLPE 109
Query: 246 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 294
L YLH+ II+RD+K N+LLD E + D+G+ K + DT
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350
T+ GT +IAPE L D + GV++ E++ G+ FD+ +++ D
Sbjct: 167 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 40/238 (16%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVE-MISM 188
++ ++F +LG+G FGKV+ A+K LK++ + T VE +
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 189 AVHRN--LLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 245
+ L + E L V + +NG G L + ++
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEY-LNG---------GD----LMYHIQSCHKFDL 117
Query: 246 AR----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDT 294
+R GL +LH I++RD+K NILLD++ + DFG+ K M
Sbjct: 118 SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174
Query: 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
T GT +IAPE L K + D + +GV+L E++ GQ F D++ +
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEEL 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TT 298
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ + +V
Sbjct: 197 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335
R + +APE + + ++DV+ +GV+L E+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 8/108 (7%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE-MIS 187
D LGRG FG+V + VAVK LKE T +E++ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 188 MAVHRNLLRLRGFCMTPTERLLV-YPFMVNGSVASCLRERGQSQPPLN 234
+ H N++ L G C P L+V F G++++ LR + P
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER-TQGGELQF-QTEVEMIS 187
+V ++F +LG+G FGKV R G A+K L++E E+ TE ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 188 MAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
H L L+ + +RL V + NG G+ L + + ++
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEY-ANG---------GE----LFFHLSRERVFTEE 105
Query: 247 R----------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTH 295
R L YLH +++RD+K N++LD++ + DFGL K + T
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161
Query: 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
GT ++APE L D +G GV++ E++ G+ F D + +
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDHERL 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 29/234 (12%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER-TQGGELQFQTEVE- 184
++ + F +LG+GG+GKV++ R G + A+K LK+ + + T+ E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 185 -MISMAVHRNLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVR---K 239
++ H ++ L + +L L+ ++ G + L G
Sbjct: 73 NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT---ACFYLA 128
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVTT 298
+I++ L +LH II+RD+K NI+L+ + + DFGL K + T
Sbjct: 129 EISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--TH 179
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
GTI ++APE L + D + G ++ +++TG F +
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT----GENRKKT 229
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 25/73 (34%), Positives = 34/73 (46%), Gaps = 13/73 (17%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP----PP 57
G IP++++ + L +DLSNN L+G IP G F F P F NN P P
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN---------PGLCGYP 744
Query: 58 LQPTPPGASSGNS 70
L P + G +
Sbjct: 745 LPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 19/48 (39%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLN 48
G+IP +L+N + L L LS N L+G IP++ GS S + N L
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 20/53 (37%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53
GEIP L+N +L + LSNN+LTG+IP G + +NN + P+
Sbjct: 480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 15/47 (31%), Positives = 21/47 (44%), Gaps = 1/47 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQL 47
G IP SL +++ L+ L L N L G+IP + N L
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 15/52 (28%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
G+ R+++ L++L++S+N+ G IP SL +S A N+ P
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL-QYLSLAENKFTGEIPD 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 20/48 (41%), Positives = 29/48 (60%), Gaps = 1/48 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLN 48
GEIP+ L V +L+ L L N LTG+IP+ + + IS +NN+L
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 16/48 (33%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIP-TNGSFSLFTPISFANNQLN 48
GEIP+ + + +L +L LSNN +G+IP G + N N
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 12/55 (21%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNP-PPS 53
G +P + + L+ L LS+N +G++P + + + N+ + P S
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 18/75 (24%), Positives = 25/75 (33%), Gaps = 3/75 (4%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS-PPPPLQP 60
G IP L + SL LDL+ N G IP + + AN ++
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 61 TPPGASSGNSATGAI 75
GA + G
Sbjct: 586 ECHGAGNLLEFQGIR 600
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 10/30 (33%), Positives = 19/30 (63%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 31
G IP+ + ++ L +L+L +N ++G IP
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 19/55 (34%), Positives = 25/55 (45%), Gaps = 5/55 (9%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNP-PPS 53
G IP + SLQ L L+ NK TG+IP G+ T + + N PP
Sbjct: 261 GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 12/54 (22%), Positives = 24/54 (44%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 55
+ SL ++ L+ L LSN+ + G + + T + + N L+ P +
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLT 120
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 12/52 (23%), Positives = 25/52 (48%), Gaps = 2/52 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
G++ ++ +L+ LD+S+N + IP G S + + N+L+
Sbjct: 192 GDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR 241
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 18/51 (35%), Positives = 24/51 (47%), Gaps = 4/51 (7%)
Query: 2 GEIPRSLTNV-NSLQVLDLSNNKLTGDIPT---NGSFSLFTPISFANNQLN 48
GE+P SLTN+ SL LDLS+N +G I + + NN
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 3/50 (6%)
Query: 2 GEIPRSLTNV--NSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLN 48
G I +L N+LQ L L NN TG IP + S + + N L+
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 2/54 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP-PPS 53
G + N S+ LD+S N L+G IP GS ++ +N ++ P
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 5/47 (10%), Positives = 15/47 (31%), Gaps = 1/47 (2%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQL 47
G L +++ ++++ G + + + N L
Sbjct: 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 15/57 (26%), Positives = 24/57 (42%), Gaps = 4/57 (7%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPSPP 55
G + SL LDLS N L+G + T S + ++ ++N L+ P
Sbjct: 91 GSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 10/55 (18%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 2 GEIPRSLT---NVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
G L+ L +S NK++GD+ + ++N + P
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNNFSTGIPF 218
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 11/57 (19%), Positives = 23/57 (40%), Gaps = 4/57 (7%)
Query: 2 GEIP--RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLF--TPISFANNQLNNPPPSP 54
G + SL + + L+ L++S+N L +G L + + N ++
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 6e-13
Identities = 17/44 (38%), Positives = 26/44 (59%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANN 45
G +P+ LT + L L++S N L G+IP G+ F ++ANN
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 18/55 (32%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSF-SLFTPISFANNQLNNP-PPS 53
G +P S++++ +L + N+++G IP + GSF LFT ++ + N+L PP+
Sbjct: 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 18/54 (33%), Positives = 28/54 (51%), Gaps = 2/54 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP-PPS 53
G IP L+ + +L LD S N L+G +P + S I+F N+++ P S
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 14/54 (25%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP-PPS 53
G IP ++ + L L +++ ++G IP + F+ N L+ PPS
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 9e-08
Identities = 9/46 (19%), Positives = 18/46 (39%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQL 47
G+ + + Q + L+ N L D+ G + NN++
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 19/53 (35%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53
G+IP + N+N L +DLS N L GD GS I A N L
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 46/260 (17%), Positives = 93/260 (35%), Gaps = 68/260 (26%)
Query: 130 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT-EVEMIS 187
L+ ++ +S LG G FG V + + G A+K++ ++ +++ E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK-------- 239
+ H N+++L + T + P + + G + + V
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 240 ---------------------------------QIALGAARGLAYLHDHCDPKIIHRDVK 266
Q+ R + ++H I HRD+K
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIK 168
Query: 267 AANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAV----RGTIGHIAPEYLSTGKS-SEK 320
N+L++ + + + DFG AK + + V R APE + +
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPS 222
Query: 321 TDVFGYGVMLLELITGQRAF 340
D++ G + ELI G+ F
Sbjct: 223 IDLWSIGCVFGELILGKPLF 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 23/206 (11%), Positives = 56/206 (27%), Gaps = 48/206 (23%)
Query: 143 LGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLLRL 197
G + ++ D +L VA+ + + ++ + +S + R+
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 198 RGFCMTPTERLLVYPFM--VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
T L+V + G L+E + P ++R A H
Sbjct: 97 LDVVHTRAGGLVV---AEWIRGGS---LQEVADTSPSPVGAIR--AMQSLAAAADAAHRA 148
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
+ + + + + + V+ +
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD- 178
Query: 316 KSSEKTDVFGYGVMLLELITGQRAFD 341
++ + D+ G G L L+ +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLP 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 2e-12
Identities = 32/223 (14%), Positives = 55/223 (24%), Gaps = 45/223 (20%)
Query: 120 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF 179
Q + T+ +G G FG+V++ D + VA+K + E
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 180 QTEVEMISMAV----------------HRNLLRLRGFCM----TPTERLLVYPFM--VNG 217
Q E I + + L P L + G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 218 SVASCLRERGQSQPPL-------------------NWSVRKQIALGAARGLAYLHDHCDP 258
S Q + + + K I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
+ HRD+ N+LL + + K + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT---------EV 183
++ + + G +G V G ++G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 237
+++ H N+L LR E LV M +A + ++ + ++
Sbjct: 81 RLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ---RIVISPQH 135
Query: 238 RK----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
+ I GL LH+ ++HRD+ NILL + + + DF LA+ D
Sbjct: 136 IQYFMYHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-AD 187
Query: 294 THVTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ T V + APE + ++ D++ G ++ E+ + F
Sbjct: 188 ANKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVH 191
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGG 90
Query: 192 RNLLRLRGFCMTPTERLLVYPFM-VNGSVASCLRERGQSQPPLNWSVR---KQIALGAAR 247
N++ L P R F VN + ++ Q+ + +R +I +
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTD---FKQLYQTLTDYD--IRFYMYEIL----K 141
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGH 306
L Y H I+HRDVK N+++D E + + D+GLA+ + V +
Sbjct: 142 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYF 196
Query: 307 IAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAF 340
PE L + D++ G ML +I + F
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 39/225 (17%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83
Query: 201 CMTPTERLLVYPFMVNGSVAS--C---------LRE--RGQSQPPLNWSVRKQIALGAAR 247
+LL + F G L + + KQI+
Sbjct: 84 GANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 248 GLAYLHDHCDPKIIHRDVKAANILLDEE------FEAVVGDFGLAKLMDYKDTHVTTAV- 300
GL Y+H C IIH D+K N+L++ + + D G A + D H T ++
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 301 ----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
R +PE L D++ ++ ELITG F+
Sbjct: 198 TREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 183
+ N +G G G V VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 236
++ H+N++ L TP + L +V M + ++ ++ L+
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELM-DANLCQVIQM------ELDHE 127
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 182
Query: 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T T + APE + E D++ G ++ E+I G F
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 51/230 (22%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 183
+ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 236
++ H N++ L TP L LV PFM + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMG-----LKFSEEK 127
Query: 237 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
++ Q+ +GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ D +
Sbjct: 128 IQYLVYQML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 294 TH--VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T VT R APE LS ++ D++ G ++ E++TG+ F
Sbjct: 181 TGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 43/193 (22%), Positives = 66/193 (34%), Gaps = 31/193 (16%)
Query: 143 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEV-------EMISMAVHRNL 194
+G GGFG +Y A +K E + G L + + + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 195 LRLRGF-----CMTPTERLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGA 245
L G + Y FMV + + G S Q+ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIRM 160
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--THVTTAVR 301
L Y+H++ +H D+KAAN+LL + V D+GL+ Y H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQEN 215
Query: 302 GTIGHI-APEYLS 313
GH E+ S
Sbjct: 216 PRKGHNGTIEFTS 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 38/161 (23%), Positives = 58/161 (36%), Gaps = 32/161 (19%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRG 199
+LG G GKV + A+K L++ + + EVE + +++R+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 78
Query: 200 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGL 249
L+V + G L R Q + ++ R K I +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIG----EAI 130
Query: 250 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 287
YLH I HRDVK N+L + DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 38/224 (16%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 183
+ N +G G G V VA+K+L FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 236
++ H+N++ L TP + L LV M + ++ ++ L+
Sbjct: 113 VLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELM-DANLCQVIQM------ELDHE 164
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296
+ G+ +LH IIHRD+K +NI++ + + DFGLA+ + +
Sbjct: 165 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFM 219
Query: 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T T + APE + E D++ G ++ E++ + F
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 50/230 (21%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 183
+ + N + +G G +G V T G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 236
++ H N++ L TP L LV M + L + Q +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 237 VRK---QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
V+ QI RGL Y+H IIHRD+K +N+ ++E+ E + DFGLA+ +
Sbjct: 134 VQFLIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 294 T--HVTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
T T R APE L+ ++ D++ G ++ EL+TG+ F
Sbjct: 187 TGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 35/212 (16%), Positives = 72/212 (33%), Gaps = 51/212 (24%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQT---------EV 183
D + R+++G G +G V + + +VA+K++ F+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL-----LVYPFMVNGSVASCLRERGQSQPPLNWSVR 238
+++ H +++++ + +V R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFR 148
Query: 239 KQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288
+ L G+ Y+H I+HRD+K AN L++++ V DFGLA+
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 320
+DY + + + K
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 183
+ + +G G +G V G+ VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL-------LVYPFMVNGSVASCLRERGQSQPPLNWS 236
++ H N++ L TP E L LV PFM + L + + + L
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEK-LGED 128
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 295
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D + T
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 296 -VTTAVRGTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
VT R APE L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 186 VVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 59/236 (25%)
Query: 135 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 186
D+ + R ++G+G FG+V K VA+K ++ E Q E+ ++
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRIL 147
Query: 187 SMAVHR------NLLRL------RG-FCMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 231
+ N++ + R CMT E L + L E +
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMT-FELL-----------SMNLYELIKKNKFQ 195
Query: 232 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 289
+ + ++ A + L LH + +IIH D+K NILL ++ + V DFG +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC-- 250
Query: 290 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
Y+ V T + R APE + + D++ G +L EL+TG
Sbjct: 251 -YEHQRVYTYIQSRFYR------APEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 64/267 (23%)
Query: 102 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GS 160
H A PE+ GQ F + ++N + +G G +G V
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQ--VFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKV 53
Query: 161 LVAVKRLKEERTQGGELQFQT---------EVEMISMAVHRNLLRLRGFCMTPTERL--- 208
VA+K++ F+ E++++ H N++ + +
Sbjct: 54 RVAIKKIS---------PFEHQTYCQRTLREIKILLRFRHENIIGIND-IIRAPTIEQMK 103
Query: 209 ---LVYPFMVNGSVASCLRERGQSQPPLNWSVRK---QIALGAARGLAYLHDHCDPKIIH 262
+V M + L + ++Q N + QI RGL Y+H ++H
Sbjct: 104 DVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL----RGLKYIHS---ANVLH 151
Query: 263 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--------VTTAVRGTIGHIAPEY-LS 313
RD+K +N+LL+ + + DFGLA++ D H T R APE L+
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR------APEIMLN 205
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAF 340
+ ++ D++ G +L E+++ + F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 41/182 (22%), Positives = 68/182 (37%), Gaps = 41/182 (22%)
Query: 143 LGRGGFGKVYKGRLTDGSLVAVKR---LKEERTQGGELQFQTEV-------EMISMAVHR 192
+G+GGFG +Y + V +K E + G L + + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 193 NLLRLRGFCM-----TPTERLLVYPFMVNGSVASCLRER-GQS-QPPLNWSVRK------ 239
L+ G + Y FM+ +R G Q + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI--------MDRFGSDLQKIYEANAKRFSRKTV 154
Query: 240 -QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKD--T 294
Q++L L Y+H+H +H D+KA+N+LL+ + V D+GLA Y
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY--RYCPEGV 209
Query: 295 HV 296
H
Sbjct: 210 HK 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 45/201 (22%)
Query: 127 LRELQVATDNFSNR----NILGRGGFGKVYKGR---------LTDGSLVAVKRLKEERTQ 173
L V TD + + R G +Y+ ++K ++
Sbjct: 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 174 GGELQF-QTEVEMISMAVHRNLLRLRGFCMTPT-----ERLLVYPFMVNGSVASCLRER- 226
E F Q + + + + L + PT Y F+V
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLV--------LPSL 140
Query: 227 GQS-QPPLNWSVRK--------QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277
G+S Q L+ S + Q+A L +LH++ +H +V A NI +D E +
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197
Query: 278 AVV--GDFGLAKLMDYKDTHV 296
+ V +G A Y +
Sbjct: 198 SQVTLAGYGFAFR--YCPSGK 216
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 47/236 (19%), Positives = 91/236 (38%), Gaps = 57/236 (24%)
Query: 135 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 186
+ + +R +++G+G FG+V K + VA+K +K + Q Q EV ++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLL 104
Query: 187 SM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQP 231
+ + ++ L+ C+ E L + L + R +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLV-FEML-----------SYNLYDLLRNTNFR 152
Query: 232 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV--VGDFGLAKLM 289
++ ++ ++ A L +L + IIH D+K NILL + + DFG +
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-- 209
Query: 290 DYKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ + R +PE L D++ G +L+E+ TG+ F
Sbjct: 210 -QLGQRIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTH--------VT 297
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA++MD +H VT
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 298 TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
R +P LS ++ D++ G + E++TG+ F
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 307 I----------APEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ APE L++ K S DV+ G +L EL + F
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/248 (17%), Positives = 77/248 (31%), Gaps = 71/248 (28%)
Query: 135 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 185
D R LG G FGKV + S VA+K ++ R + E+ +
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINV 69
Query: 186 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 230
+ + + + C+ E L E + +
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIA-FELL-----------GKNTFEFLKENNF 117
Query: 231 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 286
P + +A L +LH++ ++ H D+K NIL + + +
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 287 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPEYLSTGKSSEKTDVFGYGVM 329
++ D + H TT V R PE + ++ DV+ G +
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCI 228
Query: 330 LLELITGQ 337
L E G
Sbjct: 229 LFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 44/258 (17%), Positives = 80/258 (31%), Gaps = 87/258 (33%)
Query: 135 DNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRLKEE---RTQGGELQFQTEVEMI 186
+N +G G FG+V + + + AVK ++ + E +++
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADIL 85
Query: 187 SM-----AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQPP 232
+ N+++ G C+ E L L E +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLI-FEPL-----------GPSLYEIITRNNYNG 133
Query: 233 LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA------ 286
+ K + + L YL + H D+K NILLD+ +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 287 -----------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSE 319
KL+D +K + + + R APE +
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DV 238
Query: 320 KTDVFGYGVMLLELITGQ 337
+D++ +G +L EL TG
Sbjct: 239 SSDMWSFGCVLAELYTGS 256
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 10/57 (17%), Positives = 21/57 (36%), Gaps = 2/57 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPL 58
E P +T SL L + +N + + + ++ + +N + S P
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISV-LDIKDNPNISIDLSYVCPY 610
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 14/52 (26%), Positives = 24/52 (46%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
+ SL + L +L+ N+L G +P GS ++ A NQ+ P +
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPAN 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 8/61 (13%), Positives = 18/61 (29%), Gaps = 2/61 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG--SFSLFTPISFANNQLNNPPPSPPPPLQ 59
G +P ++ + L+VL L ++ + G S + +
Sbjct: 95 GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
Query: 60 P 60
Sbjct: 155 R 155
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 11/60 (18%), Positives = 23/60 (38%), Gaps = 5/60 (8%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPPSPPPPL 58
+ + ++ ++LSNN+++ FS +P+S N L P +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPK--ELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 7/63 (11%), Positives = 20/63 (31%), Gaps = 10/63 (15%)
Query: 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS---------FANNQLNN-P 50
+ ++P L + +Q+++++ N+ + N L P
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 51 PPS 53
+
Sbjct: 322 VET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 3/51 (5%), Positives = 14/51 (27%), Gaps = 4/51 (7%)
Query: 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
+ +++ + L+ + N+ + + + Q
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENI----CEAWENENSEYAQQYKTEDL 243
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 8/67 (11%), Positives = 17/67 (25%), Gaps = 1/67 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSPPPPLQP 60
N+ L +++ N +PT + I+ A N+ +
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 61 TPPGASS 67
Sbjct: 299 ADAPVGE 305
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 10/55 (18%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPPS 53
+ + N L +DL NKLT + + + + + N + P
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 5/63 (7%)
Query: 3 EIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPSPPPPL 58
EIP + ++ L ++NKL IP + I F+ N++ + PL
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 59 QPT 61
PT
Sbjct: 426 DPT 428
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 46/254 (18%), Positives = 89/254 (35%), Gaps = 75/254 (29%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT---------EV 183
DN+ ++++GRG +G VY + VA+K++ F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76
Query: 184 EMISMAVHRNLLRLRGFCMTPTERL------LVYPFMVNGSVASCLRERGQSQPPLNWSV 237
+++ ++RL + P + L +V L
Sbjct: 77 TILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA---------------DSDLKKLF 120
Query: 238 RKQIALGAA----------RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287
+ I L G ++H+ IIHRD+K AN LL+++ V DFGLA+
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 288 LMDYKDTHVTTAVRGTIGHI---------------------APEYLSTGKS-SEKTDVFG 325
++ + APE + ++ ++ D++
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 326 YGVMLLELITGQRA 339
G + EL+ ++
Sbjct: 238 TGCIFAELLNMLQS 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 49/254 (19%), Positives = 85/254 (33%), Gaps = 83/254 (32%)
Query: 135 DNFSNR----NILGRGGFGKVYKG--RLTDGSLVAVKRLKEE---RTQGGELQFQTEVEM 185
D S R + LG G FGKV + G VAVK +K ++E+++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQV 64
Query: 186 ISM------AVHRNLLRLRGF-------CMTPTERLLVYPFMVNGSVASCLRE--RGQSQ 230
+ +++ + C+ E L + +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIV-FELL-----------GLSTYDFIKENGF 112
Query: 231 PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---- 286
P +++A + + +LH + K+ H D+K NIL + + +
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 287 -------KLMD-----YKDTHVTTAV-----RGTIGHIAPE------YLSTGKSSEKTDV 323
K++D Y D H +T V R APE + S+ DV
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILALGW------SQPCDV 217
Query: 324 FGYGVMLLELITGQ 337
+ G +L+E G
Sbjct: 218 WSIGCILIEYYLGF 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
+ + YLH ++HRD+K +NILL+ E V DFGL++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 307 I--------------------APEY-LSTGKSSEKTDVFGYGVMLLELITGQ 337
APE L + K ++ D++ G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 11/56 (19%), Positives = 20/56 (35%), Gaps = 4/56 (7%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP----ISFANNQLNNPPPS 53
P + L L L+N +L + L +S +N+QL+ +
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 9/54 (16%), Positives = 23/54 (42%), Gaps = 6/54 (11%)
Query: 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPS 53
+ + + L+VLDL N++ ++ + ++F I + N+ +
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELT-GQEWRGLENIFE-IYLSYNKYLQLTRN 448
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 14/54 (25%), Positives = 19/54 (35%), Gaps = 3/54 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANNQLNNPPPS 53
G L ++ L +L+L +N F L I N LN P S
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI-IDLGLNNLNTLPAS 578
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 13/54 (24%), Positives = 18/54 (33%), Gaps = 5/54 (9%)
Query: 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPS 53
S V SLQ L L L + F +L + +NN + N
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI-LDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 11/57 (19%), Positives = 20/57 (35%), Gaps = 5/57 (8%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS-----FANNQLNNPPPS 53
G T + +L+ L LSN+ + TN +F N+++
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 13/55 (23%), Positives = 21/55 (38%), Gaps = 7/55 (12%)
Query: 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS-----FANNQLNNPPPS 53
+ + +LQ L LSNNK+ +F S ++NQ+ P
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKS--EELDIFANSSLKKLELSSNQIKEFSPG 189
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 10/61 (16%), Positives = 19/61 (31%), Gaps = 5/61 (8%)
Query: 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPSPPPPLQP 60
+L LDLS+N L+ G+ + +NN++
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKL--GTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 61 T 61
+
Sbjct: 171 S 171
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 37/184 (20%), Positives = 54/184 (29%), Gaps = 62/184 (33%)
Query: 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268
+V+ + G + Q L K+I +GL YLH C +IIH D+K
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE 176
Query: 269 NILL-------------------------------------------------DEEFEAV 279
NILL E+ +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 280 VGDFGLAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 337
+ D G A + T T R + E L + D++ M EL TG
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATGD 290
Query: 338 RAFD 341
F+
Sbjct: 291 YLFE 294
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 7/56 (12%), Positives = 17/56 (30%), Gaps = 10/56 (17%)
Query: 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS------FANNQLNNPPPS 53
+ + + L+ LD ++ L FS+F + ++
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSE----FSVFLSLRNLIYLDISHTHTRVAFNG 439
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 9/55 (16%), Positives = 21/55 (38%), Gaps = 5/55 (9%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP---ISFANNQLNNPPPS 53
P + +++SLQVL++S+N + + ++ N +
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 10/56 (17%), Positives = 21/56 (37%), Gaps = 6/56 (10%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPS 53
++SL+VL ++ N + + F +L + + QL P+
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPD-IFTELRNLTF-LDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 14/54 (25%), Positives = 22/54 (40%), Gaps = 4/54 (7%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNPPPS 53
G +S SL+ LDLS N + + +N G L + F ++ L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEH-LDFQHSNLKQMSEF 414
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 13/59 (22%), Positives = 24/59 (40%), Gaps = 9/59 (15%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS-------LFTPISFANNQLNNPPPS 53
++P +N+ +L+ LDLS+NK+ L + + N +N P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYC--TDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 9/55 (16%), Positives = 18/55 (32%), Gaps = 3/55 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANNQLNNPPPSP 54
+ +++ L L L+ N + +G SL + L + P
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK-LVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 6/58 (10%), Positives = 17/58 (29%), Gaps = 1/58 (1%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPPPLQ 59
+I + ++ L + + + +F + N + P L+
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH-LELVNCKFGQFPTLKLKSLK 328
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 11/60 (18%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN-PPPSPPPPLQP 60
+ P +T SL L + +N + + + L+ + A+N + S P ++
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYI-LDIADNPNISIDVTSVCPYIEA 853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 11/64 (17%), Positives = 21/64 (32%), Gaps = 10/64 (15%)
Query: 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP----------ISFANNQLNNP 50
M ++P L ++ LQ L+++ N+ ++ N L
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563
Query: 51 PPSP 54
P S
Sbjct: 564 PASA 567
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 3/52 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
I +++ + LQ++ +N+ T D + S Q N S
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNI---AVDWEDANSDYAKQYENEELS 486
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 12/62 (19%), Positives = 26/62 (41%), Gaps = 7/62 (11%)
Query: 3 EIPRSL-TNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPSPPPP 57
EIP + ++ L S+NKL IP + + + + F+ N++ + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGS-VDFSYNKIGSEGRNISCS 666
Query: 58 LQ 59
+
Sbjct: 667 MD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 8/55 (14%), Positives = 17/55 (30%), Gaps = 2/55 (3%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPPP 56
G +P ++ + L+VL + T G L + + +
Sbjct: 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL--TPDMSEERKHRIRMHYKK 389
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 35/166 (21%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGF 200
+G G FG +++G L + VA+K E + Q + E + + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK-------QIALGAARGLAYL 252
+LV + G S L + RK A + +
Sbjct: 75 GQEGLHNVLVIDLL------------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKD 293
H+ +++RD+K N L+ V DFG+ K Y+D
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRD 163
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 14/61 (22%), Positives = 19/61 (31%), Gaps = 4/61 (6%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF---ANNQLNNPPPSPPPPL 58
G LQ LDLS+N L S + ++ + L P P L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRD-AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL 276
Query: 59 Q 59
Sbjct: 277 S 277
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 41/183 (22%), Positives = 61/183 (33%), Gaps = 36/183 (19%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE 184
S+ L V NF +G G FG++ G+ L VA+K E + Q E
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYR 56
Query: 185 MISMAVH-RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPL-NWSVRK--- 239
+ ++ F +V + G S L + R
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL------------GPSLEDLFDLCDRTFSL 104
Query: 240 ----QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG-----DFGLAKLMD 290
IA+ + Y+H +I+RDVK N L+ DF LAK +
Sbjct: 105 KTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--E 159
Query: 291 YKD 293
Y D
Sbjct: 160 YID 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 42/167 (25%), Positives = 61/167 (36%), Gaps = 39/167 (23%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G G FG +Y G + G VA+K E + Q E + +++ + G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESK-----IYKMMQGGVGIP 68
Query: 202 MTPTERLLVYPFMVNGS----VASCLRERGQSQPPL-NWSVRK-------QIALGAARGL 249
+ G V L G S L N+ RK +A +
Sbjct: 69 T-------IRWCGAEGDYNVMVMELL---GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 250 AYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKD 293
Y+H IHRDVK N L+ + + DFGLAK Y+D
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRD 160
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 8/63 (12%), Positives = 15/63 (23%), Gaps = 3/63 (4%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFT---PISFANNQLNNPPPSPPPPL 58
I + Q L+ + I S +F + + P+ L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 59 QPT 61
Sbjct: 252 CEM 254
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 14/51 (27%), Positives = 20/51 (39%), Gaps = 4/51 (7%)
Query: 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53
L LQ L +S NKL +P F + + + NQL + P
Sbjct: 445 SFSLFLPR---LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 7/55 (12%), Positives = 16/55 (29%), Gaps = 6/55 (10%)
Query: 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSF----SLFTPISFANNQLNNPPPS 53
+ + + LQ LD ++ L + +F L + +
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLEKLLY-LDISYTNTKIDFDG 442
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 19/159 (11%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGF 200
+G G FG++Y G + VA+K E + Q E ++ + + +R F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 201 CMTPTERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK 259
+ +LV + G S+ + L+ +A + ++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 260 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTH 295
+HRD+K N L+ + + DFGLAK Y+DT
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTS 160
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 460 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.35 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 96.89 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 96.87 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 96.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 96.71 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 96.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 96.48 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 96.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 96.45 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 96.36 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 96.36 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 96.31 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 96.27 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 96.26 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 96.25 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 96.23 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 96.14 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 96.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.02 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 96.01 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 95.85 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 95.81 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 95.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 95.79 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 95.75 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.68 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 95.66 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 95.64 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 95.63 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 95.54 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 95.53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 95.45 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 95.43 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 95.4 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 95.39 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 95.24 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 95.15 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 95.14 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 95.09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 95.09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 95.05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 95.02 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 94.99 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 94.92 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 94.82 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 94.68 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 94.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 94.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 94.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 94.39 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 94.36 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 94.35 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 94.35 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 94.12 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 94.08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 94.05 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 93.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 93.93 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 93.88 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 93.84 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 93.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 93.82 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 93.82 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 93.75 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 93.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 93.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 93.68 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 93.66 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 93.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 93.57 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 93.57 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 93.56 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 93.53 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 93.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 93.45 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 93.41 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 93.4 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 93.37 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 93.31 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 93.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 93.07 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 93.03 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 93.03 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 92.98 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 92.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 92.93 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 92.93 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 92.82 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 92.8 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 92.79 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 92.74 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 92.7 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 92.68 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 92.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 92.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 92.4 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 92.23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 92.11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 92.1 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 92.07 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 92.03 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 91.98 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 91.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 91.84 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 91.84 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.75 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 91.66 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 91.56 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 91.46 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 91.46 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 91.14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 91.11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 90.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 90.56 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 90.52 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 90.49 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 90.14 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 89.51 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 89.02 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 88.97 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 88.94 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 88.52 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.46 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 87.29 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 86.68 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 86.42 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 85.91 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.77 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 85.76 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 84.7 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 84.41 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 83.27 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 83.2 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 82.18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 80.28 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 80.22 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=430.64 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=211.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
+++.+.+.||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45666788999999999999863 467899999986655555668999999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 209 LVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
+|||||++|+|.++|..... ....++|..++.|+.|||.||+|||++ +|+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999975431 123589999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHH
Q 012610 277 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 354 (460)
++||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||... ...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--------~~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--------CHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CHH
Confidence 999999999987643322 22334568999999999999999999999999999999999 89999532 122
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
+.+......... ..+..++..+.++|.+||+.||++||||.||++.|+.
T Consensus 255 ~~~~~i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 DVVEMIRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 222222221111 1122345678999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-58 Score=428.14 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=210.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|.+.+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 357888899999999999999864 36789999997543 33455799999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 208 LLVYPFMVNGSVASCLRERG---------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
++|||||++|+|.++|+..+ .....++|..++.|+.||+.||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997643 2234699999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 356 (460)
||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence 999999998765433322 223458999999999999999999999999999999999 899995321 2222
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
+......... ..+..++..+.+++.+||+.||++||||++|++.|++
T Consensus 240 ~~~i~~~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 240 IECITQGRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222222111 1112234678999999999999999999999999976
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=420.70 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=203.1
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++..+++.+.+.||+|+||+||+|++. ..||||+++.... ......|.+|++++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 445678888899999999999999875 3599999975433 2334579999999999999999999998864 56899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|||||++|+|.++++.... ++++..+..|+.|||.||+|||++ +|+||||||+||||++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999976432 499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CceeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 290 DYKD-THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 290 ~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
.... ........||+.|||||++.+ +.|+.++|||||||+||||+||+.||.... . ...+...+....
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~---~~~~~~~~~~~~ 254 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----N---RDQIIFMVGRGY 254 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C---HHHHHHHHHTTC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhcCC
Confidence 5332 223345679999999999864 468999999999999999999999995311 1 111111111111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+.. ......++..+.+++.+||+.||++||||.||++.|+.
T Consensus 255 ----~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 255 ----ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ----CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ----CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 11122344678999999999999999999999998874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=427.67 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=204.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++|.+.++||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56777889999999999999864 47889999997542 334557999999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc
Q 012610 209 LVYPFMVNGSVASCLRERGQ-----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 277 (460)
+|||||++|+|.++++.... ...+++|..++.|+.||+.||+|||++ +|+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999986532 224699999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHH
Q 012610 278 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~ 355 (460)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 99999999987654332 22334569999999999999999999999999999999999 899995321 122
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.+......... ..+..+...+.+++.+||+.||++||||.||++.|+.+
T Consensus 269 ~~~~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 AIDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22222222111 11122346689999999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=420.85 Aligned_cols=324 Identities=94% Similarity=1.420 Sum_probs=274.5
Q ss_pred CCCCCCCcccccCCccccCHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHh
Q 012610 108 DVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 187 (460)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 187 (460)
+.+.+..+....+..+.+++.++....++|...+.||+|+||.||+|+..+++.||||++...........+.+|++++.
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 82 (326)
T 3uim_A 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82 (326)
T ss_dssp ------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred CCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence 45566667777888899999999999999999999999999999999988899999999987655444457899999999
Q ss_pred ccCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCC
Q 012610 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKA 267 (460)
Q Consensus 188 ~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp 267 (460)
.++||||+++++++......++||||+.+|+|.+++........++++..++.++.|++.||+|||+++.++|+||||||
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 99999999999999999999999999999999999988766666799999999999999999999998777899999999
Q ss_pred CCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccC
Q 012610 268 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347 (460)
Q Consensus 268 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 347 (460)
+|||++.++.+||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||++|+.||+......
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999999876555555566679999999999998899999999999999999999999998766666
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCcchhhHHHHhh
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 427 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 427 (460)
.......+|+...........+.+..............+.+++.+||+.||.+|||+.||++.|++..+.++|..|..++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 322 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 322 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC------
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHH
Confidence 77788889988888888888888888888888899999999999999999999999999999999999999999999998
Q ss_pred hhhc
Q 012610 428 MFRQ 431 (460)
Q Consensus 428 ~~~~ 431 (460)
|.++
T Consensus 323 ~~~q 326 (326)
T 3uim_A 323 MFRQ 326 (326)
T ss_dssp ----
T ss_pred hhcC
Confidence 8764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=416.59 Aligned_cols=251 Identities=21% Similarity=0.333 Sum_probs=202.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999975 6899999999765433 334578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
||+||+|.+++..... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999976432 3478999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||... ...+.+....... ..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~-~~----- 243 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------SMKNLVLKIISGS-FP----- 243 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTC-CC-----
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCC-CC-----
Confidence 1 2233456999999999999999999999999999999999999999532 1223333322221 11
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1122356889999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=411.76 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=206.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+++++.++|||||++++++.+.+..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888899999999999999986 689999999975433 2344688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
|++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|++||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999763 389999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ...+......... . +.
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~-~-----~~ 289 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRDNL-P-----PR 289 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSS-C-----CC
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCC-C-----CC
Confidence 2 334567999999999999999999999999999999999999999531 1112222111110 0 00
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.||++|||+.|+++
T Consensus 290 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111223456889999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=423.63 Aligned_cols=269 Identities=27% Similarity=0.393 Sum_probs=218.7
Q ss_pred cCHHHHHHHhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhccCC-Ccceee
Q 012610 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRL 197 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l 197 (460)
+...+|++..++|++.+.||+|+||+||+|++.. ++.||||+++..........|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4566788889999999999999999999998642 357999999876655556679999999999976 899999
Q ss_pred eeeeecC-CcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 012610 198 RGFCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 264 (460)
Q Consensus 198 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 264 (460)
+|+|.+. +..++|||||++|+|.++|+.... ....+++..++.++.|||.||+|||++ +|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999976432 134589999999999999999999999 999999
Q ss_pred CCCCCEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccc
Q 012610 265 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 342 (460)
Q Consensus 265 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~ 342 (460)
|||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3345568999999999999999999999999999999998 9999953
Q ss_pred ccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 343 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.. ... .+...+..+... ..+..+...+.++|.+||+.||++|||+.||++.|+.
T Consensus 291 ~~----~~~----~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VK----IDE----EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CC----CSH----HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----HHH----HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 21 111 111222221111 1112234568899999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=409.34 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=202.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..|+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 46778889999999999999976 689999999975432 24799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 292 (460)
|+||+|.++++..+ ++++..++.++.||+.||+|||++ +|+||||||+||||+.+| ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998754 399999999999999999999999 999999999999999988 6999999999876543
Q ss_pred CCc----eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 293 DTH----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 293 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.... ........... .....+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~---~~~~~~ 277 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKIASE---PPPIRE 277 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHHHHS---CCGGGG
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHcC---CCCchh
Confidence 211 1233579999999999999999999999999999999999999996321 11112111110 000011
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
+ .......+.+++.+||+.||++|||+.||++.|..
T Consensus 278 -----~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 -----I----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -----S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----c----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 11223568889999999999999999999988754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=406.30 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=207.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.++||+|+||+||+|+.. +++.||||++.+... ......+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 689999999975432 233456899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||++||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+........ ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~-~~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKL-EY---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT-CC----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-CC----
Confidence 33 233455679999999999999999999999999999999999999995321 12222222221 11
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
.+... ....+.+++.+||+.||++|||++|++
T Consensus 252 --~~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEK----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11111 234578899999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-55 Score=409.26 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=201.2
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC----cceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~lv 210 (460)
++|.+.+.||+|+||+||+|++. |+.||||++..... ....+..|+..+.+++|||||+++++|..++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45777899999999999999985 88999999965321 1223345666677889999999999998654 46899
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-----CDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
||||++|+|.++++.. +++|..+..++.|++.||+|||++ +.++|+||||||+||||+.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999864 389999999999999999999986 245899999999999999999999999999
Q ss_pred ccccCCCCCce---eecccccccccCcccccCC------CCCcccCchhhHHHHHHHHhCCCccccccccCCC-------
Q 012610 286 AKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDD------- 349 (460)
Q Consensus 286 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~------- 349 (460)
++......... .....||+.|||||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98765443221 2235699999999998764 4678999999999999999999887532211111
Q ss_pred CccHHHHHHHHhhhccccccccccCCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
....... ........ .++.+... ...+....+.+++.+||+.||++||||.||++.|+++
T Consensus 235 ~~~~~~~-~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 235 DPSVEEM-RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHH-HHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHH-HHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111222 22211111 11111111 1234567799999999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-54 Score=396.98 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=195.2
Q ss_pred ccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec----CCcceEEe
Q 012610 138 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 211 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~ 211 (460)
...++||+|+||+||+|.+. ++..||+|++...... .....|.+|+++++.++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55677999999999999976 5889999999765432 334568999999999999999999999865 24578999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEecC-CCcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDE-EFEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~ 288 (460)
|||++|+|.+++.... .+++..++.++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999998754 389999999999999999999998 6 999999999999984 79999999999986
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ............ ....
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~i~~~-~~~~ 249 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSG-VKPA 249 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTT-CCCG
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHHHHcC-CCCC
Confidence 432 22345679999999998865 69999999999999999999999995211 111222221111 1111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+ ......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 111245888999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=412.83 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=206.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++|||||++++++.+.+..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999986 689999999975433 3344688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
|+||+|.+++.... +++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999997542 89999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+...... ....
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~-~~~~----- 366 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDN-LPPR----- 366 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-CCCC-----
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC-CCCC-----
Confidence 2 3345679999999999999999999999999999999999999995311 11222221111 1000
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+ .........+.+++.+||..||++|||+.|+++
T Consensus 367 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 011122356889999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=391.47 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=190.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 6899999999765322 23456899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+ +|+|.+++...+ ++++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999997654 399999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||... ...+........ ..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~~-~~---- 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISNG-VY---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHT-CC----
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcC-CC----
Confidence 22 2334679999999999998876 57999999999999999999999532 122222222211 11
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+. ......+.+++.+||+.||++|||++|+++
T Consensus 230 --~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011 112355788999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=398.36 Aligned_cols=243 Identities=26% Similarity=0.323 Sum_probs=194.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC----CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++|++.+.||+|+||+||+|+.. .++.||||++++.... .....+.+|++++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 4689999999765322 223368889999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|||||+||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998754 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
..... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||... ...+........ ..
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~-~~--- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--------DRKETMTMILKA-KL--- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHC-CC---
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--------CHHHHHHHHHcC-CC---
Confidence 43222 234467999999999999999999999999999999999999999532 122222222221 11
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
.. +......+.+++.+||+.||++|||+
T Consensus 244 ---~~----p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GM----PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CC----CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01 11123568899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=395.12 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=190.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC--------
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-------- 205 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-------- 205 (460)
++|+..+.||+|+||+||+|+.. +|+.||||+++..........+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999976 689999999976554445567899999999999999999999987543
Q ss_pred ----cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 206 ----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 206 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
..|+|||||.+|+|.+++..... ....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 25899999999999999986543 22356778899999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCc-----------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCC
Q 012610 282 DFGLAKLMDYKDTH-----------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350 (460)
Q Consensus 282 Dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~ 350 (460)
|||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 99999876543211 1233569999999999999999999999999999999996 774210
Q ss_pred ccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.....+... ..... +.........+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~-~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDV-RNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHH-HTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHH-hcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111 11110 0112223345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=380.22 Aligned_cols=262 Identities=20% Similarity=0.287 Sum_probs=198.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec------CCc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 206 (460)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 6899999999764332 234568899999999999999999998754 356
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.|+|||||. |+|.+++...+ ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999995 68999997543 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 287 KLMDYKD---THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 287 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.... .......+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-----~~~~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-----YVHQLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhcC
Confidence 8764321 2233456799999999998875 56999999999999999999999995321 1111111111111
Q ss_pred hccccccc-----------c--ccCCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 EKKLEQLV-----------D--SDMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ~~~~~~~~-----------~--~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........ . +....... ......+.+++.+||..||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0 00000000 011345788999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=376.62 Aligned_cols=196 Identities=23% Similarity=0.403 Sum_probs=168.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
..++|++.+.||+|+||+||+|+.+ .++.||||.+.... ...++.+|++++..+ .||||+++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999753 46789999986543 234678899999988 699999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 286 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~ 286 (460)
++||||+++|+|.+++.. +++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999842 89999999999999999999999 99999999999999877 79999999999
Q ss_pred cccCCCCC---------------------------ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCC
Q 012610 287 KLMDYKDT---------------------------HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQR 338 (460)
Q Consensus 287 ~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~ 338 (460)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 76542211 112335699999999999876 48999999999999999999999
Q ss_pred ccc
Q 012610 339 AFD 341 (460)
Q Consensus 339 p~~ 341 (460)
||.
T Consensus 246 Pf~ 248 (361)
T 4f9c_A 246 PFY 248 (361)
T ss_dssp SSS
T ss_pred CCC
Confidence 994
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=369.91 Aligned_cols=279 Identities=40% Similarity=0.671 Sum_probs=236.7
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++...+++|...+.||+|+||.||+|+..+++.||||++..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 33446789999999999999999999988899999999876532 33457889999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999977654445699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........|.........+.
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhccccccHH
Confidence 54322 2222334589999999999999999999999999999999999999964322 23334556655555566667
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
+.+++.............+.+++.+||+.||++|||+.||++.|+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 7777777667778888999999999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=387.81 Aligned_cols=245 Identities=27% Similarity=0.344 Sum_probs=196.0
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHH---HHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~---e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
-++|++.++||+|+||+||+|+.. +|+.||||++.+.... .......+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999976 6899999999754321 11222333 45667788999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
|+||||+.||+|.++|...+ .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
...... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... ............ ..
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~-~~ 411 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTM-AV 411 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHC-CC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCC-CC
Confidence 765332 334679999999999975 57999999999999999999999999642211 111211111111 10
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
.. +......+.+++.+||+.||.+|++.
T Consensus 412 ------~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 412 ------EL----PDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp ------CC----CTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred ------CC----CccCCHHHHHHHHHHccCCHhHCCCC
Confidence 01 11123558899999999999999983
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=388.46 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=205.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++|+.++||||+++++++.+....++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999976 68999999997543 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC--CcEEEeecccccccC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 290 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~ 290 (460)
||.||+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999996533 2489999999999999999999999 99999999999999864 899999999999875
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+......... .
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~-~---- 373 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCD-W---- 373 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTC-C----
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCC-C----
Confidence 433 3344579999999999999999999999999999999999999995321 112222211110 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 374 --~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111122356788999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=362.89 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=210.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
..++|.+.+.||+|+||.||+|+.. ++..||||+++..........+.+|+++++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3468899999999999999999852 34579999998765544556789999999999 89999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEE
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 271 (460)
.+..++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999987542 123489999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCC
Q 012610 272 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDD 349 (460)
Q Consensus 272 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~ 349 (460)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----- 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 999999999999999866433221 1223346789999999999999999999999999999999 999995321
Q ss_pred CccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...+...+ ..... ......+...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 311 ~~~~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 311 VEELFKLL----KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GGGHHHHH----HTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHH----hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111 11110 111122345688999999999999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=343.39 Aligned_cols=250 Identities=19% Similarity=0.317 Sum_probs=205.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||+||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 468999999999999999999864 6899999999754432 34568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+|+|.+++.... +++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999997642 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .............. ..
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~~-~~--- 236 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP-EL--- 236 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC-CC---
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCC-CC---
Confidence 32 2334569999999999999999999999999999999999999995321 11111111111110 00
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.||++|||+.|+++
T Consensus 237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 ----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111223356889999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.90 Aligned_cols=283 Identities=39% Similarity=0.632 Sum_probs=227.8
Q ss_pred CccccCHHHHHHHhcCCccC------CeecccCCeEEEEEEECCCcEEEEEEeccccc---cchhHHHHHHHHHHhccCC
Q 012610 121 QLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVH 191 (460)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h 191 (460)
....|++.++..++++|... +.||+|+||.||+|.. ++..||||++..... ......+.+|+++++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678999999999999887 8999999999999987 478999999975432 2234568899999999999
Q ss_pred CcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEE
Q 012610 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 192 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 271 (460)
|||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999975432 23589999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCC
Q 012610 272 LDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350 (460)
Q Consensus 272 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~ 350 (460)
++.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 240 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP---- 240 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----
Confidence 999999999999999876543222 2233468999999998865 5889999999999999999999999643221
Q ss_pred ccHHHHHHHHhhh-ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 351 VMLLDWVKGLLKE-KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 351 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.....+....... ..+...++..+ ..........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1222222222111 12233333333 234556778899999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=355.88 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=207.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|++++..++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999975 3456999999876555556679999999999999999999999999899999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.++++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999975432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 290 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 290 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ..+...........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~~~~~~~~ 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYRL 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHcCCCC
Confidence 543222 1222335778999999998999999999999999999999 999995321 11222221111111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 274 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 ----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112345688999999999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=355.79 Aligned_cols=265 Identities=27% Similarity=0.417 Sum_probs=202.6
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
...++.+..++|++.+.||+|+||+||+|+.. +..||||++...... .....+.+|++++++++||||+++++++...
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34444556778999999999999999999874 788999999765432 2334688999999999999999999999999
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEecCCCcEEEee
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~D 282 (460)
...++||||+.+|+|.+++..... ...+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999976431 12388999999999999999999999 8 99999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.......
T Consensus 183 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~ 253 (309)
T 3p86_A 183 FGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGF 253 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHH
T ss_pred CCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 99997644322 12233458999999999999999999999999999999999999995321 1111111111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.... . .........+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 254 ~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 254 KCKR-----L----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp SCCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC-----C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1100 0 1111223568899999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=344.74 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=207.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|...++||+|+||+||+|... ++..||+|.+... .......+.+|++++..++||||+++++++.+....++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 467888999999999999999976 5899999998643 23344578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999987432 489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCce-------------eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCC-CccHHHHHH
Q 012610 293 DTHV-------------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVK 358 (460)
Q Consensus 293 ~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~ 358 (460)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11456899999999999999999999999999999999999998532221111 111111111
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.. .. ......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 242 ~~-------------~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 RY-------------CP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HT-------------CC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-------------CC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 00 11123588899999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=365.64 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=209.7
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.+..++|...+.||+|+||.||+|++. +++.||||.++..........+.+|+++++.++||||+++++++......++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 455678999999999999999999986 6899999999765444444568899999999999999999999999889999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999986532 388999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcee-ecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 290 DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 290 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+.. .......
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--------~~~~~-~~~~~~~-- 332 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQTR-EFVEKGG-- 332 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--------HHHHH-HHHHTTC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCC--
Confidence 32211111 11224678999999998899999999999999999998 999995321 11111 1111111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......+...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 333 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0011112345688999999999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.79 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=211.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..++|+..+.||+|+||.||+|...++..||+|++..... ....+.+|++++..++||||+++++++.+....++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4568899999999999999999998888999999976433 23468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999977532 389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.......... ...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~---~~~ 226 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGHR---LYR 226 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCC---CCC
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHHHcCCC---CCC
Confidence 4333334446778999999998899999999999999999999 999995321 1111111111110 011
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
+ ......+.+++.+||+.||++|||+.++++.|+...
T Consensus 227 ~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 P-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp C-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred C-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 112346889999999999999999999999998854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=361.25 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=198.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|...+.||+|+||.||+|+.. ++..||||+++..........+.+|++++.+++||||+++++++......++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468899999999999999999864 4678999999865544455679999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.++++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcee--ecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 290 DYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 290 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
........ ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~~~~~ 269 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGYRL 269 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHTTEEC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCC
Confidence 54322211 12235678999999999999999999999999999998 999995321 11222211111111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.....+...+.+++.+||+.||++||++.+|++.|+..
T Consensus 270 ----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 ----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 01112345689999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=371.21 Aligned_cols=269 Identities=27% Similarity=0.403 Sum_probs=217.4
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.+++..++|...+.||+|+||.||+|.+.. +..||||.++.... ....+.+|++++++++||||++++++|......
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 344556788889999999999999999874 78999999976432 345789999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999986432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..............++..|+|||.+.+..++.++|||||||++|||++ |+.||.... .....+.+. ..
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~~~---~~--- 435 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE---KD--- 435 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHH---TT---
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH---cC---
Confidence 765433222233346778999999999999999999999999999999 999995321 111222111 11
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCcchhhH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERWEE 422 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 422 (460)
........+...+.+++.+||+.||++|||+.+|++.|+..........
T Consensus 436 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~~ 484 (495)
T 1opk_A 436 -------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484 (495)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccccch
Confidence 1111122234668899999999999999999999999998755444433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=343.36 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=209.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..++|+..+.||+|+||.||+|...++..||+|++..... ....+.+|++++.+++||||+++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 4568889999999999999999998889999999976433 23568999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999976432 489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.......... ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~~---~~~ 228 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR---LYK 228 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC---CCC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCcc---CCC
Confidence 2222333446778999999999999999999999999999999 999995321 1122222211110 000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......+.+++.+||+.||++|||+.++++.|+++
T Consensus 229 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 -------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111235688999999999999999999999999763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.13 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=204.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457999999999999999999974 7899999999765432 33446889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997754 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCC-cccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. ......||+.|+|||.+.+..+. .++|||||||++|||++|+.||.... ..+........ ...
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~-~~~--- 232 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRG-KYR--- 232 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC---
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCC---
Confidence 32 23445699999999999888764 79999999999999999999995321 22222222211 110
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. +......+.+++.+||+.||.+|||++|+++
T Consensus 233 ---~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 ---I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 1112345788999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=340.56 Aligned_cols=271 Identities=19% Similarity=0.221 Sum_probs=214.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC--cceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv 210 (460)
.++|.+.++||+|+||.||+|... +++.||||++...........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367889999999999999999986 489999999986554455567889999999999999999999988655 67899
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe----cCCCcEEEeecccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 286 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 286 (460)
|||+++++|.+++...... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999865432 2389999999999999999999999 99999999999999 88888999999999
Q ss_pred cccCCCCCceeecccccccccCccccc--------CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
+....... .....||..|+|||++. +..++.++|||||||++|||++|+.||...... ....+.+.
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHH
Confidence 87654332 23345899999999886 567899999999999999999999999642221 11222222
Q ss_pred HHhhhccc---cccc-----------cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 359 GLLKEKKL---EQLV-----------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 359 ~~~~~~~~---~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
........ ..+. +..............+.+++.+||+.||++|||++|+++...+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 22222111 1000 00111234566777899999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=340.07 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=210.3
Q ss_pred cccCHHHHHHHhcC----------CccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCC
Q 012610 123 KRFSLRELQVATDN----------FSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 191 (460)
Q Consensus 123 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h 191 (460)
..++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.+++.++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 45677777776654 666778999999999999986 689999999975432 334568899999999999
Q ss_pred CcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEE
Q 012610 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 192 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 271 (460)
|||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998643 389999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCc
Q 012610 272 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 351 (460)
Q Consensus 272 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~ 351 (460)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------- 245 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------- 245 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Confidence 99999999999999987654322 2234569999999999999999999999999999999999999995321
Q ss_pred cHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 352 MLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+........ ...... ........+.+++.+||+.||++|||+.++++
T Consensus 246 -~~~~~~~~~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 246 -PVQAMKRLRDS-PPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHHHHHHHS-SCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHhcC-CCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111 110000 01122356889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=372.82 Aligned_cols=262 Identities=23% Similarity=0.408 Sum_probs=212.7
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
..+++..++|...+.||+|+||.||+|.+.++..||||+++... .....+.+|+++++.++||||+++++++. ....
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 34566778899999999999999999999888899999997643 23557999999999999999999999986 5678
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|.++++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 999999999999999975422 1378899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..............++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+...........
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~~~ 404 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIRALERGYRM 404 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHHHHTCCC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCC
Confidence 764322222222346778999999998999999999999999999999 99999531 112222222111111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.....+...+.+++.+||+.||++|||+++|++.|+...
T Consensus 405 ----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 ----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111223466899999999999999999999999998854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=359.09 Aligned_cols=270 Identities=27% Similarity=0.413 Sum_probs=215.5
Q ss_pred ccCHHHHHHHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCccee
Q 012610 124 RFSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLR 196 (460)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~ 196 (460)
.+...++++..++|.+.+.||+|+||.||+|++ .+++.||||+++..........+.+|++++..+ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355677788899999999999999999999974 246789999998665555556789999999999 7999999
Q ss_pred eeeeeecCCc-ceEEeeccCCCCHHHHhhhcCCC----------------------------------------------
Q 012610 197 LRGFCMTPTE-RLLVYPFMVNGSVASCLRERGQS---------------------------------------------- 229 (460)
Q Consensus 197 l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------- 229 (460)
+++++...+. .++||||+.+|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 89999999999999999865421
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 230 ----------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 230 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12288999999999999999999999 99999999999999999999999999998664332
Q ss_pred C-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 294 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 294 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .... ...........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~----~~~~~~~~~~~--- 316 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEF----CRRLKEGTRMR--- 316 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHH----HHHHHHTCCCC---
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHH----HHHHHcCCCCC---
Confidence 2 23334457889999999999999999999999999999998 9999953211 1111 11111111111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
........+.+++.+||+.||.+|||+.||++.|+.
T Consensus 317 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 317 ------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 011123568899999999999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=337.62 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=205.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|++.+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.++..++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999975 6889999998654332 2345688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++++|.+++.... ++++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............. ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~-~~~- 232 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSV-PNV- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCC-CCH-
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccC-CCc-
Confidence 443333444568999999999999999999999999999999999999995321 1111111111110 000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcCC
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEGDG 415 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~ 415 (460)
.... .......+.+++.+||+.||++|| +++++.+.|+...
T Consensus 233 ~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0001 112235688999999999999998 9999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.34 Aligned_cols=266 Identities=26% Similarity=0.434 Sum_probs=214.4
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeee
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 202 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 202 (460)
.+.+..++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34556789999999999999999999874 347899999986655455567899999999999999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQS--------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIH 262 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H 262 (460)
.....++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999874321 14689999999999999999999999 9999
Q ss_pred eCCCCCCEEecCCCcEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcc
Q 012610 263 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAF 340 (460)
Q Consensus 263 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~ 340 (460)
|||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986543221 12233457889999999999899999999999999999999 99999
Q ss_pred ccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 341 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.... ..+...... ...... ........+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 278 ~~~~--------~~~~~~~~~-~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMA--------HEEVIYYVR-DGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSC--------HHHHHHHHH-TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCC--------hHHHHHHHh-CCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 5311 112222211 111111 11122356889999999999999999999999999854
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=357.11 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=212.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+..++|.+.+.||+|+||.||+|+.. .+..||||++...........+.+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34568899999999999999999852 23579999998765555556789999999999 8999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCE
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 270 (460)
..+..++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999987542 123589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 348 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~ 348 (460)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---- 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999987654322 22233447889999999999999999999999999999999 999995321
Q ss_pred CCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+............ ........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 299 ----~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 299 ----VEELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ----HHHHHHHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 122222221111111 1112235688999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=346.76 Aligned_cols=270 Identities=26% Similarity=0.312 Sum_probs=206.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc----ce
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----RL 208 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----~~ 208 (460)
..++|+..++||+|+||+||+|+.. ++.||||++.... ........|+.++..++||||+++++++..... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3568899999999999999999986 7899999996542 223346678888999999999999999987543 59
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-------DPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
+||||+++|+|.++++... +++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999997642 899999999999999999999862 3389999999999999999999999
Q ss_pred ecccccccCCCCCc-eeecccccccccCcccccCC-----CCCcccCchhhHHHHHHHHhCCCccccccccCCC------
Q 012610 282 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLARLANDD------ 349 (460)
Q Consensus 282 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~------ 349 (460)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 22334689999999999763 4567899999999999999999999643221110
Q ss_pred --CccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 350 --DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 350 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.....++....... .......... ........+.+++.+||+.||++|||+.||++.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHK-KKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTS-CCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcc-cCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111111111111 1111111000 0123456799999999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=348.09 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=205.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcce
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~ 208 (460)
..++|+..++||+|+||.||+|+.. +++.||+|++++..... ....+..|..++.++ +||||+++++++.+....+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3468999999999999999999976 57899999997654322 223577889988876 8999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999998754 389999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.+..........
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 3322 22334567999999999999999999999999999999999999999643222221111122222222111111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH---HHHHHhhcCCC
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS---EVVRMLEGDGL 416 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~---evl~~L~~~~~ 416 (460)
. +......+.+++.+||+.||.+||++. .+.+.++-..+
T Consensus 281 -----~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 281 -----I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp -----C----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred -----C----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 1 111235688999999999999999973 34444444443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.89 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=208.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|...+.||+|+||.||+|++. ++..||||+++..........+.+|+.+++.++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999853 36689999997655555566788999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEEe
Q 012610 208 LLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVG 281 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~ 281 (460)
++||||+.+|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999875432 23589999999999999999999999 999999999999999555 59999
Q ss_pred ecccccccCCCC-CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHH
Q 012610 282 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 282 Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++ |..||.... ..+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH
Confidence 999997543211 122233457889999999999999999999999999999998 999995321 1122222
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
....... .........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 299 i~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 299 VTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2111111 1111223568899999999999999999999999976
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=349.01 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=200.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|++.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57899999999999999999976 68999999997655444445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999986543 389999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-ceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 294 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 294 ~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .......+.. ...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~----~~~------ 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE----KKT------ 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT---TSHHHHHHHT----TCT------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhc----ccc------
Confidence 1 22234568999999999988775 7899999999999999999999963221 1111111111 000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...........+.+++.+||+.||++|||+.|+++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00011122356789999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.88 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=197.6
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
++..++|++.+.||+|+||.||+|.... +..||+|.+...........+.+|+.+++.++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3445789999999999999999998753 45799999876554445567899999999999999999999974 567
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 899999999999999998653 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
+..............+++.|+|||.+.+..++.++||||||+++|||++ |..||.... .......+ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-----~~~~~~~i---~~~~~ 235 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRI---ENGER 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHH---HTTCC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-----HHHHHHHH---HcCCC
Confidence 8765433333333446788999999998899999999999999999997 999996321 11111111 11110
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. .........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 236 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 L----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 01112335688999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=343.11 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=204.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc--ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|+..+.||+|+||.||+|+.. +++.||+|++++.. .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999976 68999999997543 122344688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997654 389999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~~---- 222 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILME-EI---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC----
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-CC----
Confidence 222 22344569999999999999999999999999999999999999995321 11222221111 10
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.. .......+.+++.+||+.||++|| +++||++
T Consensus 223 --~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 --RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01 111235688999999999999999 8888875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=340.22 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=200.2
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhc--cCCCcceeeeeeeecC----Cc
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP----TE 206 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~----~~ 206 (460)
..++|...+.||+|+||+||+|+. +++.||||++.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 356899999999999999999998 58899999986532 2345566666655 7999999999986543 45
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
.++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 78999999999999999643 3899999999999999999999 77 99999999999999999999
Q ss_pred EEeecccccccCCCCCce---eecccccccccCcccccCC------CCCcccCchhhHHHHHHHHhC----------CCc
Q 012610 279 VVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITG----------QRA 339 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg----------~~p 339 (460)
||+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999998665433322 2233689999999999876 456799999999999999999 777
Q ss_pred cccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 340 FDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
|..... ....................+.. ..........+.+++.+||+.||++|||+.+|++.|+++
T Consensus 233 f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVP---NDPSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSC---SSCCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCC---CCcchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 743211 11112221111111111111100 011234667899999999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=349.75 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=212.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
+...++|...+.||+|+||.||+|.. .++..||||++...........+.+|+++++.++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34567899999999999999999986 235789999998655444556789999999999999999999999999
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQS--------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 264 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 264 (460)
+..++||||+.+++|.+++...... ...+++..++.++.||+.||+|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 9999999999999999999875431 23488999999999999999999999 999999
Q ss_pred CCCCCEEecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccc
Q 012610 265 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 342 (460)
Q Consensus 265 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~ 342 (460)
|||+||+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765433221 223346788999999999899999999999999999999 9999953
Q ss_pred ccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 343 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.. ...+...+. .... ..........+.+++.+||+.||++|||+.+|++.|+++
T Consensus 256 ~~-----~~~~~~~~~----~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IP-----PERLFNLLK----TGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CC-----GGGHHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-----HHHHHHHhh----cCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 111111111 1110 011112335688999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=342.82 Aligned_cols=258 Identities=21% Similarity=0.356 Sum_probs=207.3
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
++..++|...+.||+|+||.||++...++..||+|++..... ....+.+|++++..++||||+++++++.+....++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 345678899999999999999999998888999999976433 235688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999976332 389999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~---- 239 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLR---- 239 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTCC----
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhcccC----
Confidence 332222233346778999999998899999999999999999998 999995321 1111111111100
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. .........+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 240 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 --L----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 00111235688999999999999999999999999763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.77 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=199.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|+..++||+|+||+||+|++. +++ +||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 457888999999999999999865 343 46888887655445566799999999999999999999999875 478
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++++|+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999987543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||..... ......+.. ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~---~~~- 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEK---GER- 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHT---TCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHHHc---CCC-
Confidence 6543322 2223346889999999999999999999999999999999 9999963211 112111111 110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
......+...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 238 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112335688999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=352.89 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=208.9
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeec
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 203 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 203 (460)
+.++....++|+..++||+|+||.||+|+.. +++.||+|++.+... ......+.+|..++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999986 588999999975321 1223357899999999999999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
....++||||+++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999764 289999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCC----CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHH
Confidence 999876554433444567999999999997765 7899999999999999999999995321 1122222
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~ 409 (460)
...........+ .......+.+++.+||..+|.+ ||+++||++
T Consensus 285 i~~~~~~~~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHHCCCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhccccccCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 221110000000 0012255888999999999988 999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=345.17 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=204.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----hhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.+.|.+.+.||+|+||.||+|... +|+.||+|++....... ....+.+|+.++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 68999999997654321 245688999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC----cEEEeec
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 283 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df 283 (460)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999996543 489999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAV 233 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765322 2234569999999999999999999999999999999999999995311 11111111111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .+. .........+.+++.+||..||.+|||+.|+++
T Consensus 234 -~~~--~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 -SYD--FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCC--CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000 001112356889999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.81 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=206.7
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.+++..++|...+.||+|+||.||+|.+.++..||||+++.... ....+.+|+++++.++||||+++++++.+ +..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34566788999999999999999999998888899999976432 24578999999999999999999999876 6789
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 99999999999999975322 2389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.............++..|+|||.+.+..++.++|||||||++|||++ |+.||... ...+...........
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~~~- 400 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVERGYRM- 400 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTCCC-
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCC-
Confidence 65333222233446789999999999999999999999999999999 99999531 112222222111111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.....+...+.+++.+||+.||++|||+++|++.|+...
T Consensus 401 ---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111223466889999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.29 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=200.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------ 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------ 206 (460)
.++|+..+.||+|+||.||+|+.. +++.||||++...........+.+|+++++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357889999999999999999986 7899999999765555556679999999999999999999998865432
Q ss_pred ---------------------------------------------------ceEEeeccCCCCHHHHhhhcCCCCCCCCH
Q 012610 207 ---------------------------------------------------RLLVYPFMVNGSVASCLRERGQSQPPLNW 235 (460)
Q Consensus 207 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~ 235 (460)
.++||||+++++|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 7899999999999999987543 234677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC-----------ceeecccccc
Q 012610 236 SVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-----------HVTTAVRGTI 304 (460)
Q Consensus 236 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~g~~ 304 (460)
..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78899999999999999999 999999999999999999999999999987654321 1123345899
Q ss_pred cccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHH
Q 012610 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVE 384 (460)
Q Consensus 305 ~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (460)
.|+|||.+.+..++.++|||||||++|||++|..|+... ....... .... ..........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~-~~~~---------~~~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDV-RNLK---------FPLLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHH-HTTC---------CCHHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHh-hccC---------CCcccccCCh
Confidence 999999999999999999999999999999998776321 0111111 1110 0111233345
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 385 QLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 385 ~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6789999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=351.64 Aligned_cols=265 Identities=24% Similarity=0.370 Sum_probs=209.8
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+++..++|...+.||+|+||.||+|.. .++..||||++...........+.+|+.++..+ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 455678899999999999999999986 235689999998654444556789999999999 8999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEee
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQS-------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHR 263 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 263 (460)
..+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999865421 12479999999999999999999999 99999
Q ss_pred CCCCCCEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccc
Q 012610 264 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFD 341 (460)
Q Consensus 264 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~ 341 (460)
||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866443322 2333457889999999999999999999999999999998 999995
Q ss_pred cccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 342 LARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
... ........ ..... ...........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 277 ~~~----~~~~~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 277 GIP----VDANFYKL----IQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TCC----CSHHHHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----cHHHHHHH----HhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 321 11111111 11110 0011112235688999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=358.77 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=205.6
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC-cceE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLL 209 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-~~~l 209 (460)
++..++|...+.||+|+||.||+|.+. ++.||||+++... ....+.+|++++++++||||+++++++.... ..++
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 345678889999999999999999986 6899999997643 3457899999999999999999999987665 6899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 265 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999987543 2378999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..... .......
T Consensus 340 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~---~i~~~~~--- 404 (450)
T 1k9a_A 340 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVP---RVEKGYK--- 404 (450)
T ss_dssp C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHH---HHHTTCC---
T ss_pred cccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---HHHcCCC---
Confidence 3221 12246889999999999999999999999999999998 9999953211 11111 1111111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+...+.++|.+||+.||++|||+.+|++.|+.
T Consensus 405 -------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 405 -------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11122234678999999999999999999999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=339.39 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=200.3
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||+||+|+..+++.||+|++....... ....+.+|+++++.++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46899999999999999999999889999999997543322 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+ +|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 8888886543 2489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .. .....+..............
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~-~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT----DD-DQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----TT-THHHHHHHHHCCCCTTTSGG
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC----hH-HHHHHHHHHHCCCChHHhhh
Confidence 222 233458999999999876 568999999999999999999999996321 11 11222211111111100000
Q ss_pred ------------ccCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 ------------SDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ------------~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... .......+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 0112346789999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=341.05 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=200.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 209 (460)
.++|+..+.||+|+||.||+|+.. +++.||+|++.+..... ....+.+|..++..+ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357889999999999999999986 58899999997654322 234578899999887 89999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999998654 389999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................+..........
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-- 237 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-- 237 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--
Confidence 3222 2234456999999999999999999999999999999999999999643222111111111221111111111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
+ .......+.+++.+||+.||.+||++
T Consensus 238 ----~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 ----I----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----C----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----C----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 11123568889999999999999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=344.48 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=214.4
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
+++..++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+|+++++.++||||+++++++.+....+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3456678999999999999999999986 47889999997543 23457889999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999987433 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+.+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~---~---- 228 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEK---D---- 228 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHT---T----
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc---c----
Confidence 76554444444557889999999999999999999999999999999 9999953211 111111111 1
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
............+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 229 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 001111122356889999999999999999999999998743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.57 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=212.3
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
++..++|...+.||+|+||.||+|+. .++..||||+++..........+.+|++++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34557899999999999999999985 246789999998665544556789999999999 89999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQS--------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
.+..++||||+++|+|.+++...... ..++++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999875421 22489999999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccC
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 347 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 347 (460)
|+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--- 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc---
Confidence 99999999999999999876544332 2223446788999999999999999999999999999999 999995321
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
........ ..... .. .........+.+++.+||+.||.+|||+.+|++.|++
T Consensus 253 -~~~~~~~~----~~~~~-~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 253 -VDSKFYKM----IKEGF-RM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp -SSHHHHHH----HHHTC-CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -chhHHHHH----hccCC-CC--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111111 11110 00 0011223568899999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=352.98 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=210.1
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeee
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 202 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 202 (460)
.+.++....++|+..++||+|+||+||+|+.. +++.||+|++.+... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35556677889999999999999999999987 478999999975322 112234889999999999999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
+....++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997632 2389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHH
Confidence 9999876554444445567999999999987 5678999999999999999999999995321 11222
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPME--RPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~ 409 (460)
......... ..-+.. .......+.+++.+||..+|++ ||+++|+++
T Consensus 291 ~~i~~~~~~--~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNHKER--FQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTHHHH--CCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Hhhhhcccc--ccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 222111100 000000 0112345788999999888888 999999885
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=339.20 Aligned_cols=251 Identities=20% Similarity=0.253 Sum_probs=204.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|++++..++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 367899999999999999999976 58899999987432 234468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC--CCcEEEeecccccccC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 290 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 290 (460)
|+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999997543 2489999999999999999999999 9999999999999997 7899999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.......... . .
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~-~--~ 222 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEY-T--F 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC-C--C
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCC-C--C
Confidence 332 2334558999999999999889999999999999999999999995321 1122222211110 0 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+. .........+.+++.+||..||.+|||+.|+++
T Consensus 223 ~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Ch----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 000112356889999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=343.32 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=204.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc----cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT----QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467899999999999999999875 689999999864321 113457899999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc---EEEeeccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGL 285 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~ 285 (460)
+||||+++++|.+.+.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988876543444589999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .+........ .
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~-~ 248 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKG-K 248 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHT-C
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcC-C
Confidence 987654322 2334569999999999999999999999999999999999999995311 1111111111 1
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ..+. ........+.+++.+||+.||++|||+.++++
T Consensus 249 ~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0000 00112356889999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=340.78 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=209.2
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++++..++|...+.||+|+||.||+|...++..||+|.+..... ....+.+|+++++.++||||+++++++. .+..+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 34455678999999999999999999998888999999975432 3457889999999999999999999876 45689
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 99999999999999975321 1389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~- 229 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYRM- 229 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC-
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhcccCC-
Confidence 65433333333446788999999998889999999999999999999 999995311 11222222111100
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.||++|||+.++++.|++
T Consensus 230 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 230 ---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 0111223568899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=337.23 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=209.2
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
..++|...+.||+|+||.||++...++..||+|++..... ....+.+|++++..++||||+++++++.+.+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3567888999999999999999998888999999976433 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999976532 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+........... ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~~---~~ 226 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFRL---YK 226 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCCC---CC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCcC---CC
Confidence 2222223346778999999998899999999999999999999 899995321 11222222111110 00
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......+.+++.+||+.||++|||+.++++.|+++
T Consensus 227 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 227 -------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111235688999999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=338.91 Aligned_cols=266 Identities=25% Similarity=0.398 Sum_probs=203.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--C
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--T 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~ 205 (460)
..++|+..+.||+|+||+||+|++. +++.||||++.... ......+.+|++++..++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3468889999999999999999842 57899999997542 23345688999999999999999999998653 5
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 68999999999999999987532 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc------C-CCCccHHHH
Q 012610 286 AKLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------N-DDDVMLLDW 356 (460)
Q Consensus 286 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~------~-~~~~~~~~~ 356 (460)
++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... . .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876433221 222334677899999999999999999999999999999999998532110 0 001111111
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
+....... ........+...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 241 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111111 01111222346789999999999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=345.46 Aligned_cols=251 Identities=28% Similarity=0.372 Sum_probs=198.9
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
...++|+..++||+|+||.||+|+.. +++.||||++++... ......+..|.+++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999976 589999999976432 22334577899999887 699999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-~- 241 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE-V- 241 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C-
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-C-
Confidence 54322 223344569999999999999899999999999999999999999995321 122222222111 0
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM------SEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~ 409 (460)
.+.......+.+++.+||+.||++||++ +++++
T Consensus 242 ---------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0011123558889999999999999998 66654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=335.16 Aligned_cols=254 Identities=30% Similarity=0.457 Sum_probs=193.8
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc---chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|+..+.||+|+||.||+|... +..||||++...... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888999999999999999986 789999998754322 2234688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC--------CCcEEEee
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--------EFEAVVGD 282 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--------~~~~kl~D 282 (460)
|||+++++|.+++... .+++..++.++.|++.||+|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998642 3899999999999999999999992112999999999999986 77899999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHT
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhc
Confidence 999986543222 23458999999999999999999999999999999999999995321 1111111111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.. . ...........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 229 ~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NK-L--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SC-C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC-C--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 0 111112233568899999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=333.69 Aligned_cols=253 Identities=31% Similarity=0.548 Sum_probs=201.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchh------HHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGE------LQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
.++|+..+.||+|+||.||+|+.. +++.||+|++......... ..+.+|++++..++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999975 6899999999754332211 46889999999999999999999986544
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEecCCCc-----EE
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE-----AV 279 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~-----~k 279 (460)
++||||+.+|+|.+++.... .++++..++.++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887543 2489999999999999999999999 8 999999999999988876 99
Q ss_pred EeecccccccCCCCCceeecccccccccCccccc--CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 280 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
|+|||+++.... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..... ......
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~ 239 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFI 239 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHH
Confidence 999999975432 233456899999999984 45578999999999999999999999963211 111111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
....... . ...........+.+++.+||+.||++|||+.+|++.|++
T Consensus 240 ~~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEG-L--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSC-C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccC-C--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111111 1 111112234568999999999999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=345.49 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=205.7
Q ss_pred CccCCeecccCCeEEEEEEEC-----CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceE
Q 012610 137 FSNRNILGRGGFGKVYKGRLT-----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLL 209 (460)
Q Consensus 137 ~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~l 209 (460)
|...+.||+|+||.||++.+. +++.||||++...........+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998653 57899999998765545556789999999999999999999999874 56789
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++.... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997643 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc-----C-CCCccHHHHHHHHh
Q 012610 290 DYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-----N-DDDVMLLDWVKGLL 361 (460)
Q Consensus 290 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~-----~-~~~~~~~~~~~~~~ 361 (460)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... . .........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE-- 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH--
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH--
Confidence 544322 122344788899999999989999999999999999999999999642110 0 000000000111
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.+...............+.+++.+||+.||++|||+.+|++.|+.
T Consensus 263 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 263 -------LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111111122334678999999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=336.05 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=203.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----hhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|...+.||+|+||.||+|... ++..||+|++....... ....+.+|++++..++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457889999999999999999986 58999999997543321 345688999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC----cEEEeec
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 283 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df 283 (460)
++||||+.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997532 489999999999999999999999 999999999999999888 8999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+........
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 232 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHT
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHhc
Confidence 99987653322 233458999999999999999999999999999999999999995311 11111111110
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ............+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 -NYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCC------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCC------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 000001112356889999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=336.45 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=203.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
..++|...+.||+|+||.||+|...+ +..||+|.+...........+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45688999999999999999998642 346999999876555556678999999999999999999999764 4578
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999976542 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+. ......
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~---~~~~~~ 234 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLE---KGDRLP 234 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHH---HTCCCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHh---cCCCCC
Confidence 65443333334457889999999998899999999999999999998 999995321 111111111 111100
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
........+.+++.+||+.||++|||+.++++.|+.+
T Consensus 235 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 235 ----------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0111235688999999999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=341.53 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=200.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+++++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57889999999999999999974 6899999999754221 22346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+ +|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999887654 389999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||+...... ....+.
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~~~~i~ 221 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------LFKKVN 221 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------CBCCCC
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------HHHHHH
Confidence 32 2233469999999999988776 789999999999999999999996422110 011111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 100 0111122356889999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.92 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=200.0
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|...+.||+|+||.||++... ++..+|+|++...........+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367889999999999999999975 5889999999876655556678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeeccccccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 289 (460)
|+.+|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999876433334599999999999999999999999 99999999999999 55678999999999865
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... ......|++.|+|||.+. ..++.++||||||+++|||++|+.||.... ..+......... ....
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~-~~~~ 245 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKE-PNYA 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-CCCC
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCC-cccc
Confidence 4322 223445899999999875 568899999999999999999999995321 111111111111 0000
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ... ....+.+++.+||+.||++|||+.||++
T Consensus 246 ~~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VE---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001 1346889999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=335.61 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=190.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||.||+|... +++.||+|+++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999875 5899999999765544445578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 213 FMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|+. |+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999987643 2223589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc---c
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK---L 366 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 366 (460)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+........ .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHh
Confidence 3322 22334589999999999764 689999999999999999999999953211 111111111110000 0
Q ss_pred ccc-----ccccCC---CC---------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQL-----VDSDME---GN---------YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~-----~~~~~~---~~---------~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+ ..+... .. ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000000 00 00012346889999999999999999998874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=343.66 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=210.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+..++|...+.||+|+||.||+|+.. ++..||||++...........+.+|++++..+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 44678999999999999999999863 46789999998665544556788999999999 8999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCE
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 270 (460)
..+..++||||+.+|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 999999999999999999999865421 22489999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 348 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~ 348 (460)
+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence 99999999999999998765433221 222346788999999998889999999999999999999 999995321
Q ss_pred CCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+........... .........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 265 ----~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 ----VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11222221111110 01112235688999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.71 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=198.6
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|+||.||+|+..+++.||+|++...... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 478889999999999999999988999999999754332 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.+ +|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 9999887643 2489999999999999999999999 99999999999999999999999999998764322
Q ss_pred CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc---cc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---QL 369 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 369 (460)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......... .+
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhh
Confidence 2 22334589999999998764 589999999999999999999999953211 11111111111100000 00
Q ss_pred -----ccccCC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 -----VDSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 -----~~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0001123456889999999999999999999885
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=338.24 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=194.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-------------------------hhHHHHHHHHHHh
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------------------------GELQFQTEVEMIS 187 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~ 187 (460)
.++|...+.||+|+||.||+|+.. +++.||||++....... ....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368899999999999999999875 68899999997543211 1245889999999
Q ss_pred ccCCCcceeeeeeeec--CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC
Q 012610 188 MAVHRNLLRLRGFCMT--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 265 (460)
Q Consensus 188 ~~~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 265 (460)
.++||||+++++++.+ ....++||||+++++|.+++.. .++++..++.++.||+.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 4578999999999999876532 2489999999999999999999999 9999999
Q ss_pred CCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCC---CCcccCchhhHHHHHHHHhCCCcccc
Q 012610 266 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 266 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233456899999999997765 47889999999999999999999953
Q ss_pred ccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 343 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ...+.... ....... .... .....+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~--------~~~~~~~~-~~~~~~~----~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER--------IMCLHSKI-KSQALEF----PDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS--------HHHHHHHH-HHCCCCC----CSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc--------HHHHHHHH-hcccCCC----CCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 11111111 1111110 0011 12356889999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.10 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=206.0
Q ss_pred hcCCccCCeecccCCeEEEEEEE-----CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC--Cc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~ 206 (460)
.+.|+..+.||+|+||.||+|++ .+++.||+|++...........+.+|++++..++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688889999999999999984 358899999998665555556789999999999999999999999876 66
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 7999999999999999966542 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccc------cCCCCccHHHHHH
Q 012610 287 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------ANDDDVMLLDWVK 358 (460)
Q Consensus 287 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~~~ 358 (460)
......... ......||..|+|||.+.+..++.++||||||+++|||++|..|+..... ...........+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 876544322 22334578889999999999999999999999999999999998743210 0011111111111
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
....... ...........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 254 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111 111112234568899999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=348.94 Aligned_cols=254 Identities=17% Similarity=0.244 Sum_probs=204.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
..++|+..+.||+|+||.||+|... +|+.+|+|++...... .....+.+|+++++.++||||+++++++.+....++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3578999999999999999999875 6889999999765432 2344688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec---CCCcEEEeeccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~ 287 (460)
|||+.+|+|.+.+.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998753 389999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+....... ....
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~-~~~~ 231 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQIKA-GAYD 231 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-TCCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHh-CCCC
Confidence 7654332 2234569999999999999999999999999999999999999995311 1111121111 1110
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...........+.+++.+||+.||++|||+.|+++
T Consensus 232 -~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -F-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -C-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00111122356889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=349.06 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=208.5
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeee
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCM 202 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 202 (460)
.+++.....++|+..++||+|+||.||+++.. +++.||+|++++... ......+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566677889999999999999999999986 689999999975321 122335889999999999999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
+.+..++||||+++|+|.+++...+. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999987532 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCccccc-------CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHH
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 355 (460)
||+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~ 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------TAE 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------HHH
Confidence 9999876554443344467999999999987 4568999999999999999999999995321 111
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER---PKMSEVVR 409 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~evl~ 409 (460)
........... ..-+.. .......+.+++.+||. +|.+| |+++|+++
T Consensus 278 ~~~~i~~~~~~--~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKEH--LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHHH--CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhcccC--cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11122111000 000100 11123568899999999 99998 58888864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=333.13 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=202.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|+..+.||+|+||.||+++.. +|+.||+|++++... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367889999999999999999976 689999999975432 12344678899999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999998643 389999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~---- 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE-L---- 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC-C----
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C----
Confidence 32 234569999999999999999999999999999999999999995321 112222222111 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.. .......+.+++.+||+.||++|| ++++|++
T Consensus 221 --~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 --RF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01 111235688999999999999999 7888774
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=348.80 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=211.5
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+++..++|...+.||+|+||.||+|.... ...||+|.+...........+.+|++++..+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45567889999999999999999998752 2479999998765545556789999999999 8999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ----------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
.....++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999976421 123489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCC
Q 012610 273 DEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 350 (460)
Q Consensus 273 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~ 350 (460)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||+| |..||.... ..
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~ 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----VN 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----SS
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----hh
Confidence 99999999999999865433222 2233446788999999999999999999999999999999 999995321 11
Q ss_pred ccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...... ....... .........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 274 ~~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 274 SKFYKL----VKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111 1111100 00111235688999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=346.07 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=201.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|+..+.||+|+||.||+|.+. ++. +||+|.+...........+.+|+.++..++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888899999999999999875 344 388888865443333446778999999999999999999886 45688
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997642 2488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... .......+. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~---~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLE---KGERL 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHH---TTCBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHH---cCCCC
Confidence 6543322 2334457889999999999999999999999999999999 999996321 111111111 11110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. . .......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 237 ~---~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 237 A---Q-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp C---C-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred C---C-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 011123477899999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.29 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=194.2
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECC-C---cEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTD-G---SLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
+.+..++|+..+.||+|+||.||+|.... + ..||||+++.... ......+.+|+++++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34556789999999999999999998753 2 2799999976532 23345789999999999999999999999876
Q ss_pred Ccc------eEEeeccCCCCHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC
Q 012610 205 TER------LLVYPFMVNGSVASCLRERGQ--SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 205 ~~~------~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 276 (460)
... ++||||+.+|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 899999999999999975432 223589999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHH
Q 012610 277 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~ 354 (460)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... .....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~ 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIY 249 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hHHHH
Confidence 9999999999865433221 2223346788999999999999999999999999999999 999996321 11111
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. ........ .........+.+++.+||+.||++|||+.++++.|+++
T Consensus 250 ~---~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 N---YLIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp H---HHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11111111 11112235688999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=331.90 Aligned_cols=263 Identities=21% Similarity=0.297 Sum_probs=199.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|+||+||+|... +++.||||++....... ....+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999986 58899999997554332 33568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+ ++.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 6666665432 2489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc--
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL-- 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 369 (460)
.. ......||+.|+|||.+.+.. ++.++|||||||++|||++|..||... .........+............
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~----~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC----CCHHHHHHHHHHHhCCCChhhhhh
Confidence 22 223345899999999998766 799999999999999999998886321 1111111111111111000000
Q ss_pred -c---c---------ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 -V---D---------SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 -~---~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. + ..............+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 00000111223456889999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=332.47 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=203.4
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC--CcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~--~~~~lv 210 (460)
.++|...+.||+|+||.||+|++. +..||||++...... .....+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457888999999999999999986 789999999865432 3345689999999999999999999999877 678999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 2489999999999999999999998 7 99999999999999999999999988764
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCc---ccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||.... ..+..........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGL 228 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSCC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcCC
Confidence 322 1234789999999998765544 7999999999999999999995321 1111112111111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. . .........+.+++.+||+.||++|||+.++++.|+.+
T Consensus 229 ~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 R-----P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp C-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 1 11112335688999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.28 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=202.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+|++++..++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999976 588999999975431 22345688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .............. ..
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~-~~- 237 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETT-VV- 237 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHC-CC-
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhc-cc-
Confidence 33 22344569999999999864 458999999999999999999999996321 11122222221111 00
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~ 409 (460)
.........+.+++.+||+.||.+||+ +++|++
T Consensus 238 ---------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011112356889999999999999999 666553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.94 Aligned_cols=270 Identities=25% Similarity=0.396 Sum_probs=215.7
Q ss_pred cCHHHHHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeee
Q 012610 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 198 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~ 198 (460)
+..+++++..++|...+.||+|+||.||+|... ++..||||.+...........+.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455677889999999999999999999764 36789999998655544555788999999999999999999
Q ss_pred eeeecCCcceEEeeccCCCCHHHHhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 199 GFCMTPTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 199 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
+++.+.+..++||||+.+|+|.+++.... ....++++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999997632 1123478999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCC
Q 012610 273 DEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDD 350 (460)
Q Consensus 273 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~ 350 (460)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 999999999999998654322211 122336788999999999999999999999999999999 899985321
Q ss_pred ccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
..+........ .... ........+.+++.+||+.||.+|||+.++++.|++..
T Consensus 246 --~~~~~~~~~~~-~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 246 --NEQVLRFVMEG-GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --HHHHHHHHHTT-CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --HHHHHHHHHcC-CcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11222221111 1110 11122356889999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=337.74 Aligned_cols=259 Identities=17% Similarity=0.190 Sum_probs=206.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+..|+++++.+ +||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 467999999999999999999974 689999999865432 23588999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc-----EEEeecccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGLA 286 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~ 286 (460)
||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 999999998652 2489999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 287 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 287 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i 232 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKI 232 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHH
Confidence 876433221 1234569999999999999999999999999999999999999996421 11222222211
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
....... .. ..... ..+ .+.+++.+||+.||.+||++.+|++.|++.
T Consensus 233 ~~~~~~~-~~-~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 233 GDTKRAT-PI-EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHS-CH-HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhhhccC-CH-HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 1110000 00 00000 012 689999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=341.43 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=204.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
..++|...+.||+|+||.||+|... ++..||+|++...... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999976 6899999999765432 2344688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEEeeccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~ 287 (460)
|||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999987543 489999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+....... ....
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~-~~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKA-GAYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-TCCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh-CCCC
Confidence 765332 2234569999999999999999999999999999999999999995321 1111111111 1110
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............+.+++.+||+.||++|||+.++++
T Consensus 249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000111223456889999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=337.85 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=193.1
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~l 209 (460)
..++|+..++||+|+||+||+|+.. +++.||||++...... ........|+..+..+ +||||+++++++.+....++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999986 6899999998654322 2233455555555544 89999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+ +++|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 7799999877543 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+ .. +......
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~-~~-~~~~~~~-- 270 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GW-QQ-LRQGYLP-- 270 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HH-HH-HTTTCCC--
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HH-HH-HhccCCC--
Confidence 4322 2233458999999999876 78999999999999999999977663211 00 11 1111100
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .........+.+++.+||+.||++|||+.|+++
T Consensus 271 --~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 --P----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --c----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 001112356889999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=341.89 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=202.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCc
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~ 206 (460)
....++|...++||+|+||.||+|+.. +++.||||+++.... ......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999986 588999999976432 22344577888888876 89999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998754 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMD-N- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-C-
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhC-C-
Confidence 8643222 22344569999999999999999999999999999999999999995321 11222221111 1
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVV 408 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 408 (460)
... .......+.+++.+||+.||++||++. +|+
T Consensus 235 -----~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 001 111235688999999999999999997 554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=369.80 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=209.7
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++.... ....+.+|+++++.++||||+++++++.+ ...++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 4455667888899999999999999998888899999976432 24578999999999999999999999876 67899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 339 v~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999999975321 2388999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
............++..|+|||.+.+..++.++|||||||++|||++ |+.||... ...+.+.........
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~~~-- 483 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVERGYRM-- 483 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--------CHHHHHHHHHTTCCC--
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCC--
Confidence 4322111222346788999999999999999999999999999999 99999531 112222222111111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.....+...+.++|.+||+.||++|||+.+|++.|+...
T Consensus 484 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 --------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111223456889999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.66 Aligned_cols=261 Identities=15% Similarity=0.190 Sum_probs=206.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 210 (460)
..++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|+..+..+ .|+|++++++++......++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 346799999999999999999996 4689999999864432 23578899999998 799999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc-----EEEeeccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-----AVVGDFGL 285 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~ 285 (460)
|||+ +++|.+++..... ++++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 9999999986532 489999999999999999999999 9999999999999988776 99999999
Q ss_pred ccccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 286 AKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 286 ~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHHHHHh
Confidence 9876543221 223456899999999999999999999999999999999999999642211 11111111111
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......... .. .....+.+++.+||+.||++|||+++|++.|+++
T Consensus 236 ~~~~~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 236 KKQSTPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHSCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCccHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111111110 00 1235688999999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=341.60 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=199.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|+..++||+|+||.||+|.+. +++ +||+|.+...........+.+|+.++..++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467899999999999999999875 344 468888766555555667999999999999999999999998754 78
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++++|+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987543 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... .......+. ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~---~~~~- 237 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE---KGER- 237 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHHHH---TTCC-
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHH---cCCC-
Confidence 6433222 2223346788999999999999999999999999999999 999996321 111211111 1110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..........+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 238 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 238 ---------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011112235688999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=338.48 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=202.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++..++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999976 689999999975432 223446888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998754 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~~----- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG-KV----- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC-----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcC-CC-----
Confidence 2 223468999999999999999999999999999999999999995321 11222222211 11
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
.. .......+.+++.+||+.||.+||+ +++|++
T Consensus 256 -~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01 1112356889999999999999998 777764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=341.21 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=201.3
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.++|...+.||+|+||.||+|.... +..||||.++..........+.+|++++..++||||+++++++......+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998642 24699999986554445557899999999999999999999999989999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999976432 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 289 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 289 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCCc
Confidence 6533221 1122335778999999999999999999999999999999 999995321 1122222211111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.. ........+.+++.+||+.||++||++.+|++.|++.
T Consensus 269 ~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 LP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 10 1112335688999999999999999999999999763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.24 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=194.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcc---
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER--- 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~--- 207 (460)
.++|++.+.||+|+||.||+|+.. +++.||||++....... ....+.+|++++..++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999974 68899999997654322 234688999999999999999999998765544
Q ss_pred -eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 208 -LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 208 -~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
++||||+++++|.+++.... ++++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999998654 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 287 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 287 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
+........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC
Confidence 866433221 2233458999999999999999999999999999999999999995321 111111111111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ... .......+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPP---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCH---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCc---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1000 000 0112356889999999999999998777664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=334.00 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=205.6
Q ss_pred hcCCccCC-eecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|...+ .||+|+||.||+|.+. ++..||||+++..........+.+|++++..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566665 8999999999999864 57789999998765445556789999999999999999999998 4566899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 290 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 290 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... . .+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~---~~~~~~i~~~~~- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----G---PEVMAFIEQGKR- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----T---HHHHHHHHTTCC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H---HHHHHHHhcCCc-
Confidence 5433222 122346789999999988889999999999999999998 999995321 1 111111111110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 232 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=341.73 Aligned_cols=270 Identities=27% Similarity=0.428 Sum_probs=215.3
Q ss_pred cCHHHHHHHhcCCccCCeecccCCeEEEEEEE------CCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceee
Q 012610 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRL 197 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l 197 (460)
+...++.+..++|...+.||+|+||.||+|+. .+++.||||++...........+.+|++++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45666777889999999999999999999974 246889999998765544555788999999999 69999999
Q ss_pred eeeeecCC-cceEEeeccCCCCHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 012610 198 RGFCMTPT-ERLLVYPFMVNGSVASCLRERGQS------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 264 (460)
Q Consensus 198 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 264 (460)
++++...+ ..++||||+.+++|.+++...... ...+++..++.++.|++.||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987754 489999999999999999875432 12378999999999999999999999 999999
Q ss_pred CCCCCEEecCCCcEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccc
Q 012610 265 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 342 (460)
Q Consensus 265 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~ 342 (460)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987644332 22333457889999999999999999999999999999998 9999953
Q ss_pred ccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 343 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
... .. ..... ........ . .......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 254 ~~~----~~---~~~~~-~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKI----DE---EFCRR-LKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCC----SH---HHHHH-HHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cch----hH---HHHHH-hccCccCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 211 11 11111 11111100 0 111235688999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=341.34 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=204.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++..++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 367999999999999999999976 688999999875432 233468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC--CCcEEEeecccccccC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMD 290 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 290 (460)
|+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999987543 2489999999999999999999999 9999999999999974 4679999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+....... . ..
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~-~--~~ 269 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD-W--EF 269 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-C--CC
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C--CC
Confidence 4332 233468999999999999999999999999999999999999995321 112222211110 0 01
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+. .........+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11 111123356889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=344.21 Aligned_cols=270 Identities=19% Similarity=0.229 Sum_probs=213.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC--cceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~--~~~lv 210 (460)
.++|.+.++||+|+||.||+|... +++.||||++...........+.+|+++++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467889999999999999999986 489999999986554455567889999999999999999999988755 67999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe----cCCCcEEEeecccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA 286 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~ 286 (460)
|||+.+|+|.+++...... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999765332 2389999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCCceeecccccccccCcccccC--------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
+...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+.
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~----~~~~~~ 237 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----NKEVMY 237 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT----CHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc----hHHHHH
Confidence 8764322 2233458999999999865 5678899999999999999999999964322111 122222
Q ss_pred HHhhhccccc---cc-----------cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 359 GLLKEKKLEQ---LV-----------DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 359 ~~~~~~~~~~---~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.......... +. +..............+.+++.+||+.||++|||+.++++.+++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 2222211110 00 0011123346677888999999999999999999999998866
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.82 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=196.6
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++..++|+..+.||+|+||.||+|+.. ..+|+|+++..... .....+.+|+++++.++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344678999999999999999999865 35999999765433 3345688999999999999999999965 4566899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999996543 3489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC-CceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 290 DYKD-THVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 290 ~~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
.... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||.... . . +.+........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~---~-~~~~~~~~~~~ 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----N---R-DQIIEMVGRGS 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----C---H-HHHHHHHHHTS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----h---H-HHHHHHhcccc
Confidence 4322 22233456899999999986 5678889999999999999999999995321 1 1 11111111111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
...... .....+...+.+++.+||+.+|.+|||+.+|++.|+++.
T Consensus 243 ~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 LSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111100 111223467899999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=367.08 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=200.5
Q ss_pred cCCccCC-eecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+++...+ .||+|+||.||+|.+. ++..||||+++..........+.+|+++++.++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999864 4567999999876555556689999999999999999999999876 568999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997543 3489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 291 YKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 291 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .. +...........
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~---~~~~~i~~~~~~- 558 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GP---EVMAFIEQGKRM- 558 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----SH---HHHHHHHTTCCC-
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-----HH---HHHHHHHcCCCC-
Confidence 332221 122235688999999999999999999999999999998 999995321 11 111111111111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.....+...+.++|.+||+.||++|||+.+|++.|+.
T Consensus 559 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1112234678999999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.55 Aligned_cols=260 Identities=21% Similarity=0.258 Sum_probs=199.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+|+.++..++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 368999999999999999999976 68899999997653322 235688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++++|.+++.... ++++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998753 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
...........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+......... ..
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~-~~- 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAIP-RP- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCCC-CG-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCCC-Cc-
Confidence 4433333345689999999999999999999999999999999999999953211 111111111100 00
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcCCC
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEGDGL 416 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~ 416 (460)
... .......+.+++.+||+.||++|| |++++++.|+....
T Consensus 255 -~~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 -STV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -GGT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -ccc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 001 111234588899999999999999 99999999987543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.93 Aligned_cols=266 Identities=17% Similarity=0.198 Sum_probs=202.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccch----------hHHHHHHHHHHhccCCCccee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGG----------ELQFQTEVEMISMAVHRNLLR 196 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~~~h~niv~ 196 (460)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998764 47899999865432110 112344556677889999999
Q ss_pred eeeeeecC----CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 197 LRGFCMTP----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 197 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 3479999999 999999998743 2499999999999999999999999 99999999999999
Q ss_pred c--CCCcEEEeecccccccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccc
Q 012610 273 D--EEFEAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 344 (460)
Q Consensus 273 ~--~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~ 344 (460)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876432211 1123459999999999999999999999999999999999999996321
Q ss_pred ccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 345 LANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.............. ..+..+.+..+... .....+.+++.+||+.+|.+||++.+|++.|++
T Consensus 266 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 ----KDPKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp ----TCHHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ----cCHHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11122222221111 12222222222111 123568899999999999999999999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=334.68 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=193.4
Q ss_pred hcCCccCCeecccCCeEEEEEEE----CCCcEEEEEEeccccc---cchhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
.++|+..+.||+|+||.||+++. .+++.||+|+++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999987 3689999999976532 1223457889999999999999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999998654 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-~ 238 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCK-L 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC-C
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-C
Confidence 7543222 22334568999999999999999999999999999999999999995321 112222222111 0
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.+ .......+.+++.+||+.||++|| ++.|+++
T Consensus 239 ------~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01 111235688999999999999999 5666654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=346.37 Aligned_cols=254 Identities=31% Similarity=0.469 Sum_probs=192.8
Q ss_pred CCccCCeecccCCeEEEEEEEC--C--CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcceEE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT--D--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 210 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv 210 (460)
.|...++||+|+||.||+|... + +..||+|.++..........+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999864 2 246899998765554555679999999999999999999998765 4578999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 2478999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 291 YKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 291 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .......+. .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~~---~~~~~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLL---QGRRL 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHHH---TTCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHHH---cCCCC
Confidence 32211 1223346788999999999999999999999999999999 677774321 111221111 11110
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.. ...+...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 316 ---~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 316 ---LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp ---CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 11123568899999999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.79 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=194.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|...+.||+|+||+||+++.. +++.||||++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 468999999999999999999986 689999999975432 23468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc--EEEeecccccccC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 290 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~ 290 (460)
|+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999997654 389999999999999999999999 9999999999999988765 9999999997533
Q ss_pred CCCCceeecccccccccCcccccCCCCCcc-cCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... .......+....... .. .
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~-~~-~ 241 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVK-YS-I 241 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTC-CC-C
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCC-CC-C
Confidence 221 2233458999999999988887655 8999999999999999999964221 122222222222111 00 0
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+ .......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PD-------DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CT-------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CC-------cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 00 0011256889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=337.43 Aligned_cols=246 Identities=23% Similarity=0.316 Sum_probs=199.4
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
...++|+..++||+|+||.||+|+.. +++.||+|++++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999987 478999999976432 22344678899999887 799999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ...
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-~~~ 239 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEH-NVA 239 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CCC
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhC-CCC
Confidence 643222 22344569999999999999999999999999999999999999995321 11222222211 110
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
. .......+.+++.+||+.||.+||+.
T Consensus 240 ------~----p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 ------Y----PKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ------C----CTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ------C----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 11223568899999999999999964
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=330.76 Aligned_cols=261 Identities=21% Similarity=0.339 Sum_probs=198.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|.+.+.||+|+||.||+|... ++..||||++..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57888999999999999999974 689999999975332 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+++|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999976443344589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ........... ........
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~~~~- 259 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE-QCDYPPLP- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHH-TTCSCCCC-
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhh-cccCCCCc-
Confidence 322 2223458999999999999999999999999999999999999995321 11222222211 11111110
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111235688999999999999999999999999763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=334.75 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=202.7
Q ss_pred HHHhcCCccCC-eecccCCeEEEEEEEC---CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 131 QVATDNFSNRN-ILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 131 ~~~~~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
.+..++|.+.+ .||+|+||.||+|.+. .+..||||+++...... ....+.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788777 9999999999999642 46789999997654322 245789999999999999999999998 556
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 7899999999999999998643 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcee--ecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhh
Q 012610 286 AKLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 286 ~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
+........... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~-~~ 234 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAM-LE 234 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHH-HH
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHH-HH
Confidence 987654433221 22335688999999998889999999999999999999 999995321 1111111 11
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..... .........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 235 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 235 KGERM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11100 1111234568999999999999999999999999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=340.99 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=195.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCC--CcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~l 209 (460)
..++|++.+.||+|+||.||++...+++.||||++...... .....+.+|++++..++| +||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35678999999999999999999888999999999754332 233568899999999987 999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||| +.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 56889999998743 489999999999999999999999 999999999999997 578999999999876
Q ss_pred CCCCCc-eeecccccccccCcccccC-----------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 290 DYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 290 ~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHH
Confidence 533222 2234569999999999865 678899999999999999999999995311 111111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... ..............+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 HAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11111 11111111112246889999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.16 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=201.1
Q ss_pred CCccCCeecccCCeEEEEEEEC-C---CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc-eEE
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-D---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-LLV 210 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~-~lv 210 (460)
.|...++||+|+||.||+|.+. + +..+|+|.+...........+.+|+++++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4555689999999999999853 2 2379999998655545556789999999999999999999999876655 999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997633 3489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC---CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 291 YKD---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 291 ~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+.. ..........+.. ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~----~~~~~~~~~~~~~---~~~~- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR----HIDPFDLTHFLAQ---GRRL- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT----TSCGGGHHHHHHT---TCCC-
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc----cCCHHHHHHHhhc---CCCC-
Confidence 321 1122234578899999999999999999999999999999996666521 1111112221111 1100
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||+.||.+|||++++++.|+++
T Consensus 248 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 ---------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111235688999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=339.69 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=202.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcE--EEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSL--VAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 210 (460)
++|...+.||+|+||.||+|+.. ++.. +|+|.+...........+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999865 4554 4999987654444455788999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 211 YPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
|||+++++|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997653 2234589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 357 (460)
||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 251 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHH
Confidence 999999997432211 1122346789999999988889999999999999999998 999995321 11222
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......... .........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 252 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 252 EKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HHGGGTCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhcCCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 221111000 1111223568899999999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.01 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=201.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-------hhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
..++|...+.||+|+||.||+|... +++.||||++....... ....+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999865 68899999997653211 223577899999999999999999999999
Q ss_pred CcceEEeeccCCC-CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 205 TERLLVYPFMVNG-SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 205 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
...++||||+.+| +|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999997643 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
|+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654332 233458999999999988876 88999999999999999999999531110
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM 410 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 410 (460)
....... . ......+.+++.+||+.||++|||+.++++.
T Consensus 237 ---~~~~~~~---~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIHP---P---YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCCC---S---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccCC---C---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0 0123568899999999999999999999873
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=337.19 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=188.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
..++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+|++++.+++||||+++++++......++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3567999999999999999999986 57899999997543 2345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~ 288 (460)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999997543 389999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. .......... ...
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~---~~~~~~i~~~-~~~- 269 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER----GD---QFMFRRILNC-EYY- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT----CH---HHHHHHHHTT-CCC-
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc----cc---HHHHHHHHhC-CCc-
Confidence 54322 2233568999999999999999999999999999999999999995311 11 1111111111 110
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...........+.+++.+||+.||++|||+.++++
T Consensus 270 ~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 F-----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00111223456889999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=339.81 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=197.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHH-HhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEM-ISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|+..++||+|+||.||+|+.. ++..||+|++++.... .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357899999999999999999986 5789999999765432 223345666666 567899999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998754 388999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~-~~--- 256 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PL--- 256 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHS-CC---
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc-cc---
Confidence 3222 22344569999999999999999999999999999999999999995321 12222222211 10
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..... ....+.+++.+||+.||.+||++.+.++.+..+
T Consensus 257 ---~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 257 ---QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp ---CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred ---CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 01111 234588899999999999999997655555544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=331.48 Aligned_cols=269 Identities=24% Similarity=0.346 Sum_probs=201.3
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhc--cCCCcceeeeeeeecC-
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMTP- 204 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~~- 204 (460)
.......++|...+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 334455678999999999999999999986 8999999985432 2234455555554 4899999999998876
Q ss_pred ---CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeeCCCCCCEEecCCC
Q 012610 205 ---TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEF 276 (460)
Q Consensus 205 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~ 276 (460)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+++ .++|+||||||+|||++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 6789999999999999999764 3899999999999999999999762 34899999999999999999
Q ss_pred cEEEeecccccccCCCCCce---eecccccccccCcccccCCCCCcc------cCchhhHHHHHHHHhC----------C
Q 012610 277 EAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGVMLLELITG----------Q 337 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~Dvws~G~il~el~tg----------~ 337 (460)
.+||+|||+++......... .....||+.|+|||++.+...+.. +|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654332221 123468999999999988766655 9999999999999999 4
Q ss_pred CccccccccCCCCccHHHHHHHHhhhccccccccccCCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 338 RAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 338 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.||..... ....... ........... +..... ....+...+.+++.+||+.||++|||+.+|++.|+++
T Consensus 260 ~p~~~~~~---~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 260 LPYHDLVP---SDPSYED-MREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CTTTTTSC---SSCCHHH-HHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHhhhcC---CCCchhh-hHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 55532111 1111111 11111111111 111110 1235677899999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=336.03 Aligned_cols=264 Identities=26% Similarity=0.332 Sum_probs=204.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec----CCc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTE 206 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~ 206 (460)
+..++|...+.||+|+||.||+++. .+++.||||++.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3457899999999999999999997 468999999986532 2334568899999999999999999999863 346
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+.+|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 7899999999999999987544445699999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCc--------eeecccccccccCcccccCCC---CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHH
Q 012610 287 KLMDYKDTH--------VTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 287 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 355 (460)
......... ......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhH
Confidence 754321110 011234689999999987654 6889999999999999999999996321111 01111
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.+. . . ............+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 259 ~~~----~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQ----N-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHH----C-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred Hhh----c-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 111 0 0 000001122356889999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=332.44 Aligned_cols=256 Identities=32% Similarity=0.477 Sum_probs=200.1
Q ss_pred cCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~l 209 (460)
.+|...++||+|+||.||+|...+ ...+|+|.+...........+.+|++++++++||||+++++++.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999998642 236899999875555555678999999999999999999998654 567899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997533 2488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC---ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 290 DYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 290 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||... ........+ .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~~~---~~~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYL---LQGRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-----CTTTHHHHH---HTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-----CHHHHHHHH---hcCCC
Confidence 43221 12223447788999999999999999999999999999999 55555321 111111111 11110
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. .. .......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 251 ~---~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 L---LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C---CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00 111235688999999999999999999999999763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=347.09 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=195.9
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc--ccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
+..++|+..++||+|+||.||+|+.. +++.||||++.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999975 68999999997542 2222345778999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++
T Consensus 225 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 9999999999999997654 38999999999999999999998 8 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ..
T Consensus 298 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~~- 366 (446)
T 4ejn_A 298 EGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILME-EI- 366 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC-
T ss_pred eccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhC-CC-
Confidence 643222 22344669999999999999999999999999999999999999995321 11222221111 10
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.. .......+.+++.+||+.||.+|| |++|+++
T Consensus 367 -----~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -----RF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01 111235688999999999999999 9999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=340.88 Aligned_cols=204 Identities=22% Similarity=0.298 Sum_probs=175.8
Q ss_pred hcCCccCCeeccc--CCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRG--GFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|++.++||+| +||.||+|+.. +++.||||++....... ....+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999986 68999999997654332 33467889999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999987532 2489999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCCC------ceeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 290 DYKDT------HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 290 ~~~~~------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 22111 11122358899999999987 5789999999999999999999999963
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=338.57 Aligned_cols=267 Identities=18% Similarity=0.216 Sum_probs=199.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccccc----------hhHHHHHHHHHHhccCCCcceeeee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNLLRLRG 199 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~niv~l~~ 199 (460)
.++|...+.||+|+||.||+|... ++..+|+|++....... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467899999999999999999975 46789999987543211 1123667888899999999999999
Q ss_pred eeec----CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC
Q 012610 200 FCMT----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275 (460)
Q Consensus 200 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 275 (460)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 67789999999 999999997654 489999999999999999999999 99999999999999988
Q ss_pred C--cEEEeecccccccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccC
Q 012610 276 F--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 347 (460)
Q Consensus 276 ~--~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~ 347 (460)
+ .+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--- 264 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL--- 264 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---
Confidence 7 9999999999876432111 1133468999999999999999999999999999999999999995311
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 416 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 416 (460)
....................+. ..... ......+.+++.+||+.||++|||+.+|++.|+...+
T Consensus 265 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 -KDPVAVQTAKTNLLDELPQSVL-KWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -TCHHHHHHHHHHHHHTTTHHHH-HHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cccHHHHHHHHhhcccccHHHH-hhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111111111111000 00000 0123568999999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=327.25 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=204.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367889999999999999999986 6899999999765544555678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++.... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999986532 489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CC-ceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 293 DT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 293 ~~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. .......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||..... .......+.. .... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----~~~~---~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE----KKTY---L 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT---TSHHHHHHHT----TCTT---S
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHhhh----cccc---c
Confidence 21 12234558999999999987765 7899999999999999999999964221 1111111111 0000 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.||++|||+.++++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122356889999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=328.88 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=200.3
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-C-------cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-G-------SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
.++|...+.||+|+||.||+|.... + ..||+|++.... ......+.+|+++++.++||||+++++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4678889999999999999998652 3 479999996543 233457899999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc--------
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-------- 277 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------- 277 (460)
..++||||+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999986432 388999999999999999999999 9999999999999998887
Q ss_pred EEEeecccccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHH
Q 012610 278 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 356 (460)
+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|..|+... ......
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRK 227 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHH
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHH
Confidence 999999998754321 22347889999999987 67899999999999999999965544211 111111
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 416 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 416 (460)
........... .. ....+.+++.+||+.||++|||+.++++.|++..-
T Consensus 228 ~~~~~~~~~~~----~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 228 LQFYEDRHQLP----AP--------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHTTCCCC----CC--------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHhhccCCCC----CC--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111111111 00 12347889999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=344.67 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=196.2
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccc-cchhHHHHHHHHHHhccC--CCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~~~lv 210 (460)
.++|.+.+.||+|+||.||++...+++.||||++..... ......+.+|++++..++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999988899999999975433 233456889999999997 59999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|| +.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56889999998754 488999999999999999999999 999999999999996 5799999999998764
Q ss_pred CCCCc-eeecccccccccCcccccC-----------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 291 YKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 291 ~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHH
Confidence 33222 2334569999999999865 368899999999999999999999995311 1111122
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... .............+.+++.+||+.||.+|||+.||++
T Consensus 279 ~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 AIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCc---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 22111 1111111111346889999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.05 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=196.2
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
.++|+..+.||+|+||.||+|+.. ++.||||.+... .....+.+|++++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 357888899999999999999986 688999998643 23457889999999999999999999886 458999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc-EEEeecccccccCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK 292 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~ 292 (460)
+++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999976432 224788999999999999999999932228999999999999998886 799999999755322
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .............. ..
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~-~~----- 223 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNGT-RP----- 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHHTTC-CC-----
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHhcCC-CC-----
Confidence 123358999999999999999999999999999999999999996321 11111111111111 10
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 224 ----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11112235688999999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=332.95 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=180.0
Q ss_pred CCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeeccCCC
Q 012610 140 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 378999999999999986 6899999999643 2346778999999997 999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEEeecccccccCCCCC
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~ 294 (460)
+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999998753 489999999999999999999999 999999999999998766 899999999986543322
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccC
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (460)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......+........ .. ..
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~-~~------~~ 235 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKG-DF------SF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTT-CC------CC
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcC-CC------CC
Confidence 2233458999999999999999999999999999999999999996432111 111122222222111 10 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 375 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111223466889999999999999999999873
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=336.99 Aligned_cols=261 Identities=22% Similarity=0.217 Sum_probs=200.9
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc----ccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
....++|...+.||+|+||.||+|... ++..||+|++.... .......+.+|+++++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 455678999999999999999999975 68899999997542 2233457889999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQS------------------------------------QPPLNWSVRKQIALGAARGL 249 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~l 249 (460)
..++||||+++|+|.+++...... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998531110 11235777889999999999
Q ss_pred HHHHhCCCCCeEeeCCCCCCEEecCCC--cEEEeecccccccCCCCC---ceeecccccccccCcccccC--CCCCcccC
Q 012610 250 AYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLST--GKSSEKTD 322 (460)
Q Consensus 250 ~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~D 322 (460)
+|||++ +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998777 899999999986543221 12334568999999999875 67899999
Q ss_pred chhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 012610 323 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP 402 (460)
Q Consensus 323 vws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 402 (460)
||||||++|||++|+.||.... ..+............ ...........+.+++.+||+.||.+||
T Consensus 259 iwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999995321 112222222211100 0001111235688999999999999999
Q ss_pred CHHHHHH
Q 012610 403 KMSEVVR 409 (460)
Q Consensus 403 t~~evl~ 409 (460)
|+.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=350.50 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=205.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|...++||+|+||.||+|+.. +|+.||+|++.+.... .....+..|++++..++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999986 6899999999754322 2334688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++|+|..++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987654455699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+......... .
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~----~~~~~~~~~~~i~~~~-~---- 410 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQA-V---- 410 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT----CCCCHHHHHHHHHHCC-C----
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc----cchhHHHHHHHHhhcc-c----
Confidence 3322 2233569999999999999999999999999999999999999996421 1112222222222111 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS 405 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 405 (460)
.........+.+++.+||+.||++||++.
T Consensus 411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 ------TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ------CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 01112235688899999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.47 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=200.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+.++|+..+.||+|+||.||+|... ++..||+|++...... .....+.+|+++++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3568999999999999999999876 5779999998654322 224468899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999998754 389999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....... ...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~--- 224 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISR-VEF--- 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-TCC---
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHh-CCC---
Confidence 322 2233458999999999999999999999999999999999999995321 1111111111 000
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.||.+|||++|+++
T Consensus 225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011112356889999999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.62 Aligned_cols=246 Identities=29% Similarity=0.428 Sum_probs=198.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+.|...+.||+|+||.||+|+.. +++.||||++....... ....+.+|+++++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999974 68999999997543322 2346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+. |+|.+++.... .++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 68888886543 2489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+........ .
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~-~- 271 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-P- 271 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC-C-
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCC-C-
Confidence 2 2345899999999984 5678999999999999999999999995321 1112222211111 0
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ......+.+++.+||+.||++|||+.++++
T Consensus 272 ----~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 272 ----ALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----CCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111 112355888999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=340.23 Aligned_cols=209 Identities=22% Similarity=0.292 Sum_probs=181.0
Q ss_pred ccccCHHHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-----CCcce
Q 012610 122 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----HRNLL 195 (460)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h~niv 195 (460)
...+++.+.....++|.+.++||+|+||.||+|+.. +++.||||++... ......+..|++++..+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 445666666777899999999999999999999985 6889999999743 223345678899988886 99999
Q ss_pred eeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-
Q 012610 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE- 274 (460)
Q Consensus 196 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~- 274 (460)
++++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 9999999987543 2489999999999999999999999 9999999999999975
Q ss_pred ------------------------CCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHH
Q 012610 275 ------------------------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 330 (460)
Q Consensus 275 ------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il 330 (460)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999865432 2334589999999999999999999999999999
Q ss_pred HHHHhCCCcccc
Q 012610 331 LELITGQRAFDL 342 (460)
Q Consensus 331 ~el~tg~~p~~~ 342 (460)
|||++|+.||..
T Consensus 250 ~ell~g~~pf~~ 261 (360)
T 3llt_A 250 AELYTGSLLFRT 261 (360)
T ss_dssp HHHHHSSCSCCC
T ss_pred HHHHHCCCCCCC
Confidence 999999999953
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=340.43 Aligned_cols=267 Identities=27% Similarity=0.365 Sum_probs=207.8
Q ss_pred hcCCccCCeecccCCeEEEEEEE-----CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec--CCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~ 206 (460)
.++|...+.||+|+||.||++++ .++..||||++.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46788999999999999999984 357899999997643 2334468999999999999999999998864 456
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 8899999999999999986432 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc------CCCCccHHHHHH
Q 012610 287 KLMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------NDDDVMLLDWVK 358 (460)
Q Consensus 287 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~~~ 358 (460)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543322 122334788899999999989999999999999999999999998532210 000000111111
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGL 416 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 416 (460)
..... .............+.+++.+||+.||++|||+.+|++.|+....
T Consensus 255 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEE---------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhc---------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111 11111122234668999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=338.86 Aligned_cols=256 Identities=26% Similarity=0.343 Sum_probs=203.7
Q ss_pred hcCCccCCeecccCCeEEEEEEE----CCCcEEEEEEeccccc---cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCC
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL----TDGSLVAVKRLKEERT---QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPT 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~ 205 (460)
.++|+..+.||+|+||.||+++. .+++.||||+++.... ......+.+|++++..+ .||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999987 3689999999975432 12234567899999999 6999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998754 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCC--CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC----ccchHHHHHHHHhcc
Confidence 986644333333445699999999999863 47899999999999999999999996321 112222332222221
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVRML 411 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 411 (460)
. .. ........+.+++.+||+.||++|| |++|+++..
T Consensus 282 ~-------~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 E-------PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C-------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred C-------CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1 01 1112235588899999999999999 888888643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=338.78 Aligned_cols=247 Identities=23% Similarity=0.269 Sum_probs=194.3
Q ss_pred cCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCCC
Q 012610 139 NRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 217 (460)
Q Consensus 139 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 217 (460)
..+.||+|+||.||+|... ++..||+|+++.... .....+.+|++++..++||||+++++++...+..++||||++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3568999999999999875 689999999976432 33457899999999999999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe--cCCCcEEEeecccccccCCCCCc
Q 012610 218 SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTH 295 (460)
Q Consensus 218 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~ 295 (460)
+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 9999887543 2389999999999999999999999 99999999999999 5678999999999987653322
Q ss_pred eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCC
Q 012610 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDME 375 (460)
Q Consensus 296 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (460)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........ .. .
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~--~~-----~ 308 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRW--DL-----E 308 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC--CS-----C
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccC--CC-----C
Confidence 233458999999999999999999999999999999999999995321 1122222221110 00 0
Q ss_pred CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 376 GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 376 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.||.+|||+.|+++
T Consensus 309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001122356889999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=331.18 Aligned_cols=268 Identities=24% Similarity=0.314 Sum_probs=208.6
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhc--cCCCcceeeeeeeec
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM--AVHRNLLRLRGFCMT 203 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~~~~~~ 203 (460)
.+.......++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444566789999999999999999999985 899999999643 23457788888876 789999999999987
Q ss_pred CC----cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeeCCCCCCEE
Q 012610 204 PT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--------DHCDPKIIHRDVKAANIL 271 (460)
Q Consensus 204 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nil 271 (460)
.. ..++||||+.+|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 75 789999999999999999764 3899999999999999999999 77 9999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCCc---eeecccccccccCcccccCC------CCCcccCchhhHHHHHHHHhC------
Q 012610 272 LDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITG------ 336 (460)
Q Consensus 272 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~G~il~el~tg------ 336 (460)
++.++.+||+|||++......... ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876544322 12334589999999999775 234789999999999999999
Q ss_pred ----CCccccccccCCCCccHHHHHHHHhhhccccccccccCCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 012610 337 ----QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRML 411 (460)
Q Consensus 337 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 411 (460)
..||..... .......+....... .. .+.+... ........+.+++.+||+.||++|||+.+|++.|
T Consensus 260 ~~~~~~p~~~~~~---~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 260 HEDYQLPYYDLVP---SDPSVEEMRKVVCEQ-KL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCCCTTTTTSC---SSCCHHHHHHHHTTS-CC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCccccCc---CcccHHHHHHHHHHH-Hh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 667743211 111222222222111 11 1111111 1235667899999999999999999999999999
Q ss_pred hcC
Q 012610 412 EGD 414 (460)
Q Consensus 412 ~~~ 414 (460)
+.+
T Consensus 332 ~~i 334 (342)
T 1b6c_B 332 SQL 334 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=331.04 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=205.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999875 6889999999766555555678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++... ++++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998642 489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (460)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........ ..... +
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~-----~ 237 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLI-PKNNP-----P 237 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHH-HHSCC-----C
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHh-hcCCC-----C
Confidence 22 2233458999999999999999999999999999999999999995321 11111111 11111 1
Q ss_pred cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... ....+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 238 TLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 2345889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=333.65 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=204.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeec--CCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~l 209 (460)
.++|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367889999999999999999986 689999999975443 2334568899999999999999999998753 567899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeeCCCCCCEEecCCCcEEEeecc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK-----IIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987554445689999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
+++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+..... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i-~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKI-REG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHHH-hhc
Confidence 9987643321 1223458999999999999899999999999999999999999995321 11111111 111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.... + .......+.+++.+||+.||++|||+.||++.+..
T Consensus 232 ~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRR-----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccc-----C----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 1 11223568899999999999999999999986643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=337.95 Aligned_cols=268 Identities=25% Similarity=0.356 Sum_probs=195.8
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHH--HhccCCCcceeeeeeeec-----CCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHRNLLRLRGFCMT-----PTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~h~niv~l~~~~~~-----~~~ 206 (460)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46889999999999999999987 47899999996432 2234444444 556899999999975532 235
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeeCCCCCCEEecCCCcEEE
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------DPKIIHRDVKAANILLDEEFEAVV 280 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~kl 280 (460)
.++||||+++|+|.+++.... .++..++.++.||+.||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 689999999999999997653 588999999999999999999873 338999999999999999999999
Q ss_pred eecccccccCCCC-------CceeecccccccccCcccccC-------CCCCcccCchhhHHHHHHHHhCCCcccccccc
Q 012610 281 GDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELITGQRAFDLARLA 346 (460)
Q Consensus 281 ~Dfg~~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~ 346 (460)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764322 112223458999999999977 45678999999999999999998887432211
Q ss_pred CCCCccH---------HHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 347 NDDDVML---------LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 347 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
....... ................+... ..........+.+++.+||+.||++|||+.||++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1111100 11111111111111111100 11123456679999999999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=320.07 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=203.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|+..+.||+|+||.||+|... +++.||+|++...... .....+.+|++++..++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999976 5889999999765432 23346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc---EEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~ 288 (460)
||+.+++|.+.+.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999987653 389999999999999999999999 9999999999999987665 99999999976
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... .....
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~-~~~~~ 226 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKA-GAYDY 226 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-TCCCC
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------hhHHHHHHHh-ccccC
Confidence 64332 2233568999999999999999999999999999999999999995311 1111111111 11100
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ..........+.+++.+||+.||++|||+.|+++
T Consensus 227 -~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -P-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -C-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -C-----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0001122356889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=327.24 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=204.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----hhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|.+.+.||+|+||.||+|... +++.||+|.+....... ....+.+|++++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999976 58999999997643322 245688999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC----cEEEeec
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 283 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df 283 (460)
++||||+.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997542 489999999999999999999999 999999999999999988 7999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765332 2233458999999999999999999999999999999999999995311 11111111111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ..+... .......+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 -SY--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CC--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -cc--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000 0112356889999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=325.62 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=182.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|...+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57888999999999999999974 689999999965432 122356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++.... .++++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999997643 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~ 226 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------LNKVVL 226 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------HHHHhh
Confidence 3222 2234589999999999998999999999999999999999999964221100 000000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .........+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 011112356889999999999999999999885
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=334.94 Aligned_cols=265 Identities=26% Similarity=0.438 Sum_probs=198.6
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEEC----CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeee
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCM 202 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~ 202 (460)
.++.+..++|...+.||+|+||.||+|... .+..||+|.++..... .....+.+|+.++..++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334456778999999999999999999764 2458999999755332 23456889999999999999999999988
Q ss_pred cCCc-----ceEEeeccCCCCHHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC
Q 012610 203 TPTE-----RLLVYPFMVNGSVASCLRERG--QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275 (460)
Q Consensus 203 ~~~~-----~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 275 (460)
.... .++||||+.+++|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7543 489999999999999985432 2234599999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccH
Q 012610 276 FEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVML 353 (460)
Q Consensus 276 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~ 353 (460)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEM 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHH
Confidence 99999999999865433211 1223346789999999999999999999999999999999 889985321 1111
Q ss_pred HHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.. ........ .........+.+++.+||+.||.+|||+.+|++.|++
T Consensus 259 ~~---~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 259 YD---YLLHGHRL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HH---HHHTTCCC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HH---HHHcCCCC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 11111110 1112233568999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.29 Aligned_cols=261 Identities=18% Similarity=0.228 Sum_probs=200.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeee-ecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~-~~~~~~~lv 210 (460)
..++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+|++++..++|++++..++.+ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999997 46889999987544322 2578899999999998887777666 556778999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeeccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~ 287 (460)
|||+ +++|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 9999999985432 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 288 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 288 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhcccc
Confidence 76543321 12344689999999999999999999999999999999999999964322211 111111111111
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.. ..... . ......+.+++.+||+.||++|||+.+|++.|++.
T Consensus 236 ~~-~~~~~-----~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 236 ST-PIEVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HS-CHHHH-----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cc-hhhhh-----h----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 10 00000 0 01135689999999999999999999999999763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.86 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=202.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|.+.+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999986 6899999999754321 23346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997543 489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+... ........... ...
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~-~~~--- 234 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKICDG-IFY--- 234 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHHTT-CCC---
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcC-CcC---
Confidence 32 2334569999999999988765 789999999999999999999996321 11111221111 100
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .......+.+++.+||+.||.+|||+.++++
T Consensus 235 ---~----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---T----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---C----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 0112245889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=336.25 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=194.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|...+.||+|+||.||+|+.. +++.||+|++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47888999999999999999986 68999999997654433333456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+. |+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 589998876532 489999999999999999999999 99999999999999999999999999998654332
Q ss_pred CceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc---cc
Q 012610 294 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---QL 369 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 369 (460)
. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.......... ..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhh
Confidence 2 2233458999999999876 568999999999999999999999995321 111112221111111000 00
Q ss_pred cc---------ccCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VD---------SDMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~---------~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. +...... .......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 0000000 0112356789999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=325.50 Aligned_cols=260 Identities=18% Similarity=0.227 Sum_probs=203.3
Q ss_pred hcCCccCCeecccCCeEEEEEEE-CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeee-ecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~-~~~~~~~lv~ 211 (460)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+|++++..++|++++..+.++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46899999999999999999997 4789999999865432 23588999999999998877776665 4566779999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~ 288 (460)
||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 9999999975432 489999999999999999999999 99999999999999 4888999999999987
Q ss_pred cCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 289 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 289 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhcccccC
Confidence 6543321 12344689999999999999999999999999999999999999964322111 1111111111111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. ..... . ......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 237 ~-~~~~~-----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 237 T-PIEVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp S-CHHHH-----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred C-chHHH-----H----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 00000 0 11235688999999999999999999999999763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=335.95 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=204.8
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
+..++|...+.||+|+||.||+|+.. ++..||||.+...........+.+|+.++..++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34578999999999999999999842 467899999976555555567889999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEE
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAV 279 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~k 279 (460)
..++||||+++++|.+++...... ...+++..++.++.||+.||.|||++ +|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999875432 23489999999999999999999999 9999999999999994 44699
Q ss_pred EeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHH
Q 012610 280 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 357 (460)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVL 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHH
Confidence 999999975533221 12233457889999999999999999999999999999998 999995311 11111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......... .........+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 256 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 256 EFVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 111111110 0111223568899999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.76 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=189.3
Q ss_pred cCCccC-CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHH-hccCCCcceeeeeeeec----CCcc
Q 012610 135 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 207 (460)
Q Consensus 135 ~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~~~~~~----~~~~ 207 (460)
++|... ++||+|+||+||++... +++.||||++... ..+.+|++++ ...+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456655 68999999999999976 6889999998632 2466788876 45589999999998865 4568
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeecc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 284 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg 284 (460)
++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999986432 3489999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+. ..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~----~~ 282 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIR----MG 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHH----HT
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHH----cC
Confidence 998654322 2234568999999999999999999999999999999999999996432211111 1111111 11
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ............+.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 283 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 000011123356889999999999999999999997
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.71 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=197.2
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc----chhHHHHHHHHHHhccC---CCcceeeeeeeec
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ----GGELQFQTEVEMISMAV---HRNLLRLRGFCMT 203 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~ 203 (460)
...++|+..+.||+|+||+||+|+.. +++.||||++...... .....+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45679999999999999999999974 6899999999743321 12235667777776664 9999999999987
Q ss_pred CC-----cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 204 PT-----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 204 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
.. ..+++|||+. ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 4689999996 599999986543 2389999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence 999999998654322 2234568999999999999999999999999999999999999995321 111111111
Q ss_pred HHhhhccccccc------cccCCC---CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 359 GLLKEKKLEQLV------DSDMEG---NY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 359 ~~~~~~~~~~~~------~~~~~~---~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............ ...... .. .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111100000000 000000 00 0112356889999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.89 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=162.2
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccC-CCcceeeeeeeecCC--c
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPT--E 206 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~--~ 206 (460)
...++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999875 689999999865432 233446788999999997 999999999987544 6
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+. ++|..++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 799999997 5899998763 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC--------------------CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 287 KLMDYK--------------------DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 287 ~~~~~~--------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 865321 1112234569999999999976 6789999999999999999999999953
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=334.53 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=199.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 210 (460)
..++|+..+.||+|+||.||++... +++.||||++..... ...+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999986 588999999975432 234688888777 799999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC----CcEEEeecccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLA 286 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~ 286 (460)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999997643 389999999999999999999999 99999999999998543 35999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+....... ...
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~-~~~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEILARIGS-GKF 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHHHHHHH-CCC
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHHHHHcc-CCc
Confidence 87654332 2334568999999999988889999999999999999999999996321 1122222222211 111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ............+.+++.+||+.||++|||+.++++
T Consensus 241 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 S------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 111111223456889999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.70 Aligned_cols=255 Identities=26% Similarity=0.350 Sum_probs=205.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
..++|...++||+|+||.||+|+.. +|+.||+|++..... ......+.+|++++..++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567899999999999999999986 689999999975432 2234467899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976542 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ......
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~----~~~~~~i~~~-i~~~~~--- 406 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERL-VKEVPE--- 406 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS----CCCHHHHHHH-HHHCCC---
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc----chhHHHHHHH-hhcccc---
Confidence 4332 23345699999999999999999999999999999999999999964221 1111111111 111110
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.+.......+.+++.+||+.||.+|| +++||++
T Consensus 407 -------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 -------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01111235688999999999999999 6677764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.61 Aligned_cols=252 Identities=17% Similarity=0.193 Sum_probs=202.1
Q ss_pred HHhcCCccCCeecccCCeEEEEEE------ECCCcEEEEEEeccccccchhHHHHHHHHHHhccC---CCcceeeeeeee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCM 202 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~ 202 (460)
...++|...++||+|+||+||+|. ..+++.||||++.... ...+..|++++..++ |+||+.+++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 445789999999999999999994 3468899999997542 335677777777776 999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-------
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ-SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE------- 274 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~------- 274 (460)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999976432 234599999999999999999999999 9999999999999998
Q ss_pred ----CCcEEEeecccccccCC-CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCC
Q 012610 275 ----EFEAVVGDFGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 349 (460)
Q Consensus 275 ----~~~~kl~Dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~ 349 (460)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 89999999999976542 2233445567999999999999999999999999999999999999999532110
Q ss_pred CccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhhc
Q 012610 350 DVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMER-PKMSEVVRMLEG 413 (460)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Pt~~evl~~L~~ 413 (460)
....... ..... ..+.+.+++..|++.+|.+| |+++++.+.|++
T Consensus 292 -------------~~~~~~~----~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 -------------ECKPEGL----FRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------------EEEECSC----CTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------------ceeechh----ccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0011111 11111 13457778889999999998 678888887765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.83 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=197.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|+||.||+|... +++.||+|++....... ....+.+|++++..++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999986 58999999987654332 24467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|..++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886543 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh---------
Q 012610 293 DTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 362 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 362 (460)
.. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccc
Confidence 22 2233458999999999876 5679999999999999999999999953211 111111111100
Q ss_pred ---hccccc--cccccCCCC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 ---EKKLEQ--LVDSDMEGN---YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ---~~~~~~--~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... +.++..... ........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 000000000 00122355889999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=322.58 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=201.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|...+.||+|+||.||+|... ++..+|+|++...... ....+.+|+++++.++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 467899999999999999999976 4778999999765432 34578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeeccccccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 289 (460)
|+.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999987654 389999999999999999999999 99999999999999 88899999999999876
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||.... ..+....... .....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~- 226 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIRE-GTFTF- 226 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCCC-
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHh-CCCCC-
Confidence 5332 22334589999999988654 8999999999999999999999995321 1111111111 11000
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .........+.+++.+||+.||++|||+.++++
T Consensus 227 ~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PE-----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cc-----hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000012356889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.58 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=176.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|+..+.||+|+||.||+|... ++..||+|++...........+.+|+.++..++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999986 6899999999876544455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+++++|.+++.... .+++..+..++.+++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998754 3899999999999999999999832 7999999999999999999999999999754321
Q ss_pred CCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12334689999999999999999999999999999999999999953
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.92 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=206.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEE-----CCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC--
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~-- 205 (460)
..++|+..+.||+|+||.||++++ .+++.||||++.... ......+.+|+++++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 346788899999999999999984 358899999997642 333457899999999999999999999887643
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 68999999999999999987532 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccc------cC-CCCccHHHH
Q 012610 286 AKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL------AN-DDDVMLLDW 356 (460)
Q Consensus 286 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~------~~-~~~~~~~~~ 356 (460)
+.......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... .. .........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98765443221 1223467789999999988899999999999999999999999853210 00 000111111
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
+...+.... ...........+.+++.+||+.||++|||+.+|++.|+++
T Consensus 272 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111110 0111122346689999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=334.06 Aligned_cols=278 Identities=24% Similarity=0.357 Sum_probs=203.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|+||.||+|+.. +++.||||++....... ....+.+|++++..++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888999999999999999986 58999999986544332 23457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.+++|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999988875433 389999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH-----------HH
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-----------GL 360 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~ 360 (460)
.. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+...+. ..
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhhhHh
Confidence 22 22334589999999999875 689999999999999999999999953211 001111110 00
Q ss_pred hhhccccccccccCCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhcCCCcchhhHHH
Q 012610 361 LKEKKLEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGDGLAERWEEWQ 424 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~~~~~~~~~~ 424 (460)
...........+...... .......+.+++.+||+.||++|||+.|+++ .++.....+++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 323 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQEL 323 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHHHHHH
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhhhHHH
Confidence 001111111111111110 0123466899999999999999999999985 344433344444333
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.55 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=196.9
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC-CcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-~~~~lv~ 211 (460)
..++|+..+.||+|+||.||+++.. ++.||||+++... ....+.+|++++..++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4568899999999999999999886 7899999997543 345688999999999999999999987654 4789999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999976432 1278899999999999999999999 999999999999999999999999999975443
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ........
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~---~~~~~~~~------ 231 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV---VPRVEKGY------ 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGH---HHHHTTTC------
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHH---HHHHhcCC------
Confidence 21 22347889999999998899999999999999999998 9999953211 111 11111110
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...........+.+++.+||+.||++|||+.++++.|+.+
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 ----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111122345688999999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=326.67 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=202.5
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec--------
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-------- 203 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-------- 203 (460)
..++|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+|++++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567899999999999999999986 78999999997542 256789999999999999999998754
Q ss_pred --------CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC
Q 012610 204 --------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE 275 (460)
Q Consensus 204 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~ 275 (460)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 3447899999999999999976432 2489999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHH
Q 012610 276 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 276 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 355 (460)
+.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 9999999999987654322 22345899999999999999999999999999999999999988421 01
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.... ...... ... ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 227 ~~~~-~~~~~~--------~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTD-LRDGII--------SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHH-HHTTCC--------CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-hhcccc--------ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 111111 111 124578899999999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=360.79 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=196.1
Q ss_pred CeecccCCeEEEEEEEC---CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
+.||+|+||.||+|.+. .++.||||+++..... .....+.+|++++..++||||+++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 4678999999765432 234579999999999999999999999864 568899999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCc-
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 295 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 295 (460)
|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 389999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 296 -VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 296 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--------~~~~~~~i~~~~~-------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGER-------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCC--------
Confidence 2222346788999999999999999999999999999998 999995321 1111111111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+...+.+++.+||+.||++|||+.+|++.|++
T Consensus 591 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 591 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11112234678999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=326.92 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=198.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999986 689999999976433 23345688899999888 899999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC---------------
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--------------- 275 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--------------- 275 (460)
|||+++++|.+++.........+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999987543334589999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeecccccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCC
Q 012610 276 ----FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 350 (460)
Q Consensus 276 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~ 350 (460)
..+||+|||++....... ...|+..|+|||.+.+. .++.++|||||||++|||++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998765332 23489999999999776 56789999999999999999988763211
Q ss_pred ccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 351 VMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .. ........ ... .....+.+++.+||+.||++|||+.++++
T Consensus 236 -~~----~~-~~~~~~~~-----~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -QW----HE-IRQGRLPR-----IPQ----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HH----HH-HHTTCCCC-----CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH----HH-HHcCCCCC-----CCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 01 11 11111111 111 12356889999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=328.40 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=203.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|...+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999986 578999999875432 22345688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ..+........ ..
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~-~~---- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKN-EY---- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT-CC----
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcC-CC----
Confidence 3322 2233458999999999999999999999999999999999999995321 11111111111 10
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 259 --~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 --SIPK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 12245888999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.47 Aligned_cols=260 Identities=22% Similarity=0.255 Sum_probs=194.8
Q ss_pred cCCccC-CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+.|.+. ++||+|+||.||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 467764 78999999999999865 68999999997543 23345788999999884 7999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc---EEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~ 288 (460)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999998753 389999999999999999999999 9999999999999998876 99999999876
Q ss_pred cCCCCC------ceeecccccccccCcccccC-----CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCc---c--
Q 012610 289 MDYKDT------HVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV---M-- 352 (460)
Q Consensus 289 ~~~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~---~-- 352 (460)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 542211 11223458999999999875 5578999999999999999999999964322110000 0
Q ss_pred --HHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 353 --LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 353 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ....... .... ........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~-i~~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFES-IQEGKYE-FPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHH-HHHCCCC-CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHH-HhccCcc-cCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011111 1111100 0000 00112356889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.87 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=201.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-----chhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|+..+.||+|+||.||++... +++.||+|.++..... .....+.+|++++..++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457889999999999999999986 6899999998754322 1245789999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC----cEEEeec
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 283 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df 283 (460)
++||||+.+++|.+++.... .+++..++.++.||+.||.|||++ +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997643 389999999999999999999999 999999999999999887 8999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTNISAV 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHHhHhc
Confidence 9998654322 2233458999999999999999999999999999999999999995321 11111111110
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .... ........+.+++.+||+.||++|||+.++++
T Consensus 227 -~~~--~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 -NYD--FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCC--CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccC--Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 0000 01112356889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=329.90 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=188.7
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHH-HHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+..++|+..+.||+|+||.||+|... +++.||+|++........... +.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34578999999999999999999975 689999999976544333333 4445555788899999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||++ |+|.+++.........+++..++.++.|++.||+|||++. +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 5888887664333446999999999999999999999853 8999999999999999999999999999865
Q ss_pred CCCCCceeecccccccccCcccc----cCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..... .....|++.|+|||.+ .+..++.++|||||||++|||++|+.||.... . ....+........
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~-~~~~~~~~~~~~~ 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------T-PFQQLKQVVEEPS 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------C-HHHHHHHHHHSCC
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------c-hHHHHHHHhccCC
Confidence 43322 2233589999999996 55678999999999999999999999995311 1 1111122211111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .. .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~-~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQ-LP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC-CC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-cc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 10 00 1112356889999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.02 Aligned_cols=261 Identities=18% Similarity=0.206 Sum_probs=202.2
Q ss_pred hcCCccCCeecccCCeEEEEEEECC---------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCccee--------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-------- 196 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~-------- 196 (460)
.++|...+.||+|+||.||+|+... ++.||+|++... ..+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3688999999999999999999763 789999998653 25789999999999999988
Q ss_pred -------eeeeeec-CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 012610 197 -------LRGFCMT-PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 197 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 268 (460)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5666665 67789999999 999999998642 12489999999999999999999999 9999999999
Q ss_pred CEEecCCC--cEEEeecccccccCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcc
Q 012610 269 NILLDEEF--EAVVGDFGLAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340 (460)
Q Consensus 269 Nill~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~ 340 (460)
|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999865432211 113346899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 341 DLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..... .............. ....+.+.... .......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 269 ~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 269 TNCLP---NTEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGGTT---CHHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCc---CHHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 64221 11112222221111 11111111110 011235688999999999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=321.26 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=203.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|...+.||+|+||.||++... +++.+|+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999986 578999999875432 22345688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987653 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........ ..
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~---- 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKN-EY---- 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-CC----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhc-cC----
Confidence 3322 2233458999999999999899999999999999999999999995321 11111111111 00
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ......+.+++.+||+.||++|||+.++++
T Consensus 233 --~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 --SIP----KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCc----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011 112345888999999999999999999885
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.30 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=196.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec----CCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~ 208 (460)
+.|...+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677788999999999999875 5789999999765432 334568899999999999999999998865 34578
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEec-CCCcEEEeeccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGL 285 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~ 285 (460)
+||||+++++|.+++.... .+++..++.++.||+.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999998753 389999999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
+....... .....|++.|+|||.+. +.++.++|||||||++|+|++|+.||.... ..............
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC
T ss_pred cccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHHHHHhccCC
Confidence 97644322 23345899999999886 458999999999999999999999995311 11222222211111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...+ ......+.+++.+||+.||.+|||+.++++
T Consensus 248 ~-~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 P-ASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C-GGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-cccC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1111 111245889999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.57 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=192.0
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-------cchhHHHHHHHHHHhccCCCcceeeeeeeec
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 203 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 203 (460)
...++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999876 578999999975431 1112258899999999999999999999754
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---cEEE
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVV 280 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl 280 (460)
...++||||+.+|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 45799999999999999886543 489999999999999999999999 999999999999997544 5999
Q ss_pred eecccccccCCCCCceeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 281 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+...+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHHH
Confidence 999999876432 22334568999999999864 567889999999999999999999996321 111222211
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ....... + .........+.+++.+||+.||++|||+.|+++
T Consensus 358 ~----~~~~~~~--~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 T----SGKYNFI--P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H----TTCCCCC--H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred h----cCCCCCC--c----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 1111000 0 000112356889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.50 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=192.4
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
..++|...+.||+|+||+||+|... +++.||||++....... ....+.+|+++++.++||||+++++++......++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999865 68899999997554322 234577899999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe-----cCCCcEEEeeccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGL 285 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-----~~~~~~kl~Dfg~ 285 (460)
|||+. |+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 59999997654 389999999999999999999999 99999999999999 4555699999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++........ .....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...... ....
T Consensus 184 a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~-~~~~ 257 (329)
T 3gbz_A 184 ARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIFEV-LGLP 257 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHH-HCCC
T ss_pred ccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHHHH-hCCC
Confidence 9876533222 2334579999999999875 489999999999999999999999953211 0111111111 0000
Q ss_pred ccc---ccc--------cccCCCCCcHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLE---QLV--------DSDMEGNYIEE-----EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~---~~~--------~~~~~~~~~~~-----~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ... .+......... ....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000 00000111111 2356789999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=341.35 Aligned_cols=259 Identities=20% Similarity=0.233 Sum_probs=192.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
.++|+..+.||+|+||+||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999876 588999999975432 233456889999999999999999999986543
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 46999999976 46666642 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh----
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL---- 361 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 361 (460)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...+
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-----~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-----IDQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCSCC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCC
Confidence 9875432 223445689999999999999999999999999999999999999953211 00111110000
Q ss_pred ---------------hhc-ccc-----ccccccCC-C--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 ---------------KEK-KLE-----QLVDSDME-G--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 ---------------~~~-~~~-----~~~~~~~~-~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ... ......+. . .........+.+++.+||+.||++|||++|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000 00000000 0 001122566899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=319.73 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=202.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|...+.||+|+||.||+|+.. ++..||+|++..... ......+.+|++++..++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367889999999999999999976 578899999965432 22245688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++++|.+++.... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998754 389999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+........ .
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~-~----- 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIVNV-D----- 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-C-----
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHhcc-c-----
Confidence 322 233458999999999999999999999999999999999999995321 11111111111 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ......+.+++.+||+.||.+|||+.++++
T Consensus 229 -~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -LKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0111 112356889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=336.37 Aligned_cols=264 Identities=19% Similarity=0.249 Sum_probs=194.9
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC----
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP---- 204 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~---- 204 (460)
++...++|...+.||+|+||+||+|... +++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456678999999999999999999874 689999999865432 234799999999999999999988543
Q ss_pred ----------------------------------CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 012610 205 ----------------------------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250 (460)
Q Consensus 205 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 250 (460)
...++||||++ |+|.+.+.........+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 23789999997 5888887654333445999999999999999999
Q ss_pred HHHhCCCCCeEeeCCCCCCEEec-CCCcEEEeecccccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHH
Q 012610 251 YLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGV 328 (460)
Q Consensus 251 ~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~ 328 (460)
|||++ +|+||||||+|||++ .++.+||+|||+++....... .....+|..|+|||.+.+. .++.++|||||||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999998 688999999999987643332 2334589999999998775 4899999999999
Q ss_pred HHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc----------cccccccccCCCC-----CcHHHHHHHHHHHHHc
Q 012610 329 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK----------KLEQLVDSDMEGN-----YIEEEVEQLIQVALLC 393 (460)
Q Consensus 329 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~c 393 (460)
++|||++|+.||..... ...+...+. ..... ......-+..... ........+.+++.+|
T Consensus 231 il~ell~g~~pf~~~~~----~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 231 VFGELILGKPLFSGETS----IDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHSSCSSCCSSH----HHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCh----HHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 99999999999953211 111111111 00000 0000000011111 0111235688999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 012610 394 TQGSPMERPKMSEVVR 409 (460)
Q Consensus 394 l~~~P~~RPt~~evl~ 409 (460)
|+.||++|||+.|+++
T Consensus 306 L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSSGGGSCCHHHHHT
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=329.50 Aligned_cols=264 Identities=25% Similarity=0.282 Sum_probs=195.1
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc----hhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
..++|...+.||+|+||.||+|... +|+.||||++....... ....+.+|++++..++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3568999999999999999999976 58999999997543221 123578999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+ +|..++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999976 8888887543 2488899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||.... .......+.........
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-----~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHcCCCCh
Confidence 7643322 22334589999999998764 48999999999999999999999985321 11111111111110000
Q ss_pred cccc------cccC---CCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLV------DSDM---EGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~------~~~~---~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... +... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000 00000 122356899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=326.39 Aligned_cols=255 Identities=19% Similarity=0.240 Sum_probs=197.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeec--CCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~--~~~~~lv 210 (460)
++|+..+.||+|+||.||+|... +++.||||++.... ...+.+|++++..++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 67889999999999999999874 68999999997432 346889999999997 9999999999987 5668999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeeccccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 289 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 289 (460)
|||+.+++|.+++.. +++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999853 78999999999999999999999 999999999999999777 8999999999876
Q ss_pred CCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ........+..........+
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~----~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH----DNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS----SHHHHHHHHHHHHCHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC----chHHHHHHHHHhcCCchhhh
Confidence 43322 233458899999999877 678999999999999999999999994211 11011100000000000000
Q ss_pred c-----------------------ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 L-----------------------VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~-----------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ................+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000011111123466899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.60 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=192.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
.++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367889999999999999999975 6899999999654322 23456889999999999999999999987653
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+ +++|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999999763 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTP 245 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCC
Confidence 9875432 233468999999999887 6789999999999999999999999953211 01111110000000
Q ss_pred ------------------cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ------------------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 0011122356889999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.21 Aligned_cols=244 Identities=14% Similarity=0.121 Sum_probs=188.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHH---HHHhccCCCcceeee-------ee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEV---EMISMAVHRNLLRLR-------GF 200 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~---~~l~~~~h~niv~l~-------~~ 200 (460)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+ +.++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888899999999999999964 689999999975422 23345688999 455566899999998 55
Q ss_pred eecCC-----------------cceEEeeccCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012610 201 CMTPT-----------------ERLLVYPFMVNGSVASCLRERGQS---QPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260 (460)
Q Consensus 201 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 260 (460)
+.+.+ ..+++|||+ +|+|.+++...... ...+++..++.++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 68999999864321 11244688889999999999999999 99
Q ss_pred EeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCC-----------CCCcccCchhhHHH
Q 012610 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-----------KSSEKTDVFGYGVM 329 (460)
Q Consensus 261 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dvws~G~i 329 (460)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 2344557 999999999887 89999999999999
Q ss_pred HHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 330 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 330 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+|||++|+.||....... ....+.... . .....+.+++.+||+.||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~-----------------~~~~~~~~~--~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-----------------GSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-----------------CSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-----------------chhhhhhhc--c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999995322110 111111100 1 12356889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.86 Aligned_cols=268 Identities=25% Similarity=0.369 Sum_probs=186.4
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
+.+..++|...+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455678999999999999999999864 688999999976544444556889999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 209 LVYPFMVNGSVASCLRERG----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
+||||+.+++|.+++.... .....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999987521 1223589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC----ceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 285 LAKLMDYKDT----HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 285 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
++........ .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~---~~ 238 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----KVL---ML 238 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHH---HH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----hHH---HH
Confidence 9976543221 11233458999999999876 56899999999999999999999999632111 111 11
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... .....................+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Hhcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111 010000000000111112356889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=340.63 Aligned_cols=260 Identities=18% Similarity=0.243 Sum_probs=202.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc-ceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~ 211 (460)
.++|.+.++||+|+||.||+|+.. +++.||||++...... ..+..|++++..++|++ +..+..++......++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 468999999999999999999974 6899999988654322 25788999999998754 555556666778889999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~ 288 (460)
||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 9999999985432 489999999999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCCc------eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 289 MDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 289 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~i~~ 230 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKISE 230 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHHHhh
Confidence 6543321 12245689999999999999999999999999999999999999964221 111111111111
Q ss_pred hccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 363 EKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. .....+.. + .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ~-~~~~~~~~-l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 231 K-KVATSIEA-L----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H-HHHSCHHH-H----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred c-cccccHHH-H----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 01000000 0 011235689999999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=335.42 Aligned_cols=200 Identities=23% Similarity=0.323 Sum_probs=167.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC-----Cc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 206 (460)
.++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 5789999999754322 2345788999999999999999999998765 56
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 59999997543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------ceeecccccccccCcccc-cCCCCCcccCchhhHHHHHHHHhCCCccc
Q 012610 287 KLMDYKDT---------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 287 ~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
+....... .......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643321 123455689999999986 55679999999999999999999766664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.79 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=201.7
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
..++|.+.++||+|+||+||+|+.. +++.||||++..... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999976 689999999965432 23345788999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec---CCCcEEEeeccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 287 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~ 287 (460)
|||+.+|+|.+.+.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999987654 389999999999999999999999 999999999999995 45679999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+....... ..
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~-~~ 240 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGK-YA 240 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-CC
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC
Confidence 654332 2334469999999999875 58999999999999999999999995321 122222221111 10
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...........+.+++.+||+.||.+|||+.++++
T Consensus 241 ~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 F------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp S------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00011223356889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.65 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=199.6
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc------------chhHHHHHHHHHHhccCCCcceeeee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ------------GGELQFQTEVEMISMAVHRNLLRLRG 199 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~~~h~niv~l~~ 199 (460)
..++|...+.||+|+||+||+|+.. ++..||+|++...... .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999976 5789999999754322 22456889999999999999999999
Q ss_pred eeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC---
Q 012610 200 FCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF--- 276 (460)
Q Consensus 200 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--- 276 (460)
++.+....++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999997654 389999999999999999999999 999999999999999876
Q ss_pred cEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHH
Q 012610 277 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 356 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~ 356 (460)
.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.... ..+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~ 255 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDI 255 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHH
Confidence 69999999998765332 223446999999999986 468999999999999999999999995321 1222
Q ss_pred HHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+...... .... +. .........+.+++.+||+.||.+|||+.|+++
T Consensus 256 ~~~i~~~-~~~~--~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEKG-KYYF--DF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHC-CCCC--CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcC-CCCC--Cc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222111 1000 00 000112356889999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.36 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=198.4
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
...++|+..+.||+|+||.||+|... +|+.||+|.+.... ....+.+|++++..++||||+++++++......++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34578999999999999999999986 58999999997543 234688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++.... ..+++..++.++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999997533 2489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ........... .....
T Consensus 177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~- 245 (314)
T 3com_A 177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTN-PPPTF- 245 (314)
T ss_dssp TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHS-CCCCC-
T ss_pred hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcC-CCccc-
Confidence 3322 2233458999999999999999999999999999999999999995321 11111111111 10000
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.||.+|||+.++++
T Consensus 246 ------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011112356889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=331.24 Aligned_cols=256 Identities=25% Similarity=0.304 Sum_probs=185.4
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeee-------
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM------- 202 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~------- 202 (460)
....+|...++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34568899999999999999999975 68999999985442 233446889999999996 999999999984
Q ss_pred -cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEecCCCcEE
Q 012610 203 -TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 203 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~k 279 (460)
.....+++|||+. |+|.+++..... ..++++..++.++.||+.||+|||++ + |+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 2334689999995 799998876322 22489999999999999999999998 8 99999999999999999999
Q ss_pred EeecccccccCCCCCce-----------eecccccccccCcccc---cCCCCCcccCchhhHHHHHHHHhCCCccccccc
Q 012610 280 VGDFGLAKLMDYKDTHV-----------TTAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFDLARL 345 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~ 345 (460)
|+|||+++......... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 1134488999999998 566789999999999999999999999953211
Q ss_pred cCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 346 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. ..+.. ... ... .......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 259 ~--------~~~~~-----~~~----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 259 L--------RIVNG-----KYS----IPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CC----CCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred H--------HhhcC-----ccc----CCc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 00000 000 000 011123478899999999999999999999999764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=358.36 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=206.4
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
+.++..++|...+.||+|+||.||+|.+.. +..||||.++..........+.+|+.+++.++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344556788889999999999999998742 45799999876554445567899999999999999999999985 4
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
+..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 56899999999999999998643 2389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
+++..............+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ..+........
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENG 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcC
Confidence 998765443333333456789999999998899999999999999999997 999995321 11222222111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
... .........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 609 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 01112335688999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=326.97 Aligned_cols=258 Identities=29% Similarity=0.391 Sum_probs=196.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC--CCc--EEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|+..+.||+|+||.||+|++. ++. .||||+++.... ......+.+|++++..++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467899999999999999999853 233 689999875432 233457889999999999999999999987654 8
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+++|.+++..... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999976532 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 288 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 288 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC
Confidence 765433221 223346788999999998889999999999999999999 999995321 122222221111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
.. ..........+.+++.+||+.||++|||+.++++.|++..
T Consensus 242 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 0011123456889999999999999999999999998643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=320.64 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=196.4
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
+|....+||+|+||.||+|... ++..||||.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4555568999999999999975 68899999997543 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeecccccccCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~ 293 (460)
++++|.+++..... ...+++..++.++.|++.||+|||++ +++|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999986532 23467899999999999999999999 9999999999999987 8999999999998754322
Q ss_pred CceeecccccccccCcccccCCC--CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. ......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .......... . ..
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~-~-----~~ 244 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMF-K-----VH 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHH-C-----CC
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhccc-c-----cc
Confidence 2 123345899999999987654 789999999999999999999999532110 0011110000 0 00
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.+ .......+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1122356889999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=320.63 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=202.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|...+.||+|+||.||+++.. +++.||+|++..... .....+.+|++++..++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 467889999999999999999976 689999999975432 223468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeeccccccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 289 (460)
|+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999997654 389999999999999999999999 99999999999999 78899999999999754
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+....... ....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~-~~~~-- 225 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIKE-GYYE-- 225 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH-CCCC--
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHc-CCCC--
Confidence 322 1223458999999999999999999999999999999999999995321 1111111111 1100
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhhc
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEG 413 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~ 413 (460)
.. ..........+.+++.+||+.||++|||+.++++ .+.+
T Consensus 226 ~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 226 FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 00 1111123356889999999999999999999986 4444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.36 Aligned_cols=259 Identities=19% Similarity=0.247 Sum_probs=202.3
Q ss_pred HHHHHhcCCccC-CeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccC-CCcceeeeeeeecC
Q 012610 129 ELQVATDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 204 (460)
Q Consensus 129 ~~~~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~ 204 (460)
..+...++|... +.||+|+||.||+|... +++.||+|++...... .....+.+|+.++..+. ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345556677776 88999999999999976 5899999999765433 33457889999999885 69999999999999
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEe
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVG 281 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~ 281 (460)
...++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999986532 23489999999999999999999999 9999999999999998 7899999
Q ss_pred ecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 282 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 282 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......
T Consensus 177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYLNIS 246 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHHHH
Confidence 9999987643222 233468999999999999999999999999999999999999995321 111111111
Q ss_pred hhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .. .............+.+++.+||+.||++|||++++++
T Consensus 247 ~~-~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 QV-NV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HT-CC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hc-cc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 10 00 0011111223456889999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=341.79 Aligned_cols=195 Identities=24% Similarity=0.368 Sum_probs=154.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC-----Cc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 206 (460)
.++|++.++||+|+||+||+|... +++.||||++...... .....+.+|++++..++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999876 6899999999754322 2345688999999999999999999998433 56
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 578999987543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--------------------------ceeecccccccccCcccc-cCCCCCcccCchhhHHHHHHHHhC
Q 012610 287 KLMDYKDT--------------------------HVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITG 336 (460)
Q Consensus 287 ~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~G~il~el~tg 336 (460)
+....... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643221 122345689999999976 456799999999999999999994
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=343.88 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=204.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
..++|...++||+|+||.||+|+.. +++.||||++..... ......+.+|+++++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999986 689999999965432 2335578999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe---cCCCcEEEeecccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 286 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~ 286 (460)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999997643 389999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+...... ..
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~-~~ 244 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVEKG-KY 244 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC-CC
Confidence 87654332 233458999999999876 68999999999999999999999995321 11222222111 11
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 TF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00111223456889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=324.07 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=203.3
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-------chhHHHHHHHHHHhcc-CCCcceeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-------GGELQFQTEVEMISMA-VHRNLLRLRGF 200 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~~-~h~niv~l~~~ 200 (460)
.....++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++..+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999986 6899999998754321 1133578899999998 79999999999
Q ss_pred eecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEE
Q 012610 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 280 (460)
Q Consensus 201 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl 280 (460)
+......++||||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998653 389999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCceeecccccccccCcccccC------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHH
Q 012610 281 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 354 (460)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~ 311 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QI 311 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HH
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HH
Confidence 9999998765332 2234568999999998863 357889999999999999999999995311 11
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........ ..... ..+. .......+.+++.+||+.||++|||+.++++
T Consensus 312 ~~~~~i~~-~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LMLRMIME-GQYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHH-TCCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHh-CCCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 11000 0000 0012345889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=331.28 Aligned_cols=271 Identities=19% Similarity=0.261 Sum_probs=198.9
Q ss_pred cCHHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccc----------hhHHHHHHHHHHhccCCCcc
Q 012610 125 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG----------GELQFQTEVEMISMAVHRNL 194 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~ni 194 (460)
..+.++....++|...+.||+|+||.||+|...++..||||++....... ....+.+|++++..++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 44677888899999999999999999999998889999999997543221 12568899999999999999
Q ss_pred eeeeeeeecC-----CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 195 LRLRGFCMTP-----TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 195 v~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
+++++++... ...++||||+. |+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 9999998542 35689999997 68888887532 3489999999999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCC
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 348 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~ 348 (460)
|+++.++.+||+|||+++...... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--- 239 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--- 239 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---
Confidence 999999999999999997543322 2233458899999999877 6789999999999999999999999963211
Q ss_pred CCccHHHHHHHHhhhcccc-----------cccccc---CCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 349 DDVMLLDWVKGLLKEKKLE-----------QLVDSD---MEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......+.......... ...... ..... .......+.+++.+||+.||++|||+.|+++
T Consensus 240 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 --YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 01111111100000000 000000 00000 0112355889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.12 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=195.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467889999999999999999986 689999999975432 22344688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+.+++|.+++.... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997654 389999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ........ .....
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~--- 228 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKI-RGGVF--- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHCCC---
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHh-hcCcc---
Confidence 322 2223458899999999988765 689999999999999999999995321 11111111 11110
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .......+.+++.+||+.||++|||+.++++
T Consensus 229 ---~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ---YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 1112356889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.05 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=197.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|...+.||+|+||+||+|+.. ++..||+|++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999986 688999999976542 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC---CcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~ 288 (460)
||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887654 389999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ..+......... ..
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~-~~- 255 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVEKGK-YT- 255 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-CC-
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC-
Confidence 65332 233456999999999886 568999999999999999999999995321 112222221111 10
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... .........+.+++.+||+.||.+|||+.|+++
T Consensus 256 -~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 -FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 001122356889999999999999999999884
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.82 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=203.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccc--ccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~ 207 (460)
...++|+..++||+|+||.||+|+.. +++.||||++++.. .......+..|..++..+ .||||+.+++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44578999999999999999999976 57899999997542 122344677899999887 699999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|..++...+ .+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998754 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~-~- 559 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN-V- 559 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSC-C-
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC-C-
Confidence 643322 22345679999999999999999999999999999999999999995321 122222222211 0
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKM-----SEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~ 409 (460)
.+.......+.+++.+||+.||++||++ +||++
T Consensus 560 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0111223568899999999999999998 56553
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=326.59 Aligned_cols=262 Identities=20% Similarity=0.321 Sum_probs=199.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC-----Ccc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 207 (460)
.++|+..+.||+|+||.||+|... ++..||||++...........+.+|++++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999876 68899999997654444456788999999999999999999998654 357
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+. |+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 89999997 5999998764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 288 LMDYKDTHV--TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 288 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHHhCCC
Confidence 765332211 2334689999999987554 58999999999999999999999995322 111111111111110
Q ss_pred cccc---ccc--------c-cCCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQ---LVD--------S-DMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~---~~~--------~-~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.... ..+ . ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000 0 000000 0112356889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.62 Aligned_cols=253 Identities=11% Similarity=0.015 Sum_probs=179.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHHHHH---HHhccCCCcceeee-------eee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQTEVE---MISMAVHRNLLRLR-------GFC 201 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~~~h~niv~l~-------~~~ 201 (460)
.+|...+.||+|+||.||+|.+. +++.||||++...... .....+.+|++ .+.. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888899999999999999976 6899999999875432 22345677754 4555 799988754 333
Q ss_pred ecC-----------------CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 012610 202 MTP-----------------TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR------KQIALGAARGLAYLHDHCDP 258 (460)
Q Consensus 202 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 258 (460)
... ...++||||+. |+|.+++..... .+.+..+ +.++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 322 23699999998 899999987532 2455555 67889999999999999
Q ss_pred CeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhC
Q 012610 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITG 336 (460)
Q Consensus 259 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg 336 (460)
+|+||||||+|||++.++.+||+|||+++.... ......+++.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986532 1223447799999999987 6789999999999999999999
Q ss_pred CCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 337 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 337 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.||.......... .........................+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99996432111000 0000000001111111111223467889999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.65 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=197.3
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|++++..++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3468899999999999999999986 58899999987543 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++++|.+++..... .+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999876432 389999999999999999999999 999999999999999999999999998754221
Q ss_pred CCCceeecccccccccCcccc-----cCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYL-----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
. ........|+..|+|||.+ .+..++.++||||||+++|+|++|+.||.... ..............
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDPP 240 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCCC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCCc
Confidence 1 1112234589999999998 36678999999999999999999999995321 11112222111111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ........+.+++.+||+.||++|||+.++++
T Consensus 241 -~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -TLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -ccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 11122356889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.21 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=199.0
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec--
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT-- 203 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~-- 203 (460)
.++....++|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.++..+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445678999999999999999999975 68999999986543 2345688999999998 79999999999876
Q ss_pred ----CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 204 ----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 204 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
....++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 4578999999999999999986432 2489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHH
Q 012610 280 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 354 (460)
|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|+|++|+.||.... ..
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~ 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PM 240 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HH
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HH
Confidence 999999986543221 123345899999999987 5678899999999999999999999995321 11
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhcC
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR--MLEGD 414 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~ 414 (460)
........ ........ ......+.+++.+||+.||.+|||+.++++ .+.+.
T Consensus 241 ~~~~~~~~-~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 241 RALFLIPR-NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHH-SCCCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHhhc-CccccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 11111111 11111111 112356889999999999999999999987 45543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=324.46 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=198.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC--------
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-------- 204 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-------- 204 (460)
++|+..+.||+|+||.||+|+.. +++.||||++...... .....+.+|++++..++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999985 6899999998655432 2344678999999999999999999998763
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
+..++||||+.+ +|.+.+..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 77777765432 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC---CceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 285 LAKLMDYKD---THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 285 ~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 998764322 122234458999999999876 457999999999999999999999996321 11111111111
Q ss_pred hhhccc---ccccccc---------CCCCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 361 LKEKKL---EQLVDSD---------MEGNYIEEE------VEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 361 ~~~~~~---~~~~~~~---------~~~~~~~~~------~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... ....... ......... ...+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000 0000000 000011111 234789999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=331.73 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=192.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC------Ccc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~ 207 (460)
.+|+..++||+|+||.||+|++. +++.||||++..... ...+|+++++.++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 36888899999999999999986 589999999865432 234799999999999999999988542 125
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-CcEEEeecccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 286 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~ 286 (460)
++||||+.+ +|.+.+.........+++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999975 67666654333334599999999999999999999999 99999999999999965 57899999999
Q ss_pred cccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh---
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 362 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 362 (460)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...+...-.
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 87643322 2334689999999998765 789999999999999999999999953211 1111121111000
Q ss_pred ------hccccccccccCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 ------EKKLEQLVDSDMEGNYI-----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ------~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+..... ......+.+++.+||+.||.+|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00011111111111111 112356889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=326.41 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=202.6
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccch----------------hHHHHHHHHHHhccCCCcceee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGG----------------ELQFQTEVEMISMAVHRNLLRL 197 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~~~h~niv~l 197 (460)
.++|...+.||+|+||.||+|.. +++.||||++........ ...+.+|++++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 799999999975432211 1578999999999999999999
Q ss_pred eeeeecCCcceEEeeccCCCCHHHH------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCE
Q 012610 198 RGFCMTPTERLLVYPFMVNGSVASC------LRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANI 270 (460)
Q Consensus 198 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Ni 270 (460)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ . +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4432 13459999999999999999999999 8 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCC-CCCc-ccCchhhHHHHHHHHhCCCccccccccCC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSE-KTDVFGYGVMLLELITGQRAFDLARLAND 348 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dvws~G~il~el~tg~~p~~~~~~~~~ 348 (460)
+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS--- 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC---
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc---
Confidence 9999999999999999875432 33445689999999999887 5666 99999999999999999999963211
Q ss_pred CCccHHHHHHHHhhhccccccccc-----cCC----CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 349 DDVMLLDWVKGLLKEKKLEQLVDS-----DME----GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .+....... .......+. ... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 258 -~---~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 -L---VELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -S---HHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H---HHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 111111111 111100000 000 0000223456889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.60 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
..++++..++|+..+.||+|+||.||+|...+ .+|+|+++..... .....+.+|+.++..++||||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445567889999999999999999999864 4999999754322 22345778999999999999999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999997643 2489999999999999999999999 999999999999998 67999999999
Q ss_pred ccccCCCC----CceeecccccccccCcccccC---------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCcc
Q 012610 286 AKLMDYKD----THVTTAVRGTIGHIAPEYLST---------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352 (460)
Q Consensus 286 ~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~ 352 (460)
++...... ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------- 247 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------- 247 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 87653211 111223448899999999864 357889999999999999999999995321
Q ss_pred HHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
........... ........ .....+.+++.+||+.||++|||+.+|++.|+...
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 248 AEAIIWQMGTG-MKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHHHHHTT-CCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHHHHHhccC-CCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111111111 11111111 11234889999999999999999999999999854
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.00 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=197.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc---cchhHHHHHHHHHHhccCCCcceeeeeeee--cCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~~~~~--~~~~~ 207 (460)
.++|.+.+.||+|+||.||++... ++..||+|++..... ......+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999975 688999999975432 233457899999999999999999999984 44578
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.++ |.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777766432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CceeecccccccccCcccccCCC--CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 288 LMDYKD-THVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 288 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
...... ........|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.... ..+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~-~ 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGK-G 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-C
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhc-C
Confidence 764322 22333456899999999987654 4789999999999999999999995321 1222222111 1
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .... .....+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 229 SY------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 0111 12356889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=320.88 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=195.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-------cchhHHHHHHHHHHhccCCCcceeeeeeeecC
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 204 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~ 204 (460)
..++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999976 578999999975431 11233588999999999999999999998765
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc---EEEe
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVG 281 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~ 281 (460)
. .++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4 899999999999999986533 489999999999999999999999 9999999999999987665 9999
Q ss_pred ecccccccCCCCCceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 282 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 282 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
|||+++..... .......|++.|+|||++. ...++.++|||||||++|+|++|..||.... ....+...+.
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQIT 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHHH
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHHH
Confidence 99999875432 1222345899999999874 4678899999999999999999999996321 1112222211
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...... +. ........+.+++.+||+.||++|||+.++++
T Consensus 234 ~----~~~~~~--~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 S----GKYNFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H----TCCCCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h----CccccC--ch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 111000 00 00112356889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=325.56 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=190.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367899999999999999999875 688999999975432 233446889999999999999999999987654
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999974 78888752 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh---
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--- 362 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 362 (460)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~ 243 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--------IDQWNKVIEQLG 243 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHC-CC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 9865432 122345689999999999999999999999999999999999999953211 011111100
Q ss_pred -------------------hc-c-----ccccccccCCC---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 -------------------EK-K-----LEQLVDSDMEG---NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 -------------------~~-~-----~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. . ..........+ .........+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 0 00000000000 011223567899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=330.58 Aligned_cols=265 Identities=21% Similarity=0.249 Sum_probs=199.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC--------CCcceeeeeeee--
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV--------HRNLLRLRGFCM-- 202 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--------h~niv~l~~~~~-- 202 (460)
.++|.+.++||+|+||+||+|+.. +++.||||++... ......+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 468999999999999999999875 5889999999743 223446788999998885 788999999887
Q ss_pred --cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC----
Q 012610 203 --TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF---- 276 (460)
Q Consensus 203 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---- 276 (460)
.....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 456789999999 6677776655322 34899999999999999999999964 799999999999999876
Q ss_pred ---------------------------------------------cEEEeecccccccCCCCCceeecccccccccCccc
Q 012610 277 ---------------------------------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311 (460)
Q Consensus 277 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 311 (460)
.+||+|||+++..... .....||..|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999875432 223458999999999
Q ss_pred ccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCC-CccHHHHHHHHhhhc---------ccccccccc--------
Q 012610 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLKEK---------KLEQLVDSD-------- 373 (460)
Q Consensus 312 ~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~-------- 373 (460)
+.+..++.++|||||||++|||++|+.||......... .......+....... .........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999643221110 001111111111000 000000000
Q ss_pred C-----------CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 M-----------EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~-----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...........+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01224556778999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.39 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=191.6
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc------c
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE------R 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~------~ 207 (460)
..+|...++||+|+||+||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3578899999999999999999987777999988654322 2369999999999999999999865432 6
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec-CCCcEEEeecccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLA 286 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~ 286 (460)
++||||+.++. ...+.........+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETV-YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEH-HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccH-HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 79999997754 444332222233589999999999999999999999 999999999999999 7999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc-
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK- 364 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 364 (460)
+....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+...+.. ....
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i~~~-~g~p~ 262 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEIIKV-LGTPS 262 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHH-HCCCC
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHH-hCCCC
Confidence 87643322 2334589999999998765 589999999999999999999999953211 1111111111 0000
Q ss_pred ---------cccccccccCCCCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ---------KLEQLVDSDMEGNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ---------~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
......-+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000 1112356899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.60 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=197.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC-----Ccc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~~ 207 (460)
.++|...+.||+|+||.||+|... +++.||||++...........+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468899999999999999999976 68899999997654444455688999999999999999999987654 567
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+. ++|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 6899998763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---------eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 288 LMDYKDTH---------VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 288 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHH
Confidence 76532211 1123458999999998765 6789999999999999999999999963211 0011111
Q ss_pred HHHhhhcccccc------------ccc--cCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQL------------VDS--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~------------~~~--~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............ ... ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111100000000 000 000000 0122356889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=314.57 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=202.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--------cchhHHHHHHHHHHhccC-CCcceeeeeeeec
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--------QGGELQFQTEVEMISMAV-HRNLLRLRGFCMT 203 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~ 203 (460)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999986 588999999975431 112345788999999996 9999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeec
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 283 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df 283 (460)
....++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999998653 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccCccccc------CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLS------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
|++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||.... .....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~ 238 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLML 238 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHH
Confidence 9998765332 223345899999999885 4567899999999999999999999995321 11111
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... ... ............+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~-~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSG-NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHT-CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcC-Ccc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111 110 000111223456889999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.61 Aligned_cols=197 Identities=20% Similarity=0.263 Sum_probs=169.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhcc------CCCcceeeeeeeecCCc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMA------VHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~------~h~niv~l~~~~~~~~~ 206 (460)
..+|++.++||+|+||.||+|... +++.||||++.... .....+.+|++++..+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457999999999999999999876 58899999997532 2233566777777666 57899999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc--EEEeecc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFG 284 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg 284 (460)
.++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999995 699999987543 2489999999999999999999999 9999999999999999987 9999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99764422 2234689999999999999999999999999999999999999953
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=326.73 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=181.0
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecC------C
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------T 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~ 205 (460)
.++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999865 688999999975432 23345688999999999999999999998654 5
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++++|++ +++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999999 78999888652 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 9865422 233568999999999877 6789999999999999999999999953211 11111111111100
Q ss_pred c---ccccc--------cc--cCCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 K---LEQLV--------DS--DMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~---~~~~~--------~~--~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...+. .. ....... ......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 00000 00 0000000 011345889999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=331.46 Aligned_cols=201 Identities=24% Similarity=0.380 Sum_probs=154.4
Q ss_pred cCCcc-CCeecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec--CCcce
Q 012610 135 DNFSN-RNILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERL 208 (460)
Q Consensus 135 ~~~~~-~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~ 208 (460)
+.|+. +++||+|+||.||+|+.. ++..||||++..... ...+.+|+++++.++||||+++++++.. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 44555 458999999999999965 478899999975432 2367899999999999999999999954 56789
Q ss_pred EEeeccCCCCHHHHhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe----cCCCcEE
Q 012610 209 LVYPFMVNGSVASCLRERG-----QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAV 279 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~k 279 (460)
+||||+. ++|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58888775422 1122489999999999999999999999 99999999999999 7788999
Q ss_pred EeecccccccCCCCC--ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 280 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 280 l~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999987653221 223345689999999999874 589999999999999999999999963
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=320.55 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=196.5
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-chhHHHHHHHHHHhccC--CCcceeeeeeeecCCc
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 206 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~ 206 (460)
+.+..++|...+.||+|+||.||++...+++.||||++...... .....+.+|++++..++ |+||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34556789999999999999999999888999999999754332 33456889999999997 5999999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||| +.+++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||++++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 56889999998653 489999999999999999999999 9999999999999975 79999999999
Q ss_pred cccCCCCCc-eeecccccccccCcccccC-----------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHH
Q 012610 287 KLMDYKDTH-VTTAVRGTIGHIAPEYLST-----------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 287 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 354 (460)
+........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~ 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQI 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------HHH
Confidence 876433221 2233458999999999875 467889999999999999999999995311 111
Q ss_pred HHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 355 DWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+....... ............+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SKLHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111111 111111111356889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=323.21 Aligned_cols=270 Identities=21% Similarity=0.266 Sum_probs=188.7
Q ss_pred HHHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc
Q 012610 128 RELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 206 (460)
Q Consensus 128 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~ 206 (460)
.......++|...+.||+|+||.||+|+.. ++..||||++...... .....++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345566789999999999999999999985 6899999998654322 2246678888889999999999999865433
Q ss_pred -------ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeeCCCCCCEEecC-CC
Q 012610 207 -------RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH--DHCDPKIIHRDVKAANILLDE-EF 276 (460)
Q Consensus 207 -------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nill~~-~~ 276 (460)
.++||||+.+ +|...+.........+++..++.++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 6899999976 555555443333445899999999999999999999 87 9999999999999997 89
Q ss_pred cEEEeecccccccCCCCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHH
Q 012610 277 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 355 (460)
Q Consensus 277 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 355 (460)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS----AGQLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh----HHHHHH
Confidence 999999999987653332 23345899999999987654 89999999999999999999999953211 111111
Q ss_pred HHHHHh-----------hhcccccccccc------CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 356 WVKGLL-----------KEKKLEQLVDSD------MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 356 ~~~~~~-----------~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.+.... .........+.. ............+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111100 000000000000 000111113467899999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.51 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=198.6
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC--CCcEEEEEEeccccccc-hhHHHHHHHHHHhcc---CCCcceeeeeeee----
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCM---- 202 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~---- 202 (460)
..++|+..+.||+|+||.||+|... +++.||+|++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 57899999997543221 223566777777665 8999999999987
Q ss_pred -cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEe
Q 012610 203 -TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 281 (460)
Q Consensus 203 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 281 (460)
.....++||||+. |+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4566889999997 699999987543 2489999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh
Q 012610 282 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361 (460)
Q Consensus 282 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 361 (460)
|||+++...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVI 235 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHc
Confidence 999998654322 22334589999999999999999999999999999999999999963211 11111111111
Q ss_pred hhcccccc----------cccc---CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 KEKKLEQL----------VDSD---MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 ~~~~~~~~----------~~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........ .... ............+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0000 000011123456889999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=308.22 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=201.8
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
...++|.+.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 689999999975433 2334578899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC---CcEEEeecccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLA 286 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~ 286 (460)
||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +++|+||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999987653 389999999999999999999999 99999999999999764 46999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
........ .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+........ ..
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~ 239 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETG-KY 239 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-CC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC-CC
Confidence 86543322 222347889999998865 48899999999999999999999995321 11222222111 11
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. +. .........+.+++.+||+.||++|||+.++++
T Consensus 240 ~~--~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AF--DL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC--CS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC--Cc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00 001112356889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.79 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=193.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcc----
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER---- 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~---- 207 (460)
.++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468888999999999999999876 6899999999764332 2245688999999999999999999999876654
Q ss_pred --eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 208 --LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 208 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
++||||+. ++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 688887742 289999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+.+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~ 258 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLTQILKVT 258 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHh
Confidence 9865322 233568999999999887 678999999999999999999999996321 111111111100
Q ss_pred --ccccccc------------c--cCCCCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 --KLEQLVD------------S--DMEGNY----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 --~~~~~~~------------~--~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...+... . ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000 0 000000 0112356889999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=315.66 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=190.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec---------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT--------- 203 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------- 203 (460)
.++|+..+.||+|+||.||+|+.. +++.||||++... ......+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467899999999999999999975 6899999999642 2334568899999999999999999998764
Q ss_pred ----CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEE
Q 012610 204 ----PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279 (460)
Q Consensus 204 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k 279 (460)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 345789999999999999998643 2378899999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCC-------------CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccc
Q 012610 280 VGDFGLAKLMDYKD-------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARL 345 (460)
Q Consensus 280 l~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~ 345 (460)
|+|||++....... ........|+..|+|||.+.+. .++.++|||||||++|||++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 99999998654221 1122334588999999999765 68999999999999999998 44211
Q ss_pred cCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 346 ANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....+....... . ...............+.+++.+||+.||++|||+.++++
T Consensus 232 -----~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 -----MERVNILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HHHHHHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hhHHHHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 011111111111 0 011111222233456889999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=320.82 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=179.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHH-HHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|...+.||+|+||.||+|... +++.||||++...........+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 468889999999999999999986 689999999976544444445566665 677889999999999999999999999
Q ss_pred eccCCCCHHHHhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 212 PFMVNGSVASCLRERG-QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
||+.+ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 8888776421 11235899999999999999999999853 79999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCcccc----cCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYL----STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
.... .....|+..|+|||.+ .+..++.++|||||||++|||++|+.||...... .+.+..... .
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~-- 245 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVK-G-- 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCC-S--
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhc-C--
Confidence 3221 2223589999999998 4567899999999999999999999999532110 000000000 0
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+.+...........+.+++.+||+.||++|||+.+|++
T Consensus 246 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 ---DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0001111111123356889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=316.41 Aligned_cols=259 Identities=21% Similarity=0.271 Sum_probs=199.7
Q ss_pred hcCCccCCeecccCCeEEEEEEE-C-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc------ceeeeeeeecCC
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRL-T-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~~~~~~~~ 205 (460)
.++|++.+.||+|+||.||+|.. . +++.||||+++... .....+.+|++++..++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 46899999999999999999987 3 68899999997532 23346788999888887654 999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-----------
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE----------- 274 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----------- 274 (460)
..++||||+ +++|.+++..... .++++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 8999999987543 3488999999999999999999999 9999999999999988
Q ss_pred --------CCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc
Q 012610 275 --------EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 346 (460)
Q Consensus 275 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~ 346 (460)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS- 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-
Confidence 668999999999864432 2234589999999999999999999999999999999999999953211
Q ss_pred CCCCccHHHHHHHHhhhcc--------cccc-ccccC---------------------CCCCcHHHHHHHHHHHHHccCC
Q 012610 347 NDDDVMLLDWVKGLLKEKK--------LEQL-VDSDM---------------------EGNYIEEEVEQLIQVALLCTQG 396 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~---------------------~~~~~~~~~~~l~~l~~~cl~~ 396 (460)
......+........ .... ..... ...........+.+++.+||+.
T Consensus 240 ----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 240 ----KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp ----HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ----HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 111111111110000 0000 00000 0011223457789999999999
Q ss_pred CCCCCCCHHHHHH
Q 012610 397 SPMERPKMSEVVR 409 (460)
Q Consensus 397 ~P~~RPt~~evl~ 409 (460)
||.+|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=319.14 Aligned_cols=244 Identities=22% Similarity=0.398 Sum_probs=198.7
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----hhHHHHHHHHHHhccC--CCcceeeeeeee
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFCM 202 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~~~~~ 202 (460)
+...++|...+.||+|+||.||+|... +++.||||++....... ....+.+|++++..++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445678999999999999999999865 68899999997653321 2235678999999986 599999999999
Q ss_pred cCCcceEEeeccCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec-CCCcEEE
Q 012610 203 TPTERLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVV 280 (460)
Q Consensus 203 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl 280 (460)
..+..++|+|++.+ ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 89999998753 389999999999999999999999 999999999999999 7899999
Q ss_pred eecccccccCCCCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHH
Q 012610 281 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 359 (460)
+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~---- 254 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E---- 254 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------h----
Confidence 9999998765322 233458999999999987765 788999999999999999999995321 0
Q ss_pred HhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... . . .... ....+.+++.+||+.||++|||+.+|++
T Consensus 255 ~~~~~-~--~----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIRGQ-V--F----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHCC-C--C----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccc-c--c----cccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01100 0 0 0111 2356889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.09 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=185.6
Q ss_pred CCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEeecc
Q 012610 136 NFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.|...++||+|+||+||.+...+|+.||||++.... ...+.+|++++..+ +||||+++++++.+....++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445568899999999987766779999999986532 23567899999876 8999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC-------------CcE
Q 012610 215 VNGSVASCLRERGQSQPP---LNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE-------------FEA 278 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-------------~~~ 278 (460)
. |+|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999865432211 13334578999999999999999 99999999999999754 489
Q ss_pred EEeecccccccCCCCCc---eeecccccccccCcccccC-------CCCCcccCchhhHHHHHHHHh-CCCccccccccC
Q 012610 279 VVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLST-------GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAN 347 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~ 347 (460)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-- 245 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-- 245 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--
Confidence 99999999876543322 1223469999999999875 568999999999999999999 9999953110
Q ss_pred CCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 348 DDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.....+.... .. ..............+.+++.+||+.||.+|||+.+|++
T Consensus 246 ----~~~~i~~~~~---~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 ----RESNIIRGIF---SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHHHTCC---CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hHHHHhcCCC---Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111100 00 01111123455678999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.15 Aligned_cols=253 Identities=23% Similarity=0.254 Sum_probs=172.8
Q ss_pred HhcCCccC-CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec----CCc
Q 012610 133 ATDNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTE 206 (460)
Q Consensus 133 ~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~ 206 (460)
..++|.+. ++||+|+||.||+|... +++.||||++.... ....+....+..+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 34678885 46999999999999987 68999999986431 112223334667799999999999875 345
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeec
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 283 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df 283 (460)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 7899999999999999986542 3489999999999999999999999 9999999999999986 455999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+++...... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ .... ......
T Consensus 176 g~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~-~~~~~~ 247 (336)
T 3fhr_A 176 GFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI----SPGM-KRRIRL 247 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh----hhhH-HHhhhc
Confidence 9998654222 2234589999999999888899999999999999999999999953221100 0000 000000
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 GQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00011111223456889999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.21 Aligned_cols=200 Identities=24% Similarity=0.317 Sum_probs=168.0
Q ss_pred HhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CC-----cceeeeeeeecCC
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HR-----NLLRLRGFCMTPT 205 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~-----niv~l~~~~~~~~ 205 (460)
..++|...+.||+|+||+||+|... +++.||||+++... .....+..|+.++..++ |+ +++++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4578999999999999999999876 57899999997432 22345667888877775 44 4999999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec--CCCcEEEeec
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDF 283 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Df 283 (460)
..++||||+. ++|.+++..... ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 599999987542 2489999999999999999999952 12899999999999995 4778999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999876432 2234689999999999999999999999999999999999999963
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=316.84 Aligned_cols=244 Identities=24% Similarity=0.396 Sum_probs=190.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----hhHHHHHHHHHHhcc----CCCcceeeeee
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMA----VHRNLLRLRGF 200 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~----~h~niv~l~~~ 200 (460)
+...++|...+.||+|+||.||+|+.. +++.||||++....... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999875 68899999997543221 122456788888888 89999999999
Q ss_pred eecCCcceEEeec-cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec-CCCcE
Q 012610 201 CMTPTERLLVYPF-MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEA 278 (460)
Q Consensus 201 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~ 278 (460)
+...+..++|+|+ +.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9998999999999 78999999998754 389999999999999999999999 999999999999999 88999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 357 (460)
||+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... +
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~-- 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E-- 244 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H--
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H--
Confidence 999999998765332 233458999999999877766 458999999999999999999995311 0
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ... .. .......+.+++.+||+.||++|||+.|+++
T Consensus 245 --~~~-~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 --ILE-AEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HHH-TCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --Hhh-hcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 01 1112356889999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=310.85 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=180.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHH-HHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|+..+.||+|+||.||+|... +++.||||++..........+ +.++..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999986 689999999976544333333 444455678889999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
||+ ++.+..+..... ..+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 556666555432 248999999999999999999998 5 89999999999999999999999999997654
Q ss_pred CCCCceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
... ......|++.|+|||.+. +..++.++|||||||++|||++|+.||.... ...+..........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccCC
Confidence 322 222345899999999984 4568899999999999999999999995311 11222222222111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. .... .......+.+++.+||+.||.+|||+.++++
T Consensus 248 ~-~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 P-LLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-CCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0000 0012356889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=315.81 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=193.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCc-----
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 206 (460)
.++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999975 6899999999764332 224468899999999999999999999887654
Q ss_pred -ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 207 -RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 207 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
.++||||+. ++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 588777642 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVP 243 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHHHHHHHHCBC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 9864322 223458999999999877 6789999999999999999999999963221 01111110000000
Q ss_pred ------------------cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ------------------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.......... ..........+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0111223456889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=320.04 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=197.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-----------CCcceeeeeee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFC 201 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~~~~ 201 (460)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357999999999999999999974 68899999997532 23346788998888776 89999999998
Q ss_pred ecCC----cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec----
Q 012610 202 MTPT----ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---- 273 (460)
Q Consensus 202 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---- 273 (460)
.... ..+++|||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7543 678999999 8999999987443 23899999999999999999999953 899999999999994
Q ss_pred --CCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCC-C
Q 012610 274 --EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-D 350 (460)
Q Consensus 274 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~-~ 350 (460)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999875432 22345899999999999999999999999999999999999999643211100 0
Q ss_pred -ccHHHHHHHHhhhc-------------------ccccccccc---------CCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 012610 351 -VMLLDWVKGLLKEK-------------------KLEQLVDSD---------MEGNYIEEEVEQLIQVALLCTQGSPMER 401 (460)
Q Consensus 351 -~~~~~~~~~~~~~~-------------------~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~~P~~R 401 (460)
..+..... ..... ....+.... ............+.+++.+||+.||++|
T Consensus 247 ~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 00111110 00000 000000000 0112345667889999999999999999
Q ss_pred CCHHHHHH
Q 012610 402 PKMSEVVR 409 (460)
Q Consensus 402 Pt~~evl~ 409 (460)
||+.|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=311.11 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=188.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeee----------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM---------- 202 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~---------- 202 (460)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 367889999999999999999987 48999999986542 233456889999999999999999998874
Q ss_pred ----cCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec-CCCc
Q 012610 203 ----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD-EEFE 277 (460)
Q Consensus 203 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~ 277 (460)
.....++||||+. |+|.+++... ++++..++.++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3356789999997 6999998642 389999999999999999999999 999999999999997 5679
Q ss_pred EEEeecccccccCCCCC--ceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHH
Q 012610 278 AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 354 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~ 354 (460)
+||+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~ 231 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------L 231 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------H
Confidence 99999999987643211 11223447889999998865 6789999999999999999999999963211 1
Q ss_pred HHHHHHhhhccc------ccc-------ccccCC-CCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 355 DWVKGLLKEKKL------EQL-------VDSDME-GNY-----IEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 355 ~~~~~~~~~~~~------~~~-------~~~~~~-~~~-----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+........... .++ ...... ... .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111110000 000 000000 000 0112456889999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=313.56 Aligned_cols=259 Identities=19% Similarity=0.241 Sum_probs=196.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CC-cEEEEEEeccccccchhHHHHHHHHHHhccCCCc------ceeeeeeeecCC
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DG-SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN------LLRLRGFCMTPT 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~~~~~~~~ 205 (460)
.++|.+.+.||+|+||.||+|... ++ ..||+|+++... .....+.+|++++..++|++ ++.+.+++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468999999999999999999875 34 689999997532 23446788999998887766 889999999999
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe-------------
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL------------- 272 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill------------- 272 (460)
..++||||+ +++|.+++..... .++++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 6677777765432 3489999999999999999999999 99999999999999
Q ss_pred ------cCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccccccc
Q 012610 273 ------DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 346 (460)
Q Consensus 273 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~ 346 (460)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN- 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-
Confidence 66789999999999864432 2334689999999999999999999999999999999999999963211
Q ss_pred CCCCccHHHHHHHHhhhc--------cc-cccccccC---------------------CCCCcHHHHHHHHHHHHHccCC
Q 012610 347 NDDDVMLLDWVKGLLKEK--------KL-EQLVDSDM---------------------EGNYIEEEVEQLIQVALLCTQG 396 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~---------------------~~~~~~~~~~~l~~l~~~cl~~ 396 (460)
......+....... .. ........ ...........+.+++.+||+.
T Consensus 245 ----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 245 ----REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ----HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ----HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 11111111111000 00 00000000 0011123345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 012610 397 SPMERPKMSEVVR 409 (460)
Q Consensus 397 ~P~~RPt~~evl~ 409 (460)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.30 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=198.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec------CCcc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTER 207 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~~ 207 (460)
++|++.+.||+|+||.||+|... +|+.||||++...........+.+|++++..++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999875 6889999999765555555678999999999999999999998765 5677
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc---EEEeecc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFG 284 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg 284 (460)
++||||+++|+|.+++..... ...+++..++.++.+++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999987543 23488999999999999999999999 9999999999999997765 9999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++....... ......|+..|+|||.+.+..++.++|||||||++|||++|..||.... ....|........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVREKS 240 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC---
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhccc
Confidence 998765332 2234568999999999999999999999999999999999999995321 1111111000000
Q ss_pred ccccccc----c------c--CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 012610 365 KLEQLVD----S------D--MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407 (460)
Q Consensus 365 ~~~~~~~----~------~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 407 (460)
....... . . ............+.+++.+||..||++|||+.++
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 0 0 0112234456789999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=324.32 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=185.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEe
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 211 (460)
...+|...++||+|+||+|+.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+....++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34578888999999999976555567899999999654322 356899999998 7999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-----CCcEEEeecccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 286 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~ 286 (460)
||+. |+|.+++...... ..+..++.++.||+.||+|||++ +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 6999999865432 44455678999999999999999 9999999999999953 235889999999
Q ss_pred cccCCCCC--ceeecccccccccCccccc---CCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHH
Q 012610 287 KLMDYKDT--HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 287 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
+....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .. ....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~---~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQ---ANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HH---HHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HH---HHHH
Confidence 87653321 2233456999999999997 4567889999999999999999 9999852110 00 1111
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ... ........+.+++.+||+.||.+|||+.+|++
T Consensus 242 ~~~~~~~-----~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLD-----CLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCT-----TSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCcc-----ccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1110000 000 11223455788999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.17 Aligned_cols=239 Identities=21% Similarity=0.286 Sum_probs=192.6
Q ss_pred hcCCccCCeecccCCeEEEEEEEC--CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCc-----
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT--DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE----- 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~----- 206 (460)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|++++..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 5889999999765444445568899999999999999999999987655
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887653 389999999999999999999999 99999999999999986 8999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 876433 3345899999999987654 889999999999999999999885321100
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~~L~~ 413 (460)
+. ...........+.+++.+||+.||.+||+ ++++.+.|.+
T Consensus 284 --~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 --LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00011123356889999999999999995 5556666553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=298.60 Aligned_cols=230 Identities=12% Similarity=0.037 Sum_probs=181.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
.++|++.+.||+|+||.||+|... +++.||||++....... ....+.+|+..+..++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999986 48999999998654332 235688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++++|.++++.. .....+..++.||+.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999542 34556888999999999999999 99999999999999999999998443
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
|++| ++.++|||||||++|||++|+.||.......... ......
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~ 218 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDT 218 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCT
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHh
Confidence 3333 6789999999999999999999996432111000 000000
Q ss_pred cccCCC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 371 DSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 371 ~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
...... .........+.+++.+||+.||++| |+.|+++.|++..
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000000 0011223568899999999999999 9999999998743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=316.83 Aligned_cols=244 Identities=15% Similarity=0.108 Sum_probs=179.7
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCC-Ccceeee---------e-
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVH-RNLLRLR---------G- 199 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h-~niv~l~---------~- 199 (460)
..+|...++||+|+||+||+|.+. +|+.||||++....... ....+.+|+.++..++| +|...+. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777789999999999999965 68999999987433222 24568899999999987 3221111 1
Q ss_pred -----------eeec-----CCcceEEeeccCCCCHHHHhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012610 200 -----------FCMT-----PTERLLVYPFMVNGSVASCLRER---GQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260 (460)
Q Consensus 200 -----------~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 260 (460)
++.. ....+++|+++ +++|.++++.. ......+++..++.++.||+.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111 12345666665 68999988532 22233478889999999999999999999 99
Q ss_pred EeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccc----------cCCCCCcccCchhhHHHH
Q 012610 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL----------STGKSSEKTDVFGYGVML 330 (460)
Q Consensus 261 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dvws~G~il 330 (460)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998864322 334457 999999999 555688999999999999
Q ss_pred HHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 331 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 331 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
|||++|+.||....... ....+.... .. ....+.+++.+||+.||++|||+.++++
T Consensus 308 ~elltg~~Pf~~~~~~~-----------------~~~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG-----------------GSEWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGS-----------------CSGGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhh-----------------hHHHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999996422111 111111100 01 1256889999999999999999988864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.78 Aligned_cols=228 Identities=22% Similarity=0.269 Sum_probs=176.6
Q ss_pred cCCccC-CeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHH-hccCCCcceeeeeeeec----CCcc
Q 012610 135 DNFSNR-NILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLLRLRGFCMT----PTER 207 (460)
Q Consensus 135 ~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~~~~~~----~~~~ 207 (460)
++|... ++||+|+||.||++... +++.||+|++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 78999999999999975 6889999998642 2467888887 66689999999999876 5678
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeecc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFG 284 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg 284 (460)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987542 3489999999999999999999999 9999999999999998 7889999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++.... +..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------------~~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------------SPG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------------hHH
Confidence 986432 23467899999999999999999999953211100 000
Q ss_pred cccccccccCCCC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 KLEQLVDSDMEGN--YIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....+........ ........+.+++.+||+.||.+|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001100000000 00123456889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.13 Aligned_cols=243 Identities=16% Similarity=0.178 Sum_probs=182.8
Q ss_pred HhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccc-------cchhHHHHHHHHHHhccC---------CCccee
Q 012610 133 ATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-------QGGELQFQTEVEMISMAV---------HRNLLR 196 (460)
Q Consensus 133 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~---------h~niv~ 196 (460)
..++|+..+.||+|+||+||+|+. +++.||||++..... ......+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788899999999999999998 579999999976532 222356888998888775 666666
Q ss_pred eeee-----------------eec-------------CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHH
Q 012610 197 LRGF-----------------CMT-------------PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246 (460)
Q Consensus 197 l~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~ 246 (460)
+.+. +.+ ....++||||+.+|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 5554 332 6788999999999987776643 2389999999999999
Q ss_pred HHHHHHH-hCCCCCeEeeCCCCCCEEecCCC--------------------cEEEeecccccccCCCCCceeeccccccc
Q 012610 247 RGLAYLH-DHCDPKIIHRDVKAANILLDEEF--------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIG 305 (460)
Q Consensus 247 ~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~ 305 (460)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999987 8999999999876432 2358999
Q ss_pred ccCcccccCCCCCcccCchhhHHH-HHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc-cccccCCCCCcHHHH
Q 012610 306 HIAPEYLSTGKSSEKTDVFGYGVM-LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ-LVDSDMEGNYIEEEV 383 (460)
Q Consensus 306 y~aPE~~~~~~~~~~~Dvws~G~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 383 (460)
|+|||++.+.. +.++||||||++ .+++++|..||.. ..|....... .... ...............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHh-hhhhhccCcccchhhhhhcC
Confidence 99999998766 889999998777 7788999999842 1111111100 0000 001111111234567
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHH
Q 012610 384 EQLIQVALLCTQGSPMERPKMSEVV 408 (460)
Q Consensus 384 ~~l~~l~~~cl~~~P~~RPt~~evl 408 (460)
..+.+++.+||+.| |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 78999999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=269.58 Aligned_cols=186 Identities=15% Similarity=0.074 Sum_probs=129.8
Q ss_pred ecccCCeEEEEEE-ECCCcEEEEEEeccccc---------cchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEEe
Q 012610 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERT---------QGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 143 lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv~ 211 (460)
.+.|+.|.+..++ ..-|+.+|+|.+..... .....+|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4445555554433 22378899999975421 12234689999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||++|++|.++|...+ +++.. +|+.||+.||+|+|++ ||+||||||+|||++.+|++||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999998654 35543 5889999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~ 340 (460)
... .....+||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 332 2334569999999999875 4667899999999998887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-28 Score=244.24 Aligned_cols=185 Identities=14% Similarity=0.218 Sum_probs=145.9
Q ss_pred ccCCeecccCCeEEEEEEECCCcEEEEEEeccccccc-------hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 138 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQG-------GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
...++||+|+||.||++... +..+++|+........ ....+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34578999999999999554 6888999875432211 123478999999999999999777777777888999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 9999999999999999 99999999999765
Q ss_pred CCCCce------eecccccccccCcccccC--CCCCcccCchhhHHHHHHHHhCCCcc
Q 012610 291 YKDTHV------TTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAF 340 (460)
Q Consensus 291 ~~~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~G~il~el~tg~~p~ 340 (460)
...... .....||+.|||||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 432211 234569999999999977 56888899999999888888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=201.83 Aligned_cols=154 Identities=15% Similarity=0.059 Sum_probs=122.0
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-----------------chhHHHHHHHHHHhcc
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMA 189 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~ 189 (460)
+..+......|...+.||+|+||.||+|...+|+.||+|.++..... .....+.+|+++++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 33444455667778999999999999999977899999999643221 1234688999999999
Q ss_pred CCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 012610 190 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAAN 269 (460)
Q Consensus 190 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N 269 (460)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 5 666665433 56799999999999988 421 12457999999999999999 99999999999
Q ss_pred EEecCCCcEEEeecccccccCCCCCceeecccccccccCccccc
Q 012610 270 ILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313 (460)
Q Consensus 270 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 313 (460)
||++ ++.+||+|||+++. +..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999 99999999999863 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=169.67 Aligned_cols=138 Identities=17% Similarity=0.184 Sum_probs=106.4
Q ss_pred CCccCCeecccCCeEEEEEEE-CCCcE--EEEEEecccccc-----------------------chhHHHHHHHHHHhcc
Q 012610 136 NFSNRNILGRGGFGKVYKGRL-TDGSL--VAVKRLKEERTQ-----------------------GGELQFQTEVEMISMA 189 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~~ 189 (460)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 57888 999987543111 0112578899999999
Q ss_pred CCCcc--eeeeeeeecCCcceEEeeccCC-C----CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 012610 190 VHRNL--LRLRGFCMTPTERLLVYPFMVN-G----SVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH-DHCDPKII 261 (460)
Q Consensus 190 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~ 261 (460)
.|+++ ..++.+ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88764 333332 367899999942 4 67766532 224456789999999999999 88 999
Q ss_pred eeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 262 HRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 262 H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||||.|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.4e-18 Score=161.29 Aligned_cols=141 Identities=15% Similarity=0.125 Sum_probs=98.8
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-------------chhHHH--------HHHHHHHhccCCC
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-------------GGELQF--------QTEVEMISMAVHR 192 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~--------~~e~~~l~~~~h~ 192 (460)
..-|++.+.||+|++|.||+|...+|+.||||+++..... ...... ..|...+.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3448889999999999999999989999999987632110 001111 2344445544333
Q ss_pred cceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEe
Q 012610 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILL 272 (460)
Q Consensus 193 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 272 (460)
++....-+. ....++||||++|++|..+... .....++.||+.+|.|||+. +||||||||.|||+
T Consensus 174 gv~vp~p~~--~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIA--QSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEE--EETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred CCCCCeeee--ccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 321111111 1234799999999888654321 12356789999999999999 99999999999999
Q ss_pred cCCC----------cEEEeeccccccc
Q 012610 273 DEEF----------EAVVGDFGLAKLM 289 (460)
Q Consensus 273 ~~~~----------~~kl~Dfg~~~~~ 289 (460)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 9887 3889999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=4.5e-12 Score=116.11 Aligned_cols=143 Identities=13% Similarity=0.036 Sum_probs=110.8
Q ss_pred hcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e 212 (460)
-+.|.....++.|+.+.||++... +..+++|+...... .....+.+|.+++..+. +..+.++++++......++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 356777778888889999999755 68899999875321 12235888999998874 6778889998888888999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------ 256 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 256 (460)
|++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876421 1123467889999999999810
Q ss_pred --------------------CCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 257 --------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 257 --------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1359999999999999876666799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.6e-11 Score=110.80 Aligned_cols=129 Identities=14% Similarity=0.040 Sum_probs=95.7
Q ss_pred cccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc--ceeeeeeeecCCcceEEeeccCCCCHHH
Q 012610 144 GRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGFCMTPTERLLVYPFMVNGSVAS 221 (460)
Q Consensus 144 g~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~ 221 (460)
+.|..+.||++...+|..+++|..... ....+..|.++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 456679999998777788999997643 1235778999888886544 455888877777789999999998874
Q ss_pred HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 012610 222 CLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--------------------------------------------- 256 (460)
Q Consensus 222 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------- 256 (460)
... .. ...++.++++.|..||+..
T Consensus 104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2356677778888888642
Q ss_pred ----------CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 257 ----------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 257 ----------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-10 Score=111.96 Aligned_cols=142 Identities=13% Similarity=0.160 Sum_probs=104.5
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEec--cccccchhHHHHHHHHHHhccC--CCcceeeeeeeecC---CcceEEee
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLK--EERTQGGELQFQTEVEMISMAV--HRNLLRLRGFCMTP---TERLLVYP 212 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~---~~~~lv~e 212 (460)
.+.|+.|.++.||+....+ ..+++|+.. ..........+.+|..+++.+. +..+.+++.++.+. ...++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4568999999999998764 678888776 3322222346788999998886 45578888888765 34789999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------ 256 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 256 (460)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998764311 122678888899999999999999731
Q ss_pred -------------------CCCeEeeCCCCCCEEecCCCc--EEEeecccccc
Q 012610 257 -------------------DPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 288 (460)
Q Consensus 257 -------------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~ 288 (460)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-10 Score=107.27 Aligned_cols=183 Identities=20% Similarity=0.193 Sum_probs=119.1
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCc--ceeeeeeeecCC---cceEEeec
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRN--LLRLRGFCMTPT---ERLLVYPF 213 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~n--iv~l~~~~~~~~---~~~lv~e~ 213 (460)
.+.++.|..+.||+.. ..+++|+.... .....+.+|.+++..+. +.. +..++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999863 45888886532 23346888999988773 322 334444433332 34789999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH-------------------------------------- 255 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 255 (460)
++|.+|...... .++...+..++.++++.|+.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888654321 156677777888888888888851
Q ss_pred -----------------CCCCeEeeCCCCCCEEecC--CCcEEEeecccccccCCCCCceeecccccccc---cCccccc
Q 012610 256 -----------------CDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH---IAPEYLS 313 (460)
Q Consensus 256 -----------------~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y---~aPE~~~ 313 (460)
..+.++|+|++|.||+++. +..+.|+||+.+...+...... . ...+ ..|+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-~----~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-S----LMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-T----TCCTTTSCCHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-H----HHhhccccCHHHHH
Confidence 1236899999999999998 5567899999887543211000 0 0000 1222110
Q ss_pred C-----C---------CCCcccCchhhHHHHHHHHhCCCcc
Q 012610 314 T-----G---------KSSEKTDVFGYGVMLLELITGQRAF 340 (460)
Q Consensus 314 ~-----~---------~~~~~~Dvws~G~il~el~tg~~p~ 340 (460)
. + ......+.|++|.++|.+.+|..+|
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0 0112258899999999999999887
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.2e-06 Score=80.06 Aligned_cols=134 Identities=19% Similarity=0.153 Sum_probs=93.3
Q ss_pred ecccCCe-EEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGFG-KVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
+..|..| .||+.... ++..+++|+-... ....+..|...++.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 4556555 68988765 4567889976532 2335778888887764 33366788888888889999999999888
Q ss_pred HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 012610 220 ASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------------------- 256 (460)
Q Consensus 220 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 256 (460)
.+..... ......+..+++..|+-||+..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765431 1122344555556666666321
Q ss_pred ------------CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 257 ------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 257 ------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
.+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887777999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.2e-06 Score=81.58 Aligned_cols=135 Identities=18% Similarity=0.170 Sum_probs=89.5
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCC---cceeeeeeee-cCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR---NLLRLRGFCM-TPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 216 (460)
+.++.|....||+. +..+++|+... ......+..|.+++..+.+. .+.+++.++. ..+..+++|+|++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46788889999988 45678887532 22334688999999988652 2455566654 34557899999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH----------------------------------------- 255 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 255 (460)
..+...... .++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 887663211 023333444444444444444432
Q ss_pred ----------------CCCCeEeeCCCCCCEEecC---CCc-EEEeecccccc
Q 012610 256 ----------------CDPKIIHRDVKAANILLDE---EFE-AVVGDFGLAKL 288 (460)
Q Consensus 256 ----------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~~~~ 288 (460)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999998 455 47999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=1.6e-06 Score=82.65 Aligned_cols=80 Identities=8% Similarity=-0.010 Sum_probs=53.1
Q ss_pred Cee-cccCCeEEEEEEEC-------CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCC---CcceeeeeeeecC---
Q 012610 141 NIL-GRGGFGKVYKGRLT-------DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH---RNLLRLRGFCMTP--- 204 (460)
Q Consensus 141 ~~l-g~G~~g~v~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h---~niv~l~~~~~~~--- 204 (460)
+.| +.|..+.+|+.... ++..+++|+...... ......+..|..++..+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78889999998754 256788887654320 1012356788888877642 2466677776554
Q ss_pred CcceEEeeccCCCCHH
Q 012610 205 TERLLVYPFMVNGSVA 220 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~ 220 (460)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=2e-05 Score=76.32 Aligned_cols=76 Identities=11% Similarity=-0.035 Sum_probs=48.2
Q ss_pred CCeecccCCeEEEEEEEC-CCcEEEEEEeccccc------cchhHHHHHHHHHHhccCC--Ccc-eeeeeeeecCCcceE
Q 012610 140 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT------QGGELQFQTEVEMISMAVH--RNL-LRLRGFCMTPTERLL 209 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~~~h--~ni-v~l~~~~~~~~~~~l 209 (460)
.+.||.|..+.||++... ++..++||....... ......+..|.+++..+.. +.. .+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 356899999999999754 467899998653211 1122346778888876632 333 344443 3456789
Q ss_pred EeeccCCC
Q 012610 210 VYPFMVNG 217 (460)
Q Consensus 210 v~e~~~~g 217 (460)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=5.7e-05 Score=71.29 Aligned_cols=141 Identities=16% Similarity=0.193 Sum_probs=77.9
Q ss_pred CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhcc-----CCCcceeee-e--eeecCCcceEEee
Q 012610 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLR-G--FCMTPTERLLVYP 212 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-----~h~niv~l~-~--~~~~~~~~~lv~e 212 (460)
+.|+.|..+.||+....++ .+++|+..... ..+..|.+++..+ ..|.++... | +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH-----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH-----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999987654 58899886521 2233444444433 234444311 1 1123456789999
Q ss_pred ccCCCCHH--------------HHhhhcCCCC----------CCCCHHHH------------------------------
Q 012610 213 FMVNGSVA--------------SCLRERGQSQ----------PPLNWSVR------------------------------ 238 (460)
Q Consensus 213 ~~~~g~L~--------------~~l~~~~~~~----------~~l~~~~~------------------------------ 238 (460)
|++|..+. ..++...... ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122111100 00122211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 239 -KQIALGAARGLAYLHD----------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 239 -~~i~~~i~~~l~~LH~----------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
..+...+..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 023489999999999999888899999999875
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=6.1e-06 Score=87.12 Aligned_cols=50 Identities=40% Similarity=0.759 Sum_probs=23.7
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
|.||.++++|++|++||||+|+|+|.||.. ..+..+..+++++|+++|..
T Consensus 670 g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~i 720 (768)
T 3rgz_A 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEEC
T ss_pred CCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccC
Confidence 445555555555555555555555554433 33344444444444444433
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=9.7e-05 Score=68.59 Aligned_cols=139 Identities=14% Similarity=0.117 Sum_probs=89.9
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC---CCcceeeeeeeecCCcceEEeeccCC
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV---HRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
.+.|+.|....+|+.... +..+++|+.... ....+..|.+.++.+. ...+.+++.++......++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356899999999999864 678889987542 2345788888887764 35577788887777788999999998
Q ss_pred CCHH--------H---HhhhcCC-C-----------------CCCCCHHHHH---HHH----------------HHHHHH
Q 012610 217 GSVA--------S---CLRERGQ-S-----------------QPPLNWSVRK---QIA----------------LGAARG 248 (460)
Q Consensus 217 g~L~--------~---~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~~i~~~ 248 (460)
..+. . .|+.... . ...-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 2233221 0 0012454322 111 111212
Q ss_pred H-HHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 249 L-AYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 249 l-~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23432 2356899999999999999987 8889974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00016 Score=70.34 Aligned_cols=79 Identities=11% Similarity=0.024 Sum_probs=47.0
Q ss_pred CCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCC---CCCcccCchhhHHHHHHHH
Q 012610 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELI 334 (460)
Q Consensus 258 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~G~il~el~ 334 (460)
+.++|+|+++.||+++.++ ++++||+.+...............-...|.+|+..... ......++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999998875331110000000001245666544311 1122345557777788877
Q ss_pred hCC
Q 012610 335 TGQ 337 (460)
Q Consensus 335 tg~ 337 (460)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00036 Score=64.13 Aligned_cols=80 Identities=16% Similarity=0.216 Sum_probs=55.4
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCC---cceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR---NLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~~~~~~~~~~~lv~ 211 (460)
......+.+|.|..+.||+.+..+|+.+++|+...... .....|..|.+.|+.+.-- .+.+++++ +..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 44555677999999999999999999999998754322 2223577898888776421 23444443 2357899
Q ss_pred eccCCCCH
Q 012610 212 PFMVNGSV 219 (460)
Q Consensus 212 e~~~~g~L 219 (460)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=9.1e-06 Score=85.78 Aligned_cols=54 Identities=26% Similarity=0.563 Sum_probs=45.6
Q ss_pred CCCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCCC
Q 012610 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPSP 54 (460)
Q Consensus 1 ~G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~~ 54 (460)
+|.||.++++|++|+.||||+|+|+|.||.. +.+..+..+++++|.++|..|..
T Consensus 645 ~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~ 699 (768)
T 3rgz_A 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699 (768)
T ss_dssp BSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred cccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence 5888999999999999999999999999975 77788888889999988877643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00043 Score=64.02 Aligned_cols=139 Identities=12% Similarity=0.089 Sum_probs=74.3
Q ss_pred CCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEeecc-CCC
Q 012610 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFM-VNG 217 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 217 (460)
.+.|+.|....+|+. ..+++|+....... ......|..++..+....+ .+++++ +....++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567889999999998 45788887643211 1123467777666542222 344443 344467899999 654
Q ss_pred CHHH---------------H---hhhcCCCC-CCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCC
Q 012610 218 SVAS---------------C---LRERGQSQ-PPLN-WSVRKQIAL--------------GAARGL----AYLHD-HCDP 258 (460)
Q Consensus 218 ~L~~---------------~---l~~~~~~~-~~l~-~~~~~~i~~--------------~i~~~l----~~LH~-~~~~ 258 (460)
++.. . ++...... .... +.....+.. .+...+ ..|.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 0 11111000 0011 111111111 011111 11211 2234
Q ss_pred CeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 259 KIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 259 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6899999999999 5667889999998764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.46 E-value=2.6e-06 Score=84.89 Aligned_cols=30 Identities=20% Similarity=0.036 Sum_probs=25.7
Q ss_pred hHHHHHHHHHHhccCCCcceeeeeeeecCC
Q 012610 176 ELQFQTEVEMISMAVHRNLLRLRGFCMTPT 205 (460)
Q Consensus 176 ~~~~~~e~~~l~~~~h~niv~l~~~~~~~~ 205 (460)
..+|..|++++.+++|+|+|+++|||....
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 457999999999999999999999997653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0019 Score=60.12 Aligned_cols=159 Identities=11% Similarity=0.080 Sum_probs=85.0
Q ss_pred cCHHHHHHHhcCCccC-----CeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc--ceee
Q 012610 125 FSLRELQVATDNFSNR-----NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRL 197 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l 197 (460)
++.+++......|... +.|+.|....+|+....++ .+++|....... ...+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4445555444556542 3466788899999987655 578998865311 123556666665553212 2222
Q ss_pred eee------eecCCcceEEeeccCCCCHHH--------------HhhhcCCC-CCC----C---CHHHHHH---------
Q 012610 198 RGF------CMTPTERLLVYPFMVNGSVAS--------------CLRERGQS-QPP----L---NWSVRKQ--------- 240 (460)
Q Consensus 198 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~-~~~----l---~~~~~~~--------- 240 (460)
+.. ....+..+++++|++|..+.. .++..... ..+ . .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 211 112345689999998865311 12221111 000 1 1222110
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 241 ---IALGAARGLAYLHDH----CDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 241 ---i~~~i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
+...+...+++++.. ...+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455566532 23479999999999999987666899998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.001 Score=62.49 Aligned_cols=33 Identities=42% Similarity=0.391 Sum_probs=28.1
Q ss_pred CCCeEeeCCCCCCEEecCC----CcEEEeeccccccc
Q 012610 257 DPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLM 289 (460)
Q Consensus 257 ~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 289 (460)
...++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999875 67899999988653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00067 Score=66.06 Aligned_cols=72 Identities=14% Similarity=0.186 Sum_probs=47.4
Q ss_pred CeecccCCeEEEEEEECC--------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEe
Q 012610 141 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 211 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 211 (460)
+.|+.|....+|++...+ +..+++|+..... ....+..|..++..+...++ .++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 468888899999998753 4788999884321 11345578888877753333 456665432 4899
Q ss_pred eccCCCCH
Q 012610 212 PFMVNGSV 219 (460)
Q Consensus 212 e~~~~g~L 219 (460)
+|++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.12 E-value=0.002 Score=55.43 Aligned_cols=99 Identities=16% Similarity=0.117 Sum_probs=65.2
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
-+|.+.|...+. |++++++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|...+ ..+.
T Consensus 33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 489999987654 6999999999999999887762210 111233457999999999998764 1110
Q ss_pred eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh
Q 012610 297 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 335 (460)
Q Consensus 297 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t 335 (460)
.....+.|||... ...+.+.-|||+|+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123467888763 345678899999999998876
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0025 Score=59.51 Aligned_cols=142 Identities=18% Similarity=0.184 Sum_probs=78.5
Q ss_pred eecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc--ceeeeee-----eecCCcceEEeecc
Q 012610 142 ILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN--LLRLRGF-----CMTPTERLLVYPFM 214 (460)
Q Consensus 142 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 214 (460)
.++ |....||+....+|+.+++|....... ....+..|..++..+.... +.+++.. ....+..+++|+|+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 888899998776777899999864322 2234566777766653212 3333332 11234457899999
Q ss_pred CCCCHH-----H------H---hhhcCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 012610 215 VNGSVA-----S------C---LRERGQ-----SQPPLNWSVR----KQI---------------ALGAARGLAYLHDH- 255 (460)
Q Consensus 215 ~~g~L~-----~------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~i~~~l~~LH~~- 255 (460)
+|..+. . . ++.... .....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 1 111110 0111222211 001 11111223333221
Q ss_pred ---CCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 256 ---CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 256 ---~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0025 Score=62.38 Aligned_cols=73 Identities=11% Similarity=0.100 Sum_probs=46.3
Q ss_pred CeecccCCeEEEEEEECC-CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEeeccCCCC
Q 012610 141 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 218 (460)
+.|+.|-...+|+....+ +..+++|+...... .......|..++..+...++ .++++.+. ...||+|++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence 468889999999998865 47788888743221 11123578888887765444 45666652 236999998754
Q ss_pred H
Q 012610 219 V 219 (460)
Q Consensus 219 L 219 (460)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0019 Score=61.57 Aligned_cols=142 Identities=14% Similarity=0.139 Sum_probs=80.9
Q ss_pred CeecccCCeEEEEEEEC--------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCc-ceeeeeeeecCCcceEEe
Q 012610 141 NILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~ 211 (460)
+.|..|-...+|+.... ++..+++|+.... ......+.+|..+++.+.--. ..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45777888999999864 2478899986332 122335668888887764222 3455665543 3899
Q ss_pred eccCCCCHHH--------------H---hhhcCC--CCCCC-CHHHHHHHHHHHHH-------------------HHHHH
Q 012610 212 PFMVNGSVAS--------------C---LRERGQ--SQPPL-NWSVRKQIALGAAR-------------------GLAYL 252 (460)
Q Consensus 212 e~~~~g~L~~--------------~---l~~~~~--~~~~l-~~~~~~~i~~~i~~-------------------~l~~L 252 (460)
||++|.+|.. . ++.... ...+. -+..+.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998765431 1 111111 11111 24445555443321 23333
Q ss_pred H----hC-CCCCeEeeCCCCCCEEecCC----CcEEEeecccccc
Q 012610 253 H----DH-CDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKL 288 (460)
Q Consensus 253 H----~~-~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~ 288 (460)
. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 23369999999999999876 7899999998753
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0013 Score=55.38 Aligned_cols=47 Identities=26% Similarity=0.359 Sum_probs=26.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.||..+. +.|+.|+|++|+|++..|.. ..+..+..+.+++|.+.+.+
T Consensus 26 ~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~ 73 (174)
T 2r9u_A 26 SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIP 73 (174)
T ss_dssp SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccC
Confidence 4555553 55666666666666655532 44555555666666655543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0016 Score=61.97 Aligned_cols=73 Identities=8% Similarity=0.037 Sum_probs=42.3
Q ss_pred CeecccCCeEEEEEEECC---------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCc-ceeeeeeeecCCcceEE
Q 012610 141 NILGRGGFGKVYKGRLTD---------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLV 210 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv 210 (460)
+.|+.|....+|+....+ +..+++|+...... .......|.+++..+...+ ..++++.. ..++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 457788889999998764 26788887754221 1112456777777664333 33555433 24789
Q ss_pred eeccCCCCH
Q 012610 211 YPFMVNGSV 219 (460)
Q Consensus 211 ~e~~~~g~L 219 (460)
|+|++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0014 Score=54.78 Aligned_cols=45 Identities=31% Similarity=0.414 Sum_probs=21.2
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
|..++++++|++|+|++|+|++..|.. ..+..+..+++++|.+.+
T Consensus 47 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~ 92 (170)
T 3g39_A 47 PGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS 92 (170)
T ss_dssp TTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred hhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCE
Confidence 444455555555555555555433322 334444455555555444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.001 Score=56.96 Aligned_cols=45 Identities=22% Similarity=0.333 Sum_probs=29.0
Q ss_pred CCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
++++++|++|+|++|++++.+|.. ..+..+..+.+++|.+.+.++
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 95 (192)
T 1w8a_A 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISN 95 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECS
T ss_pred cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCH
Confidence 666777777777777777766643 455666666666666665443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.00093 Score=63.04 Aligned_cols=46 Identities=17% Similarity=0.214 Sum_probs=25.9
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
..|++|++|+.|+|++|+|+|..|.. ..+..|..+++++|.+.+.+
T Consensus 50 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 96 (347)
T 2ifg_A 50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLS 96 (347)
T ss_dssp GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCC
T ss_pred hHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeC
Confidence 44556666666666666666655543 44555556666666655443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0014 Score=56.14 Aligned_cols=53 Identities=19% Similarity=0.274 Sum_probs=45.7
Q ss_pred CCCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 1 ~G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
+|.+|..++++++|++|+|++|+|++..|.. ..+..+..+++++|.+.+.+|.
T Consensus 67 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 120 (192)
T 1w8a_A 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120 (192)
T ss_dssp CCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTT
T ss_pred CCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHH
Confidence 3556889999999999999999999988863 6788899999999999886554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0018 Score=60.63 Aligned_cols=51 Identities=14% Similarity=0.167 Sum_probs=39.3
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.||..++++++|++|+|++|++.|.+|.. ..+..+..+.+++|.+.+..|.
T Consensus 220 ~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~ 271 (328)
T 4fcg_A 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271 (328)
T ss_dssp CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCT
T ss_pred cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcch
Confidence 46777888888888888888888888864 6677778888888877766553
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.012 Score=55.16 Aligned_cols=31 Identities=26% Similarity=0.354 Sum_probs=27.7
Q ss_pred CCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 258 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 258 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0031 Score=51.27 Aligned_cols=48 Identities=15% Similarity=0.226 Sum_probs=37.2
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
|.||..++++++|+.|+|++|++++. +....+..+..+++++|.+.+.
T Consensus 32 ~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~ 79 (149)
T 2je0_A 32 GKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGG 79 (149)
T ss_dssp TBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSC
T ss_pred hHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccch
Confidence 67888778888888888888888876 5556677778888888887663
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0011 Score=68.29 Aligned_cols=51 Identities=10% Similarity=0.180 Sum_probs=45.3
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceec-----------------CCCC-C--CCCCCccccccCCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGD-----------------IPTN-G--SFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~-----------------iP~~-~--~~~~l~~~~~~~N~l~~~~p~ 53 (460)
| ||..+++|++|++|+|++|+|+|. +|.. + .+..+..+.+++|.+.+..|.
T Consensus 197 ~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp E-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred c-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH
Confidence 5 999999999999999999999996 8876 5 688899999999999887654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.004 Score=52.25 Aligned_cols=51 Identities=24% Similarity=0.300 Sum_probs=42.6
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
+-+|..++++++|++|+|++|+|++..+.. ..+..+..+++++|.+.+.++
T Consensus 47 ~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~ 98 (174)
T 2r9u_A 47 KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPR 98 (174)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCH
Confidence 445788999999999999999999965543 678899999999999987554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0043 Score=53.06 Aligned_cols=50 Identities=26% Similarity=0.464 Sum_probs=34.5
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||..++++++|+.|+|++|++++..|. +..+..+..+.+++|.+.+.++
T Consensus 45 ~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~ 95 (193)
T 2wfh_A 45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPP 95 (193)
T ss_dssp SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCH
Confidence 4666777777777777777777776554 3556667777777777766544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=96.36 E-value=0.00071 Score=62.93 Aligned_cols=50 Identities=26% Similarity=0.470 Sum_probs=35.2
Q ss_pred CCCCCCCCCCCCCEEECcC-CcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSN-NKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~-N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||..++++++|++|+|++ |+++|.+|.. ..+..+..+++++|.+.+..|
T Consensus 67 ~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p 118 (313)
T 1ogq_A 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118 (313)
T ss_dssp ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC
T ss_pred ccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCC
Confidence 6777777777777777774 7777777754 556667777777777765443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0031 Score=55.19 Aligned_cols=51 Identities=22% Similarity=0.242 Sum_probs=42.7
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
..|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+.+|.
T Consensus 96 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 96 VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 34456899999999999999999988864 6678899999999999887554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.00094 Score=62.09 Aligned_cols=52 Identities=23% Similarity=0.534 Sum_probs=43.5
Q ss_pred CCCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 1 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 1 ~G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
+|.||..++++++|++|+|++|+++|.+|.. ..+..+..+++++|.+.+..|
T Consensus 90 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 142 (313)
T 1ogq_A 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142 (313)
T ss_dssp ESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCC
T ss_pred cccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCC
Confidence 3678989999999999999999999998874 667888888999998876544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0049 Score=51.44 Aligned_cols=48 Identities=21% Similarity=0.265 Sum_probs=39.9
Q ss_pred CCCC-CCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCC
Q 012610 3 EIPR-SLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~-~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~ 50 (460)
.||. .++++++|++|+|++|+|++..|. ...+..+..+.+++|++.+.
T Consensus 68 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 68 VLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 3454 468999999999999999997665 46788899999999998765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0061 Score=52.08 Aligned_cols=49 Identities=24% Similarity=0.289 Sum_probs=41.8
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.|..+++|++|+.|+|++|+|++..|. ...+..+..+++++|.+...++
T Consensus 70 ~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~ 119 (193)
T 2wfh_A 70 SNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPE 119 (193)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeCh
Confidence 456799999999999999999998775 3677889999999999986554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0024 Score=64.60 Aligned_cols=44 Identities=25% Similarity=0.425 Sum_probs=27.3
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
||. +++|++|+.|+||+|+|+ .+|.. +.+..+..+++++|.+.+
T Consensus 456 lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 456 LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence 554 666666666666666666 55543 455566666666666655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0068 Score=52.99 Aligned_cols=50 Identities=8% Similarity=0.113 Sum_probs=42.6
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.|..++++++|++|+|++|++++..|. ...+..+..+.+++|.+.+.++.
T Consensus 73 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 123 (220)
T 2v70_A 73 EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGND 123 (220)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTT
T ss_pred CHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHh
Confidence 345799999999999999999998775 36788899999999999887654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0034 Score=52.21 Aligned_cols=48 Identities=17% Similarity=0.211 Sum_probs=32.3
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
|.||..++.+++|++|+|++|.+++. +....+..+..+++++|.+.+.
T Consensus 39 ~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~ 86 (168)
T 2ell_A 39 GKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGG 86 (168)
T ss_dssp TBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSC
T ss_pred hhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchH
Confidence 56676667777777777777777765 5445666666777777776653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.01 E-value=0.0022 Score=68.03 Aligned_cols=49 Identities=16% Similarity=0.234 Sum_probs=42.8
Q ss_pred CCCCCCCCCCCCEEECcCCccee-----------------cCCCC-C--CCCCCccccccCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTG-----------------DIPTN-G--SFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G-----------------~iP~~-~--~~~~l~~~~~~~N~l~~~~p 52 (460)
||.+|++|++|++|+|++|+|+| .||.. + .+..+..+.+++|.+.+..|
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP 508 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCC
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccCh
Confidence 89999999999999999999999 48876 4 68888999999998887665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0051 Score=57.88 Aligned_cols=50 Identities=14% Similarity=0.165 Sum_probs=43.8
Q ss_pred CCCCCCCCCCCCCEEECcC-CcceecCCC-CCCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSN-NKLTGDIPT-NGSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~-N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.||. |+.+++|+.|+|++ |+|++..|. +..+..|..+++++|.+.+.++.
T Consensus 23 ~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 23 SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 4899 99999999999996 999998764 47788999999999999987654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.014 Score=48.84 Aligned_cols=38 Identities=26% Similarity=0.333 Sum_probs=18.7
Q ss_pred CCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 12 NSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 12 ~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
++|+.|+|++|++++..|.. ..+..+..+.+++|.+.+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 66 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS 66 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE
Confidence 45555555555555433322 344455555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.014 Score=48.82 Aligned_cols=49 Identities=18% Similarity=0.247 Sum_probs=38.1
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+.++.
T Consensus 45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 94 (177)
T 2o6r_A 45 HGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNG 94 (177)
T ss_dssp TTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred HHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHH
Confidence 345688999999999999998765553 6677888889999988876543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0032 Score=63.59 Aligned_cols=48 Identities=23% Similarity=0.436 Sum_probs=43.8
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
.||..+++|++|+.|+||+|+|++ +|..+.+..+..+++++|.+.+..
T Consensus 477 ~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~ 524 (567)
T 1dce_A 477 ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSA 524 (567)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSS
T ss_pred ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCC
Confidence 689999999999999999999999 787688899999999999998874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.0082 Score=56.05 Aligned_cols=51 Identities=18% Similarity=0.295 Sum_probs=43.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.||..++++++|+.|+|++|++++..+....+..+..+++++|.+.+..|.
T Consensus 197 ~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~ 247 (328)
T 4fcg_A 197 SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPP 247 (328)
T ss_dssp CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCC
T ss_pred cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHH
Confidence 689999999999999999999998545456778889999999988887654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.025 Score=54.67 Aligned_cols=141 Identities=10% Similarity=0.099 Sum_probs=82.6
Q ss_pred CeecccCCeEEEEEEECC--------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCc-ceeeeeeeecCCcceEEe
Q 012610 141 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN-LLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~ 211 (460)
+.+..|-...+|+....+ +..+++|+..... .......+|..+++.+...+ ..++++.+ ..+.|+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 457778899999998763 5788898864422 11113457777777664222 33445433 237899
Q ss_pred eccCCCCHHH--------------H---hhhc-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 012610 212 PFMVNGSVAS--------------C---LRER-------GQ--SQPPLNWSVRKQIALGA-------------------A 246 (460)
Q Consensus 212 e~~~~g~L~~--------------~---l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------~ 246 (460)
+|++|.+|.. . ++.. .. ...+..+..+..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 1110 00 11222344444443322 2
Q ss_pred HHHHHHHh---------------------CCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 247 RGLAYLHD---------------------HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 247 ~~l~~LH~---------------------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
..+.+|.. .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11236899999999999 8888999999998753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0086 Score=52.67 Aligned_cols=47 Identities=26% Similarity=0.412 Sum_probs=38.8
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
|..++.+++|++|+|++|+|+ .+|.. ..+..+..+++++|.+.+.++
T Consensus 105 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred hhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 345789999999999999999 67754 567888999999999887654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.017 Score=50.79 Aligned_cols=48 Identities=25% Similarity=0.388 Sum_probs=32.1
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
+.||..+. ++|++|+|++|++++..|.. ..+..+..+.+++|.+...+
T Consensus 32 ~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 80 (229)
T 3e6j_A 32 ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80 (229)
T ss_dssp SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence 35666554 77777777777777766653 55666777777777775543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=95.63 E-value=0.018 Score=50.16 Aligned_cols=47 Identities=19% Similarity=0.377 Sum_probs=38.1
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
..+..+++|+.|+|++|++++..|.. ..+..+..+++++|.+..-++
T Consensus 50 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 97 (220)
T 2v9t_B 50 GAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPK 97 (220)
T ss_dssp TSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred hHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCH
Confidence 47888999999999999999887754 667788888899998876544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0094 Score=60.85 Aligned_cols=50 Identities=26% Similarity=0.355 Sum_probs=35.0
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.+|..++.+++|++||||+|+|++.+|.. ..+..+..+++++|.+.+.++
T Consensus 485 ~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 535 (635)
T 4g8a_A 485 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 535 (635)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCC
T ss_pred cCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCCh
Confidence 35667777777777777777777776654 556667777777777766544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=95.53 E-value=0.018 Score=51.26 Aligned_cols=42 Identities=24% Similarity=0.320 Sum_probs=18.8
Q ss_pred CCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLN 48 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~ 48 (460)
.++++++|++|+|++|++++..|.. ..+..+..+.+++|.+.
T Consensus 54 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 96 (251)
T 3m19_A 54 TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc
Confidence 3444444444444444444433332 33344444444444444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.0078 Score=61.83 Aligned_cols=46 Identities=20% Similarity=0.260 Sum_probs=41.0
Q ss_pred CCCCCC--CCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCC-CCC
Q 012610 4 IPRSLT--NVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQ-LNN 49 (460)
Q Consensus 4 iP~~l~--~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~-l~~ 49 (460)
||.+++ +|++|++|+|++|+++|.+|.. +.+..+..+++++|. +.+
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~ 288 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCH
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcc
Confidence 999999 9999999999999999999965 678888899999998 765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=95.43 E-value=0.019 Score=51.93 Aligned_cols=50 Identities=22% Similarity=0.268 Sum_probs=41.0
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.|..++++++|+.|+|++|++++..|.. ..+..+..+++++|.+.+.++.
T Consensus 149 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 199 (272)
T 3rfs_A 149 PKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDG 199 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHH
Confidence 3455789999999999999999876654 6678899999999999876653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=95.40 E-value=0.019 Score=50.08 Aligned_cols=49 Identities=24% Similarity=0.441 Sum_probs=38.7
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.||..+. +.|+.|+|++|++++..|. ...+..+..+.+++|.+.+..+.
T Consensus 25 ~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~ 74 (220)
T 2v9t_B 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD 74 (220)
T ss_dssp SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTT
T ss_pred cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHH
Confidence 5777665 7899999999999987663 36678888999999998876443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=95.39 E-value=0.0036 Score=66.36 Aligned_cols=48 Identities=17% Similarity=0.216 Sum_probs=41.4
Q ss_pred CCCCCCCC--CCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCC-CCC
Q 012610 2 GEIPRSLT--NVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQ-LNN 49 (460)
Q Consensus 2 G~iP~~l~--~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~-l~~ 49 (460)
|.||.+++ +|++|++|+|++|+++|.+|.. ..+..+..+.+++|. +.+
T Consensus 479 g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg 530 (876)
T 4ecn_A 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530 (876)
T ss_dssp HHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCH
T ss_pred ccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCccc
Confidence 35999998 9999999999999999999964 677888889999997 766
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=95.24 E-value=0.026 Score=50.19 Aligned_cols=51 Identities=20% Similarity=0.252 Sum_probs=41.2
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
+..|..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+.+.++
T Consensus 73 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 124 (251)
T 3m19_A 73 TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPS 124 (251)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcCh
Confidence 345566899999999999999999876654 677888999999999876544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=95.15 E-value=0.0054 Score=50.93 Aligned_cols=46 Identities=22% Similarity=0.406 Sum_probs=39.1
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
..++++++|++|+|++|++++.+|.. ..+..+..+++++|.+.+.+
T Consensus 65 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 111 (168)
T 2ell_A 65 SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS 111 (168)
T ss_dssp SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSG
T ss_pred hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcch
Confidence 57889999999999999999987765 34788899999999987743
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.14 E-value=0.031 Score=48.04 Aligned_cols=49 Identities=24% Similarity=0.400 Sum_probs=37.4
Q ss_pred CCC-CCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 4 IPR-SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP~-~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
||. .++++++|++|+|++|++++..+.. ..+..+..+.+++|.+.+.++
T Consensus 67 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 117 (208)
T 2o6s_A 67 LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPD 117 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCH
Confidence 444 4678999999999999999765543 567788888888888876544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.0081 Score=62.67 Aligned_cols=46 Identities=37% Similarity=0.642 Sum_probs=34.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
.||..|++|++|++|||++|+|+ .||.. +.+..|..+.+++|.+..
T Consensus 261 ~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 307 (727)
T 4b8c_D 261 ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT 307 (727)
T ss_dssp CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC
T ss_pred ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc
Confidence 57777888888888888888888 66754 556677777777777653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=95.09 E-value=0.03 Score=50.52 Aligned_cols=51 Identities=20% Similarity=0.260 Sum_probs=42.1
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
..|..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+.+.++.
T Consensus 124 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 175 (272)
T 3rfs_A 124 LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEG 175 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHH
Confidence 34455899999999999999999877654 6778899999999999876553
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=95.05 E-value=0.028 Score=51.30 Aligned_cols=42 Identities=29% Similarity=0.446 Sum_probs=22.0
Q ss_pred CCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
+.+++|++|+|++|+|+ .+|.. ..+..+..+.+++|.+.+.+
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~ 116 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccC
Confidence 45555666666666555 33432 34445555555555555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.032 Score=48.01 Aligned_cols=49 Identities=20% Similarity=0.337 Sum_probs=40.2
Q ss_pred CC-CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 4 IP-RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP-~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
+| ..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+.++
T Consensus 91 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 44 44789999999999999999876653 667889999999999887554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.021 Score=57.47 Aligned_cols=49 Identities=35% Similarity=0.481 Sum_probs=28.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.+|..++.+++|++|+|++|++++.+|.. ..+..+..+.+++|.+.+.+
T Consensus 461 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 510 (570)
T 2z63_A 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510 (570)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred cchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCC
Confidence 45555666666666666666666655533 44555556666666655543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=94.92 E-value=0.013 Score=61.00 Aligned_cols=45 Identities=24% Similarity=0.425 Sum_probs=28.8
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLN 48 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~ 48 (460)
.||..+++|++|++|+|++|+|+ .||.. ..+..|..+++++|.+.
T Consensus 238 ~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 238 NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 46666666666777777777666 56642 45566666666666665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=94.82 E-value=0.021 Score=58.24 Aligned_cols=52 Identities=17% Similarity=0.256 Sum_probs=35.6
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
+-+|..+++|++|++|+||+|+|++..|.. ..+.++..+++++|.+.+.+|.
T Consensus 508 ~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 560 (635)
T 4g8a_A 508 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 560 (635)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSS
T ss_pred CcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHH
Confidence 345666777777777777777777766643 5566677777777777766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=94.68 E-value=0.028 Score=54.88 Aligned_cols=50 Identities=26% Similarity=0.329 Sum_probs=42.4
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.+|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+.++
T Consensus 338 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 388 (455)
T 3v47_A 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPD 388 (455)
T ss_dssp ECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCH
Confidence 34677899999999999999999988864 677889999999999887554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=94.67 E-value=0.015 Score=49.67 Aligned_cols=47 Identities=13% Similarity=0.259 Sum_probs=35.4
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
+.+..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+
T Consensus 79 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~ 126 (197)
T 4ezg_A 79 TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126 (197)
T ss_dssp SCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBG
T ss_pred CcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCc
Confidence 34456788888888888888888855543 667778888888888775
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=94.57 E-value=0.01 Score=48.09 Aligned_cols=45 Identities=22% Similarity=0.452 Sum_probs=38.6
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
..++++++|++|+|++|++++.+|.. ..+..+..+++++|.+.+.
T Consensus 58 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~ 103 (149)
T 2je0_A 58 ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103 (149)
T ss_dssp TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSH
T ss_pred hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCCh
Confidence 56889999999999999999988865 3478899999999998763
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.031 Score=56.30 Aligned_cols=50 Identities=20% Similarity=0.253 Sum_probs=43.4
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
+.+|..++++++|+.|+|++|++++..|.. ..+..+..+.+++|++.|..
T Consensus 484 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred cCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 456889999999999999999999987764 67788999999999998754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.015 Score=53.79 Aligned_cols=41 Identities=22% Similarity=0.289 Sum_probs=24.1
Q ss_pred CCCCCCEEECcCCcceecCCCC---CCCCCCccccccCCCCCCC
Q 012610 10 NVNSLQVLDLSNNKLTGDIPTN---GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 10 ~l~~L~~l~ls~N~l~G~iP~~---~~~~~l~~~~~~~N~l~~~ 50 (460)
++++|++|+|++|+++|.+|.. ..+..+..+++++|.+.+.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 136 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch
Confidence 5666666666666666666653 3455555666666665554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=94.36 E-value=0.04 Score=50.55 Aligned_cols=50 Identities=20% Similarity=0.329 Sum_probs=37.8
Q ss_pred CCCCCCCCCCCCCEEECcCCccee-cCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTG-DIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G-~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.+|..++++++|++|+|++|.+++ .+|.. ..+..+..+++++|.+.+.++
T Consensus 141 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 192 (306)
T 2z66_A 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192 (306)
T ss_dssp CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCH
Confidence 456778888888888888888887 45653 566778888888888776544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=94.35 E-value=0.032 Score=54.38 Aligned_cols=52 Identities=13% Similarity=0.074 Sum_probs=43.8
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
+..|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+..+.
T Consensus 313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh
Confidence 345778999999999999999999987764 6788899999999998876543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.067 Score=49.20 Aligned_cols=41 Identities=20% Similarity=0.243 Sum_probs=24.9
Q ss_pred CCCCCCCEEECcCCcceecCCCC-CCC---CCCccccccCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPTN-GSF---SLFTPISFANNQLNN 49 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~~-~~~---~~l~~~~~~~N~l~~ 49 (460)
+++++|++||||+|++++.+|.. ..+ ..+..+++++|.+..
T Consensus 221 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~ 265 (310)
T 4glp_A 221 AAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ 265 (310)
T ss_dssp HHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS
T ss_pred hcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc
Confidence 45666777777777777665543 222 456666666666663
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=94.12 E-value=0.068 Score=48.73 Aligned_cols=51 Identities=25% Similarity=0.324 Sum_probs=42.4
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.||..++.+++|+.|+|++|++++..|. ...+..+..+.+++|.+.+.++.
T Consensus 91 ~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~ 142 (290)
T 1p9a_G 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142 (290)
T ss_dssp SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChh
Confidence 6888899999999999999999987664 36778888999999998876543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.04 Score=50.55 Aligned_cols=50 Identities=26% Similarity=0.355 Sum_probs=40.5
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.+|..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+.+.++
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 36888999999999999999999987754 567788888888888876543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.0038 Score=53.56 Aligned_cols=48 Identities=23% Similarity=0.389 Sum_probs=38.8
Q ss_pred CCCCCC------CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 1 MGEIPR------SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 1 ~G~iP~------~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
+|.+|. .++++++|++|+|++|++++ +|....+..+..+.+++|.+..
T Consensus 31 ~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~~ 84 (198)
T 1ds9_A 31 HGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIKK 84 (198)
T ss_dssp CBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEECS
T ss_pred ccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCccc
Confidence 466665 88899999999999999998 7755667788888899888763
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.053 Score=57.58 Aligned_cols=45 Identities=18% Similarity=0.234 Sum_probs=30.0
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
|..+++|++|++|+|++|++++..|.. ..+.++..+.+++|.+.+
T Consensus 66 ~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 111 (844)
T 3j0a_A 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111 (844)
T ss_dssp TTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSS
T ss_pred HHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCc
Confidence 556677777777777777777766643 556666666666666665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.93 E-value=0.019 Score=56.73 Aligned_cols=49 Identities=22% Similarity=0.262 Sum_probs=38.5
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
+..|..++++++|++|+|++|+++|.+| ...+..+..+++++|.+.+.+
T Consensus 48 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~ 96 (487)
T 3oja_A 48 QISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL 96 (487)
T ss_dssp CCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE
T ss_pred CCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC
Confidence 3445678899999999999999998777 667778888888888776543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=93.88 E-value=0.035 Score=56.46 Aligned_cols=47 Identities=21% Similarity=0.299 Sum_probs=37.5
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
..++++++|++|+|++|++++.+|.. ..+..+..+++++|.+.+..|
T Consensus 470 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 517 (606)
T 3t6q_A 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517 (606)
T ss_dssp CGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGG
T ss_pred hhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCCh
Confidence 45788888999999999988887764 667788888888888877554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.84 E-value=0.041 Score=46.86 Aligned_cols=46 Identities=9% Similarity=0.190 Sum_probs=36.1
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.|| .+..+++|++|+|++|.++.. +....+..+..+.+++|.+.+.
T Consensus 58 ~l~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~ 103 (197)
T 4ezg_A 58 DLT-GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSD 103 (197)
T ss_dssp CCT-TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGG
T ss_pred ChH-HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcc
Confidence 467 688999999999999976553 3446678888899999988763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=93.83 E-value=0.028 Score=57.11 Aligned_cols=50 Identities=20% Similarity=0.197 Sum_probs=41.9
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
+|..++++++|+.|+|++|++++.+|.. ..+..+..+++++|.+.+..|.
T Consensus 465 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 515 (606)
T 3vq2_A 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515 (606)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGG
T ss_pred hHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHH
Confidence 6888999999999999999999988864 6778888899999988876443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=93.82 E-value=0.015 Score=52.18 Aligned_cols=42 Identities=26% Similarity=0.392 Sum_probs=33.3
Q ss_pred CCCCCCCEEECcCCccee--cCCCC-CCCCCCccccccCCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTG--DIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G--~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
.+++.|+.|+||+|+|++ .+|.. ..+.++..+++++|.+.+.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 357889999999999998 66643 4577888889999988764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=93.82 E-value=0.059 Score=52.60 Aligned_cols=48 Identities=17% Similarity=0.263 Sum_probs=30.9
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+...+
T Consensus 91 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 139 (452)
T 3zyi_A 91 QADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIP 139 (452)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCC
T ss_pred CHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccC
Confidence 3556677777777777777777665543 45566666777777666543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.75 E-value=0.093 Score=53.28 Aligned_cols=49 Identities=18% Similarity=0.215 Sum_probs=37.2
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.|..++++++|++|+|++|.+++..|.. +.+..+..+.+++|.+.+.++
T Consensus 91 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~ 140 (597)
T 3oja_B 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 140 (597)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCH
Confidence 4557888888888888888888876654 667778888888887776544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=93.71 E-value=0.0033 Score=61.72 Aligned_cols=49 Identities=18% Similarity=0.161 Sum_probs=26.8
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCC-------------CccccccCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSL-------------FTPISFANNQLNNP 50 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~-------------l~~~~~~~N~l~~~ 50 (460)
|.||.++++|++|++|+|++|.++|.+|.. +.+.. +..+++++|.+.+-
T Consensus 24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l 86 (454)
T 1jl5_A 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL 86 (454)
T ss_dssp ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC
T ss_pred hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC
Confidence 678888888888888888888888888864 33332 25566666666653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=93.70 E-value=0.13 Score=46.18 Aligned_cols=49 Identities=27% Similarity=0.392 Sum_probs=38.0
Q ss_pred CC-CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 4 IP-RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP-~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
+| ..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+.+.++
T Consensus 100 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 150 (270)
T 2o6q_A 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPK 150 (270)
T ss_dssp CCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCH
Confidence 44 45688899999999999998876654 667788888898888876544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.68 E-value=0.065 Score=54.43 Aligned_cols=50 Identities=14% Similarity=0.251 Sum_probs=33.1
Q ss_pred CCCCC-CCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRS-LTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~-l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||.. +++++.|++|+|++|++++..|. ...+..+..+++++|.+.+.++
T Consensus 65 ~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 116 (597)
T 3oja_B 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP 116 (597)
T ss_dssp EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCH
Confidence 45543 45677777777777777776663 3566677777777777766554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=93.66 E-value=0.052 Score=54.36 Aligned_cols=48 Identities=19% Similarity=0.193 Sum_probs=30.1
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+.+
T Consensus 42 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 90 (549)
T 2z81_A 42 GHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90 (549)
T ss_dssp CSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCC
T ss_pred ChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccC
Confidence 3556667777777777777777665542 55566666666666665543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.64 E-value=0.046 Score=58.07 Aligned_cols=49 Identities=22% Similarity=0.272 Sum_probs=28.6
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
|-+|..++++++|+.|+||+|+|++..|.... ..+..+++++|.+.+.+
T Consensus 494 ~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~ 542 (844)
T 3j0a_A 494 SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN 542 (844)
T ss_dssp TCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred ccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence 44556677777777777777777765443322 44444555555544443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=93.57 E-value=0.023 Score=51.04 Aligned_cols=48 Identities=17% Similarity=0.299 Sum_probs=36.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCC--CCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFS--LFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~--~l~~~~~~~N~l~~~~ 51 (460)
.||..++++++|+.||||+|+|++. .....+. .+..+.+.+|++++..
T Consensus 187 ~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 187 DMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTF 236 (267)
T ss_dssp GGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred cchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCcccc
Confidence 4566667899999999999999985 2222233 7888899999987643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=93.57 E-value=0.055 Score=52.84 Aligned_cols=43 Identities=23% Similarity=0.268 Sum_probs=24.1
Q ss_pred CCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
++.+++|+.|+|++|++++..|.. ..+..+..+.+++|.+.+.
T Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 556666666666666666655532 4444555555555555443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=93.56 E-value=0.07 Score=48.34 Aligned_cols=48 Identities=19% Similarity=0.279 Sum_probs=40.4
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+.+.++
T Consensus 98 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 146 (285)
T 1ozn_A 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146 (285)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCH
Confidence 678899999999999999999977754 567888899999998876554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.53 E-value=0.079 Score=49.97 Aligned_cols=46 Identities=17% Similarity=0.101 Sum_probs=32.5
Q ss_pred CCC-CCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 7 SLT-NVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 7 ~l~-~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.+. ++++|+.|+|++|+|++..|. ...+..+..+++++|.+...++
T Consensus 58 ~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~ 105 (361)
T 2xot_A 58 WTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDE 105 (361)
T ss_dssp SSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred hhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCH
Confidence 344 788888888888888876654 3566777777888887765443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=93.51 E-value=0.092 Score=48.70 Aligned_cols=44 Identities=25% Similarity=0.372 Sum_probs=29.3
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+..
T Consensus 70 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 114 (330)
T 1xku_A 70 GDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 114 (330)
T ss_dssp TTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB
T ss_pred hhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc
Confidence 35677777777777777777765643 555666677777776653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.45 E-value=0.067 Score=53.83 Aligned_cols=48 Identities=33% Similarity=0.597 Sum_probs=35.8
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
|.+|..+. ++|+.|+|++|+++ .||.. ..+..+..+++++|.+..-++
T Consensus 442 ~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~ 490 (562)
T 3a79_B 442 GSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPD 490 (562)
T ss_dssp GGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCT
T ss_pred cchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCH
Confidence 45666554 78999999999998 56754 567788888899998885443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.41 E-value=0.083 Score=51.30 Aligned_cols=48 Identities=29% Similarity=0.369 Sum_probs=29.6
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.|| .++++++|+.|||++|++++..|.. ..+..+..+.+++|.+.+.+
T Consensus 199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 247 (440)
T 3zyj_A 199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE 247 (440)
T ss_dssp SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence 345 3667777777777777777765543 44555666666666655443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=93.40 E-value=0.075 Score=53.94 Aligned_cols=48 Identities=21% Similarity=0.279 Sum_probs=29.6
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
|..++++++|++|||++|++++..|.. ..+..+..+++++|.+.+.+|
T Consensus 49 ~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p 97 (606)
T 3vq2_A 49 SYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97 (606)
T ss_dssp TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCT
T ss_pred hhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccCh
Confidence 345666666777777766666665543 455666666666666655433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=93.37 E-value=0.11 Score=46.88 Aligned_cols=49 Identities=22% Similarity=0.303 Sum_probs=40.5
Q ss_pred CCCCCCCCCCCCEEECcCCc-ceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNK-LTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~-l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.|..++++++|++|+|++|. +++..|.. ..+..+..+.+++|.+.+.++
T Consensus 72 ~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 122 (285)
T 1ozn_A 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122 (285)
T ss_dssp CTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred CHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECH
Confidence 47889999999999999998 66654543 667889999999999887654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.31 E-value=0.079 Score=48.79 Aligned_cols=41 Identities=24% Similarity=0.204 Sum_probs=30.6
Q ss_pred CCCCCCCEEECcCCcceecCCC--CCCCCCCccccccCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPT--NGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~--~~~~~~l~~~~~~~N~l~~ 49 (460)
.++++|+.|||++|++++.+|. ...+..+..+++++|.+..
T Consensus 225 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 267 (312)
T 1wwl_A 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267 (312)
T ss_dssp HTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSS
T ss_pred hcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccCh
Confidence 4678888888888888887653 2446777888888888773
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=93.28 E-value=0.044 Score=45.69 Aligned_cols=46 Identities=15% Similarity=0.168 Sum_probs=34.5
Q ss_pred CCCCCCCCC-CCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 4 IPRSLTNVN-SLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 4 iP~~l~~l~-~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
||. ++.+. +|++|||++|++++. +....+..+..+++++|.+.+.+
T Consensus 34 i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~ 80 (176)
T 1a9n_A 34 IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIG 80 (176)
T ss_dssp CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEEC
T ss_pred hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccC
Confidence 443 55555 889999999988885 66677778888888888887644
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.19 E-value=0.032 Score=53.63 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.2
Q ss_pred CeEeeCCCCCCEEe------cCCCcEEEeecccccc
Q 012610 259 KIIHRDVKAANILL------DEEFEAVVGDFGLAKL 288 (460)
Q Consensus 259 ~i~H~dlkp~Nill------~~~~~~kl~Dfg~~~~ 288 (460)
.++|+|+.+.||++ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4566799999998753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=93.07 E-value=0.071 Score=47.81 Aligned_cols=46 Identities=22% Similarity=0.347 Sum_probs=34.5
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.|| .++.+++|+.|+|++|++++..| ...+..+..+++++|.+.+.
T Consensus 55 ~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~l 100 (263)
T 1xeu_A 55 SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKNL 100 (263)
T ss_dssp CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSCC
T ss_pred cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCCc
Confidence 455 57788888888888888887655 56677777888888887664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=93.03 E-value=0.079 Score=49.22 Aligned_cols=45 Identities=18% Similarity=0.236 Sum_probs=29.5
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+..
T Consensus 71 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 116 (332)
T 2ft3_A 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE 116 (332)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCS
T ss_pred HhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCc
Confidence 445677777777777777777665543 555666667777776654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.03 E-value=0.094 Score=49.45 Aligned_cols=48 Identities=21% Similarity=0.184 Sum_probs=38.7
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
|..++++++|+.|+|++|+|++..|. ...+..+..+.+++|.+.+..+
T Consensus 81 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 129 (361)
T 2xot_A 81 SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDR 129 (361)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred hhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECH
Confidence 45689999999999999999987664 3667888888999998876544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=92.98 E-value=0.071 Score=54.13 Aligned_cols=46 Identities=15% Similarity=0.111 Sum_probs=28.7
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+.+.
T Consensus 50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 96 (606)
T 3t6q_A 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96 (606)
T ss_dssp TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEE
T ss_pred hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccccc
Confidence 556666666777777776666665543 5555666666666665543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.96 E-value=0.098 Score=48.10 Aligned_cols=43 Identities=14% Similarity=0.113 Sum_probs=34.7
Q ss_pred CCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
.++.+++|++|+|++|++++..|.. ..+..+..+++++|.+.+
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 183 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLG 183 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCH
T ss_pred HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCcc
Confidence 3457899999999999998877654 577888889999998764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=92.93 E-value=0.12 Score=46.62 Aligned_cols=48 Identities=23% Similarity=0.227 Sum_probs=38.8
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
|..++++++|++|+|++|++++..|. ...+..+..+.+++|.+.+.++
T Consensus 45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (276)
T 2z62_A 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 93 (276)
T ss_dssp TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccCh
Confidence 34788999999999999999987664 3667888889999998876554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.93 E-value=0.11 Score=51.09 Aligned_cols=47 Identities=17% Similarity=0.297 Sum_probs=32.5
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+...+
T Consensus 49 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 96 (477)
T 2id5_A 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIP 96 (477)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred HhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccC
Confidence 556777777777777777777766643 55666777777777766544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=92.82 E-value=0.11 Score=48.12 Aligned_cols=48 Identities=23% Similarity=0.214 Sum_probs=37.0
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
..|..++++++|+.|+|++|.+++..|.. ..+..+..+.+++|.+...
T Consensus 207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 255 (330)
T 1xku_A 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 255 (330)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC
T ss_pred cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccC
Confidence 34677888899999999999998877643 5667788888888887743
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=92.80 E-value=0.088 Score=48.91 Aligned_cols=46 Identities=17% Similarity=0.149 Sum_probs=32.7
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~ 49 (460)
.|..++++++|+.|+|++|++++..|. ...+..+..+++++|.+..
T Consensus 209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 255 (332)
T 2ft3_A 209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR 255 (332)
T ss_dssp CTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCB
T ss_pred CHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCee
Confidence 446777888888888888888876653 2556667777777777763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=92.79 E-value=0.089 Score=43.77 Aligned_cols=42 Identities=29% Similarity=0.366 Sum_probs=29.9
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCC-CCccccccCCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFS-LFTPISFANNQLNNP 50 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~-~l~~~~~~~N~l~~~ 50 (460)
+.++.+|+.|+|++|+++. +|....+. .+..+++++|.+.+.
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~ 57 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL 57 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE
T ss_pred cCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc
Confidence 4567788888888888884 56554444 777788888877653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.16 Score=45.50 Aligned_cols=51 Identities=22% Similarity=0.364 Sum_probs=41.2
Q ss_pred CCCCC-CCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRS-LTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~-l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.||.. +.++++|++|+|++|++++..+.. ..+..+..+.+++|.+.+.++.
T Consensus 75 ~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 127 (270)
T 2o6q_A 75 TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPR 127 (270)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTT
T ss_pred eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHH
Confidence 46655 478999999999999999865543 6678899999999998876553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=92.70 E-value=0.13 Score=46.27 Aligned_cols=48 Identities=25% Similarity=0.193 Sum_probs=38.6
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||..+. ++|+.|+|++|++++..|. ...+..+..+++++|.+.+.++
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCH
Confidence 4777664 5799999999999998773 4778889999999998876544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=92.68 E-value=0.089 Score=52.94 Aligned_cols=46 Identities=20% Similarity=0.135 Sum_probs=35.0
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+++++|.+..-
T Consensus 69 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l 115 (562)
T 3a79_B 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI 115 (562)
T ss_dssp GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCcc
Confidence 457888888888888888888877753 5667778888888877643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.54 E-value=0.082 Score=52.55 Aligned_cols=47 Identities=34% Similarity=0.542 Sum_probs=35.7
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
|.+|..+. ++|+.|||++|+++ .+|.. ..+..+..+++++|.+..-+
T Consensus 413 ~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~ 460 (520)
T 2z7x_B 413 DTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460 (520)
T ss_dssp GGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred cchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccC
Confidence 45666554 78999999999998 67763 56778888889999887544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.52 E-value=0.077 Score=51.57 Aligned_cols=51 Identities=20% Similarity=0.195 Sum_probs=43.5
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
..|..+.++++|+.|+|++|++++..|.. ..+.++..+++++|.+.+.++.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence 45788999999999999999999988864 6678899999999999876543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.40 E-value=0.056 Score=53.77 Aligned_cols=41 Identities=29% Similarity=0.448 Sum_probs=22.7
Q ss_pred CCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
+.+++|++|+|++|++++.+|.. ..+..+..+.+++|.+.+
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 362 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCB
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCc
Confidence 45556666666666666655543 444555555555555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=92.23 E-value=0.057 Score=54.03 Aligned_cols=48 Identities=23% Similarity=0.283 Sum_probs=40.2
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~ 49 (460)
+..|..++++++|++|||++|++++..|. .+.+..+..+++++|.+.+
T Consensus 64 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 112 (549)
T 2z81_A 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112 (549)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred ccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence 34567899999999999999999998776 4778888999999998875
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.11 E-value=0.071 Score=50.05 Aligned_cols=48 Identities=23% Similarity=0.244 Sum_probs=39.6
Q ss_pred CCC-CCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCC
Q 012610 4 IPR-SLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 4 iP~-~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~ 51 (460)
||. .++++++|++|+|++|++++..|. ...+..+..+++++|.+.+.+
T Consensus 67 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 116 (353)
T 2z80_A 67 ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLS 116 (353)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCC
T ss_pred cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCC
Confidence 444 789999999999999999998775 467788889999999887654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.10 E-value=0.13 Score=48.31 Aligned_cols=48 Identities=27% Similarity=0.343 Sum_probs=38.9
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||..+. ++|++|+|++|++++..+. ...+..+..+++++|.+.+.++
T Consensus 45 ~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (353)
T 2z80_A 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93 (353)
T ss_dssp SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT
T ss_pred ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH
Confidence 5787665 5899999999999986653 4778889999999999887544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=92.07 E-value=0.15 Score=51.39 Aligned_cols=38 Identities=29% Similarity=0.385 Sum_probs=23.7
Q ss_pred CCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
+.+++|++|+|++|+|++ ||... .++..+.+++|.+.+
T Consensus 97 ~~l~~L~~L~Ls~N~l~~-ip~l~--~~L~~L~Ls~N~l~~ 134 (571)
T 3cvr_A 97 ELPASLEYLDACDNRLST-LPELP--ASLKHLDVDNNQLTM 134 (571)
T ss_dssp CCCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSC
T ss_pred cccCCCCEEEccCCCCCC-cchhh--cCCCEEECCCCcCCC
Confidence 346677777777777776 66521 256666666666665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=92.03 E-value=0.028 Score=51.99 Aligned_cols=45 Identities=24% Similarity=0.343 Sum_probs=32.7
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
|..++++++|++|+|++|++++..| ...+..+..+++++|.+.+.
T Consensus 51 ~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~l 95 (317)
T 3o53_A 51 AADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQEL 95 (317)
T ss_dssp HHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEEE
T ss_pred HHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccccc
Confidence 4567778888888888888887665 55667777777777776653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=91.98 E-value=0.17 Score=48.10 Aligned_cols=42 Identities=7% Similarity=0.051 Sum_probs=19.5
Q ss_pred CCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~ 50 (460)
.++++|++|+|++|++++..|. ...+..+..+++++|.+.+.
T Consensus 66 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 108 (390)
T 3o6n_A 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL 108 (390)
T ss_dssp HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcC
Confidence 4445555555555555444332 23344444445555544443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=91.94 E-value=0.2 Score=47.65 Aligned_cols=48 Identities=19% Similarity=0.245 Sum_probs=38.1
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
|..++++++|++|+|++|++++..|.. ..+..+..+.+++|.+..-++
T Consensus 86 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~ 134 (390)
T 3o6n_A 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134 (390)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCH
Confidence 457888999999999999998877764 677788888888888875443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=91.84 E-value=0.14 Score=52.77 Aligned_cols=50 Identities=12% Similarity=0.131 Sum_probs=34.8
Q ss_pred CCCC-CCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCCC
Q 012610 3 EIPR-SLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~-~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||. .++++++|++|+|++|++++..|. ...+..+..+++++|.+.+.++
T Consensus 87 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 138 (680)
T 1ziw_A 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138 (680)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCC
T ss_pred ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCc
Confidence 3554 477888888888888888765554 3566777777777777766544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=91.84 E-value=0.13 Score=53.00 Aligned_cols=48 Identities=21% Similarity=0.341 Sum_probs=28.2
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
|.+|..++++++|+.|+|++|++++..|.. ..+..+..+.+++|.+.+
T Consensus 470 ~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 518 (680)
T 1ziw_A 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518 (680)
T ss_dssp TCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGG
T ss_pred ccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccc
Confidence 345666666666666666666666544432 445556666666666554
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.75 E-value=0.32 Score=41.67 Aligned_cols=117 Identities=10% Similarity=0.094 Sum_probs=78.6
Q ss_pred cCCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 012610 189 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 189 ~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 268 (460)
..||+++.. .+-.+.+...+.++.-..+.=...++. ++...+++++.+|+....+++.. +|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 357888765 455555666666665443222222332 78899999999999877666654 78899999
Q ss_pred CEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccc
Q 012610 269 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341 (460)
Q Consensus 269 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~ 341 (460)
|++++.++.+++.-.|+...+. |.- .+...=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998777644322 210 1111122356678999999999985
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=91.66 E-value=0.2 Score=48.94 Aligned_cols=40 Identities=33% Similarity=0.333 Sum_probs=18.6
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
++++++|+.|+|++|+|+| +| ...+..+..+.+++|.+.+
T Consensus 208 l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 208 LNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSC
T ss_pred cccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCC
Confidence 4444444444444444444 34 3334444444455554444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=91.56 E-value=0.17 Score=39.85 Aligned_cols=45 Identities=18% Similarity=0.218 Sum_probs=30.6
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
.||..| -.+|+.|||++|+|+.--+.. ..+..+..+.+.+|++.+
T Consensus 24 ~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 24 SLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred cCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 466543 236899999999998743322 345667778888887754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=91.46 E-value=0.19 Score=50.61 Aligned_cols=40 Identities=43% Similarity=0.556 Sum_probs=26.0
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
||. +++ +|+.|+|++|+|++ ||. .+..+..+++++|.+.+
T Consensus 115 ip~-l~~--~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~l~~ 154 (571)
T 3cvr_A 115 LPE-LPA--SLKHLDVDNNQLTM-LPE--LPALLEYINADNNQLTM 154 (571)
T ss_dssp CCC-CCT--TCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC
T ss_pred cch-hhc--CCCEEECCCCcCCC-CCC--cCccccEEeCCCCccCc
Confidence 565 544 67777777777777 565 45666666666666665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.46 E-value=0.18 Score=49.43 Aligned_cols=45 Identities=18% Similarity=0.171 Sum_probs=27.9
Q ss_pred CCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.++++++|+.|+|++|++++..+.. ..+..+..+.+++|.+.+..
T Consensus 243 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 288 (477)
T 2id5_A 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288 (477)
T ss_dssp HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEEC
T ss_pred HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceEC
Confidence 4566777777777777777655532 44556666666666665543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.25 E-value=0.67 Score=39.83 Aligned_cols=114 Identities=15% Similarity=0.156 Sum_probs=76.4
Q ss_pred CCCcceeeeeeeecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeeCCCCC
Q 012610 190 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA-YLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 190 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlkp~ 268 (460)
.||.+ -..+-.+.+...+.++.-+++.=...++. ++...+++++.+|+.... +++. -+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 33444566666676766544433334432 788999999998887665 4544 478899999
Q ss_pred CEEecCCCcEEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCc-hhhHHHHHHHHhCCCccc
Q 012610 269 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV-FGYGVMLLELITGQRAFD 341 (460)
Q Consensus 269 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv-ws~G~il~el~tg~~p~~ 341 (460)
|+++|.++.+++.-.|+-..+ +|.-+ + ..|. -.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB------------------SSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877765432 22211 1 1122 256678888999988885
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=91.14 E-value=0.11 Score=47.95 Aligned_cols=43 Identities=37% Similarity=0.210 Sum_probs=36.1
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
...+++|+.|+|++|++++..|....+..+..+++++|.+..-
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l 229 (317)
T 3o53_A 187 QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLI 229 (317)
T ss_dssp CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEE
T ss_pred ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccch
Confidence 4469999999999999998766666778889999999998854
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=91.11 E-value=0.17 Score=45.34 Aligned_cols=45 Identities=20% Similarity=0.404 Sum_probs=36.6
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.+|. ++++++|+.|+|++|++++ +|.... ..+..+.+++|.+.+.
T Consensus 77 ~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~~ 121 (263)
T 1xeu_A 77 DLSP-LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNNELRDT 121 (263)
T ss_dssp CCGG-GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECCSSCCSBS
T ss_pred CChh-hccCCCCCEEECCCCccCC-cCcccc-CcccEEEccCCccCCC
Confidence 3555 8999999999999999998 454444 7888899999988764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=90.88 E-value=0.24 Score=48.28 Aligned_cols=37 Identities=32% Similarity=0.428 Sum_probs=19.7
Q ss_pred CCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 12 NSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 12 ~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
++|++|+|++|++++ +|..+.+..+..+++++|.+.+
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~ 167 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK 167 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc
Confidence 355555555555554 5544445555555555555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=90.56 E-value=0.083 Score=46.43 Aligned_cols=48 Identities=19% Similarity=0.248 Sum_probs=37.8
Q ss_pred CCCC-CCCCCCCCCEEECcC-CcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 3 EIPR-SLTNVNSLQVLDLSN-NKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~-~l~~l~~L~~l~ls~-N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
.||. .++++++|+.|+|++ |++++..|.. ..+..+..+.+++|.+.+-
T Consensus 70 ~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~l 120 (239)
T 2xwt_C 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF 120 (239)
T ss_dssp EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSC
T ss_pred eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccc
Confidence 3554 678999999999998 9999765543 5677888899999988774
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=90.52 E-value=0.16 Score=46.22 Aligned_cols=46 Identities=17% Similarity=0.224 Sum_probs=37.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.+| .++.+++|+.|+|++|++++..| ...+..+..+.+++|.+.+.
T Consensus 60 ~~~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~ 105 (291)
T 1h6t_A 60 SVQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL 105 (291)
T ss_dssp CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG
T ss_pred cCh-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCC
Confidence 344 47889999999999999998655 66778888889999988764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=90.49 E-value=0.15 Score=46.74 Aligned_cols=46 Identities=26% Similarity=0.393 Sum_probs=35.2
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.+| .+..+++|++|+|++|++++..| ...+..+..+++++|.+.+.
T Consensus 55 ~l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~ 100 (308)
T 1h6u_A 55 TIE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV 100 (308)
T ss_dssp CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC
T ss_pred Cch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc
Confidence 355 57788888888888888887655 66677788888888887664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=90.14 E-value=0.11 Score=52.75 Aligned_cols=44 Identities=16% Similarity=0.404 Sum_probs=35.0
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
..+++|++|+.|+|++|+|++..| ...+..|..+++++|.+.+.
T Consensus 147 ~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 147 TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC
T ss_pred hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC
Confidence 357788888888888888888777 66777888888888887764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=89.51 E-value=0.26 Score=48.06 Aligned_cols=41 Identities=20% Similarity=0.212 Sum_probs=20.7
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
.++++++|++|+|++|++++. | .+.+..+..+++++|.+.+
T Consensus 59 ~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~ 99 (457)
T 3bz5_A 59 GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN 99 (457)
T ss_dssp TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC
T ss_pred hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce
Confidence 355555555555555555552 3 3344445555555555444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=89.02 E-value=0.15 Score=44.74 Aligned_cols=49 Identities=22% Similarity=0.266 Sum_probs=38.6
Q ss_pred CCC-CCCCCCCCCEEECcCCc-ceecCCCC-CCCCCCccccccC-CCCCCCCC
Q 012610 4 IPR-SLTNVNSLQVLDLSNNK-LTGDIPTN-GSFSLFTPISFAN-NQLNNPPP 52 (460)
Q Consensus 4 iP~-~l~~l~~L~~l~ls~N~-l~G~iP~~-~~~~~l~~~~~~~-N~l~~~~p 52 (460)
||. .++++++|++|+|++|+ +++..|.. ..+..+..+.+++ |.+...++
T Consensus 46 i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 444 78999999999999997 77755533 6678899999998 88876543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=88.97 E-value=0.2 Score=45.56 Aligned_cols=45 Identities=27% Similarity=0.409 Sum_probs=35.7
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.++++++|+.|+|++|++++. +....+..+..+++++|.+.+.++
T Consensus 129 ~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 129 GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred hhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 578889999999999998885 555667788888888888876543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=88.94 E-value=0.2 Score=50.85 Aligned_cols=45 Identities=27% Similarity=0.409 Sum_probs=37.8
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~p 52 (460)
.+++|++|+.|+|++|+|++. +....+..|..+++++|.+.+.++
T Consensus 126 ~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 126 GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp GGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred cccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh
Confidence 588899999999999999985 655778888999999999887644
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=88.52 E-value=0.29 Score=44.92 Aligned_cols=39 Identities=13% Similarity=0.247 Sum_probs=20.7
Q ss_pred CCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 10 NVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 10 ~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
++++|+.|++++|+++. +|....+..+..+++++|.+.+
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~~~~~l~~L~~L~L~~n~i~~ 77 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITD 77 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCC
T ss_pred HcCCcCEEEeeCCCccC-chhhhccCCCCEEEccCCcCCC
Confidence 35555566666655554 3433444555555555555544
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.46 E-value=0.44 Score=29.14 Aligned_cols=32 Identities=22% Similarity=0.229 Sum_probs=17.8
Q ss_pred ccccccccchhhhHhhhhhhhHHHhhhccCCC
Q 012610 72 TGAIAGGVAAGAALLFAAPAIALAYWRKRKPE 103 (460)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 103 (460)
...+++++..+..+++++....++++|+++.+
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34455555555555555555556666666554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=87.29 E-value=0.26 Score=48.15 Aligned_cols=42 Identities=24% Similarity=0.385 Sum_probs=32.6
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
++++++|+.|+|++|++++..| ...+..+..+.+++|.+.+.
T Consensus 305 ~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 305 ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC
T ss_pred hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc
Confidence 6788888888888888888766 45667777788888877664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=86.68 E-value=0.38 Score=44.74 Aligned_cols=45 Identities=20% Similarity=0.357 Sum_probs=31.7
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
+|. ++.+++|++|+|++|++++..+ ...+..+..+.+++|.+...
T Consensus 59 ~~~-~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~ 103 (347)
T 4fmz_A 59 IQG-IEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDI 103 (347)
T ss_dssp CTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC
T ss_pred chh-hhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCc
Confidence 443 7778888888888888876433 56667777777777776653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=86.42 E-value=0.46 Score=44.36 Aligned_cols=47 Identities=21% Similarity=0.157 Sum_probs=34.6
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~ 51 (460)
.||..| .++|+.|+|++|+++.--+. +..+.++..+++++|.+.+..
T Consensus 23 ~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i 70 (350)
T 4ay9_X 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70 (350)
T ss_dssp SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEE
T ss_pred ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCcc
Confidence 577766 36789999999999864332 366788888899999876543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=85.91 E-value=0.44 Score=46.53 Aligned_cols=46 Identities=28% Similarity=0.399 Sum_probs=31.4
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
||. +..+++|++|||++|++++..| ...+..+..+.+++|.+.+.+
T Consensus 61 l~~-~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~ 106 (466)
T 1o6v_A 61 IDG-VEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADIT 106 (466)
T ss_dssp CTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG
T ss_pred Ccc-hhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccCh
Confidence 453 6677777778887777777655 556666777777777666543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.77 E-value=0.34 Score=29.57 Aligned_cols=33 Identities=27% Similarity=0.338 Sum_probs=18.2
Q ss_pred ccccccccchhhhHhhhhhhhHHHhhhccCCCC
Q 012610 72 TGAIAGGVAAGAALLFAAPAIALAYWRKRKPED 104 (460)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (460)
.+.+++++..+..+++++....++++|+++.++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 344555555555555555555566666665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=85.76 E-value=0.082 Score=50.32 Aligned_cols=46 Identities=11% Similarity=0.358 Sum_probs=36.4
Q ss_pred CCCCCCCCCCCCEEECcCC---cceecCCCC--------CCCCCCccccccCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNN---KLTGDIPTN--------GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N---~l~G~iP~~--------~~~~~l~~~~~~~N~l~~ 49 (460)
|+..+.++++|++|+|++| +++|.+|.. ..+..+..+++++|.+.+
T Consensus 52 l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 108 (386)
T 2ca6_A 52 LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108 (386)
T ss_dssp HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred HHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCH
Confidence 4456889999999999994 777888753 356788889999998876
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=84.70 E-value=0.24 Score=46.07 Aligned_cols=43 Identities=21% Similarity=0.418 Sum_probs=30.1
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.+..+++|+.|+|++|++++. |....+..+..+.+++|.+.+.
T Consensus 260 ~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 260 AVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGG
T ss_pred hHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCc
Confidence 467777888888888877773 5445566677777777776543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=84.41 E-value=0.49 Score=48.10 Aligned_cols=38 Identities=32% Similarity=0.317 Sum_probs=28.8
Q ss_pred CCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
..+++|+.|+||+|+|++ +|. .+.++..+++++|.+..
T Consensus 238 ~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~L~~ 275 (622)
T 3g06_A 238 VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQLTR 275 (622)
T ss_dssp CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCCS
T ss_pred CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCCCCc
Confidence 456778888888888884 665 56778888888998874
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=83.27 E-value=0.42 Score=44.13 Aligned_cols=42 Identities=19% Similarity=0.165 Sum_probs=23.2
Q ss_pred CCCCCCCCCEEECcCCcceec-CCCC-CCCCCCccccccCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGD-IPTN-GSFSLFTPISFANNQLN 48 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~-iP~~-~~~~~l~~~~~~~N~l~ 48 (460)
.++++++|+.|+|++|++++. +|.. ..+..+..+++++|.+.
T Consensus 88 ~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~ 131 (336)
T 2ast_B 88 EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 131 (336)
T ss_dssp SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCC
T ss_pred hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccC
Confidence 355566666666666666554 4432 44555555666655543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=83.20 E-value=0.043 Score=46.77 Aligned_cols=45 Identities=22% Similarity=0.363 Sum_probs=34.5
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
.|| .++++++|++|+|++|+++ .+|.. ..+..+..+++++|.+.+
T Consensus 62 ~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~ 107 (198)
T 1ds9_A 62 KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC
T ss_pred ccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc
Confidence 377 7888999999999999998 56753 233567778888888755
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=82.18 E-value=1.2 Score=45.33 Aligned_cols=42 Identities=24% Similarity=0.442 Sum_probs=22.4
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
.||..+. ++|+.|+|++|+|++ ||. .+.++..+++++|.+..
T Consensus 54 ~lp~~l~--~~L~~L~L~~N~l~~-lp~--~l~~L~~L~Ls~N~l~~ 95 (622)
T 3g06_A 54 TLPDCLP--AHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLTS 95 (622)
T ss_dssp CCCSCCC--TTCSEEEECSCCCSC-CCC--CCTTCCEEEECSCCCSC
T ss_pred ccChhhC--CCCcEEEecCCCCCC-CCC--cCCCCCEEEcCCCcCCc
Confidence 4555554 566666666666653 443 34455555555555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=80.28 E-value=0.76 Score=42.87 Aligned_cols=48 Identities=23% Similarity=0.294 Sum_probs=26.3
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC--CCCCCCccccccCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN--GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~--~~~~~l~~~~~~~N~l~~~~ 51 (460)
||..+++..+|+.|++++|+.-+.||.. ..+..+..+++++|.+..-|
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp 218 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence 4555555555666666555555555542 34455566666666665443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=80.22 E-value=0.19 Score=46.50 Aligned_cols=45 Identities=18% Similarity=0.243 Sum_probs=37.1
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCC-CCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANN-QLN 48 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N-~l~ 48 (460)
+|..+.++++|+.|+|++|++++.+|.. ..+..+..+.+++| .+.
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~ 156 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence 5666789999999999999999887764 56788888999888 443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 460 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 4e-67
Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRN 193
+ +G G FG VYKG+ VAVK L +LQ F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+L G+ T + +V + S+ L + IA A+G+ YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYL 312
IIHRD+K+ NI L E+ +GDFGLA + + +H + G+I +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 313 STGKS---SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369
S ++DV+ +G++L EL+TGQ + N+ D ++ +G L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSK-- 233
Query: 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ + ++ C + ERP +++ +E
Sbjct: 234 --------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-66
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
+ LG G FG+V+ G + VAVK LK+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
+RL T ++ +M NGS+ L+ L + +A A G+A++ +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
IHRD++AANIL+ + + DFGLA+L++ + + I APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
G + K+DV+ +G++L E++T R + ++ Q ++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY-----------------PGMTNPEVIQNLERGY 227
Query: 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ E+L Q+ LC + P +RP + +LE
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-65
Identities = 69/290 (23%), Positives = 130/290 (44%), Gaps = 30/290 (10%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEM 185
++ + + ++G G FG+VYKG L S VA+K LK T+ + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 186 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGA 245
+ H N++RL G +++ +M NG++ LRE+ + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGI 119
Query: 246 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 303
A G+ YL + +HRD+ A NIL++ V DFGL++++ D + T+ T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 304 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363
I APE +S K + +DV+ +G+++ E++T L
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------LSN 219
Query: 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413
++ + ++ + + Q+ + C Q RPK +++V +L+
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 3e-65
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 125 FSLRELQVATDNFSNR---------NILGRGGFGKVYKGRLT----DGSLVAVKRLKEER 171
F+ + A F+ ++G G FG+V G L VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 172 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP 231
T+ F +E ++ H N++ L G T +++ FM NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DG 123
Query: 232 PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291
+ G A G+ YL D +HRD+ A NIL++ V DFGL++ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 292 KDTHVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 346
+ T + I APE + K + +DV+ YG+++ E+++ G+R +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 406
+ + + ++ D + L Q+ L C Q RPK +
Sbjct: 236 -------------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 407 VVRMLE 412
+V L+
Sbjct: 283 IVNTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (533), Expect = 4e-65
Identities = 73/314 (23%), Positives = 128/314 (40%), Gaps = 47/314 (14%)
Query: 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQF 179
L L+ +N +G G FG+V++ R ++VAVK LKEE + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 180 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ--------- 230
Q E +++ + N+++L G C L++ +M G + LR
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 231 -----------PPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 279
PPL+ + + IA A G+AYL + K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 280 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 338
+ DFGL++ + D I + PE + + + ++DV+ YGV+L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 339 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSP 398
G+ E+ + + D ++ E +L + LC P
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLP 283
Query: 399 MERPKMSEVVRMLE 412
+RP + R+L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-64
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 25/278 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
+ +G G FG V+ G + VA+K ++E E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 62
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
++L G C+ LV+ FM +G ++ LR + + L G+AYL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE 119
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
C +IHRD+ A N L+ E V DFG+ + + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ S K+DV+ +GV++ E+ + + R ++ +V+ + + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVV---------------EDISTGF 219
Query: 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ Q+ C + P +RP S ++R L
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-63
Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 33/285 (11%)
Query: 136 NFSNRNILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVH 191
+F+ ++GRG FG VY G L D AVK L G QF TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 192 RNLLRLRGFCM-TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
N+L L G C+ + L+V P+M +G + + +R L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGM- 143
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHI 307
K +HRD+ A N +LDE+F V DFGLA+ M ++ H T + + +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
A E L T K + K+DV+ +GV+L EL+T DV D LL+ ++L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTFDITVYLLQGRRLL 254
Query: 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
Q E + L +V L C RP SE+V +
Sbjct: 255 Q----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 7e-63
Identities = 62/307 (20%), Positives = 123/307 (40%), Gaps = 37/307 (12%)
Query: 130 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 188
+++ D+F + LG G G V+K G ++A K + E Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 189 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
++ G + E + M GS+ L++ G + + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L YL + KI+HRDVK +NIL++ E + DFG++ + + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368
PE L S ++D++ G+ L+E+ G+ A + ++M V+G E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRP 230
Query: 369 LVDSDMEGNYIEEEVEQLIQVALL--------------------------CTQGSPMERP 402
+Y + + LL C +P ER
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 403 KMSEVVR 409
+ +++
Sbjct: 291 DLKQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 1e-62
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 25/291 (8%)
Query: 123 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQT 181
+ + ++ + + ++ LG G +G+VY+G VAVK LKE+ + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 182 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQI 241
E ++ H NL++L G C ++ FM G++ LRE + ++ V +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120
Query: 242 ALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 301
A + + YL IHRD+ A N L+ E V DFGL++LM +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 361
I APE L+ K S K+DV+ +GV+L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------------PGI 220
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++ +L++ D E E++ ++ C Q +P +RP +E+ + E
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-62
Identities = 66/292 (22%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 128 RELQVATDNFSNRNI-LGRGGFGKVYKGRL---TDGSLVAVKRLKEERTQGGELQFQTEV 183
++L + DN +I LG G FG V +G VA+K LK+ + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 184 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIAL 243
+++ + ++RL G C +LV G + L + + + S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 244 GAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 301
+ G+ YL + +HRD+ A N+LL A + DFGL+K + D++ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 302 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGL 360
+ APE ++ K S ++DV+ YGV + E ++ GQ+ + ++ +++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIE-- 226
Query: 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ K++E E +L + C +RP V + +
Sbjct: 227 -QGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-62
Identities = 55/279 (19%), Positives = 109/279 (39%), Gaps = 27/279 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
+ + LG G FG V G+ VA+K +KE E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 61
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
++L G C ++ +M NG + + LRE + ++ + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
+HRD+ A N L++++ V DFGL++ + + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K S K+D++ +GV++ E+ + G+ ++ + + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE------------------RFTNSETAEHIAQG 217
Query: 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ E++ + C ERP ++ +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-62
Identities = 69/278 (24%), Positives = 114/278 (41%), Gaps = 25/278 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
++ LG+G FG+V+ G + VA+K LK F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74
Query: 195 LRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
++L + +V +M GS+ +G++ L +A A G+AY+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 255 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 314
+HRD++AANIL+ E V DFGLA+L++ + + I APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 315 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
G+ + K+DV+ +G++L EL T R +++ V+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQVERGY 231
Query: 375 EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
E E L + C + P ERP + LE
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-61
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMIS- 187
+ S LG G FGKV + VAVK LK +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQS--------------QPPL 233
+ H N++ L G C L++ + G + + LR + S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 234 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
+ + A+G+A+L IHRD+ A NILL + DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 294 TH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
+ V R + +APE + + ++DV+ YG+ L EL + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
G+ + K +++ E ++ + C P++RP ++V+++E
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 413 GD 414
Sbjct: 304 KQ 305
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-61
Identities = 63/294 (21%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 140 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 199
+ +G+G FG+V++G+ G VAVK + + E+ M H N+L
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIA 64
Query: 200 FCM----TPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
T T+ LV + +GS+ L + ++AL A GLA+LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119
Query: 256 C-----DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---TTAVRGTIGHI 307
P I HRD+K+ NIL+ + + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 308 APEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--DDVMLLDWVKG 359
APE L +S ++ D++ G++ E+ + D++ D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 360 LLKEKKLEQLVDSDMEGNYIE-EEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+++ EQ + ++ + E + + ++ C + R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-61
Identities = 65/306 (21%), Positives = 116/306 (37%), Gaps = 48/306 (15%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGS------LVAVKRLKEERTQGGELQFQTEVEMISM 188
+N +LG G FGKV S VAVK LKE+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 189 AV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQP---------------- 231
H N++ L G C L++ + G + + LR + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 232 ---PLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288
L + A A+G+ +L +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 289 MDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLA 346
+ +V R + +APE L G + K+DV+ YG++L E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268
Query: 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSE 406
G+ + +L+ + + + E++ + C +RP
Sbjct: 269 ------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 407 VVRMLE 412
+ L
Sbjct: 317 LTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-60
Identities = 70/317 (22%), Positives = 138/317 (43%), Gaps = 41/317 (12%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMIS-MAV 190
++ ++++G G FG+V K R+ L A+KR+KE ++ F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRER------------GQSQPPLNWSVR 238
H N++ L G C L + +G++ LR+ + L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
A ARG+ YL + IHRD+ A NIL+ E + A + DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
R + +A E L+ + +DV+ YGV+L E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCAELYE 237
Query: 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 418
L + +LE+ ++ D +++ + C + P ERP ++++ L + E
Sbjct: 238 KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN--RMLE 285
Query: 419 RWEEWQKEEMFRQDFNH 435
+ + ++ + F +
Sbjct: 286 ERKTYVNTTLY-EKFTY 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 194
+G+G FG V G G+ VAVK +K + T F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 195 LRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++L G + L +V +M GS+ LR RG+S L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLE 120
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
+ +HRD+ A N+L+ E+ A V DFGL K + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K S K+DV+ +G++L E+ + R + L D V + K K++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ +V C RP ++ LE
Sbjct: 227 ----------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-59
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 25/281 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHR 192
+++ +G G +G+ K R +DG ++ K L E Q +EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 193 NLLRLRGFCMTPTERLL--VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
N++R + T L V + G +AS + + + + L+ ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 251 YLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
H ++HRD+K AN+ LD + +GDFGLA++++ DT A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368
PE ++ +EK+D++ G +L EL F L + +E K +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKI----REGKFRR 233
Query: 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ +E+ ++I RP + E++
Sbjct: 234 IPYR------YSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-58
Identities = 57/278 (20%), Positives = 108/278 (38%), Gaps = 26/278 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+++ LG G +G+V VAVK + +R + E+ + M H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+++ G + L + G + + + ++ G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYL 312
I HRD+K N+LLDE + DFGLA + Y + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 313 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+ +E DV+ G++L ++ G+ +D +D DW + ++
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKK--- 231
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
I+ L+ +P R + ++ +
Sbjct: 232 -------IDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-58
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 33/279 (11%)
Query: 141 NILGRGGFGKVYKGRLTD---GSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLR 196
LG G FG V KG VAVK LK E + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 197 LRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC 256
+ G C + +LV G + L++ + ++ + G+ YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAPEYLST 314
+HRD+ A N+LL + A + DFGL+K + D T + + APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 315 GKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K S K+DV+ +GV++ E + GQ+ + +K ++ +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR------------------GMKGSEVTAMLEKG 226
Query: 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
++ + LC RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 8e-58
Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 141 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLR 198
+GRG F VYKG T+ VA L++ + E Q F+ E EM+ H N++R
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 199 GFCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD 254
+ + +LV M +G++ + L+ + V + +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 255 HCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
P IIHRD+K NI + +GD GLA L AV GT +APE
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373
K E DV+ +G+ +LE+ T + + + + V +K +++
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAI-- 239
Query: 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
++ ++ C + + ER + +++
Sbjct: 240 ----------PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-57
Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 123 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEER--TQGGELQF 179
++++L ++F LG+G FG VY R ++A+K L + + G E Q
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 180 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRK 239
+ EVE+ S H N+LRL G+ T L+ + G+V L++ +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTA 109
Query: 240 QIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 299
A L+Y H ++IHRD+K N+LL E + DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 163
Query: 300 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 359
+ GT+ ++ PE + EK D++ GV+ E + G+ F+ AN +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV 219
Query: 360 LLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
++ E LI + +P +RP + EV+
Sbjct: 220 EFTFPD------------FVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 9e-56
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 35/282 (12%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV 190
FS+ +G G FG VY R + + +VA+K++ Q E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
H N ++ RG + LV + + + + PL + GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
YLH H +IHRDVKA NILL E +GDFG A +M ++ V GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 181
Query: 311 YLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
+ G+ K DV+ G+ +EL + N + + L +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSAL---------YHIA 227
Query: 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
Q ++ + E + C Q P +RP +++
Sbjct: 228 QNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-55
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 32/285 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMA 189
F +LG G FG VYKG VA+K L+E + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 190 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
+ ++ RL G C+T T +L+ M G + +RE + + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGM 124
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIA 308
YL D +++HRD+ A N+L+ + DFGLAKL+ ++ + + I +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
E + + ++DV+ YGV + EL+T G + +D + ++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------------GIPASEIS 223
Query: 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+++ + + + C RPK E++
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 9e-55
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 33/299 (11%)
Query: 129 ELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTE 182
E +VA + + LG+G FG VY+G + VA+K + E + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 183 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQ------PPLNWS 236
++ +++RL G L++ M G + S LR + P + S
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 237 VRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-TH 295
Q+A A G+AYL+ + K +HRD+ A N ++ E+F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 296 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 355
+ ++PE L G + +DV+ +GV+L E+ T ++ +L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF 247
Query: 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414
++G L +K + + L ++ +C Q +P RP E++ ++ +
Sbjct: 248 VMEGGLLDK--------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-54
Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 135 DNFSNRNILGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 188
D LGRG FG+V + VAVK LKE T +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 189 AVHR-NLLRLRGFCMTPTERL-LVYPFMVNGSVASCLRERGQSQPP------------LN 234
H N++ L G C P L ++ F G++++ LR + P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 235 WSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294
+ A+G+ +L K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 295 HV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 353
+V R + +APE + + ++DV+ +GV+L E+ + + V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 242
Query: 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ LKE + D ++ Q L C G P +RP SE+V L
Sbjct: 243 DEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-53
Identities = 76/287 (26%), Positives = 110/287 (38%), Gaps = 33/287 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 188
+ LG G FG V +G VAVK LK + E F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 189 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
HRNL+RL G +TP ++ V GS+ LR+ Q + A+ A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 123
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAVRGTIGH 306
+ YL IHRD+ A N+LL +GDFGL + + D H + +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKK 365
APE L T S +D + +GV L E+ T GQ + GL +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----------------GLNGSQI 223
Query: 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
L ++ E+ + + V + C P +RP + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-53
Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 30/282 (10%)
Query: 134 TDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
D + LG G FGKVYK + + L A K + + + E + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++L ++ F G+V + + E + PL S + + L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
HD+ KIIHRD+KA NIL + + + DFG++ + + GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 313 STGKS-----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367
S K DV+ G+ L+E+ + + + +L K +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVL--------LKIAK 229
Query: 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ + + + ++ C + + R S++++
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-52
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLT--------DGSLVAVKRLKEERTQGGELQFQTEVEMI 186
D LG G FG+V + VAVK LK + T+ +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 187 SMAV-HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERG------------QSQPPL 233
M H+N++ L G C ++ + G++ L+ R + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 234 NWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
+ A ARG+ YL K IHRD+ A N+L+ E+ + DFGLA+ + + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 294 THVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 352
+ T R + +APE L + ++DV+ +GV+L E+ T +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------- 240
Query: 353 LLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ ++L +L+ + +L + C P +RP ++V L+
Sbjct: 241 --------VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-52
Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 28/282 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAV 190
+ +G G FG V++G VA+K K + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
H ++++L G T ++ G + S L+ R + L+ + A + LA
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 122
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
YL + +HRD+ A N+L+ +GDFGL++ M+ + + + I +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
++ + + +DV+ +GV + E++ V D + + ++L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNNDVIGRIENGERLPMPP 232
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ L + C P RP+ +E+ L
Sbjct: 233 NCP----------PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 50/277 (18%), Positives = 106/277 (38%), Gaps = 27/277 (9%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
++ +G+G G VY + G VA++++ ++ E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N++ + E +V ++ GS+ + E + + L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFL 132
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H + ++IHRD+K+ NILL + + DFG + + + +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372
+ K D++ G+M +E+I G+ + N++ + L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRAL--------YLIATNGTPE 235
Query: 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ + C +R E+++
Sbjct: 236 LQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-47
Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 30/282 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVH 191
++F ILG G F V R L A+K L++ + E +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
++L + + NG L + + + + + L Y
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 310
LH IIHRD+K NILL+E+ + DFG AK++ + + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
L+ + + +D++ G ++ +L+ G F A ++ ++ +K +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKLEYDFPE----- 231
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
+ L++ +R E+
Sbjct: 232 -------KFFPKARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-47
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 21/291 (7%)
Query: 133 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 189
A + +G G +GKV+K R G VA+KR++ + +G L EV ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 190 V---HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRE--RGQSQPPLNWSVRKQIALG 244
H N++RL C +V V L +P + K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
RGL +LH H +++HRD+K NIL+ + + DFGLA++ ++ + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF----DLARLANDDDVMLL----DW 356
+ APE L + D++ G + E+ + F D+ +L DV+ L DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 357 VKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+ + ++ + ++ + E + L C +P +R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (413), Expect = 7e-47
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
D++ LG G FG V++ G+ A K + E + E++ +S+ H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
L+ L E +++Y FM G + + + ++ + +GL ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141
Query: 254 DHCDPKIIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
++ +H D+K NI+ E + DFGL +D K + T GT APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
TD++ GV+ L++G F +DD L +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNMD------- 245
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
D + I E+ + I+ P R + +
Sbjct: 246 -DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (403), Expect = 3e-46
Identities = 62/289 (21%), Positives = 111/289 (38%), Gaps = 40/289 (13%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK--------EERTQGGELQFQTEVEM 185
+N+ + ILGRG V + AVK + E Q EV++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 186 IS-MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 244
+ ++ H N+++L+ T T LV+ M G + L E+ L+ ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
+ LH I+HRD+K NILLD++ + DFG + +D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 305 GHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
++APE + ++ D++ GV++ L+ G F + +++L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIM 228
Query: 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+ + D + V+ L+ P +R E
Sbjct: 229 SGNYQFGSPEWDD-------YSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 5e-46
Identities = 61/310 (19%), Positives = 122/310 (39%), Gaps = 24/310 (7%)
Query: 128 RELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMI 186
++ + D + R++LG G F +V LVA+K + ++ +G E + E+ ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 187 SMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
H N++ L + L+ + G + + E+G ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 306
+ YLHD + LDE+ + ++ DFGL+K+ D V + GT G+
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGY 175
Query: 307 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366
+APE L+ S+ D + GV+ L+ G F +++D L + + E
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDS 230
Query: 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRM--LEGDGLAERWEEWQ 424
D I + + I+ + P +R + ++ + GD ++
Sbjct: 231 PYWDD-------ISDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
Query: 425 KEEMFRQDFN 434
E +++F
Sbjct: 281 VSEQIKKNFA 290
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 8e-46
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 27/278 (9%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
D + LG G FG V++ G + K + + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
L+ L E +L+ F+ G + + ++ + A GL ++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH 144
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
+H I+H D+K NI+ + + + V DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+ TD++ GV+ L++G F +DD+ L VK E +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAF-- 252
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ + E + I+ Q P +R + + +
Sbjct: 253 -----SSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 9e-45
Identities = 50/278 (17%), Positives = 100/278 (35%), Gaps = 28/278 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
+ + LGRG FG V++ + K +K + T ++ + E+ ++++A HRN
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRN 62
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+L L + E ++++ F+ + + LN L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH 119
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVV--GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
H I H D++ NI+ + + +FG A+ + D + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
S TD++ G ++ L++G F A + ++ + + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNA--------EYTF 222
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ I E + R SE ++
Sbjct: 223 DEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (399), Expect = 9e-45
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEER--TQGGELQFQTEVEMISMAV- 190
++FS I+GRGGFG+VY R D G + A+K L ++R + GE E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 191 --HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
++ + TP + + M G + L + G + + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L ++H+ +++RD+K ANILLDE + D GLA K H + GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 309 PEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 341
PE L G + D F G ML +L+ G F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 5e-44
Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 31/294 (10%)
Query: 129 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 187
EL+V + + +G G FG +Y G + G VA+K + Q E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYK 57
Query: 188 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAAR 247
M + +C + ++ ++ S+ + + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 248 GLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHV------TT 298
+ Y+H IHRDVK N L + + DFGLAK TH
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358
+ GT + + + S + D+ G +L+ G + + A
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-- 229
Query: 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
EKK+ ++ +G E + C ++P S + ++
Sbjct: 230 ----EKKMSTPIEVLCKG--YPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (388), Expect = 5e-44
Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 18/286 (6%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRN 193
+ + +G G +G VYK + G A+K+++ E+ +G E+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
+++L T +LV+ + G L K L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH 117
Query: 254 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 313
D +++HRD+K N+L++ E E + DFGLA+ T + +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 314 TGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDDVMLLDWVKGLLKE 363
+ K S D++ G + E++ G F + R+ + V L K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ + ++++ E I + + P +R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 1e-43
Identities = 63/289 (21%), Positives = 117/289 (40%), Gaps = 32/289 (11%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEE--RTQGGELQFQTEVEMISMAV 190
+D + ILG GG +V+ R L VAVK L+ + R L+F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 191 HRNLLRLRGFCMTPTERL----LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAA 246
H ++ + T +V ++ ++ + G P+ ++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 247 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTI 304
+ L + H + IIHRDVK ANI++ V DFG+A+ + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364
+++PE ++DV+ G +L E++TG+ F D + + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPV------SVAYQH 226
Query: 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-MSEVVRMLE 412
E + + +++ ++ +P R + +E+ L
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-42
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAV- 190
++F +LG+G FGKV+ A+K LK++ + E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 191 HRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
H L + T V ++ G + ++ + S A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 310
+LH I++RD+K NILLD++ + DFG+ K D T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
L K + D + +GV+L E++ GQ F D+ L ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRM----------- 217
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
D+ ++E+E + L+ P +R + +R
Sbjct: 218 DNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-42
Identities = 52/292 (17%), Positives = 117/292 (40%), Gaps = 20/292 (6%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 192
++N + +G G +G V + VA+K++ Q + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N++ + PT + ++V + + L + ++Q L+ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE 310
H ++HRD+K +N+LL+ + + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 311 YLSTG-KSSEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDVMLLDWVKGLLK 362
+ ++ D++ G +L E+++ + F L + + + ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 363 EKKLEQLVDSDMEGNYIEEEV-----EQLIQVALLCTQGSPMERPKMSEVVR 409
K L+ + + + + + +P +R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-41
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 24/288 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 192
+NF +G G +G VYK R G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N+++L T + LV+ F+ + + + K +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
H H ++HRD+K N+L++ E + DFGLA+ T V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFD-----------LARLANDDDVMLLDWVKGLL 361
S D++ G + E++T + F L D+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 362 KEKKLEQLVDSDMEG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
+ + D ++E+ L+ P +R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 2e-41
Identities = 38/282 (13%), Positives = 84/282 (29%), Gaps = 32/282 (11%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
+G G FG +++G L + VA+K Q + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 202 MTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKII 261
++ ++ S+ L G + A + +H+ ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 262 HRDVKAANILLDEEFEAVVG-----DFGLAKLMDYKDTHV------TTAVRGTIGHIAPE 310
+RD+K N L+ DFG+ K T + GT +++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 311 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370
+ S + D+ G + + + G + L + + + + L +L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ--GLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412
EE + + + P + +
Sbjct: 242 AG------FPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-41
Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 33/277 (11%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRG 199
+LG G GKV + A+K L++ + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 200 FCMTPTER----LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
L+V + G + S +++RG +I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130
Query: 256 CDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
I HRDVK N+L + + DFG AK ++ T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS 372
K + D++ GV++ L+ G F ++ + + +K ++ + E
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYEF---P 237
Query: 373 DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ E + + EEV+ LI+ + P +R ++E +
Sbjct: 238 NPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 6e-41
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 191
+F LG G FG+V+ R +G A+K LK+E + E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
++R+ G + ++ ++ G + S LR+ + P+ ++ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------A 116
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
L II+RD+K NILLD+ + DFG AK + + GT +IAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEV 172
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+ST ++ D + +G+++ E++ G F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-41
Identities = 64/290 (22%), Positives = 116/290 (40%), Gaps = 26/290 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 193
++++ ++G G FG VY+ +L D G LVA+K++ +++ E++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCN 74
Query: 194 LLRLRGFCMTPTE-RLLVYPFMV----NGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
++RLR F + E + VY +V +V R +++ L K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 307
LAY+H I HRD+K N+LLD + + DFG AK + + +V+ +
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRA 190
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------LARLANDDDVMLLDWV 357
+ DV+ G +L EL+ GQ F + ++ + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEV 407
E K Q+ + + I + + +P R E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-41
Identities = 75/320 (23%), Positives = 116/320 (36%), Gaps = 44/320 (13%)
Query: 141 NILGRGGFGKVYKGRLT-DGSLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLL 195
+ LG G F VYK R +VA+K++K E G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 196 RLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDH 255
L + LV+ FM + L S K L +GL YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 256 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 315
I+HRD+K N+LLDE + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 316 KS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDM 374
+ D++ G +L EL+ D D+ L + L EQ D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLP-----GDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 375 EGNYIEEEV--------------EQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 420
+Y+ + + L+ + +P R ++ ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------- 280
Query: 421 EEWQKEEMFRQDFNHTPHPN 440
++ P PN
Sbjct: 281 -KYFSNRPGPTPGCQLPRPN 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-39
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 34/285 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-----QFQTEVEMISM 188
D + LG G F V K R + G A K +K+ RT+ + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 189 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
H N++ L T+ +L+ + G L + + L + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEE----FEAVVGDFGLAKLMDYKDTHVTTAVRGTI 304
+ YLH I H D+K NI+L + + DFGLA +D+ + + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 305 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364
+APE ++ + D++ GV+ L++G F D L V + E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEF 235
Query: 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ E + + I+ P +R + + ++
Sbjct: 236 EDEYF-------SNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-38
Identities = 57/278 (20%), Positives = 112/278 (40%), Gaps = 44/278 (15%)
Query: 142 ILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGE-----LQFQTEVEMISM--AVHRN 193
+LG GGFG VY G ++D VA+K ++++R + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 194 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLH 253
++RL + P +L+ L + + L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 254 DHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
+ ++HRD+K NIL+D E + DFG L+ V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 313 STGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371
+ V+ G++L +++ G F+ +D++++ +G + ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII-----RGQVFFRQ------ 225
Query: 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
+ E + LI+ C P +RP E+
Sbjct: 226 ------RVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-37
Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 20/288 (6%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHR 192
+ +G G +G V+K + +VA+KR++ ++ +G E+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 193 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYL 252
N++RL + + LV+ F G P + S Q+ G L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG-------L 114
Query: 253 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 312
++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 313 STGKSSEKTDVFGYGVMLLELITGQRAF-----------DLARLANDDDVMLLDWVKGLL 361
S D++ G + EL R + RL + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 362 KEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409
K + N + + + + +P++R E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 132 VATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISM 188
V ++F +LG+G FGKV R G A+K L++E + TE ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 189 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARG 248
H L L+ T V + G + L +I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 249 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 308
L +++RD+K N++LD++ + DFGL K GT ++A
Sbjct: 118 ---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 309 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
PE L D +G GV++ E++ G+ F
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-36
Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 34/300 (11%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 192
+ +G+G FG+V+K R G VA+K++ E +G + E++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 193 NLLRLRGFCMTPTER--------LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALG 244
N++ L C T LV+ F + + V + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 245 AARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVR 301
L L+ KI+HRD+KAAN+L+ + + DFGLA+ + T
Sbjct: 127 ----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 302 GTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD-------LARLANDDDVML 353
T+ + PE L + D++G G ++ E+ T LA ++ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 354 LDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALL------CTQGSPMERPKMSEV 407
+ + + E+L + +++ ++ ++ P +R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 7e-36
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 19/226 (8%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL--QFQTEVEMISMAVH 191
D F LG G FG+V + G+ A+K L +++ + E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
L++L + +V ++ G + S LR G + + A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEY 156
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH +I+RD+K N+L+D++ V DFG AK + + + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEI 209
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 357
+ + ++ D + GV++ E+ G F D + + + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYEKI 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 46/222 (20%), Positives = 88/222 (39%), Gaps = 12/222 (5%)
Query: 125 FSLRELQVATDNFSNR----NILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQ 178
F +E+ +G G +G V G+ VA+K+L + +++ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 179 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVR 238
E+ ++ H N++ L F + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 239 KQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 298
+ + +GL Y+H IIHRD+K N+ ++E+ E + DFGLA+ D+ +T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 299 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
V L+ + ++ D++ G ++ E+ITG+ F
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-33
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 131 QVATDNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEER---TQGGELQFQTEV 183
+V +NF +LG G +GKV+ R G L A+K LK+ +TE
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 184 EMISMAVHR-NLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIA 242
+++ L+ L T T+ L+ ++ G + + L +R + +I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 243 LGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 302
+ L II+RD+K NILLD V+ DFGL+K +T G
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 303 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQRAFD 341
TI ++AP+ + G S + D + GV++ EL+TG F
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (299), Expect = 6e-31
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHR 192
D++ LGRG + +V++ +T+ V VK LK + + + + E++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90
Query: 193 NLLRLRGFCMTPTERL--LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLA 250
N++ L P R LV+ + N + L + + L
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143
Query: 251 YLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 309
Y H I+HRDVK N+++D E + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 310 E-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 340
E + D++ G ML +I + F
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-29
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 8/210 (3%)
Query: 134 TDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVH 191
+ + N + +G G +G V G VAVK+L + E+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N++ L + + L + + RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
+H IIHRD+K +N+ ++E+ E + DFGLA+ D +T V
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
L+ ++ D++ G ++ EL+TG+ F
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 4e-29
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 10/209 (4%)
Query: 135 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQFQTEVEMISMAVHR 192
+ N +G G G V VA+K+L + + Q + E+ ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 193 NLLRLRGFCMTP-TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
N++ L T ++V + + L + Q + + G+ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKH 134
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 311
LH IIHRD+K +NI++ + + DFGLA+ + + T T + APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEV 189
Query: 312 LSTGKSSEKTDVFGYGVMLLELITGQRAF 340
+ E D++ G ++ E++ + F
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 1e-26
Identities = 39/214 (18%), Positives = 76/214 (35%), Gaps = 19/214 (8%)
Query: 143 LGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 201
LG G F V+ + + + + VA+K ++ ++ + E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 202 MTPTERLLVYP------------FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGL 249
+LL + + + KQI+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 250 AYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHI 307
Y+H C IIH D+K N+L++ + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 308 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 341
+PE L D++ ++ ELITG F+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.6 bits (237), Expect = 1e-23
Identities = 24/162 (14%), Positives = 48/162 (29%), Gaps = 20/162 (12%)
Query: 141 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERT---------QGGELQFQTEVEMISMAVH 191
++G G V+ VK K T G+L F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 192 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAY 251
R L +L+G + + G+ + + ++ +A
Sbjct: 66 RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 252 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293
+ I+H D+ N+L+ E + DF + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.7 bits (161), Expect = 9e-13
Identities = 19/54 (35%), Positives = 29/54 (53%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPPSPP 55
G +P+ LT + L L++S N L G+IP G+ F ++ANN+ P P
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 8e-04
Identities = 11/51 (21%), Positives = 27/51 (52%), Gaps = 3/51 (5%)
Query: 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 52
P ++++ LQ L +NNK++ + + + + +S +NQ+++ P
Sbjct: 321 DISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.001
Identities = 10/53 (18%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 1 MGEIPR-SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPPP 52
+ E+P + +LD+S ++ +P+ G +L + + L P
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLKKLPT 240
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 460 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.86 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 96.54 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 95.66 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 95.59 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 95.14 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 94.94 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 94.94 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 94.63 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 93.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 93.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 93.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 93.39 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 91.3 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 90.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 90.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 90.58 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 90.56 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 90.03 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 89.69 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 89.45 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 88.58 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 87.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 85.93 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 83.98 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 83.3 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 81.82 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-56 Score=412.84 Aligned_cols=268 Identities=28% Similarity=0.382 Sum_probs=218.6
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
++++..++|+..+.||+|+||+||+|.+. +++.||||+++.... ..+++.+|++++++++||||++++++|.+.+..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34556678999999999999999999986 588999999975433 345799999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999976433 3489999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
..............|++.|+|||++.+..++.++|||||||++|||++|..|+.. +....+... .+...
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-------~~~~~~~~~-~i~~~--- 232 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYE-LLEKD--- 232 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-------TCCHHHHHH-HHHTT---
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-------cchHHHHHH-HHhcC---
Confidence 8765554444455688999999999999999999999999999999997777632 111111111 11111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCcchh
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDGLAERW 420 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 420 (460)
............+.+++.+||+.||++|||+.||++.|+........
T Consensus 233 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~ 279 (287)
T d1opja_ 233 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence 11111222345689999999999999999999999999876544433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=398.32 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=199.2
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
++|+..+.||+|+||+||+|++.+++.||||+++.... ...+|.+|++++++++||||++++|+|...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 57888899999999999999998888999999976432 3457999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987643 3489999999999999999999999 999999999999999999999999999987655444
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhC-CCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......||+.|+|||++.+..++.++|||||||++|||+|+ +.||.. ....+.+......... ..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--------~~~~~~~~~i~~~~~~---~~-- 223 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTGFRL---YK-- 223 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--------CCHHHHHHHHHHTCCC---CC--
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--------CCHHHHHHHHHhcCCC---CC--
Confidence 444445689999999999999999999999999999999995 444431 1122222222221111 11
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
+..+...+.+++.+||+.||++||||+||++.|+++
T Consensus 224 -----p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 -----PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112235688999999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-56 Score=407.92 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=209.9
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
+++..++|++.+.||+|+||.||+|.++++..||||+++.... ....|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3445678899999999999999999998888999999975432 34579999999999999999999998754 56799
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++..... .++++..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++..
T Consensus 85 v~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 9999999999998765432 2389999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
............||+.|+|||++.++.++.++|||||||++|||+||..|+.. .....+...........
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-------~~~~~~~~~~i~~~~~~--- 229 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-------GMTNPEVIQNLERGYRM--- 229 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHHHTTCCC---
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC-------CCCHHHHHHHHHhcCCC---
Confidence 65544444455689999999999999999999999999999999997665531 11122222222111111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.||++||||++|++.|+.
T Consensus 230 -------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 -------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111234568899999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=402.44 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=201.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|++.+.||+|+||+||+|+.. +|+.||||++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999985 68999999997655444455789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999996533 489999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-ceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 294 T-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 294 ~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||..... ....... .......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~~----~~~~~~~----- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSD----WKEKKTY----- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST---TSHHHHH----HHTTCTT-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh---HHHHHHH----HhcCCCC-----
Confidence 2 22345679999999999988776 6789999999999999999999963221 1111111 1111000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.||++|||++|+++
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122356788999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=402.30 Aligned_cols=261 Identities=27% Similarity=0.410 Sum_probs=202.1
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++..++|++.+.||+|+||+||+|+.. ..||||+++.... ......|.+|++++++++||||+++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999875 3599999975543 3344578999999999999999999998754 56899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++..... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 v~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 9999999999999976432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ceeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 290 DYKDT-HVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 290 ~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.... . ...+........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~----~----~~~~~~~~~~~~ 226 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----N----RDQIIFMVGRGY 226 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----C----HHHHHHHHHHTS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC----h----HHHHHHHHhcCC
Confidence 54322 23345569999999999864 357899999999999999999999995321 1 111111111111
Q ss_pred ccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 366 LEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..... . .....+...+.+++.+||+.||++|||++||++.|+.
T Consensus 227 ~~p~~-~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 227 LSPDL-S----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp CCCCG-G----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcc-h----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11000 0 1112234568999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=395.12 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=212.6
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
++|+..++||+|+||+||+|++++++.||||+++.... ...++.+|++++++++||||++++|+|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 68899999999999999999998888999999986443 3457999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++|+|..++..... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999765433 388999999999999999999999 999999999999999999999999999987665444
Q ss_pred ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 295 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+... ..+...........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~~~------- 220 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLRL------- 220 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCC-------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhCCCC-------
Confidence 44444568999999999999999999999999999999998 899995321 12222222211111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+......+.+++.+||+.||++|||+++|++.|.++
T Consensus 221 ---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11112335689999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-54 Score=405.10 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=199.4
Q ss_pred hcCCccCCeecccCCeEEEEEEECC-C---cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTD-G---SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|++.++||+|+||+||+|++.. + ..||||.+.........+.|.+|++++++++|||||+++|++...+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3567778899999999999998752 2 36899998776555556679999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998876432 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce----eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 290 DYKDTHV----TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 290 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
....... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.... ..+.+.......
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC
Confidence 5332211 122347899999999999999999999999999999998 899995321 122222221111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.. .....+...+.+++.+||+.||++|||+.||++.|++
T Consensus 251 ~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 251 RL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 1122234668899999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=391.37 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=205.9
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..+.||+|+||+||+|... +|+.||||+++..... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999975 6899999999754332 345689999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988753 389999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.......... +
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~~-~---- 236 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPE-L---- 236 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCC-C----
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCCC-C----
Confidence 2 2344569999999999999999999999999999999999999995311 111222222211110 0
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.........+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456889999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=399.39 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=195.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec--CCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--~~~~~lv 210 (460)
++|++.+.||+|+||+||+|+.. +|+.||||.+...... .....+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999975 6899999999765433 334568899999999999999999999865 3567899
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC--DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
|||+++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765434446999999999999999999999861 11499999999999999999999999999988
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+..... .......
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i-~~~~~~~ 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKI-REGKFRR 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHH-HHTCCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHHH-HcCCCCC
Confidence 654322 2334569999999999999999999999999999999999999995321 12222221 1122111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+ . ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-----~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 I-----P----YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C-----C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----C----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1 112356889999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=397.33 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=206.6
Q ss_pred hcCCccCCe-ecccCCeEEEEEEEC---CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 134 TDNFSNRNI-LGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 134 ~~~~~~~~~-lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
.++|...+. ||+|+||+||+|.+. ++..||||+++..........|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 355666664 999999999999764 3557999999876555556679999999999999999999999865 56899
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986543 2489999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 290 DYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 290 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.... . .+...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~---~~~~~~i~~~~~~ 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----G---PEVMAFIEQGKRM 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----T---HHHHHHHHTTCCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHcCCCC
Confidence 6443322 223458899999999999999999999999999999998 999995321 1 1222222111111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+..++..+.+++.+||+.||++||||.+|++.|+.
T Consensus 232 ----------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122234668899999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=388.62 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=205.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||+||+|+.. +++.||+|++.+... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999986 688999999975432 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998654 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~-~~----- 221 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRV-EF----- 221 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-CC-----
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-CC-----
Confidence 22 234569999999999999999999999999999999999999995321 11222221111 10
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+......+.+++.+||+.||++|||++|+++
T Consensus 222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011112356888999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=398.91 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=201.9
Q ss_pred hcCCccCCeecccCCeEEEEEEECCC-----cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLTDG-----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
.+.|+..++||+|+||.||+|.+.+. ..||||+++..........|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35678889999999999999987532 4799999987655555667999999999999999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+.++++.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998876543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 289 MDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 289 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+.. .....+.........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~-------~~~~~~~~~~i~~~~-- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGF-- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHHHHHHTTC--
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc-------cCCHHHHHHHHhccC--
Confidence 6533221 22334589999999999999999999999999999999997666531 111122222221111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.......+...+.+++.+||+.||++||||.||++.|++
T Consensus 231 --------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111122234668999999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=405.49 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=208.2
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECC------CcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeec
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT 203 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~ 203 (460)
++..++|++.++||+|+||+||+|+... ...||+|.+...........+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4456789999999999999999998642 2369999997665555556789999999988 89999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 012610 204 PTERLLVYPFMVNGSVASCLRERGQS-------------------QPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRD 264 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 264 (460)
.+..++||||+++|+|.++++..... ...+++..++.++.||+.||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 99999999999999999999765321 23589999999999999999999999 999999
Q ss_pred CCCCCEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCcccc
Q 012610 265 VKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDL 342 (460)
Q Consensus 265 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~ 342 (460)
|||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544333 2334558999999999999999999999999999999998 8999953
Q ss_pred ccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 012610 343 ARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLE 412 (460)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 412 (460)
.. ....+...+. .. .....+......+.+++.+||+.||++|||++||++.|.
T Consensus 270 ~~----~~~~~~~~~~----~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IP----VDANFYKLIQ----NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CC----CSHHHHHHHH----TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC----HHHHHHHHHh----cC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1111222211 11 111112223456899999999999999999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=396.54 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=203.6
Q ss_pred HHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 131 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 131 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
++..++|++.+.||+|+||.||+|++.++..||||+++.... ....|.+|+.++++++|||||++++++.+ +..++|
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 344578999999999999999999998888999999975433 34579999999999999999999999854 568999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++|+|..++..... ..++|..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++...
T Consensus 90 ~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp ECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence 999999999999876432 2389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
...........||+.|+|||++.++.++.++|||||||++|||++|..|+.. .....+.+........
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~-------~~~~~~~~~~i~~~~~----- 232 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------GMVNREVLDQVERGYR----- 232 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHHHTTCC-----
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC-------CCCHHHHHHHHHhcCC-----
Confidence 4444444445689999999999999999999999999999999997766632 1112222222211111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
......+...+.+++.+||+.||++|||+++|+++|+.
T Consensus 233 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 233 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 11122234568899999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=388.97 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=196.9
Q ss_pred CeecccCCeEEEEEEEC---CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeeccCC
Q 012610 141 NILGRGGFGKVYKGRLT---DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVN 216 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 216 (460)
++||+|+||+||+|.+. .++.||||+++..... .....+.+|++++++++||||++++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 2468999999754332 234579999999999999999999999865 467899999999
Q ss_pred CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCCce
Q 012610 217 GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 296 (460)
Q Consensus 217 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 296 (460)
|+|.++++... ++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998643 389999999999999999999999 99999999999999999999999999998765443332
Q ss_pred --eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccccccc
Q 012610 297 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSD 373 (460)
Q Consensus 297 --~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (460)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+...........
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~~------- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGERM------- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCC-------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHHHHHcCCCC-------
Confidence 223458999999999999999999999999999999998 899995321 11222211111111
Q ss_pred CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 374 MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 374 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+..++..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 230 ---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1112234668899999999999999999999998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=397.75 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=179.3
Q ss_pred HHhcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
+..++|+..+.||+|+||+||+|+.. +|+.||+|+++..........+.+|+.+++.++|||||++++++.+....++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999975 68999999998665555556789999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
|||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+ + +|+||||||+|||++.++++||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999998754 38999999999999999999997 5 8999999999999999999999999999865
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCcccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 342 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~ 342 (460)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 156 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 422 22345799999999999999999999999999999999999999953
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=388.61 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=202.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
+.|++.+.||+|+||+||+|+.. ++..||||++.... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46888999999999999999975 68899999997543 33345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+++|+|.+++..... ++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999876432 489999999999999999999999 99999999999999999999999999997543221
Q ss_pred CceeecccccccccCccccc-----CCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 294 THVTTAVRGTIGHIAPEYLS-----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||..... ... +....... ...
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~~---~~~i~~~~-~~~ 234 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRV---LLKIAKSE-PPT 234 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGH---HHHHHHSC-CCC
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HHH---HHHHHcCC-CCC
Confidence 1223456999999999984 45678999999999999999999999953211 111 11111111 100
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+ .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111223456889999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=378.67 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=194.8
Q ss_pred ccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeec----CCcceEEe
Q 012610 138 SNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMT----PTERLLVY 211 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~----~~~~~lv~ 211 (460)
+..++||+|+||+||+|... ++..||+|.+..... ......+.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999976 588999999976543 2334568999999999999999999999864 34578999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCEEec-CCCcEEEeecccccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKL 288 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~ 288 (460)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999998754 389999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... .............. ..
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~-~~ 232 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVK-PA 232 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCC-CG
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcCCC-Cc
Confidence 4432 2334579999999998865 59999999999999999999999995211 11122122111111 11
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+ ......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 112245888999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-52 Score=389.47 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=190.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.+.|++.+.||+|+||+||+|+.. +++.||||++...........+.+|+++++.++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999976 6899999999866554445568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec---CCCcEEEeeccccccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLM 289 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~ 289 (460)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 499999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~-~~-- 227 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAE-YE-- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTC-CC--
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccC-CC--
Confidence 4332 2334569999999999999999999999999999999999999995311 111112222111 00
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. ...........+.+++.+||+.||++|||+.|+++
T Consensus 228 ~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 F----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp C----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 11111223356889999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=387.66 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=203.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||+||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 689999999975432 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988764 389999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 292 KDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 292 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~-~~---- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKL-EY---- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT-CC----
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcC-CC----
Confidence 332 23344569999999999999999999999999999999999999995321 11222222111 11
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. +......+.+++.+||+.||++|||++|+++
T Consensus 228 --~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 --DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 01 1112356889999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=389.69 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=198.5
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC----CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
+..++|++.+.||+|+||.||+|++.. +..||||.++..........+.+|++++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 445789999999999999999998752 35689999876655555667999999999999999999999985 4678
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+.+|+|.+++..... ++++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998876432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhccc
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKL 366 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (460)
..............||+.|+|||.+.+..++.++|||||||++|||+| |..||..... ..+...+. .....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i~---~~~~~ 228 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIE---NGERL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHH---TTCCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHHH---cCCCC
Confidence 776544444455568999999999999999999999999999999998 8999863221 11222111 11111
Q ss_pred cccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 367 EQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.........+.+++.+||+.||++|||+.||++.|+.
T Consensus 229 ----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112234568999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-53 Score=394.01 Aligned_cols=267 Identities=26% Similarity=0.421 Sum_probs=215.6
Q ss_pred HHHHHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeee
Q 012610 127 LRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 200 (460)
Q Consensus 127 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~ 200 (460)
+.++++..++|++.+.||+|+||+||+|+.. +++.||||+++.........++.+|+++++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667789999999999999999999864 3578999999876555556679999999999999999999999
Q ss_pred eecCCcceEEeeccCCCCHHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012610 201 CMTPTERLLVYPFMVNGSVASCLRERGQ--------------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKI 260 (460)
Q Consensus 201 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 260 (460)
|......+++|||+.+|+|.+++..... ....+++..++.++.||+.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999975321 123489999999999999999999999 99
Q ss_pred EeeCCCCCCEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCC-C
Q 012610 261 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-R 338 (460)
Q Consensus 261 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~ 338 (460)
+||||||+|||++.++.+||+|||+++........ ......|++.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876433322 233456889999999999999999999999999999999986 5
Q ss_pred ccccccccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 339 AFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 339 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
||... ...+.+.... .+.... .....+..+.+++.+||+.+|++||||.||++.|+++
T Consensus 242 p~~~~--------~~~e~~~~v~-~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGM--------AHEEVIYYVR-DGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTS--------CHHHHHHHHH-TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC--------CHHHHHHHHH-cCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66421 1222222222 221111 1112235688999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-52 Score=389.70 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=200.2
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
+.|+..+.||+|+||+||+|+.. +++.||||++....... ....+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999975 68899999997654332 2346889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
|||.+|+|..++.... ++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987765432 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccC---CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ 368 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (460)
. ....||+.|||||++.+ +.++.++|||||||++|||++|+.||.... ..+.+....... ...
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~-~~~ 233 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE-SPA 233 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCC
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-CCC
Confidence 2 23469999999999864 458999999999999999999999995311 112222222111 111
Q ss_pred cccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 LVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 112356889999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=388.49 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=201.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCc----EEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 209 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~l 209 (460)
++|+..++||+|+||+||+|.+. +|+ +||+|.++........+.+.+|++++++++||||++++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999875 343 68999987665555567899999999999999999999999864 5678
Q ss_pred EeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccccc
Q 012610 210 VYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 289 (460)
Q Consensus 210 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 289 (460)
+++|+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998876533 489999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 290 DYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 290 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||+... ...+...+.. ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~---~~~~- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK---GERL- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHH---TCCC-
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc---CCCC-
Confidence 544332 2233458999999999999999999999999999999998 788885321 1112222211 1111
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
..+..+...+.+++.+||+.||++|||+.||++.|+.
T Consensus 233 ---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1112234568899999999999999999999998875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=381.21 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=198.0
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcceEE
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLV 210 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv 210 (460)
+..++|+..+.||+|+||.||+|+++ |..||||+++... ..+.+.+|++++++++||||++++|+|.+ .+..++|
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 34567888999999999999999986 7889999997543 33578999999999999999999999865 4568999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 999999999999976432 2389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhcccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQL 369 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (460)
.. .....++..|+|||++.++.++.++|||||||++|||+| |+.||... .......++. ...
T Consensus 155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i~----~~~---- 217 (262)
T d1byga_ 155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE----KGY---- 217 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHT----TTC----
T ss_pred CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH----cCC----
Confidence 32 222347889999999999999999999999999999998 68777532 1122222221 111
Q ss_pred ccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 370 VDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...........+.+++.+||+.||++||||.+|++.|+.+
T Consensus 218 -----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 -----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111222335688999999999999999999999999763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.2e-51 Score=386.33 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=205.4
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 58999999999999999999975 689999999975432 3345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC--CCcEEEeecccccccCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~ 291 (460)
|++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999986533 2489999999999999999999999 9999999999999964 57899999999987654
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||... ...+.+....... .. ..
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~-~~--~~ 245 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCD-WN--MD 245 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-CC--SC
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-CC--CC
Confidence 332 33456999999999999999999999999999999999999999532 1122222221111 00 00
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..........+.+++.+||+.||++|||+.|+++
T Consensus 246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122356889999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=376.15 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=204.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-----chhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.... .....+.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999985 6899999999754322 2245789999999999999999999999999999
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC----cEEEeec
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF----EAVVGDF 283 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df 283 (460)
++|||||++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999998754 399999999999999999999999 999999999999998877 4999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV 231 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhc
Confidence 9998765332 2234468999999999999999999999999999999999999995321 11111111111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ............+.+++.+||+.||++|||++|+++
T Consensus 232 -~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 -NYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000001112356889999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-50 Score=384.62 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=205.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|++.+.||+|+||+||+|... +|+.||||+++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999975 689999999976432 2344688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEec--CCCcEEEeecccccccCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~ 291 (460)
|++|+|.+++.... .++++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998876543 2489999999999999999999999 999999999999998 678999999999988754
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+........ ...
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~-~~~---- 246 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRC-DWE---- 246 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHC-CCC----
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCC----
Confidence 332 334568999999999999999999999999999999999999995321 11222221111 100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
............+.+++.+||+.||.+|||+.|+++
T Consensus 247 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111222356889999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=379.68 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=205.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEE
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv 210 (460)
-++|++.+.||+|+||.||+|+.. +|+.||||++++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999975 689999999975432 22345688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998765 389999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... ...
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~-~~~---- 222 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM-EEI---- 222 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCC----
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhc-CCC----
Confidence 332 23344679999999999999999999999999999999999999995321 1122222111 111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
.. +......+.+++.+||+.||++||+ ++|+++
T Consensus 223 --~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11 1112345788999999999999995 667664
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=385.13 Aligned_cols=269 Identities=27% Similarity=0.369 Sum_probs=202.4
Q ss_pred CHHHHHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeee
Q 012610 126 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLR 198 (460)
Q Consensus 126 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~ 198 (460)
...++++..++|++.+.||+|+||.||+|.+. +++.||||+++..........+.+|.+.+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556677789999999999999999999853 24689999998665555556678888887776 689999999
Q ss_pred eeeecC-CcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC
Q 012610 199 GFCMTP-TERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDV 265 (460)
Q Consensus 199 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 265 (460)
+++... ...++||||+++|+|.++++.... ....+++..++.++.||+.||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 988765 468999999999999999976432 123589999999999999999999999 9999999
Q ss_pred CCCCEEecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCC-Cccccc
Q 012610 266 KAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDLA 343 (460)
Q Consensus 266 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~p~~~~ 343 (460)
||+||||++++++||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 233456999999999999999999999999999999999975 567421
Q ss_pred cccCCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 344 RLANDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
. ... .+...+..+... .........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 241 ~----~~~----~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 K----IDE----EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp C----CSH----HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----HHH----HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111 111112211111 11112235688999999999999999999999999763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=385.48 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=213.1
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+++..++|++.++||+|+||.||+|++. +++.||||+++..........+.+|+.+++.+ +||||++++++|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3455678999999999999999999852 45789999998766655666789999999998 6999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ--------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAA 268 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 268 (460)
+.+..++||||+++|+|.++++.... ....+++..++.++.||+.||+|||++ +++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 99999999999999999999976432 223589999999999999999999999 9999999999
Q ss_pred CEEecCCCcEEEeecccccccCCCCC-ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhC-CCcccccccc
Q 012610 269 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG-QRAFDLARLA 346 (460)
Q Consensus 269 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg-~~p~~~~~~~ 346 (460)
||+++.++.+|++|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+ .+||...
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~--- 251 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--- 251 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC---
Confidence 99999999999999999997764433 333445689999999999999999999999999999999995 4445321
Q ss_pred CCCCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 347 NDDDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.....+...+. .+. ...........+.+++.+||+.||++||||.+|+++|++
T Consensus 252 -~~~~~~~~~i~----~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 252 -PVDSKFYKMIK----EGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp -CSSHHHHHHHH----HTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CHHHHHHHHHh----cCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111222221 111 111112234568999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=378.06 Aligned_cols=256 Identities=29% Similarity=0.383 Sum_probs=196.2
Q ss_pred hcCCccCCeecccCCeEEEEEEEC--CC--cEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT--DG--SLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 207 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~ 207 (460)
.++|++.+.||+|+||.||+|++. ++ ..||||+++.... ....+.|.+|++++++++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 357889999999999999999863 22 3789999876533 2234578999999999999999999999976 467
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
++||||+++|++.+++..... ++++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998876533 389999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCce--eecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 288 LMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 288 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
......... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+.+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCC
Confidence 875443322 223457889999999999999999999999999999998 89999532 1222222222221
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
. ...........+.+++.+||+.||++||||.||.+.|++
T Consensus 232 ~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 E---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 111112233568899999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=379.12 Aligned_cols=252 Identities=33% Similarity=0.466 Sum_probs=201.2
Q ss_pred CCeecccCCeEEEEEEECCC----cEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec-CCcceEEeecc
Q 012610 140 RNILGRGGFGKVYKGRLTDG----SLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPFM 214 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~-~~~~~lv~e~~ 214 (460)
.++||+|+||+||+|++.++ ..||||+++.........+|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 36899999765555555679999999999999999999999875 45789999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876433 378899999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 295 H---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 295 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. ......||..|+|||.+.+..++.++||||||+++|||+||..||.... . ..++.......... ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~---~~~~~~~i~~g~~~---~~ 255 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----N---TFDITVYLLQGRRL---LQ 255 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC---CC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----C---HHHHHHHHHcCCCC---CC
Confidence 2 2223458999999999999999999999999999999999888874211 1 11111222221111 11
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
...+...+.+++.+||+.||++||||.||++.|+++
T Consensus 256 -------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112235688999999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=382.71 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=203.1
Q ss_pred cCCccCCeecccCCeEEEEEEECC-Cc--EEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTD-GS--LVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~~~~~~~lv 210 (460)
++|++.++||+|+||+||+|++.+ +. .||||+++..........+.+|+++++++ +||||++++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999998753 43 57888886554444555799999999998 799999999999999999999
Q ss_pred eeccCCCCHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcE
Q 012610 211 YPFMVNGSVASCLRERG------------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 278 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~ 278 (460)
|||+++|+|.++++... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2334599999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCC-ccccccccCCCCccHHHHH
Q 012610 279 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-AFDLARLANDDDVMLLDWV 357 (460)
Q Consensus 279 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~-p~~~~~~~~~~~~~~~~~~ 357 (460)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||... ...+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHH
Confidence 9999999986542222 223458999999999999999999999999999999999765 56421 122222
Q ss_pred HHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 358 KGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
.......+ ..........+.+++.+||+.||++||||+||++.|+++
T Consensus 237 ~~i~~~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22221111 111222345788999999999999999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-50 Score=374.59 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=203.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||+||+|+.. +|+.||||++++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57899999999999999999975 689999999975432 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|..++..... +++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999887543 78899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+......... .
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~-~----- 218 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAE-L----- 218 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCC-C-----
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--------CHHHHHHHHHcCC-C-----
Confidence 3 23457999999999999999999999999999999999999999532 1122222222211 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
.. .......+.+++.+||..||.+|+ |++++++
T Consensus 219 -~~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01 111234588999999999999996 8888875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=382.33 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=206.9
Q ss_pred HHhcCCccCCeecccCCeEEEEEEECC--------CcEEEEEEeccccccchhHHHHHHHHHHhcc-CCCcceeeeeeee
Q 012610 132 VATDNFSNRNILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 202 (460)
Q Consensus 132 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~~~~~ 202 (460)
+..++|++.+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +||||++++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 456789999999999999999998532 2479999998766655556788898888887 7999999999999
Q ss_pred cCCcceEEeeccCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCE
Q 012610 203 TPTERLLVYPFMVNGSVASCLRERGQ------------SQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANI 270 (460)
Q Consensus 203 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 270 (460)
++...++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999976532 124589999999999999999999999 999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCCc-eeecccccccccCcccccCCCCCcccCchhhHHHHHHHHh-CCCccccccccCC
Q 012610 271 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLAND 348 (460)
Q Consensus 271 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~t-g~~p~~~~~~~~~ 348 (460)
|++.++.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---- 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----
Confidence 9999999999999999876543322 2344568899999999999999999999999999999998 688885211
Q ss_pred CCccHHHHHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 349 DDVMLLDWVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..+ +...+..+.. ...+......+.+++.+||+.||++|||+.||++.|+++
T Consensus 243 ----~~~-~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 ----VEE-LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ----HHH-HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHH-HHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 1112221111 111112235689999999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=376.09 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=214.8
Q ss_pred HHHHhcCCccCCeecccCCeEEEEEEEC------CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeec
Q 012610 130 LQVATDNFSNRNILGRGGFGKVYKGRLT------DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 203 (460)
Q Consensus 130 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~ 203 (460)
+++..++|+..+.||+|+||+||+|.+. ++..||||+++..........+.+|++++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4555688999999999999999999863 2578999999866555555578999999999999999999999999
Q ss_pred CCcceEEeeccCCCCHHHHhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCc
Q 012610 204 PTERLLVYPFMVNGSVASCLRERG------QSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 277 (460)
Q Consensus 204 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~ 277 (460)
.+..++||||+.+|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999986532 2223478999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCce-eecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCC-CccccccccCCCCccHHH
Q 012610 278 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFDLARLANDDDVMLLD 355 (460)
Q Consensus 278 ~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~-~p~~~~~~~~~~~~~~~~ 355 (460)
+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+||. .||.. ....+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQ 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 9999999998765433222 22335889999999999999999999999999999999985 56632 22333
Q ss_pred HHHHHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 012610 356 WVKGLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGDG 415 (460)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 415 (460)
............ ....+...+.+++.+||+.+|++||||++|++.|++..
T Consensus 244 ~~~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 244 VLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHhCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 333332222111 11123356999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-49 Score=366.60 Aligned_cols=258 Identities=25% Similarity=0.324 Sum_probs=201.1
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--hhHHHHHHHHHHhccCCCcceeeeeeeecCCc----
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE---- 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~---- 206 (460)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 68999999997654332 34468999999999999999999999876543
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.++||||+++++|.+++...+ ++++..++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987764 389999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC--ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 287 KLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 287 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcC
Confidence 76543322 23344569999999999999999999999999999999999999995321 122222222221
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERP-KMSEVVRMLEG 413 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~ 413 (460)
... ..... ......+.+++.+||+.||++|| |++++++.|.+
T Consensus 231 ~~~---~~~~~----~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIP---PSARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCC---GGGTS----SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC---Cchhc----cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 111 00111 11235688999999999999999 89999988865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=373.91 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=199.5
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC----cceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~lv 210 (460)
++|...+.||+|+||.||+|++. |+.||||+++.... .......|+..+..++||||++++++|...+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46777889999999999999975 78999999964321 1112334555566789999999999998654 46899
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC-----DPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
|||+.+|+|.++++.. +++|..++.++.+++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999864 3899999999999999999999731 23999999999999999999999999999
Q ss_pred ccccCCCCCc---eeecccccccccCcccccCCC------CCcccCchhhHHHHHHHHhCCCccccccccCCC------C
Q 012610 286 AKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGK------SSEKTDVFGYGVMLLELITGQRAFDLARLANDD------D 350 (460)
Q Consensus 286 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~------~ 350 (460)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 223456999999999987643 577999999999999999999887532211111 1
Q ss_pred ccHHHHHHHHhhhccccccccccCCCC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 351 VMLLDWVKGLLKEKKLEQLVDSDMEGN-YIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
....+........... .+.+... ...+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1112222222221111 1111111 1234566799999999999999999999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-49 Score=362.69 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=203.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc--------hhHHHHHHHHHHhccC-CCcceeeeeeeecC
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG--------GELQFQTEVEMISMAV-HRNLLRLRGFCMTP 204 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~ 204 (460)
++|++.+.||+|+||+||+|+.. +|+.||||++....... ....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 68999999997543221 1235788999999997 99999999999999
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
+..++||||+++|+|.++++..+ ++++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999998654 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccCcccccC------CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHH
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 358 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 358 (460)
+++...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ..+...
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~ 225 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 225 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHH
Confidence 998765432 2334569999999998853 346889999999999999999999995321 111112
Q ss_pred HHhhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 359 GLLKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... ... ............+.+++.+||+.||++|||++||++
T Consensus 226 ~i~~~-~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSG-NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHT-CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhC-CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22211 111 011112223456889999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-49 Score=374.63 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=203.5
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEe
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~ 211 (460)
++|++.+.||+|+||.||+|+.. +|+.||||++.+... ......+.+|+++++.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 689999999975432 223446889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCC
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 291 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 291 (460)
||+.+|+|..++...+ .+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998764 389999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccccccc
Q 012610 292 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVD 371 (460)
Q Consensus 292 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (460)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||... ............ ...
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~-~~~---- 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSG-KVR---- 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHC-CCC----
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHhcC-CCC----
Confidence 3 23356999999999999999999999999999999999999999531 112222222111 110
Q ss_pred ccCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 012610 372 SDMEGNYIEEEVEQLIQVALLCTQGSPMERP-----KMSEVVR 409 (460)
Q Consensus 372 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 409 (460)
. .......+.+++.+||+.||.+|+ |++++++
T Consensus 257 --~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 --F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --C----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 111235688999999999999994 8888875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=367.86 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=203.5
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
.++|++.+.||+|+||+||+|... +++.||||+++.... ....+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999999999999986 688999999976432 23458899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCC--CcEEEeecccccccC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMD 290 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~ 290 (460)
||.+|+|.+++...+ .++++..++.++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999997643 2489999999999999999999999 99999999999999854 479999999998764
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+.......... . .
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~-~--~ 222 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEY-T--F 222 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC-C--C
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-C--C
Confidence 332 2334558999999999999999999999999999999999999995321 1122222211110 0 0
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+... .......+.+++.+||..||++|||+.|+++
T Consensus 223 ~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0112345789999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=372.04 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=200.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccc--cchhHHHHHHHHHHh-ccCCCcceeeeeeeecCCcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERT--QGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~-~~~h~niv~l~~~~~~~~~~~lv 210 (460)
++|++.++||+|+||+||+|+.. +++.||||++++... ......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 689999999975431 222334566666654 68999999999999999999999
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccC
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 290 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 290 (460)
|||+++|+|.+++..... +++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987543 88999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc
Q 012610 291 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV 370 (460)
Q Consensus 291 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (460)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... ....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~-~~~~---- 220 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIR-MDNP---- 220 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCC----
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCCC----
Confidence 3332 2344569999999999999999999999999999999999999996321 111111111 1111
Q ss_pred cccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 012610 371 DSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMS-EVVR 409 (460)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~ 409 (460)
.. +......+.+++.+||+.||++|||+. ++++
T Consensus 221 --~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 111235588999999999999999996 6653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=372.34 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=196.6
Q ss_pred hcCCccCC-eecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhc-cCCCcceeeeeeeec----CCc
Q 012610 134 TDNFSNRN-ILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRLRGFCMT----PTE 206 (460)
Q Consensus 134 ~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~~~~~~----~~~ 206 (460)
.++|.+.+ +||+|+||+||+|+.. +++.||||+++.. ..+.+|++++.+ .+||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35787764 6999999999999974 6899999998642 356789988655 589999999999865 356
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeec
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDF 283 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df 283 (460)
.|+|||||+||+|.+++...+. ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 7999999999999999986432 3499999999999999999999999 9999999999999986 567999999
Q ss_pred ccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 284 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 284 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ....+.
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~----- 226 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMK----- 226 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-----HHHHHH-----
Confidence 99987654332 234569999999999999999999999999999999999999996422110 000000
Q ss_pred cccccccccc--CCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSD--MEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+.... ............+.+++.+||+.||++|||+.|+++
T Consensus 227 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 ---TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0111111 111112334567899999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=367.96 Aligned_cols=257 Identities=26% Similarity=0.280 Sum_probs=192.6
Q ss_pred CCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc----hhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeecc
Q 012610 140 RNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFM 214 (460)
Q Consensus 140 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 214 (460)
.++||+|+||+||+|+.. +|+.||||+++...... ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 68999999997543322 1235889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCCC
Q 012610 215 VNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 294 (460)
Q Consensus 215 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 294 (460)
.++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 988777665432 2488899999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccccc-
Q 012610 295 HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLVDS- 372 (460)
Q Consensus 295 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 372 (460)
. .....||+.|+|||++.+. .++.++|||||||++|||++|..||.... .......+.............+.
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhccchh
Confidence 2 2334689999999998654 57999999999999999999999995321 11111111111111111100000
Q ss_pred ---------cCCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 373 ---------DMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 373 ---------~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 112356889999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.8e-49 Score=376.17 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=196.8
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc--chhHHHHH---HHHHHhccCCCcceeeeeeeecCCcce
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ--GGELQFQT---EVEMISMAVHRNLLRLRGFCMTPTERL 208 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~---e~~~l~~~~h~niv~l~~~~~~~~~~~ 208 (460)
++|++.++||+|+||.||+|+.. +|+.||||++.+.... .....+.+ ++.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999976 6899999998653321 11223333 466777888999999999999999999
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998754 388999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcccc
Q 012610 289 MDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 367 (460)
Q Consensus 289 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (460)
..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... .............
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~---- 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTM---- 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSC----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcccC----
Confidence 65332 234569999999999875 5689999999999999999999999964221 1111111111100
Q ss_pred ccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 368 QLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
.... .......+.+++.+||+.||++||| ++|+++
T Consensus 225 ---~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0001 1112345889999999999999999 566664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=361.41 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=196.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999975 6899999999754332 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
|+.++ +..++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99764 444443322 22489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh--cccccc
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--KKLEQL 369 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 369 (460)
.. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||..... ...+.......... ......
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhcccc
Confidence 32 233346899999999877665 58899999999999999999999953211 00011111110000 000000
Q ss_pred c---cc-----cCCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 370 V---DS-----DMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 370 ~---~~-----~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
. +. ....... ......+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00 0000000 112356788999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=358.30 Aligned_cols=240 Identities=23% Similarity=0.405 Sum_probs=195.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccc-----hhHHHHHHHHHHhccC--CCcceeeeeeeecCCc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQG-----GELQFQTEVEMISMAV--HRNLLRLRGFCMTPTE 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~~~~~~~~~ 206 (460)
++|++.++||+|+||+||+|+.. +|+.||||++....... ...++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 68999999997543221 1224678999999886 8999999999999999
Q ss_pred ceEEeeccCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-CCcEEEeecc
Q 012610 207 RLLVYPFMVN-GSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFG 284 (460)
Q Consensus 207 ~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg 284 (460)
.++||||+.+ +++.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 68888887654 389999999999999999999999 9999999999999985 4799999999
Q ss_pred cccccCCCCCceeecccccccccCcccccCCCC-CcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 285 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 285 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~ 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRG 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhc
Confidence 99865432 2334569999999999987765 677999999999999999999995311 01111
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. . .... ....+.+++.+||+.||++|||++|+++
T Consensus 220 -~~--~----~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 -QV--F----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CC--C----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cc--C----CCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 0 1111 1245888999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-47 Score=355.83 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=198.8
Q ss_pred cCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccc-cchhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEeec
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPF 213 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 213 (460)
++|+..++||+|+||+||+|+.++|+.||||+++.... ......+.+|+.++++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58899999999999999999999999999999976543 22345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCCC
Q 012610 214 MVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 293 (460)
Q Consensus 214 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 293 (460)
+.++.+..+.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887776666543 2499999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccccc--
Q 012610 294 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQLV-- 370 (460)
Q Consensus 294 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 370 (460)
.. .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+.............
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-----HHHHHHHHHhhCCCChhhccch
Confidence 22 2334588999999998765 568999999999999999999999953211 01111111111000000000
Q ss_pred ------cccCC-------CCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 371 ------DSDME-------GNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 371 ------~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0011122356889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=355.53 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=194.0
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-C-CcEEEEEEeccccccc-hhHHHHHHHHHHhcc---CCCcceeeeeeeec----
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-D-GSLVAVKRLKEERTQG-GELQFQTEVEMISMA---VHRNLLRLRGFCMT---- 203 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~~~~~~---- 203 (460)
.++|++.+.||+|+||+||+|+.. + ++.||||+++...... ....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 5679999997543322 233466777776655 79999999998853
Q ss_pred -CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEee
Q 012610 204 -PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 282 (460)
Q Consensus 204 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D 282 (460)
....+++|||+.++.+........ ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 245789999998877665544322 3489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhh
Q 012610 283 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 362 (460)
Q Consensus 283 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 362 (460)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.....
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIG 232 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhhC
Confidence 9999865432 223445699999999999999999999999999999999999999953211 111111111110
Q ss_pred hcccccc----------ccccC---CCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 363 EKKLEQL----------VDSDM---EGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 363 ~~~~~~~----------~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
....... ..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000 00011122345788999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=352.19 Aligned_cols=263 Identities=20% Similarity=0.299 Sum_probs=194.9
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecCC----cce
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERL 208 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~----~~~ 208 (460)
+++|++.+.||+|+||+||+|+.. +|+.||||++...........+.+|+++++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999874 799999999976554444557889999999999999999999987543 235
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566677799999999764 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 289 MDYKDTH--VTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 289 ~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPS 233 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HHHHHHhhhccCCC
Confidence 6433221 1233558999999999854 46789999999999999999999999532110 00000000000000
Q ss_pred ccc-------------cccccCCCCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LEQ-------------LVDSDMEGNYIE----EEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~~-------------~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ...+........ .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000000000 11235789999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-46 Score=346.15 Aligned_cols=259 Identities=17% Similarity=0.185 Sum_probs=195.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeee-eeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR-GFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~-~~~~~~~~~~lv~e 212 (460)
++|++.+.||+|+||+||+|++. +|+.||||++..... ..++..|+++++.++|+|++..+ .+..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 57999999999999999999975 688999999865432 23578899999999887766554 45566778889999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC---CCcEEEeeccccccc
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAVVGDFGLAKLM 289 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~ 289 (460)
|+ ++++...+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+++..
T Consensus 84 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5667666654332 489999999999999999999999 9999999999999864 457999999999876
Q ss_pred CCCCC------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhh
Q 012610 290 DYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 363 (460)
Q Consensus 290 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 363 (460)
..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... .....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccCC-
Confidence 54322 1233456999999999999999999999999999999999999999642221110 001111111000
Q ss_pred ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 012610 364 KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEGD 414 (460)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 414 (460)
..... ... ..+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus 235 ~~~~~-----~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 TPIEV-----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp SCHHH-----HTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CChhH-----hcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000 011 1235688999999999999999999999888753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=345.62 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=193.0
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec--------C
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--------P 204 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~--------~ 204 (460)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ....++.+|+++++.++|||++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68899999999999999999975 7899999998654332 334568899999999999999999998865 3
Q ss_pred CcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecc
Q 012610 205 TERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 284 (460)
Q Consensus 205 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg 284 (460)
+..+++|||+.++.+....... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4578999999887766554332 2488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC---ceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 285 LAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 285 ~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
+++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||+... .......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHh
Confidence 9976653221 122334589999999998765 68999999999999999999999995311 11111111111
Q ss_pred hhhcc---ccccccccC---------CCCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 361 LKEKK---LEQLVDSDM---------EGNYIEE------EVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 361 ~~~~~---~~~~~~~~~---------~~~~~~~------~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..... ......... ......+ ....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11100 000000000 0001111 1234678999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=351.66 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=189.7
Q ss_pred CCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcceeeeeeeecC------Ccce
Q 012610 136 NFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP------TERL 208 (460)
Q Consensus 136 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~------~~~~ 208 (460)
+|...++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5778899999999999999986 689999999975432 234799999999999999999998543 2368
Q ss_pred EEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeeccccc
Q 012610 209 LVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK 287 (460)
Q Consensus 209 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~ 287 (460)
+||||+.++.+..+.. .......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999997664444332 222234599999999999999999999999 999999999999999775 89999999998
Q ss_pred ccCCCCCceeecccccccccCcccccC-CCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH---------
Q 012610 288 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--------- 357 (460)
Q Consensus 288 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------- 357 (460)
....... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+...+
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTRE 245 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHHCCCCHH
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHhCCChHH
Confidence 7654332 233468999999998765 46899999999999999999999999532110 0111111
Q ss_pred --HHHhhh---ccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 --KGLLKE---KKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 --~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...... ......................+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100000 0000000000000001122345888999999999999999999885
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=349.04 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=202.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC----CCcEEEEEEeccccc---cchhHHHHHHHHHHhccCC-CcceeeeeeeecCCc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERT---QGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTE 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~ 206 (460)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 478999999975432 1223467899999999977 899999999999999
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.+++|||+.+|+|.+++..... +++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999987653 67889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCC--CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
+.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||..... ...............
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~----~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcccCC
Confidence 87655444444556699999999999765 468899999999999999999999964322 122222222221111
Q ss_pred cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 012610 365 KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPK-----MSEVVR 409 (460)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 409 (460)
. .........+.+++.+||+.||++||| ++|+++
T Consensus 253 -~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -P----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -C----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -C----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 011123456889999999999999995 677753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=341.54 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=202.3
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCCcceEEee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 212 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~~~~lv~e 212 (460)
++|++.+.||+|+||+||+|+.. +++.||||+++..... ....++.+|+.+++.++||||+++++++......+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57899999999999999999975 6889999999755433 334578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccccccCCC
Q 012610 213 FMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 292 (460)
Q Consensus 213 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 292 (460)
++.+++|..++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888876543 388999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhccccc---
Q 012610 293 DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEQ--- 368 (460)
Q Consensus 293 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 368 (460)
... .....++..|+|||.+.+.. ++.++|||||||++|||++|+.||... .........+...........
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC----CCHHHHHHHHHhhcCCCChhhhhh
Confidence 332 22334778999999987665 689999999999999999999997321 111111111111111100000
Q ss_pred ---cccc---------cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 369 ---LVDS---------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 369 ---~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
..+. .............+.+++.+||+.||.+|||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000111222345788999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-45 Score=340.89 Aligned_cols=259 Identities=15% Similarity=0.199 Sum_probs=202.4
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccCC-CcceeeeeeeecCCcceEEe
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLVY 211 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~~~~~~~~~~~lv~ 211 (460)
.++|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.+..++| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468999999999999999999976 688999998865432 2257788999998875 89999999999999999999
Q ss_pred eccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecC-----CCcEEEeecccc
Q 012610 212 PFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDE-----EFEAVVGDFGLA 286 (460)
Q Consensus 212 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~ 286 (460)
||+ +++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7899999876543 489999999999999999999999 9999999999999974 578999999999
Q ss_pred cccCCCCC------ceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHH
Q 012610 287 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 360 (460)
Q Consensus 287 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 360 (460)
+....... .......||+.|||||++.+..++.++|||||||++|||+||+.||...... ........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHHHhc
Confidence 87653321 1233456999999999999999999999999999999999999999632211 010111111111
Q ss_pred hhhccccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 012610 361 LKEKKLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVRMLEG 413 (460)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 413 (460)
.......++ ... .+..+.+++..|++.+|++||+++.+.+.|++
T Consensus 232 ~~~~~~~~l-----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHHh-----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111 111 23568889999999999999999999887765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=347.36 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=190.8
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecCC------
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT------ 205 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~~------ 205 (460)
.++|+..+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++++.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 6899999999754332 23446889999999999999999999987654
Q ss_pred cceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeeccc
Q 012610 206 ERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 285 (460)
Q Consensus 206 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 285 (460)
..++||||+ +.+|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 468999999 66788877653 399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccCcccccCC-CCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhc
Q 012610 286 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 364 (460)
Q Consensus 286 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (460)
++..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... ..............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTP 238 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-----HHHHHHHHhccCCC
Confidence 9876432 2345689999999998764 568999999999999999999999953211 00000000000000
Q ss_pred ------------------cccccccccCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 365 ------------------KLEQLVDSDMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 365 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
...+...... ..........+.+++.+||..||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 0001112245778999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=343.36 Aligned_cols=255 Identities=19% Similarity=0.257 Sum_probs=193.7
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecC--CcceEE
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTP--TERLLV 210 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~--~~~~lv 210 (460)
++|++.++||+|+||+||+|+.. +++.||||+++... ..++.+|++++..++ ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 58999999999999999999975 68999999997532 346889999999985 99999999998744 568899
Q ss_pred eeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCC-cEEEeeccccccc
Q 012610 211 YPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM 289 (460)
Q Consensus 211 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~ 289 (460)
|||+.+++|..+.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999876642 389999999999999999999999 999999999999998655 6999999999876
Q ss_pred CCCCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHh-------
Q 012610 290 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL------- 361 (460)
Q Consensus 290 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 361 (460)
.... ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||.... ........+....
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~----~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH----DNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS----SHHHHHHHHHHHHCHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc----hhHHHHHHHHHHHCCchhhh
Confidence 5332 233455899999999987654 7999999999999999999999995321 1111100000000
Q ss_pred --hhc------cccccccc--------cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 362 --KEK------KLEQLVDS--------DMEGNYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 362 --~~~------~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
... ........ .............+.+++.+||..||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000 0001111222356789999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=339.91 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=187.6
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeec------CCc
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT------PTE 206 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~------~~~ 206 (460)
++|++.++||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999986 6899999999765432 234468899999999999999999999864 357
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.|+||||+.++.+ +.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHH-Hhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 7999999976544 44432 289999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHH---------
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--------- 357 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------- 357 (460)
+...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-----~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-----IDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCH
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-----HHHHHHHHHhccCCCH
Confidence 8654322 23344589999999999999999999999999999999999999953210 0000000
Q ss_pred ----------HHHhhhcc-c-----cccccccC-CC--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 358 ----------KGLLKEKK-L-----EQLVDSDM-EG--NYIEEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 358 ----------~~~~~~~~-~-----~~~~~~~~-~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
........ . ........ .. .........+.+++.+||..||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0 00000000 11 112334567889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=337.54 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=192.3
Q ss_pred hcCCccCCeecccCCeEEEEEEEC-CCcEEEEEEecccccc-chhHHHHHHHHHHhccCCCcceeeeeeeecC-----Cc
Q 012610 134 TDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 206 (460)
Q Consensus 134 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~~~~~~~-----~~ 206 (460)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+++++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999975 6899999999765432 2344688999999999999999999988643 34
Q ss_pred ceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEEeecccc
Q 012610 207 RLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 286 (460)
Q Consensus 207 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 286 (460)
.+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 46778888899999998643 399999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccCcccccCCC-CCcccCchhhHHHHHHHHhCCCccccccccCCCCccHHHHHHHHhhhcc
Q 012610 287 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 365 (460)
Q Consensus 287 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (460)
..... ......|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.... .......+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRLVGTPG 239 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCC
Confidence 75432 223345889999999877654 6889999999999999999999995321 1111111111000000
Q ss_pred cc-----------cccc--ccCCCCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 012610 366 LE-----------QLVD--SDMEGNYI----EEEVEQLIQVALLCTQGSPMERPKMSEVVR 409 (460)
Q Consensus 366 ~~-----------~~~~--~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 409 (460)
.. .... ........ ......+.+++.+||..||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 0000 00000000 012345788999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-39 Score=309.58 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=186.1
Q ss_pred cCCccCCeecccCCeEEEEEEEC-CCcEEEEEEeccccccchhHHHHHHHHHHhccC-----------CCcceeeeeeee
Q 012610 135 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-----------HRNLLRLRGFCM 202 (460)
Q Consensus 135 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~~~~~ 202 (460)
.+|++.++||+|+||+||+|+.. +|+.||||+++.... ....+.+|+++++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35899999999999999999975 689999999975432 2335677888877665 578999998875
Q ss_pred c--CCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCc--
Q 012610 203 T--PTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFE-- 277 (460)
Q Consensus 203 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~-- 277 (460)
. ....+++++++..+.......... ....+++..++.++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 345566666665544333332222 22348899999999999999999998 6 8999999999999987654
Q ss_pred ----EEEeecccccccCCCCCceeecccccccccCcccccCCCCCcccCchhhHHHHHHHHhCCCccccccccCCCC--c
Q 012610 278 ----AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD--V 351 (460)
Q Consensus 278 ----~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G~il~el~tg~~p~~~~~~~~~~~--~ 351 (460)
++++|||.+...... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||.......... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 899999999865432 233568999999999999999999999999999999999999996432111110 0
Q ss_pred cHHHHHHHHhh--------hccccccccc-----c--------------CCCCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 012610 352 MLLDWVKGLLK--------EKKLEQLVDS-----D--------------MEGNYIEEEVEQLIQVALLCTQGSPMERPKM 404 (460)
Q Consensus 352 ~~~~~~~~~~~--------~~~~~~~~~~-----~--------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 404 (460)
.+...+..... ........+. . ............+.+++.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 01111110000 0000000000 0 0112235567789999999999999999999
Q ss_pred HHHHH
Q 012610 405 SEVVR 409 (460)
Q Consensus 405 ~evl~ 409 (460)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.2e-24 Score=186.51 Aligned_cols=164 Identities=12% Similarity=0.052 Sum_probs=119.6
Q ss_pred ccCCeecccCCeEEEEEEECCCcEEEEEEecccccc-----------------chhHHHHHHHHHHhccCCCcceeeeee
Q 012610 138 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQ-----------------GGELQFQTEVEMISMAVHRNLLRLRGF 200 (460)
Q Consensus 138 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~h~niv~l~~~ 200 (460)
.++++||+|+||+||+|+..+|+.||||+++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999988999999987632110 001234567888899999999888765
Q ss_pred eecCCcceEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCEEecCCCcEEE
Q 012610 201 CMTPTERLLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 280 (460)
Q Consensus 201 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl 280 (460)
. ..+++|||+.+..+.+ ++......++.|++.+|+|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 3479999998865432 33444568999999999999999 99999999999999976 4899
Q ss_pred eecccccccCCCCCceeecccccccccCcc-----cccCCCCCcccCchhhHHH
Q 012610 281 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPE-----YLSTGKSSEKTDVFGYGVM 329 (460)
Q Consensus 281 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~Dvws~G~i 329 (460)
+|||+|......... .|.... .+..+.|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999999765433211 111100 0124567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=2.5e-07 Score=82.00 Aligned_cols=149 Identities=13% Similarity=0.041 Sum_probs=95.5
Q ss_pred HHHHHhcCCccCCeecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccC-CCcceeeeeeeecCCcc
Q 012610 129 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER 207 (460)
Q Consensus 129 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~~~~~~~~~~ 207 (460)
++...-+.|+..+..+.++.+.||+... ++..+++|+....... ....+.+|...+..+. +--+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3444445666555444445578999865 4566788887644322 2234677888776653 33356677777778888
Q ss_pred eEEeeccCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 012610 208 LLVYPFMVNGSVASCLRERGQSQPPLNWSVRKQIALGAARGLAYLHDHC------------------------------- 256 (460)
Q Consensus 208 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 256 (460)
++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999988765542210 11223444445555555321
Q ss_pred -------------------------CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 257 -------------------------DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 257 -------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=5.1e-06 Score=72.84 Aligned_cols=141 Identities=16% Similarity=0.085 Sum_probs=82.6
Q ss_pred ecccCC-eEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCC--CcceeeeeeeecCCcceEEeeccCCCCH
Q 012610 143 LGRGGF-GKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLLVYPFMVNGSV 219 (460)
Q Consensus 143 lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 219 (460)
+..|.. +.||+....++..+++|.-..... ..+..|...++.+.. -.+.+++.++.+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 679999888788888998654322 246677777766542 2356677777777888999999987654
Q ss_pred HHH--------------hhhcCC---CCCCC--CHHHHHHHHH--------------------HHHHHHHHHHhCC----
Q 012610 220 ASC--------------LRERGQ---SQPPL--NWSVRKQIAL--------------------GAARGLAYLHDHC---- 256 (460)
Q Consensus 220 ~~~--------------l~~~~~---~~~~l--~~~~~~~i~~--------------------~i~~~l~~LH~~~---- 256 (460)
.+. +..... ...++ .......-.. .....+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 321 111000 00000 0100000000 0112233333221
Q ss_pred CCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 257 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
.+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2248999999999999988667899998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.86 E-value=6.3e-05 Score=70.18 Aligned_cols=76 Identities=11% Similarity=-0.027 Sum_probs=46.9
Q ss_pred CeecccCCeEEEEEEECC-CcEEEEEEecccc------ccchhHHHHHHHHHHhccC-C--CcceeeeeeeecCCcceEE
Q 012610 141 NILGRGGFGKVYKGRLTD-GSLVAVKRLKEER------TQGGELQFQTEVEMISMAV-H--RNLLRLRGFCMTPTERLLV 210 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~~~-h--~niv~l~~~~~~~~~~~lv 210 (460)
+.||.|....||++...+ ++.++||.-.... ......+...|.+.+..+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 6788999754321 1112223456777776552 2 234445543 45567899
Q ss_pred eeccCCCC
Q 012610 211 YPFMVNGS 218 (460)
Q Consensus 211 ~e~~~~g~ 218 (460)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.14 E-value=2.5e-05 Score=70.57 Aligned_cols=50 Identities=26% Similarity=0.470 Sum_probs=44.7
Q ss_pred CCCCCCCCCCCCCEEECcC-CcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSN-NKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~-N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.||.+|++|+.|++|||++ |+|+|.||.. +.+.++..+++++|.+.+.++
T Consensus 67 ~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~ 118 (313)
T d1ogqa_ 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118 (313)
T ss_dssp ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC
T ss_pred CCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccc
Confidence 6999999999999999996 9999999975 778899999999999887554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.98 E-value=0.0016 Score=58.63 Aligned_cols=139 Identities=15% Similarity=0.118 Sum_probs=76.5
Q ss_pred cCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-----eeee--eeeecCCcceEEeeccCCCC
Q 012610 146 GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-----LRLR--GFCMTPTERLLVYPFMVNGS 218 (460)
Q Consensus 146 G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-----v~l~--~~~~~~~~~~lv~e~~~~g~ 218 (460)
+.-..||++...+|..+++|+.+.... ...++..|...+..+....+ +..- .........+.+++++.|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 334789999999999999999876533 23457778877766542221 1111 12233455678889887633
Q ss_pred HH-----HH---------hhhc----C-CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCC
Q 012610 219 VA-----SC---------LRER----G-QSQPPLNWS----------------------VRKQIALGAARGLAYL-HDHC 256 (460)
Q Consensus 219 L~-----~~---------l~~~----~-~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~ 256 (460)
+. .+ ++.. . ......++. .....+..+...+.-+ .+..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 21 11 1110 0 000111111 1112222232222221 1223
Q ss_pred CCCeEeeCCCCCCEEecCCCcEEEeecccccc
Q 012610 257 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 288 (460)
Q Consensus 257 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 288 (460)
..+++|+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4479999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.97 E-value=0.0046 Score=55.15 Aligned_cols=159 Identities=11% Similarity=0.060 Sum_probs=79.8
Q ss_pred cCHHHHHHHhcCCccCCe-----ecccCCeEEEEEEECCCcEEEEEEeccccccchhHHHHHHHHHHhccCC-----Ccc
Q 012610 125 FSLRELQVATDNFSNRNI-----LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH-----RNL 194 (460)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-----~ni 194 (460)
++.++++....+|.+++. |..|--.+.|+.+..+|+ +++|+....... ..+..|++++..+.. |..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence 456777777778877654 345666889999877654 889988653222 234455666555532 222
Q ss_pred eeee-e--eeecCCcceEEeeccCCCCHH--------------HHhhhcCCC---C--CCCCHH----------------
Q 012610 195 LRLR-G--FCMTPTERLLVYPFMVNGSVA--------------SCLRERGQS---Q--PPLNWS---------------- 236 (460)
Q Consensus 195 v~l~-~--~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~~~~---~--~~l~~~---------------- 236 (460)
+... | +.........++.+..+.... ..++..... . ......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 0 111123344555555443221 011110000 0 000000
Q ss_pred --HHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCEEecCCCcEEEeeccccc
Q 012610 237 --VRKQIALGAARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 287 (460)
Q Consensus 237 --~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 287 (460)
.....+..+...+.-.+. ....+++|+|+.++||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222221 123479999999999999998777899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.61 E-value=0.003 Score=58.49 Aligned_cols=72 Identities=14% Similarity=0.181 Sum_probs=47.3
Q ss_pred CeecccCCeEEEEEEECC--------CcEEEEEEeccccccchhHHHHHHHHHHhccCCCcc-eeeeeeeecCCcceEEe
Q 012610 141 NILGRGGFGKVYKGRLTD--------GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLVY 211 (460)
Q Consensus 141 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~~~~~~~~~~~lv~ 211 (460)
+.|+.|-...+|++...+ ...|.+++.-.. .......+|..+++.+.-.++ .++++++. -.+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 568889999999998754 245667665421 122345678888877753344 46666653 26899
Q ss_pred eccCCCCH
Q 012610 212 PFMVNGSV 219 (460)
Q Consensus 212 e~~~~g~L 219 (460)
+|++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.54 E-value=0.00077 Score=51.27 Aligned_cols=43 Identities=26% Similarity=0.403 Sum_probs=33.2
Q ss_pred CCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~ 50 (460)
.+++++.|+.||||+|.++. +|. ...+..+..+.+++|.+...
T Consensus 15 ~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l 58 (124)
T d1dcea3 15 HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58 (124)
T ss_dssp CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC
T ss_pred ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc
Confidence 47888888888888888875 554 36677788888888887764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.66 E-value=0.0054 Score=53.15 Aligned_cols=46 Identities=26% Similarity=0.267 Sum_probs=37.3
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
..+..++.|+.|++++|+|++..|.. ..+..+..+++++|.+..-|
T Consensus 142 ~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ccccccccchhcccccccccccCccccccccccceeecccCCCcccC
Confidence 44577899999999999999877654 66788889999999987543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=95.59 E-value=0.0065 Score=49.74 Aligned_cols=43 Identities=23% Similarity=0.352 Sum_probs=22.3
Q ss_pred CCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
++++++|+.|+|++|++++.++.. ..+..+..+.+++|.+...
T Consensus 50 f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l 93 (192)
T d1w8aa_ 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEE
T ss_pred cCCCceEeeeeccccccccccccccccccccceeeecccccccc
Confidence 345555555555555555554433 3344455555555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.14 E-value=0.009 Score=47.05 Aligned_cols=45 Identities=16% Similarity=0.184 Sum_probs=29.1
Q ss_pred CCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~ 51 (460)
.|.+|++|+.|+|++|+|+.--|.. ..+.++..+++++|.+...+
T Consensus 51 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~ 96 (156)
T d2ifga3 51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLS 96 (156)
T ss_dssp GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCC
T ss_pred hhccccccCcceeeccccCCcccccccccccccceeccCCCCcccC
Confidence 4666777777777777777654542 45566667777777766443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.94 E-value=0.0085 Score=47.54 Aligned_cols=45 Identities=13% Similarity=0.245 Sum_probs=23.5
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
||.-..+++.|+.||||+|+++. ++....+..+..+.+++|.+..
T Consensus 33 i~~~~~~l~~L~~L~Ls~N~i~~-l~~~~~l~~L~~L~ls~N~i~~ 77 (162)
T d1a9na_ 33 IENLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNRICR 77 (162)
T ss_dssp CCCGGGGTTCCSEEECCSSCCCE-ECCCCCCSSCCEEECCSSCCCE
T ss_pred cCccccccccCCEEECCCCCCCc-cCCcccCcchhhhhcccccccC
Confidence 44333445556666666665553 3444445555555566655544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=94.94 E-value=0.011 Score=48.21 Aligned_cols=52 Identities=19% Similarity=0.283 Sum_probs=43.8
Q ss_pred CCCCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 2 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 2 G~iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
+.++..+..+++|++|+||+|++++-.|.. ..+..+..+.+++|.+.+.++.
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~ 120 (192)
T d1w8aa_ 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120 (192)
T ss_dssp CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHH
Confidence 346778899999999999999999877753 6788899999999999886654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.63 E-value=0.0082 Score=45.22 Aligned_cols=48 Identities=23% Similarity=0.436 Sum_probs=39.9
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
.||..++.+++|++|+|++|++++ +|....+..+..+++++|.+...+
T Consensus 34 ~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i~~~~ 81 (124)
T d1dcea3 34 ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSA 81 (124)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSS
T ss_pred cchhhhhhhhcccccccccccccc-cCccccccccCeEECCCCccCCCC
Confidence 578889999999999999999986 466677888888999999887543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.91 E-value=0.026 Score=44.29 Aligned_cols=45 Identities=20% Similarity=0.122 Sum_probs=34.2
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
|..+..+++|++|||++|+|+.--+.......+..+.+++|++.+
T Consensus 73 ~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred cccccccccccceeccCCCCcccChhhhccccccccccCCCcccC
Confidence 455789999999999999999543333334467788999998854
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.91 E-value=0.0087 Score=52.30 Aligned_cols=49 Identities=20% Similarity=0.293 Sum_probs=41.0
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPP 52 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p 52 (460)
.|..+.++++|+.|+|++|++++..|.. ..+.++..+++++|.+.+.++
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccc
Confidence 3567789999999999999999988865 666788899999999887654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.77 E-value=0.019 Score=49.49 Aligned_cols=45 Identities=20% Similarity=0.286 Sum_probs=29.9
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~ 49 (460)
.||+.|. +.|++|||++|++++..+. +..+..+..+.+++|.+..
T Consensus 24 ~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~ 69 (266)
T d1p9ag_ 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69 (266)
T ss_dssp SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE
T ss_pred eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc
Confidence 4676554 4677778888877765443 2556677777777777664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=93.39 E-value=0.016 Score=48.67 Aligned_cols=43 Identities=26% Similarity=0.438 Sum_probs=30.7
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.++++++|+.|||++|++++ +|....+.++..+.+++|++++-
T Consensus 168 ~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 168 PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCCC
Confidence 36778888888888888876 44455667777777888877654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=91.30 E-value=0.058 Score=44.42 Aligned_cols=42 Identities=17% Similarity=0.192 Sum_probs=31.9
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
.|..+++|++|+|++|++++. |....+..+..+.+++|.+.+
T Consensus 63 ~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 63 GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC
T ss_pred hHhhCCCCCEEeCCCccccCc-cccccCccccccccccccccc
Confidence 367788888888888888874 444667778888888887765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.96 E-value=0.06 Score=42.33 Aligned_cols=44 Identities=18% Similarity=0.173 Sum_probs=36.1
Q ss_pred CCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
.+..|++|++|+|++|+++.-.+.. ..+..+..+.+++|.+...
T Consensus 58 ~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~ 102 (162)
T d1a9na_ 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 102 (162)
T ss_dssp CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCG
T ss_pred CcccCcchhhhhcccccccCCCccccccccccccceecccccccc
Confidence 4889999999999999999865543 4577888999999988653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.95 E-value=0.1 Score=45.12 Aligned_cols=51 Identities=14% Similarity=0.292 Sum_probs=41.1
Q ss_pred CCC-CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCCCCCC
Q 012610 3 EIP-RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNNPPPS 53 (460)
Q Consensus 3 ~iP-~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~~~p~ 53 (460)
.|| ..+.++++|+.|+|++|+|++-.|.. ..+..+..+.+++|.+.+..|.
T Consensus 143 ~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~ 195 (284)
T d1ozna_ 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (284)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChh
Confidence 454 56789999999999999999876654 5677888899999998876554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=90.58 E-value=0.18 Score=43.75 Aligned_cols=43 Identities=30% Similarity=0.461 Sum_probs=21.4
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCC-CCCCCCccccccCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTN-GSFSLFTPISFANNQLNN 49 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~-~~~~~l~~~~~~~N~l~~ 49 (460)
..+.++++|++|+|++|+|+. ||.. ..+..+..+++++|++..
T Consensus 213 ~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 213 GSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp TTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccccccccceeeecccccccc-cccccccccCCCEEECCCCccCc
Confidence 344455555555555555552 3332 334455555555555443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=90.56 E-value=0.0066 Score=50.03 Aligned_cols=44 Identities=18% Similarity=0.321 Sum_probs=36.4
Q ss_pred CCCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 5 PRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 5 P~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
|.+|++|++|+.|+|++|+++ .|+....+.++..+++++|.+..
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N~i~~ 84 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK 84 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCCCHHHHTTCCEEECCEEEECS
T ss_pred hhHHhcccccceeECcccCCC-CcccccCCccccChhhccccccc
Confidence 356888999999999999998 46655667889999999998754
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=90.03 E-value=0.085 Score=42.90 Aligned_cols=41 Identities=29% Similarity=0.449 Sum_probs=24.4
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
+..+++|++|+|++|++++..| ...+..+..+.+++|....
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred cccCCCcCcCccccccccCccc-ccCCccccccccccccccc
Confidence 5556666677777766666433 4455556666666665443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=89.69 E-value=0.084 Score=47.55 Aligned_cols=45 Identities=24% Similarity=0.341 Sum_probs=36.8
Q ss_pred CCCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCCC
Q 012610 6 RSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 6 ~~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~~ 51 (460)
+.|..|++|++|||++|++++. |....+..+..+++++|.+.+.+
T Consensus 60 ~gl~~L~nL~~L~Ls~N~l~~l-~~l~~L~~L~~L~L~~n~i~~i~ 104 (384)
T d2omza2 60 DGVEYLNNLTQINFSNNQLTDI-TPLKNLTKLVDILMNNNQIADIT 104 (384)
T ss_dssp TTGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCCG
T ss_pred cccccCCCCCEEeCcCCcCCCC-ccccCCccccccccccccccccc
Confidence 3577899999999999999985 44677888899999999887643
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=89.45 E-value=0.061 Score=48.54 Aligned_cols=41 Identities=27% Similarity=0.447 Sum_probs=19.4
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
+..+..|+.|+|++|++++..| ...+..+..+.+++|.+++
T Consensus 303 ~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 303 ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred cchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCC
Confidence 3444555555555555554322 2334444555555554443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=88.58 E-value=0.34 Score=41.92 Aligned_cols=45 Identities=24% Similarity=0.366 Sum_probs=22.7
Q ss_pred CCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCC
Q 012610 4 IPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 4 iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~ 50 (460)
||..|. +.|++|||++|+++.-.+. +..+..+..+.+++|.+..-
T Consensus 25 lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred cCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc
Confidence 555443 4556666666665554332 23444555555555555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=87.77 E-value=0.13 Score=42.06 Aligned_cols=40 Identities=28% Similarity=0.405 Sum_probs=17.7
Q ss_pred CCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCC
Q 012610 8 LTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLN 48 (460)
Q Consensus 8 l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~ 48 (460)
+.+++.|+.+++++|.+++.. ....+..+..+.+++|.+.
T Consensus 130 l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 130 LVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCC
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccc
Confidence 444455555555555544421 1223344444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=85.93 E-value=0.25 Score=39.94 Aligned_cols=43 Identities=26% Similarity=0.495 Sum_probs=31.8
Q ss_pred CCCCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCCC
Q 012610 7 SLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 7 ~l~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~~ 50 (460)
.+.++++|+.|++++|++.. +|....+..+..+.+.+|.+.+.
T Consensus 123 ~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 123 PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCC
T ss_pred ccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccCC
Confidence 46778888888888888875 45455667777788888877664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.98 E-value=0.11 Score=40.58 Aligned_cols=41 Identities=24% Similarity=0.280 Sum_probs=31.3
Q ss_pred CCCCCCEEECcCCcceecC--CCC-CCCCCCccccccCCCCCCC
Q 012610 10 NVNSLQVLDLSNNKLTGDI--PTN-GSFSLFTPISFANNQLNNP 50 (460)
Q Consensus 10 ~l~~L~~l~ls~N~l~G~i--P~~-~~~~~l~~~~~~~N~l~~~ 50 (460)
+++.|++||||+|+++.-- +.. ..+.++..+++++|.+...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l 106 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 106 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCG
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccc
Confidence 5889999999999998732 221 3467788899999988754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.30 E-value=0.41 Score=39.72 Aligned_cols=47 Identities=21% Similarity=0.170 Sum_probs=35.6
Q ss_pred CCCCCCCCCCCCCEEECcCCcceecCCC-CCCCCCCccccccCCCCCCCC
Q 012610 3 EIPRSLTNVNSLQVLDLSNNKLTGDIPT-NGSFSLFTPISFANNQLNNPP 51 (460)
Q Consensus 3 ~iP~~l~~l~~L~~l~ls~N~l~G~iP~-~~~~~~l~~~~~~~N~l~~~~ 51 (460)
.||..+. +.|++|||++|+++.--+. +..+.++..+.+++|......
T Consensus 22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i 69 (242)
T d1xwdc1 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69 (242)
T ss_dssp SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEE
T ss_pred CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhcccccccee
Confidence 5777664 5799999999999864332 356788899999999876643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=81.82 E-value=0.7 Score=40.35 Aligned_cols=38 Identities=29% Similarity=0.335 Sum_probs=28.1
Q ss_pred CCCCCCCEEECcCCcceecCCCCCCCCCCccccccCCCCCC
Q 012610 9 TNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFANNQLNN 49 (460)
Q Consensus 9 ~~l~~L~~l~ls~N~l~G~iP~~~~~~~l~~~~~~~N~l~~ 49 (460)
..+++|++|+|++|+|+ .+|. .+.++..+.+++|.+..
T Consensus 281 ~~~~~L~~L~Ls~N~l~-~lp~--~~~~L~~L~L~~N~L~~ 318 (353)
T d1jl5a_ 281 DLPPSLEELNVSNNKLI-ELPA--LPPRLERLIASFNHLAE 318 (353)
T ss_dssp CCCTTCCEEECCSSCCS-CCCC--CCTTCCEEECCSSCCSC
T ss_pred ccCCCCCEEECCCCccC-cccc--ccCCCCEEECCCCcCCc
Confidence 34678889999998888 5674 35667777888887764
|